Citrus Sinensis ID: 042831
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LXA5 | 651 | L-type lectin-domain cont | yes | no | 0.944 | 0.935 | 0.479 | 1e-161 | |
| Q9LSL5 | 675 | L-type lectin-domain cont | no | no | 0.920 | 0.88 | 0.462 | 1e-144 | |
| Q9FHG4 | 681 | Probable L-type lectin-do | no | no | 0.950 | 0.900 | 0.378 | 1e-114 | |
| Q9M2S4 | 684 | L-type lectin-domain cont | no | no | 0.852 | 0.804 | 0.386 | 1e-103 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.927 | 0.883 | 0.361 | 1e-103 | |
| Q9LYX1 | 711 | L-type lectin-domain cont | no | no | 0.858 | 0.779 | 0.374 | 1e-101 | |
| O04534 | 666 | Putative L-type lectin-do | no | no | 0.866 | 0.839 | 0.375 | 1e-101 | |
| O81292 | 674 | L-type lectin-domain cont | no | no | 0.913 | 0.873 | 0.356 | 3e-98 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.866 | 0.835 | 0.376 | 7e-98 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.852 | 0.814 | 0.369 | 2e-97 |
| >sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 567 bits (1461), Expect = e-161, Method: Compositional matrix adjust.
Identities = 311/648 (47%), Positives = 418/648 (64%), Gaps = 39/648 (6%)
Query: 9 SNSPLLLSFFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPAN 68
+NS LL SF + ++P ++ FN + F + I Y+ +N ++L
Sbjct: 2 ANSILLFSF--------VLVLPFVCSVQFNISRFGSDVSE-IAYQ-GDARANGAVELTNI 51
Query: 69 RET--AGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSY--YADGLAFFLAPQGSK 124
T AG ATY + + LW+ T +DF+T FSF ID+RN Y Y G AFFLAP +
Sbjct: 52 DYTCRAGWATYGKQVPLWNPGTSKPSDFSTRFSFRIDTRNVGYGNYGHGFAFFLAPARIQ 111
Query: 125 IPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVN-SWDP--TFSHVGIDINSVKSKKNV 181
+P N GG GL +S+ P V VEFD + N WDP SHVGI+ NS+ S
Sbjct: 112 LPPNSAGGFLGLFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNYT 171
Query: 182 SWWSDVKSGRRNEAWISYNSSTHNLSVAFT-GFRNNLVVMQGLDYQVDLRQHLPEFVTFG 240
SW + + I Y+S+ NLSV++T ++ + L Y +DL + LP VT G
Sbjct: 172 SWNATSHNQDIGRVLIFYDSARRNLSVSWTYDLTSDPLENSSLSYIIDLSKVLPSEVTIG 231
Query: 241 FSMATGVDFAIFSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTALVVGLSLGGGVLVGG 300
FS +G + SWEF+SSLE+ D K+ + ++ +++G+S+ G VL+
Sbjct: 232 FSATSGGVTEGNRLLSWEFSSSLELID--------IKKSQNDKKGMIIGISVSGFVLLTF 283
Query: 301 VV--LIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQ 358
+ LI++L RK+++ E+ + + I+++ ERGAGP++F YK+LA A N+F DD+
Sbjct: 284 FITSLIVFLK---RKQQKKKAEETENLTS-INEDLERGAGPRKFTYKDLASAANNFADDR 339
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
KLG+GGFG VY+G+ + +A+K+ + GSKQG +E+ +EVKIIS LRHRNLVQL+GWC
Sbjct: 340 KLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWC 399
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
HEK E L++YEFMPNGSLD+HLF + L W R KI LAS LLYL EEWEQCVVHRD
Sbjct: 400 HEKDEFLMIYEFMPNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRD 459
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
IK+SN+MLDSNFNAK+GDFGLARL++H G QTT LAGT GYMAPE +TG+ASKESDVY
Sbjct: 460 IKASNVMLDSNFNAKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVY 519
Query: 539 SFGIVALEIACGRKPINPKAPQGQV----SLLQWVWDLYGNGKLLEAVDPRL-CRDFDGQ 593
SFG+V LEI GRK ++ + QG+V +L++ +WDLYG G+++ A+D +L FD +
Sbjct: 520 SFGVVTLEIVTGRKSVDRR--QGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEK 577
Query: 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTY 641
Q E LMIVGLWCAHPD N RPSI+Q I VLN EAP+P LP KMPV TY
Sbjct: 578 QAECLMIVGLWCAHPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LSL5|LRK92_ARATH L-type lectin-domain containing receptor kinase IX.2 OS=Arabidopsis thaliana GN=LECRK92 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 292/632 (46%), Positives = 386/632 (61%), Gaps = 38/632 (6%)
Query: 31 LASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPANRETA--GRATYNQSMRLWDKA 87
+ +L FN+TSF +I Y A PD + + +T+ G TY++ + +W
Sbjct: 32 VVDSLYFNFTSFRQGDPGDIFYHGDATPDEDGTVNFNNAEQTSQVGWITYSKKVPIWSHK 91
Query: 88 TGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSI 147
TG +DF+T FSF ID+RN S G+ FFLAP G+++P GG L +SS
Sbjct: 92 TGKASDFSTSFSFKIDARNLSADGHGICFFLAPMGAQLPAYSVGGFLNLFTRKNNYSSSF 151
Query: 148 PFVAVEFDVYVN-SWDP--TFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTH 204
P V VEFD + N WDP SHVGI+ NS+ S SW + S A ISY+S T
Sbjct: 152 PLVHVEFDTFNNPGWDPNDVGSHVGINNNSLVSSNYTSWNASSHSQDICHAKISYDSVTK 211
Query: 205 NLSVAFT---GFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261
NLSV + ++ L Y +DL + LP V FGF A G N+
Sbjct: 212 NLSVTWAYELTATSDPKESSSLSYIIDLAKVLPSDVMFGFIAAAGT------------NT 259
Query: 262 SLEMDDETTNPVSNPKRRRKNRTALVVGLSLGGGVLVGGVVL---IIWLAGIGRKRKEGD 318
S + +R LV+G+S G V + +V+ ++W + RK+KE D
Sbjct: 260 EEHRLLSWELSSSLDSDKADSRIGLVIGISASGFVFLTFMVITTVVVW-SRKQRKKKERD 318
Query: 319 EEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNS 378
E+ I+ + ER AGP++F YK+L ATN F+ +KLG+GGFG VY+G +E N+
Sbjct: 319 IENMIS----INKDLEREAGPRKFSYKDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINT 374
Query: 379 YIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDS 438
+AVK++S S+QG E+ +EVKIIS+LRHRNLVQL+GWC+EK E LL+YE +PNGSL+S
Sbjct: 375 MVAVKKLSGDSRQGKNEFLNEVKIISKLRHRNLVQLIGWCNEKNEFLLIYELVPNGSLNS 434
Query: 439 HLF-KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497
HLF K +LL+W+ RYKI LAS LLYL EEW+QCV+HRDIK+SNIMLDS FN K+GDF
Sbjct: 435 HLFGKRPNLLSWDIRYKIGLGLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDF 494
Query: 498 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPI--- 554
GLARL+ H GS TT LAGT GYMAPE G ASKESD+YSFGIV LEI GRK +
Sbjct: 495 GLARLMNHELGSHTTGLAGTFGYMAPEYVMKGSASKESDIYSFGIVLLEIVTGRKSLERT 554
Query: 555 ----NPKAPQGQVSLLQWVWDLYGNGKLLEA-VDPRLCRDFDGQQIERLMIVGLWCAHPD 609
+ + SL++ VW+LYG +L+ + VD +L DFD ++ E L+++GLWCAHPD
Sbjct: 555 QEDNSDTESDDEKSLVEKVWELYGKQELITSCVDDKLGEDFDKKEAECLLVLGLWCAHPD 614
Query: 610 ENLRPSIRQVIHVLNFEAPLPALPPKMPVPTY 641
+N RPSI+Q I V+NFE+PLP LP K PV Y
Sbjct: 615 KNSRPSIKQGIQVMNFESPLPDLPLKRPVAMY 646
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHG4|LRKS7_ARATH Probable L-type lectin-domain containing receptor kinase S.7 OS=Arabidopsis thaliana GN=LECRKS7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 255/674 (37%), Positives = 377/674 (55%), Gaps = 61/674 (9%)
Query: 13 LLLSFFT--ITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVI----QLP 66
LL+ FFT +S I + + F + SF+ + N+T+ N V+ +L
Sbjct: 7 LLVIFFTWITALSMSKPIFVSSDNMNFTFKSFTIR---NLTFLGDSHLRNGVVGLTRELG 63
Query: 67 ANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNS--SYYADGLAFFLAPQGSK 124
++G YN +R +D + F+THFSF + + N + DGLAFFL+
Sbjct: 64 VPDTSSGTVIYNNPIRFYDPDSNTTASFSTHFSFTVQNLNPDPTSAGDGLAFFLSHDNDT 123
Query: 125 IPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHVGIDINSVKSKKN-- 180
+ GG GL ++P+ + FVA+EFD ++ DP +H+G+D++S+ S
Sbjct: 124 L--GSPGGYLGLVNSSQPMKNR--FVAIEFDTKLDPHFNDPNGNHIGLDVDSLNSISTSD 179
Query: 181 --VSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQG-----LDYQVDLRQHL 233
+S D+KSG+ +WI Y + L+V F + + + + L +DL L
Sbjct: 180 PLLSSQIDLKSGKSITSWIDYKNDLRLLNV-FLSYTDPVTTTKKPEKPLLSVNIDLSPFL 238
Query: 234 PEFVTFGFSMATGVDFAIFSIYSWEFNSSLEM-------------DDETTN--PVSNPKR 278
+ GFS +T I I +W F +S + D N PV P +
Sbjct: 239 NGEMYVGFSGSTEGSTEIHLIENWSFKTSGFLPVRSKSNHLHNVSDSSVVNDDPVVIPSK 298
Query: 279 RRKNRTALVVGLSLGGGVLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAG 338
+R++R L +GL + VL+ + + + + + E++ + +E I G
Sbjct: 299 KRRHRHNLAIGLGISCPVLICLALFVFGYFTLKKWKSVKAEKELK--TELI-------TG 349
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS 398
+ F YKEL AT F+ + +G+G FG VY+ F + + AVKR S +G E+ +
Sbjct: 350 LREFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFLA 409
Query: 399 EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL----LTWEFRYK 454
E+ II+ LRH+NLVQL GWC+EK ELLLVYEFMPNGSLD L++E+ L W R
Sbjct: 410 ELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRLN 469
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514
IA LAS L YL E EQ VVHRDIK+SNIMLD NFNA++GDFGLARL EH K +T+
Sbjct: 470 IAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTLT 529
Query: 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ--VSLLQWVWDL 572
AGTMGY+APE G A++++D +S+G+V LE+ACGR+PI+ K P+ Q V+L+ WVW L
Sbjct: 530 AGTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPID-KEPESQKTVNLVDWVWRL 588
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE---APL 629
+ G++LEAVD RL +FD + +++L++VGL CAHPD N RPS+R+V+ +LN E +P+
Sbjct: 589 HSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNEIEPSPV 648
Query: 630 PALPPKMPVPTYLS 643
P + P + LS
Sbjct: 649 PKMKPTLSFSCGLS 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (965), Expect = e-103, Method: Compositional matrix adjust.
Identities = 232/601 (38%), Positives = 340/601 (56%), Gaps = 51/601 (8%)
Query: 68 NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAP----QGS 123
+ G A Y+ +R F+T F+ + + GLAF + P +GS
Sbjct: 58 TQRVIGHAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGS 117
Query: 124 KIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVY--VNSWDPTFSHVGIDINSVKS---- 177
+P+ G ++ +N S F AVEFD + D +HVGIDINS++S
Sbjct: 118 -LPSQYLG-----LLNSSRVNFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSMESSIST 171
Query: 178 ----------KKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQV 227
KK + + GR +AWI Y+S+ L V + F + L Y V
Sbjct: 172 PAGYFLANSTKKELF----LDGGRVIQAWIDYDSNKKRLDVKLSPFSEK-PKLSLLSYDV 226
Query: 228 DLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDETTNPV----SNPKRRRKNR 283
DL L + + GFS +TG+ + I W FN S E + + S+ K+R+K R
Sbjct: 227 DLSSVLGDEMYVGFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKR 286
Query: 284 TALVVGLSLGGGVLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFP 343
+L++G+SL +L+ V++ L + RK K+ D + E+E GP RF
Sbjct: 287 QSLILGVSLLCSLLIFAVLVAASLFVV-RKVKDEDRVE----------EWELDFGPHRFS 335
Query: 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKII 403
Y+EL ATN F D + LG GGFG VYKG ++ ++AVKR+S S+QG++E+ SEV I
Sbjct: 336 YRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSI 395
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS--LLTWEFRYKIAQDLAS 461
LRHRNLVQLLGWC + +LLLVY+FMPNGSLD +LF EN +LTW+ R+KI + +AS
Sbjct: 396 GHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVAS 455
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
GLLYL E WEQ V+HRDIK++N++LDS N ++GDFGLA+L EH T + GT GY+
Sbjct: 456 GLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYL 515
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
APE +GK + +DVY+FG V LE+ACGR+PI A ++ ++ WVW + +G + +
Sbjct: 516 APELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDV 575
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTY 641
VD RL +FD +++ ++ +GL C++ +RP++RQV+ L + P P + +P P +
Sbjct: 576 VDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQFPSPEV---VPAPDF 632
Query: 642 L 642
L
Sbjct: 633 L 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (961), Expect = e-103, Method: Compositional matrix adjust.
Identities = 227/628 (36%), Positives = 342/628 (54%), Gaps = 30/628 (4%)
Query: 25 CLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLP-ANRETAGRATYNQSMRL 83
C +I + L F Y F P D A N +++L + + G A + +R
Sbjct: 15 CQIMISSSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRF 74
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
D GN++ F+T F F I S+ + G+AF +AP +P GL +
Sbjct: 75 KDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPT-LGLPFALPSQYIGLFNISNNG 133
Query: 144 NSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKK-NVSWWSD---------VKSGR 191
N + AVEFD +S DP +HVGID+N ++S + + + D + S +
Sbjct: 134 NDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRK 193
Query: 192 RNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAI 251
R + WI Y++ +H + V F ++ + Y DL L E + GFS ATG +
Sbjct: 194 RIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSE 253
Query: 252 FSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTA--LVVGLSLGGGVLVGGVVLIIWLAG 309
+ W F + E + + + R R + +G+ L L+ ++ + +
Sbjct: 254 HFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFY-- 311
Query: 310 IGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVY 369
I R++K+ +EE D++E G RF +KEL AT F + LG GGFG VY
Sbjct: 312 IVRRKKKYEEEL---------DDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVY 362
Query: 370 KGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429
+G T +AVKRVS SKQG+KE+ +E+ I R+ HRNLV LLG+C + ELLLVY+
Sbjct: 363 RGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYD 422
Query: 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488
+MPNGSLD +L+ + L W+ R I + +ASGL YL EEWEQ V+HRD+K+SN++LD+
Sbjct: 423 YMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDA 482
Query: 489 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA 548
+FN ++GDFGLARL +H QTT + GT+GY+APE + TG+A+ +DVY+FG LE+
Sbjct: 483 DFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVV 542
Query: 549 CGRKPIN-PKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL-CRDFDGQQIERLMIVGLWCA 606
GR+PI A L++WV+ L+ G ++EA DP+L +D +++E ++ +GL C+
Sbjct: 543 SGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCS 602
Query: 607 HPDENLRPSIRQVIHVLNFEAPLPALPP 634
H D RPS+RQV+ L + LP L P
Sbjct: 603 HSDPRARPSMRQVLQYLRGDMALPELTP 630
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYX1|LRK82_ARATH L-type lectin-domain containing receptor kinase VIII.2 OS=Arabidopsis thaliana GN=LECRK82 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (950), Expect = e-101, Method: Compositional matrix adjust.
Identities = 231/617 (37%), Positives = 338/617 (54%), Gaps = 63/617 (10%)
Query: 64 QLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGS 123
+L TAG+A Y + ++ T + FTT+FSF + + N S GLAF ++P
Sbjct: 65 ELSVPTSTAGKALYGKPVKFRHPETKSPASFTTYFSFSVTNLNPSSIGGGLAFVISPDED 124
Query: 124 KIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHVGIDINSVKSKKNV 181
+ + GG GLT++ S FVAVEFD ++ D +HVG+D+N+V S
Sbjct: 125 YLGST--GGFLGLTEET---GSGSGFVAVEFDTLMDVQFKDVNGNHVGLDLNAVVSAAVA 179
Query: 182 SWWS---DVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVT 238
+ D+KSG +WI+Y+ S L+V + + N L +DL +++ + +
Sbjct: 180 DLGNVDIDLKSGNAVNSWITYDGSGRVLTV-YVSYSNLKPKSPILSVPLDLDRYVSDSMF 238
Query: 239 FGFSMATGVDFAIFSIYSWEFNSSL----------------------------EMDDETT 270
GFS +T I S+ W F+SS + +T
Sbjct: 239 VGFSGSTQGSTEIHSVDWWSFSSSFEESSESPPPMPNSPPPSSPSSSITPSLSTVRRKTA 298
Query: 271 NPVSNPKRRR-KNRTALVVGLSLGGG---VLVGGVVLIIWLAGIGRKRKEGDEEDNQGFS 326
+P S+ + + K A V G+ G L GV++ ++ I RK S
Sbjct: 299 DPSSSCRNKLCKKSPAAVAGVVTAGAFFLALFAGVIIWVYSKKIKYTRK----------S 348
Query: 327 EYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS 386
E + E + P+ F YKEL LAT+ F+ + +G G FG VYKG +++ IA+KR S
Sbjct: 349 ESLASEIMKS--PREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRCS 406
Query: 387 QGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL 446
S QG E+ SE+ +I LRHRNL++L G+C EK E+LL+Y+ MPNGSLD L++ +
Sbjct: 407 HIS-QGNTEFLSELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPTT 465
Query: 447 LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506
L W R KI +AS L YL +E E ++HRD+K+SNIMLD+NFN K+GDFGLAR EH
Sbjct: 466 LPWPHRRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEHD 525
Query: 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG----- 561
K T AGTMGY+APE TG+A++++DV+S+G V LE+ GR+PI P+
Sbjct: 526 KSPDATAAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRPG 585
Query: 562 -QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ SL+ WVW LY GKLL AVD RL +F+ +++ R+M+VGL C+ PD RP++R V+
Sbjct: 586 LRSSLVDWVWGLYREGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSVV 644
Query: 621 HVLNFEAPLPALPPKMP 637
+L EA +P +P P
Sbjct: 645 QILVGEADVPEVPIAKP 661
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 225/599 (37%), Positives = 338/599 (56%), Gaps = 40/599 (6%)
Query: 55 AYPDSNRVIQLP-ANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADG 113
AY ++N +I+L + +T G+ YN +R + G ++ F+T F F I+ N Y G
Sbjct: 40 AYINNNGLIRLTNSTPQTTGQVFYNDQLRFKNSVNGTVSSFSTTFVFSIEFHNGIYGGYG 99
Query: 114 LAFFLAPQGSKIPT--NKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHVG 169
+AF + P PT G F + +P N VAVE D V+ D +HVG
Sbjct: 100 IAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNH---IVAVELDTKVDQQFEDKDANHVG 156
Query: 170 IDINSVKSKKNV--SWWSD--------VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVV 219
IDIN++ S ++ D + SG+ + WI Y+S ++V
Sbjct: 157 IDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHPLYVPKPK 216
Query: 220 MQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDETTNPVSNPKRR 279
+ L + DL +L E + GF+ TG A I W F + D +P PK
Sbjct: 217 IPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPD--IDPSRLPKIP 274
Query: 280 RKNRT-------ALVVGLSLGGGVLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDE 332
R N+ L + L++ G +++ + L +WL KRK+ E ++D
Sbjct: 275 RYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLF---LKRKK--------LLEVLED- 322
Query: 333 FERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG 392
+E GP RF +K+L +AT F D + LG+GGFG VYKG +N IAVK VS S+QG
Sbjct: 323 WEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQG 382
Query: 393 IKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS-LLTWEF 451
++E+ +E+ I RLRH NLV+L G+C K EL LVY+ M GSLD L+ + + L W
Sbjct: 383 MREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDWSQ 442
Query: 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511
R+KI +D+ASGL YL ++W Q ++HRDIK +NI+LD+N NAK+GDFGLA+L +H QT
Sbjct: 443 RFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQT 502
Query: 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD 571
+ +AGT+GY++PE + TGKAS SDV++FGIV LEIACGRKPI P+A Q ++ L WV +
Sbjct: 503 SHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLE 562
Query: 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630
+ N +++ +D ++ +++ +Q ++ +GL+C+HP +RP++ VI +L+ A LP
Sbjct: 563 CWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLP 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 360 bits (923), Expect = 3e-98, Method: Compositional matrix adjust.
Identities = 224/628 (35%), Positives = 338/628 (53%), Gaps = 39/628 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE-TAGRATYNQSMRLWDKATG 89
+ +L F Y SF + NI+ + A SN +++L + G A Y + +R D
Sbjct: 24 SQSLNFTYNSFH-RPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSPND 82
Query: 90 NLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
++ F+T F I S + G+AFF+AP + + GL N +
Sbjct: 83 TVSSFSTTFVIGIYSGIPTISGHGMAFFIAPN-PVLSSAMASQYLGLFSSTNNGNDTNHI 141
Query: 150 VAVEFDVYVNSW--DPTFSHVGIDINSVKSKKN--VSWWSDVK--------SGRRNEAWI 197
+AVEFD +N D +HVGI+INS+ S K+ V +W ++ S +R + W+
Sbjct: 142 LAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNNLTLISRKRMQVWV 201
Query: 198 SYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSW 257
Y+ T+ + V F + DL + + GFS ATG + ++ W
Sbjct: 202 DYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGW 261
Query: 258 EFNSS------LEMDDETTNPVSNP---KRRRKNRTALVVGLSLGGGVLVGGVVLIIWLA 308
F L + P P +R KNR L L + +V + L+ ++
Sbjct: 262 SFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFI- 320
Query: 309 GIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGV 368
+ R+RK F+E +D +E G R +K+L AT F D LG GGFG V
Sbjct: 321 -VRRRRK---------FAEEFED-WETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRV 369
Query: 369 YKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428
Y+G T IAVKRVS S+QG+KE+ +E+ I R+ HRNLV LLG+C + ELLLVY
Sbjct: 370 YRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVY 429
Query: 429 EFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
++MPNGSLD +L+ L W+ R+ + +ASGL YL EEWEQ V+HRDIK+SN++LD
Sbjct: 430 DYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLD 489
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
+ +N ++GDFGLARL +H QTT + GT GY+AP+ TG+A+ +DV++FG++ LE+
Sbjct: 490 AEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEV 549
Query: 548 ACGRKPINPKAPQGQ-VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCA 606
ACGR+PI + + V L+ V+ + G +L+A DP L +D +++E ++ +GL C+
Sbjct: 550 ACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCS 609
Query: 607 HPDENLRPSIRQVIHVLNFEAPLPALPP 634
H D +RP++RQV+ L +A LP L P
Sbjct: 610 HSDPQVRPTMRQVLQYLRGDATLPDLSP 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (919), Expect = 7e-98, Method: Compositional matrix adjust.
Identities = 226/600 (37%), Positives = 334/600 (55%), Gaps = 41/600 (6%)
Query: 55 AYPDSNRVIQLPANRE-TAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADG 113
A +S +++L + E + G YN +R + G ++ F+T F F I S ++ G
Sbjct: 41 AITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGTVSSFSTTFVFAIVSNVNALDGHG 100
Query: 114 LAFFLAPQGSKIPTNKGG---GSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHV 168
LAF ++P +P + G F LT + +P N VAVEFD + N D +HV
Sbjct: 101 LAFVISPTKG-LPYSSSSQYLGLFNLTNNGDPSNH---IVAVEFDTFQNQEFDDMDNNHV 156
Query: 169 GIDINSVKSKK--NVSWWSDVKSGRRN---------EAWISYNSSTHNLSVAFTGFRNNL 217
GIDINS+ S+K ++ D +N +AWI Y+SS L+V
Sbjct: 157 GIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPK 216
Query: 218 VVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF--NSSLEMDDETTNPVSN 275
+ L DL +L + + GF+ ATG + I W F N + D + P
Sbjct: 217 PKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTASNIDISRLP-KL 275
Query: 276 PKRRRKNRTALVVGLSLGGGVLVGGVVLII-WLAGIGRKRKEGDEEDNQGFSEYIDDEFE 334
P+ R ++ +SL L V L I ++ + RK+ E ++D +E
Sbjct: 276 PRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKK----------LMEVLED-WE 324
Query: 335 RGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK 394
GP RF YK+L +AT F + + LG+GGFG VYKG +N IAVK+VS S+QG++
Sbjct: 325 VQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMR 384
Query: 395 EYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRY 453
E+ +E+ I RLRH NLV+LLG+C K EL LVY+ MP GSLD L+ + L W R+
Sbjct: 385 EFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRF 444
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513
KI +D+ASGL YL +W Q ++HRDIK +N++LD + N K+GDFGLA+L EH QT+
Sbjct: 445 KIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSN 504
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ-GQVSLLQWVWDL 572
+AGT GY++PE + TGKAS SDV++FGI+ LEI CGR+P+ P+A ++ L WV D
Sbjct: 505 VAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDC 564
Query: 573 YGNGKLLEAVDPRLCRD--FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630
+ + +L+ VD R+ +D + +Q+ ++ +GL+C+HP +RPS+ VI L+ A LP
Sbjct: 565 WED-DILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLP 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 357 bits (916), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 216/584 (36%), Positives = 317/584 (54%), Gaps = 34/584 (5%)
Query: 70 ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNK 129
+ G A Y + +R D G ++ F+T F F I S+ + G+AF +AP S +P
Sbjct: 61 QKTGHAFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNAS-LPYGN 119
Query: 130 GGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHVGIDINSVKSKKN--VSWWS 185
GL N + AVE D +++ D +HVGIDINS+KS ++ +W
Sbjct: 120 PSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWD 179
Query: 186 D--------VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFV 237
+ + S + + W+ Y+ T+ + V F + + DL L + +
Sbjct: 180 EKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDM 239
Query: 238 TFGFSMATGVDFAIFSIYSWEFNSS-----LEMDDETTNPVSNPKRRRKNRTALVVGLSL 292
GFS ATG + I W F + L + P PKR + +G+ L
Sbjct: 240 YVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYK---IGMPL 296
Query: 293 GGGVLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN 352
L+ + ++ I R+R++ EE + E+ G RF +K+L AT
Sbjct: 297 ISLFLIFSFIFLVCY--IVRRRRKFAEELEEWEKEF---------GKNRFRFKDLYYATK 345
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
F + LG GGFG VYKG T IAVKRVS S+QG+KE+ +E+ I R+ HRNLV
Sbjct: 346 GFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLV 405
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEWE 471
LLG+C + ELLLVY++MPNGSLD +L+ + L W+ R K+ +ASGL YL EEWE
Sbjct: 406 PLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWE 465
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
Q V+HRD+K+SN++LD N ++GDFGLARL +H QTT + GT+GY+APE TG+A
Sbjct: 466 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRA 525
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL-QWVWDLYGNGKLLEAVDPRLCRDF 590
+ +DV++FG LE+ACGR+PI + + LL WV+ L+ G +L A DP + +
Sbjct: 526 TMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSEC 585
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPP 634
D +++E ++ +GL C+H D RPS+RQV+H L +A LP L P
Sbjct: 586 DEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPELSP 629
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | ||||||
| 224096774 | 713 | predicted protein [Populus trichocarpa] | 0.968 | 0.876 | 0.666 | 0.0 | |
| 224092745 | 681 | predicted protein [Populus trichocarpa] | 0.947 | 0.897 | 0.663 | 0.0 | |
| 225470605 | 720 | PREDICTED: L-type lectin-domain containi | 0.967 | 0.866 | 0.652 | 0.0 | |
| 356527993 | 709 | PREDICTED: L-type lectin-domain containi | 0.982 | 0.894 | 0.613 | 0.0 | |
| 356527997 | 709 | PREDICTED: L-type lectin-domain containi | 0.978 | 0.889 | 0.607 | 0.0 | |
| 224059892 | 613 | predicted protein [Populus trichocarpa] | 0.882 | 0.928 | 0.676 | 0.0 | |
| 357476157 | 782 | Class I heat shock protein [Medicago tru | 0.964 | 0.795 | 0.624 | 0.0 | |
| 147765964 | 692 | hypothetical protein VITISV_007747 [Viti | 0.937 | 0.874 | 0.641 | 0.0 | |
| 356519481 | 691 | PREDICTED: L-type lectin-domain containi | 0.955 | 0.891 | 0.614 | 0.0 | |
| 356528003 | 671 | PREDICTED: L-type lectin-domain containi | 0.941 | 0.904 | 0.603 | 0.0 |
| >gi|224096774|ref|XP_002334671.1| predicted protein [Populus trichocarpa] gi|222874064|gb|EEF11195.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2195), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/654 (66%), Positives = 512/654 (78%), Gaps = 29/654 (4%)
Query: 18 FTITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRETA----- 72
F + F L IIP AS L+FN+TSF D NI+YE AYP ++ IQL N A
Sbjct: 11 FVFSTLFTL-IIPSASGLSFNFTSFIVGADQNISYEEAYP-ADGAIQLTKNLRNANMNSS 68
Query: 73 -GRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTN-KG 130
GRATY + M+LWD+A+GNLTDFTTHFSF IDS+ + Y DGLAFFLAP+GSK+P+N
Sbjct: 69 SGRATYYKPMQLWDEASGNLTDFTTHFSFSIDSQRRTAYGDGLAFFLAPEGSKLPSNLSE 128
Query: 131 GGSFGLTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKS 189
G GLT+ ++ LN++ FVAVEFD+Y N +DP HVGIDINS++S N++W D+
Sbjct: 129 GAGLGLTRRDQLLNTTANHFVAVEFDIYPNYFDPPGEHVGIDINSMQSVNNITWPCDISG 188
Query: 190 GRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDF 249
GR EAWISYNSSTHNLSVAFTG+RNN V MQ L V LR +LPE V+FGFS +TG
Sbjct: 189 GRITEAWISYNSSTHNLSVAFTGYRNNTVEMQFLSQIVSLRDYLPERVSFGFSASTGSAS 248
Query: 250 AIFSIYSWEFNSSLEMDDETTNPV---SNP--------------KRRRKNRTALVVGLSL 292
A+ ++YSW+F+SSLE+DD TNP+ +NP + R+KNRT L VGL +
Sbjct: 249 ALHTLYSWDFSSSLEIDDNVTNPIDPATNPLDPAAASPPNGGSLRNRKKNRTGLAVGLGV 308
Query: 293 GGGVLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN 352
GGG +V G L+ + R +E DE D EY+DDEFERG GPK+F Y+ELA ATN
Sbjct: 309 GGGAIVVGAALVGIVIKFMRGHEE-DEGDGHVLEEYMDDEFERGTGPKKFSYQELARATN 367
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
+F D++KLG+GGFGGVYKGF + +S++AVKRVS+GSKQGIKEYA+EVKIISRLRHRNLV
Sbjct: 368 NFKDEEKLGEGGFGGVYKGFLKGIDSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLV 427
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
QL+GWCHE+KELLLVYEFMP+GSLDSHLFKE SLLTWE RYKI Q LASGLLYL EEWEQ
Sbjct: 428 QLIGWCHERKELLLVYEFMPHGSLDSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQ 487
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
CVVHRDIKSSNIMLDS FNAK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECA TGKAS
Sbjct: 488 CVVHRDIKSSNIMLDSEFNAKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKAS 547
Query: 533 KESDVYSFGIVALEIACGRKPINPKAP-QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591
+ESDVYSFGIVALEIACGRKPINPKA + QVS++QWVW+LYG GKLLEAVDPRLC DF+
Sbjct: 548 RESDVYSFGIVALEIACGRKPINPKASNEDQVSMVQWVWELYGEGKLLEAVDPRLCGDFN 607
Query: 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
Q+ERLMIVGL CAHPDE+LRPSIRQ +HVLNF+APLP LP KMPVP+Y +PP
Sbjct: 608 KTQMERLMIVGLSCAHPDEHLRPSIRQALHVLNFDAPLPILPSKMPVPSYFAPP 661
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092745|ref|XP_002334872.1| predicted protein [Populus trichocarpa] gi|222831889|gb|EEE70366.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/636 (66%), Positives = 495/636 (77%), Gaps = 25/636 (3%)
Query: 18 FTITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRETA----- 72
F + F L IIP AS L+FN+TSF D NI+YE AYP ++ IQL N A
Sbjct: 11 FVFSTLFTL-IIPSASGLSFNFTSFVVGADQNISYEEAYP-ADGAIQLTKNLRNANMNSS 68
Query: 73 -GRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGG 131
GRATY + M+LWD+A+GNLTDFTTHFSF IDS+ + Y DGLAFFL P+ P G
Sbjct: 69 SGRATYYKPMQLWDEASGNLTDFTTHFSFSIDSQGQTAYGDGLAFFLGPE-ELPPLRFQG 127
Query: 132 GSFGLTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSG 190
GS GL ++N+ LN++ FVAVEFD++ N +DP HVGIDINS++S N++W D++ G
Sbjct: 128 GSLGLLRNNQALNTTDNHFVAVEFDIFQNYFDPPGEHVGIDINSMQSVNNITWLCDIRRG 187
Query: 191 RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFA 250
RR EAWISYNSSTHNLSVAFTG+RNN V MQ L V LR +LPE V+FGFS +TG FA
Sbjct: 188 RRTEAWISYNSSTHNLSVAFTGYRNNTVEMQFLSQIVSLRDYLPERVSFGFSASTGDLFA 247
Query: 251 IFSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTALVVGLSLGGGVLVGGVVLIIWLAGI 310
I ++YSW+F+SSLE+DD N + + G + G LVG V I ++ G
Sbjct: 248 IHTLYSWDFSSSLEIDD-------NNRTGLAVGLGVGGGAIVVGAALVGFV--IKFMCG- 297
Query: 311 GRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYK 370
E DEE EY+DDEFERG GPK+F Y+ELA AT++F D++KLG+GGFGGVYK
Sbjct: 298 ----HEEDEEGGHVLEEYMDDEFERGTGPKKFSYQELARATSNFKDEEKLGEGGFGGVYK 353
Query: 371 GFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430
GF +E +S++AVKRVS+GSKQGIKEYA+EVKIISRLRHRNLVQL+GWCHE+KELLLVYEF
Sbjct: 354 GFLKEIDSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRNLVQLIGWCHERKELLLVYEF 413
Query: 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490
MP+GSLDSHLFKE SLLTWE RYKI Q LASGLLYL EEWEQCVVHRDIKSSNIMLDS F
Sbjct: 414 MPHGSLDSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEWEQCVVHRDIKSSNIMLDSEF 473
Query: 491 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACG 550
NAK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECA TGKAS+ESDVYSFGIVALEIACG
Sbjct: 474 NAKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGKASRESDVYSFGIVALEIACG 533
Query: 551 RKPINPKAP-QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPD 609
RKPINPKA + QVS++QWVW+LYG GKLLEAVDPRLC DF+ Q+ERLMIVGL CAHPD
Sbjct: 534 RKPINPKASNEDQVSMVQWVWELYGEGKLLEAVDPRLCGDFNKTQMERLMIVGLSCAHPD 593
Query: 610 ENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
E+LRPSIRQ +H+LNF+APLP LP KMPVP+Y +PP
Sbjct: 594 EHLRPSIRQALHILNFDAPLPILPSKMPVPSYFAPP 629
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470605|ref|XP_002262748.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/642 (65%), Positives = 502/642 (78%), Gaps = 18/642 (2%)
Query: 17 FFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLP-ANRETAGRA 75
F I+I F L +IP A++L FN+TSFSP Y+DNITYE + N++IQL A + G A
Sbjct: 31 FTMISIFFILLMIPSATSLDFNFTSFSP-YNDNITYEGSAFPRNQIIQLTQAQSASIGWA 89
Query: 76 TYNQSMRLWDKATGNLTDFTTHFSFVIDSRN-SSYYADGLAFFLAPQGSKIPTNKGGGSF 134
TY Q + LWDKA+GNLTDFTTHFSFVID++N S + DG+AFFL P S+ P GG
Sbjct: 90 TYVQPLHLWDKASGNLTDFTTHFSFVIDTQNRSGSHGDGIAFFLMPADSQKPNVTKGGGL 149
Query: 135 GLTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRN 193
GL D +PLN+++ FVAVEFD+Y N WDP +H GIDINSV+S +NV WW + +GRRN
Sbjct: 150 GLASDTQPLNTTVNHFVAVEFDIYKNRWDPNDTHAGIDINSVQSIRNVKWWDSIINGRRN 209
Query: 194 EAWISYNSSTHNLSVAFTGFRNNLVVMQ-GLDYQVDLRQHLPEFVTFGFSMATGVDFAIF 252
+AWISYNSS+ NLSV FTGFRN+ ++Q L Y+VDLR +LPE+V+FGFS ATG AI
Sbjct: 210 DAWISYNSSSKNLSVVFTGFRNDSTILQDNLYYEVDLRLYLPEWVSFGFSGATGNASAIH 269
Query: 253 SIYSWEFNSSLEMDDETTNPVS----------NPKRRRKNRTALVVGLSLGGGVLVGGVV 302
+IYSW F+SSL+ D+ TNP S N RK + LVVGL++GG VGG+
Sbjct: 270 AIYSWSFSSSLQTDENKTNPTSPEAETPTSNPNSNPSRKIKVKLVVGLTVGGCAFVGGLS 329
Query: 303 LIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQ 362
L+++L R+ K + +Q ++D+FE+G GPK+F Y ELA +TN+F ++ KLG+
Sbjct: 330 LVLFLFLKSRRGKVDNPVIDQ---LSMEDDFEKGTGPKKFRYNELASSTNNFAEEGKLGE 386
Query: 363 GGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422
GGFGGVYKGF +E +SYIAVKRVS GSKQGIKEY SEVKIISRLRHRNLVQL+GWCHEK+
Sbjct: 387 GGFGGVYKGFLKELDSYIAVKRVSSGSKQGIKEYVSEVKIISRLRHRNLVQLIGWCHEKR 446
Query: 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482
+LLLVYEFMPNGSL+SH+F E SLLTWE RYKIAQ LAS LLYL E WEQCV+HRDIKSS
Sbjct: 447 DLLLVYEFMPNGSLESHIFSERSLLTWEMRYKIAQGLASALLYLHEGWEQCVLHRDIKSS 506
Query: 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGI 542
NIMLDS FNAK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECATTGKASK+SD+YSFG+
Sbjct: 507 NIMLDSGFNAKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECATTGKASKQSDIYSFGV 566
Query: 543 VALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602
VALEIACGRKPIN KA + Q+ +L+WVWDLYG G +LEA DPRLC +FD QQ++ LM VG
Sbjct: 567 VALEIACGRKPINLKAKEDQIMMLEWVWDLYGKGNILEAADPRLCAEFDAQQMQCLMTVG 626
Query: 603 LWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSP 644
LWCAHPD NLRPS+R+VIHVLNFEAPLP LPPKMPVPTY P
Sbjct: 627 LWCAHPDRNLRPSVREVIHVLNFEAPLPILPPKMPVPTYSIP 668
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527993|ref|XP_003532590.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/650 (61%), Positives = 486/650 (74%), Gaps = 16/650 (2%)
Query: 9 SNSPLLLSFFTITIS-FCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPA 67
SN F + +S F + IIP A L+FN TSF P +I YE + VI+L
Sbjct: 14 SNLSFSHHFLVMLLSIFFIFIIPCAFPLSFNITSFDPN-GKSIIYEGSANPVTPVIELTG 72
Query: 68 N-RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIP 126
N R+ GRATY Q M LWDKATGNLTDFTTHFSFVIDSRN S Y DG+AFFLAP G K P
Sbjct: 73 NVRDITGRATYFQPMHLWDKATGNLTDFTTHFSFVIDSRNQSAYEDGMAFFLAPAGLKFP 132
Query: 127 TNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSD 186
GG+ GLT +++ LNS+ PFVAVEFD+Y N DP HVGIDINS++S NV+W +D
Sbjct: 133 YVSRGGALGLTLEDQRLNSTDPFVAVEFDIYENPDDPPGEHVGIDINSLRSVANVTWLAD 192
Query: 187 VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG 246
+K G+ NE WISYNSS+ NLSV FTGF N+ ++ Q L DLR HLPEFVT GFS ATG
Sbjct: 193 IKQGKLNEVWISYNSSSFNLSVVFTGFNNDTILRQHLSAITDLRLHLPEFVTVGFSAATG 252
Query: 247 VDFAIFSIYSWEFNSSLEMDDETTN--------PVSN---PKRRRKNRTALVVGLSLGGG 295
+D AI S+ SW+F+S+L + T P ++ P +++KN+T L VGLS+GG
Sbjct: 253 IDTAIHSVNSWDFSSTLAAQENITKGADTVARYPATSNIAPSQKKKNKTGLAVGLSIGGF 312
Query: 296 VLVGGVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFN 355
VL+GG+ LI G+ +K K+G E++ F EY+ ++F RGAGP+++ Y EL A N F
Sbjct: 313 VLIGGLGLIS--IGLWKKWKKGSVEEDLVFEEYMGEDFGRGAGPRKYSYAELTEAANGFK 370
Query: 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
D+ KLGQGGFGGVYKG+ ++ S++A+KRVS+GS QGIKE+ASEV IISRLRHRNLV L+
Sbjct: 371 DEHKLGQGGFGGVYKGYLKDIKSHVAIKRVSEGSDQGIKEFASEVNIISRLRHRNLVHLI 430
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
GWCH K+LLLVYE+MPNGSLD HLFK+ SLL W RY IA+ LAS LLYL EEWEQCVV
Sbjct: 431 GWCHAGKKLLLVYEYMPNGSLDIHLFKKQSLLKWTVRYNIARGLASALLYLHEEWEQCVV 490
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
HRDIKSSNIMLDS FNAK+GDFGLAR V+HAK +QTT LAGTMGYMAPECAT+G+ASKES
Sbjct: 491 HRDIKSSNIMLDSEFNAKLGDFGLARFVDHAKSAQTTALAGTMGYMAPECATSGRASKES 550
Query: 536 DVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595
DVYSFG+VALEIACGRKPIN +A + ++++++WVW LYG G++LEA D RL +F+ +QI
Sbjct: 551 DVYSFGVVALEIACGRKPINHRAQENEINIVEWVWGLYGEGRILEAADQRLEGEFEEEQI 610
Query: 596 ERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
+ LMIVGLWCAHPD N RPS+RQ I VLNFEAPLP LP +PVPTYL P
Sbjct: 611 KCLMIVGLWCAHPDHNNRPSMRQAIQVLNFEAPLPNLPSSLPVPTYLEGP 660
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527997|ref|XP_003532592.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/653 (60%), Positives = 484/653 (74%), Gaps = 22/653 (3%)
Query: 9 SNSPLLLSFFTITIS-FCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPA 67
SN F + +S F + IIP A L+FN TSF P +I YE + VI+L
Sbjct: 14 SNLSFSHHFLVMLLSIFFIFIIPCAFPLSFNITSFDPN-GKSIIYEGSANPVTPVIELTG 72
Query: 68 N-RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIP 126
N R++ GRATY Q M LWDKATGNLTDFTTHFSFVIDSRN S Y DG+AFFLAP G K P
Sbjct: 73 NVRDSTGRATYFQPMHLWDKATGNLTDFTTHFSFVIDSRNRSGYGDGMAFFLAPAGLKFP 132
Query: 127 TNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSD 186
GG+ GLT +N+ LNS+ PFVAVEFD+Y N +DP HVGIDINS++S NV+W +D
Sbjct: 133 YVSRGGALGLTLENQRLNSTDPFVAVEFDIYKNFYDPPGEHVGIDINSLRSVANVTWLAD 192
Query: 187 VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG 246
+K G+ NE WISYNSS+ NLSV FTGF N+ ++ Q L +DLR HLPEFVT GFS ATG
Sbjct: 193 IKQGKLNEVWISYNSSSFNLSVVFTGFNNDTILRQHLSAIIDLRLHLPEFVTVGFSAATG 252
Query: 247 VDFAIFSIYSWEFNSSLEMDDETT--------NPVSN---PKRRRKNRTALVVGLSLGGG 295
AI S+ SW+F+S+L + T +P ++ P +++KN+T L VGLS+GG
Sbjct: 253 SSTAIHSVNSWDFSSTLAAQENITKGADTVARSPATSNIAPSQKKKNKTGLAVGLSIGGF 312
Query: 296 VLVGGVVLI---IWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN 352
VL+GG+ LI +W +K K+G E+ F EY+ +F RG GP+++ Y EL A N
Sbjct: 313 VLIGGLGLISICLW-----KKWKKGSVEEVHVFEEYMGKDFGRGGGPRKYSYAELTQAAN 367
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
F D+ KLGQGGFGGVYKG+ ++ S++A+KRVS+ S QGIKE+ASEV IISRLRHRNLV
Sbjct: 368 GFKDEHKLGQGGFGGVYKGYLKDIKSHVAIKRVSESSDQGIKEFASEVNIISRLRHRNLV 427
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
L+GWCH K+LLLVYE+MPNGSLD HLFK+ SLL W RY IA+ LAS LLYL EEWEQ
Sbjct: 428 HLIGWCHAGKKLLLVYEYMPNGSLDIHLFKKQSLLKWTVRYNIARGLASALLYLHEEWEQ 487
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
CVVHRDIKSSNIMLDS FNAK+GDFGLAR V+HAK +QTT LAGTMGYMAPECAT+G+AS
Sbjct: 488 CVVHRDIKSSNIMLDSEFNAKLGDFGLARFVDHAKSAQTTALAGTMGYMAPECATSGRAS 547
Query: 533 KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
KESDVYSFG+VALEIACGRKPIN +A + ++++++WVW LYG G++LEA D RL +F+
Sbjct: 548 KESDVYSFGVVALEIACGRKPINHRAQENEINIVEWVWGLYGEGRILEAADQRLEGEFEE 607
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
+QI+ LMIVGLWCAHPD N RPS+RQ I VLNFEAPLP LP +PVPTYL P
Sbjct: 608 EQIKCLMIVGLWCAHPDHNNRPSMRQAIQVLNFEAPLPNLPSSLPVPTYLEGP 660
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059892|ref|XP_002300009.1| predicted protein [Populus trichocarpa] gi|222847267|gb|EEE84814.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/596 (67%), Positives = 480/596 (80%), Gaps = 27/596 (4%)
Query: 73 GRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTN-KGG 131
GRATY + M+LWD+A+GNLTDFTTHFSF IDS+ Y DGLAFFLAP+GSK+P N G
Sbjct: 6 GRATYYKPMQLWDEASGNLTDFTTHFSFSIDSQGRRAYGDGLAFFLAPEGSKLPPNLSQG 65
Query: 132 GSFGLTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSG 190
S GLT++++ LN++ FVAVEFD+Y N +DP HVGIDINS++S N++W ++ G
Sbjct: 66 RSLGLTRNDQQLNTTDNHFVAVEFDIYKNYFDPPGEHVGIDINSMQSVNNITWLCNISGG 125
Query: 191 RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFA 250
+ +AWISY+SSTHNLSVAFTG+RNN V MQ L V LR +LPE V+FGFS +TG A
Sbjct: 126 IKTDAWISYSSSTHNLSVAFTGYRNNTVEMQFLSQIVSLRDYLPERVSFGFSASTGSASA 185
Query: 251 IFSIYSWEFNSSLEMDDETTNPV-----------SNP------KRRRKNRTALVVGLSLG 293
+ ++YSW+F+SSLE+DD TNP+ ++P + R+KNRT L VGL +G
Sbjct: 186 LHTLYSWDFSSSLEIDDNVTNPIDPDTNTLDPAAASPPNGGSRRNRKKNRTGLAVGLGVG 245
Query: 294 GGVLVGGVVLIIWLAGIGRKRKEGDEEDNQG---FSEYIDDEFERGAGPKRFPYKELALA 350
GG +V G L+ G K G EED +G EY+D+EFERG GPK+F Y+ELA A
Sbjct: 246 GGAIVVGAALV----GFVIKFMCGHEEDEEGGHVVEEYMDEEFERGTGPKKFSYQELARA 301
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
T++F D++KLG+GGFGGVYKGF +E +S++AVKRVS+GSKQGIKEYA+EVKIISRLRHRN
Sbjct: 302 TSNFKDEEKLGEGGFGGVYKGFLKEIDSFVAVKRVSRGSKQGIKEYAAEVKIISRLRHRN 361
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
LVQL+GWCHE+KELLLVYEFM +GSLDSHLFKE SLLTWE RYKI Q LASGLLYL EEW
Sbjct: 362 LVQLIGWCHERKELLLVYEFMSHGSLDSHLFKETSLLTWEVRYKIVQGLASGLLYLHEEW 421
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
EQCVVHRDIKSSNI+LDS FNAK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECA TGK
Sbjct: 422 EQCVVHRDIKSSNIILDSEFNAKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECAMTGK 481
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAP-QGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
AS+ESDVYSFGIVALEIACGRKPINPKA + +VS++QWVW+LYG GKLLEAVDPRLC D
Sbjct: 482 ASRESDVYSFGIVALEIACGRKPINPKASNEDRVSMVQWVWELYGEGKLLEAVDPRLCGD 541
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
F+ Q+ERLMIVGL CAHPDE+LRPSIRQ +HVLNF+APLP LP KMPVP+Y +PP
Sbjct: 542 FNKTQMERLMIVGLSCAHPDEHLRPSIRQALHVLNFDAPLPILPSKMPVPSYFAPP 597
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357476157|ref|XP_003608364.1| Class I heat shock protein [Medicago truncatula] gi|355509419|gb|AES90561.1| Class I heat shock protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2027), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 399/639 (62%), Positives = 484/639 (75%), Gaps = 17/639 (2%)
Query: 17 FFTITISFCLTI-IPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRETAGRA 75
F TI + L + IP AS+LTFN+TSF P D +I YE + ++ IQL N + GRA
Sbjct: 10 FLTIFLILNLNLFIPNASSLTFNFTSFDPN-DKSIIYEGSANPASSAIQLTINYGSIGRA 68
Query: 76 TYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFG 135
TY Q + LW+K T NLTDFT+HF+F IDS+N Y DG+AFFLAP GSK P GGS G
Sbjct: 69 TYYQPIHLWNKITNNLTDFTSHFTFTIDSQNRQMYGDGIAFFLAPYGSKKPNATKGGSMG 128
Query: 136 LTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNE 194
LT DN+ LNS+ PFVAVEFD+Y N WDP H GIDINS+ S NV+W +D+K GR NE
Sbjct: 129 LTLDNQRLNSTDNPFVAVEFDIYRNHWDPPLEHAGIDINSMLSVANVTWLADIKQGRLNE 188
Query: 195 AWISYNSSTHNLSVAFTGFRN--NLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIF 252
AWI+YN+S+ NLSV FTGF N + +V Q L VDLR +LPEFVT GFS ATG A+
Sbjct: 189 AWINYNASSLNLSVLFTGFNNVTSSIVNQHLSSIVDLRLYLPEFVTIGFSAATGNRTAVH 248
Query: 253 SIYSWEFNSSLE--MDDETTN---PVS-NPKRRRKNRTALVVGLSLGGGVLVGGVVLIIW 306
SI SW+F+S+LE D+ TN PV+ +P +K +T L VGL GG VL+G V IW
Sbjct: 249 SISSWDFSSTLEGQQDNNKTNTQDPVTKSPSSNKKAKTGLAVGLGTGGFVLIG-VFGFIW 307
Query: 307 LAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFG 366
+ + RKR+E +ED + F EY+ ++F RG GPK++ Y ELA A N+F D+ KLGQGGFG
Sbjct: 308 VF-LWRKRRE--QEDGE-FQEYMGEDFGRGTGPKKYTYAELANAANNFKDEHKLGQGGFG 363
Query: 367 GVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426
GVY+GF ++T SY+A+K VS+ S QGIKE+ASEV IIS+LRHRNLVQL+GWCH++K+LLL
Sbjct: 364 GVYRGFLKDTKSYVAIKSVSEDSHQGIKEFASEVTIISKLRHRNLVQLIGWCHQRKKLLL 423
Query: 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486
VYE+MPNGSLD HLFK+ SLL W RY IA+ LAS LLYL EEWEQCVVHRDIK+SNIML
Sbjct: 424 VYEYMPNGSLDIHLFKKQSLLKWGVRYTIAKGLASALLYLHEEWEQCVVHRDIKASNIML 483
Query: 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546
DS FNAK+GDFGLAR V+HAKG QTT LAGTMGYMAPECATTG+ASKE+DVYSFGIVALE
Sbjct: 484 DSEFNAKLGDFGLARFVDHAKGGQTTALAGTMGYMAPECATTGRASKETDVYSFGIVALE 543
Query: 547 IACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCA 606
IACGRKPI A + ++++++WVW LYG G+++EAVDPRL D++ +QI+ +MIVGLWCA
Sbjct: 544 IACGRKPI-INAQENEINIVEWVWGLYGRGRIVEAVDPRLDGDYEEEQIKCMMIVGLWCA 602
Query: 607 HPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
HPD N RPSIRQ I VLNFE PLP LP MPVPTYL P
Sbjct: 603 HPDPNNRPSIRQAIQVLNFEVPLPNLPSSMPVPTYLDGP 641
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765964|emb|CAN70210.1| hypothetical protein VITISV_007747 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/633 (64%), Positives = 486/633 (76%), Gaps = 28/633 (4%)
Query: 17 FFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLP-ANRETAGR 74
F I+I F L +IP A++L FN+TSFSP Y+DNITYE AYP N++IQL A + G
Sbjct: 31 FTMISIFFILLMIPSATSLDFNFTSFSP-YNDNITYEGSAYP-RNQIIQLTQAQSASIGW 88
Query: 75 ATYNQSMRLWDKATGNLTDFTTHFSFVIDSRN-SSYYADGLAFFLAPQGSKIPTNKGGGS 133
ATY Q + LWDKA+GNLTDFTTHFSFVID++N S + DG+AFFL P S+ P GG
Sbjct: 89 ATYVQPLHLWDKASGNLTDFTTHFSFVIDTQNRSGSHGDGIAFFLMPADSQKPNVTKGGG 148
Query: 134 FGLTKDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRR 192
GL D +PLN+++ FVAVEFD+Y N WDP +H GIDINSV+S +NV WW + +GR
Sbjct: 149 LGLASDTQPLNTTVNHFVAVEFDIYKNRWDPNDTHAGIDINSVQSIRNVKWWDSIINGRI 208
Query: 193 NEAWISYNSSTHNLSVAFTGFRNNLVVMQ-GLDYQVDLRQHLPEFVTFGFSMATGVDFAI 251
N+AWISYNSS+ NLSV FTGFRN+ ++Q L Y+VDLR +LPE+ + T
Sbjct: 209 NDAWISYNSSSKNLSVVFTGFRNDSTILQDNLYYEVDLRLYLPEWADENKTNPT------ 262
Query: 252 FSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTALVVGLSLGGGVLVGGVVLIIWLAGIG 311
S E + T+NP SNP R+ K + LVVGL++GG VG + L+++L
Sbjct: 263 ----------SPEAETPTSNPNSNPSRKIKVK--LVVGLTVGGCAFVGSLSLVLFLFLKS 310
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKG 371
R+ K + +Q ++D+FE+G GPK+F Y ELA +TN+F ++ KLG+GGFGGVYKG
Sbjct: 311 RRGKVDNPVIDQ---LSMEDDFEKGTGPKKFRYNELASSTNNFAEEGKLGEGGFGGVYKG 367
Query: 372 FFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431
F +E +SYIAVKRVS GSKQGIKEY SEVKIISRLRHRNLVQL+GWCHEK++LLLVYEFM
Sbjct: 368 FLKELDSYIAVKRVSSGSKQGIKEYVSEVKIISRLRHRNLVQLIGWCHEKRDLLLVYEFM 427
Query: 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491
PNGSL+SHLF E SLLTWE RYKIAQ LAS LLYL E WEQCV+HRDIKSSNIMLDS FN
Sbjct: 428 PNGSLESHLFSERSLLTWEMRYKIAQGLASALLYLHEGWEQCVLHRDIKSSNIMLDSGFN 487
Query: 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551
AK+GDFGLARLV+H KGSQTTVLAGTMGYMAPECATTGKASK+SD+YSFG+VALEIACGR
Sbjct: 488 AKLGDFGLARLVDHGKGSQTTVLAGTMGYMAPECATTGKASKQSDIYSFGVVALEIACGR 547
Query: 552 KPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDEN 611
KPIN KA + Q+ +L+WVWDLYG G +LEA DPRLC +FD QQ++ LM VGLWCAHPD N
Sbjct: 548 KPINLKAKEDQIMMLEWVWDLYGKGNILEAADPRLCAEFDAQQMQCLMTVGLWCAHPDRN 607
Query: 612 LRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSP 644
LRPS+R+VIHVLNFEAPLP LPPKMPVPTY P
Sbjct: 608 LRPSVREVIHVLNFEAPLPILPPKMPVPTYSIP 640
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519481|ref|XP_003528401.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/643 (61%), Positives = 484/643 (75%), Gaps = 27/643 (4%)
Query: 24 FCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE------TAGRATY 77
F L IIP AS+L+FN+TSF P D +I +E + IQL N+ + GRATY
Sbjct: 6 FFLLIIPYASSLSFNFTSFDPN-DKSIVFEGSANPVAPTIQLTRNQMDKGMIGSIGRATY 64
Query: 78 NQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLT 137
Q M+LWDKATGNLTDFTTHFSFVIDS+N S Y DG+AFFLAP GSKIP G S GLT
Sbjct: 65 YQPMQLWDKATGNLTDFTTHFSFVIDSQNRSKYGDGIAFFLAPAGSKIPNATKGASMGLT 124
Query: 138 KDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAW 196
DN+ LNS+ FVAVEFD+Y N WDP HVGIDINS++S NV+W +D+K G+ NEAW
Sbjct: 125 LDNQQLNSTDNSFVAVEFDIYQNGWDPPHEHVGIDINSMRSASNVTWLADIKEGKLNEAW 184
Query: 197 ISYNSSTHNLSVAFTGFRNNL---VVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS 253
ISYNSS+ NLSV FTGF N+ + Q L VDLR HLPE V+FGFS ATG AI S
Sbjct: 185 ISYNSSSLNLSVVFTGFNNDTDHTIQQQHLSAIVDLRLHLPELVSFGFSAATGNATAIHS 244
Query: 254 IYSWEFNSSLEMDDETT--------NPVSN--PKRRRKNRTALVVGLSLGGGVL-VGGVV 302
+YSW+F S+L + T +P SN P +++KN+T L VGLS+GG V +G +
Sbjct: 245 LYSWDFTSTLAAQENITKGADPVARSPTSNIAPSQKKKNKTGLAVGLSIGGFVCGLGLIS 304
Query: 303 LIIWLAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQ 362
+++W +K K+G EE+ F E++ ++F RG +++ Y ELA A N F D+QKLGQ
Sbjct: 305 IVLW-----KKWKKGTEEEEHDFEEFMGEDFGRGVETRKYSYAELAQAANGFKDEQKLGQ 359
Query: 363 GGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422
GGFGGVY+G+ ++ S++A+KRVS+ S QGIKE+ASE++ I+RLRHRNLV L+GWCHE+K
Sbjct: 360 GGFGGVYRGYLKDIKSHVAIKRVSEDSDQGIKEFASEIRTINRLRHRNLVHLIGWCHERK 419
Query: 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482
+LLLVYE+MPNGSLD+HLFK+ SLL W RY IA+ LAS LLYL EEWEQCVVHRDIKSS
Sbjct: 420 KLLLVYEYMPNGSLDTHLFKKQSLLKWAVRYNIARGLASALLYLHEEWEQCVVHRDIKSS 479
Query: 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGI 542
NIMLDS FNAK+GDFGLAR V+HAKG+QTT LAGTMGYMAPECAT G+ASKESDVYS G+
Sbjct: 480 NIMLDSEFNAKLGDFGLARFVDHAKGAQTTALAGTMGYMAPECATLGRASKESDVYSCGV 539
Query: 543 VALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602
VALEIACGRKPIN KA + +++++QWVW+L+G G++L+A DPRL DF+ +QI+ LMIVG
Sbjct: 540 VALEIACGRKPINLKAQENEINIVQWVWELFGGGRILDAADPRLEGDFEEEQIKCLMIVG 599
Query: 603 LWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
LWCAHPD N R SIRQ I VLNFEAPLP LP +PVPTYL P
Sbjct: 600 LWCAHPDHNNRASIRQAIQVLNFEAPLPNLPSSLPVPTYLDGP 642
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528003|ref|XP_003532595.1| PREDICTED: L-type lectin-domain containing receptor kinase IX.1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1983), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/630 (60%), Positives = 468/630 (74%), Gaps = 23/630 (3%)
Query: 24 FCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE------TAGRATY 77
F L IIP AS+L+FN+ SF P D+ I Y R+ IQL N+ + GRATY
Sbjct: 6 FFLLIIPYASSLSFNFPSFDPN-DNRIIYNRSANAVAPNIQLTTNQADKGMNGSIGRATY 64
Query: 78 NQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLT 137
Q M LWDKATG LTDF+T+FSFVI+SR S Y DG+AFFLAP GS +P + GG+ GLT
Sbjct: 65 YQPMHLWDKATGTLTDFSTNFSFVINSRGQSVYGDGIAFFLAPAGSMVPNSTLGGTMGLT 124
Query: 138 KDNEPLNSSI-PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAW 196
DN+ LNS+ PFVAVEFD++ N WDP HVGIDINS++S N +W +D+K G+ N+A
Sbjct: 125 LDNQILNSTDNPFVAVEFDIFGNDWDPPGEHVGIDINSLRSVANATWLADIKGGKVNQAL 184
Query: 197 ISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYS 256
ISYNS++ NLSVAFTGF+N ++ L VDL+ +LPEFVT GFS ATG AI ++ S
Sbjct: 185 ISYNSTSLNLSVAFTGFKNGTALLHHLSVIVDLKLYLPEFVTVGFSAATGNLTAIHTLNS 244
Query: 257 WEFNSSLEMDDETTNPVSNPKRRRKNRTALVVGLSLGGGVLVGGVVLIIWLAGIGRKRKE 316
W+FNS+ + P +++K++ AL VGL +GG VL+ G+ LI R K+
Sbjct: 245 WDFNST---------SIIAPSQKKKDKKALAVGLGVGGFVLIAGLGLISI-----RLWKK 290
Query: 317 GDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRET 376
EE++ F EYID++FERGAGP+++ Y ELA A N F D+ KLGQGGFGGVYKG+ ++
Sbjct: 291 TSEEEDHDFEEYIDEDFERGAGPQKYSYAELAQAANGFKDEHKLGQGGFGGVYKGYLKDL 350
Query: 377 NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436
S++A+K+VS+GS QGIKE+ASEV+IISRLRHRNLV L+GWCH K+LLLVYE+M NGSL
Sbjct: 351 KSHVAIKKVSEGSDQGIKEFASEVRIISRLRHRNLVNLIGWCHAGKKLLLVYEYMSNGSL 410
Query: 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496
D HLFK+ S+L W RY IA+ LAS LLYL EEWEQCVVHRDIK SNIMLDS FNAK+GD
Sbjct: 411 DIHLFKKQSILQWAVRYNIARGLASALLYLHEEWEQCVVHRDIKPSNIMLDSEFNAKLGD 470
Query: 497 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPIN 555
FGLAR V+HAK +QTT LAGTMGYMAPEC + ASKESDVYSFG+VALEIACGRKPIN
Sbjct: 471 FGLARFVDHAKSAQTTALAGTMGYMAPECTLGYRPASKESDVYSFGVVALEIACGRKPIN 530
Query: 556 PKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS 615
+A + ++S++QWVW LYG G++LEA D RL F+ +QI+ LMIVGLWCAHPD + RPS
Sbjct: 531 HRAQENEISIVQWVWGLYGEGRILEAADQRLEGKFEEEQIKCLMIVGLWCAHPDHSNRPS 590
Query: 616 IRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
IRQ I VLNFEAPLP LP +PVPTYL P
Sbjct: 591 IRQAIQVLNFEAPLPNLPSSLPVPTYLEHP 620
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 645 | ||||||
| TAIR|locus:2142499 | 651 | AT5G10530 [Arabidopsis thalian | 0.941 | 0.932 | 0.444 | 9.3e-130 | |
| TAIR|locus:2155685 | 675 | AT5G65600 [Arabidopsis thalian | 0.962 | 0.92 | 0.423 | 2.2e-121 | |
| TAIR|locus:2162212 | 681 | AT5G55830 [Arabidopsis thalian | 0.446 | 0.422 | 0.515 | 9.9e-95 | |
| TAIR|locus:2083986 | 715 | AT3G53380 [Arabidopsis thalian | 0.441 | 0.398 | 0.491 | 8.9e-92 | |
| TAIR|locus:2143528 | 711 | AT5G03140 [Arabidopsis thalian | 0.455 | 0.413 | 0.460 | 1e-88 | |
| TAIR|locus:2099941 | 684 | AT3G55550 [Arabidopsis thalian | 0.908 | 0.856 | 0.344 | 2.4e-85 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.928 | 0.884 | 0.338 | 3.8e-85 | |
| TAIR|locus:2020608 | 666 | AT1G70110 [Arabidopsis thalian | 0.460 | 0.445 | 0.448 | 1.3e-84 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.462 | 0.442 | 0.438 | 4.5e-82 | |
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.928 | 0.887 | 0.330 | 7.4e-82 |
| TAIR|locus:2142499 AT5G10530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 282/635 (44%), Positives = 371/635 (58%)
Query: 20 ITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRET--AGRATY 77
+ SF L ++P ++ FN + F + I Y+ +N ++L T AG ATY
Sbjct: 6 LLFSFVL-VLPFVCSVQFNISRFGSDVSE-IAYQ-GDARANGAVELTNIDYTCRAGWATY 62
Query: 78 NQSMRLWDKATGNLTDFTTHFSFVIDSRNSSY--YADGLAFFLAPQGSKIPTNKGGGSFG 135
+ + LW+ T +DF+T FSF ID+RN Y Y G AFFLAP ++P N GG G
Sbjct: 63 GKQVPLWNPGTSKPSDFSTRFSFRIDTRNVGYGNYGHGFAFFLAPARIQLPPNSAGGFLG 122
Query: 136 LTKDNEPLNSSIPFVAVEFDVYVN-SWDP--TFSHVGIDIXXXXXXXXXXXXXXXXXGRR 192
L +S+ P V VEFD + N WDP SHVGI+
Sbjct: 123 LFNGTNNQSSAFPLVYVEFDTFTNPEWDPLDVKSHVGINNNSLVSSNYTSWNATSHNQDI 182
Query: 193 NEAWISYNSSTHNLSVAFT-GFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAI 251
I Y+S+ NLSV++T ++ + L Y +DL + LP VT GFS +G
Sbjct: 183 GRVLIFYDSARRNLSVSWTYDLTSDPLENSSLSYIIDLSKVLPSEVTIGFSATSGGVTEG 242
Query: 252 FSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTAXXXXXXXXXXXXXXXXXXXXXXXXXX 311
+ SWEF+SSLE+ D ++ +N
Sbjct: 243 NRLLSWEFSSSLELIDI---------KKSQNDKKGMIIGISVSGFVLLTFFITSLIVFLK 293
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLXXXXXXXXXXX 371
RK+++ E+ + + I+++ ERGAGP++F YK+LA A N+F DD+KL
Sbjct: 294 RKQQKKKAEETENLTS-INEDLERGAGPRKFTYKDLASAANNFADDRKLGEGGFGAVYRG 352
Query: 372 XXRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431
+ +A+K+ + GSKQG +E+ +EVKIIS LRHRNLVQL+GWCHEK E L++YEFM
Sbjct: 353 YLNSLDMMVAIKKFAGGSKQGKREFVTEVKIISSLRHRNLVQLIGWCHEKDEFLMIYEFM 412
Query: 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491
PNGSLD+HLF + L W R KI LAS LLYL EEWEQCVVHRDIK+SN+MLDSNFN
Sbjct: 413 PNGSLDAHLFGKKPHLAWHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFN 472
Query: 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551
AK+GDFGLARL++H G QTT LAGT GYMAPE +TG+ASKESDVYSFG+V LEI GR
Sbjct: 473 AKLGDFGLARLMDHELGPQTTGLAGTFGYMAPEYISTGRASKESDVYSFGVVTLEIVTGR 532
Query: 552 KPINPKAPQGQV----SLLQWVWDLYGNGKLLEAVDPRL-CRDFDGQQIERLMIVGLWCA 606
K ++ + QG+V +L++ +WDLYG G+++ A+D +L FD +Q E LMIVGLWCA
Sbjct: 533 KSVDRR--QGRVEPVTNLVEKMWDLYGKGEVITAIDEKLRIGGFDEKQAECLMIVGLWCA 590
Query: 607 HPDENLRPSIRQVIHVLNFEXXXXXXXXKMPVPTY 641
HPD N RPSI+Q I VLN E KMPV TY
Sbjct: 591 HPDVNTRPSIKQAIQVLNLEAPVPHLPTKMPVATY 625
|
|
| TAIR|locus:2155685 AT5G65600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
Identities = 278/657 (42%), Positives = 367/657 (55%)
Query: 4 CNTCSSNSPLLLSFFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYER-AYPDSNRV 62
C SS+S + S +++ L + +L FN+TSF +I Y A PD +
Sbjct: 7 CQNLSSSSSMSNSILFLSLFLFLPFV--VDSLYFNFTSFRQGDPGDIFYHGDATPDEDGT 64
Query: 63 IQLPANRETA--GRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAP 120
+ +T+ G TY++ + +W TG +DF+T FSF ID+RN S G+ FFLAP
Sbjct: 65 VNFNNAEQTSQVGWITYSKKVPIWSHKTGKASDFSTSFSFKIDARNLSADGHGICFFLAP 124
Query: 121 QGSKIPTNKGGGSFGL-TKDNEPLNSSIPFVAVEFDVYVN-SWDPTF--SHVGIDIXXXX 176
G+++P GG L T+ N +SS P V VEFD + N WDP SHVGI+
Sbjct: 125 MGAQLPAYSVGGFLNLFTRKNN-YSSSFPLVHVEFDTFNNPGWDPNDVGSHVGINNNSLV 183
Query: 177 XXXXXXXXXXXXXGRRNEAWISYNSSTHNLSVAFT---GFRNNLVVMQGLDYQVDLRQHL 233
A ISY+S T NLSV + ++ L Y +DL + L
Sbjct: 184 SSNYTSWNASSHSQDICHAKISYDSVTKNLSVTWAYELTATSDPKESSSLSYIIDLAKVL 243
Query: 234 PEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTAXXXXXXXX 293
P V FGF A G + + SWE +SSL+ D K +
Sbjct: 244 PSDVMFGFIAAAGTNTEEHRLLSWELSSSLDSD----------KADSRIGLVIGISASGF 293
Query: 294 XXXXXXXXXXXXXXXXXXRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATND 353
RK+KE D E+ I+ + ER AGP++F YK+L ATN
Sbjct: 294 VFLTFMVITTVVVWSRKQRKKKERDIENMIS----INKDLEREAGPRKFSYKDLVSATNR 349
Query: 354 FNDDQKLXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
F+ +KL +E N+ +AVK++S S+QG E+ +EVKIIS+LRHRNLVQ
Sbjct: 350 FSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGDSRQGKNEFLNEVKIISKLRHRNLVQ 409
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLF-KENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
L+GWC+EK E LL+YE +PNGSL+SHLF K +LL+W+ RYKI LAS LLYL EEW+Q
Sbjct: 410 LIGWCNEKNEFLLIYELVPNGSLNSHLFGKRPNLLSWDIRYKIGLGLASALLYLHEEWDQ 469
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
CV+HRDIK+SNIMLDS FN K+GDFGLARL+ H GS TT LAGT GYMAPE G AS
Sbjct: 470 CVLHRDIKASNIMLDSEFNVKLGDFGLARLMNHELGSHTTGLAGTFGYMAPEYVMKGSAS 529
Query: 533 KESDVYSFGIVALEIACGRKPI-------NPKAPQGQVSLLQWVWDLYGNGKLLEA-VDP 584
KESD+YSFGIV LEI GRK + + + SL++ VW+LYG +L+ + VD
Sbjct: 530 KESDIYSFGIVLLEIVTGRKSLERTQEDNSDTESDDEKSLVEKVWELYGKQELITSCVDD 589
Query: 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEXXXXXXXXKMPVPTY 641
+L DFD ++ E L+++GLWCAHPD+N RPSI+Q I V+NFE K PV Y
Sbjct: 590 KLGEDFDKKEAECLLVLGLWCAHPDKNSRPSIKQGIQVMNFESPLPDLPLKRPVAMY 646
|
|
| TAIR|locus:2162212 AT5G55830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 9.9e-95, Sum P(2) = 9.9e-95
Identities = 152/295 (51%), Positives = 201/295 (68%)
Query: 338 GPKRFPYKELALATNDFNDDQKLXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYA 397
G + F YKEL AT F+ + + + + AVKR S +G E+
Sbjct: 349 GLREFSYKELYTATKGFHSSRVIGRGAFGNVYRAMFVSSGTISAVKRSRHNSTEGKTEFL 408
Query: 398 SEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL----LTWEFRY 453
+E+ II+ LRH+NLVQL GWC+EK ELLLVYEFMPNGSLD L++E+ L W R
Sbjct: 409 AELSIIACLRHKNLVQLQGWCNEKGELLLVYEFMPNGSLDKILYQESQTGAVALDWSHRL 468
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513
IA LAS L YL E EQ VVHRDIK+SNIMLD NFNA++GDFGLARL EH K +T+
Sbjct: 469 NIAIGLASALSYLHHECEQQVVHRDIKTSNIMLDINFNARLGDFGLARLTEHDKSPVSTL 528
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ--VSLLQWVWD 571
AGTMGY+APE G A++++D +S+G+V LE+ACGR+PI+ K P+ Q V+L+ WVW
Sbjct: 529 TAGTMGYLAPEYLQYGTATEKTDAFSYGVVILEVACGRRPID-KEPESQKTVNLVDWVWR 587
Query: 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626
L+ G++LEAVD RL +FD + +++L++VGL CAHPD N RPS+R+V+ +LN E
Sbjct: 588 LHSEGRVLEAVDERLKGEFDEEMMKKLLLVGLKCAHPDSNERPSMRRVLQILNNE 642
|
|
| TAIR|locus:2083986 AT3G53380 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 8.9e-92, Sum P(2) = 8.9e-92
Identities = 143/291 (49%), Positives = 187/291 (64%)
Query: 339 PKRFPYKELALATNDFNDDQKLXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYAS 398
PK F YKEL T +FN+ + + ET +AVKR S S+ E+ S
Sbjct: 361 PKEFSYKELKAGTKNFNESRIIGHGAFGVVYRGILPETGDIVAVKRCSHSSQDKKNEFLS 420
Query: 399 EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD 458
E+ II LRHRNLV+L GWCHEK E+LLVY+ MPNGSLD LF+ L W+ R KI
Sbjct: 421 ELSIIGSLRHRNLVRLQGWCHEKGEILLVYDLMPNGSLDKALFESRFTLPWDHRKKILLG 480
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+AS L YL E E V+HRD+KSSNIMLD +FNAK+GDFGLAR +EH K + TV AGTM
Sbjct: 481 VASALAYLHRECENQVIHRDVKSSNIMLDESFNAKLGDFGLARQIEHDKSPEATVAAGTM 540
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKPINP--KAPQGQV----SLLQWVWDL 572
GY+APE TG+AS+++DV+S+G V LE+ GR+PI + V +L++WVW L
Sbjct: 541 GYLAPEYLLTGRASEKTDVFSYGAVVLEVVSGRRPIEKDLNVQRHNVGVNPNLVEWVWGL 600
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
Y GK+ A D RL FD ++ R+++VGL C+HPD RP++R V+ +L
Sbjct: 601 YKEGKVSAAADSRLEGKFDEGEMWRVLVVGLACSHPDPAFRPTMRSVVQML 651
|
|
| TAIR|locus:2143528 AT5G03140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.0e-88, Sum P(2) = 1.0e-88
Identities = 140/304 (46%), Positives = 196/304 (64%)
Query: 326 SEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLXXXXXXXXXXXXXRETNSYIAVKRV 385
SE + E + P+ F YKEL LAT+ F+ + + +++ IA+KR
Sbjct: 348 SESLASEIMKS--PREFTYKELKLATDCFSSSRVIGNGAFGTVYKGILQDSGEIIAIKRC 405
Query: 386 SQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS 445
S S QG E+ SE+ +I LRHRNL++L G+C EK E+LL+Y+ MPNGSLD L++ +
Sbjct: 406 SHIS-QGNTEFLSELSLIGTLRHRNLLRLQGYCREKGEILLIYDLMPNGSLDKALYESPT 464
Query: 446 LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
L W R KI +AS L YL +E E ++HRD+K+SNIMLD+NFN K+GDFGLAR EH
Sbjct: 465 TLPWPHRRKILLGVASALAYLHQECENQIIHRDVKTSNIMLDANFNPKLGDFGLARQTEH 524
Query: 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ-G--- 561
K T AGTMGY+APE TG+A++++DV+S+G V LE+ GR+PI P+ G
Sbjct: 525 DKSPDATAAAGTMGYLAPEYLLTGRATEKTDVFSYGAVVLEVCTGRRPITRPEPEPGLRP 584
Query: 562 --QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ SL+ WVW LY GKLL AVD RL +F+ +++ R+M+VGL C+ PD RP++R V
Sbjct: 585 GLRSSLVDWVWGLYREGKLLTAVDERLS-EFNPEEMSRVMMVGLACSQPDPVTRPTMRSV 643
Query: 620 IHVL 623
+ +L
Sbjct: 644 VQIL 647
|
|
| TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 218/633 (34%), Positives = 318/633 (50%)
Query: 18 FTITISFCLTIIPLASALT--FNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRETA-G 73
F + + + + L S+L F++ F + N+T A I+L + G
Sbjct: 5 FAVILLLLIFLTHLVSSLIQDFSFIGFK-KASPNLTLNGVAEIAPTGAIRLTTETQRVIG 63
Query: 74 RATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAP----QGSKIPTNK 129
A Y+ +R F+T F+ + + GLAF + P +GS +P+
Sbjct: 64 HAFYSLPIRFKPIGVNRALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGS-LPSQY 122
Query: 130 GGGSFGLTKDNEPLNSSIPFVAVEFDVY--VNSWDPTFSHVGIDIXXXXXXXXXXXXXXX 187
GL + +N S F AVEFD + D +HVGIDI
Sbjct: 123 ----LGLLNSSR-VNFSSHFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFL 177
Query: 188 XX----------GRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFV 237
GR +AWI Y+S+ L V + F + L Y VDL L + +
Sbjct: 178 ANSTKKELFLDGGRVIQAWIDYDSNKKRLDVKLSPFSEK-PKLSLLSYDVDLSSVLGDEM 236
Query: 238 TFGFSMATGVDFAIFSIYSWEFNSS-----LEMDDETTNPVSNPKRRRKNRTAXXXXXXX 292
GFS +TG+ + I W FN S L + P S KR++K ++
Sbjct: 237 YVGFSASTGLLASSHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLL 296
Query: 293 XXXXXXXXXXXXXXXXXXXRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN 352
RK K+ D + E+E GP RF Y+EL ATN
Sbjct: 297 CSLLIFAVLVAASLFVV--RKVKDEDRVE----------EWELDFGPHRFSYRELKKATN 344
Query: 353 DFNDDQKLXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
F D + L ++ ++AVKR+S S+QG++E+ SEV I LRHRNLV
Sbjct: 345 GFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLV 404
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS--LLTWEFRYKIAQDLASGLLYLQEEW 470
QLLGWC + +LLLVY+FMPNGSLD +LF EN +LTW+ R+KI + +ASGLLYL E W
Sbjct: 405 QLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGW 464
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
EQ V+HRDIK++N++LDS N ++GDFGLA+L EH T + GT GY+APE +GK
Sbjct: 465 EQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGK 524
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590
+ +DVY+FG V LE+ACGR+PI A ++ ++ WVW + +G + + VD RL +F
Sbjct: 525 LTTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEF 584
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
D +++ ++ +GL C++ +RP++RQV+ L
Sbjct: 585 DEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL 617
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 852 (305.0 bits), Expect = 3.8e-85, P = 3.8e-85
Identities = 212/627 (33%), Positives = 313/627 (49%)
Query: 13 LLLSFFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLP-ANRET 71
L L FF + C +I + L F Y F P D A N +++L + +
Sbjct: 5 LKLIFFFFLL--CQIMISSSQNLNFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQK 62
Query: 72 AGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGG 131
G A + +R D GN++ F+T F F I S+ + G+AF +AP +P
Sbjct: 63 TGHAFCTERIRFKDSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLG-LPFALPS 121
Query: 132 GSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDIXXXXXXXXXXXXX---- 185
GL + N + AVEFD +S DP +HVGID+
Sbjct: 122 QYIGLFNISNNGNDTNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDH 181
Query: 186 ------XXXXGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTF 239
+R + WI Y++ +H + V F ++ + Y DL L E +
Sbjct: 182 DKFQNLSLISRKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYV 241
Query: 240 GFSMATGVDFAIFSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTAXXXXXXXXXXXXXX 299
GFS ATG + + W F + E + + + R R +
Sbjct: 242 GFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSL 301
Query: 300 XXXXXXXXXXXXRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQK 359
R++K+ +EE +DD +E G RF +KEL AT F +
Sbjct: 302 IFSIIFLAFYIVRRKKKYEEE--------LDD-WETEFGKNRFRFKELYHATKGFKEKDL 352
Query: 360 LXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419
L T +AVKRVS SKQG+KE+ +E+ I R+ HRNLV LLG+C
Sbjct: 353 LGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCR 412
Query: 420 EKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
+ ELLLVY++MPNGSLD +L+ + L W+ R I + +ASGL YL EEWEQ V+HRD
Sbjct: 413 RRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRD 472
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
+K+SN++LD++FN ++GDFGLARL +H QTT + GT+GY+APE + TG+A+ +DVY
Sbjct: 473 VKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVY 532
Query: 539 SFGIVALEIACGRKPIN-PKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL-CRDFDGQQIE 596
+FG LE+ GR+PI A L++WV+ L+ G ++EA DP+L +D +++E
Sbjct: 533 AFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVE 592
Query: 597 RLMIVGLWCAHPDENLRPSIRQVIHVL 623
++ +GL C+H D RPS+RQV+ L
Sbjct: 593 MVLKLGLLCSHSDPRARPSMRQVLQYL 619
|
|
| TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 690 (248.0 bits), Expect = 1.3e-84, Sum P(2) = 1.3e-84
Identities = 134/299 (44%), Positives = 200/299 (66%)
Query: 327 EYIDDEFERGAGPKRFPYKELALATNDFNDDQKLXXXXXXXXXXXXXRETNSYIAVKRVS 386
E ++D +E GP RF +K+L +AT F D + L +N IAVK VS
Sbjct: 318 EVLED-WEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVS 376
Query: 387 QGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF-KENS 445
S+QG++E+ +E+ I RLRH NLV+L G+C K EL LVY+ M GSLD L+ ++
Sbjct: 377 HDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTG 436
Query: 446 LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
L W R+KI +D+ASGL YL ++W Q ++HRDIK +NI+LD+N NAK+GDFGLA+L +H
Sbjct: 437 NLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDH 496
Query: 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL 565
QT+ +AGT+GY++PE + TGKAS SDV++FGIV LEIACGRKPI P+A Q ++ L
Sbjct: 497 GTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVL 556
Query: 566 LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
WV + + N +++ +D ++ +++ +Q ++ +GL+C+HP +RP++ VI +L+
Sbjct: 557 TDWVLECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLD 615
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 678 (243.7 bits), Expect = 4.5e-82, Sum P(2) = 4.5e-82
Identities = 132/301 (43%), Positives = 193/301 (64%)
Query: 325 FSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLXXXXXXXXXXXXXRETNSYIAVKR 384
F+E +D +E G R +K+L AT F D L T IAVKR
Sbjct: 327 FAEEFED-WETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKR 385
Query: 385 VSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK-E 443
VS S+QG+KE+ +E+ I R+ HRNLV LLG+C + ELLLVY++MPNGSLD +L+
Sbjct: 386 VSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCP 445
Query: 444 NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
L W+ R+ + +ASGL YL EEWEQ V+HRDIK+SN++LD+ +N ++GDFGLARL
Sbjct: 446 EVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLC 505
Query: 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ- 562
+H QTT + GT GY+AP+ TG+A+ +DV++FG++ LE+ACGR+PI + +
Sbjct: 506 DHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDES 565
Query: 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
V L+ V+ + G +L+A DP L +D +++E ++ +GL C+H D +RP++RQV+
Sbjct: 566 VLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQY 625
Query: 623 L 623
L
Sbjct: 626 L 626
|
|
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 7.4e-82, P = 7.4e-82
Identities = 208/630 (33%), Positives = 312/630 (49%)
Query: 13 LLLSFFTITISFCLTIIPLASA--LTFNYTS-FSPQYDDNIT-YERAYPDSNRVIQLPAN 68
+ L TI F +I +S+ L F Y + F+P D +I P N +++L
Sbjct: 1 MFLKLLTIFFFFFFNLIFQSSSQSLNFAYNNGFNPPTDLSIQGITTVTP--NGLLKLTNT 58
Query: 69 R-ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPT 127
+ G A Y + +R D G ++ F+T F F I S+ + G+AF +AP S +P
Sbjct: 59 TVQKTGHAFYTKPIRFKDSPNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNAS-LPY 117
Query: 128 NKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW--DPTFSHVGIDIXXXXXXXXXXXXX 185
GL N + AVE D +++ D +HVGIDI
Sbjct: 118 GNPSQYIGLFNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGY 177
Query: 186 XXXXGR-RN---------EAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPE 235
G+ +N + W+ Y+ T+ + V F + + DL L +
Sbjct: 178 WDEKGQFKNLTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQ 237
Query: 236 FVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDETTNPVSNPKRRRKNRTAXXXXXXXXXX 295
+ GFS ATG + I W F + + + + R R +
Sbjct: 238 DMYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLI 297
Query: 296 XXXXXXXXXXXXXXXXRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFN 355
R+R++ F+E ++ E+E+ G RF +K+L AT F
Sbjct: 298 SLFLIFSFIFLVCYIVRRRRK--------FAEELE-EWEKEFGKNRFRFKDLYYATKGFK 348
Query: 356 DDQKLXXXXXXXXXXXXXRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+ L T IAVKRVS S+QG+KE+ +E+ I R+ HRNLV LL
Sbjct: 349 EKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLL 408
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEWEQCV 474
G+C + ELLLVY++MPNGSLD +L+ + L W+ R K+ +ASGL YL EEWEQ V
Sbjct: 409 GYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVV 468
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKE 534
+HRD+K+SN++LD N ++GDFGLARL +H QTT + GT+GY+APE TG+A+
Sbjct: 469 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMA 528
Query: 535 SDVYSFGIVALEIACGRKPINPKAPQGQVSLL-QWVWDLYGNGKLLEAVDPRLCRDFDGQ 593
+DV++FG LE+ACGR+PI + + LL WV+ L+ G +L A DP + + D +
Sbjct: 529 TDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEK 588
Query: 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
++E ++ +GL C+H D RPS+RQV+H L
Sbjct: 589 EVEMVLKLGLLCSHSDPRARPSMRQVLHYL 618
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LXA5 | LRK91_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4799 | 0.9441 | 0.9354 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 645 | |||
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 5e-75 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-57 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-56 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-52 | |
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 3e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-29 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-28 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-27 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-27 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-25 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-24 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-22 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-18 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 5e-75
Identities = 99/238 (41%), Positives = 127/238 (53%), Gaps = 11/238 (4%)
Query: 35 LTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE---TAGRATYNQSMRLWDKATGN 90
L+FN+ FS N+T + A SN +QL + + GRA Y++ +RLWD TG
Sbjct: 1 LSFNFNGFSS-DQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGK 59
Query: 91 LTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFV 150
+ F+T FSF I N S DGLAFFLAP S P GG GL + NSS V
Sbjct: 60 VASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPP-ASSGGYLGLFNSSNNGNSSNHIV 118
Query: 151 AVEFDVYVNSW--DPTFSHVGIDINSVKSKKNVSWWSD---VKSGRRNEAWISYNSSTHN 205
AVEFD + N DP +HVGID+NS+ S K W D +KSG+ +AWI Y+SS+
Sbjct: 119 AVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSSKR 178
Query: 206 LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSL 263
LSV L Y VDL + LPE V GFS +TG+ + I SW F+S+
Sbjct: 179 LSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 9e-57
Identities = 65/191 (34%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLGWC 418
LG+GGFG VY ++T +A+K + + + E E++I+ +L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
++ L LV E+ GSL L + L+ + +I + GL YL ++HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 479 IKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TGKASKESD 536
+K NI+LDS N K+ DFGL++L+ S + GT YMAPE G S++SD
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS-DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 537 VYSFGIVALEI 547
++S G++ E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 8e-56
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 7/201 (3%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLV 412
+ +KLG+G FG VY ++T +A+K + + + +E E+KI+ +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+L ++ +L LV E+ G L L K L E R+ + + S L YL +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLHS---K 116
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
+VHRD+K NI+LD + + K+ DFGLAR ++ G + T GT YMAPE
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 533 KESDVYSFGIVALEIACGRKP 553
K D++S G++ E+ G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 40/282 (14%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHRNL 411
+ +KLG G FG VYK + T +AVK + + + E++I+ RL H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+L+ +K L LV E+ G L +L + L E + KIA + GL YL
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAK-KIALQILRGLEYLHSNG- 118
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTGK 530
++HRD+K NI+LD N KI DFGLA+ + S T GT YMAPE
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 531 ASKESDVYSFGIVALEIACGRKP-----------INPKAPQGQVSLLQWVWDLYGNGKLL 579
+ DV+S G++ E+ G+ P + + + + W
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS------- 228
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+D I+ C + D + RP+ +++
Sbjct: 229 ---GSEEAKDL----IK-------KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 86/276 (31%), Positives = 136/276 (49%), Gaps = 31/276 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+KLG+G FG VYKG + +AVK + + S+Q I+E+ E +I+ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+LLG C E++ L +V E+M G L S+L K L+ A +A G+ YL+
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATT 528
+ +HRD+ + N ++ N KI DFGL+R + G +MAPE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYRKRGGKLPIRWMAPESLKE 177
Query: 529 GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
GK + +SDV+SFG++ EI G +P + + +L+++ NG L P C
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE---EVLEYL----KNGYRLPQ--PPNC 228
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+ LM L C D RP+ +++ +L
Sbjct: 229 PPE----LYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 84/277 (30%), Positives = 136/277 (49%), Gaps = 32/277 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+KLG+G FG VYKG + +AVK + + S+Q I+E+ E +I+ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
V+LLG C E++ L++V E+MP G L +L L+ A +A G+ YL+
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECAT 527
+ +HRD+ + N ++ N KI DFGL+R + + G +MAPE
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD---DDYYKVKGGKLPIRWMAPESLK 177
Query: 528 TGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586
GK + +SDV+SFG++ EI G +P + +L+++ G L P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA---EVLEYL----KKGYRLPK--PPN 228
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
C + +LM L C D RP+ +++ +L
Sbjct: 229 CPPE----LYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-52
Identities = 86/276 (31%), Positives = 136/276 (49%), Gaps = 30/276 (10%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+KLG+G FG VYKG + +AVK + +G S++ +E+ E I+ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+LLG C + + L +V E+MP G L L K LT + ++A +A G+ YL+
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATT 528
+ VHRD+ + N ++ N KI DFGL+R + + G +MAPE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIY--EDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 529 GKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
GK + +SDV+SFG++ EI G +P + + + LL+ +G L P C
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE-------DGYRLPR--PENC 229
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
++ LM L C D RP+ +++ L
Sbjct: 230 ----PDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-51
Identities = 91/243 (37%), Positives = 121/243 (49%), Gaps = 27/243 (11%)
Query: 33 SALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATGN 90
S ++FNY FS N+T + A N ++QL +AGRA Y++ +RLWD +TG
Sbjct: 1 STVSFNYNGFSNV--SNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTGK 58
Query: 91 LTDFTTHFSFVIDSRNSSY-YADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
+ F+T F F I + S DGLAFFLAP G+ P GG GL + NSS
Sbjct: 59 VASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGT-QPGASSGGYLGLFNSSNNGNSSNHI 117
Query: 150 VAVEFDVY----VNSWDPTFSHVGIDINSVKSKK-----NVSWWSDVKSGRRNEAWISYN 200
VAVEFD + N D +HVGID+NS+ S V D+ SG+ + WI Y+
Sbjct: 118 VAVEFDTFLNPEFNDIDD--NHVGIDVNSIISVASESASFVPL--DLNSGKPIQVWIDYD 173
Query: 201 SSTHNLSVAFTGF---RNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSW 257
S+ LSV + L L VDL LPE+V GFS +TG + SW
Sbjct: 174 GSSKRLSVTLAYPNKPKRPL-----LSASVDLSTVLPEWVYVGFSASTGGATESHYVLSW 228
Query: 258 EFN 260
F+
Sbjct: 229 SFS 231
|
Length = 231 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 1e-50
Identities = 85/283 (30%), Positives = 135/283 (47%), Gaps = 41/283 (14%)
Query: 359 KLGQGGFGGVYKGFFRETNSY---IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQL 414
KLG+G FG VYKG + + +AVK + + S++ K++ E +++ +L H N+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHL--------FKENSLLTWEFRYKIAQDLASGLLYL 466
LG C E++ L LV E+M G L +L E S L+ + A +A G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YM 521
+ VHRD+ + N ++ + KI DFGL+R V + T G +M
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRWM 174
Query: 522 APECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580
APE G + +SDV+SFG++ EI G P + + +L+++ G L
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL----RKGYRLP 227
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
P C D ++ LM L C D RP+ +++ L
Sbjct: 228 K--PEYCPD----ELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 6e-49
Identities = 77/276 (27%), Positives = 125/276 (45%), Gaps = 43/276 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+ LG+G FG VY ++T +AVK +S S++ ++ E++I+S L+H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 416 GWCH--EKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYLQE 468
G EK L + E++ GSL S L E R K + + GL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-----VIR-KYTRQILEGLAYLHS 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECAT 527
+VHRDIK +NI++DS+ K+ DFG A+ + + G T + GT +MAPE
Sbjct: 120 ---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY--GNGKLLEAVDPR 585
+ + +D++S G +E+A G+ P + LY G+ +
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--------LYKIGSSGEPPEIPEH 228
Query: 586 L---CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
L +DF + + C D RP+ +
Sbjct: 229 LSEEAKDF----LRK-------CLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 68/207 (32%), Positives = 110/207 (53%), Gaps = 17/207 (8%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
F +K+G+GGFG VYK + T +A+K + SK+ ++ +E++I+ + +H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDS------HLFKENSLLTWEFRYKIAQDLASGLLYL 466
+ G +K EL +V EF GSL E+ + + ++L GL YL
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY------VCKELLKGLEYL 114
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
++HRDIK++NI+L S+ K+ DFGL+ + K T V GT +MAPE
Sbjct: 115 H---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVI 169
Query: 527 TTGKASKESDVYSFGIVALEIACGRKP 553
++D++S GI A+E+A G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 17/203 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+G+G FG VYKG ET ++A+K++S + ++ +K E+ ++ L+H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 416 GWCHEKKELLLVYEFMPNGSLDS-----HLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
G L ++ E+ NGSL F E SL+ Y + Q L GL YL E
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPE-SLVA---VY-VYQVL-QGLAYLHE-- 117
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
Q V+HRDIK++NI+ + K+ DFG+A + +V GT +MAPE
Sbjct: 118 -QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-VGTPYWMAPEVIEMSG 175
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
AS SD++S G +E+ G P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 29/211 (13%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRNLVQLL 415
+++G+G FG VY + +K + + +E A +EVKI+ +L H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK-- 63
Query: 416 GWCHE----KKELLLVYEFMPNGSLDSHL---------FKENSLLTWEFRYKIAQDLASG 462
+E K +L +V E+ G L + F E +L W Q L
Sbjct: 64 --YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-----FVQ-LCLA 115
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L YL + ++HRDIK NI L SN K+GDFG+++++ TV+ GT Y++
Sbjct: 116 LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKP 553
PE + +SD++S G V E+ + P
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 49/285 (17%)
Query: 357 DQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNLV 412
++ +G G FG V +G + +A+K + GS + ++ +E I+ + H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+L G + + ++++ E+M NGSLD L + + T + + +ASG+ YL E
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EM 125
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG------YMAPECA 526
VHRD+ + NI+++SN K+ DFGL+R +E ++ + T T G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT-----TKGGKIPIRWTAPEAI 180
Query: 527 TTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD-- 583
K + SDV+SFGIV E+ + G +P W N +++AV+
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPY-------------WDMS---NQDVIKAVEDG 224
Query: 584 -----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
P C + +LM L C D N RP+ Q++ L
Sbjct: 225 YRLPPPMDCP----SALYQLM---LDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 25/272 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVKIISRLRHRN 410
+D + LGQG G VYK + T A+K++ G ++ K+ E+K +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V+ G +++ E+ +V E+M GSL L K+ + IA+ + GL YL +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
+HRDIK SN++++S KI DFG+++++E+ T + GT+ YM+PE
Sbjct: 120 HI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC--- 587
S +D++S G+ LE A G+ P P L+Q + ++
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSLPAEEFSPE 231
Query: 588 -RDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
RDF I C D RPS +
Sbjct: 232 FRDF----ISA-------CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 87/269 (32%), Positives = 132/269 (49%), Gaps = 27/269 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS-----QGSKQGIKEYASEVKIISRLRHRNLV 412
+ LG G FG VY+G + + AVK VS Q ++ +K+ E+ ++S+L+H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
Q LG E+ L + E +P GSL L K S R Q L GL YL ++
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-LGLEYLH---DR 121
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTGKA 531
VHRDIK +NI++D+N K+ DFG+A+ V + S G+ +MAPE A G
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591
+D++S G LE+A G K P Q+ + V+ + G K L + L +
Sbjct: 180 GLAADIWSLGCTVLEMATG------KPPWSQLEGVAAVFKI-GRSKELPPIPDHLSDE-- 230
Query: 592 GQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ I L C D +LRP+ +++
Sbjct: 231 ----AKDFI--LKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 84/282 (29%), Positives = 135/282 (47%), Gaps = 32/282 (11%)
Query: 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL 406
A+ + + +G+G FG V G +R +AVK + S + + +E +++ L
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTL 57
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLY 465
RH NLVQLLG + L +V E+M GSL +L + +++T + A D+ G+ Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAP 523
L+ E+ VHRD+ + N+++ + AK+ DFGL AK + +G + + AP
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGL------AKEASQGQDSGKLPVKWTAP 168
Query: 524 ECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582
E K S +SDV+SFGI+ EI + GR P P+ P V G +EA
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVV------PHVEKGYRMEA- 220
Query: 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P C ++ ++M C D RP+ +Q+ L
Sbjct: 221 -PEGCPP----EVYKVM---KDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 78/282 (27%), Positives = 129/282 (45%), Gaps = 33/282 (11%)
Query: 358 QKLGQGGFGGVYKGFFR----ETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNL 411
++LG+G FG V + T +AVK S + ++ E++I+ L H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH-RSDFEREIEILRTLDHENI 68
Query: 412 VQLLGWCHE--KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
V+ G C + + L L+ E++P+GSL +L + + + + + G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECAT 527
Q +HRD+ + NI+++S KI DFGLA+++ K G + + APEC
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 528 TGKASKESDVYSFGIVALEI-ACGRKPINPKA--------PQGQVSLLQWVWDLYGNGKL 578
T K S SDV+SFG+ E+ G +P A QGQ+ + + + +L G+
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-ELLKEGER 244
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
L C D + LM + C + RPS +I
Sbjct: 245 LPRPPS--CPDE----VYDLMKL---CWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 38/281 (13%)
Query: 343 PYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKI 402
P +E L ++KLG G FG V++G ++ +A+K + +++ EV+
Sbjct: 4 PREEFTL-------ERKLGSGYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQKEVQA 55
Query: 403 ISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLAS 461
+ RLRH++L+ L C + + ++ E M GSL + L E +L +A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAE 115
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGY 520
G+ YL+ EQ +HRD+ + NI++ + K+ DFGLARL+ E S + +
Sbjct: 116 GMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKW 170
Query: 521 MAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV----SLLQWVWDLYGNG 576
APE A+ G S +SDV+SFGI+ E+ GQV V+D G
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT----------YGQVPYPGMNNHEVYDQITAG 220
Query: 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR 617
+ P C Q+I ++M+ W A P++ RPS +
Sbjct: 221 YRMPC--PAKCP----QEIYKIML-ECWAAEPED--RPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 76/284 (26%), Positives = 137/284 (48%), Gaps = 51/284 (17%)
Query: 360 LGQGGFGGVYKGFFR---ETNSY-IAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQL 414
LG G FG VYKG + E +A+K + + + + KE E +++ + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKEN-------SLLTWEFRYKIAQDLASGLLYLQ 467
LG C + + L+ + MP G L ++ + + LL W +A G+ YL+
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYV-RNHKDNIGSQYLLNW------CVQIAKGMSYLE 126
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE------HAKGSQTTVLAGTMGYM 521
E + +VHRD+ + N+++ + + KI DFGLA+L++ HA+G + + +M
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI-----KWM 178
Query: 522 APECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580
A E + +SDV+S+G+ E+ G KP P ++ DL G+ L
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIP------DLLEKGERLP 231
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P +C I+ M++ + C D RP+ +++I+ +
Sbjct: 232 --QPPIC------TIDVYMVL-VKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQL 414
+ +G+G FG V R+T A+K +++ K ++ +E +I+ L H LV L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+++ + LV + + G L HL F E + W ++ L YL
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW------ICEIVLALEYLHS- 118
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
+ ++HRDIK NI+LD + I DF +A V + TT +GT GYMAPE
Sbjct: 119 --KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
S D +S G+ A E G++P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNL 411
+ + +K+G+G G VYK R T +A+K R+ + +K+ I +E+ I+ +H N+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 412 VQLLGWCHE-KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
V + EL +V E+M GSL + + + + +++ GL YL
Sbjct: 78 VDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-- 134
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
Q V+HRDIKS NI+L + + K+ DFG A + K + +V+ GT +MAPE
Sbjct: 135 -QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKRKD 192
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
+ D++S GI+ +E+A G P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA------SEVKIISRLRHRNLVQ 413
LG+G FG V ++T A+K + K+ I + +E I+SR+ H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 414 LLGWC--HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
L +++L LV E+ P G L SHL KE R+ A+ + L YL
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE-IVLALEYLHS--- 111
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+++RD+K NI+LD++ + K+ DFGLA+ + +GS+T GT Y+APE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFCGTPEYLAPEVLLGKGY 170
Query: 532 SKESDVYSFGIVALEIACGRKP 553
K D +S G++ E+ G+ P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 75/267 (28%), Positives = 133/267 (49%), Gaps = 22/267 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
Q++G G FG V+ G++ E +A+K + +G+ +++ E +++ +L H LVQL G
Sbjct: 10 QEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C E+ + LV+EFM +G L +L + + E + D+ G+ YL+ V+HR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHR 124
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
D+ + N ++ N K+ DFG+ R V + + +T + + +PE + K S +SDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 538 YSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596
+SFG++ E+ + G+ P ++ +V V + +L + PRL Q +
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRS-NSEV-----VETINAGFRLYK---PRLA----SQSVY 231
Query: 597 RLMIVGLWCAHPDENLRPSIRQVIHVL 623
LM C RPS ++H L
Sbjct: 232 ELM---QHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 73/202 (36%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
++KLG G FG V+ G + T +AVK + G+ + + E +I+ +LRH LVQL
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
C E++ + +V E+M GSL L E L +A +A G+ YL+ + +
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYI 125
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGKAS 532
HRD+ + NI++ N KI DFGLARL+E + T G + + APE A G+ +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 533 KESDVYSFGIVALEIAC-GRKP 553
+SDV+SFGI+ EI GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 9/208 (4%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
F+ +KLG+G +G VYK +ET +A+K V ++ ++E E+ I+ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYI 60
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+ G + +L +V E+ GS+ + N LT E I GL YL
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+HRDIK+ NI+L+ AK+ DFG++ + + TV+ GT +MAPE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGY 176
Query: 532 SKESDVYSFGIVALEIACGRKP---INP 556
+ ++D++S GI A+E+A G+ P I+P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 8e-30
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNL 411
+ +KLG+G FG VY R+ + + + + + ++ + E++I++ L H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL--FKENSLLTWEFRYKIAQDLASGLLYLQEE 469
V+L + ++ L LV E++ GSL+ L L+ I + S L YL
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL--- 117
Query: 470 WEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKGSQ-----TTVLAGTMGYMAP 523
+ ++HRDIK NI+LD + K+ DFGLA+L+ + + GT GYMAP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 524 ECAT---TGKASKESDVYSFGIVALEIACGRKP 553
E AS SD++S GI E+ G P
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 67/196 (34%), Positives = 111/196 (56%), Gaps = 14/196 (7%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+K+G+G FG VYKG + N+ +AVK R + K + E +I+ + H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLI 58
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
G C +K+ + +V E +P GSL + L K+ + LT + +++ D A+G+ YL+ + +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCI 115
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT----MGYMAPECATTGKA 531
HRD+ + N ++ N KI DFG++R E G TV G + + APE G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-EEE--GGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 532 SKESDVYSFGIVALEI 547
+ ESDV+S+GI+ E
Sbjct: 173 TSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 73/278 (26%), Positives = 134/278 (48%), Gaps = 44/278 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY-IAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
++LG G FG V+ G +R +A+K + +G+ ++ E K++ +L H NLVQL G
Sbjct: 10 KELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYG 66
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
C +++ + +V E+M NG L ++L + L E+ + D+ + YL+ +H
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIH 123
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGKASK 533
RD+ + N ++ + K+ DFGLAR V Q T GT + + PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 534 ESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV-------DPR 585
+SDV+SFG++ E+ + G+ P ++ + N +++E+V P+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMP----------------YERFSNSEVVESVSAGYRLYRPK 224
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
L ++ +M C H RP+ ++++ L
Sbjct: 225 LA----PTEVYTIMYS---CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 74/204 (36%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
K+G G FG VY +T +AVK R+ + IKE A E+K++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
G ++++ + E+ G+L+ L + +L L GL YL +V
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIV 121
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAK--GSQTTVLAGTMGYMAPECATTGKAS 532
HRDIK +NI LD N K+GDFG A +L + G + LAGT YMAPE T GK
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 533 ---KESDVYSFGIVALEIACGRKP 553
+ +D++S G V LE+A G++P
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 8/208 (3%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G FG V++G + T +AVK + G+ K++ +E +I+ +LRH L+QL
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
C ++ + +V E M GSL +L L +A +ASG+ YL+ Q +H
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+ + N+++ N K+ DFGLAR+++ + + APE A + S +SD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 537 VYSFGIVALEIAC-GRKPINPKAPQGQV 563
V+SFGI+ EI GR P P +V
Sbjct: 187 VWSFGILLTEIVTYGRMPY-PGMTNAEV 213
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 77/270 (28%), Positives = 135/270 (50%), Gaps = 26/270 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
KLG G +G VY+G +++ + +AVK + + + + ++E+ E ++ ++H NLVQLLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+ ++ EFM G+L +L + N + +A ++S + YL+ ++ +HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHR 128
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGKASKE 534
D+ + N ++ N K+ DFGL+RL+ G T AG + + APE K S +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 535 SDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594
SDV++FG++ EIA +P + L Q V++L G +E P C +
Sbjct: 186 SDVWAFGVLLWEIA-----TYGMSPYPGIDLSQ-VYELLEKGYRMER--PEGCP----PK 233
Query: 595 IERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ LM C + + RPS ++
Sbjct: 234 VYELM---RACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 358 QKLGQGGFGGV----YKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
Q+LG+G FG V Y T +AVK++ + + ++++ E++I+ L+H N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 414 LLGWCHE--KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
G C+ ++ L LV E++P GSL +L K L A + G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS--- 126
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTG 529
+ VHRD+ + NI+++S KIGDFGL +++ K G + + APE T
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 530 KASKESDVYSFGIVALEI-ACGRKPINPKA---------PQGQVSLLQWVWDLYGNGKLL 579
K S SDV+SFG+V E+ K +P A QGQ+ + + +L N L
Sbjct: 187 KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI-ELLKNNGRL 245
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
A P C +I +M C + D + RPS ++
Sbjct: 246 PA--PPGCPA----EIYAIM---KECWNNDPSQRPSFSELAL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE----YAS-EVKIISRL 406
+DF + +G+G F V +ETN A+K + + +Q IKE Y E ++++RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRL 58
Query: 407 -RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
H +++L +++ L V E+ PNG L ++ K SL R+ A+ + L Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLALEY 117
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-------------------EHA 506
L + ++HRD+K NI+LD + + KI DFG A+++
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
+ GT Y++PE A K SD+++ G + ++ G+ P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 84/279 (30%), Positives = 128/279 (45%), Gaps = 32/279 (11%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI-KEYASEVKIISRLRHRN 410
+D +LG G G V K R T +AVK + + I K+ E+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY-KIAQDLASGLLYLQEE 469
+V G + ++ + E+M GSLD + KE E KIA + GL YL E+
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ ++HRD+K SNI+++S K+ DFG++ +LV + GT YMAPE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT----FVGTSSYMAPERIQG 173
Query: 529 GKASKESDVYSFGIVALEIACGRKPINP--KAPQGQVSLLQWVWDLYGNGKLLEAVD--- 583
S +SD++S G+ +E+A GR P P P G LLQ++ V+
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI------------VNEPP 221
Query: 584 PRLCRD-FDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
PRL F + V L C D RPS ++++
Sbjct: 222 PRLPSGKFSPDFQD---FVNL-CLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 79/297 (26%), Positives = 134/297 (45%), Gaps = 58/297 (19%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKE-YASEVKIISRLRHRNL 411
++LG+G FG V+ G +AVK + + + ++ + E ++++ +H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLD----SHLFKENSL---------LTWEFRYKIAQD 458
V+ G C E ++V+E+M +G L+ SH L LT +IA
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLA 515
+ASG++YL Q VHRD+ + N ++ + KIGDFG++R V ++ + T+L
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYG 574
+ +M PE K + ESDV+SFG+V EI G++P W
Sbjct: 188 --IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP----------------WYGLS 229
Query: 575 NGKLLEAVD-------PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
N +++E + PR C + +M L C D R +I+ + L
Sbjct: 230 NEEVIECITQGRLLQRPRTCPSE----VYDIM---LGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 6e-28
Identities = 85/272 (31%), Positives = 127/272 (46%), Gaps = 30/272 (11%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYA---SEVKIISRLRHRNLVQ 413
LG+G +G VY G IAVK+V + + KEY EV ++ L+H N+VQ
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
LG C + + + EF+P GS+ S L + L F K + + G+ YL C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHN---NC 122
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVE--HAKGSQTTVLA---GTMGYMAPECATT 528
VVHRDIK +N+ML N K+ DFG AR + G+ + +L GT +MAPE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
++SD++S G E+A G+ P+ + + G + L PRL
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GAHRGLM---PRLPD 232
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
F I+ + C D++ RPS Q++
Sbjct: 233 SFSAAAIDFVTS----CLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEY-ASEVKIISRLRHRNLVQLLG 416
+G+G FG V K + + K + G+ + K+ SEV I+ L+H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 417 WCH--EKKELLLVYEFMPNGSLDS---HLFKENSLLTWEFRYKIAQDLASGLLYLQE--- 468
+ L +V E+ G L KE + EF ++I L LL L E
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL---LLALYECHN 123
Query: 469 --EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ V+HRD+K +NI LD+N N K+GDFGLA+++ H S GT YM+PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPEQL 182
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPIN 555
++SD++S G + E+ P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 81/280 (28%), Positives = 142/280 (50%), Gaps = 34/280 (12%)
Query: 357 DQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ +G G FG V +G + + ++A+K + G +++ +++ SE I+ + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
L G + + ++++ EFM NG+LDS L + + T + + +A+G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG--SQTTVLAGTMG--YMAPECATT 528
VHRD+ + NI+++SN K+ DFGL+R +E + T+ L G + + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 529 GKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV--DPR 585
K + SDV+S+GIV E+ + G +P WD+ N ++ A+ D R
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP---------------YWDM-SNQDVINAIEQDYR 229
Query: 586 LCRDFD-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L D + +LM L C D N RP Q++ L+
Sbjct: 230 LPPPMDCPTALHQLM---LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 66/239 (27%), Positives = 96/239 (40%), Gaps = 28/239 (11%)
Query: 35 LTFNYTSFSPQYDDNITY--ERAYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATGNL 91
+ N+++FS N + V++L P AG A Y + L
Sbjct: 1 TSLNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS------- 53
Query: 92 TDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVA 151
DFTT F F + ++ ++ ADG+AF L Q GGG G NS VA
Sbjct: 54 KDFTTTFKFYLGTKGTNG-ADGIAFVL--QNDPAGALGGGGGGGGLGYGGIGNS----VA 106
Query: 152 VEFDVYVNS--WDPTFSHVGIDINSVKSKKN-------VSWWSDVKSGRRNEAWISYNSS 202
VEFD Y N DP +H+ ID+N + S + G + I+Y+ +
Sbjct: 107 VEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITYDPT 166
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261
T+ L+V + VDL Q P FGF+ +TG + I +W F S
Sbjct: 167 TNTLTVYLDNGSTLTS--LDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 46/289 (15%)
Query: 357 DQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQG-IKEYASEVKIISRLRHRN 410
++LGQG FG VY+G + E + +A+K V++ + E+ +E ++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS---------LLTWEFRYKIAQDLAS 461
+V+LLG + L+V E M G L S+L T + ++A ++A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EH---AKGSQTTVLAGT 517
G+ YL + VHRD+ + N M+ + KIGDFG+ R + E KG + G
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK-----GL 182
Query: 518 MG--YMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYG 574
+ +MAPE G + +SDV+SFG+V E+A +P QG + + V
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSN--EEVLKFVI 235
Query: 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+G L+ P C D + LM C + +RP+ +++ L
Sbjct: 236 DGGHLDL--PENCPDK----LLELM---RMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 64/188 (34%), Positives = 106/188 (56%), Gaps = 5/188 (2%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNLVQLLGWC 418
LG+G FG V+KG ++ +AVK + Q +K ++ SE +I+ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
+++ + +V E +P G S L K+ L + K A D A+G+ YL E + C +HRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESKNC-IHRD 118
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
+ + N ++ N KI DFG++R + S + + + + APE G+ S ESDV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 539 SFGIVALE 546
S+GI+ E
Sbjct: 179 SYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 360 LGQGGFGGVYKGFFRETNSY---IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLL 415
LG G FG V KG + + +AVK + Q G KE+ E ++++L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
G C + + L+LV E P G L +L + L A +A G+ YL+
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG------YMAPE 524
+ VHRD+ + N++L + AKI DFG++R A G+ + T + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPE 168
Query: 525 CATTGKASKESDVYSFGIVALEI-ACGRKP 553
C GK S +SDV+S+G+ E + G KP
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIK-EYASEVKIISRLRHRNLVQLLG 416
++G+G +G VYK ++T +A+K++ + K+G E+K++ +LRH N+V+L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 417 WCHEKK--ELLLVYEFMP---NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
K + +V+E+M G LDS K T + L GL YL
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK----FTESQIKCYMKQLLEGLQYLHS--- 118
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC---ATT 528
++HRDIK SNI+++++ K+ DFGLAR + T T+ Y PE AT
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT- 177
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574
+ E D++S G + E+ G+ Q+ +++L G
Sbjct: 178 -RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCG 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV-----SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LGQG FG VY + +T +AVK+V S +K+ + E++++ L+H +VQ
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
G + + L + E+MP GS+ L K LT K + + G+ YL +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHS---NMI 125
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAPECATTGKAS 532
VHRDIK +NI+ DS N K+GDFG ++ ++ + G+ + GT +M+PE +
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 533 KESDVYSFGIVALEIACGRKP 553
+++DV+S G +E+ + P
Sbjct: 186 RKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 7/169 (4%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYA-SEVKIISRLRHRNLVQLL 415
+KLG+G +G VYK ++T +A+K++ ++GI A E+ ++ L+H N+V+LL
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
H +++L LV+E+ L +L K L+ I L GL Y ++
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRIL 120
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
HRD+K NI+++ + K+ DFGLAR + T + T+ Y APE
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419
LG G FG VYK +ET + A K + S++ ++++ E+ I+S +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 420 EKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
+ +L ++ EF G+LDS + + E L + RY + + + L +L V+HRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHRD 128
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGKASKE- 534
+K+ NI+L + + K+ DFG++ + + T + GT +MAPE C T +
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYDY 187
Query: 535 -SDVYSFGIVALEIACGRKP 553
+D++S GI +E+A P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYA-SEVKIISRLRHRNLVQLLG 416
K+G+G +G VYK + T +A+K++ + +GI + A E+K++ L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKE----NSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
K +L LV+EFM D+ L+K L L GL +
Sbjct: 66 VFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
++HRD+K N+++++ K+ DFGLAR T + T Y APE K
Sbjct: 119 -ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 533 KES-DVYSFGIVALEIACGRKPINP 556
D++S G + E+ R P+ P
Sbjct: 177 STPVDIWSVGCIFAELLSRR-PLFP 200
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 8/197 (4%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
KLGQG FG V+ G + T + +A+K + G+ + + E +++ +LRH LVQL
Sbjct: 13 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENS-LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
E+ + +V E+M GSL L E L +A +ASG+ Y++ VHR
Sbjct: 71 SEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
D++++NI++ N K+ DFGLARL+E + + + + APE A G+ + +SDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 538 YSFGIVALEIAC-GRKP 553
+SFGI+ E+ GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 80/278 (28%), Positives = 141/278 (50%), Gaps = 32/278 (11%)
Query: 357 DQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ +G G FG V G + + +A+K + G +++ +++ SE I+ + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
L G + K +++V E+M NGSLD+ L K + T + + +ASG+ YL +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DM 125
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGK 530
VHRD+ + NI+++SN K+ DFGL+R++E + T G + + APE K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 531 ASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP--RLC 587
+ SDV+S+GIV E+ + G +P W++ N +++A++ RL
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP---------------YWEM-SNQDVIKAIEEGYRLP 229
Query: 588 RDFD-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
D + +LM L C D N RP Q++ +L+
Sbjct: 230 APMDCPAALHQLM---LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 75/275 (27%), Positives = 138/275 (50%), Gaps = 32/275 (11%)
Query: 360 LGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLL 415
+G G FG V++G + +A+K + G +++ +++ SE I+ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
G + K +++ E+M NG+LD +L + + + + +A+G+ YL + V
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYV 129
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--YMAPECATTGKASK 533
HRD+ + NI+++SN K+ DFGL+R++E T G + + APE K +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 534 ESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP--RLCRDF 590
SDV+SFGIV E+ + G +P WD+ N ++++A++ RL
Sbjct: 190 ASDVWSFGIVMWEVMSFGERP---------------YWDM-SNHEVMKAINDGFRLPAPM 233
Query: 591 D-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
D + +LM L C D RP ++++L+
Sbjct: 234 DCPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 16/220 (7%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI-KEYASEVKIISRLRHRNLVQLLGW 417
+LG+G G V K + T A+K ++ + K+ E++I + +V+ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 418 CHEKKE--LLLVYEFMPNGSLDSHL--FKENSLLTWEFRY-KIAQDLASGLLYLQEEWEQ 472
++ + + E+ GSLDS K+ E KIA+ + GL YL +
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---R 124
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
++HRDIK SNI+L K+ DFG++ LV S GT YMAPE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN----SLAGTFTGTSFYMAPERIQGKPY 180
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQ--GQVSLLQWV 569
S SDV+S G+ LE+A R P P+ G + LL ++
Sbjct: 181 SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 86/284 (30%), Positives = 129/284 (45%), Gaps = 33/284 (11%)
Query: 358 QKLGQGGFGGV----YKGFFRETNSYIAVKRVSQGSKQGIKE-YASEVKIISRLRHRNLV 412
+ LG+G FG V Y T +AVK + + Q + E+ I+ L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 413 QLLGWCHEK--KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+ G C E+ K L L+ E++P GSL +L K L + AQ + G+ YL
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF--AQQICEGMAYLHS-- 125
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATT 528
Q +HRD+ + N++LD++ KIGDFGLA+ V G + + A EC
Sbjct: 126 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 529 GKASKESDVYSFGIVALEIA--CGRKPINPKA-------PQGQVSLLQWVWDLYGNGKLL 579
K S SDV+SFG+ E+ C K PK QGQ+++++ + +LL
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI-------ELL 237
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
E C Q++ LM W RP+ R +I +L
Sbjct: 238 ERGMRLPCPKNCPQEVYILM-KNCWETEA--KFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRN 410
F + +G+G FG VYK + TN +A+K + + ++ I++ E++ +S+ R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGS----LDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466
+ + G + +L ++ E+ GS L E + I +++ GL YL
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF------ILREVLLGLEYL 114
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPEC 525
E + +HRDIK++NI+L + K+ DFG++ +L T V GT +MAPE
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV--GTPFWMAPEV 169
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKP 553
+++D++S GI A+E+A G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 34/275 (12%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNLVQLLG 416
+++G+G FG V+ G R N+ +AVK + +K ++ E +I+ + H N+V+L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
C +K+ + +V E + G + L E L + ++ ++ A+G+ YL+ + +H
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIH 117
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-------YMAPECATTG 529
RD+ + N ++ KI DFG++R E G V A T G + APE G
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR--EEEDG----VYASTGGMKQIPVKWTAPEALNYG 171
Query: 530 KASKESDVYSFGIVALE-IACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
+ S ESDV+SFGI+ E + G P + Q ++ G L P LC
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QGVRLPC--PELCP 222
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
D + RLM C D RPS V L
Sbjct: 223 D----AVYRLM---ERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 31/215 (14%)
Query: 358 QKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQ-GSKQGIKEYASEVKIISRLRHRNL 411
++LG+G FG VYKG R + + +A+K + + + +E+ E +++S L+H N+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFK----------------ENSLLTWEFRYKI 455
V LLG C +++ +++E++ +G L L + ++SL +F I
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF-LHI 129
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTT 512
A +A+G+ YL VHRD+ + N ++ KI DFGL+R + ++ + +
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
+L + +M PE GK + ESD++SFG+V EI
Sbjct: 187 LLP--VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 68/198 (34%), Positives = 107/198 (54%), Gaps = 8/198 (4%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G FG V+ G + N+ +AVK + G+ + + E +I+ +LRH LVQL
Sbjct: 12 KKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
E+ + +V E+M GSL L E L +A +A+G+ Y++ +H
Sbjct: 70 VSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD++S+NI++ KI DFGLARL+E + + + + APE A G+ + +SD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 537 VYSFGIVALEIAC-GRKP 553
V+SFGI+ E+ GR P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 85/294 (28%), Positives = 142/294 (48%), Gaps = 57/294 (19%)
Query: 358 QKLGQGGFGGV-----YKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
++LG+G FG V Y + +AVK + S K++ E ++++ L+H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 413 QLLGWCHEKKELLLVYEFMPNGSL---------DSHLFKEN---SLLTWEFRYKIAQDLA 460
+ G C E L++V+E+M +G L D+ L E + LT IAQ +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLAGT 517
+G++YL Q VHRD+ + N ++ N KIGDFG++R V ++ + T+L
Sbjct: 131 AGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-- 185
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNG 576
+ +M PE K + ESDV+S G+V EI G++P W N
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP----------------WYQLSNN 229
Query: 577 KLLEAVD-------PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+++E + PR C +++ LM+ G W P ++R +I++ IH L
Sbjct: 230 EVIECITQGRVLQRPRTCP----KEVYDLML-GCWQREP--HMRLNIKE-IHSL 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 33/279 (11%)
Query: 355 NDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI-KEYASEVKIISRLRHR 409
N+D LG G G V K T + +A K V G+K + K+ E++I+ R
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+V G + + + EFM GSLD ++K+ + E KIA + GL YL
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATT 528
++HRDIK SNI+++S K+ DFG++ L+ + T V GT YM+PE
Sbjct: 123 HR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV--GTSTYMSPERIQG 176
Query: 529 GKASKESDVYSFGIVALEIACGRKPI--NPKAPQGQVS------LLQWVWDLYGNGKLLE 580
GK + +SDV+S GI +E+A G+ P + GQ LLQ ++++
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ---------QIVQ 227
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
PRL D + R + C D RP+ +Q+
Sbjct: 228 EPPPRLPSS-DFPEDLRDFVDA--CLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 63/198 (31%), Positives = 109/198 (55%), Gaps = 8/198 (4%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G FG V+ G++ ++ +A+K + QGS + + +E ++ +L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 418 CHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
++ + ++ E+M NGSL L E LT +A +A G+ +++ + +H
Sbjct: 70 V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD++++NI++ KI DFGLARL+E + + + + APE G + +SD
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 537 VYSFGIVALEIAC-GRKP 553
V+SFGI+ EI GR P
Sbjct: 186 VWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 65/236 (27%), Positives = 108/236 (45%), Gaps = 33/236 (13%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
++ + LG+G +G VY T IA+K + + + ++ E+ + S L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHL--------FKENSLLTWEFRYKIAQDLASG 462
+VQ LG E + E +P GSL + L E +++ + + + G
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFY------TKQILEG 120
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNA-KIGDFG----LARLVEHAKGSQTTVLAGT 517
L YL + +VHRDIK N+++++ KI DFG LA + T GT
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-----NPCTETFTGT 172
Query: 518 MGYMAPECATTGKA--SKESDVYSFGIVALEIACGRKPI----NPKAPQGQVSLLQ 567
+ YMAPE G +D++S G +E+A G+ P P+A +V + +
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV-----SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LG+G FG VY + +T +AVK+V SQ + + + E++++ LRH +VQ
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 415 LGWC---HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
G C E+K+L + E+MP GS+ L K LT + + + G+ YL
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHS--- 124
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAPECATTG 529
+VHRDIK +NI+ DS N K+GDFG ++ ++ G+ + GT +M+PE +
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
+++DV+S +E+ + P
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 6/202 (2%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
++LG G FG V+ G +R +A+K +++G+ +++ E K++ +L H LVQL G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C ++K L +V EFM NG L ++L + L+ + + QD+ G+ YL+ +HR
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
D+ + N ++ S K+ DFG+ R V + + ++ + + PE K S +SDV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 538 YSFGIVALEIAC-GRKPINPKA 558
+SFG++ E+ G+ P K+
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 44/297 (14%)
Query: 358 QKLGQGGFGGVYKG---FFRETNS--YIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
++LG+G FG V+ T +AVK + + K++ E ++++ L+H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHL---------------FKENSLLTWEFRYKIAQ 457
+ G C + L++V+E+M +G L+ L + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVL 514
+ASG++YL Q VHRD+ + N ++ +N KIGDFG++R V ++ + T+L
Sbjct: 131 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLY 573
+ +M PE K + ESDV+SFG++ EI G++P + + +
Sbjct: 188 P--IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT------ 239
Query: 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR-PSIRQVIHVLNFEAPL 629
G++LE PR+C +++ +M+ G W P + L I +++H L P+
Sbjct: 240 -QGRVLER--PRVCP----KEVYDIML-GCWQREPQQRLNIKEIYKILHALGKATPI 288
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 88/277 (31%), Positives = 133/277 (48%), Gaps = 34/277 (12%)
Query: 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR 407
AL + Q +G+G FG V G +R +AVK + + + + +E ++++LR
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLR 57
Query: 408 HRNLVQLLG-WCHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLY 465
H NLVQLLG EK L +V E+M GSL +L + S+L + K + D+ + Y
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L+ VHRD+ + N+++ + AK+ DFGL + E + T L + + APE
Sbjct: 118 LE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEA 170
Query: 526 ATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD- 583
K S +SDV+SFGI+ EI + GR P P+ P L+ V G ++A D
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP------LKDVVPRVEKGYKMDAPDG 223
Query: 584 -PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
P + D Q C H D RPS Q+
Sbjct: 224 CPPVVYDVMKQ-----------CWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 68/225 (30%), Positives = 115/225 (51%), Gaps = 26/225 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQ----GSKQG--IKEYASEVKIISRLRHRNL 411
Q+LG G F Y+ +T + +AVK+V+ S+Q ++ E+++++RL H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYL 466
+++LG E L E+M GS+ L FKE ++ + L GL YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYL 119
Query: 467 QEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLA-RLVEHAKGS---QTTVLAGTMGYM 521
E ++HRD+K +N+++DS +I DFG A RL G+ Q +L GT+ +M
Sbjct: 120 HENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL-GTIAFM 175
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
APE + + DV+S G V +E+A + P N + ++L+
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 87/288 (30%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 360 LGQGGFGGVYKGFFR------ETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLV 412
LG G FG VY+G +AVK + +G+ Q KE+ E ++S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFK------ENSLLTWEFRYKIAQDLASGLLYL 466
+LLG C + ++ E M G L S+L LLT + I D+A G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 467 QEEWEQCVVHRDIKSSNIML-----DSNFNAKIGDFGLARLV----EHAKGSQTTVLAGT 517
+ + +HRD+ + N ++ D++ KIGDFGLAR + + K + +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL---P 176
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNG 576
+ +MAPE GK + +SDV+SFG++ EI G++P +LQ V G
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY---PALNNQEVLQHV----TAG 229
Query: 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L+ P C D +I +LM W P E RP+ ++ +L
Sbjct: 230 GRLQK--PENCPD----KIYQLMTN-CWAQDPSE--RPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV----------SQGSKQGIKEYASEVKIISRLR 407
+ +G+G +G VY T +AVK+V K +K SE++ + L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 408 HRNLVQLLGWCHEKKELLLVY-EFMPNGSLDSHLFK----ENSLLTWEFRYKIAQDLASG 462
H N+VQ LG +E L ++ E++P GS+ S L E L+ R+ Q L G
Sbjct: 67 HLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV----RFFTEQVL-EG 120
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYM 521
L YL + ++HRD+K+ N+++D++ KI DFG+++ + + Q + G++ +M
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177
Query: 522 APECATTGKA--SKESDVYSFGIVALEIACGRKP 553
APE + S + D++S G V LE+ GR+P
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 7e-23
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 7/199 (3%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
Q++G G +G VYK T +A+K + + E+ ++ RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+ +L +V E+ GSL L+ + ++ GL YL E +HR
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA---TTGKASKE 534
DIK +NI+L + + K+ DFG++ + + + + GT +MAPE A G +
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGK 184
Query: 535 SDVYSFGIVALEIACGRKP 553
D+++ GI A+E+A + P
Sbjct: 185 CDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-23
Identities = 80/279 (28%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLRHRN 410
DF +KLG+G +G VYK N + A+K V GS Q +E A +E++I++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 411 LVQLLGWCHEK----KELLLVYEFMPNGSLDSHLFKENS---LLTWEFRYKIAQDLASGL 463
++ E +L +V E+ P G L + K L+ + ++I L GL
Sbjct: 61 IISY----KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
L E Q ++HRD+KS+NI+L +N KIGD G++++ K + GT YMAP
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQIGTPHYMAP 170
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583
E S +SD++S G + E+A P ++ Q DL K+
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----------DLR--YKVQRGKY 218
Query: 584 PRLCRDF--DGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
P + + D Q R LRP+ +++
Sbjct: 219 PPIPPIYSQDLQNFIR------SMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 360 LGQGGFGGVYKGFFRETNSY-----IAVK-RVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
LG G FG VY+G +R + +AVK S+Q ++ E I+S+ H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKEN-------SLLTWEFRYKIAQDLASGLLYL 466
L+G E+ ++ E M G L S L +EN S LT + A+D+A G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFGLARLVEHA----KGSQTTVLAGTMG 519
+E +HRDI + N +L AKI DFG+AR + A KG + + +
Sbjct: 133 EENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML---PIK 186
Query: 520 YMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578
+M PE G + ++DV+SFG++ EI + G P P +V + G G+L
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-PGRTNQEVMEF-----VTGGGRL 240
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625
P+ C + R+M C RP+ ++ + +
Sbjct: 241 DP---PKGCPG----PVYRIMTD---CWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 8e-23
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYAS-------EVKIISRLRHRN 410
+G G FG VY G + +AVK+V S S E+ ++ L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+VQ LG + L + E++P GS+ + L + R + Q L GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-KGLNYLHN-- 124
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPEC 525
+ ++HRDIK +NI++D+ KI DFG+++ +E L G++ +MAPE
Sbjct: 125 -RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562
++++D++S G + +E+ G+ P P Q Q
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQLQ 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+GGFG V + T A K++ + ++G + +E KI+ ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKI-AQDLASGLLYLQEEWEQCVV 475
K +L LV M G L H++ E R A + GL +L + +V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IV 117
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
+RD+K N++LD + N +I D GLA VE G + AGT GYMAPE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 536 DVYSFGIVALEIACGRKP 553
D ++ G E+ GR P
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 68/199 (34%), Positives = 107/199 (53%), Gaps = 8/199 (4%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
D KLGQG FG V+ G + T +A+K + G+ + + E +I+ +LRH LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA 68
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
E+ + +V EFM GSL L + + L +A +A G+ Y++ +
Sbjct: 69 VVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
HRD++++NI++ N KI DFGLARL+E + + + + APE A G+ + +S
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 536 DVYSFGIVALEIAC-GRKP 553
DV+SFGI+ E+ GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRN 410
DF K+G+G FG V+K + A+K++ + +E A E +++++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEE 469
+++ +K +L +V E+ NG L L + L + ++ + GL +L
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA----GTMGYMAPEC 525
+ ++HRDIKS N+ LD+ N KIGD G+A+L+ S T A GT Y++PE
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----SDNTNFANTIVGTPYYLSPEL 172
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
+++SDV++ G+V E G+ P + Q +L+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV-----SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LGQG FG VY + +T +A K+V S + + + E++++ L+H +VQ
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 415 LGWC---HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
G C +K L + E+MP GS+ L K LT K + + G+ YL
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHS--- 124
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH--AKGSQTTVLAGTMGYMAPECATTG 529
+VHRDIK +NI+ DS N K+GDFG ++ ++ G+ + GT +M+PE +
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
+++DV+S G +E+ + P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV-----SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LGQG FG VY + +T +AVK+V S + + + E++++ L H +VQ
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 415 LGWCHEKKE--LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
G + E L + E MP GS+ L K LT K + + G+ YL
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHS---N 125
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA--KGSQTTVLAGTMGYMAPECATTGK 530
+VHRDIK +NI+ DS N K+GDFG ++ ++ G+ + GT +M+PE +
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
+++D++S G +E+ + P
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 70/214 (32%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVKIISRLRH-R 409
D D ++G+G FG V K + + + +AVKR+ S ++ K ++ ++ R
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK-----ENSLLTWEFRYKIAQDLASGLL 464
+V+ G + + + E M + SLD +K S++ E KIA L
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDK-FYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEH-AKGSQTTVLAGTMGYMA 522
YL+EE + ++HRD+K SNI+LD N N K+ DFG++ +LV+ AK T AG YMA
Sbjct: 122 YLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMA 175
Query: 523 PECATTGKASK---ESDVYSFGIVALEIACGRKP 553
PE SDV+S GI E+A G+ P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY---IAVKRVSQGSKQGI-KEYASEVKIISRLRHRNLVQ 413
+KLG G FG V +G + + +AVK + I ++ E I+ L H NL++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKEN------SLLTWEFRYKIAQDLASGLLYLQ 467
L G L++V E P GSL L K+ S L ++ +IA +G+ YL+
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIA----NGMRYLE 114
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR--LVEHAKGSQTTVLAGTMGYMAPEC 525
+ +HRD+ + NI+L S+ KIGDFGL R L + APE
Sbjct: 115 S---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 526 ATTGKASKESDVYSFGIVALEI-ACGRKP 553
T S SDV+ FG+ E+ G +P
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 9/210 (4%)
Query: 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQGSKQGIKE-YASEVKIIS 404
+ D + +G+G FG VY+G + + +AVK + ++E + E I+
Sbjct: 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMR 62
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
+ H ++V+L+G + + +V E P G L S+L L + L++ L
Sbjct: 63 QFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
YL E ++ V HRDI + N+++ S K+GDFGL+R +E + + + +MAPE
Sbjct: 122 YL--ESKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 525 CATTGKASKESDVYSFGIVALEI-ACGRKP 553
+ + SDV+ FG+ EI G KP
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 71/209 (33%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLR 407
+DF + LG G FG V + + Y A+K +S+ KQ ++ +E +I+ +R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
H LV L G + L LV E++P G L SHL K R+ AQ + L YL
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ-VVLALEYLH 118
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE--- 524
+V+RD+K N++LDS+ KI DFG A+ V+ + T L GT Y+APE
Sbjct: 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK--GRTYT--LCGTPEYLAPEIIL 171
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKP 553
GKA D ++ GI+ E+ G P
Sbjct: 172 SKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 70/266 (26%), Positives = 129/266 (48%), Gaps = 26/266 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
++LG G FG V G +R +A+K + +GS E+ E K++ +L H LVQL G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGV 67
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C +++ + +V E+M NG L ++L + ++ +D+ G+ YL+ + +HR
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHR 124
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
D+ + N ++D K+ DFGL+R V + + + + + PE K S +SDV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 538 YSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP--RLCRDFDGQQ 594
++FG++ E+ + G+ P ++ + N + +E V RL R
Sbjct: 185 WAFGVLMWEVYSLGKMP----------------YERFNNSETVEKVSQGLRLYR--PHLA 226
Query: 595 IERLMIVGLWCAHPDENLRPSIRQVI 620
E++ + C H RP+ +Q++
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRN 410
+D+ + +G G VY N +A+KR+ + + + E EV+ +S+ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSL--------DSHLFKENSLLTWEFRYKIAQDLASG 462
+V+ EL LV ++ GSL E + T + +++ G
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------VLKEVLKG 114
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG----LARLVEHAKGSQTTVLAGTM 518
L YL +HRDIK+ NI+L + + KI DFG LA + + + T GT
Sbjct: 115 LEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF-VGTP 170
Query: 519 GYMAPECAT--TGKASKESDVYSFGIVALEIACGRKP 553
+MAPE G K +D++SFGI A+E+A G P
Sbjct: 171 CWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 28/218 (12%)
Query: 359 KLGQGGFGGVYKG-----FFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
+LG+G FG V+ + +AVK + + S+ +++ E ++++ L+H+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 414 LLGWCHEKKELLLVYEFMPNGSL---------DSHLFKENSL-----LTWEFRYKIAQDL 459
G C E + LL+V+E+M +G L D+ + LT IA +
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLAG 516
ASG++YL VHRD+ + N ++ KIGDFG++R + ++ + T+L
Sbjct: 132 ASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 187
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKP 553
+ +M PE K + ESD++SFG+V EI G++P
Sbjct: 188 -IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 43/247 (17%)
Query: 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQ-GSKQGIKEYASEVKIIS 404
L ND +G+G FG V K ++ + A+KR+ + SK +++A E++++
Sbjct: 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 405 RL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKEN---------------SLLT 448
+L H N++ LLG C + L L E+ P+G+L L K S L+
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 449 WEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
+ A D+A G+ YL ++ +HRD+ + NI++ N+ AKI DFGL+R
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR------- 172
Query: 509 SQTTVLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-------CGRK--PI 554
Q + TMG +MA E + SDV+S+G++ EI CG +
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232
Query: 555 NPKAPQG 561
K PQG
Sbjct: 233 YEKLPQG 239
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-------SQGSKQGIKEYASEVKII 403
+F ++K+G+G F VYK +A+K+V ++ + +KE + ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD---SHLFKENSLLTWEFRYKIAQDLA 460
+L H N+++ L E EL +V E G L H K+ L+ +K L
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV---LAGT 517
S L ++ + ++HRDIK +N+ + + K+GD GL R S+TT L GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS----SKTTAAHSLVGT 169
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEIACGRKPI-NPKAPQGQVSLLQWVWDLYGNG 576
YM+PE + +SD++S G + E+A + P K +LY
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------------NLYSLC 217
Query: 577 KLLEAVD-PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
K +E D P L D +++ L+ C +PD RP I V+ V
Sbjct: 218 KKIEKCDYPPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 360 LGQGGFGGVYKG-----FFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQ 413
+GQG FG V++ E + +AVK + + S ++ E +++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSL----------------LTWEFR 452
LLG C K + L++E+M G L+ L + SL L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR---LVEHAKGS 509
IA+ +A+G+ YL E + VHRD+ + N ++ N KI DFGL+R ++ K S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
+ + + +M PE + + ESDV+++G+V EI
Sbjct: 190 ENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 72/220 (32%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RH 408
T F + +G+G +G VYK ++T +A+K + + +E E I+ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 409 RNLVQLLGWCHEKK-------ELLLVYEFMPNGS---LDSHLFKENSLLTWEFRYKIAQD 458
N+ G KK +L LV E GS L L K+ L E+ I ++
Sbjct: 63 PNIATFYG-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
GL YL E V+HRDIK NI+L N K+ DFG++ ++ G + T + GT
Sbjct: 122 TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTP 177
Query: 519 GYMAPE---CATTGKAS--KESDVYSFGIVALEIACGRKP 553
+MAPE C AS SDV+S GI A+E+A G+ P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 5e-21
Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 10/201 (4%)
Query: 359 KLGQGGFGGVYKGFFRETNSYI--AVKRVSQGSKQGIK-EYASEVKIISRLRHRNLVQLL 415
+LG G FG V KG ++ I A+K + +++ ++ E E +I+ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
G C E + L+LV E G L+ L + +T ++ ++ G+ YL+ + V
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFV 117
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT--MGYMAPECATTGKASK 533
HRD+ + N++L + AKI DFGL++ + AG + + APEC K S
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 534 ESDVYSFGIVALE-IACGRKP 553
SDV+S+GI E + G+KP
Sbjct: 178 RSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 87/290 (30%), Positives = 134/290 (46%), Gaps = 37/290 (12%)
Query: 360 LGQGGFGGV----YKGFFRETNSYIAVKRVSQGSKQG-IKEYASEVKIISRLRHRNLVQL 414
LG+G FG V Y T +AVK + S I + E++I+ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 415 LGWCHEK--KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
G C E + L+ EF+P+GSL +L + + + + + K A + G+ YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---R 128
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPECATTGK 530
VHRD+ + N++++S KIGDFGL + +E K T L + + APEC K
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 531 ASKESDVYSFGIVALEIA--CGR---------KPINPKAPQGQVSLLQWVWDLYGNGKLL 579
SDV+SFG+ E+ C K I P GQ+++ + V L GK L
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT--HGQMTVTRLVRVLE-EGKRL 245
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPL 629
P C + ++ +LM W P + R + + +I FEA L
Sbjct: 246 PR--PPNCPE----EVYQLM-RKCWEFQPSK--RTTFQNLIE--GFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 6e-21
Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 17/210 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG- 416
+ +G+G FG V +G + T +AVK + + + E ++++L H+NLV+LLG
Sbjct: 12 EIIGEGEFGAVLQGEY--TGQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 417 WCHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
H L +V E M G+L + L + +L++ + + D+A G+ YL+ + +V
Sbjct: 68 ILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLV 122
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
HRD+ + NI++ + AK+ DFGLAR+ + G + L + + APE K S +S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 536 DVYSFGIVALEI-ACGRKPINPKAPQGQVS 564
DV+S+G++ E+ + GR P PK +V
Sbjct: 179 DVWSYGVLLWEVFSYGRAPY-PKMSLKEVK 207
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 77/267 (28%), Positives = 130/267 (48%), Gaps = 27/267 (10%)
Query: 360 LGQGGFGGVYKGFF-RETNSY---IAVKRV-SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LG G FG V+KG + E +S +A+K + + +Q +E + + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
LG C L LV + P GSL H+ + L + +A G+ YL+E +
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRM 130
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTGKASK 533
VHR++ + NI+L S+ +I DFG+A L+ K + + +MA E G+ +
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 534 ESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
+SDV+S+G+ E+ + G +P P V DL G+ L P++C
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--QPQIC----- 236
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQV 619
I+ M++ + C DEN+RP+ +++
Sbjct: 237 -TIDVYMVM-VKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 54/191 (28%), Positives = 102/191 (53%), Gaps = 6/191 (3%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G FG V+ G++ + +AVK + G+ ++ + E ++ L+H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 418 CHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+++ + ++ E+M GSL L E + + +A G+ Y++ + +H
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD++++N+++ + KI DFGLAR++E + + + + APE G + +SD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 537 VYSFGIVALEI 547
V+SFGI+ EI
Sbjct: 187 VWSFGILLYEI 197
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 20/210 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
+LG G FG VYK +ET + A K + S++ +++Y E++I++ H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
+ +L ++ EF P G++D+ + + + LT I + + L YL ++HRD
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRD 135
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPE---CATTGKA 531
+K+ N++L + + K+ DFG++ AK +T GT +MAPE C T
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 532 SKE--SDVYSFGIVALEIACGRKP---INP 556
+ +D++S GI +E+A P +NP
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 36/272 (13%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQLL-G 416
+G+G +G V R +K+++ S++ K E +++S+L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 417 WCHEKKELLLVYEFMPNGSL-------DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
W E L +V F G L L EN ++ W + +A L YL E+
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHEK 121
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
++HRD+K+ N+ L K+GD G+AR++E+ +T L GT YM+PE +
Sbjct: 122 H---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNK 177
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
+ +SDV++ G E+A + N K V +++E P + +D
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY------------RIIEGKLPPMPKD 225
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+ + E +I + P++ RPS++ ++
Sbjct: 226 YSPELGE--LIATMLSKRPEK--RPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 360 LGQGGFGGVYKGFF----RETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRHRNLVQ 413
LG G FG VYKG + +A+K +++ G K + E+ E I++ + H +LV+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV-EFMDEALIMASMDHPHLVR 73
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
LLG C + LV + MP+G L ++ + + + +A G++YL+E +
Sbjct: 74 LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 129
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTGKA 531
+VHRD+ + N+++ S + KI DFGLARL+E + G M +MA EC K
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 532 SKESDVYSFGIVALEIAC-GRKP 553
+ +SDV+S+G+ E+ G KP
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 40/282 (14%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNL 411
++LGQG FG VY+G + E + +A+K V++ + + E+ +E ++ ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFK---------ENSLLTWEFRYKIAQDLASG 462
V+LLG + + L++ E M G L S+L + + + ++A ++A G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA----KGSQTTVLAGTM 518
+ YL VHRD+ + N M+ +F KIGDFG+ R + KG + + +
Sbjct: 132 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL---PV 185
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578
+M+PE G + SDV+SFG+V EIA + P +L++V + G L
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVME----GGL 239
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
L+ P C D L + C + +RPS ++I
Sbjct: 240 LD--KPDNCPDM-------LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNL 411
DF +LG G G V K R + +A K + K I+ + E+K++ +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V G + E+ + E M GSLD L K+ + KI+ + GL YL+E+ +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLREKHK 120
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
++HRD+K SNI+++S K+ DFG++ +L++ S GT YM+PE
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTH 174
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
+ +SD++S G+ +E+A GR PI P + ++
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 33/210 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+KLG+G + VYKG R T +A+K + +++G A E+ ++ L+H N+V+L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 417 WCHEKKELLLVYEFMPN------------GSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
H + +L+LV+E+M G+LD + K F Y++ + G+
Sbjct: 66 VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS-------FTYQLLK----GIA 114
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL--VEHAKGSQTTVLAGTMGYMA 522
+ E V+HRD+K N++++ K+ DFGLAR + S V T+ Y A
Sbjct: 115 FCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRA 168
Query: 523 PECATTGKASKES-DVYSFGIVALEIACGR 551
P+ + S D++S G + E+ GR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 57/209 (27%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
+G+G +G V K + T +A+K + S+ + K EVK++ +LRH N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 417 WCHEKKELLLVYEF-----------MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
K L LV+E+ P G L + W+ L + Y
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGG-LPPDAVR---SYIWQ--------LLQAIAY 115
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE- 524
++HRDIK NI++ + K+ DFG AR + S T T Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 525 --CATTGKASKESDVYSFGIVALEIACGR 551
T K DV++ G + E+ G
Sbjct: 173 LVGDT--NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 51/149 (34%), Positives = 79/149 (53%), Gaps = 11/149 (7%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----KQGIKEYA-SEVKIISRLRHRNLVQ 413
KLG+G + VYK +ET +A+K++ G K GI A E+K++ L+H N++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK-IAQDLASGLLYLQEEWEQ 472
LL K + LV+EFM L + K+ S++ K GL YL W
Sbjct: 67 LLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
++HRD+K +N+++ S+ K+ DFGLAR
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRN 410
F D +++G G FG VY TN +A+K++S KQ +++ EV+ + +LRH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 411 LVQLLGWCHEKKELL-LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
++ G C+ ++ LV E+ + D + L E I GL YL
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-AICHGALQGLAYLHS- 133
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CA 526
+HRDIK+ NI+L K+ DFG A LV A GT +MAPE
Sbjct: 134 --HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAM 186
Query: 527 TTGKASKESDVYSFGIVALEIACGRKP 553
G+ + DV+S GI +E+A RKP
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA-ERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 59/201 (29%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG-IKEYASEVKIISRLRH---RNLVQLL 415
+G+G +G VY+G T +A+K ++ + + + EV ++S+LR N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK--IAQDLASGLLYLQEEWEQC 473
G + L ++ E+ GS+ + L K + +Y I +++ L Y+ +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRT-LMKAGPI---AEKYISVIIREVLVALKYIHKV---G 121
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-S 532
V+HRDIK++NI++ + N K+ DFG+A L+ ++T GT +MAPE T GK
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYD 180
Query: 533 KESDVYSFGIVALEIACGRKP 553
++D++S GI E+A G P
Sbjct: 181 TKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYA-SEVKIISRLRHRN 410
D+ +K+G+G +G VYKG ++T +A+K++ S+ +G+ A E+ ++ L+H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 411 LVQLLGWCHEKKELLLVYEFM------------PNGSLDSHLFKENSLLTWEFRYKIAQD 458
+V L ++ L L++EF+ +D+ L K + Y+I Q
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS-------YLYQILQ- 112
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG-- 516
G+L+ + V+HRD+K N+++D+ K+ DFGLAR A G V
Sbjct: 113 ---GILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR----AFGIPVRVYTHEV 162
Query: 517 -TMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPI 554
T+ Y APE + S D++S G + E+A +KP+
Sbjct: 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 49/297 (16%)
Query: 358 QKLGQGGFGGVY------------KGFFRETNS----YIAVKRVSQG-SKQGIKEYASEV 400
+KLG+G FG V+ K F N+ +AVK + S +++ EV
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD----SHLFKENSL------LTWE 450
KI+SRL N+ +LLG C L ++ E+M NG L+ H+ + + L L++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAK 507
+A +ASG+ YL+ VHRD+ + N ++ N+ KI DFG++R + ++ +
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187
Query: 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA--CGRKPINPKAPQGQVSL 565
L + +MA E GK + +SDV++FG+ EI C +P QV
Sbjct: 188 VQGRAPLP--IRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-HLTDQQV-- 242
Query: 566 LQWVWDLYGNGKLLEAVD-PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
++ + + + P C + I LM L C DE RP+ R+ IH
Sbjct: 243 IENAGHFFRDDGRQIYLPRPPNCP----KDIYELM---LECWRRDEEDRPTFRE-IH 291
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS---EVKIISRLRHRNLVQL 414
+K+G+G FG +Y + + + +K + +K +KE + EV ++++++H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSH-------LFKENSLLTWEFRYKIAQDLASGLLYLQ 467
E L +V E+ G L LF E+ +L+W + ++ GL ++
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIH 118
Query: 468 EEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ + ++HRDIKS NI L N AK+GDFG+AR + + T GT Y++PE
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEIC 174
Query: 527 TTGKASKESDVYSFGIVALEIACGRKP 553
+ ++D++S G V E+ + P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
LG GGFG V + N A+K V + G +E+ SE +I+ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+KK + ++ E+ G L + L + R+ IA + YL + +++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHN---RGIIY 116
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+K N++LDSN K+ DFG A+ ++ G +T GT Y+APE D
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAPEIILNKGYDFSVD 174
Query: 537 VYSFGIVALEIACGRKP 553
+S GI+ E+ GR P
Sbjct: 175 YWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-19
Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 39/213 (18%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNLVQLLGW 417
++G G G VYK R T A+K + + ++ + E++I+ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK---- 136
Query: 418 CHE----KKELLLVYEFMPNGSLD-SHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
CH+ E+ ++ EFM GSL+ +H+ E L +A+ + SG+ YL +
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA------DVARQILSGIAYLHR---R 187
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPECATT 528
+VHRDIK SN++++S N KI DFG++R++ +QT GT+ YM+PE T
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRIL-----AQTMDPCNSSVGTIAYMSPERINT 242
Query: 529 --------GKASKESDVYSFGIVALEIACGRKP 553
G A D++S G+ LE GR P
Sbjct: 243 DLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 9/210 (4%)
Query: 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLR 407
L +DF +LG G G V K + + +A K + K I+ + E++++
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+V G + E+ + E M GSLD + KE + E K++ + GL YL+
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECA 526
E+ + ++HRD+K SNI+++S K+ DFG++ +L++ S GT YM+PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 174
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINP 556
S +SD++S G+ +E+A GR PI P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 9/201 (4%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
+G+G +G V K +ET +A+K+ S+ K K E++++ +LRH NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
KK L LV+EF+ + LD N L R + Q L G+ + ++H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL-RGIEFCH---SHNIIH 123
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKES 535
RDIK NI++ + K+ DFG AR + A G T T Y APE K +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVATRWYRAPELLVGDTKYGRAV 182
Query: 536 DVYSFGIVALEIACGRKPINP 556
D+++ G + E+ G +P+ P
Sbjct: 183 DIWAVGCLVTEMLTG-EPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 81/286 (28%), Positives = 143/286 (50%), Gaps = 42/286 (14%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRN 410
++LGQG FG VY+G R E + +AVK V++ + ++ I E+ +E ++ +
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 70
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLF-----KENS----LLTWEFRYKIAQDLAS 461
+V+LLG + + L+V E M +G L S+L EN+ T + ++A ++A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV----EHAKGSQTTVLAGT 517
G+ YL + VHRD+ + N M+ +F KIGDFG+ R + + KG + +
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL---P 184
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577
+ +MAPE G + SD++SFG+V EI + P +L++V D G
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE--QPYQGLSNEQVLKFVMD----GG 238
Query: 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
L+ P C +++ LM + C + +RP+ +++++L
Sbjct: 239 YLD--QPDNCP----ERVTDLMRM---CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 72/227 (31%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 339 PKRFPYKE-LALATNDFNDDQKLGQGGFGGVYK----GFFRETNSY-IAVKRVSQGSKQG 392
P + PY N+ + + LG G FG V + G + +AVK + +
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 393 IKE-YASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF-KENSLLTW 449
+E SE+KI+S L H N+V LLG C +L++ E+ G L + L K S LT
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 450 E----FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
E F Y++A+ G+ +L + C+ HRD+ + N++L KI DFGLAR + +
Sbjct: 141 EDLLSFSYQVAK----GMAFL--ASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMN 193
Query: 506 -----AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
KG+ + +MAPE + ESDV+S+GI+ EI
Sbjct: 194 DSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 44/280 (15%)
Query: 360 LGQGGFGGVYKGFF-----RETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LG G FG + +G RE I R KQ + + +E + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIVRL 71
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
G +++V E+M NG+LDS L K L + LASG+ YL E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGY 128
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGKAS 532
VH+ + + ++++S+ KI F RL E + T ++G + + APE S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 533 KESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD-------P 584
SDV+SFGIV E+ + G +P WD+ +++AV+ P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP---------------YWDM-SGQDVIKAVEDGFRLPAP 230
Query: 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
R C + +LM L C + RP Q+ +L+
Sbjct: 231 RNCP----NLLHQLM---LDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 26/269 (9%)
Query: 360 LGQGGFGGVYKGFFRETNS---YIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLL 415
+G+G FG VY G +++ + AVK +++ + + ++++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 416 GWCHEKKEL-LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
G C + L+V +M +G L + + E T + +A G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKF 119
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGKA 531
VHRD+ + N MLD +F K+ DFGLAR + E+ T + +MA E T K
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591
+ +SDV+SFG++ E+ P P V L +LL+ P C D
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRRLLQ---PEYCPD-- 229
Query: 592 GQQIERLMIVGLWCAHPDENLRPSIRQVI 620
L V L C HP +RP+ +++
Sbjct: 230 -----PLYEVMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 68/243 (27%), Positives = 119/243 (48%), Gaps = 43/243 (17%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVY----KGF----------FRETNSYIAVKRV-S 386
FP ++L L +KLG+G FG V+ +G F +AVK + +
Sbjct: 2 FPRQQLRLK-------EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA 54
Query: 387 QGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD--------- 437
+K ++ E+KI+SRL++ N+++LLG C L ++ E+M NG L+
Sbjct: 55 DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIE 114
Query: 438 SHLFKENSL--LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495
S N++ ++ +A +ASG+ YL VHRD+ + N ++ +++ KI
Sbjct: 115 STFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIA 171
Query: 496 DFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI--ACG 550
DFG++R + ++ + VL + +MA E GK + SDV++FG+ E+ C
Sbjct: 172 DFGMSRNLYSGDYYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
Query: 551 RKP 553
+P
Sbjct: 230 EQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 6/168 (3%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GI-KEYASEVKIISRLRHRNLVQLLG 416
++G+G G V+K RET +A+K+V+ + GI + E+K + +H +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+LV E+MP L L E L + L G+ Y+ ++H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
RD+K +N+++ ++ KI DFGLARL + + T Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA----SEVKIISRLRH 408
+ + +G+G +G V + T +A+K++S Q + E+KI+ R +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62
Query: 409 RNLVQLL-----GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLASG 462
N++ +L ++ +V E M D + L K L +Y + Q L G
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLSNDHIQYFLYQIL-RG 118
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGY 520
L Y+ V+HRD+K SN++L++N + KI DFGLAR+ EH T T Y
Sbjct: 119 LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175
Query: 521 MAPECATTGKA-SKESDVYSFGIVALEIACGRKPINP 556
APE K +K D++S G + E+ R P+ P
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 55/161 (34%), Positives = 83/161 (51%), Gaps = 12/161 (7%)
Query: 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLR 407
D+ KLG+G FG VYK +T +A+K++ + K G A E+KI+ +L+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 408 HRNLVQLLGWCHEK-----KELLLVYEFMPNGSLD-SHLFKENSLLTWEFRYK-IAQDLA 460
H N+V L+ E+ ++ VY P D S L + S+ E + K L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
G+ YL E ++HRDIK++NI++D+ KI DFGLAR
Sbjct: 126 EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 57/296 (19%)
Query: 360 LGQGGFGGVYKGFFRETN-----SYIAVKRV-SQGSKQGIKEYASEVKIISRL-RHRNLV 412
LG+G FG V K + S +AVK + +++ + + SE++++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHL-------FKENSLLTWEFRYKIAQ-DLAS--- 461
LLG C ++ L +V E+ +G+L L + + Q DL S
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 462 ----GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
G+ +L ++C+ HRD+ + N+++ + KI DFGLAR + H + T T
Sbjct: 140 QVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT----T 192
Query: 518 MG-----YMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWD 571
G +MAPE + +SDV+SFG++ EI G P P P V +
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP---------VEE 242
Query: 572 LYGN---GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L+ G +E P+ C Q++ LM C H + RP+ +Q++ L+
Sbjct: 243 LFKLLKEGYRMEK--PQNCT----QELYHLM---RDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
+LG G FG VYK +ET A K + S++ +++Y E+ I++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 419 HEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+ + L ++ EF G++D+ + + E L + R Q L + L YL E ++HR
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA-LNYLH---ENKIIHR 127
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT----VLAGTMGYMAPE---CATTGK 530
D+K+ NI+ + + K+ DFG++ AK ++T GT +MAPE C T+
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182
Query: 531 ASKE--SDVYSFGIVALEIACGRKP---INP 556
+ +DV+S GI +E+A P +NP
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 71/230 (30%), Positives = 108/230 (46%), Gaps = 19/230 (8%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRH 408
TN + D Q +G G FG V + T +A+K++ + + K E+K++ LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 409 RNLVQLLG-WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
N++ L + +++ V E + D H + L +F + GL Y+
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
VVHRD+K SNI+++ N + KI DFGLAR+ + Q T T Y APE
Sbjct: 126 S---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIML 178
Query: 528 T-GKASKESDVYSFGIVALEIACGRKPINP-KAPQGQVSLLQWVWDLYGN 575
T K E D++S G + E+ G KP+ P K Q S++ DL G
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQFSIIT---DLLGT 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 20/196 (10%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SE 399
FP+ + + + K+GQG FG V+K ++T +A+K+V + K+G A E
Sbjct: 5 FPFCD---EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61
Query: 400 VKIISRLRHRNLVQLLGWCHEKK--------ELLLVYEFMPNGSLDSHLFKENSLLTWEF 451
+KI+ L+H N+V L+ C K LV+EF + L L +N T
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSE 120
Query: 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511
K+ + L +GL Y+ ++HRD+K++NI++ + K+ DFGLAR +K S+
Sbjct: 121 IKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 512 TVLAG---TMGYMAPE 524
T+ Y PE
Sbjct: 178 NRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 41/218 (18%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS--------EVKIISRL-RH 408
++LG G FG VY +ET +A+K++ K++ S EVK + +L H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSL-------DSHLFKENSLLTWEFRYKIAQDLAS 461
N+V+L E EL V+E+M G+L F E+ + R I Q +
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVI-----RSIIYQ-ILQ 110
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMG 519
GL ++ + HRD+K N+++ KI DFGLAR + S+ T T
Sbjct: 111 GLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIR----SRPPYTDYVSTRW 163
Query: 520 YMAPECA-TTGKASKESDVYSFGIVALEIACGRKPINP 556
Y APE + S D+++ G + E+ R P+ P
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 15/211 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNLV 412
F +++G+G FG V+KG T +A+K + + ++ I++ E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 413 QLLGWCHEKKELLLVYEFMPNGS----LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+ G + +L ++ E++ GS L + F E + T + +++ GL YL
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
E + +HRDIK++N++L + K+ DFG+A + + + T GT +MAPE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIQQ 175
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAP 559
++D++S GI A+E+A G P + P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 25/277 (9%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHR 409
+F ++K+G+G F VY+ +A+K+V K A E+ ++ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDS---HLFKENSLLTWEFRYKIAQDLASGLLYL 466
N+++ E EL +V E G L H K+ L+ + +K L S L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ V+HRDIK +N+ + + K+GD GL R +K + L GT YM+PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD-PR 585
+ +SD++S G + E+A + P +LY K +E D P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLYSLCKKIEQCDYPP 227
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
L D +++ +L+ + C +PD RP I V V
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 9/210 (4%)
Query: 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK-EYASEVKIISRLR 407
L +DF +LG G G V+K + + +A K + K I+ + E++++
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+V G + E+ + E M GSLD + K+ + + K++ + GL YL+
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECA 526
E+ + ++HRD+K SNI+++S K+ DFG++ +L++ S GT YM+PE
Sbjct: 121 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 174
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINP 556
S +SD++S G+ +E+A GR PI P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/199 (32%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+GGFG V + T A K++ + K G K E +I+ ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
K L LV M G L H++ E L + AQ + G+L+L +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ-ITCGILHLHS---MDI 116
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKE 534
V+RD+K N++LD N ++ D GLA VE G T AGT GYMAPE S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 535 SDVYSFGIVALEIACGRKP 553
D ++ G E+ GR P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 60/208 (28%), Positives = 108/208 (51%), Gaps = 9/208 (4%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNLV 412
F +++G+G FG VYKG T +A+K + + ++ I++ E+ ++S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 413 QLLGWCHEKKELLLVYEFMPNGS-LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
+ G + +L ++ E++ GS LD L K L + I +++ GL YL E +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPL-EETYIATILREILKGLDYLHSERK 122
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+HRDIK++N++L + K+ DFG+A + + + T GT +MAPE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 178
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAP 559
++D++S GI A+E+A G P + P
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 38/277 (13%)
Query: 360 LGQGGFGGVYKGFFRETN---SYIAVKRVS----------QGSKQGIKEYASEVKII-SR 405
LG G FG VYK R+ N + +A+K ++ + + I + SEV II +
Sbjct: 8 LGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL--FKENSLLTWEFR-YKIAQDLASG 462
LRH N+V+ E L +V + + L H KE E R + I +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L YL +E + +VHRD+ +NIML + I DFGLA+ + S+ T + GT+ Y
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582
PE +++DV++FG + ++ C +P P +SL K++EAV
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM-CTLQP--PFYSTNMLSLAT---------KIVEAV 229
Query: 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
L + + +I C PD RP I QV
Sbjct: 230 YEPLPEGMYSEDV-TDVIT--SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/199 (30%), Positives = 109/199 (54%), Gaps = 8/199 (4%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
++KLG G FG V+ + + ++ +AVK + GS ++ + +E ++ L+H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 417 WCHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
K+ + ++ EFM GSL L E S + +A G+ ++++ + +
Sbjct: 69 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
HRD++++NI++ ++ KI DFGLAR++E + + + + APE G + +S
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 536 DVYSFGIVALEIAC-GRKP 553
DV+SFGI+ +EI GR P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVKIISRLRH-R 409
+D ++LG+G +G V K T + +AVKR+ + + Q K ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDS---HLFKENSLLTWEFRYKIAQDLASGLLYL 466
V G + ++ + E M + SLD ++ + + + KIA + L YL
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEH-AKGSQTTVLAGTMGYMAPE 524
+ V+HRD+K SN++++ N K+ DFG++ LV+ AK T+ AG YMAPE
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TIDAGCKPYMAPE 173
Query: 525 ---CATTGKA-SKESDVYSFGIVALEIACGRKP 553
K +SDV+S GI +E+A GR P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ-GSKQGIKEYASEVKIISRLRHR- 409
ND + ++G G G VYK F++T +AVK++ + G+K+ K ++ ++ H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVL-KSHDC 73
Query: 410 -NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+V+ G+ ++ + E M LD L + + + K+ + L YL+E
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ V+HRD+K SNI+LD++ N K+ DFG++ RLV+ +++ AG YMAPE
Sbjct: 133 K--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS---AGCAAYMAPERID 187
Query: 528 ----TGKASKESDVYSFGIVALEIACGRKP 553
K +DV+S GI +E+A G+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 40/218 (18%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G V+K RET+ +A+KRV +G+ A E+ ++ L+H+N+V+L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 416 GWCHEKKELLLVYEFMP----------NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
H K+L LV+E+ NG +D + K F +++ + GL +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-------FMFQLLK----GLAF 114
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG------SQTTVLAGTMG 519
V+HRD+K N++++ N K+ DFGLAR A G S V T+
Sbjct: 115 CHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVV---TLW 164
Query: 520 YMAPECATTGKASKES-DVYSFGIVALEIACGRKPINP 556
Y P+ K S D++S G + E+A +P+ P
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
LG+G FG E +S + K V ++ S++ ++ +E+ I+S L+H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 418 CHEKKELLLVYEFMPNGSL-------DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+ LL+ E+ G+L LF+E +L + F+ + S + Y+ +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ------IVSAVSYIHKA- 120
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
++HRDIK+ NI L K+GDFG+++++ TV+ GT YM+PE K
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177
Query: 531 ASKESDVYSFGIVALEIACGRK 552
+ +SD+++ G V E+ ++
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 68/242 (28%), Positives = 117/242 (48%), Gaps = 43/242 (17%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQ-GSKQGIKEYASEVKIISRL-RH 408
D + +G+G FG V + ++ + A+K + + S+ +++A E++++ +L H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSL------------DSHLFKEN---SLLTWEFRY 453
N++ LLG C + L + E+ P G+L D KE+ S LT +
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513
+ A D+A+G+ YL E+ +HRD+ + N+++ N +KI DFGL+R +
Sbjct: 123 QFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR-------GEEVY 172
Query: 514 LAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-------CGRK--PINPKAP 559
+ TMG +MA E + +SDV+SFG++ EI CG + K P
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 560 QG 561
QG
Sbjct: 233 QG 234
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 56/297 (18%)
Query: 357 DQKLGQGGFGGVYKGFFRETN-----SYIAVKRVSQGSKQG-IKEYASEVKIISRLRHRN 410
+ LG+G FG V K + +AVK + + + +++ SE ++ ++ H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL-----------------------L 447
+++L G C + LLL+ E+ GSL S L + + L
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 448 TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---- 503
T A ++ G+ YL E +VHRD+ + N+++ KI DFGL+R V
Sbjct: 125 TMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQ 562
+ K S+ + + +MA E + +SDV+SFG++ EI G P AP+
Sbjct: 182 SYVKRSKGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER- 237
Query: 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+++L G +E P C +++ LM+ W PD+ RP+ +
Sbjct: 238 ------LFNLLKTGYRMER--PENC----SEEMYNLMLT-CWKQEPDK--RPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNLV 412
F +K+G+G FG V+KG T +A+K + + ++ I++ E+ ++S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 413 QLLGWCHEKKELLLVYEFMPNGS----LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+ G + +L ++ E++ GS L+ E + T I +++ GL YL
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT------ILREILKGLDYLHS 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
E + +HRDIK++N++L + K+ DFG+A + + + GT +MAPE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQ 175
Query: 529 GKASKESDVYSFGIVALEIACGRKP 553
++D++S GI A+E+A G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 15/211 (7%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLG 416
+ LG G G VYK + T +AVK + + + K+ SE++I+ + ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+ + + EFM GSLD + +L +IA + GL YL W ++H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILH 118
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
RD+K SN+++++ K+ DFG++ LV S GT YMAPE + + S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 536 DVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
DV+S GI +E+A GR P P+ + Q SL+
Sbjct: 175 DVWSLGISFMELALGRFPY-PQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 3e-18
Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNL 411
+ + +G G +G V + T +A+K++S I K E+K++ LRH N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 412 VQLL-----GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWE-FRYKIAQDLASGLL 464
+ LL + ++ +V E M D H + K LT + +Y + Q L GL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLYQIL-RGLK 117
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYM 521
YL V+HRD+K SNI+++SN + KI DFGLAR V+ + L T Y
Sbjct: 118 YLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP-DEDEKGFLTEYVVTRWYR 173
Query: 522 APECATTGKA-SKESDVYSFG-IVALEIACGRKPINP 556
APE + +K D++S G I A E+ RKP+ P
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFA-ELL-TRKPLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 63/203 (31%), Positives = 111/203 (54%), Gaps = 14/203 (6%)
Query: 359 KLGQGGFGGVYKGFFR--ETNSYIAVKRV-SQGSKQGIK-EYASEVKIISRLRHRNLVQL 414
+LG G FG V KG ++ ++ +AVK + + + +K E E ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
+G C E + +LV E G L+ L K N +T + ++ ++ G+ YL+E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEE---TNF 116
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGKA 531
VHRD+ + N++L + AKI DFGL++ + E+ ++T + + APEC K
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KWPVKWYAPECMNYYKF 175
Query: 532 SKESDVYSFGIVALE-IACGRKP 553
S +SDV+SFG++ E + G+KP
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 360 LGQGGFGGVYKGFFRE---TNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LG+G FG V +G + + +AVK ++ + I+E+ SE + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 415 LGWCHEKKEL------LLVYEFMPNGSLDSHLFK----ENSL-LTWEFRYKIAQDLASGL 463
+G C E L +++ FM +G L S L L + K D+A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGY 520
YL + +HRD+ + N ML + + DFGL++ + G Q + + +
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI--YSGDYYRQGRIAKMPVKW 181
Query: 521 MAPECATTGKASKESDVYSFGIVALEIA 548
+A E + +SDV++FG+ EIA
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIA 209
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ---GSKQGIKEYASEVKIISRLRH 408
DF+ +G+G FG V + T A+K + + +++ + + E I+S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQ-DLASGLLYLQ 467
+ QL +K L LV E+ P G L S L + +F +AQ LA +L +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIH 116
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ VHRDIK N+++D + K+ DFG A + K + + GT Y+APE T
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 528 T----GKASK--ESDVYSFGIVALEIACGRKP 553
T GK + E D +S G++A E+ GR P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRN 410
F ++G G FG VY TN +AVK++S KQ +++ EVK + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
++ G ++ LV E+ + D + L E I GL YL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS-- 139
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 527
++HRDIK+ NI+L K+ DFG A +K S GT +MAPE
Sbjct: 140 -HNMIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMD 193
Query: 528 TGKASKESDVYSFGIVALEIACGRKP 553
G+ + DV+S GI +E+A RKP
Sbjct: 194 EGQYDGKVDVWSLGITCIELA-ERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRN 410
F D +++G G FG VY TN +A+K++S KQ +++ EVK + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
++ G + LV E+ + D + L E I GL YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH--- 142
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 527
++HRDIK+ NI+L K+ DFG A + A GT +MAPE
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMD 197
Query: 528 TGKASKESDVYSFGIVALEIACGRKP 553
G+ + DV+S GI +E+A RKP
Sbjct: 198 EGQYDGKVDVWSLGITCIELA-ERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 57/193 (29%), Positives = 101/193 (52%), Gaps = 9/193 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKR--VSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+G+G FG V+ + + +K+ V Q +K +E +++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
E K L++V E+ P G+L ++ K NSLL + I LL L + ++H
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED---TILHFFVQILLALHHVHTKLILH 124
Query: 477 RDIKSSNIMLDSNFN-AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
RD+K+ NI+LD + KIGDFG+++++ + T V GT Y++PE +++S
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGKPYNQKS 182
Query: 536 DVYSFGIVALEIA 548
D+++ G V E+A
Sbjct: 183 DIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+GGFG V R T A K++++ ++G + E +I++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFR--YKIAQDLASGLLYLQEEWE 471
K +L LV M G L H++ +EN E R + AQ + SGL +L +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPRACFYTAQ-IISGLEHLHQ--- 115
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGK 530
+ +++RD+K N++LD++ N +I D GLA VE G S+T AGT G+MAPE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
D ++ G+ E+ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRN 410
F+D +++G G FG VY + +A+K++S KQ +++ EV+ + +LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+Q G + LV E+ + D + L E + GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS-- 133
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 527
++HRD+K+ NI+L K+GDFG A ++ A GT +MAPE
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMD 187
Query: 528 TGKASKESDVYSFGIVALEIACGRKP 553
G+ + DV+S GI +E+A RKP
Sbjct: 188 EGQYDGKVDVWSLGITCIELA-ERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 33/227 (14%)
Query: 346 ELALATNDFNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQ-GSKQGIKEYASEV 400
EL L+ F ++ LG+ FG +YKG + +A+K + + Q E+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK-----------------E 443
+++ L H N+V LLG +++ + +++E++ G L L +
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 444 NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
+SL +F + IA +A+G+ YL + VH+D+ + NI++ + KI D GL+R +
Sbjct: 119 SSLDHGDFLH-IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 504 ---EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
++ + ++L + +M PE GK S +SD++SFG+V EI
Sbjct: 175 YSADYYRVQPKSLLP--IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 9e-18
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+K+GQG G VY T +A+K+++ +Q KE +E+ ++ +H N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
EL +V E++ GSL + + E + + + ++ L +L V+H
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIH 138
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RDIKS NI+L + + K+ DFG + + ++T + GT +MAPE T + D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 537 VYSFGIVALEIACGRKP 553
++S GI+A+E+ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 67/236 (28%), Positives = 111/236 (47%), Gaps = 45/236 (19%)
Query: 358 QKLGQGGFGGV---------------YKGFFRETNSY-IAVKRV-SQGSKQGIKEYASEV 400
+KLG+G FG V + R+ +AVK + +K ++ EV
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD----SHLFKENS----------- 445
KI+SRL+ N+++LLG C ++ L ++ E+M NG L+ SH +
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 446 ---LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502
+++ +A +ASG+ YL VHRD+ + N ++ N KI DFG++R
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRN 187
Query: 503 V---EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI--ACGRKP 553
+ ++ + VL + +MA EC GK + SDV++FG+ EI C +P
Sbjct: 188 LYAGDYYRIQGRAVLP--IRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY-------IAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+ LGQG F ++KG RE Y + +K + + + + + ++S+L H++
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
LV G C E ++V E++ GSLD++L K +L+ ++ ++A+ LA L +L+
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--- 117
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM-----GYMAPEC 525
++ + H ++ + N++L + K G+ +L + G TVL + ++ PEC
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD--PGISITVLPKEILLERIPWVPPEC 175
Query: 526 ATTGKA-SKESDVYSFGIVALEIACG-RKPINPKAPQ 560
+ S +D +SFG EI G KP++ Q
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 70/235 (29%), Positives = 113/235 (48%), Gaps = 43/235 (18%)
Query: 360 LGQGGFGGVYKGFFRETNSYI--AVKRVSQ-GSKQGIKEYASEVKIISRL-RHRNLVQLL 415
+G+G FG V K ++ + A+KR+ + SK +++A E++++ +L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLA 460
G C + L L E+ P+G+L L K S L+ + A D+A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG- 519
G+ YL ++ +HRD+ + NI++ N+ AKI DFGL+R Q + TMG
Sbjct: 123 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172
Query: 520 ----YMAPECATTGKASKESDVYSFGIVALEIA-------CGRK--PINPKAPQG 561
+MA E + SDV+S+G++ EI CG + K PQG
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV------SQGSKQGIKEYASEVKIISRLRHRNL 411
++G G FG V G E + ++ RV + + + EV+ L H N+
Sbjct: 1 DEIGNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTW----EFRYKIAQDLASGLLYLQ 467
+Q LG C E LLV EF P G L ++L ++ + ++A ++ASGLL+L
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPEC 525
+ +H D+ N L ++ + KIGD+GLA L ++ + T A + ++APE
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 526 AT-------TGKASKESDVYSFGIVALEI 547
+K+S+++S G+ E+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G VYK R TN IA+K++ + +G+ A E+ ++ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
H +K L LV+E++ + L H+ F +N L + Y+I G+ Y
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQI----LRGIAYCH--- 119
Query: 471 EQCVVHRDIKSSNIMLDSNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
V+HRD+K N+++D NA K+ DFGLAR + T + T+ Y APE
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGS 178
Query: 530 KA-SKESDVYSFGIVALEIACGRKPINP 556
+ S D++S G + E+ +KP+ P
Sbjct: 179 RHYSTPVDIWSVGCIFAEMV-NQKPLFP 205
|
Length = 294 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 63/227 (27%), Positives = 116/227 (51%), Gaps = 33/227 (14%)
Query: 346 ELALATNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQGSKQGIKE-YASE 399
E+ L+T F ++ LG+ FG VYKG E +A+K + ++ ++E + E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 400 VKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN----------------GSLDSHLFKE 443
+ SRL+H N+V LLG +++ L +++ + + GS D +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 444 NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
++L +F + + Q +A+G+ +L VVH+D+ + N+++ N KI D GL R V
Sbjct: 119 STLEPADFVHIVTQ-IAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 504 ---EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
++ K ++L + +M+PE GK S +SD++S+G+V E+
Sbjct: 175 YAADYYKLMGNSLLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 78/291 (26%), Positives = 137/291 (47%), Gaps = 51/291 (17%)
Query: 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYI----AVKRVSQG-SKQGIKEYASEVKII 403
L +F + LG G FG VYKG + + A+K + + S + KE E ++
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS-------LLTWEFRYKIA 456
+ + + ++ +LLG C + L+ + MP G L ++ +E+ LL W
Sbjct: 64 ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNW------C 115
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE------HAKGSQ 510
+A G+ YL+E + +VHRD+ + N+++ + + KI DFGLA+L+ HA+G +
Sbjct: 116 VQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWV 569
+ +MA E + +SDV+S+G+ E+ G KP + P ++S
Sbjct: 173 VPI-----KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEIS----- 221
Query: 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ G+ L P +C I+ MI+ + C D + RP R++I
Sbjct: 222 -SILEKGERLP--QPPIC------TIDVYMIM-VKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQL--- 414
+G+G +G V ETN +A+K+++ I K E+K++ L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 415 LGWCHEK--KELLLVYEFMPNGSLDSH-LFKENSLLTWEF-RYKIAQDLASGLLYLQEEW 470
+ H + ++ +VYE M D H + + + L+ + +Y + Q L GL Y+
Sbjct: 73 MPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHCQYFLYQ-LLRGLKYIHS-- 126
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE----CA 526
V+HRD+K SN++L++N + KI DFGLAR KG T T Y APE C+
Sbjct: 127 -ANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLLNCS 184
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINP 556
A DV+S G + E+ GRKP+ P
Sbjct: 185 EYTTA---IDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 68/244 (27%), Positives = 115/244 (47%), Gaps = 44/244 (18%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVY-------KGFFRETNSY---------IAVKRV 385
FP K L +KLG+G FG V+ + F + S +AVK +
Sbjct: 2 FPRKRLTF-------KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML 54
Query: 386 -SQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD----SHL 440
+K ++ E+KI+SRL+ N+++LL C L ++ E+M NG L+ H
Sbjct: 55 REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE 114
Query: 441 FKENSL------LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494
+E + +++ +A +ASG+ YL VHRD+ + N ++ N+ KI
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKI 171
Query: 495 GDFGLARLV---EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA--C 549
DFG++R + ++ + VL + +M+ E GK + SDV++FG+ EI C
Sbjct: 172 ADFGMSRNLYSGDYYRIQGRAVLP--IRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229
Query: 550 GRKP 553
+P
Sbjct: 230 KEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 23/276 (8%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS---QGSKQGIKEYASEVKIISRLRHR 409
+F ++K+G+G F VY+ +A+K+V + ++ E+ ++ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDS---HLFKENSLLTWEFRYKIAQDLASGLLYL 466
N+++ L E EL +V E G L + K+ L+ +K L S + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ V+HRDIK +N+ + + K+GD GL R +K + L GT YM+PE
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586
+ +SD++S G + E+A + P SL Q K+ + P L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLFSLCQ---------KIEQCDYPPL 228
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
+ +++ L+ + C +PD + RP I V +
Sbjct: 229 PTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 44/220 (20%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G VYK + T +A+K++ + +G+ A E+ ++ L H N+V+LL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 416 GWCHEKKELLLVYEFM-----------PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
H + +L LV+EF+ P LD L K + Y++ Q G+
Sbjct: 65 DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKS-------YLYQLLQ----GIA 113
Query: 465 YLQEEWEQC----VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG---SQTTVLAGT 517
Y C V+HRD+K N+++D K+ DFGLAR A G T T
Sbjct: 114 Y-------CHSHRVLHRDLKPQNLLIDREGALKLADFGLAR----AFGVPVRTYTHEVVT 162
Query: 518 MGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINP 556
+ Y APE + S D++S G + E+ R+P+ P
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEM-VNRRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG---IKEYASEVKIISRLRHRNLVQLLG 416
+ +G +G V+ + T A+K + + + + +E I+S+ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC-VV 475
KK L LV E++P G L S L SL R IA+ + L YL ++
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-IVLALEYLH----SNGII 115
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLAR--LVEHAKG-----SQTTVLAGTMGYMAPECATT 528
HRD+K NI++DSN + K+ DFGL++ LV + + GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQ 560
SK D +S G + E G P + + P+
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 31/273 (11%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+LG+G +G VYK R T +A+K + + + + E+ I+ + +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTW---EFRYKIAQDLASGLLYLQEEWEQCV 474
+ + + E+M GSLD L+ + +I + GL +L+EE +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
+HRD+K +N++++ N K+ DFG++ LV A ++T + G YMAPE +G ++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNI--GCQSYMAPERIKSGGPNQ 180
Query: 534 ------ESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
+SDV+S G+ LE+A GR P P+ + L +++ P L
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---------AIVDGDPPTLP 231
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ + V C + N RP+ Q++
Sbjct: 232 SGYSDDAQD---FVAK-CLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 28/213 (13%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYA-SEVKIISRLRHRNLVQL--- 414
+G+G +G VYK ++T +A+K+V K+G A E+KI+ +L HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 415 -------LGWCHEKKELLLVYEFMPN---GSLDSHL--FKENSLLTWEFRYKIAQDLASG 462
L + +K LV+E+M + G L+S L F E+ + + + L G
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS------FMKQLLEG 128
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L Y + + +HRDIK SNI+L++ K+ DFGLARL + T T+ Y
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 523 PECATTGKASKES-DVYSFGIVALEIACGRKPI 554
PE + + DV+S G + E+ +KPI
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLL 415
LG+G FG V + T+ AVK + + ++ +E ++++ +H L QL
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
K L V E++ G L H+ F E + A ++ GL +L E
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVLGLQFLHE-- 114
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTG 529
+ +++RD+K N++LDS + KI DFG+ + E G TT GT Y+APE +
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
D ++ G++ E+ G+ P
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 70/222 (31%), Positives = 113/222 (50%), Gaps = 22/222 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+G G +G VYKG +T A+K V+ ++ IK+ + +K S HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYYGA 71
Query: 418 CHEKK------ELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLYLQEE 469
+K +L LV EF GS+ + L K + + L E+ I +++ GL +L +
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ- 129
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CA 526
V+HRDIK N++L N K+ DFG++ ++ G + T + GT +MAPE C
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 527 TTGKASKE--SDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
A+ + SD++S GI A+E+A G P+ P + L+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 51/291 (17%)
Query: 360 LGQGGFGGVYKGFF----RETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQL 414
LG G FG VYKG + +A+K + + S + KE E +++ + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENS-------LLTWEFRYKIAQDLASGLLYLQ 467
LG C + LV + MP G L ++ +EN LL W +A G+ YL+
Sbjct: 75 LGICLTST-VQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE------HAKGSQTTVLAGTMGYM 521
E +VHRD+ + N+++ S + KI DFGLARL++ HA G + + +M
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI-----KWM 178
Query: 522 APECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580
A E + + +SDV+S+G+ E+ G KP + P ++ DL G+ L
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIP------DLLEKGERLP 231
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631
P +C I+ MI+ + C D RP R+++ + A P+
Sbjct: 232 --QPPIC------TIDVYMIM-VKCWMIDSECRPRFRELVDEFSRMARDPS 273
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 8/205 (3%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
DF Q++G G +G VYK T A+K + + E+ ++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
G + +L + EF GSL L + Y ++++ GL YL + +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK- 127
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT---G 529
+HRDIK +NI+L N + K+ DFG++ + + + + GT +MAPE A G
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184
Query: 530 KASKESDVYSFGIVALEIACGRKPI 554
++ D+++ GI A+E+A + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 362 QGGFGGVYKGFFRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
+G FG VY R T Y A+K + +K + +E I+ V L +
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 419 HEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+ K+ L LV E++ G S L K L ++ + ++ G+ L + + ++HR
Sbjct: 66 FQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHR 121
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
DIK N+++D + K+ DFGL+R K GT Y+APE K SD
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDKMSDW 176
Query: 538 YSFGIVALEIACGRKPINPKAPQ 560
+S G V E G P + + P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+GGFG V R T A K++ + ++G +E +I+ ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 417 WCHEKKE-LLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
+ +E K+ L LV M G L H++ N + A +L GL LQ E +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---I 123
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKE 534
V+RD+K NI+LD + +I D GLA V+ +G GT+GYMAPE K +
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 535 SDVYSFGIVALEIACGRKP 553
D + G + E+ G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 8/206 (3%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+D+ Q++G G +G VYK T AVK + E+ ++ +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V G +++L + E+ GSL L + Y + ++ GL YL + +
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETLQGLAYLHSKGK 127
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT---T 528
+HRDIK +NI+L N + K+ DFG+A + + + + GT +MAPE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKN 183
Query: 529 GKASKESDVYSFGIVALEIACGRKPI 554
G ++ D+++ GI A+E+A + P+
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 27/203 (13%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+K+G+G FG +E +K + S+ S + +E EV ++S ++H N+VQ
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 416 GWCHEKKELLLVYEFMPNGSLDSH-------LFKENSLLTWEFRYKIAQDLASGLLYLQE 468
E L +V ++ G L LF E+ +L W + +A L+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKH 116
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA----GTMGYMAPE 524
++ ++HRDIKS NI L + K+GDFG+AR++ + T LA GT Y++PE
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSPE 171
Query: 525 CATTGKASKESDVYSFGIVALEI 547
+ +SD+++ G V E+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRN 410
F + LG+GGFG V R T A K++ + ++G +E +I+ ++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 411 LVQLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKI-AQDLASGLLYLQE 468
+V L + +E K+ L LV M G L H++ E R A ++ GL L +
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
E +V+RD+K NI+LD + + +I D GLA V +G GT+GYMAPE
Sbjct: 121 ER---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPK 557
+ + D ++ G + E+ G+ P +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 13/213 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH 408
DF ++GQGG+G V+ ++T +A+KR+ + ++ +E I++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
LV+LL + + L L E++P G + L L R+ +A+ + +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA----VDA 116
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECAT 527
E +HRD+K N ++D++ + K+ DFGL++ +V +A + G+ YMAPE
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLR 171
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQ 560
D +S G + E CG P + P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 86/354 (24%), Positives = 149/354 (42%), Gaps = 32/354 (9%)
Query: 277 KRRRKNRTA-LVVGLSLGGGVLVG----GVVLIIWLAGIGRKRKEGDEEDNQGFSEYIDD 331
KR RK + + +LG +++ G V I + KR E ED ++ D
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVE--NEDGTWELQFFDS 677
Query: 332 EFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ 391
+ K ++ + + N + +G G YKG + VK ++
Sbjct: 678 KVS-----KSITINDILSSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEIND--VN 727
Query: 392 GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEF 451
I SE+ + +L+H N+V+L+G C +K L++E++ +L L L+WE
Sbjct: 728 SIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWER 781
Query: 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511
R KIA +A L +L VV ++ I++D + L L+
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLL-----CTD 835
Query: 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD 571
T + Y+APE T +++SD+Y FG++ +E+ G+ P + + S+++W
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARY 894
Query: 572 LYGNGKLLEAVDPRLCRDFDGQQIE--RLMIVGLWCAHPDENLRPSIRQVIHVL 623
Y + L +DP + D Q E +M + L C D RP V+ L
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY--IAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
+ LG+G FG V +G + +S +AVK +++ ++ ++++ SE + H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 414 LLGWCHEKKEL------LLVYEFMPNGSLDSHLFKEN-----SLLTWEFRYKIAQDLASG 462
L+G C + E +++ FM +G L S L L + K D+ASG
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYM 521
+ YL + +HRD+ + N ML+ N N + DFGL++ + + Q + + ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 522 APECATTGKASKESDVYSFGIVALEIAC-GRKP 553
A E + +SDV+SFG+ EIA G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 60/197 (30%), Positives = 89/197 (45%), Gaps = 8/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+G FG V + T Y A+K + + +K + +E +++ RH L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
L V E+ G L HL +E R+ A+ + S L YL VV+
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALGYLHS---CDVVY 118
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+K N+MLD + + KI DFGL + + G+ GT Y+APE + D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 537 VYSFGIVALEIACGRKP 553
+ G+V E+ CGR P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 54/179 (30%), Positives = 85/179 (47%), Gaps = 29/179 (16%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKR-VSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
K+G+G +G V+K RET +A+K+ V IK+ A E++++ +L+H NLV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 417 WCHEKKELLLVYEFM-----------PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
K++L LV+E+ P G + HL K KI + +
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIK-----------KIIWQTLQAVNF 115
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
+ C+ HRD+K NI++ K+ DFG AR++ T +A T Y APE
Sbjct: 116 CHKH--NCI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+ +G G +G VYKG +T A+K V++ ++ IK + +K S HRN+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSH--HRNIATYY 79
Query: 416 GWCHEKK------ELLLVYEFMPNGSLDSHL--FKENSLLTWEFRYKIAQDLASGLLYLQ 467
G +K +L LV EF GS+ + K N+L Y I +++ GL +L
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH 138
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE--- 524
V+HRDIK N++L N K+ DFG++ ++ G + T + GT +MAPE
Sbjct: 139 A---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 525 CATTGKASKE--SDVYSFGIVALEIACGRKPI 554
C A+ + SD++S GI A+E+A G P+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+G FG V + T Y A+K + + +K + +E +++ RH L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
L V E+ G L HL +E R+ A+ + S L YL E VV+
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 119
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKES 535
RD+K N+MLD + + KI DFGL + E K G+ GT Y+APE +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 536 DVYSFGIVALEIACGRKP 553
D + G+V E+ CGR P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 13/213 (6%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----KQGIKEYASEVKIISRLRH 408
D + +G G FG V+ R + Y A+K ++ KQ + +E +++ + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+++L H+++ L ++ E++P G L S+L + A ++ L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLHS 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ +V+RD+K NI+LD + K+ DFG A+ + +T L GT Y+APE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLAPEVIQS 172
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQG 561
+K D ++ GI+ E+ G P P G
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 28/218 (12%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
++ K+G+G G V + T +AVK++ +Q + +EV I+ +H N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLD---SHL-FKENSLLTWEFRYKIAQDLASGLLYLQE 468
++ EL +V EF+ G+L +H E + T + + L +L
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLHA 133
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV-------LAGTMGYM 521
Q V+HRDIKS +I+L S+ K+ DFG +Q + L GT +M
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFC--------AQVSKEVPRRKSLVGTPYWM 182
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559
APE + E D++S GI+ +E+ G P + P
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 21/225 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIK-EYASEVKIISRLRHRNLVQLLG 416
++G+G +G VY+ + +A+K+V + GI E+ ++ LRH N+V+L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 417 WCHEKK--ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK-IAQDLASGLLYLQEEWEQC 473
K + LV E+ L S L + + E + K + L GL YL E +
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-ESQVKCLMLQLLRGLQYLHENF--- 128
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE----CATTG 529
++HRD+K SN++L KI DFGLAR T + T+ Y APE C T
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYT 187
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574
A D+++ G + E+ KP+ P ++ L + L G
Sbjct: 188 TA---IDMWAVGCILAELLAH-KPLLPGK--SEIEQLDLIIQLLG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 74/283 (26%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+K+GQG G VY T +A+K+++ + + +E+ ++ ++ N+V L
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
EL +V E++ GSL + + E + + + ++ L +L V+HR
Sbjct: 85 YLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALDFLHSNQ---VIHR 139
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
DIKS NI+L + + K+ DFG + + ++T + GT +MAPE T + D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 538 YSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIER 597
+S GI+A+E+ G P + P L+ ++ + NG P L Q ER
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGT------PEL------QNPER 240
Query: 598 LMIVGL----WCAHPDENLRPSIRQVIH--VLNFEAPLPALPP 634
L V C D + R S ++++ L PL +L P
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRN---LVQ 413
+G+G FG VY+ ++T A+K +S+ KE A E I+ R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L +L LV ++M G L HL KE ++ IA+ + L L+ +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELV----LALEHLHKYD 116
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-S 532
+V+RD+K NI+LD+ + + DFGL++ T GT Y+APE K +
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 533 KESDVYSFGIVALEIACGRKPINPKAPQGQ 562
K D +S G++ E+ CG P A Q
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPF--YAEDTQ 203
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 75/284 (26%), Positives = 133/284 (46%), Gaps = 32/284 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+K+GQG G V+ T +A+K+++ KQ KE +E+ ++ L++ N+V L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
EL +V E++ GSL + + E + + + ++ L +L V+H
Sbjct: 84 SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIA-AVCRECLQALEFLHANQ---VIH 138
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RDIKS N++L + + K+ DFG + + ++T + GT +MAPE T + D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197
Query: 537 VYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----KLLEAVDPRLCRDFDG 592
++S GI+A+E+ G P + P L+ ++ + NG + E + P + RDF
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTPELQNPEKLSP-IFRDFLN 250
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIH--VLNFEAPLPALPP 634
+ C D R S ++++ L PL +L P
Sbjct: 251 R-----------CLEMDVEKRGSAKELLQHPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNL 411
+N + +G+G FG ++ A+K + S +++ E ++++++H N+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSL-------DSHLFKENSLLTWEFRYKIAQDLASGLL 464
V L +V E+ G L LF E+++L W L
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW---------FVQMCL 111
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
+Q E+ V+HRDIKS NI L N K+GDFG ARL+ G+ GT Y+ PE
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYACTYVGTPYYVPPE 170
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKP 553
+ +SD++S G + E+ + P
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQL 414
+ +G G +G V + +A+K++ K E+KI+ +H N++ +
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 415 LGWCHEK----KELLLVYEFMPNGSLDSH-LFKENSLLTWE-FRYKIAQDLASGLLYLQE 468
K++ +V + M + D H + + LT E RY + Q L GL Y+
Sbjct: 70 RDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLTEEHIRYFLYQ-LLRGLKYIHS 125
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL-----VEHAKGSQTTVLAGTMGYMAP 523
V+HRD+K SN++++ + +IGDFG+AR EH K T +A T Y AP
Sbjct: 126 ---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH-KYFMTEYVA-TRWYRAP 180
Query: 524 ECA-TTGKASKESDVYSFGIVALEIACGRKPINP-KAPQGQVSLL 566
E + + + D++S G + E+ GR+ + P K Q+ L+
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPGKNYVHQLKLI 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 8/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+G FG V + T Y A+K + + +K + +E +++ RH L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
L V E+ G L HL +E R+ A+ + S L YL + VV+
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEYLHS---RDVVY 118
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RDIK N+MLD + + KI DFGL + + G+ GT Y+APE + D
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 537 VYSFGIVALEIACGRKP 553
+ G+V E+ CGR P
Sbjct: 178 WWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYA-SEVKIISRLRHRNL 411
F +K+G+G +G VYK + T +A+K++ ++ +G+ A E+ ++ L H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 412 VQLLGWCHEKKELLLVYEFM-----------PNGSLDSHLFKENSLLTWEFRYKIAQDLA 460
V+LL H + +L LV+EF+ P + L K S L L
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYL---------FQLL 110
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY 520
GL + V+HRD+K N+++++ K+ DFGLAR + T + T+ Y
Sbjct: 111 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWY 166
Query: 521 MAPECATTGK-ASKESDVYSFGIVALEI 547
APE K S D++S G + E+
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 12/221 (5%)
Query: 343 PYKELALATNDFNDDQKLGQGGFGGVYKGFFRETN-SYIAVKRVSQGS---KQGIKEYAS 398
P ++ + DFN + LG G FG V ++ + +A+KR + ++ + S
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 399 EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD 458
E KI++ + H V L G ++ L LV EF+ G + L + N + A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQ 139
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+ YLQ +V+RD+K N++LD + K+ DFG A++V+ ++T L GT
Sbjct: 140 IVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTP 192
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559
Y+APE K +D ++ GI EI G P P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 9/204 (4%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRN 410
F + LG+GGFG V R T A KR+ + ++G +E +I+ ++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEE 469
+V L K L LV M G L H++ N E A ++ GL L E
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
V+RD+K NI+LD + +I D GLA V+ +G GT+GYMAPE
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
+ + D + G + E+ G+ P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 37/197 (18%)
Query: 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKI 402
Y+ELA +G+G +G VYK T ++A+K+V S++GI S ++
Sbjct: 1 YEELAE----------IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP--LSTLRE 48
Query: 403 ISRLR------HRNLVQLLGWCH-----EKKELLLVYEFMPNGSLDSHLFKEN----SLL 447
I+ L+ H N+V+LL CH + +L LV+E + D + L
Sbjct: 49 IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ---DLATYLSKCPKPGLP 105
Query: 448 TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507
+ + Q L G+ +L +VHRD+K NI++ S+ KI DFGLAR+
Sbjct: 106 PETIKDLMRQ-LLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161
Query: 508 GSQTTVLAGTMGYMAPE 524
+ T+V+ T+ Y APE
Sbjct: 162 -ALTSVVV-TLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 6/201 (2%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
K+G+G G V + + +AVK++ +Q + +EV I+ +H N+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
EL +V EF+ G+L ++ + E +IA + L L Q V+HRD
Sbjct: 87 LVGDELWVVMEFLEGGALTD--IVTHTRMNEE---QIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
IKS +I+L + K+ DFG V + + L GT +MAPE + E D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS-LVGTPYWMAPELISRLPYGPEVDIW 200
Query: 539 SFGIVALEIACGRKPINPKAP 559
S GI+ +E+ G P + P
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----KQGIKEYASEVKIISRLRH 408
DF + LG G FG V + T Y A+K + + KQ ++ A E I+ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+V ++ ++ + + EF+ G L +HL K F +A+ + L+ E
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFE 132
Query: 469 EWEQC-VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+++RD+K N++LD+ + K+ DFG A+ V +T L GT Y+APE
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRTFTLCGTPEYLAPEVIQ 188
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAP--------QGQVSLLQWV 569
+ K D ++ G++ E G P P G++ W
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238
|
Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 60/208 (28%), Positives = 106/208 (50%), Gaps = 22/208 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+KLG+G + V+KG + T + +A+K + ++G A EV ++ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWE----FRYKIAQDLASGLLYLQEEWEQ 472
H K L LV+E++ + L ++ ++++ F Y+I + GL Y +
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR----GLAYCHR---R 123
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-T 528
V+HRD+K N++++ K+ DFGLAR AK T + T+ Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 529 GKASKESDVYSFGIVALEIACGRKPINP 556
+ S + D++ G + E+A GR P+ P
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKI---ISRLRHRNLVQ 413
LG+G FG V +++T A+K + +G ++ ++ E +I + RH LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS----GLLYLQEE 469
L + + V E+ G L H+ + F A A+ GL YL E
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE- 119
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
+V+RD+K N++LD+ KI DFGL + G +T+ GT ++APE T
Sbjct: 120 --NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
++ D + G++ E+ G P
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 40/244 (16%)
Query: 332 EFERGAGPK-RFPYKELALATNDFNDDQKLGQGGFG--------GVYKGFFRETNSYIAV 382
E+E P+ F +L L + LG+G FG G+ K +E + +AV
Sbjct: 1 EYELPEDPRWEFSRDKLTLG-------KPLGEGCFGQVVMAEALGIDKDKPKEAVT-VAV 52
Query: 383 KRVS-QGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL 440
K + +++ + + SE++++ + +H+N++ LLG C + L ++ E+ G+L +L
Sbjct: 53 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 112
Query: 441 FKENSLLTWEFRYKIAQ----------------DLASGLLYLQEEWEQCVVHRDIKSSNI 484
+ E+ Y IA+ +A G+ YL + +C+ HRD+ + N+
Sbjct: 113 -RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCI-HRDLAARNV 168
Query: 485 MLDSNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIV 543
++ N KI DFGLAR V + +TT + +MAPE + +SDV+SFG++
Sbjct: 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 228
Query: 544 ALEI 547
EI
Sbjct: 229 MWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 6/201 (2%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
K+G+G G V + + +AVK + +Q + +EV I+ +H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
+EL ++ EF+ G+L + L E + + + L YL Q V+HRD
Sbjct: 88 LVGEELWVLMEFLQGGALTD--IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRD 142
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
IKS +I+L + K+ DFG + + + L GT +MAPE + E D++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 539 SFGIVALEIACGRKPINPKAP 559
S GI+ +E+ G P +P
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV------SQGSKQGIKEYASEVKIISRLRHRNL 411
+++G G FG V G E NS +V S Q ++ E + L+H NL
Sbjct: 1 KEIGNGWFGKVILG---EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL 57
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL--FKENSLLTWEFR--YKIAQDLASGLLYLQ 467
+Q LG C E LLV EF P G L +L ++ L+T + ++A ++A GLL+L
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-----MA 522
+ +H D+ N +L ++ KIGD+GL+ H K + + + +A
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLS----HNKYKEDYYVTPDQLWVPLRWIA 170
Query: 523 PECA-------TTGKASKESDVYSFGIVALEI 547
PE +KES+V+S G+ E+
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 6/201 (2%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418
K+G+G G V + T +AVK++ +Q + +EV I+ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
EL +V EF+ G+L ++ + E + + L YL Q V+HRD
Sbjct: 89 LVGDELWVVMEFLEGGALTD--IVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVY 538
IKS +I+L S+ K+ DFG V + + L GT +MAPE + E D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-LVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 539 SFGIVALEIACGRKPINPKAP 559
S GI+ +E+ G P + P
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 37/232 (15%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVYK----GFFR---ETNSYIAVKRVS-QGSKQGI 393
FP L L + LG+G FG V + G + + +AVK + + + +
Sbjct: 9 FPRDRLVLG-------KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL 61
Query: 394 KEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE--------- 443
+ SE++++ + +H+N++ LLG C ++ L ++ E+ G+L L
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 444 ------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497
L+++ A +A G+ YL E +C+ HRD+ + N+++ + KI DF
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCI-HRDLAARNVLVTEDNVMKIADF 178
Query: 498 GLARLVEHAKGSQTTVLAGTM--GYMAPECATTGKASKESDVYSFGIVALEI 547
GLAR V + T G + +MAPE + +SDV+SFGI+ EI
Sbjct: 179 GLARGVHDIDYYKKTS-NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-15
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEV------KIISRLRHRNLVQ 413
LG+GGFG V R T A K++ K+ IK+ E +I+ ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 414 LLGWCHEKKE-LLLVYEFMPNGSLDSHL-------FKENSLLTWEFRYKIAQDLASGLLY 465
L + +E K+ L LV M G L H+ F E + + A ++ GL
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY------AAEITCGLED 117
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L E +V+RD+K NI+LD + +I D GLA VE +G GT+GYMAPE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEV 172
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKP 553
+ + D + G + E+ G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+K+GQG G VY T +A+++++ + + +E+ ++ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
EL +V E++ GSL + + E + + + ++ L +L V+HR
Sbjct: 86 YLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIA-AVCRECLQALEFLHSNQ---VIHR 140
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
DIKS NI+L + + K+ DFG + E +K S + GT +MAPE T +
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVGTPYWMAPEVVTRKAYGPKV 197
Query: 536 DVYSFGIVALEIACGRKP 553
D++S GI+A+E+ G P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLGW 417
KLG+G + VYKG + T++ +A+K + ++G A EV ++ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
H +K L LV+E++ + L +L + + L GL Y + V+HR
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHR 128
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-TGKASK 533
D+K N++++ K+ DFGLAR AK T + T+ Y P+ + S
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
Query: 534 ESDVYSFGIVALEIACGRKPINP 556
+ D++ G + E++ GR P+ P
Sbjct: 185 QIDMWGVGCIFYEMSTGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
LG+G FG V + + Y A+K + + +K + +E +++ RH L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
K L V E++ G L HL +E R+ A+ + S L YL +V+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE-IVSALDYLHS---GKIVY 118
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT-TVLAGTMGYMAPECATTGKASKES 535
RD+K N+MLD + + KI DFGL + E + T GT Y+APE +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 536 DVYSFGIVALEIACGRKP 553
D + G+V E+ CGR P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 41/214 (19%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-------------SEVKIIS 404
Q+LG+G FG VY K V++ + +KE E +++S
Sbjct: 6 QRLGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS 57
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL---------FKENSLLTWEFRYKI 455
+L H +V+ E+ ++ E+ LD L EN + W +
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ--- 114
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA 515
L G+ Y+ + + ++HRD+K+ NI L +N KIGDFG++RL+ + TT
Sbjct: 115 ---LLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FT 166
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIAC 549
GT YM+PE +SD++S G + E+ C
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 77/293 (26%), Positives = 140/293 (47%), Gaps = 45/293 (15%)
Query: 358 QKLGQGGFGGVYK----GFFRETNSYI---AVKRV-SQGSKQGIKEYASEVKIISRL-RH 408
+ LG+G FG V G +E + + AVK + S +++ + + SE++++ + +H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRY 453
+N++ LLG C + L ++ E+ G+L +L L+++
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-GSQTT 512
A +A G+ YL + +C+ HRD+ + N+++ + KI DFGLAR + H +TT
Sbjct: 144 SCAYQVARGMEYLASK--KCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWD 571
+ +MAPE + +SDV+SFG++ EI G P P P V +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP---------VEE 250
Query: 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L+ KLL+ R+ + + +M+ W A P + RP+ +Q++ L+
Sbjct: 251 LF---KLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQ--RPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIK-EYASEVKIISRLR---HRNLVQ 413
++G G +G VYK + ++A+K V Q ++ G+ EV ++ RL H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 414 LLGWC-----HEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQ 467
L+ C + ++ LV+E + + L ++L K L E + + GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
C+VHRD+K NI++ S K+ DFGLAR+ V+ T+ Y APE
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLL 180
Query: 528 TGKASKESDVYSFGIVALEIACGRKPI---NPKAPQ 560
+ D++S G + E+ RKP+ N +A Q
Sbjct: 181 QSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+G+G +G V K +ET +A+K+ S+ +++ + E+K++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEW--EQC 473
+ +L LV+E++ L+ L +E N + + R I Q L W +
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ------LIKAIHWCHKND 120
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
+VHRDIK N+++ N K+ DFG AR + + T T Y +PE K
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 534 ESDVYSFGIVALEIACGRKPINP 556
D++S G + E++ G +P+ P
Sbjct: 181 AVDMWSVGCILGELSDG-QPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLGW 417
KLG+G + V+KG + T + +A+K + ++G A EV ++ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
H ++ L LV+E++ + L +L +L++ L GL Y + + ++HR
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHR 127
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPECAT-TGKASK 533
D+K N++++ K+ DFGLAR AK T + T+ Y P+ + + S
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 534 ESDVYSFGIVALEIACGRKPINPKA 558
D++ G + E+A GR P+ P +
Sbjct: 184 PIDMWGVGCILYEMATGR-PMFPGS 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLR-HRNLVQL 414
QKLG+G +G V+K R T +A+K++ + + E+ + L H N+V+L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 415 LGWCHEK--KELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
L + K++ LV+E+M D H + + N L RY + Q L L Y+
Sbjct: 73 LNVIKAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRYIMYQ-LLKALKYIHS--- 125
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT----TVLAGTMGYMAPEC-- 525
V+HRD+K SNI+L+S+ K+ DFGLAR + + + T T Y APE
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKPINP 556
+T + +K D++S G + E+ G KP+ P
Sbjct: 186 GST-RYTKGVDMWSVGCILGEMLLG-KPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 360 LGQGGFGGVY---KGFFRETNSYIAVKRVSQGS-KQGIKEYA---SEVKIISRLRHRNLV 412
LG+GG+G V+ K +T A+K + + + + K+ A +E I+ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLL--TWEFRYKIAQDLASGLLYLQEEW 470
L+ +L L+ E++ G L HL +E + T F L+ L L+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY------LSEISLALEHLH 117
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPECATTG 529
+Q +++RD+K NI+LD+ + K+ DFGL + E +G+ T GT+ YMAPE
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRS 175
Query: 530 KASKESDVYSFGIVALEIACGRKP 553
K D +S G + ++ G P
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 25/206 (12%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW-- 417
LG+G FG V + TN + A+K + K+ + +V+ R V L W
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL----KKDVVLEDDDVECTMVERR---VLALAWEH 55
Query: 418 ---CH------EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKI-AQDLASGLLYLQ 467
H K+ L V E++ G L H+ ++S E R + A ++ GL +L
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLH 113
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
++ +++RD+K N++LD + + KI DFG+ + + +G +T GT Y+APE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILK 169
Query: 528 TGKASKESDVYSFGIVALEIACGRKP 553
K ++ D +SFG++ E+ G+ P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQLLGW 417
+G G +G V F +T +A+K++S+ + I K E++++ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 418 CHEKKEL------LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
L LV M G+ +++ K L ++ + Q L GL Y+
Sbjct: 83 FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQIL-RGLKYIHS--- 136
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GK 530
++HRD+K SNI ++ + KI DFGLAR + + T T Y APE
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMH 192
Query: 531 ASKESDVYSFGIVALEIACGR 551
++ D++S G + E+ G+
Sbjct: 193 YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 8/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLG 416
+G+G FG V + R+T A+K + + S+ + +E +++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
++L LV F+ G L HL +E R+ A+ L L+ + V++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELL----CALENLHKFNVIY 116
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+K NI+LD + + DFGL +L +T GT Y+APE +K D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 537 VYSFGIVALEIACGRKP 553
++ G++ E+ G P
Sbjct: 176 WWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKI-ISRLRHRNLVQLL 415
+G+G FG V + + AVK + + + K+ K +E + + ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
+L V +++ G L HL +E S R+ A ++AS L YL ++
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LNII 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGKASKE 534
+RD+K NI+LDS + + DFGL + E + S+TT GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 535 SDVYSFGIVALEIACGRKP 553
D + G V E+ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 360 LGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGSKQGIK-EYASEVKIISRLRHRNLVQ 413
LG+G FG V+ + + + VK + + + ++ E+ E+ + +L H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLF----KENSL----LTWEFRYKIAQDLASGLLY 465
LLG C E + ++ E+ G L L K+ L L+ + + + +A G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV---EHAKGSQTTVLAGTMGYMA 522
L VHRD+ + N ++ S K+ L++ V E+ K + + ++A
Sbjct: 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI---PLRWLA 186
Query: 523 PECATTGKASKESDVYSFGIVALEI 547
PE S +SDV+SFG++ E+
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIIS-RLRHRNLVQLL 415
LG+G FG V+ + TN + A+K + + ++ E +++S H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEWEQCV 474
K+ L V E++ G L H+ + L Y A ++ GL +L + +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHS---KGI 117
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASK 533
V+RD+K NI+LD++ + KI DFG+ + E+ G ++T GT Y+APE K +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175
Query: 534 ESDVYSFGIVALEIACGRKPIN 555
D +SFG++ E+ G+ P +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 15/222 (6%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+KLG+G + VYKG R +A+K +S +++G+ A E ++ L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
H K+ L V+E+M + L + R + Q L GL Y+ Q ++H
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ-LLRGLAYIHG---QHILH 126
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG--SQT-TVLAGTMGYMAPECAT-TGKAS 532
RD+K N+++ K+ DFGLAR AK SQT + T+ Y P+ S
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 533 KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574
D++ G + +E+ G +P P L + +W + G
Sbjct: 183 SALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEK-IWTVLG 222
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 71/239 (29%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 342 FPYKELALATNDFNDD-------QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK 394
FPY L D + +G+G +G VYK ++ S AVK + S +
Sbjct: 5 FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-E 63
Query: 395 EYASEVKIISRL-RHRNLVQLLGWCHEKK-----ELLLVYEFMPNGSLDSHLFKENSLLT 448
E +E I+ L H N+V+ G ++ +L LV E GS+ + L K LL
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVK--GLLI 120
Query: 449 WEFRYK---IAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
R I+ L LL LQ ++HRD+K +NI+L + K+ DFG++ +
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 506 AKGSQTTVLAGTMGYMAPE---CATTGKASKES--DVYSFGIVALEIACGRKPINPKAP 559
+ + T + GT +MAPE C S ++ DV+S GI A+E+ G P+ P
Sbjct: 181 TRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
+ D + LG G G V+ + + +AVK++ Q +K E+KII RL H N+V+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 414 L--------------LGWCHEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQ 457
+ +G E + +V E+M ++ L E L+ E
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY 121
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLV----EHAKG--SQ 510
L GL Y+ V+HRD+K +N+ +++ + KIGDFGLAR+V H KG S+
Sbjct: 122 QLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH-KGYLSE 177
Query: 511 TTVLAGTMGYMAPECA-TTGKASKESDVYSFGIVALEIACGR 551
V T Y +P + +K D+++ G + E+ G+
Sbjct: 178 GLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQL 414
+ LG+G FG V +E+ AVK + + ++ +E +I+S R+ +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 415 LGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L C + + L V EF+ G L H+ K R+ A ++ S L++L + +
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLHD---KG 116
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
+++RD+K N++LD + K+ DFG+ + G T+ GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 534 ESDVYSFGIVALEIACGRKP 553
D ++ G++ E+ CG P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 73/286 (25%), Positives = 123/286 (43%), Gaps = 46/286 (16%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--------GSKQGIKEYASE-VKIISRLRH 408
+ LGQG F +YKG R + V + GS E ++S+L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
++LV+L G C + E ++V E++ G LD L +E + ++ ++ +A+ LAS L YL++
Sbjct: 61 KHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 469 EWEQCVVHRDIKSSNIML---DSNFN----AKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
++ VH ++ NI++ N K+ D G+ V + + ++
Sbjct: 120 --KKL-VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----PWI 171
Query: 522 APECATTGKASKES--DVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKL 578
APEC G+AS D +SFG LEI G +P++ + + Y +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHR 224
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L D ++ L+ C D RPS R ++ LN
Sbjct: 225 LPMP--------DCAELANLINQ---CWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRN--LVQL 414
LG+G FG V + Y AVK + + ++ E ++++ L N L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-LAWENPFLTHL 61
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
K+ L V EF+ G L H+ + + + A ++ GL +L + +
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSKG---I 117
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASK 533
++RD+K N+MLD + + KI DFG+ + E+ G ++ + GT Y+APE K +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 534 ESDVYSFGIVALEIACGRKPIN 555
D +SFG++ E+ G+ P +
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 18/192 (9%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIK-EYASEVKIISRLRHRNLVQL-- 414
++ +G +G VY+ ++T +A+K++ + K+G E+ I+ +L+H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 415 --LGWCHEKKELLLVYEFMPNG--SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+G +K + +V E++ + SL + L E + + Q L SG+ +L + W
Sbjct: 72 VVVGSNLDK--IYMVMEYVEHDLKSLMET--MKQPFLQSEVKCLMLQ-LLSGVAHLHDNW 126
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-TG 529
++HRD+K+SN++L++ KI DFGLAR T ++ T+ Y APE
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAK 182
Query: 530 KASKESDVYSFG 541
+ S D++S G
Sbjct: 183 EYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVK-------RVSQGSKQGIKEYASEVKIISRLRHRNLV 412
+G+GGFG VY +T A+K ++ QG + E + ++S +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM-LSLVSTGDCPFIV 60
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+ H +L + + M G L HL + E R+ A ++ GL ++ +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF-- 117
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS 532
VV+RD+K +NI+LD + + +I D GLA K + GT GYMAPE G A
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAY 173
Query: 533 KES-DVYSFGIVALEIACGRKP 553
S D +S G + ++ G P
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 67/235 (28%), Positives = 107/235 (45%), Gaps = 37/235 (15%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-------EVKIISRLRHRNLV 412
+G+G +G V T +A+K++ + E+ S E+K++ LRH ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKI-----NDVFEHVSDATRILREIKLLRLLRHPDIV 62
Query: 413 QLLGWCH--------EKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLASGL 463
++ H E K++ +V+E M + D H + K N LT E L L
Sbjct: 63 EIK---HIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMGYM 521
Y+ V HRD+K NI+ +++ KI DFGLAR+ + + T T Y
Sbjct: 117 KYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 522 APE-CAT-TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574
APE C + K + D++S G + E+ G KP+ P + V L + DL G
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPG--KNVVHQLDLITDLLG 225
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 360 LGQGGFGGVY---KGFFRETNSYIAVKRVSQGSKQGIKEYAS--EVKIISRLRHRNLVQL 414
LGQG FG V+ K + A+K + + + + + E I++ + H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
+ +L L+ +F+ G L + L KE + ++ +A+ LA L +L +
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS---LGI 119
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
++RD+K NI+LD + K+ DFGL++ ++H K + GT+ YMAPE ++
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 534 ESDVYSFGIVALEIACGRKPINPK 557
+D +SFG++ E+ G P K
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGK 201
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 73/293 (24%), Positives = 135/293 (46%), Gaps = 45/293 (15%)
Query: 358 QKLGQGGFGGVYK----GFFRETNS---YIAVKRVSQ-GSKQGIKEYASEVKIISRL-RH 408
+ LG+G FG V G ++ + +AVK + + + + + SE++++ + +H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRY 453
+N++ LLG C + L ++ E+ G+L +L LT++
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-GSQTT 512
A +A G+ YL + +C+ HRD+ + N+++ + KI DFGLAR V + +TT
Sbjct: 138 SCAYQVARGMEYLASQ--KCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWD 571
+ +MAPE + +SDV+SFG++ EI G P P P ++ ++
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP------VEELFK 247
Query: 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L G ++ P C L ++ C H + RP+ +Q++ L+
Sbjct: 248 LLKEGHRMD--KPANC-------THELYMIMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 26/201 (12%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLR-HRNLVQLL 415
K+G+G F V K R+T Y A+K + + S + + E++ + RL H N+++L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLI 64
Query: 416 GWCHEKKE--LLLVYEFMPNGSL------DSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
++K L LV+E M + +L E + ++ ++ L L ++
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQ------LLKSLDHMH 117
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA- 526
+ HRDIK NI++ + K+ DFG R + ++K T ++ T Y APEC
Sbjct: 118 R---NGIFHRDIKPENILIKDD-ILKLADFGSCRGI-YSKPPYTEYIS-TRWYRAPECLL 171
Query: 527 TTGKASKESDVYSFGIVALEI 547
T G + D+++ G V EI
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEI 192
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL------ 406
DFN LG+G FG V + T+ A+K + + I++ E ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSG 58
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLAS 461
+ L QL L V E++ G L + FKE + + A ++A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAI 112
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGY 520
GL +L + +++RD+K N+MLDS + KI DFG+ + E+ G T GT Y
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 521 MAPECATTGKASKESDVYSFGIVALEIACGRKP 553
+APE K D ++FG++ E+ G+ P
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 13/148 (8%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLGW 417
KLG+G + VYKG + T +A+K + ++G A E ++ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWE----FRYKIAQDLASGLLYLQEEWEQC 473
H KK L LV+E++ + L ++ L+ F ++ L GL Y + +
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ----LLRGLAYCHQ---RR 123
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
V+HRD+K N+++ K+ DFGLAR
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 37/234 (15%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLR 407
+DF + +G+G FG V+ ++T A+K + + Q I +E I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+V+L +++ L LV E+MP G L + L +++ R+ IA+ +L L
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE----LVLALD 115
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA------------------------RLV 503
+ +HRDIK NI++D++ + K+ DFGL LV
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 504 EHAKGSQTTVLA----GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
Q V A GT Y+APE E D +S G++ E+ G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 50/182 (27%), Positives = 81/182 (44%), Gaps = 13/182 (7%)
Query: 375 ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434
E + VK V+ G G E+ I+ + HR ++ L+ H + V MP
Sbjct: 117 EQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLI---HAYRWKSTVCMVMPKY 168
Query: 435 SLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493
D + + + L E I + L L YL + ++HRD+K+ NI LD NA
Sbjct: 169 KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAV 225
Query: 494 IGDFGLA-RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK 552
+GDFG A +L H Q +GT+ +PE ++D++S G+V E++
Sbjct: 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
Query: 553 PI 554
+
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-12
Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 19/191 (9%)
Query: 375 ETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHRNLVQLL--GWCHEKKELLLVYE 429
T +A+K + + + + A E + +RL H N+V LL G L V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML--- 486
++P +L L + +L E + Q L + L Q +VHRD+K NIM+
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQVLDA----LACAHNQGIVHRDLKPQNIMVSQT 115
Query: 487 DSNFNAKIGDFGLARL------VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSF 540
+AK+ DFG+ L + A ++TT + GT Y APE + SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 541 GIVALEIACGR 551
G++ LE G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RH 408
DFN LG+G FG V + T+ A+K + + ++ E ++++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGL 463
L QL L V E++ G L H+ FKE + + A ++A GL
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIGL 114
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMA 522
+L + +++RD+K N+MLD+ + KI DFG+ + E+ G +TT GT Y+A
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIA 169
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKP 553
PE K D ++FG++ E+ G+ P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHR 409
DFN LG+G FG V + T+ A+K + + ++ E ++++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 410 NLVQLLGWCHEKKE-LLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGL 463
+ L C + + L V E++ G L H+ FKE + + A +++ GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGL 114
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMA 522
+L + +++RD+K N+MLDS + KI DFG+ + EH G T GT Y+A
Sbjct: 115 FFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIA 169
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKPIN 555
PE K D +++G++ E+ G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 41/245 (16%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHR 409
DF + +G+G FG V ++T A+K + + K+ + +E I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+V++ +K L L+ EF+P G + + L K+++L E ++ IA+ + L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV----LAIDSI 117
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA------------RLVEHAKGSQTTV---- 513
+ +HRDIK N++LDS + K+ DFGL R + H+ S T
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 514 ------------------LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPIN 555
GT Y+APE +K D +S G++ E+ G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 556 PKAPQ 560
+ PQ
Sbjct: 238 SETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 21/209 (10%)
Query: 359 KLGQGGFGGVYKGF-FRETNSYIAVKRVS-QGSKQGIK-EYASEVKIISRLR---HRNLV 412
++G+G +G V+K + ++A+KRV Q ++G+ EV ++ L H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 413 QLLGWC-----HEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLY 465
+L C + +L LV+E + + L ++L K E + T + + Q L GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDF 125
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L VVHRD+K NI++ S+ K+ DFGLAR+ ++ T + T+ Y APE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYRAPEV 180
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKPI 554
+ D++S G + E+ RKP+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF-RRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISR-LRHRNLVQLL 415
+G+G FG V + + AVK + + + K+ K SE ++ + ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
+L V +++ G L HL +E L R+ A ++AS L YL +V
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIV 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARL-VEHAKGSQTTVLAGTMGYMAPECATTGKASKE 534
+RD+K NI+LDS + + DFGL + +EH T+ GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 535 SDVYSFGIVALEIACGRKP 553
D + G V E+ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETN--SYIAVKRVSQ--GSKQGIKEYASEVKIISRLR-HRNLV 412
++LGQG +G V ET+ +A+K+++ K K E+K++ R H+N+
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 413 QLLG----WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
L + EL L E M L + L F+ I Q L GL Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILC-GLKYIHS 123
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---TMGYMAPEC 525
V+HRD+K N++++++ KI DFGLAR G + T Y APE
Sbjct: 124 ---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 526 ATTGKA-SKESDVYSFGIVALEIACGRKPI 554
+ ++ +K DV+S G + E+ GRKP+
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLL--GW 417
+G+GGFG VY +T A+K + K+ IK E L R ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLA---LNERIMLSLVSTGD 55
Query: 418 C----------HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
C H +L + + M G L HL + E R+ A ++ GL ++
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHMH 114
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ VV+RD+K +NI+LD + + +I D GLA K + GT GYMAPE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 528 TGKASKES-DVYSFGIVALEIACGRKP 553
G A S D +S G + ++ G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE----YASEVKIISRLRHRNLVQLL 415
+G+G FG V + S+ AVK + + + KE A ++ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
++L V +++ G L HL +E L R+ A ++AS + YL ++
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNII 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
+RD+K NI+LDS + + DFGL + + + T+ GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 536 DVYSFGIVALEIACGRKP 553
D + G V E+ G P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 396 YA-SEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL---FKENSLLTWEF 451
YA SE+ ++ H +V+ +LLL+ E+ G L+ + KE+
Sbjct: 111 YARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF---- 166
Query: 452 RYKIAQDLASGLLYLQ------EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR-LVE 504
Q+ GLL+ Q E + ++HRD+KS+NI L K+GDFG ++ +
Sbjct: 167 -----QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
Query: 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS 564
+ GT Y+APE + SK++D++S G++ E+ +P K P Q
Sbjct: 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF--KGPS-QRE 278
Query: 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ--IERLMIVGLWCAHPDENLRPSIRQVIH 621
++Q V LYG DP C G + ++ L+ + LRP+ +Q++H
Sbjct: 279 IMQQV--LYGK------YDPFPCPVSSGMKALLDPLL-------SKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 360 LGQGGFGGVY---KGFFRETNSYIAVKRVSQGS---KQGIKEYA-SEVKIISRLRHRNLV 412
LG G +G V+ K + A+K + + + K E+ +E +++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 413 QLLGWCHE-KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
L + + +L L+ +++ G L +HL++ E R IA+ + L L +
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV----LALDHLHQ 123
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+++RDIK NI+LDS + + DFGL++ + + GT+ YMAPE G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 532 --SKESDVYSFGIVALEIACGRKP 553
K D +S G++ E+ G P
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 58/246 (23%), Positives = 106/246 (43%), Gaps = 41/246 (16%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH 408
+DF + +G+G FG V ++T A+K + + K+ + +E I+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+V++ +K+ L L+ EF+P G + + L K+++L ++ IA+ + L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV----LAIDA 116
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA---------------------------- 500
+ +HRDIK N++LD+ + K+ DFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 501 ---RLVEHAKGSQTTVLAGTMG---YMAPECATTGKASKESDVYSFGIVALEIACGRKPI 554
R E K ++ + T+G Y+APE +K D +S G++ E+ G P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 555 NPKAPQ 560
+ PQ
Sbjct: 237 CSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 33/167 (19%)
Query: 359 KLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQ--GIKEYA-SEVKIISRLRHRNLVQ 413
+G+G +G VYK + A+K+ +Q GI + A E+ ++ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 414 LLGWC--HEKKELLLVYEFMPNGSL---------DSHLFKENSL--LTWEFRYKIAQDLA 460
L+ H K + L++++ + + + L W+ +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA----KIGDFGLARLV 503
+G+ YL W V+HRD+K +NI++ KIGD GLARL
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 30/212 (14%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+ K + TN+ +AVK+++ SK+ +K E+ +L+H N++ +
Sbjct: 10 FEDLMIVHLAK--HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 418 CHEKKELLLVYEFMPNGS----LDSHL---FKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
EL +V M GS L +H E ++ + I +D+ + L Y+ +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI-----AF-ILKDVLNALDYIHSK- 120
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR-LVEHAKGSQTTVLAGT-----MGYMAPE 524
+ HR +K+S+I+L + + + +++H K + + +++PE
Sbjct: 121 -GFI-HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 525 C---ATTGKASKESDVYSFGIVALEIACGRKP 553
G K SD+YS GI A E+A G P
Sbjct: 179 VLQQNLQGYNEK-SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 360 LGQGGFGGVYKGFFR-ETNSY--IAVK--RVSQGSKQGIKEYASEVKIISRLRHRNLVQL 414
LG+G FG V + + E S+ +AVK + S I+E+ E + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 415 LGWC---HEKKEL---LLVYEFMPNGSLDSHLFK----ENSL-LTWEFRYKIAQDLASGL 463
+G K L +++ FM +G L + L E L + + D+ASG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMG 519
YL + +HRD+ + N ML+ N + DFGL++ + + +G + + +
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL---PVK 180
Query: 520 YMAPECATTGKASKESDVYSFGIVALEIAC-GRKP 553
++A E + SDV++FG+ EI G+ P
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+KLG+G + VYKG + +A+K + ++G A E ++ L+H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 417 WCHEKKELLLVYEFMPNG---SLDSH---LFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
H K+ L LV+E++ +D H L EN L F ++ L GL Y+ + +
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL---FLFQ----LLRGLSYIHQRY 123
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
++HRD+K N+++ K+ DFGLAR
Sbjct: 124 ---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 46/250 (18%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK----IISRLR 407
+DF + +G+G FG V ++T A+K++ + S+ KE + V+ I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+ +V+L ++ L L+ E++P G + + L K+++ E R+ IA+ + L +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI----LAID 115
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL------------ARLVEHAKGSQTT--- 512
+ +HRDIK N++LD+ + K+ DFGL R++ HA S
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 513 ------------------VLA----GTMGYMAPECATTGKASKESDVYSFGIVALEIACG 550
LA GT Y+APE +KE D +S G++ E+ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
Query: 551 RKPINPKAPQ 560
P PQ
Sbjct: 236 YPPFCSDNPQ 245
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVK----RVSQGSKQGIKEYASEVKIISRLRHRNLVQLL 415
+G+G FG V + AVK ++ K+ A ++ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
++L V +F+ G L HL +E S R+ A+ +AS L YL +V
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---INIV 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
+RD+K NI+LDS + + DFGL + A+ TT GT Y+APE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV 177
Query: 536 DVYSFGIVALEIACGRKP 553
D + G V E+ G P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQLLG- 416
+G G +G V F +T +AVK++S+ + I K E++++ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 417 -----WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
E ++ LV M G+ +++ K L ++ I Q L GL Y+
Sbjct: 85 FTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL-RGLKYIHS--- 138
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
++HRD+K SN+ ++ + KI DFGLAR H T +A T Y APE
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVA-TRWYRAPEIMLNWMH 194
Query: 532 SKES-DVYSFGIVALEIACGR 551
++ D++S G + E+ GR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 16/224 (7%)
Query: 353 DFNDDQKLGQGGFGGVY---KGFFRETNSYIAVKRVSQGS---KQGIKEYA-SEVKIISR 405
+F + LG G +G V+ K +T A+K + + + K E+ +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 406 LRHRNLVQLLGWCHEKK-ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
+R + L + + + +L L+ +++ G + +HL++ ++ E R+ + + L
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII----L 116
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
L+ + +V+RDIK NI+LDS + + DFGL++ + +T GT+ YMAPE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176
Query: 525 CA-TTGKASKESDVYSFGIVALEIACGRKPIN---PKAPQGQVS 564
G K D +S GI+ E+ G P + Q +VS
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLG 416
+ +G+G +G V+K ++ S AVK + +E +E I+ L H N+V+ G
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 417 WCHEKK-----ELLLVYEFMPNGS---LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
++K +L LV E GS L K + IA L L+ LQ
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---IAYILHEALMGLQH 139
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---C 525
+HRD+K +NI+L + K+ DFG++ + + + T + GT +MAPE C
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 198
Query: 526 ATTGKASKES--DVYSFGIVALEIACGRKPI 554
++ ++ DV+S GI A+E+ G P+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-----E 399
+L + DF+ + +G+G FG V + + A+K +S+ + IK S E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK--FEMIKRSDSAFFWEE 93
Query: 400 VKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD- 458
I++ +VQL + K L +V E+MP G L +L++ Y I +
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL-------VNLMS---NYDIPEKW 143
Query: 459 ----LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514
A +L L +HRD+K N++LD + + K+ DFG ++ +
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203
Query: 515 AGTMGYMAPEC----ATTGKASKESDVYSFGIVALEIACGRKP 553
GT Y++PE G +E D +S G+ E+ G P
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQ---GSKQGIKEYASEVKIISRL-RHRNLVQLL 415
+G+G + V ++T A+K V + + I +E + + H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
+ L V E++ G L H+ ++ L R+ A+ ++ L YL E + ++
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RGII 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKE 534
+RD+K N++LDS + K+ D+G+ + E + G T+ GT Y+APE
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 535 SDVYSFGIVALEIACGRKPIN 555
D ++ G++ E+ GR P +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 12/216 (5%)
Query: 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVK 401
++L + D++ + +G+G FG V + + A+K +S+ + A E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 402 IISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS 461
I++ +VQL + K L +V E+MP G L + + + W Y A
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT-----AE 150
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
+L L ++HRD+K N++LD + + K+ DFG ++ + GT Y+
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210
Query: 522 APECATT----GKASKESDVYSFGIVALEIACGRKP 553
+PE + G +E D +S G+ E+ G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 44/224 (19%)
Query: 358 QKLGQGGFG-----------GVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL 406
Q++G G FG GV + +E + + K ++ +QG L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--------L 52
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR-------YKIAQDL 459
+H N++Q LG C E LLV+E+ G L S+L +E W R ++A ++
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQ----WHRRNSQLLLLQRMACEI 108
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL--ARLVEHAKGSQTTVLAGT 517
A+G+ ++ + +H D+ N L S+ K+GD+G+ +R E ++
Sbjct: 109 AAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-P 164
Query: 518 MGYMAPECAT-------TGKASKESDVYSFGIVALEI-ACGRKP 553
+ ++APE T + +K S+V++ G+ E+ +P
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 360 LGQGGFGGVY---KGFFRETNSYIAVKRVSQGS---KQGIKEYA-SEVKIISRLRHRNLV 412
LG G +G V+ K ++ A+K + + + K E+ +E +++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 413 QLLGWCHEKK-ELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLLYL 466
L + + +L L+ +++ G L +HL FKE + + +L L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY---------SGEIVLAL 118
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ + +++RDIK NI+LDSN + + DFGL++ + + GT+ YMAP+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 527 TTGKA--SKESDVYSFGIVALEIACGRKP 553
G K D +S G++ E+ G P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 54/172 (31%), Positives = 92/172 (53%), Gaps = 20/172 (11%)
Query: 395 EYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK 454
E AS ++ +S H+++V L G C E ++V EF+ G LD + +++ +LT +++K
Sbjct: 53 ETASMMRQVS---HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-DSNFNAKIGDFGLARLVEHAKGSQTTV 513
+A+ LAS L YL+ ++ +VH ++ + NI+L + + G F +L + G TV
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSD--PGIPITV 162
Query: 514 LA-----GTMGYMAPECATTGKA-SKESDVYSFGIVALEIAC--GRKPINPK 557
L+ + ++APEC K S +D +SFG EI C G P+ K
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 34/225 (15%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--------SQGSKQGIKEYA------SEVKIISR 405
LG+G +G V K + T +A+K+V +Q + E+KI++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
++H N++ L+ E + LV + M L + LT I + +GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDL-KKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR-------------LVEHAKGSQTT 512
L + + +HRD+ +NI ++S KI DFGLAR + + T
Sbjct: 135 LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 513 VLAGTMGYMAPECAT-TGKASKESDVYSFGIVALEIACGRKPINP 556
T+ Y APE K D++S G + E+ G KP+ P
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFP 235
|
Length = 335 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLR-HRNLVQLL 415
LG+G FG V + T+ A+K + + + +E +I++ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
K L V E++ G L + + R+ A ++ L++L V+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLHR---HGVI 118
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
+RD+K NI+LD+ + K+ DFG+ + G TT GT Y+APE +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 536 DVYSFGIVALEIACGRKP 553
D ++ G++ E+ G+ P
Sbjct: 178 DWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 49/223 (21%)
Query: 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQ---GSKQGIKEYASEVKIISRLRHRNLVQLL 415
+G+GG G VY + + +A+K++ + + K + E KI + L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 416 GWCHEKKELLLVYEFMP--NGSLDSHLFKENSLLTWEFRYKIAQDLA------------- 460
C + VY MP G L K W+ + ++++LA
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKS----VWQ-KESLSKELAEKTSVGAFLSIFH 120
Query: 461 ---SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV---- 513
+ + Y+ + V+HRD+K NI+L I D+G A + + +
Sbjct: 121 KICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 514 -------------LAGTMGYMAPECATTGKASKESDVYSFGIV 543
+ GT YMAPE AS+ +D+Y+ G++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRHRNL 411
+ D +++G G +G V R T + +A+K++ + S+ K E++++ ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 412 VQLLGWCHEKKEL------LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
+ LL L LV FM G+ L K L ++ + Q L GL Y
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML-KGLKY 133
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
+ ++HRD+K N+ ++ + KI DFGLAR + S+ T T Y APE
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEV 186
Query: 526 ATTG-KASKESDVYSFGIVALEIACGR 551
++ D++S G + E+ G+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (144), Expect = 3e-09
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 38/237 (16%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-----EVKIISRL 406
N++ +K+G G FG V+ + T + K +S +G+KE EV ++ L
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY---RGLKEREKSQLVIEVNVMREL 69
Query: 407 RHRNLVQLLGWCHEK--KELLLVYEFMPNGSLDSHL---FKENSLLTWEFRYKIAQDLAS 461
+H+N+V+ + K ++L ++ EF G L ++ +K + I + L
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 462 GLLYLQEEWE----QCVVHRDIKSSNIMLDS-------------NFN----AKIGDFGLA 500
L Y + + V+HRD+K NI L + N N AKIGDFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 501 RLVEHAKGSQTTVLAGTMGYMAPECA--TTGKASKESDVYSFGIVALEIACGRKPIN 555
+ + + + V GT Y +PE T +SD+++ G + E+ G+ P +
Sbjct: 190 KNIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 5/145 (3%)
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
LV L L LV E++ G L H+ ++ L R+ A ++ L +L E
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHE-- 114
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
+ +++RD+K N++LD++ + K+ D+G+ + G T+ GT Y+APE +
Sbjct: 115 -RGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 531 ASKESDVYSFGIVALEIACGRKPIN 555
D ++ G++ E+ GR P +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 461 SGLLYLQ------EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA-KGSQTTV 513
+GLL++Q + ++HRDIKS+NI+L SN K+GDFG +++
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPIN 555
GT Y+APE SK++D++S G++ E+ ++P +
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYA-SEVKIISRLRHRN-LVQL 414
+K+G+G +G VYK + T +A+K+ + ++GI A E+ ++ L +V+L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 415 LGWCHE-----KKELLLVYEFMP---------NGSLDSHLFKENSLLTWEFRYKIAQDLA 460
L H K L LV+E++ NG ++ ++ ++ L
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ------LL 120
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMG 519
G+ + + V+HRD+K N+++D KI D GL R S T + T+
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176
Query: 520 YMAPECATTGKA-SKESDVYSFGIVALEIA 548
Y APE S D++S G + E++
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 19/201 (9%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQLL-- 415
+G G +G V + +AVK++S+ + I + E++++ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 416 ----GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
E+ LV M G+ +++ K L ++ I Q L GL Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHS--- 136
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
++HRD+K SN+ ++ + +I DFGLAR + + T T Y APE
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIMLNWMH 192
Query: 532 SKES-DVYSFGIVALEIACGR 551
++ D++S G + E+ G+
Sbjct: 193 YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 12/216 (5%)
Query: 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVK 401
++L + D+ + +G+G FG V + T A+K +S+ + A E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 402 IISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS 461
I++ +VQL + + L +V E+MP G L + + + W Y A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYT-----AE 150
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
+L L +HRD+K N++LD + + K+ DFG + + GT Y+
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 522 APECATT----GKASKESDVYSFGIVALEIACGRKP 553
+PE + G +E D +S G+ E+ G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 19/168 (11%)
Query: 402 IISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS 461
++S++ H +L + G C E ++V EF+ +G LD L KE + ++ +AQ LAS
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLAS 128
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG--DFGLARLVEHAKGSQTTVLA---- 515
L YL+ ++ +VH ++ + NI+L A++G + + G T L+
Sbjct: 129 ALSYLE---DKNLVHGNVCAKNILL-----ARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 516 -GTMGYMAPECATTGKA-SKESDVYSFGIVALEIAC--GRKPINPKAP 559
+ ++APEC G + S +D +SFG LEI C G P+ + P
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 65/246 (26%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 353 DFNDDQKLGQGGFGGVY-------------KGFFRETNSYIAVKRVSQGSKQGIKEYASE 399
D D+ +G G FG V+ K + ++ KRV + E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-----------E 49
Query: 400 VKIISRLRHRNLVQLLGWCHEK-----KELLLVYEFMPNGSLDSH-LFKENSLLTWE--- 450
+K++ +H N++ L +E+ +V E M + D H + L+ +
Sbjct: 50 LKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS---DLHKIIVSPQPLSSDHVK 106
Query: 451 -FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509
F Y+I + GL YL ++HRDIK N++++SN KI DFGLAR+ E +
Sbjct: 107 VFLYQILR----GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159
Query: 510 QTTVLAGTMGYMAPECATTGKASKES-DVYSFGIVALEIACGRKPINPKAPQGQVSLLQW 568
T T Y APE + + D++S G + E+ R I +A Q + L
Sbjct: 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR--ILFQA-QSPIQQLDL 216
Query: 569 VWDLYG 574
+ DL G
Sbjct: 217 ITDLLG 222
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 36/133 (27%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483
L V EF+ G L H+ ++ L R+ + +++ L +L E + +++RD+K N
Sbjct: 71 LFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLHE---RGIIYRDLKLDN 126
Query: 484 IMLDSNFNAKIGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGI 542
++LD+ + K+ D+G+ + E + G T+ GT Y+APE D ++ G+
Sbjct: 127 VLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV 184
Query: 543 VALEIACGRKPIN 555
+ E+ GR P +
Sbjct: 185 LMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQLLG- 416
+G G +G V + T +A+K++S+ + I K E+ ++ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 417 -----WCHEKKELLLVYEFMPN--GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
E ++ LV +M + H E+ + +Y + Q L GL Y+
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKV-----QYLVYQML-CGLKYIHS- 135
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
++HRD+K N+ ++ + KI DFGLAR HA T + T Y APE
Sbjct: 136 --AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVILNW 189
Query: 530 -KASKESDVYSFGIVALEIACGR 551
++ D++S G + E+ G+
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+DF + +G+G FG V + T A+K +++ E A R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC-------FREERN 53
Query: 412 VQLLGWCH----------EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD--- 458
V + G C ++ L LV ++ G L + L K F ++ +D
Sbjct: 54 VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK--------FEDRLPEDMAR 105
Query: 459 --LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
+A +L + + VHRDIK N++LD N + ++ DFG + Q++V G
Sbjct: 106 FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVG 165
Query: 517 TMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKP 553
T Y++PE GK E D +S G+ E+ G P
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 54/263 (20%), Positives = 109/263 (41%), Gaps = 29/263 (11%)
Query: 368 VYKGFFRETNSYI-AVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW----CHEKK 422
+YKG F I K+ +G K I +E+K + R+ N++++ G+ +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482
L L+ E+ G L L KE L +++ + +A D GL L + + ++++ S
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNK--PYKNLTSV 152
Query: 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GKASKESDVYSF 540
+ ++ N+ KI GL +++ M Y + + + + + D+YS
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVN----FMVYFSYKMLNDIFSEYTIKDDIYSL 208
Query: 541 GIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMI 600
G+V EI G+ P + L+ + + +L D + ++
Sbjct: 209 GVVLWEIFTGKIPFENLTTKEIYDLI-----------INKNNSLKL--PLDCPLEIKCIV 255
Query: 601 VGLWCAHPDENLRPSIRQVIHVL 623
C D RP+I+++++ L
Sbjct: 256 EA--CTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 45/173 (26%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 383 KRVSQGSKQGIKEYASEVKIISRLRHRNLVQL--------LGWCHEKKELLLVYEFMPNG 434
KRV GS+ I + +E+ + RL H N++++ + +K +Y FM +
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE 256
Query: 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494
+ D +K+ LL + R I + L + Y+ + + ++HRDIK NI L+ + +
Sbjct: 257 AFD---WKDRPLL-KQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVL 308
Query: 495 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
GDFG A E + + GT+ +PE + +D++S G++ L++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 10/151 (6%)
Query: 399 EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP--NGSLDSHLFKENSLLTWEFRYKIA 456
E ++ + H +++++ +V +P + L ++L K + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
+ + GL YL Q ++HRD+K+ NI ++ IGD G A+ A LAG
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVALEI 547
T+ APE K + ++D++S GIV E+
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510
F ++AQ G+ +L + C+ HRD+ + N++L AKI DFGLAR + +
Sbjct: 217 FSSQVAQ----GMDFLASK--NCI-HRDVAARNVLLTDGRVAKICDFGLARDIMN---DS 266
Query: 511 TTVLAGT----MGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKP 553
V+ G + +MAPE + +SDV+S+GI+ EI + G+ P
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHR 409
DF + +G+G FG V + + A+K +++ E A E ++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+ L ++ L LV ++ G L + L K F ++ +D+A YL E
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK--------FEDRLPEDMAR--FYLAEM 111
Query: 470 -------WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ VHRDIK NI++D N + ++ DFG + Q++V GT Y++
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 523 PECATT-----GKASKESDVYSFGIVALEIACGRKP 553
PE GK E D +S G+ E+ G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 14/170 (8%)
Query: 385 VSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKEN 444
+ G + G A+E I+ + H +++QL G K L+ +P D + +
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY--- 172
Query: 445 SLLTWEFRYKIAQDLA---SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
L + I LA S L +Q E ++HRDIK+ NI ++ + +GDFG A
Sbjct: 173 --LAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551
++ AGT+ APE D++S GIV E+A
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS---QGSKQGIKEYASEVKIISRLRHRN 410
+ + + +G G G V + +A+K++S Q + Y E+ ++ + H+N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 84
Query: 411 LVQLLG------WCHEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASG 462
++ LL E +++ +V E M D++L + + L Y + Q L G
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLC-G 138
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ +L ++HRD+K SNI++ S+ KI DFGLAR + V+ T Y A
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 193
Query: 523 PECATTGKASKES-DVYSFGIVALEIACGR 551
PE G KE+ D++S G + E+ G
Sbjct: 194 PE-VILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 26/233 (11%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRH 408
DF + + G +G VY +ET A+K++++ + + I++ E I++ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEF-RYKIAQDLASGLLYLQ 467
+V + K+ L +V E++ G + L K L + R A+ + + L YL
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAETVLA-LEYLH 118
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR---------LVEH-----AKGSQTTV 513
+VHRD+K N+++ S + K+ DFGL++ L E +
Sbjct: 119 N---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ---GQV 563
+ GT Y+APE K D ++ GI+ E G P P+ GQV
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 12/121 (9%)
Query: 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491
P + L E+ L++ + +A+G+ +L + CV HRD+ + N+++
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK--NCV-HRDLAARNVLICEGKL 277
Query: 492 AKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546
KI DFGLAR + +KGS T L + +MAPE + SDV+SFGI+ E
Sbjct: 278 VKICDFGLARDIMRDSNYISKGS--TFLP--LKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 547 I 547
I
Sbjct: 334 I 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 31/85 (36%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECAT-----T 528
VHRDIK N++LD N + ++ DFG + L A G+ Q+ V GT Y++PE
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 529 GKASKESDVYSFGIVALEIACGRKP 553
G+ E D +S G+ E+ G P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 73/288 (25%), Positives = 117/288 (40%), Gaps = 43/288 (14%)
Query: 362 QGGFGGVYKGFFRETNSY----IAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLG 416
+G FG ++ G + + VK V + + + E ++ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 417 WCHEKKELLLV-YEFMPNGSLDSHL--------FKENSLLTWEFRYKIAQDLASGLLYLQ 467
C E E V Y +M G+L L +L T + +A +A G+ YL
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL-VHMAIQIACGMSYLH 134
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV----EHAKGSQTTVLAGTMGYMAP 523
+ + V+H+DI + N ++D KI D L+R + H G + +MA
Sbjct: 135 K---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN---RPVKWMAL 188
Query: 524 ECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582
E + S SDV+SFG++ E+ G+ P P + L+ +G L
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-------DGYRLA-- 239
Query: 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL-NFEAPL 629
P C D L V C D RPS Q++ L +F A L
Sbjct: 240 QPINCPD-------ELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 14/101 (13%)
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510
F Y++A+ G+ +L + C+ HRD+ + NI+L KI DFGLAR + +
Sbjct: 219 FSYQVAK----GMSFLASK--NCI-HRDLAARNILLTHGRITKICDFGLARDI---RNDS 268
Query: 511 TTVLAGT----MGYMAPECATTGKASKESDVYSFGIVALEI 547
V+ G + +MAPE + ESDV+S+GI+ EI
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 21/203 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS---QGSKQGIKEYASEVKIISRLRHRNLVQL 414
+ +G G G V F +AVK++S Q + Y E+ ++ + H+N++ L
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 415 LG------WCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQ 467
L E +++ LV E M D++L + + L E + + G+ +L
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
++HRD+K SNI++ S+ KI DFGLAR T T Y APE
Sbjct: 141 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRYYRAPEVIL 195
Query: 528 TGKASKESDVYSFGIVALEIACG 550
+ D++S G + E+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-----AKGSQTTV 513
+A G+ +L +C+ HRD+ + NI+L N KI DFGLAR + KGS
Sbjct: 183 VARGMEFLASR--KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDL 572
L +MAPE + +SDV+SFG++ EI + G P P Q++ +
Sbjct: 240 LK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQIN--EEFCQR 289
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+G + A + +I R+M L C D RP+ ++ +L
Sbjct: 290 LKDGTRMRA------PENATPEIYRIM---LACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/261 (21%), Positives = 103/261 (39%), Gaps = 54/261 (20%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQL 414
+ LG G FG V +T++ A+K + + ++ + +E I++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
+K L V +++P G + S L + R+ IA+ L ++ +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT----LAIESVHKMGF 122
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLA---------------------------------- 500
+HRDIK NI++D + + K+ DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 501 --------RLVEHAKGSQTTVLA----GTMGYMAPECATTGKASKESDVYSFGIVALEIA 548
L + A LA GT Y+APE ++ D +S G++ E+
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 549 CGRKP-INPKAPQGQVSLLQW 568
G+ P + P + Q+ ++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 59/290 (20%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRN 410
F + LG G FG V +T + A+K + + + + +E I++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V+L +K L V +++P G + S L + R+ IA+ + ++
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCA----VESVH 118
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLA---RLVEHAKGSQTT--------------- 512
+ +HRDIK NI++D + + K+ DFGL R +K Q+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 513 ----------------------------VLAGTMGYMAPECATTGKASKESDVYSFGIVA 544
L GT Y+APE ++ D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 545 LEIACGRKPINPKAP-QGQVSLLQWVWDLY--GNGKLL-EAVD--PRLCR 588
E+ G+ P + P + Q+ ++ W L+ KL EA D +LCR
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW-- 417
+G G FG VY+ +T+ +A+K+V Q + + E+ I+ L H N++ L +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 418 --CHEKKE----LLLVYEFMPNG--SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
C +K E L +V EF+P H + N L + L L Y+ +
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 470 WEQCVVHRDIKSSNIMLDSNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT- 527
+ + HRD+K N+++D N + K+ DFG A+ + G ++ + Y APE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRFYRAPELMLG 244
Query: 528 TGKASKESDVYSFGIVALEIACG 550
+ D++S G + E+ G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 38/102 (37%), Positives = 56/102 (54%), Gaps = 16/102 (15%)
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH----- 505
F Y++A+ G+ +L + CV HRD+ + N++L KI DFGLAR + H
Sbjct: 242 FTYQVAR----GMEFLASK--NCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYV 294
Query: 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
+KGS T L + +MAPE + SDV+S+GI+ EI
Sbjct: 295 SKGS--TFLP--VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 63/287 (21%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLG 416
+G G FG V +TN+ A+K + + + +E I++ + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFK----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+K L V +++P G + S L + E L R+ IA+ L + + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA----RFYIAE-LTCAIESVHK---M 120
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGL------------------AR------------- 501
+HRDIK NI++D + + K+ DFGL R
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 502 -------LVEHAKGSQTTVLA----GTMGYMAPECATTGKASKESDVYSFGIVALEIACG 550
L K LA GT Y+APE ++ D +S G++ E+ G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 551 RKPINPKAPQG-QVSLLQWVWDLY--GNGKL-LEAVD--PRLCRDFD 591
+ P P Q+ ++ W L+ KL EA D RLC +
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAE 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 35/209 (16%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQ------GSKQGIKEYASEVKIISRLRHRNLVQ 413
+G G G V + T +A+K++S+ +K+ +E ++ + H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIG 79
Query: 414 LLGW------CHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWE-FRYKIAQDLASGLLY 465
LL E +++ LV E M D++L + L E Y + Q L G+ +
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMDLDHERMSYLLYQMLC-GIKH 133
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT--TVLAGTMGYMAP 523
L ++HRD+K SNI++ S+ KI DFGLAR G+ T T Y AP
Sbjct: 134 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAP 186
Query: 524 ECATTGKASKES-DVYSFGIVALEIACGR 551
E G KE+ D++S G + E+ G
Sbjct: 187 E-VILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS---QGSKQGIKEYASEVKIISRLRHRN 410
+ + + +G G G V + + +A+K++S Q + Y E+ ++ + H+N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 77
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLY--- 465
++ LL +K L EF D +L E ++ L + ++ + S LLY
Sbjct: 78 IISLLNVFTPQKSL---EEFQ-----DVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 466 --LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
++ ++HRD+K SNI++ S+ KI DFGLAR T T Y AP
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAP 187
Query: 524 ECATTGKASKES-DVYSFGIVALEI 547
E G KE+ D++S G + E+
Sbjct: 188 E-VILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 30/78 (38%), Positives = 41/78 (52%), Gaps = 9/78 (11%)
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-----AKGSQTTVLAGTMGYMAPECATTG 529
+HRD+ + NI+L N KI DFGLAR + KG L +MAPE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPESIFDK 250
Query: 530 KASKESDVYSFGIVALEI 547
+ +SDV+SFG++ EI
Sbjct: 251 VYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 12/94 (12%)
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-----AKGSQTTV 513
+A G+ +L +C+ HRD+ + NI+L N KI DFGLAR + KG
Sbjct: 188 VAKGMEFLASR--KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
L +MAPE + +SDV+SFG++ EI
Sbjct: 245 LK----WMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 47/239 (19%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA---SEVKIISRLRHR 409
F + LG+G G V+ + T A+K + + + +E +I++ L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-------FKENSLLTWEFRYKIAQDLASG 462
L L + L LV ++ P G L L E R+ A+ L
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVA-----RFYAAEVLL-A 115
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-------RLVEHAKGSQT---- 511
L YL +V+RD+K NI+L + + + DF L+ V A +
Sbjct: 116 LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 512 -------TVLA----------GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T GT Y+APE + D ++ GI+ E+ G P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 10/98 (10%)
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV- 513
+A+ L S + Y+ E ++HRDIK+ N++++ + +GDFG A A+GS +T
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF---ARGSWSTPF 318
Query: 514 ---LAGTMGYMAPECATTGKASKESDVYSFGIVALEIA 548
+AGT+ APE + D++S G+V E A
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 9e-06
Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 20/152 (13%)
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+ N ++L K +L+ +++ +G L L KE L E + KI + L L L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK-KIIRQLVEALNDLH 126
Query: 468 EEWEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ ++H DIK N++ D + + D+GL + + GT+ Y +PE
Sbjct: 127 K---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-IIGTPS----CYDGTLDYFSPE-- 176
Query: 527 TTGKASKESDVYSF-----GIVALEIACGRKP 553
K + SF G++ E+ G+ P
Sbjct: 177 ---KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 53/251 (21%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRH 408
DF+ + +G+G FG V ++T A+K + + K + +E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
+V L + + L L+ EF+P G L + L K ++ R+ +A+ +L ++
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAE----CVLAIEA 116
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-------------RLVE------HAKGS 509
+ +HRDIK NI++D + K+ DFGL+ +L++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 510 QTTVL---------------------------AGTMGYMAPECATTGKASKESDVYSFGI 542
+ + GT Y+APE +E D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 543 VALEIACGRKP 553
+ E G P
Sbjct: 237 IMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 359 KLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQL- 414
K+G+G +G VYK ++ A+K++ +G+ GI A E+ ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGT--GISMSACREIALLRELKHPNVIALQ 64
Query: 415 -LGWCHEKKELLLVYEFMPNG-------SLDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466
+ H +++ L++++ + S K+ L + + G+ YL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 467 QEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGY 520
W V+HRD+K +NI++ KI D G ARL + + T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 521 MAPECATTGKA-SKESDVYSFGIVALEI 547
APE + +K D+++ G + E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 57/224 (25%)
Query: 359 KLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQL- 414
K+G+G +G VYK ++ + A+K++ +G+ GI A E+ ++ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGT--GISMSACREIALLRELKHPNVISLQ 64
Query: 415 -LGWCHEKKELLLVYEF-----------------------MPNGSLDSHLFKENSLLTWE 450
+ H +++ L++++ +P G + S L++
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ-------- 116
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLARLVEHA 506
+ G+ YL W V+HRD+K +NI++ KI D G ARL
Sbjct: 117 --------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 507 KGSQTTV--LAGTMGYMAPECATTGKA-SKESDVYSFGIVALEI 547
+ + T Y APE + +K D+++ G + E+
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 8/106 (7%)
Query: 339 PKRFPYKE-LALATNDFNDDQKLGQGGFGGVYK----GFFRETNSY-IAVKRVSQGSKQG 392
P + PY E ++ + LG G FG V + G +E N +AVK + +
Sbjct: 24 PTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 393 IKE-YASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436
+E SE+KI+S L +H+N+V LLG C +L++ E+ G L
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHR 409
+F + + +G FG VY G + + AVK V + +K + + +E ++ +
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLASGLL 464
+V L + LV E++ G + S L F E E K ++A L
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKYISEVALALD 118
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502
YL ++HRD+K N+++ + + K+ DFGL+++
Sbjct: 119 YLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.66 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 98.54 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.0 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.0 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.61 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.51 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.36 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.34 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.17 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.05 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.74 | |
| PLN02236 | 344 | choline kinase | 96.5 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.43 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.4 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.39 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.14 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.0 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.99 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.73 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.66 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.35 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.27 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.05 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-58 Score=482.67 Aligned_cols=287 Identities=48% Similarity=0.832 Sum_probs=257.9
Q ss_pred CCCccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEee
Q 042831 338 GPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417 (645)
Q Consensus 338 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~ 417 (645)
..+.|+++|+..||++|+..+.||+|+||.||+|.+.+ +..||||++.....+..++|.+|++++++++|||||+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 46789999999999999999999999999999999986 48899998876554325679999999999999999999999
Q ss_pred eeeCC-eEEEEEEecCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 418 CHEKK-ELLLVYEFMPNGSLDSHLFKENS-LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 418 ~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
|.+.+ +.+||||||++|+|.++|+.... .++|.+|++|+.++|+||+|||+.+.+.|+||||||+|||||+++++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99998 59999999999999999987766 89999999999999999999999998899999999999999999999999
Q ss_pred eccCcccccccCCcceeec-ccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 496 DFGLARLVEHAKGSQTTVL-AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+++|++..+.
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999765431 1111222 799999999999999999999999999999999999999887665566679999999999
Q ss_pred CCccccccCcccc-CCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 NGKLLEAVDPRLC-RDFDG-QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ~~~l~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
++++.+++|+++. ..+.. ++++++..++++|++.+|++||+|.||++.|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 9999999999997 66665 7899999999999999999999999999999544
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=422.05 Aligned_cols=226 Identities=43% Similarity=0.662 Sum_probs=205.6
Q ss_pred eeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C--CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 35 LTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N--RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 35 ~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~--~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
++|+|++|... .+++.++ +|.+..++.|+||+ . ..+.|||+|++||+||++.+++++||+|+|+|.|.+.....+
T Consensus 1 ~~f~f~~f~~~-~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~ 79 (236)
T cd06899 1 LSFNFNGFSSD-QSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLG 79 (236)
T ss_pred CceecCCCCCC-CCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCC
Confidence 47999999865 5689999 99995589999999 5 678999999999999999999999999999999998766778
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeecc---
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWS--- 185 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~~--- 185 (645)
||||||||+|.... +.++.|++|||++..+.++..+++|||||||++|. +||++||||||||++.|..+.+|..
T Consensus 80 gdGlAF~i~~~~~~-~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~~~ 158 (236)
T cd06899 80 GDGLAFFLAPTDSL-PPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGG 158 (236)
T ss_pred CCeEEEEEecCCCC-CCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeeccccccc
Confidence 99999999998865 34788999999998776677899999999999998 4999999999999999998888743
Q ss_pred cCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCc
Q 042831 186 DVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSS 262 (645)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~ 262 (645)
++.+|+.++|||+||+.+++|+|+|.+.+..+|..|++++.+||+++|+++|||||||+||...|.|+|++|+|++.
T Consensus 159 ~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 159 KLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN 235 (236)
T ss_pred cccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence 36799999999999999999999999887778889999999999999999999999999999999999999999875
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.41 Aligned_cols=223 Identities=39% Similarity=0.618 Sum_probs=197.7
Q ss_pred eeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC-CceEEEEeCCceecccCCCCCccceeEEEEEEEeeC--CCC
Q 042831 34 ALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR-ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR--NSS 108 (645)
Q Consensus 34 ~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~-~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~--~~~ 108 (645)
+++|+|++|. + ..++.+. +|.+..+|.|+||+ .. .+.|||+|++||+|||+.+++++||+|+|+|.|... ...
T Consensus 1 ~~~F~~~~F~-~-~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~ 78 (236)
T PF00139_consen 1 SVSFSFPSFS-N-SSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSN 78 (236)
T ss_dssp EEEEEESSBT-T-GTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSS
T ss_pred CceEEcCCCC-C-CCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCc
Confidence 4689999993 2 5689999 99986789999999 55 799999999999999999999999999999999643 456
Q ss_pred CCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceee----
Q 042831 109 YYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVS---- 182 (645)
Q Consensus 109 ~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~---- 182 (645)
.+||||||||+|.. ..+.++.|++||+++..+.+...++.|||||||++|. .||++||||||+|++.|..+.+
T Consensus 79 ~~~dGlAFvi~~~~-~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~ 157 (236)
T PF00139_consen 79 NGGDGLAFVIQPDP-NLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYY 157 (236)
T ss_dssp S-BEEEEEEEEETT-SSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----
T ss_pred cCCCceEEEEecCc-ccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccccccccc
Confidence 78999999999998 6577789999999988776666889999999999986 8999999999999999888743
Q ss_pred --ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeecc
Q 042831 183 --WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFN 260 (645)
Q Consensus 183 --~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ 260 (645)
...++.+|+.++|||+||+.+++|+|+|.... .+|..+++++.+||+.+++++||||||||||...|.|.|++|+|+
T Consensus 158 ~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 158 SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred ccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence 35568899999999999999999999999874 678899999999999999999999999999999999999999995
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=391.05 Aligned_cols=250 Identities=37% Similarity=0.549 Sum_probs=207.0
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeE-EEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-eEEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSY-IAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-ELLLVYE 429 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~-vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-~~~lV~E 429 (645)
+...+.||+|+||+||+|.+++ +. ||||++..... ...++|.+|+.+|.+++|||||+++|.|.+.. .+++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3445669999999999999984 44 99999976432 23679999999999999999999999999887 7999999
Q ss_pred ecCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC-eeeccCCCCCeEECCCC-cEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQC-VVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~ 506 (645)
||++|+|..+++. .+..+++..+++|+.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999988 47899999999999999999999999 66 99999999999999997 9999999999865432
Q ss_pred CCcceeecccCccccCccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGSQTTVLAGTMGYMAPECAT--TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
. ...+...||..|||||++. ...++.|+||||||++||||+||+.||...... +.......++.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~------- 263 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGL------- 263 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-------
Confidence 2 2333468999999999999 568999999999999999999999999865541 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+...+......+..++.+||+.||++||++.+++..|.
T Consensus 264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 12222224456777778899999999999999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=373.65 Aligned_cols=253 Identities=30% Similarity=0.410 Sum_probs=215.3
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-eEEEEEEecCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-ELLLVYEFMPN 433 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-~~~lV~Ey~~~ 433 (645)
..+.||+|..|+|||++++.+++.+|+|.+... .....+++.+|++++.+.+||+||.++|.|...+ +..|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 367899999999999999999999999999654 4456789999999999999999999999999988 59999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|||++.+... +.+++...-+|+.+|++||.|||++ ++||||||||+|||++.+|++||||||.++.+... ....
T Consensus 163 GSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~t 236 (364)
T KOG0581|consen 163 GSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANT 236 (364)
T ss_pred CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hccc
Confidence 9999988644 5699999999999999999999973 89999999999999999999999999999876543 5566
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--CCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP--QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~--~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
.+||..|||||.+.+..|+.++||||||+.++|+++|+-|+....+ .....+++++- .+ -.|++...
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv----~~-----ppP~lP~~-- 305 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV----DE-----PPPRLPEG-- 305 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh----cC-----CCCCCCcc--
Confidence 8899999999999999999999999999999999999999986422 22333333321 11 12333222
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....++..++..||++||.+||+++|+++|.+..
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 2446788889999999999999999999999853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=385.21 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=215.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
..|...+.||+|||..||.+++..+|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999999999999999999763 3445678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+|++++|..++. ..+.+++...+.++.||+.||.|||+ .+|+|||||..|+||+++.++||+|||||..+....
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999998886 67789999999999999999999999 899999999999999999999999999998876433
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......+||+.|+|||++.....+..+||||+||+||-|++|++||+...-.+ ....+ +..+..-|.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~I---k~~~Y~~P~--- 239 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKI---KLNEYSMPS--- 239 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHH---HhcCccccc---
Confidence 34455789999999999999999999999999999999999999998543111 11111 111111121
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+|+..+|++||.+|||+++|+.+-.+
T Consensus 240 ----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 240 ----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 223345677889999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=367.12 Aligned_cols=203 Identities=31% Similarity=0.556 Sum_probs=184.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
..+|...++||+|.|+.||+|+++.++..||||.+... .++..+.+..|+++|++++|||||++++++..++.++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788888999999999999999999999999999766 6667778899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC------CcEEEeeccCccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN------FNAKIGDFGLARL 502 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~------~~~kl~DfGla~~ 502 (645)
|||.+|+|..+++.. +.+++...+.++.|||.||++||+ ++||||||||.||||+.+ -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999654 479999999999999999999999 999999999999999764 4589999999998
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~ 559 (645)
+.. .......+|++-|||||+++.++|+.|+|+||.|++|||+++|+.||+....
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 763 3344567899999999999999999999999999999999999999986554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=370.62 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=212.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
+.|...+.||+|+||.|-+|..+.+|+.||||++++... .......+|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 456678999999999999999999999999999975411 1233457999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC---CcEEEeeccCcc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN---FNAKIGDFGLAR 501 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kl~DfGla~ 501 (645)
|||||||++|.|.+.+..+ +.+.+..-..+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999998654 456777778899999999999999 999999999999999655 789999999999
Q ss_pred cccccCCcceeecccCccccCccccccCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGK---ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
... ....+..++||+.|.|||++.++. +..+.|+||+||+||-++||.+||.....+. . +.+.+..|+.
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~~G~y 399 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQILKGRY 399 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHhcCcc
Confidence 765 445667789999999999997764 3458899999999999999999998654431 1 2233334433
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .+....+..++.+.++.++|..||+.|||+.|+|+|.|+.
T Consensus 400 ~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 400 AF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred cc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 21 1122334567888999999999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=379.58 Aligned_cols=249 Identities=33% Similarity=0.538 Sum_probs=208.6
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
..+.||+|.||.||.|.+++ ...||+|.++.. ....+.|.+|+++|.+|+|+|||+++|+|..++.++||||||++|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 36889999999999999986 357999998765 3345789999999999999999999999999999999999999999
Q ss_pred hhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeec
Q 042831 436 LDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 436 L~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
|.++|.. .+..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+|||||+......+......
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 9999986 56789999999999999999999999 9999999999999999999999999999996554443333333
Q ss_pred ccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
.-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+ +.+.+.+|..+. .|..|
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyRlp--~P~~C------ 429 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYRLP--RPEGC------ 429 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCcCC--CCCCC------
Confidence 44667999999999999999999999999999999 999987654322 223333443222 23333
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+.+|+..||+.+|++|||++.+...|+.
T Consensus 430 -P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 430 -PDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred -CHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 3467778899999999999999998888763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=350.91 Aligned_cols=258 Identities=27% Similarity=0.391 Sum_probs=213.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEee-eeeCCe-EEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGW-CHEKKE-LLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~-~~~~~~-~~lV 427 (645)
.+|.+.++||+|.||+|||+....+|..+|.|.+... +.+..++...|+.+|++|+|||||+++++ +.++++ +.||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3567788999999999999999999999999998754 45667889999999999999999999995 445555 8999
Q ss_pred EEecCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 428 YEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
||||..|+|...++ +.++.+++..+++++.|++.||..+|..+.+ -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998875 3567899999999999999999999996644 3889999999999999999999999999988
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
+... ......+||+.||+||.+...+|+.+|||||+||++|||+.-+.||...+ +. .....+.+|.....
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~-~L~~KI~qgd~~~~-- 248 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LL-SLCKKIEQGDYPPL-- 248 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HH-HHHHHHHcCCCCCC--
Confidence 6533 33456789999999999999999999999999999999999999998642 22 12233344432111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+..|+..|+.+||+.||+.-.+++.+..
T Consensus 249 ------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 ------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 123456778889999999999999996666655543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.84 Aligned_cols=278 Identities=28% Similarity=0.385 Sum_probs=224.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV 427 (645)
+.|+.+++||+|.||.||+|++..+|+.||+|+++.+. .....-..+||.+|++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34666788999999999999999999999999998764 44456677999999999999999999998776 689999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
+|||+. +|.-++...+-.+++.++..+++||++||.|||. ++|+|||||.+|||||.+|.+||+|||||+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999965 7777787777789999999999999999999999 999999999999999999999999999999888777
Q ss_pred CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC--------Ccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN--------GKL 578 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~--------~~l 578 (645)
....+..+-|.+|.|||.+.+. .|+.+.|+||.||||.||+.|++.|....+-++ +..++.+.+. .++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCChhccccccC
Confidence 7777788899999999998875 599999999999999999999999987665444 3334433321 111
Q ss_pred c--cccCccccCCCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc-CCCCCCCCCCCCC
Q 042831 579 L--EAVDPRLCRDFDG-------QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF-EAPLPALPPKMPV 638 (645)
Q Consensus 579 ~--~~~d~~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~p~~~p~ 638 (645)
. ..+.+. ..+.. ......+.|+..+|..||.+|.|+.++|+.-.| ..|+|.-|+..|.
T Consensus 350 P~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 350 PHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPK 417 (560)
T ss_pred CcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCC
Confidence 1 111111 11111 112446677788889999999999999999988 4566655555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.50 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=213.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..++|+..+.||+|+||+||.++.+++++.+|+|++++. .....+...+|..+|.+++||.||+++-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356899999999999999999999999999999999764 34456788899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|+||+.||.|..+|.+ .+.+++...+-.+..|+.||.|||+ ++||||||||+|||||++|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999954 4568888888889999999999999 9999999999999999999999999999985433
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.+..+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+.. . ..+.+.++++.
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~-~~~~I~~~k~~------- 243 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------K-MYDKILKGKLP------- 243 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------H-HHHHHhcCcCC-------
Confidence 334555689999999999999999999999999999999999999999865432 1 12222233311
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRP----SIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~L~~~ 626 (645)
..+.-.......++...++.||++|- .++++-+|..+.
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~ 285 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK 285 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence 11111223556777889999999994 677777777653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=381.84 Aligned_cols=260 Identities=29% Similarity=0.472 Sum_probs=219.6
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeC
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEK 421 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~ 421 (645)
+....+....+.||+|+||+||+|...+ ....||||.++..... ..++|.+|++++..++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 3344556668899999999999998753 3468999999877554 788999999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhc---------CC----CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE---------NS----LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~---------~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 488 (645)
+.+++|+|||..|+|.++|... +. .|+..+.+.|+.|||.||.||-+ +.+|||||..+|+|+.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 9999999999999999999632 12 38899999999999999999998 89999999999999999
Q ss_pred CCcEEEeeccCcccccccCCccee-ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHH
Q 042831 489 NFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLL 566 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~ 566 (645)
+..+||+||||++..-..++.+.. .-.-..+||+||.+..+++|++||||||||+|||+.+ |+.|+.....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence 999999999999866555544433 2334678999999999999999999999999999999 99999866543
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.|.+.+++|++... | .....++..|++.||+.+|++||+++||-..|+..
T Consensus 713 -EVIe~i~~g~lL~~--P-------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 -EVIECIRAGQLLSC--P-------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -HHHHHHHcCCcccC--C-------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 34556667777543 2 22345788888999999999999999999999754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.40 Aligned_cols=269 Identities=25% Similarity=0.347 Sum_probs=214.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+.|+...++|+|+||.|||+++++||+.||||++.... +.-.+-.++|+++|++++|+|+|.+++.|..+..+.||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677889999999999999999999999999986543 2334556799999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
||+..-|. -|.....-++.+...+++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||+|+.+.. .+.
T Consensus 82 ~~dhTvL~-eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd 156 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD 156 (396)
T ss_pred ecchHHHH-HHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence 99775554 444444568889999999999999999999 8999999999999999999999999999998764 445
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------HHHhc-CCccc
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV--------WDLYG-NGKLL 579 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~-~~~l~ 579 (645)
..+..+.|.+|.|||.+.+ -+|+...||||.||++.||++|.+.|.+..+-++..++... .+.+. ++...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5667788999999999877 67999999999999999999999999877766655544322 11111 11111
Q ss_pred cccCccc------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRL------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...-|.. ...++ ....-+++++..|++.||.+|++-+|++.|-.|+
T Consensus 237 Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111111 11111 2234678899999999999999999999987763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=327.25 Aligned_cols=281 Identities=25% Similarity=0.353 Sum_probs=228.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ--GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.+|...++||+|.||.||+|++..+|+.||||+++..... -.....+|++.|++++|+||+.+++.|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999999999999999999765332 24567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|| ..+|+..+..+...++..++..++.++++||+|||. +.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 99 568999998888899999999999999999999999 89999999999999999999999999999988654433
Q ss_pred ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC-----
Q 042831 510 QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD----- 583 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d----- 583 (645)
.+..+-|.+|.|||.+.+. +|+...||||.||++.||+-|.+-|.+..+-++ +..++...+...-.++-+
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ---L~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ---LSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH---HHHHHHHcCCCCcccCccccccc
Confidence 3334679999999988775 599999999999999999998887776554333 334444433221111111
Q ss_pred ----------ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC-CCCCCCCCCCCCCCC
Q 042831 584 ----------PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE-APLPALPPKMPVPTY 641 (645)
Q Consensus 584 ----------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~~p~~~p~~~~ 641 (645)
+.+ ...-.......+++...++..||.+|+|+.|++++-.+. .|.|..|.+.|.|..
T Consensus 234 dY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 234 DYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred cHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence 111 111123345568888999999999999999999999876 688888888777654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=358.64 Aligned_cols=272 Identities=25% Similarity=0.316 Sum_probs=219.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-hHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC-eEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLR-HRNLVQLLGWCHEKK-ELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~-~~~l 426 (645)
..++|...++||.|.||.||+|+..++|..||||+++..-.. ..-.=++|+..|++|+ ||||+++.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788899999999999999999999999999998754221 2223358999999999 999999999998887 9999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||| ..+|+.++..+++.+++..+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+||....
T Consensus 88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc-
Confidence 99999 668999998889999999999999999999999999 9999999999999999999999999999997653
Q ss_pred CCcceeecccCccccCccccc-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc-------
Q 042831 507 KGSQTTVLAGTMGYMAPECAT-TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL------- 578 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l------- 578 (645)
....+..+-|.+|+|||++. .+.|+.+.|+||+||+++|+++-++.|.+..+-++.. .+.+.++....
T Consensus 163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLGTPDKDSWPEGY 238 (538)
T ss_pred -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhCCCccccchhHH
Confidence 34556678899999999864 5679999999999999999999999998766554433 22333332111
Q ss_pred --ccccC---ccccC----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 579 --LEAVD---PRLCR----DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 579 --~~~~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
...+. |...+ ..-.....+.++++..|+.+||.+|||+.|++++..++...+
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 11111 11111 011124567888999999999999999999999998865433
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.25 Aligned_cols=268 Identities=29% Similarity=0.478 Sum_probs=223.4
Q ss_pred ccChHHHHHhhcCC---------CCCCccCcCCcEEEEEEEEcCCC---eEEEEEEeccC-ChhhHHHHHHHHHHHHhcC
Q 042831 341 RFPYKELALATNDF---------NDDQKLGQGGFGGVYKGFFRETN---SYIAVKRVSQG-SKQGIKEYASEVKIISRLR 407 (645)
Q Consensus 341 ~~~~~el~~~~~~f---------~~~~~LG~G~fG~Vy~g~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~ 407 (645)
.++|++...|...| .+.+.||.|.||.||+|+++..| ..||||.++.. .++...+|+.|+.+|.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 35666655544433 45788999999999999997544 57999999876 4567789999999999999
Q ss_pred CCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC
Q 042831 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487 (645)
Q Consensus 408 H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld 487 (645)
||||++|.|.....+..+||.|||+||+|+.+|.++.+.+++.+...++++||.||.||.+ .++|||||.++|||++
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeec
Confidence 9999999999999999999999999999999999888889999999999999999999998 8999999999999999
Q ss_pred CCCcEEEeeccCcccccccCCcceeeccc--CccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 042831 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVS 564 (645)
Q Consensus 488 ~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~ 564 (645)
.|..+|++||||+|.++.......+...| ..+|.|||.+...++|.+|||||||++|||+++ |.+||=+...++
T Consensus 766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--- 842 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--- 842 (996)
T ss_pred cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---
Confidence 99999999999999876555333333333 468999999999999999999999999999888 999986544321
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
|... ++..++-..+.+....|.+|++.||++|-.+||.+.|++.+|+.-.
T Consensus 843 ----VIka---------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 ----VIKA---------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ----HHHH---------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 1111 2222222233445668899999999999999999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.61 Aligned_cols=262 Identities=28% Similarity=0.456 Sum_probs=212.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--eEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--ELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--~~~lV~E 429 (645)
.++...+.||+|.||.||++.+..+|...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667889999999999999999889999999987664444677899999999999999999999754444 6999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcccccc--c
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEH--A 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~--~ 506 (645)
|+++|+|.+++.+.+..+++..+....+||++||.|||+ ++|+||||||+|||++. ++.+||+|||+++.... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998766589999999999999999999998 99999999999999999 79999999999987653 2
Q ss_pred CCcceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........||+.|||||++..+. ...++|||||||++.||+||+.||... .....++.....++.. |
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C-
Confidence 222344578999999999998643 446999999999999999999999753 1122233222222211 2
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
.++........+++..|++.||++|||++++|+|..-....+
T Consensus 243 ---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 ---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 222223345667788999999999999999999998654333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=354.21 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=215.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC----Ch-hhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SK-QGIKEYASEVKIISRLR-HRNLVQLLGWCHEKK 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~ 422 (645)
...+.|...+.||+|.||+|++|.+..++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456888999999999999999999999999999977653 11 23456668999999999 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCcc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLAR 501 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla~ 501 (645)
++++||||+.+|+|.+++.+ ...+.+.....+++|+++|++|||+ ++|+||||||+|||+|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999987 6778889999999999999999999 999999999999999999 999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCC-CC-cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGK-AS-KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ..+. ..+..+...
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~----~ki~~~~~~ 241 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLY----RKIRKGEFK 241 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHH----HHHhcCCcc
Confidence 764 3444566678999999999999876 64 889999999999999999999986321 1111 112222110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+ |. ... ...+..++.+|+.+||.+|+++.+++.+.|+..
T Consensus 242 --~-p~---~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 242 --I-PS---YLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred --C-CC---CcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0 11 110 346678889999999999999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=349.55 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=214.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|..++.||+|.|++|++|+.+.+++.+|||++.+. .....+-...|-+.|.+| .||.|++|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346888899999999999999999999999999998654 223345567899999999 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+++|+|.+++.+- +.+++...+.++.+|+.||+|||+ .|||||||||+|||||+++++||+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999999654 578999999999999999999999 9999999999999999999999999999998753
Q ss_pred cCCc------------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 506 AKGS------------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 506 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
.... ....++||..|.+||++..+..+..+|+|+|||+||+|+.|++||...++- .+.+.+..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI~~-- 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKIQA-- 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHHHH--
Confidence 2211 114589999999999999999999999999999999999999999865421 12222211
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
++-.+...++ +.+.+|+.+.|..||.+|+|.+|+.+|.-|+
T Consensus 302 --------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 302 --------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred --------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 1222333333 4566777888999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=394.34 Aligned_cols=268 Identities=25% Similarity=0.448 Sum_probs=221.8
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK 421 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~ 421 (645)
+.++++. ..|...+.||+|+||.||+|+...++..||||++...... ...|++.+++++||||++++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4444443 4577888999999999999999888999999998644322 13468899999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+..++|||||++|+|.+++. .++|..+.+|+.|+|+||+|||+.+.++|+||||||+||+++.++..++. ||...
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999999984 38999999999999999999997667899999999999999999988876 66554
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+|+...+........
T Consensus 831 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 904 (968)
T PLN00113 831 LLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMW 904 (968)
T ss_pred ccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhhe
Confidence 32211 123578999999999999999999999999999999999999964332 334567777766666666677
Q ss_pred cCccccC--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 582 VDPRLCR--DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 582 ~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+|+.+.. ..+.+++.++++++.+|++.||++||+|+||++.|+...
T Consensus 905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 7877644 345577888999999999999999999999999998653
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.30 Aligned_cols=267 Identities=27% Similarity=0.451 Sum_probs=216.5
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
+.+.++++...+++...+.||+|.||+||+|++.+ .||||.+... ..+..+.|.+|+..+++-||.||+-+.|||
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~ 457 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC 457 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence 34456777777888889999999999999999975 4999998754 556788999999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
..... .||..+|++.+|+.+++..+..++..+.+.|++|||+|+.|||. ++|||||||..||+|.+++.+||+|||
T Consensus 458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccc
Confidence 98887 99999999999999999888889999999999999999999999 999999999999999999999999999
Q ss_pred Cccccccc-CCcceeecccCccccCccccccC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 499 LARLVEHA-KGSQTTVLAGTMGYMAPECATTG---KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 499 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
++..-..- .........|...|||||+++.. ++++.+||||||+++|||+||..||.....+... | +.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi------f-mVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII------F-MVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE------E-Eec
Confidence 98643322 12223335578889999998754 5899999999999999999999999843332111 1 122
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.|.+. .|.... .....+.|.+|...||..++++||.+.+++..|+.-
T Consensus 607 rG~l~--pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 607 RGYLM--PDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccccC--ccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 33222 121111 112335666777899999999999999999977754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.39 Aligned_cols=267 Identities=25% Similarity=0.345 Sum_probs=213.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
..+.|+..+.||.|..+.||+|+...+++.||||++..+ .......+.+|+..|+.++||||++++..|..+..+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 356788899999999999999999999999999999755 3445789999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
.||.+||+.+.+... ..-+++..+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|||..-.+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998753 3458999999999999999999999 999999999999999999999999999866543322
Q ss_pred Ccc---eeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 508 GSQ---TTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 508 ~~~---~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.+. .....||++|||||++.. ..|+.|+||||||+...||++|..||....+- ..+.. . + ++......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~---t-L-qn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLL---T-L-QNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHH---H-h-cCCCCCcc
Confidence 211 144689999999999544 35999999999999999999999999854431 11111 1 1 11111000
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
-..+..+.+...-..+.+++..||+.||++|||+++++++-+|.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk 297 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK 297 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence 00111111112234677888999999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=347.85 Aligned_cols=250 Identities=28% Similarity=0.393 Sum_probs=212.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...+.||+|.||.||||+.+.+.+.||+|.+.+. .++..+.+.+|++++++++||||+.+++||+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5678889999999999999999999999999999765 45567889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+.+ +|..+|.+ .+.++++++..|+.++..||.|||+ .+|+|||+||.|||++.++.+|+||||+|+.+.. ...
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9966 99998854 4679999999999999999999999 9999999999999999999999999999997654 233
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
..+...||+-|||||.+.++.++..+|.||+||+|||+..|++||... .+.+.+.....+ +..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d--------~v~--- 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD--------PVK--- 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC--------CCC---
Confidence 456678999999999999999999999999999999999999999632 122222222111 111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+......+..++...|.+||.+|.+..+++.|..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 11234456677788899999999999999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.71 Aligned_cols=254 Identities=28% Similarity=0.426 Sum_probs=215.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
.|....+||+|+.|.||.++...+++.||||++........+-+.+|+.+|+..+|+|||++++.+..++++++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 46677899999999999999999999999999987766666778899999999999999999999988899999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+|+|.+.+.. ..+++.++..|++++++||.|||. ++|+|||||.+|||++.++++||+|||++..+..... ...
T Consensus 354 ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~ 427 (550)
T KOG0578|consen 354 GGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS 427 (550)
T ss_pred CCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence 9999998843 459999999999999999999999 9999999999999999999999999999987765443 334
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
..+||+.|||||++....|+++.||||||++++||+-|++||-...+- +.++-...+|. |.+.. ..
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~------P~lk~--~~ 493 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT------PKLKN--PE 493 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCC------CCcCC--cc
Confidence 567999999999999999999999999999999999999999764432 22222222332 22211 22
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.++..+||+.|+++||++.|+|+|....
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 2345677888999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=340.36 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=208.0
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.+++|+|++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667889999999999999999999999999986432 2334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++|+|..++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--
Confidence 99999999887643 3468999999999999999999998 99999999999999999999999999999765322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||........... +........ .
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~~----------~ 222 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKEDQ----------E 222 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhccc----------c
Confidence 122345689999999999999999999999999999999999999986543221111 111111110 0
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.+.......+..|+..||+.||++||+ +++++++.+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 111122345677889999999999997 99999998865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=340.95 Aligned_cols=270 Identities=22% Similarity=0.271 Sum_probs=209.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...+.||+|+||.||+++++.+++.||+|++... .....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688899999999999999999999999999998754 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++++++..+. .....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99988776443 444578999999999999999999998 89999999999999999999999999999876443333
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH---------HHHhcCCcccc
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV---------WDLYGNGKLLE 580 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~---------~~~~~~~~l~~ 580 (645)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+... ...........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 334456899999999999888999999999999999999999999764432211111110 00011111111
Q ss_pred ccCccccCC------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 581 AVDPRLCRD------FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 581 ~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+..... ........+.+++.+||+.||++|||++|+++|.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 101111000 001123458889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.23 Aligned_cols=262 Identities=28% Similarity=0.464 Sum_probs=214.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
....+.++||+|-||.|.++.... +..||||.++... +...++|.+|+++|.+++||||++++|.|..++.+|+|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345668899999999999998865 6899999998764 44568999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++|+|..++..+... +....-.+|+.|||+||+||.+ .++|||||.++|+|+|.++++||+|||+++-+-.++..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999876433 4566777899999999999999 89999999999999999999999999999855444443
Q ss_pred ce-eecccCccccCccccccCCCCcchhHHHHHHHHHHHH--cCCCCCCCCCCCCchhHHHHHHHHhcC-CccccccCcc
Q 042831 510 QT-TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA--CGRKPINPKAPQGQVSLLQWVWDLYGN-GKLLEAVDPR 585 (645)
Q Consensus 510 ~~-~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ell--tG~~pf~~~~~~~~~~l~~~~~~~~~~-~~l~~~~d~~ 585 (645)
.. ...+-..+|||+|.+..++++.+||||+||+.+||++ |.+.||+....++ .++-..++... +...-...|.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceeccCCC
Confidence 32 2345578999999999999999999999999999974 5889998655432 23333333332 2222223344
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+++ ..+.++++.||..|.++||+++++..+|..++
T Consensus 771 ~cp-------~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 771 ACP-------QGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCc-------HHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 433 46778999999999999999999999987653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.58 Aligned_cols=258 Identities=28% Similarity=0.404 Sum_probs=202.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC-
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK- 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~- 421 (645)
..++|...++||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567888999999999999999752 345689999987543 33456789999999999 899999999998764
Q ss_pred CeEEEEEEecCCCChhhhhhhcC---------------------------------------------------------
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN--------------------------------------------------------- 444 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 444 (645)
+.+++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999886421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCcc
Q 042831 445 ----SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMG 519 (645)
Q Consensus 445 ----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 519 (645)
..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 247888999999999999999998 89999999999999999999999999999765322211 1222345678
Q ss_pred ccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHH
Q 042831 520 YMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERL 598 (645)
Q Consensus 520 y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l 598 (645)
|+|||++.+..++.++|||||||+||||++ |+.||....... . ......++... .... .....+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~----~~~~~~~~~~~-----~~~~----~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E----FCQRLKDGTRM-----RAPE----NATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H----HHHHHhcCCCC-----CCCC----CCCHHH
Confidence 999999999899999999999999999997 999997543221 1 11112222211 1111 123457
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 599 MIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 599 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..++.+||+.||++|||+.|+++.|+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.24 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=202.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..++||+|+||.||+|++..+++.||||.+.... ....+.+.+|++++++++|+||+++++++...+.+++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556789999999999999999889999999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++|+|.... ..++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999986532 35677888999999999999998 899999999999999999999999999998654322 12
Q ss_pred eeecccCccccCccccccC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 511 TTVLAGTMGYMAPECATTG-----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....|+..|+|||++... ..+.++|||||||++|||++|+.||......+...+.... .... .+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~-----~~~ 295 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMSQ-----PPE 295 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hccC-----CCC
Confidence 2345789999999987432 2456899999999999999999999743322211111110 0000 011
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
. .......+.+++.+||+.||++||++.|+++|.+.....+
T Consensus 296 ~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 296 A----PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred C----CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 1 1122345778889999999999999999999999876543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=348.17 Aligned_cols=249 Identities=28% Similarity=0.506 Sum_probs=206.0
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
.++++++. +++-||+|+.|.||+|++. ++.||||+++.-.+ .+|+-|++|+|+||+.+.|+|..
T Consensus 120 eiPFe~Is-------ELeWlGSGaQGAVF~Grl~--netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEIS-------ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhh-------hhhhhccCcccceeeeecc--CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecC
Confidence 35555553 4678999999999999997 68899999864332 57888999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
...+|||||||+.|-|...|. .++.+.......+.++||.|+.|||. ..|||||||+-|||+..+..+||+|||-+
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK-AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred CceeEEeeeccccccHHHHHh-ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999999995 45567888889999999999999999 88999999999999999999999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+..... .....++||..|||||++++.+.++|.|||||||+||||+||..||.+.+... .+|.. + ...+.
T Consensus 260 ~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGV-G-sNsL~ 329 (904)
T KOG4721|consen 260 KELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGV-G-SNSLH 329 (904)
T ss_pred Hhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEec-c-CCccc
Confidence 865432 44556899999999999999999999999999999999999999997544321 12211 1 11222
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..-| ....+-+..|+..||+..|..||++++++.||+-.
T Consensus 330 LpvP-------stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 330 LPVP-------STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCc-------ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 2222 23345677788999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=341.29 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=214.0
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
....++|+.+.+||+|+||.||+++.++||..+|+|++++. ...+.+..++|-.+|....+|.||+|+-.|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44668999999999999999999999999999999999765 345677889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
||||||++||++..+|. ....|++...+..+.+++-|+.-||+ .|+|||||||+|+|||..|++||+||||+.-+.
T Consensus 217 YLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999885 45678999999999999999999999 999999999999999999999999999986332
Q ss_pred cc----------------------CCc-----ce-------------------eecccCccccCccccccCCCCcchhHH
Q 042831 505 HA----------------------KGS-----QT-------------------TVLAGTMGYMAPECATTGKASKESDVY 538 (645)
Q Consensus 505 ~~----------------------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~t~~sDV~ 538 (645)
.. ... .. ...+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 00 113699999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC---
Q 042831 539 SFGIVALEIACGRKPINPKAPQGQ-VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP--- 614 (645)
Q Consensus 539 SfGvll~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP--- 614 (645)
|+||++|||+.|-+||....+.+. ..++.|...+ ...-+. ....+..+|+.+|+. ||++|-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l------~fP~~~--------~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL------KFPEEV--------DLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc------cCCCcC--------cccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999997765432 2334443111 111111 112456677788888 999996
Q ss_pred CHHHHHHHhccC
Q 042831 615 SIRQVIHVLNFE 626 (645)
Q Consensus 615 s~~evl~~L~~~ 626 (645)
.++||.+|.+|.
T Consensus 438 G~~EIK~HPfF~ 449 (550)
T KOG0605|consen 438 GAEEIKKHPFFK 449 (550)
T ss_pred cHHHHhcCCccc
Confidence 699999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=348.13 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=209.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
-|..++.||.|+.|.|-+|++..||+.+|||++.... ......+.+|+-+|+-+.|||++++++.+.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3566889999999999999999999999999997652 2234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++|-|.+++..+ +.+++....+++.||+.|+.|+|. .+|+||||||+|+|||.++++||+|||+|-+.. .+.
T Consensus 93 yv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGK 166 (786)
T ss_pred ecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc--CCc
Confidence 99999999999765 457888888999999999999999 899999999999999999999999999997643 334
Q ss_pred ceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....+|.++|.+||++.+.+| +.++||||+||+||.|++|+.||++++ ...+...| ..|... +..
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV----~~G~f~--MPs---- 233 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKV----QRGVFE--MPS---- 233 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHH----HcCccc--CCC----
Confidence 4556789999999999999886 689999999999999999999998433 22333333 334321 111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. ..+...|+.+|+..||++|.|++||++|.+-.
T Consensus 234 ~I----s~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 234 NI----SSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred cC----CHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 11 12445667899999999999999999999854
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.69 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=206.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...++||+|+||.||+|....+++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999999999999999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ ++|.+++...+..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 97 58998887666678999999999999999999998 9999999999999999999999999999975432221 2
Q ss_pred eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC------------Cc
Q 042831 511 TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN------------GK 577 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~------------~~ 577 (645)
.....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. .......... ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhccccchh
Confidence 233467899999998865 4689999999999999999999999976543222 1111111110 00
Q ss_pred cccccCccccCCC----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCRDF----DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
......+...... .........+++.+||+.||.+|||++|+++|.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111111110000 00112456788999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.12 Aligned_cols=250 Identities=25% Similarity=0.329 Sum_probs=207.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|....+++.||+|++.... ....+.+.+|++++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999999899999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++.....++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999998643 468999999999999999999998 99999999999999999999999999999765322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ ....+.. .+..
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~----~i~~~~~------~~~~ 219 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYE----KILAGKL------EFPR 219 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCc------CCCc
Confidence 22346899999999999888999999999999999999999999754321 1111 1111211 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.. ...+.+++.+||+.||.+||+ ++++++|.|+.
T Consensus 220 ~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 220 HL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred cC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 11 235678889999999999995 99999999875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.80 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=205.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+|.+. ..+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999875 346789999987653 3445678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 999999999999997766689999999999999999999998 89999999999999999999999999987643222
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........++..|+|||.+.++.++.++|||||||++||+++ |+.||...... ..... ..++... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~-----~ 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKA----VEDGFRL-----P 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHH----HHCCCCC-----C
Confidence 1111122334678999999999999999999999999999775 99999754322 11221 1222111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... .....+.+++..||+++|++||+++|+++.|..
T Consensus 229 ~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 APR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111 123457778899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.30 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=210.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++.+++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999999999999999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.. ...+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 99999999999854 3568999999999999999999998 8999999999999999999999999999975533
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.. + ...+. .+.. .
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~~-~-~~~~~---~~~~-~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENLKY-W-KETLQ---RPVY-D 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHHHh-c-ccccc---CCCC-C
Confidence 22345689999999999998999999999999999999999999975433211 111110 0 00000 0111 0
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.........+.+++.+||+.+|++||++++++++.++..
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 000122345677888999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.15 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=209.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||.|+||+|.+++.+.+|..+|+|.++... -++.+...+|..+|+.+.||.++++.+.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788999999999999999999999999999997653 345567789999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||.++|.|..++.+ .+.+++...+-++.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999999954 4568999999999999999999999 9999999999999999999999999999987643
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.+-..+||+.|+|||++....+..++|.|||||++|||++|.+||....+. ...+.+.++++. -| .
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-------~iY~KI~~~~v~---fP---~ 262 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-------QIYEKILEGKVK---FP---S 262 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-------HHHHHHHhCccc---CC---c
Confidence 356689999999999999999999999999999999999999999866541 223333344331 11 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCC-----CCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLR-----PSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~evl~~L~~~ 626 (645)
.++ ..+..|+...++.|-.+| +-.++|..|.|+.
T Consensus 263 ~fs----~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~ 301 (355)
T KOG0616|consen 263 YFS----SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK 301 (355)
T ss_pred ccC----HHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence 122 234455667778888777 4567888888875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=336.20 Aligned_cols=271 Identities=21% Similarity=0.270 Sum_probs=208.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...++||+|+||.||+|+...+++.||+|.+..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4678899999999999999999998899999999875432 234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++ ++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++...... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 995 68888887666778999999999999999999998 899999999999999999999999999987543221 1
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc---c-----cc
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK---L-----LE 580 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---l-----~~ 580 (645)
......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+........ . ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcc
Confidence 2233567899999998865 45789999999999999999999999754321 111222211111100 0 00
Q ss_pred ccCcc-cc--CCCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 581 AVDPR-LC--RDFDG-------QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 581 ~~d~~-l~--~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
..++. +. ..... .....+.+++.+||+.||++|||++|+++|.++..-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00000 00 00000 012356688899999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.82 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=209.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|+..+.||+|+||.||++++..++..+|+|.+.... ....+.+.+|++++.+++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468889999999999999999999999999999987653 3445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999988543 468999999999999999999997 236999999999999999999999999998755322
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC--ccc--------
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG--KLL-------- 579 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--~l~-------- 579 (645)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......+ +..........+ ...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccc
Confidence 2233568999999999998899999999999999999999999996433211 111100000000 000
Q ss_pred -----------------------cccCccccCCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 -----------------------EAVDPRLCRDF-DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 -----------------------~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.+........ .......+.+++.+||+.||++|||++|++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 00000000000 011234678899999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=367.15 Aligned_cols=254 Identities=31% Similarity=0.485 Sum_probs=211.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCC-----eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETN-----SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.+.+..+.||+|.||.||.|...+.. ..||||.+.+. +.+...+|.+|..+|+.++|||||+++|.|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44556788999999999999987533 34999999776 5567889999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 426 LVYEFMPNGSLDSHLFKE------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
|++|||++|+|..+|.+. ...|+....+.++.|||+|+.||++ +++|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999876 5679999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCcceeec-ccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH-HhcCC
Q 042831 500 ARLVEHAKGSQTTVL-AGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD-LYGNG 576 (645)
Q Consensus 500 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~-~~~~~ 576 (645)
|+.+....+...... .-...|||||.+..+.++.|+|||||||+|||++| |..||......+ +.. ..+.|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCC
Confidence 994433333222222 33468999999999999999999999999999999 999998655321 222 22344
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
++ -.|..|+ +.+.+|+..||+.+|++||+++.+++.+..
T Consensus 922 RL---~~P~~CP-------~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 922 RL---DPPSYCP-------EKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred cc---CCCCCCC-------hHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 22 2344444 467789999999999999999999997763
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.61 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=207.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|++..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999999999999999998653 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999988653 468899999999999999999998 89999999999999999999999999999765322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... . ..+...++... +..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~----~~~~i~~~~~~------~p~ 236 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---R----IYEKILAGRLK------FPN 236 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---H----HHHHHhcCCcC------CCC
Confidence 22357899999999999988999999999999999999999999753321 1 11122222211 111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.++ ..+.+++..||+.||++||+ +++++.|.++.
T Consensus 237 ~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~ 275 (329)
T PTZ00263 237 WFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275 (329)
T ss_pred CCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence 122 35667889999999999996 89999998874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=332.45 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=202.1
Q ss_pred CccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCccEEEe
Q 042831 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ---GIKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 340 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
+.++++++ +......||+|++|.||+|.+. |+.||||.++..... ..+.+.+|+.++.+++||||++++|
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 44555555 2233467999999999999984 789999998754322 2577889999999999999999999
Q ss_pred eeee----CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 417 WCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 417 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
++.+ ....++||||+++|+|.+++.+. ..+++.....++.|++.||.|||+. .+++||||||+|||+++++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcE
Confidence 9876 35789999999999999998654 5689999999999999999999972 478899999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~ 570 (645)
||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+...+
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i- 234 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLI- 234 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHH-
Confidence 999999998653221 22457889999999876 67999999999999999999999999854321 112211
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+ . .+.+. ......+.+++.+||+.||++|||++|+++.|+
T Consensus 235 --~~~~-~----~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 235 --INKN-N----SLKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred --HhcC-C----CCCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 1111 1 11111 112345778889999999999999999999886
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.82 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=203.5
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+.||+|+||.||+++...+|+.||+|++... .......+.+|+.++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998753 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeec
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
+|.+++.. ...+++.+...++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccce
Confidence 99988854 4568999999999999999999998 8999999999999999999999999999875322 12223345
Q ss_pred ccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+. ..+.. ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~----~~~~~------~~~p~----~~ 218 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFEL----ILMEE------IRFPR----TL 218 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHH----HHcCC------CCCCC----CC
Confidence 7999999999999999999999999999999999999999753321 11111 11111 11111 12
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 595 IERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
...+.+++.+||+.||++|| ++.++++|.++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~ 255 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 34567788999999999999 899999998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=345.84 Aligned_cols=266 Identities=21% Similarity=0.214 Sum_probs=205.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
..+|...+.||+|+||.||++.+..+++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999999999999999753 23467899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+. ++|..++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 165 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 94 7888877543 468999999999999999999998 899999999999999999999999999997543322233
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc----hhHHHHHHHHhcCC----------
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ----VSLLQWVWDLYGNG---------- 576 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~----~~l~~~~~~~~~~~---------- 576 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+....+..
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 3446799999999999998999999999999999999999988753321110 01111111111000
Q ss_pred cccc---------ccCccccCCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 577 KLLE---------AVDPRLCRDF--DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 ~l~~---------~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+.. ...+...... .......+..++.+||+.||++|||++|++++.++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 0000 0000000000 0012346778899999999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.72 Aligned_cols=272 Identities=24% Similarity=0.303 Sum_probs=215.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ--GIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV 427 (645)
++|+..+.|++|.||.||+|+++.+++.||+|+++..... ---..++||.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4688899999999999999999999999999999755321 123467899999999999999999987643 579999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||||+. +|...+..-...+...+...+..|+++|+.|||. ..|+|||||++|+|+...|.+||+|||+||.+....
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999955 7888887666789999999999999999999999 889999999999999999999999999999886543
Q ss_pred CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC--ccccccC-
Q 042831 508 GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG--KLLEAVD- 583 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--~l~~~~d- 583 (645)
...+..+-|.+|.|||.+.+. .|+++.|+||+||++.||+++++.|.+..+-++ ++.++.+.+-. .+...++
T Consensus 232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ---l~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ---LDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH---HHHHHHHhCCCccccCCCccc
Confidence 334556779999999988775 599999999999999999999999987665443 34444443321 1111000
Q ss_pred --------------ccccCCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC-CCCCC
Q 042831 584 --------------PRLCRDFDGQ-QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE-APLPA 631 (645)
Q Consensus 584 --------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~ 631 (645)
..+.+.|... ..+.-..|....+..||.+|.|++|.|+|-+|. .|+|.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 1112222221 235556677888899999999999999999985 45543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.27 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=203.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcC----------------CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRE----------------TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQL 414 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l 414 (645)
++|...++||+|+||.||++.+.. ++..||+|.+... ......+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999998642 3457999998764 34456789999999999999999999
Q ss_pred EeeeeeCCeEEEEEEecCCCChhhhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeee
Q 042831 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKEN------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476 (645)
Q Consensus 415 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 476 (645)
++++.+.+..++||||+++|+|.+++.... ..+++..+.+++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999885321 247889999999999999999998 89999
Q ss_pred ccCCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc--CCCC
Q 042831 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC--GRKP 553 (645)
Q Consensus 477 ~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt--G~~p 553 (645)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765432221 1122345778999999998899999999999999999986 5677
Q ss_pred CCCCCCCCchhHHHHHHHHhcCCcc-ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 554 INPKAPQGQVSLLQWVWDLYGNGKL-LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 554 f~~~~~~~~~~l~~~~~~~~~~~~l-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
|...... .....+......... .....+. .....+.+++.+||+.||++|||++||.+.|+
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYLFRPP-------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccccccccCCC-------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7654322 223333332221111 1011111 12246788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=336.47 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=213.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
..|+..+.||+|.||.||+|.+..+++.||+|.+..+ .+....++.+|+.++.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577778999999999999999999999999999765 445678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
|.+|++.+.|. .+..+++..+.-|++++..||.|||. ++.+|||||+.|||+..+|.+||+|||++-.+.......
T Consensus 93 ~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999884 34455888888899999999999999 899999999999999999999999999997665444333
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+..-.. -+.+...|.+.+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L~~-- 233 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRLDG-- 233 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcccc--
Confidence 56789999999999998899999999999999999999999998665521111 112223344444
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++..||+.||+.||++.++++|-.
T Consensus 234 --~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 234 --DFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred --ccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 33456778889999999999999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=348.77 Aligned_cols=259 Identities=30% Similarity=0.424 Sum_probs=208.1
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCe---E-EEEEEecc---CChhhHHHHHHHHHHHHhcCCCCccEEEeeee
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNS---Y-IAVKRVSQ---GSKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~---~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~ 419 (645)
++..-++....++||+|+||.||+|++...+. . ||||..+. ..+...++|.+|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34444555567999999999999999875422 3 89999875 34678899999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
.+..+++|||+|.||+|+++|.+....++..++..++.+.|.||+|||+ .+++||||.++|+|++.++.+||+|||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999998877789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCccee-ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 500 ARLVEHAKGSQTT-VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 500 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
++.... ..... ...-...|+|||.+..+.++.++|||||||++||+.+ |..||.+.... .+..++ ..++.
T Consensus 309 s~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI---~~~~~ 380 (474)
T KOG0194|consen 309 SRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKI---VKNGY 380 (474)
T ss_pred ccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHH---HhcCc
Confidence 875431 11111 1124578999999999999999999999999999999 88999765432 111221 01221
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... +...+ ..+..+...|+..+|++||+|.++.+.++.
T Consensus 381 r~~~------~~~~p---~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 381 RMPI------PSKTP---KELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred cCCC------CCCCH---HHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 1111 11223 344455569999999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=325.01 Aligned_cols=252 Identities=28% Similarity=0.482 Sum_probs=203.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||++.+.. +..+|+|.+... ....+++.+|++++++++||||++++++|...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457778899999999999998865 567999987643 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++......+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999987655678999999999999999999998 8999999999999999999999999999876533222222
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|+|||++....++.++||||||+++|||++ |+.||...... ....++ .++.. ...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i----~~~~~--~~~~~~---- 225 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI----SRGFR--LYRPKL---- 225 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCCC--CCCCCC----
Confidence 22345668999999988889999999999999999999 89999754321 222221 11211 111111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
....+.+++.+||+++|++||++.++++.|.
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1246788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=346.38 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=203.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEE-----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~ 423 (645)
.++|...++||+|+||.||+|++ .+++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688899999999999999974 3456789999986442 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC-----------------------------------------------------------
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN----------------------------------------------------------- 444 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 444 (645)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 445 ---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 445 ---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
..+++..+..++.||++||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 247889999999999999999998 89999999999999999999999999999765432211
Q ss_pred c-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 510 Q-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 510 ~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+ ..++... ..+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~--~~~~-- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGYRM--LSPE-- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCccC--CCCC--
Confidence 1 112234567999999999999999999999999999998 88998654322 112221 2222110 0111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ....+.+++.+||++||++||++.|+++.|+.
T Consensus 341 --~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 --C---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --C---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 12357788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.32 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=202.9
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+.||+|+||.||++....+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998753 2345567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeec
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccc
Confidence 99888854 3568999999999999999999998 89999999999999999999999999998753221 1222345
Q ss_pred ccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ....+. ..+....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~----~~~~~~------~~~p~~~---- 218 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMED------IKFPRTL---- 218 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHH----HhccCC------ccCCCCC----
Confidence 7999999999999889999999999999999999999999754321 1111 111111 1111122
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 595 IERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
...+.+++.+||+.||++|| ++.|++++.++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 255 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 23567788999999999997 899999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=325.89 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=206.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|...++||+|++|.||+|.+..+++.||+|.+... ....+++.+|++++.+++|+|+++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4577788999999999999999988999999998654 334578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++++|.+++... ...+++..++.++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998654 3568999999999999999999998 899999999999999999999999999998654332222
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... . .+.....+. .+..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~-----~~~~--- 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q----VYELLEKGY-----RMER--- 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHCCC-----CCCC---
Confidence 222334568999999998899999999999999999998 99998753321 1 122221111 1111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+......+.+++.+|++.+|++||++.++++.|+
T Consensus 227 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 227 -PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1112346778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.29 Aligned_cols=247 Identities=28% Similarity=0.375 Sum_probs=202.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+.||+|+||.||++....+|+.||+|.+... .......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998753 2344567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeec
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccc
Confidence 99888754 3468999999999999999999998 89999999999999999999999999998753221 1222345
Q ss_pred ccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.|++.|+|||++.++.++.++|||||||++|||++|+.||...... .... ....+.. .+...+
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~----~~~~~~~------~~p~~~---- 218 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------RFPRTL---- 218 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCC------CCCCCC----
Confidence 6899999999999999999999999999999999999999754322 1111 1111111 111122
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 595 IERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
...+.+++.+||+.||++|| ++++++++.++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~ 255 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence 24566788899999999998 999999998775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.56 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=202.9
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||+||++.+..+++.+|+|.+.... ....+.+..|++++++++|+|++++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999986532 23345678899999999999999999999999999999999999999
Q ss_pred hhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 437 DSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 437 ~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
..++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 887753 34578999999999999999999998 8999999999999999999999999999976543222 2334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||......... .........+. . .++..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------~--~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRILNDS--------V--TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhcccC--------C--CCccc
Confidence 56899999999999999999999999999999999999999754322111 00111110110 0 11112
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 594 QIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
....+.+++..||+.||++|| +++++++|.++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 334567888999999999999 8899999988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.30 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=209.0
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+|+..++||+|+||.||++....+++.||+|++.... ......+.+|+.++++++|||++++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999999999999998889999999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888654 3568999999999999999999998 899999999999999999999999999997654222
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ..+......+ ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~~ 222 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------QE 222 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------cc
Confidence 223346899999999999888999999999999999999999999854432111 1111111111 01
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
.+.......+.+++..|++.||++|| ++++++++.++..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 11222334677889999999999999 8999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=330.96 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=199.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcC-CCeEEEEEEeccCC--hhhHHHHHHHHHHHHhc---CCCCccEEEeeee-----e
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQGS--KQGIKEYASEVKIISRL---RHRNLVQLLGWCH-----E 420 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~-----~ 420 (645)
++|...+.||+|+||.||+|.+.. ++..||+|.++... ......+.+|+.++.++ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368889999999999999999854 46889999886432 22334566777777766 6999999999985 2
Q ss_pred CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
....++||||++ ++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 6898888653 3568999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC---
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG--- 576 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--- 576 (645)
++..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+.+.....
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 9765432 22334568999999999988889999999999999999999999998654321 222222111100
Q ss_pred ccc-------cccCccccC---CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLL-------EAVDPRLCR---DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... ....+.-.. .........+.+++.+|++.||++|||+.|+++|.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000 000000000 0000112456688999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.75 Aligned_cols=267 Identities=24% Similarity=0.344 Sum_probs=209.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|+..++||+|+||.||++.+..++..+|+|.+... .......+.+|++++.+++|+||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46899999999999999999999989999999988765 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++|+|.+++... ..+++.....++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999998643 458899999999999999999997 247999999999999999999999999998754322
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc--------
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA-------- 581 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~-------- 581 (645)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .........+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL----ELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH----HHHhcCcccCCccccccCcccCC
Confidence 12234689999999999988899999999999999999999999975432111 000000000000000
Q ss_pred -------cCccc-----------------cCCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 582 -------VDPRL-----------------CRDFD-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 582 -------~d~~l-----------------~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..+.- ..... ......+.+++.+||+.||++|||++|++++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 00000 00000 011245678899999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=336.00 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=201.4
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||.||++++..+++.||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998643 334556788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 155 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCG 155 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccC
Confidence 999865 3468999999999999999999998 99999999999999999999999999999754322 122334578
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
|+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... ...+.. .+... ...
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~-~~~~~~------~~~~~----~~~ 218 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRK-ILQEPL------RFPDG----FDR 218 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHH-HHcCCC------CCCCc----CCH
Confidence 99999999999989999999999999999999999999753311 11111 111111 11111 224
Q ss_pred HHHHHHHHcCCCCCCCCC---CHHHHHHHhccCC
Q 042831 597 RLMIVGLWCAHPDENLRP---SIRQVIHVLNFEA 627 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RP---s~~evl~~L~~~~ 627 (645)
.+.+++.+||+.||++|| ++.|++.|.++..
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 566788999999999997 5789999888653
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=339.14 Aligned_cols=258 Identities=24% Similarity=0.309 Sum_probs=209.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||++....+++.||+|+++.. ..+..+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999999999999999998754 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999997766789999999999999999999998 8999999999999999999999999999986654333
Q ss_pred cceeecccCccccCccccc------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 509 SQTTVLAGTMGYMAPECAT------TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~------~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCC
Confidence 3334457899999999986 456789999999999999999999999754321 1111111111111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+ .......+..++..|++ +|++||+++++++|.++.
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~ 267 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS 267 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence 0 00122446677788997 999999999999998875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=329.97 Aligned_cols=248 Identities=32% Similarity=0.562 Sum_probs=195.4
Q ss_pred CCccCcCCcEEEEEEEEc----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 357 DQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+.||.|.||.||+|.+. ..+..|+||.++.. ..+..+++.+|++.+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 568999999999999998 34678999999654 3445789999999999999999999999999888899999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS- 509 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~- 509 (645)
++|+|.++|... ...+++.++..|+.||++||.|||+ .+++|+||+++||++++++.+||+|||+++........
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 999999999876 6789999999999999999999998 89999999999999999999999999999866322211
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
..........|+|||.+....++.++||||||+++|||++ |+.||..... ..+.. ...++.....
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~----~~~~~~~~~~------- 226 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIE----KLKQGQRLPI------- 226 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHH----HHHTTEETTS-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----ccccccccee-------
Confidence 1222446778999999999999999999999999999999 7888865421 11121 1223322111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
+......+..++..||+.||++||+++++++.|
T Consensus 227 --~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 --PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234577888999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.48 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=207.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCC-----eEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETN-----SYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
++|...+.||+|+||.||+|.....+ ..||+|.+.... .....++.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46778899999999999999986544 689999986543 344567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC
Q 042831 426 LVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 490 (645)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 9999999999999986431 458899999999999999999998 8999999999999999999
Q ss_pred cEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH
Q 042831 491 NAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQW 568 (645)
Q Consensus 491 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~ 568 (645)
.+||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999976533221 12233456788999999988899999999999999999998 99999754332 1222
Q ss_pred HHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 569 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+..+.... .+......+.+++.+||+.||++||+++||+++|..
T Consensus 238 ---~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 122222111 112234567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.74 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=213.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
-++|+.++.||+|-||.||.|+.+.++-.||+|++.+. ..+..+++.+|+++-+.|+||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 46788999999999999999999999999999998653 233457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 428 YEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
+||.++|+|...|... ...+++.....++.|+|.||.|+|. ++|+||||||+|+|++.++..||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999753 4568888999999999999999998 999999999999999999999999999986432
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......+||..|++||...+...+...|+|++|++.||++.|.+||+....+ ..... +. -.+..+|
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkr----I~---k~~~~~p-- 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKR----IR---KVDLKFP-- 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHH----HH---HccccCC--
Confidence 33445678999999999999999999999999999999999999999865522 11111 11 1122222
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
........+++..|+..+|.+|.+..|+++|.|-.
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 12234566788999999999999999999998853
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=340.75 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=206.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC-eEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN-SYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+|.+..++ ..||+|++... .....+.+.+|+.++..++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357888999999999999999876554 68999998643 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999998644 468999999999999999999998 89999999999999999999999999999865421
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......+.. .+
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~----~~~~i~~~~~------~~ 247 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L----IYQKILEGII------YF 247 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCC------CC
Confidence 23457899999999999888999999999999999999999999754321 1 1111112211 01
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
....+ ..+..++.+|++.||++|+ +++++++|.++.
T Consensus 248 p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~ 288 (340)
T PTZ00426 248 PKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG 288 (340)
T ss_pred CCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence 11122 3456788999999999995 999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.81 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=207.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|+..+.||+|+||.||+|.+... ...||+|.++.. ......+|.+|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35788899999999999999998643 457999988654 33445688999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++......+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999997766689999999999999999999998 89999999999999999999999999999876522
Q ss_pred CCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.+ ...++... +
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~----~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIK----AVEDGYRL----P 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHH----HHHcCCCC----C
Confidence 221 1122334678999999998899999999999999999998 99998643321 1222 11121111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+.+++.+|++.+|++||+++|++++|..
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 011223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.61 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=200.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
++||+|+||.||+|++..+++.+|+|.+... ..+....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999988999999987654 344567799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce-eecc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT-TVLA 515 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 515 (645)
.+++......+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.......... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99997666678999999999999999999998 8999999999999999999999999999875432211111 1112
Q ss_pred cCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 516 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.+..|+|||.+..+.++.++||||||+++|||++ |..||....... .......+. . ...+...
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~-----~----~~~~~~~ 221 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGV-----R----LPCPELC 221 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCC-----C----CCCcccC
Confidence 3456999999999899999999999999999998 888886433211 111111110 0 1111122
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 595 IERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+.+++.+|++++|++|||+.++++.|.
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 346778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=338.51 Aligned_cols=267 Identities=24% Similarity=0.317 Sum_probs=202.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----CeEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KELL 425 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~~~ 425 (645)
+|...++||+|+||.||+|++..+++.||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477789999999999999999999999999998643 233456788999999999999999999987543 3589
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|||||+ ++|.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 688888754 3468999999999999999999998 8999999999999999999999999999975432
Q ss_pred cCCc--ceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-------
Q 042831 506 AKGS--QTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------- 574 (645)
Q Consensus 506 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------- 574 (645)
.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.+..+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPETI 232 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHHHH
Confidence 2211 1234568999999999866 578999999999999999999999997543211 1111111111
Q ss_pred ----CCccc---cccCccccCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 575 ----NGKLL---EAVDPRLCRDFD---GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 575 ----~~~l~---~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..... ..+.+....... ......+.+++.+||+.||++|||++|++++.++..
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 000000000000 001234678889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.43 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=200.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||+|+||.||++....+++.||+|+++.. .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999999999999999998653 2334467888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+. ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999998653 568999999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCC
Q 042831 509 ----------------------------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPI 554 (645)
Q Consensus 509 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf 554 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999989999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHhccC
Q 042831 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLW--CAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 555 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... .....+ ......-.+.+.. ..+. +. .+++.+ |...++..||+++|+++|.++.
T Consensus 237 ~~~~~~---~~~~~i----~~~~~~~~~p~~~--~~s~-~~---~~li~~l~~~~~~r~~r~~~~ei~~hp~f~ 297 (363)
T cd05628 237 CSETPQ---ETYKKV----MNWKETLIFPPEV--PISE-KA---KDLILRFCCEWEHRIGAPGVEEIKTNPFFE 297 (363)
T ss_pred CCCCHH---HHHHHH----HcCcCcccCCCcC--CCCH-HH---HHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence 754422 111111 1111000111111 1222 22 223333 4333445679999999998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.46 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=209.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|++..+++.||+|++... .......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688899999999999999999989999999998653 2244567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC-
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK- 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~- 507 (645)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998655 678999999999999999999999 999999999999999999999999999998654332
Q ss_pred ---------------------------CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 042831 508 ---------------------------GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ 560 (645)
Q Consensus 508 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~ 560 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223356899999999999999999999999999999999999999754421
Q ss_pred CchhHHHHHHHHhc-CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHhccC
Q 042831 561 GQVSLLQWVWDLYG-NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS-IRQVIHVLNFE 626 (645)
Q Consensus 561 ~~~~l~~~~~~~~~-~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~~ 626 (645)
. . ...... ...+. -+. ... ....+..++..|++ ||++||+ +++++++.++.
T Consensus 237 ~---~---~~~i~~~~~~~~---~p~-~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~ 289 (350)
T cd05573 237 E---T---YNKIINWKESLR---FPP-DPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289 (350)
T ss_pred H---H---HHHHhccCCccc---CCC-CCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence 1 1 111111 01110 010 011 23456677788997 9999999 99999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=327.77 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=207.0
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------------hhHHHHHHHHHHHHhcCCCCccE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------------QGIKEYASEVKIISRLRHRNLVQ 413 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~nlv~ 413 (645)
...-++|+..+.||+|.||.|-+|+...+++.||||++.+... ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3445789999999999999999999999999999999864311 12357889999999999999999
Q ss_pred EEeeeeeC--CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 414 LLGWCHEK--KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 414 l~~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
|+++..+. +.+|||+|||..|.+...= ..+..+++.+.+++++++..||.|||. ++||||||||+|+||+++|.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 99998764 6899999999998875432 122338999999999999999999999 99999999999999999999
Q ss_pred EEEeeccCcccccccC----CcceeecccCccccCccccccCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 492 AKIGDFGLARLVEHAK----GSQTTVLAGTMGYMAPECATTGK----ASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
+||+|||.+.....+. .......+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-.... .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---~ 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---L 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---H
Confidence 9999999998663321 12233468999999999887743 46789999999999999999999974321 1
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ..+.+.+ ..+.-....++.+.+..|++++|++||++|.+..+|..|+|-
T Consensus 326 ~----l~~KIvn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 326 E----LFDKIVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred H----HHHHHhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 1 1222222 222111122455677888999999999999999999999984
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.69 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=203.2
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
...++|...+.||+|+||.||+|+.... +..||+|++.... ......+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3445788899999999999999986433 3579999997543 33456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC---------------------------------------------------------
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN--------------------------------------------------------- 444 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 444 (645)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc-e
Q 042831 445 ------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ-T 511 (645)
Q Consensus 445 ------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~-~ 511 (645)
..+++..+.+++.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 247888999999999999999998 899999999999999999999999999997654322111 1
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... .. ......+. .+.....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~----~~~~~~~~-----~~~~~~~- 339 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KF----YKMVKRGY-----QMSRPDF- 339 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HH----HHHHHccc-----CccCCCC-
Confidence 12234567999999998899999999999999999997 999997543221 11 11111110 1111011
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+.+++.+||+.||++||++.++++.|+.
T Consensus 340 ---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 340 ---APPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 12457788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=321.88 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=214.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..+|++.+.||+|.||+|-+++....|+.||||.++++ ++++.-.+.+|+++|+.|+||||++++++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35677888999999999999999888999999988765 456677788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||..+|.|++|+.+ .+.|++...+++++||.+|+.|+|. .+++|||||.+|||||.|+++||+|||++.++...
T Consensus 132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999954 4579999999999999999999998 99999999999999999999999999999877543
Q ss_pred CcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
...+.++|.+-|.+||++.+.+| .+..|-|||||+||-|+.|..||++.+. ..++. .+..|...+.-
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr----QIs~GaYrEP~---- 274 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR----QISRGAYREPE---- 274 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH----HhhcccccCCC----
Confidence 34556899999999999999886 6889999999999999999999986442 22332 22233332221
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
......-|++|+|..+|++|-|+++|..|.|-
T Consensus 275 -------~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 275 -------TPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred -------CCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 12244568899999999999999999999984
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=321.69 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=209.9
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
|++.+++++.....||+|+||.||+|++..++..|++|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556777777889999999999999998889999999988776667788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLL--TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARL 502 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~ 502 (645)
+|+||+++++|.+++......+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999997654445 888899999999999999998 89999999999999976 67999999999875
Q ss_pred ccccCCcceeecccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
..... .......++..|+|||++.... ++.++||||||+++|||++|+.||........ ..+..... .
T Consensus 159 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~---~--- 228 (268)
T cd06624 159 LAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF---K--- 228 (268)
T ss_pred cccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh---c---
Confidence 53222 2223345788999999986654 78999999999999999999999964322111 01100000 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+ +....+.+..++.+|++.+|++|||+.|++++.+
T Consensus 229 -~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 229 -IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred -cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 01111 1222345778889999999999999999999866
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=323.34 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=210.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
...+|...++||+|+||.||+|.+.. +..+++|.+.........++.+|+.++.+++|+|++++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44578889999999999999999987 88899999987766567789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++++|.+++... ...+++.++..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999753 4568999999999999999999998 8999999999999999999999999999976543221
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
. .....++..|+|||.+..+.++.++||||||++++||++ |+.||...... ....... .+.. .
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~-----~--- 223 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT----AGYR-----M--- 223 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH----hCCc-----C---
Confidence 1 123345678999999988889999999999999999998 89999754321 2222211 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+....+.+.+++.+|++.||++|||++++++.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111233567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.15 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=204.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
..+|+..+.||+|+||.||+|++..++. .||+|.+... .....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3568889999999999999999865554 4899998654 344567899999999999999999999999765 567
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+++|+|.+++.+....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 9999999999999998777779999999999999999999998 8999999999999999999999999999987653
Q ss_pred cCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+ ......+... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~--~~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI----SSILEKGERL--PQ 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHhCCCCC--CC
Confidence 32221 112234668999999999999999999999999999997 99999753321 11 1111121111 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+ .. ....+..++.+||+.+|++||++.+++..+...
T Consensus 233 ~---~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 233 P---PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred C---CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 11 123567888999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.34 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=205.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccC----ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~ 424 (645)
+|+..+.||+|+||.||+++.. .+++.||+|.+... .....+.+..|++++.+++ |+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999874 46889999998643 2233456788999999995 89999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999988643 468999999999999999999998 899999999999999999999999999998654
Q ss_pred ccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
...........||..|+|||++.+. .++.++|||||||++|||++|+.||.......... .+...... .+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~------~~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILK------CD 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhc------CC
Confidence 4333334456799999999998765 47899999999999999999999997543322211 11111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
+.+.... ...+.+++.+||+.||++|| ++++++++.++.
T Consensus 228 ~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 228 PPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred CCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 2222222 23566788999999999999 888999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=318.01 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=208.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|++|.||+|....+++.|++|.+... .......+.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999999989999999998643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999764 5678999999999999999999998 8999999999999999999999999999886543322
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......++..|+|||++.+..++.++|+||||++++||++|+.||..... ...... ..++.. + .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~----~~~~~~-----~----~ 220 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILK----IIRGVF-----P----P 220 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCC-----C----C
Confidence 22334678899999999998999999999999999999999999975432 111111 111111 1 1
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
........+.+++.+|++.+|++||++.+++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~ 254 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence 1112335678889999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=318.87 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=206.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|...+.||+|++|.||++....+++.+|+|.+.... ....+.+.+|++++.+++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999998889999999886432 2234678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999988543 468899999999999999999998 89999999999999999999999999998765432
Q ss_pred CCcce--eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGSQT--TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....... . .+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~~~~~-~----~~ 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAI---FKIATQP-T----NP 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHH---HHHhccC-C----CC
Confidence 21111 2345778999999999988999999999999999999999999743221 111 1111111 0 11
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+ +......+..++..||+.+|++|||+++++++.++
T Consensus 227 ~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 11 11223456778899999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.17 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=201.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|...+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++.+++|+||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999999999999999998653 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG- 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~- 508 (645)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998653 468899999999999999999998 8999999999999999999999999999764311000
Q ss_pred ---------------------------------------------cceeecccCccccCccccccCCCCcchhHHHHHHH
Q 042831 509 ---------------------------------------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIV 543 (645)
Q Consensus 509 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvl 543 (645)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999998889999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHH
Q 042831 544 ALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLW--CAHPDENLRPSIRQVIH 621 (645)
Q Consensus 544 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~ 621 (645)
+|||++|+.||......+. .. .......... +.+ ...++. .+.+++.+ |+.++|..||+++|+++
T Consensus 238 l~elltG~~Pf~~~~~~~~---~~---~i~~~~~~~~-~~~--~~~~s~----~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET---QL---KVINWENTLH-IPP--QVKLSP----EAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH---HH---HHHccccccC-CCC--CCCCCH----HHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999975443211 11 1110000000 011 011222 23334433 67777888999999999
Q ss_pred HhccC
Q 042831 622 VLNFE 626 (645)
Q Consensus 622 ~L~~~ 626 (645)
|.++.
T Consensus 305 hp~f~ 309 (381)
T cd05626 305 HPFFS 309 (381)
T ss_pred CcccC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.35 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.8
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCC-CccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHR-NLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~-nlv~l~~~~~~~~~~~lV~ 428 (645)
+|...+.||+|+||.||+|+...+++.||+|++... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999999999999999998753 234456788899999999765 5888999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-G 155 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-C
Confidence 999999999888543 468999999999999999999998 89999999999999999999999999998643221 2
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ .+.. ..+..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i----~~~~------~~~~~ 222 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI----MEHN------VSYPK 222 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----HcCC------CCCCC
Confidence 2234457999999999999999999999999999999999999999754321 112111 1111 11111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSI-----RQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~~ 626 (645)
. ....+.+++.+||+.||++||+. ++++++.++.
T Consensus 223 ~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~ 261 (324)
T cd05587 223 S----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261 (324)
T ss_pred C----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcC
Confidence 1 22456778899999999999976 8898887764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.31 Aligned_cols=272 Identities=21% Similarity=0.309 Sum_probs=208.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...++||+|+||.||+|+...+++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999999889999999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++ +|.+++...+..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 974 8888887666678999999999999999999998 8999999999999999999999999999875432221 1
Q ss_pred eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------HHHhcCC-cccc
Q 042831 511 TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV--------WDLYGNG-KLLE 580 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~-~l~~ 580 (645)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+........ |...... ....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223457889999998865 45899999999999999999999999765433221111110 1000000 0000
Q ss_pred ccCccccCC----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 581 AVDPRLCRD----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 581 ~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.-.+..... ........+.+++.+|++.||++|||++|++++.++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000000000 000112356788899999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.03 Aligned_cols=254 Identities=21% Similarity=0.332 Sum_probs=203.8
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||++++..+++.||+|.+... .....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998753 334456678899988877 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTST 155 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccc
Confidence 999888754 3568999999999999999999998 89999999999999999999999999998753221 222334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC--chhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG--QVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
..||..|+|||++.+..++.++|||||||++|||++|+.||....... ......++......+.. .+ +
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~----p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI----P 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC----C
Confidence 678999999999999999999999999999999999999996322111 11222333333322211 11 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPS------IRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L~~~ 626 (645)
......+..++.+||+.||++||+ +.++++|.++.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~ 266 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 112345667889999999999998 68999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.45 Aligned_cols=254 Identities=30% Similarity=0.444 Sum_probs=205.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|+..+.||+|++|.||+|.+.. ++.||+|.++... ...+++.+|++++++++|+|++++++++...+..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34668889999999999999999765 5789999986543 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999998654 3578999999999999999999998 8999999999999999999999999999987653222
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
........+..|+|||++.+..++.++||||||++++||++ |+.||...... .+.. ....+..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~--------- 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGYR--------- 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC---------
Confidence 11111223457999999998899999999999999999999 99999643321 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+......+.+++.+|++.+|++||++.++++.|+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 0111123356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.03 Aligned_cols=263 Identities=30% Similarity=0.410 Sum_probs=201.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCccEEEeeeeeCC----eEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR--LRHRNLVQLLGWCHEKK----ELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nlv~l~~~~~~~~----~~~l 426 (645)
.....+++|+|+||.||||.+. ++.||||++.. +..+.|.+|-++.+. ++|+||+++++.-.... +++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4455788999999999999997 58999999864 445677888777765 58999999999877655 8999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc------CCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW------EQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
|+||.++|+|.++|.. ..++|....+|+.-+++||+|||++. +++|+|||||++|||+..++.+.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999999954 57899999999999999999999864 567999999999999999999999999999
Q ss_pred ccccccCCc-ceeecccCccccCccccccCC------CCcchhHHHHHHHHHHHHcCCCCCCCCC-CCCch---------
Q 042831 501 RLVEHAKGS-QTTVLAGTMGYMAPECATTGK------ASKESDVYSFGIVALEIACGRKPINPKA-PQGQV--------- 563 (645)
Q Consensus 501 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~elltG~~pf~~~~-~~~~~--------- 563 (645)
..+...... .+...+||.+|||||++.+.. .-.+.||||+|.+||||++...-+.... ++-+.
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 988754432 334478999999999986532 2347899999999999998765543211 11111
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
--++-++++.-..+....+....... ..+..+.+.+..||..||+.|-|+.=|-+.++.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 11223333332223222222222222 346778888999999999999999888777764
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.04 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=205.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||++.+..+++.||+|.++.. .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999753 233456688999999998 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence 9998887543 568999999999999999999998 8999999999999999999999999999874321 1222334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC--chhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG--QVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~--~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
..||..|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++......++.. .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~- 228 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRSL- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCCC-
Confidence 578999999999999899999999999999999999999997432211 11222333333322221 111112
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPS------IRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L~~~ 626 (645)
...+..++..||+.||++||+ ++++++|.++.
T Consensus 229 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 229 ---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 235677889999999999987 89999998875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.97 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=208.4
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
+....++|...++||+|+||.||+++...+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 334567899999999999999999999999999999998643 22344567889999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++|+|.+++.. ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999998854 357888899999999999999998 89999999999999999999999999999865
Q ss_pred cccCCcceeecccCccccCccccccC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTG----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
............||+.|+|||++... .++.++|||||||++|||++|+.||...... .... ....+.-.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~----~i~~~~~~ 265 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYS----KIMDHKNS 265 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHH----HHHcCCCc
Confidence 43322233345799999999988653 4789999999999999999999999754321 1111 11111100
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~ 626 (645)
-.. + . .......+.+++..||+.+|++ ||++.|+++|.++.
T Consensus 266 ~~~-~---~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 266 LTF-P---D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred CCC-C---C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 000 0 0 0012345667889999999987 99999999998864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=320.41 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=203.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||+|.+.+ +..+|+|.+.... ....++.+|+.++.+++||||++++++|......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 457778899999999999998865 4569999886443 23467899999999999999999999999988999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++......+++.+++.++.||+.||.|||+ .+++|+||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999997655678999999999999999999998 8999999999999999999999999999876543222222
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|++||.+....++.++|||||||++|||++ |+.||...... .... ...++.... .+ .
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~--~~---~-- 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE----KVSQGLRLY--RP---H-- 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHhcCCCCC--CC---C--
Confidence 22345678999999988889999999999999999998 99998744321 1111 111221110 01 1
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++.+||+++|++||++.++++.|+
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 --LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12356788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.85 Aligned_cols=267 Identities=24% Similarity=0.321 Sum_probs=206.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-----eEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-----ELL 425 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-----~~~ 425 (645)
+|+..++||+|+||.||++.+..+++.||+|++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999999888999999998643 3345578889999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 577777643 4568999999999999999999998 8999999999999999999999999999986543
Q ss_pred cCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc-----
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL----- 579 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~----- 579 (645)
..........++..|+|||++.+. .++.++|||||||++|||++|+.||.......+. +.+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLITDLLGTPSLEAMRSA 232 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHHHh
Confidence 333333344678999999998764 4789999999999999999999999765432221 1111111110000
Q ss_pred ----------cccC-cccc--CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 ----------EAVD-PRLC--RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 ----------~~~d-~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.... +... ........+.+.+++.+||+.||++|||+.|++++.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0000 0000 0011112356778899999999999999999999988653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.03 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=204.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||++++..+++.||||++... .......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999999999999999998643 2344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999998654 468999999999999999999998 8999999999999999999999999999875432110
Q ss_pred c-------------------------------------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCC
Q 042831 509 S-------------------------------------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551 (645)
Q Consensus 509 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~ 551 (645)
. ......||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011235899999999999989999999999999999999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHhccC
Q 042831 552 KPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS---IRQVIHVLNFE 626 (645)
Q Consensus 552 ~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L~~~ 626 (645)
.||...... ..... .. +..-.-.+... ... ...+.+++..|+. +|.+|++ ++|+++|.++.
T Consensus 237 ~Pf~~~~~~---~~~~~---i~-~~~~~~~~~~~--~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 237 PPFCSDNPQ---ETYRK---II-NWKETLQFPDE--VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred CCCCCCCHH---HHHHH---HH-cCCCccCCCCC--CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999754321 11111 11 11000000110 011 2345566677886 9999998 99999998864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.28 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=196.7
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|.+.++++.||+|.++.. .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998753 223344566677777654 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999888543 468999999999999999999998 899999999999999999999999999997543222 23344
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .. .... .+.+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~---~~-i~~~------~~~~~~~---- 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF---DS-ILND------RPHFPRW---- 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH---HH-HHcC------CCCCCCC----
Confidence 57899999999999888999999999999999999999999754321 111 11 1111 1111111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHH-HHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIR-QVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~~ 626 (645)
....+.+++.+||+.||++||++. +++++.++.
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccC
Confidence 223456788899999999999875 777776653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=320.00 Aligned_cols=253 Identities=25% Similarity=0.479 Sum_probs=205.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|+..++||+|++|.||+|...+ +..||+|.+.... ...+.+.+|+.++.+++|+|++++++.+...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4578889999999999999999764 5679999876433 3457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999998653 4578999999999999999999998 89999999999999999999999999999866433222
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||++..+.++.++|||||||++|||++ |+.||...... ....++ .++... +. ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~~-~~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----QRGYRM----PR-ME 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----HcCCCC----CC-CC
Confidence 2222345678999999988889999999999999999998 99999753321 122211 111110 11 11
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
. ....+.+++.+|++.+|++||+++++.+.|+
T Consensus 228 ~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 228 N----CPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 1 2245778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.81 Aligned_cols=264 Identities=20% Similarity=0.273 Sum_probs=206.7
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
++....++|+..+.||+|+||.||++++..+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 4445567899999999999999999999999999999998642 2233456789999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||+++|+|.+++.. ..+++.....++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999998854 357899999999999999999998 8999999999999999999999999999986
Q ss_pred ccccCCcceeecccCccccCccccccC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTG----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
.............||+.|+|||++... .++.++|||||||++|||++|+.||...... ... .........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~---~~i~~~~~~ 265 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTY---SKIMDHKNS 265 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCcc
Confidence 643332233456799999999998654 3788999999999999999999999754321 111 111111100
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccCC
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFEA 627 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~~ 627 (645)
... . . .......+..++..|+..++.+ ||++.|+++|.++..
T Consensus 266 ~~~-p----~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 266 LNF-P----E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cCC-C----C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 000 0 0 0112234556667788755543 899999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=347.99 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=205.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCC-CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRET-NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.|...+.||+|++|.||+|....+ ++.||+|.+..........+.+|+.+++.++||||++++++|..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 377889999999999999998776 7889999876665566667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 432 PNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 432 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
++|+|.+++.+ ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998864 24468899999999999999999998 8999999999999999999999999999986543222
Q ss_pred -cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 -SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||++|+|||++.+..++.++|||||||++|||++|+.||..... ..+... ...+... + .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~----~~~~~~~----~-~- 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQ----VLYGKYD----P-F- 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCCC----C-C-
Confidence 123345699999999999999999999999999999999999999974332 111111 1111111 1 0
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
+......+.+++..||+.||++||++++++.+
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11122457788899999999999999999865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.72 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=201.9
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+.||+|+||.||++....+++.||+|.+... .......+..|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998753 2334567788999999999999999999999999999999999999
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeec
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
+|..++.. ...+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~ 156 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTF 156 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccccc
Confidence 99888754 3468999999999999999999996 268999999999999999999999999998743221 1222345
Q ss_pred ccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ....+. ..+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~----~i~~~~------~~~p~~~---- 219 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEE------IRFPRTL---- 219 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHH----HHhcCC------CCCCCCC----
Confidence 6999999999999999999999999999999999999999754321 1111 111111 1111112
Q ss_pred HHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 595 IERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
...+.+++.+||+.||++|+ +++++++|.++.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~ 256 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence 23566788999999999996 999999998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=333.00 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=200.6
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHH---HhcCCCCccEEEeeeeeCCeEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKII---SRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l---~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
|...+.||+|+||.||+|.+..+++.||||+++.. .....+.+.+|+.++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 55678999999999999999999999999998643 223345566666655 566899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|..++.. ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 999999999888743 468999999999999999999998 89999999999999999999999999998743221
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .... . ...+.. ...
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~---~-i~~~~~------~~p 221 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFD---S-IVNDEV------RYP 221 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCC------CCC
Confidence 22233467899999999999989999999999999999999999999754321 1111 1 111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
... ...+.+++.+||+.||++|| ++.+++++.++.
T Consensus 222 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~ 261 (324)
T cd05589 222 RFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261 (324)
T ss_pred CCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence 112 24567788999999999999 689999988764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.70 Aligned_cols=262 Identities=27% Similarity=0.401 Sum_probs=203.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~~ 425 (645)
.+|...+.||+|+||.||++.. ..++..||+|.+........+.+.+|++++.+++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999985 34678999999987777777889999999999999999999998754 34689
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+++++|.+++.+....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 9999999999999997666679999999999999999999998 8999999999999999999999999999986543
Q ss_pred cCCcce--eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc---------hhHHHHHHHHhc
Q 042831 506 AKGSQT--TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ---------VSLLQWVWDLYG 574 (645)
Q Consensus 506 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~---------~~l~~~~~~~~~ 574 (645)
...... ....++..|+|||++.+..++.++|||||||+++||++|..++........ ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 222111 112234569999999888899999999999999999998877543221000 000001111111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+. ...........+.+++.+||+++|++|||++|+++.|+.
T Consensus 241 ~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 241 NNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 110 001111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.05 Aligned_cols=255 Identities=24% Similarity=0.393 Sum_probs=211.6
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCe
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKE 423 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~ 423 (645)
....++|...++||+|.||+|+++..+.+++.+|||.++++ .+...+..+.|..++.... ||.|++++.+++.+++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 44557899999999999999999999999999999999876 3456677888888888775 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+++||||+.||++..+ ++...+++....-++..|+.||.|||+ ++||+||||.+|||||.+|.+||+||||++..
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999994333 355789999999999999999999999 99999999999999999999999999999854
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
- ..+..+..++||+.|||||++.+..|+.+.|.|||||+||||+.|+.||..+++++. .+ -+.. .|
T Consensus 519 m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---Fd----sI~~------d~ 584 (694)
T KOG0694|consen 519 M-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---FD----SIVN------DE 584 (694)
T ss_pred C-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH----HHhc------CC
Confidence 3 234467779999999999999999999999999999999999999999987654422 11 1111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSI-----RQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~ 625 (645)
+. ++.-...+.+.++.+++..+|++|--+ .+|.+|.-|
T Consensus 585 ~~----yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF 627 (694)
T KOG0694|consen 585 VR----YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFF 627 (694)
T ss_pred CC----CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence 22 222233455667788999999999854 677777665
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=318.12 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=201.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|+..+.||+|+||.||+|.+.. +..+|+|.+.... ....++.+|++++.+++|+|++++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 357778999999999999998864 5679999886432 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999997666678999999999999999999998 8999999999999999999999999999876532211111
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ...+. ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----~~~~~-----~~~~---- 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVES----VSAGY-----RLYR---- 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHH----HHcCC-----cCCC----
Confidence 11223457999999998899999999999999999999 89999754322 11111 11110 1111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
+......+.+++.+|++.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111234678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.13 Aligned_cols=197 Identities=30% Similarity=0.453 Sum_probs=166.5
Q ss_pred CCCeEEe-ecccCC-CCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCC
Q 042831 47 DDNITYE-RAYPDS-NRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGS 123 (645)
Q Consensus 47 ~~~~~~~-~a~~~~-~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~ 123 (645)
..++.++ ||.+.. ++.|+||+ ..+++|+++|++||++| ++|+|+|+|.|.... ..+||||||+|+|.+.
T Consensus 13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~-------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~ 84 (223)
T cd01951 13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS-------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPA 84 (223)
T ss_pred hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc-------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCC
Confidence 4578888 999854 89999999 67799999999999998 789999999999865 5679999999999875
Q ss_pred CCCCCCCC--CcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCccc-------ceeeecccCCCCce
Q 042831 124 KIPTNKGG--GSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSK-------KNVSWWSDVKSGRR 192 (645)
Q Consensus 124 ~~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~-------~~~~~~~~~~~g~~ 192 (645)
. +.+.+| ++||.. ..++.+|||||||+|. +||+.||||||+|+..+. .+..++....+|+.
T Consensus 85 ~-~~~~~g~~~~lG~~-------~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~~~~~~~~g~~ 156 (223)
T cd01951 85 G-ALGGGGGGGGLGYG-------GIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNE 156 (223)
T ss_pred C-ccccCCCCCccCcc-------ccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceeeCCCccCCCCE
Confidence 4 344444 778853 3456799999999997 599999999999998753 33344333334999
Q ss_pred eEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccC
Q 042831 193 NEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261 (645)
Q Consensus 193 ~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~ 261 (645)
++|||+||+.+++|+|+|.+... |..++++.++||+..++++|||||+||||...+.|.|++|+|+.
T Consensus 157 ~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~ 223 (223)
T cd01951 157 HTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223 (223)
T ss_pred EEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence 99999999999999999987654 66789999999999999999999999999999999999999963
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.84 Aligned_cols=263 Identities=23% Similarity=0.268 Sum_probs=213.5
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----C
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----K 422 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~ 422 (645)
....++|.+.++||+|||..||+++...++..+|+|++...+.++.+..++|++..++++||||+++++++..+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34456788999999999999999998889999999999888888889999999999999999999999987543 3
Q ss_pred eEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 423 ELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
..||+++|+..|+|.+.+.. .+..+++.+.+.|+.+|.+||.+||+. ..+++||||||.|||+.+.+.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999998864 456899999999999999999999982 33599999999999999999999999999
Q ss_pred cccccccCCcc--------eeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH
Q 042831 500 ARLVEHAKGSQ--------TTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW 568 (645)
Q Consensus 500 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~ 568 (645)
+....-..... ......|..|.|||.+. +...++++|||||||+||+|+.|..||+...+.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------- 247 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------- 247 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------
Confidence 87553211111 11234688999999874 456899999999999999999999999743321
Q ss_pred HHHHhcCCcccccc-CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 569 VWDLYGNGKLLEAV-DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 569 ~~~~~~~~~l~~~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.|.+.-++ .+.+.-.-+....+.+.+++.+|+++||.+||++.+++..++.
T Consensus 248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 22332222 2233222222356789999999999999999999999998763
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=322.88 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=204.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
.+++|...+.||+|++|.||+|.+.. ++..|++|.+.... ......+..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678889999999999999999976 67889999886543 3445679999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEE
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKI 494 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl 494 (645)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999986543 258999999999999999999998 8999999999999998654 5999
Q ss_pred eeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHH
Q 042831 495 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
+|||+++......... ......+..|+|||++.++.++.++|||||||++|||++ |+.||...... .+.+.+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~--- 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV--- 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 9999998653221111 112233567999999998999999999999999999997 99999754332 111111
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...... ..+......+.+++.+|++.+|++||++.+|+++|.
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 111112346778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.48 Aligned_cols=255 Identities=27% Similarity=0.358 Sum_probs=204.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...++||+|+||.||+|++..+++.||+|.+... .....+++.+|++++.+++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577788999999999999999888999999998655 334456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|..+. .+++.....++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999996542 46888999999999999999998 99999999999999999999999999999755322 2
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV-SLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||++.+..++.++||||||+++|||++|+.||......... ....+ ....... ..+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDE-----DPPVLPV- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhcc-----CCCCCCC-
Confidence 23356889999999999888999999999999999999999999753322111 01111 1111111 0111111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+.+++.+|++.+|++||+++|++++.+..
T Consensus 223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~ 257 (279)
T cd06619 223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIV 257 (279)
T ss_pred --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccc
Confidence 11224567888999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.41 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=203.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|...+.||+|+||.||+|.+..+++ .+++|.+.... .....++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467778999999999999999876665 47888775443 3345678889999999999999999998864 55788
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
++||+++|+|.+++......+++..+..++.||+.||.|||+ ++++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999998777789999999999999999999998 89999999999999999999999999999865432
Q ss_pred CCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...... .+. +...++... ..+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~--~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVP----DLLEKGERL--AQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCcC--CCC
Confidence 221 2233456778999999998899999999999999999998 99999754322 111 112222211 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. . ...+..++.+|++.+|++|||+.|+++.|..-
T Consensus 234 ~~---~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 234 QI---C----TIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CC---C----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 1 13456678899999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=331.31 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=200.0
Q ss_pred CccCcCCcEEEEEEEEc---CCCeEEEEEEeccC----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 358 QKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++||+|+||.||+++.. .+++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 46789999998643 223345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTV 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCc
Confidence 9999999988543 467888899999999999999998 89999999999999999999999999998743222 122
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ... .....+.. .+. ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~----~~~~~~~~--~~~----~~- 222 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTI----DKILKGKL--NLP----PY- 222 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCC--CCC----CC-
Confidence 33457899999999999888999999999999999999999999754321 111 11112211 111 11
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
....+.+++.+|++.||++|| ++++++++.++.
T Consensus 223 ---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~ 260 (323)
T cd05584 223 ---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260 (323)
T ss_pred ---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence 124567888999999999999 899999998764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=331.13 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=199.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|.+..+|+.||+|.++... ....+.+..|..++..+ +|||++++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987532 23445667788888764 899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.. ...+++.+...++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 999988854 3568999999999999999999998 89999999999999999999999999998743221 122344
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... .+. +....+ .+.+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~------~~~~~~~~--- 219 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVD------TPHYPRWI--- 219 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhC------CCCCCCCC---
Confidence 67899999999999999999999999999999999999999754321 111 111111 11111111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH-HHHHHHhccCC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI-RQVIHVLNFEA 627 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~-~evl~~L~~~~ 627 (645)
...+.+++.+||+.||++||++ .++++|.++..
T Consensus 220 -~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 220 -TKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -CHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 2356678899999999999998 57887887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.52 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=201.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
++||+|+||.||+|++..+++.||+|.+... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998753 233456677899998876 799999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 9999888543 568999999999999999999998 899999999999999999999999999987533221 22334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+.. ..+. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~----i~~~~~---~~p~---~~--- 219 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFES----ILHDDV---LYPV---WL--- 219 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCC---CCCC---CC---
Confidence 56899999999999889999999999999999999999999754421 11111 111111 0111 11
Q ss_pred HHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRP-------SIRQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~L~~~ 626 (645)
...+.+++..||+.||++|| ++++++++.++.
T Consensus 220 -~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~ 258 (321)
T cd05591 220 -SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258 (321)
T ss_pred -CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccC
Confidence 23566788999999999999 999999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=331.42 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=201.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|++..+++.||+|++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998643 233456777899988876 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccc
Confidence 9999888544 468999999999999999999998 89999999999999999999999999998753221 122334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....++... .+ ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~----~~i~~~~~~---~~---~~---- 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLF----EAILNDEVV---YP---TW---- 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCCC---CC---CC----
Confidence 57899999999999888999999999999999999999999754321 111 111122110 11 11
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH------HHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI------RQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~~ 626 (645)
....+.+++.+||+.||++||++ +++++|.++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 12356778899999999999998 8999998874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=321.51 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=203.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
..++|+..+.||+|+||.||+|.+.+ ++..||+|++.... .....++.+|+.++.+++|+||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 56789999999999999999998652 35679999886432 3445678999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEE
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN---------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl 494 (645)
.++||||+++++|.+++.+.. ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986422 246788999999999999999998 89999999999999999999999
Q ss_pred eeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHH
Q 042831 495 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
+|||+++......... .....++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 9999987553322211 112345678999999998889999999999999999999 78888654321 1111 1
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..++.... . +......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11221111 1 1112346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.70 Aligned_cols=256 Identities=26% Similarity=0.469 Sum_probs=206.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCe---EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|+..+.||+|+||.||+|++..++. .+++|.+... .....+++.+|++++.+++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4577888999999999999999875543 7999998755 34456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++......+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 999999999999997766789999999999999999999998 89999999999999999999999999999765433
Q ss_pred CCccee--ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGSQTT--VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
...... ....+..|+|||++....++.++|||||||++|||++ |+.||...... .+.. ...++.. .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~~----~i~~~~~----~ 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVMK----AINDGFR----L 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHH----HHhcCCC----C
Confidence 222111 1223457999999988889999999999999999997 99999643321 1111 1111110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+ ...+....+.+++.+|++.+|++||++.+|++.|..
T Consensus 230 ~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1 111223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.64 Aligned_cols=268 Identities=20% Similarity=0.258 Sum_probs=210.5
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
..+.++....++|...+.||+|+||.||++++..+++.+|+|.+... .....+.+.+|+.++..++||||+++++++
T Consensus 33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566777789999999999999999999999999999999998642 223445678899999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
.+++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999998854 357888999999999999999998 999999999999999999999999999
Q ss_pred CcccccccCCcceeecccCccccCccccccC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATTG----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||...... ........
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHc
Confidence 9986643332233456799999999998653 3789999999999999999999999754321 11111111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccCC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFEA 627 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~~ 627 (645)
........+. . .....+..++..|+..++.+ ||+++|+++|+++..
T Consensus 262 ~~~~~~~~~~---~----~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 262 HKNSLTFPDD---N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred CCCcccCCCc---C----CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 1111111110 1 12345566778899744433 789999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.71 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=205.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||+|+...+++.||+|++..........+.+|+.++.+++|||++++++++..++..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888999999999999999998889999999987655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 89 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 99999998854 3468999999999999999999998 8999999999999999999999999999986543221 12
Q ss_pred eecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 512 TVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....++..|+|||.+. ...++.++|||||||+++||++|+.||....+...... ...... ..+....
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~---~~~~~~~ 233 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSNF---QPPKLKD 233 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCCC---CCCCCcc
Confidence 2346788999999874 34578899999999999999999999864332111000 000110 0111110
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.......+.+++.+||+.+|++||++++++++|+
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 1122356778899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=323.31 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=206.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...+.||+|+||.||++... .++..+|+|.+........+.+.+|++++.+++|||++++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357888999999999999999852 345679999987766666788999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 426 LVYEFMPNGSLDSHLFKEN------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
+||||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999886432 258999999999999999999998 8999999999999999999999
Q ss_pred EeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH
Q 042831 494 IGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 494 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~ 571 (645)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |+.||...... ... .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~----~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI----E 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----H
Confidence 999999975532221 11122335678999999998889999999999999999998 89998644321 111 1
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+.... ....+ ...+.+++.+|+++||.+|||++++++.|+.
T Consensus 234 ~i~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 234 CITQGRVLQ-----RPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred HHHcCCcCC-----CCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 222222211 11112 2457889999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.98 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=207.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...+.||+|+||.||++.+..++..+|+|.+... ......++.+|++++.+++||||+++++.|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999999999999999998754 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... ..+++..+..++.|+++||.|||+ ..+++|+||||+|||++.++.+||+|||++...... .
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999999998654 568999999999999999999997 258999999999999999999999999998754322 1
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc-----------
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL----------- 579 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~----------- 579 (645)
.....++..|+|||++.+..++.++|+||||+++|||++|+.||....... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 233568899999999988889999999999999999999999986433211 111110000000000
Q ss_pred ----------------cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 ----------------EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ----------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+.+.. ......+.+++.+|++.+|++||+++|++++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000 01223577889999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.03 Aligned_cols=258 Identities=25% Similarity=0.323 Sum_probs=201.4
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||.||++....+|+.+|+|++.... ....+.+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999999999999999986431 22334566799999999999999999999999999999999999999
Q ss_pred hhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecc
Q 042831 437 DSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA 515 (645)
Q Consensus 437 ~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 515 (645)
.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 9888653 3468999999999999999999998 99999999999999999999999999998765432 2223456
Q ss_pred cCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHH
Q 042831 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595 (645)
Q Consensus 516 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 595 (645)
|+..|+|||++.+..++.++|||||||++|||++|+.||......... .+...... .+.. ... ... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~-~~~~----~~~-~~~----~~ 223 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTL-EDEV----KFE-HQN----FT 223 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhh-cccc----ccc-ccc----CC
Confidence 899999999999888999999999999999999999999754322111 11111111 1111 100 011 22
Q ss_pred HHHHHHHHHcCCCCCCCCCCH----HHHHHHhccCC-CCCCCCC
Q 042831 596 ERLMIVGLWCAHPDENLRPSI----RQVIHVLNFEA-PLPALPP 634 (645)
Q Consensus 596 ~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~~~~-~~p~~p~ 634 (645)
..+.+++.+||+.||++||++ ++++.|.++.. ..|.+..
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhc
Confidence 356788899999999999999 55667777643 3344443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.77 Aligned_cols=266 Identities=20% Similarity=0.243 Sum_probs=200.4
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
....+|...+.||+|+||.||+|+...+++.||+|..... ....|+.++.+++|+||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3456899999999999999999999988999999975432 2346999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+ .++|.+++......+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred Ecc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 999 568888887777789999999999999999999998 89999999999999999999999999999753221
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH----HHHHHHhcC-C----ccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL----QWVWDLYGN-G----KLL 579 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~----~~~~~~~~~-~----~l~ 579 (645)
.......||..|+|||++.+..++.++|||||||++|||+++..|+....+....... ..+...... + .+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2223456899999999999999999999999999999999865554322221111000 001111000 0 000
Q ss_pred ---------cccCc--cccCCCC-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 ---------EAVDP--RLCRDFD-------GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ---------~~~d~--~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..++. .....+. ......+..++.+||+.||++|||+.|+++|.++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~ 355 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFA 355 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhc
Confidence 00000 0000000 00112344578999999999999999999998875
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.62 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=210.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|+..+.||+|++|.||+|+...+++.|++|.+........+.+.+|+.++++++|+|++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999998889999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 99999998853 357899999999999999999998 8999999999999999999999999999875433221 12
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||.+.+...+.++|||||||++|||++|+.||........ + ......+. +.+ ...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~-~~~~~~~~------~~~--~~~ 239 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----L-YLIATNGT------PEL--QNP 239 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----H-HHHhcCCC------CCC--CCc
Confidence 234688899999999888899999999999999999999999975433211 1 11111110 001 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
......+.+++.+|+..+|++||++.+++++.+....
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 1223457788899999999999999999999887644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.55 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=204.9
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC------
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~------ 421 (645)
.+++.|+..+.||+|+||.||+|....+++.||+|++.... ....++.+|+.++.++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46678888999999999999999999999999999986543 3346788999999998 699999999998753
Q ss_pred CeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999998764 4578999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||........ . .... .
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~-~~~~-~ 230 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L-FLIP-R 230 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H-HHHh-c
Confidence 7654322 2233456889999999886 33578899999999999999999999964332111 0 0001 1
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. .+.+.. ......+.+++.+||+.+|.+|||+.|++++.|+
T Consensus 231 ~~-----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 NP-----APRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CC-----CCCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 11 111111 1122456788899999999999999999998764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=336.56 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=201.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...++||+|+||.||++....+++.||||++... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999999999999999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.. ...+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999998864 3568899999999999999999998 8999999999999999999999999999863321000
Q ss_pred c----------------------------------------------ceeecccCccccCccccccCCCCcchhHHHHHH
Q 042831 509 S----------------------------------------------QTTVLAGTMGYMAPECATTGKASKESDVYSFGI 542 (645)
Q Consensus 509 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGv 542 (645)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246899999999999889999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC---CCCHHHH
Q 042831 543 VALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL---RPSIRQV 619 (645)
Q Consensus 543 ll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~---RPs~~ev 619 (645)
++|||++|+.||......+ ... ........... +.. ... ...+.+++.+|++ +|.+ ||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~--p~~-~~~----s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE---TYR---KIINWRETLYF--PDD-IHL----SVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCC--CCC-CCC----CHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997543211 111 11110000000 100 011 2345667778887 6665 4699999
Q ss_pred HHHhccC
Q 042831 620 IHVLNFE 626 (645)
Q Consensus 620 l~~L~~~ 626 (645)
+++.++.
T Consensus 303 l~hp~~~ 309 (377)
T cd05629 303 KSHPFFR 309 (377)
T ss_pred hcCCCcC
Confidence 9999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=328.29 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=198.6
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|.+..+++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987542 23345667788888764 899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCT 155 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceee
Confidence 999998854 3568999999999999999999998 89999999999999999999999999998743221 122344
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||..|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+ .+.+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~----i~~~------~~~~~~~---- 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS----IRMD------NPCYPRW---- 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhC------CCCCCcc----
Confidence 57899999999999889999999999999999999999999754321 11211 1111 1111111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHH-HHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIR-QVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~~ 626 (645)
....+.+++.+|++.||++||++. +++++.++.
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQHPFFR 252 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHcCcccC
Confidence 123466788999999999999997 888877653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=330.65 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=203.0
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+|...+.||+|+||.||+|++..+++.||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999999999999999987542 23345667788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-G 155 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-C
Confidence 999999999888543 468999999999999999999998 89999999999999999999999999998753321 1
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ .++.. .+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i----~~~~~------~~-- 220 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI----MEHNV------AY-- 220 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH----HhCCC------CC--
Confidence 2233457899999999999999999999999999999999999999754321 222211 11111 11
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
+......+..++.+|++.||++|++ .++++++.++.
T Consensus 221 --p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~ 261 (323)
T cd05616 221 --PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261 (323)
T ss_pred --CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence 1112345678889999999999997 47888876653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.62 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=204.9
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||++....+++.||+|+++.. .....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999754 233456788999999888 599999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceec
Confidence 9998887543 468999999999999999999998 89999999999999999999999999998743221 122344
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............++.......... .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~--- 226 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRFL--- 226 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCCC---
Confidence 67999999999999999999999999999999999999999754333222233333333322211 111111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCC------HHHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPS------IRQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~L~~~ 626 (645)
...+..++.+||+.||++||+ ++++++|.++.
T Consensus 227 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~ 264 (327)
T cd05617 227 -SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFR 264 (327)
T ss_pred -CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCC
Confidence 234567889999999999998 57999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.08 Aligned_cols=253 Identities=28% Similarity=0.401 Sum_probs=209.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|+..+.||+|+||.||+|....+++.+++|.+..... .+++.+|++++++++|+|++++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999998889999999865433 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 9999999997767789999999999999999999998 8999999999999999999999999999886543321 22
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||++.+..++.++||||||+++|||++|+.||.......... .... ...+.+. .+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~-----~~~~~~~--~~ 222 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPN-----KPPPTLS--DP 222 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhcc-----CCCCCCC--ch
Confidence 33457889999999988889999999999999999999999997543321110 0000 0001110 11
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
......+.+++.+|++.+|++|||+.|++++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 122346778889999999999999999998765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.21 Aligned_cols=257 Identities=32% Similarity=0.473 Sum_probs=206.4
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhH--HHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--KEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
|+..+.||+|+||+||+++...+++.+|+|.+........ ....+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4557899999999999999999999999999987654332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++. ....+++..++.++.|+++||.+||+ .+++|+||||+||++++++.++|+|||.+... .......
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEB
T ss_pred cccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999996 44668999999999999999999999 89999999999999999999999999998754 2223344
Q ss_pred eecccCccccCccccc-cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECAT-TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|+|||++. ....+.++||||+|+++++|++|+.||......+......... ..... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----~~~~~----~~~~~-- 225 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL----KRPLP----SSSQQ-- 225 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH----HTHHH----HHTTS--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc----ccccc----ccccc--
Confidence 4567899999999998 7889999999999999999999999998552111111111110 00000 00000
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+.+++..||+.||++||++.+++++.|+
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00012678888999999999999999999998774
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=332.43 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=214.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe-EEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE-LLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~-~~lV~ 428 (645)
++|...+++|+|+||.+++.+++.++..+++|.+... .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5678889999999999999999999999999988654 34445578899999999999999999999998888 99999
Q ss_pred EecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
+||+||+|.+.+.+.+ ..++++.++.++.|++.|+.|||+ ..|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998655 678999999999999999999997 899999999999999999999999999999876544
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+-. .++..+.. + ..
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~----~---------~~ 223 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINR----G---------LY 223 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhh----c---------cC
Confidence 3445578999999999999999999999999999999999999999865432 23322111 1 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
...+......+..++..|+..+|+.||++.++|.+.
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 222334456677788999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.04 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=206.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
..+|...+.||+|+||.||+|.+.+ ++..||+|.++..... ..+.+.+|++++.+++|+|++++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3467788999999999999998753 3578999998765443 567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 425 LLVYEFMPNGSLDSHLFKEN-------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
++||||+++++|.+++...+ ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999986432 357899999999999999999998 89999999999999999999
Q ss_pred EEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 042831 492 AKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~ 569 (645)
+||+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |+.||...... ...+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH-
Confidence 999999998754322211 1122345678999999999999999999999999999998 99998654322 12222
Q ss_pred HHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 570 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+..... +......+.+++..||+.||++||++.|+++.|+
T Consensus 237 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ---ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 112222111 1112346778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.77 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=203.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC-C
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK-K 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~-~ 422 (645)
.++|...+.||+|+||.||+|...+ +++.||+|+++... ....+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4578889999999999999997543 35789999987543 33456788999999999 799999999988654 5
Q ss_pred eEEEEEEecCCCChhhhhhhcC----------------------------------------------------------
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN---------------------------------------------------------- 444 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 444 (645)
.+++++||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999998885321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCcccc
Q 042831 445 --SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYM 521 (645)
Q Consensus 445 --~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~ 521 (645)
..++|..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 268999999999999999999998 89999999999999999999999999999865432221 122234567899
Q ss_pred CccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHH
Q 042831 522 APECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMI 600 (645)
Q Consensus 522 aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~ 600 (645)
|||++.+..++.++|||||||++|||++ |+.||......+ . ......++... . .+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~-----~----~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRM-----R----APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCC-----C----CCccCCHHHHH
Confidence 9999999999999999999999999998 999997543221 1 11111222111 0 11122356788
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 601 VGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 601 l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
++++||+.+|++||++.|++++|..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHH
Confidence 8999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.23 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=210.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+.|...++||+|+||.||+|.+..+++.+++|.+........+.+.+|+.++++++|+|++++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788899999999999999999989999999998777777888999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|..++.+....+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 9999998887666779999999999999999999998 899999999999999999999999999987543221 222
Q ss_pred eecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 512 TVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
....++..|+|||++. ...++.++|||||||++|||++|+.||...... ...... .... .+.+
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~-~~~~-----~~~~ 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKI-AKSE-----PPTL 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHH-hcCC-----CccC
Confidence 3456788999999884 345688999999999999999999999653321 111111 1111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. .+......+..++.+||+.+|++||++++++++.++..
T Consensus 236 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 236 S--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred C--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 01122345677889999999999999999999988754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.44 Aligned_cols=284 Identities=21% Similarity=0.291 Sum_probs=208.3
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC------CCccEEEeeee
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH------RNLVQLLGWCH 419 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------~nlv~l~~~~~ 419 (645)
++...+++|...++||+|+||.||+|.+..+++.||||+++... ...+++..|+.++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999999889999999986432 234456678888877765 45888999887
Q ss_pred eC-CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC--------
Q 042831 420 EK-KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-------- 490 (645)
Q Consensus 420 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-------- 490 (645)
.+ ++.|+|||++ +++|.+++.+. ..+++..+..|+.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccc
Confidence 54 5789999998 77888887544 568999999999999999999997 24899999999999998765
Q ss_pred --------cEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 042831 491 --------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562 (645)
Q Consensus 491 --------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~ 562 (645)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred cccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998754321 22346799999999999999999999999999999999999999976543322
Q ss_pred hhHHHHHH-----------------HHhc-CCccccccCccc----cCC---CCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 042831 563 VSLLQWVW-----------------DLYG-NGKLLEAVDPRL----CRD---FDGQQIERLMIVGLWCAHPDENLRPSIR 617 (645)
Q Consensus 563 ~~l~~~~~-----------------~~~~-~~~l~~~~d~~l----~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 617 (645)
..++.... +++. .+.+....++.. ... ....+-..+++|+..||+.||++|||++
T Consensus 354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 22221110 0000 001111111100 000 0001124577899999999999999999
Q ss_pred HHHHHhccCC------CCCCCCCCCCC
Q 042831 618 QVIHVLNFEA------PLPALPPKMPV 638 (645)
Q Consensus 618 evl~~L~~~~------~~p~~p~~~p~ 638 (645)
|+++|.++.. ..|.+|...+.
T Consensus 434 e~L~Hp~~~~~~~~~~~~~~~~~~~~~ 460 (467)
T PTZ00284 434 QMTTHPYVLKYYPECRQHPNYPDNRSM 460 (467)
T ss_pred HHhcCccccccCCccccCCCCCCcccc
Confidence 9999999764 34555544443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=325.12 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=207.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...++||+|+||.||+|++..+++.||+|.+.... ......+.+|+.++.+++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999999889999999986543 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ ++|..++......+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++........ .
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 96 68988887666678999999999999999999998 8999999999999999999999999999875432221 1
Q ss_pred eeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc------------CCc
Q 042831 511 TTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------------NGK 577 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------------~~~ 577 (645)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+. ......... ...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcccc
Confidence 2234568899999987654 478899999999999999999999975543211 111111110 000
Q ss_pred cccccCccccCCC----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 578 LLEAVDPRLCRDF----DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 578 l~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
....-.+...... .......+.+++.+|++.||++|||+.|++++.|+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000001110000 00112356788999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.58 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=204.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKK 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~ 422 (645)
..++|...++||+|+||.||+|++... +..||||++.... ....+.+.+|++++.++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356788899999999999999987432 3579999997543 334567999999999996 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcC----------------------------------------------------------
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN---------------------------------------------------------- 444 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 444 (645)
..+||||||++|+|.+++.+..
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999998875421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC
Q 042831 445 -------------------------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487 (645)
Q Consensus 445 -------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld 487 (645)
..+++..+..++.||++||.|||+ .+++||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 247888899999999999999998 8999999999999999
Q ss_pred CCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhH
Q 042831 488 SNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSL 565 (645)
Q Consensus 488 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l 565 (645)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999999865332211 1222346778999999998889999999999999999997 999987543211
Q ss_pred HHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 566 LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 566 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
........+.. ... +......+.+++.+||+.||++||++.++.+.|..
T Consensus 348 --~~~~~~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 348 --TFYNKIKSGYR-----MAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --HHHHHHhcCCC-----CCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 11111112211 111 11223467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.79 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=199.6
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
++||+|+||.||+|... ++..+|+|.+..... .....+.+|++++.+++|||+++++++|...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999875 478899999876543 3445788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
.+++......+++..+..++.|++.+|.|||+ ++++|+||||+||+++.++.+||+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 99987666678999999999999999999998 899999999999999999999999999987543322222222334
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 595 (645)
+..|+|||++..+.++.++||||||+++||+++ |..||...... ... .....+... .......
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~ 220 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAR----EQVEKGYRM---------SCPQKCP 220 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHHcCCCC---------CCCCCCC
Confidence 567999999998899999999999999999998 99999754321 111 111111110 1111223
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 596 ERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 596 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 56788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=313.01 Aligned_cols=272 Identities=22% Similarity=0.269 Sum_probs=211.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEec--cCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-----CC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-----KK 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-----~~ 422 (645)
....|...+.||+|++|.|..+.++.+|+.||||++. .......++-.+|+++|++++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4455666789999999999999999999999999997 4566677888999999999999999999998865 35
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..|+|+|+| +.+|...+. .+..|+.....-++.|+++||.|+|+ .+|+||||||+|+|++.+...||+|||+|+.
T Consensus 100 DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred eeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceee
Confidence 789999999 667877774 44558999999999999999999999 9999999999999999999999999999998
Q ss_pred cccc-CCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------HHH
Q 042831 503 VEHA-KGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV--------WDL 572 (645)
Q Consensus 503 ~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~--------~~~ 572 (645)
.+.. .....+..+-|.+|.|||++.. ..|+.+.||||.||++.||++|++-|.+.+.-.+..++..+ ...
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 7543 1223456778999999998754 56999999999999999999999999877655444333211 111
Q ss_pred hcCCccccccCccc-cCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 573 YGNGKLLEAVDPRL-CRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 573 ~~~~~l~~~~d~~l-~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+..+....+...- .+..+. ..-...++|..++|..||.+|+|++|+|+|...+
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLA 314 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhh
Confidence 11111111111000 000000 1124566778899999999999999999999754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.00 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=207.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.+|...+.||+|+||.||+|.... ++..+++|.+........+.+.+|++++.+++|+|++++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457778899999999999998642 456799999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 427 VYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
||||+++++|.+++.... ..+++..++.++.||+.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 348999999999999999999998 89999999999999999999
Q ss_pred EEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 042831 492 AKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~ 569 (645)
+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||...... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~---- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EV---- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----
Confidence 99999999975533221 11223446778999999998899999999999999999998 99998654321 11
Q ss_pred HHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 570 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+....+..... .......+.+++.+|++++|++||++++|++.|+.-
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 235 IECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred HHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 122222222111 111234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.36 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=201.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||++.+..+++.||+|.+... .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998753 233456677899999888 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.+. ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccc
Confidence 9999888543 468999999999999999999998 89999999999999999999999999998743221 122233
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+. .....+.. .... .
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~----~~i~~~~~------~~~~----~ 218 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF----QSILEDEV------RYPR----W 218 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCC------CCCC----c
Confidence 56899999999999999999999999999999999999999754321 111 11111111 1111 1
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI-----RQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~~ 626 (645)
....+.+++.+||+.||++||++ .+++++.++.
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~ 256 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence 22456788899999999999999 9999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.19 Aligned_cols=260 Identities=21% Similarity=0.279 Sum_probs=202.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+++...+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999999999999999998642 2234566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999997656679999999999999999999998 9999999999999999999999999999876543333
Q ss_pred cceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 509 SQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||...... +............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ-FP 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-CC
Confidence 23333568999999999863 45788999999999999999999999753321 11111111111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcC--CCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCA--HPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~L~~~ 626 (645)
+. ....+ ..+..++.+|+ ..++..||+++++++|.++.
T Consensus 231 ~~-~~~~~----~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~ 270 (331)
T cd05597 231 PD-VTDVS----EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270 (331)
T ss_pred Cc-cCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence 11 11122 23344445544 44555589999999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.34 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=201.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.+|...+.||+|+||.||+++...+++.||+|.+.... ......+.+|++++.+++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999999999999999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC-
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK- 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~- 507 (645)
||+++|+|.+++.+. ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999998653 468889999999999999999998 899999999999999999999999999975321000
Q ss_pred -----------------------------------------CcceeecccCccccCccccccCCCCcchhHHHHHHHHHH
Q 042831 508 -----------------------------------------GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546 (645)
Q Consensus 508 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~e 546 (645)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123469999999999999899999999999999999
Q ss_pred HHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHh
Q 042831 547 IACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP---SIRQVIHVL 623 (645)
Q Consensus 547 lltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L 623 (645)
|++|+.||......+. . .... .......+ +. ....+ ..+.+++.+|+ .+|++|+ ++.|+++|.
T Consensus 237 ll~G~~Pf~~~~~~~~---~---~~i~-~~~~~~~~-~~-~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 237 MLVGQPPFLADTPAET---Q---LKVI-NWETTLHI-PS-QAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred hhhCCCCCCCCCHHHH---H---HHHh-ccCccccC-CC-CCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 9999999975443211 1 1111 10000000 10 11122 23344455555 4999999 999999999
Q ss_pred ccC
Q 042831 624 NFE 626 (645)
Q Consensus 624 ~~~ 626 (645)
++.
T Consensus 303 ~~~ 305 (376)
T cd05598 303 FFK 305 (376)
T ss_pred CcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.20 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=208.0
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
|+..+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45678899999999999999998999999999776666778899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
++|..++.+....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 99999887666779999999999999999999998 899999999999999999999999999987543221 12233
Q ss_pred cccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 514 LAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 514 ~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
..++..|+|||++. ...++.++|||||||++|||++|+.||....... . +.... .+.. +.+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~---~~~~~-~~~~-----~~~~- 229 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---V---LLKIA-KSEP-----PTLA- 229 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---H---HHHHh-hcCC-----CCCC-
Confidence 46889999999874 3457889999999999999999999997543211 1 11111 1110 1110
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+......+.+++.+||+.||++||++.+++++.++..
T Consensus 230 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 230 -QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 01112245678889999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.90 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=208.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...++||+|+||.||+|+...+++.||||.+... .......+.+|++++++++|||++++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788899999999999999999988999999987542 3344567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 34568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
... ......++..|+|||.+.+...+.++|+||||+++|||++|+.||...... ...+... ..... .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQCD-----YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-HhcCC-----CCC
Confidence 221 122346788999999998888999999999999999999999998643321 1111111 11111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ........+.+++.+||+.+|++||++++|++.++.
T Consensus 228 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 228 L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 1 112233567888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.70 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=203.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEc----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.+|+..+.||+|+||.||+|.+. .++..|++|.+... ..+...++.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45777899999999999999863 34678999998743 34455788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC
Q 042831 427 VYEFMPNGSLDSHLFKE----------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 490 (645)
||||+++++|.+++... ...+++.+...++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999988532 2357899999999999999999998 8999999999999999999
Q ss_pred cEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHH
Q 042831 491 NAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQW 568 (645)
Q Consensus 491 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~ 568 (645)
.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||...... .+.+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence 999999999976533221 11222345678999999988889999999999999999998 99998643321 1122
Q ss_pred HHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 569 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+.... ....+ ...+..++.+|+++||++||++.+++++|..
T Consensus 238 ---~~~~~~~~~-----~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 ---MVRKRQLLP-----CSEDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---HHHcCCcCC-----CCCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111221111 11112 2456778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.31 Aligned_cols=258 Identities=21% Similarity=0.246 Sum_probs=207.4
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK---- 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~---- 422 (645)
...++|...+.||+|+||.||++++..+++.||||++... .......+.+|+..+..++|+|++++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456889999999999999999999989999999998654 3455667889999999999999999988765332
Q ss_pred ----eEEEEEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 423 ----ELLLVYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 423 ----~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 368999999999999988642 3578999999999999999999998 899999999999999999999999
Q ss_pred eccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 496 DFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 496 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+ ....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~-~~~~ 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVM-HKTL 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHH-HHHh
Confidence 9999986543221 2233467999999999999999999999999999999999999999753311 111 1111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+... + +... ....+..++..||+.||++||++.+++++.+.
T Consensus 259 ~~~~~----~-~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 259 AGRYD----P-LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred cCCCC----C-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 12111 1 1111 23457788899999999999999999987653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.20 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=215.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
....+....++||.|.||.||.|.|+.-.-.||||.++.+ ....++|+.|+.+|+.++|||+|+|+|+|..+..+|||.
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 3334555678999999999999999987888999998654 456789999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||.+|+|.+||.+. +..++.-..+.++.||++|+.||.. +++|||||.++|+|+.++..+|++||||++++....
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999864 3467777888999999999999998 999999999999999999999999999999886554
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
+.......-.+.|.|||.+....++.|+|||+|||+|||+.| |..||...+ ...|++++++|-.++.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkgyRM~~----- 487 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKGYRMDG----- 487 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhccccccC-----
Confidence 433333334668999999999999999999999999999998 999997543 2335666655533221
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+..+...+.+|+++||++.|.+||+++|+-+.++
T Consensus 488 ----PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 488 ----PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred ----CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 2234467888999999999999999999887776
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.37 Aligned_cols=266 Identities=19% Similarity=0.210 Sum_probs=202.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
..+|...+.||+|+||.||++.+..+++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3468899999999999999999999999999996432 2456899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS- 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~- 509 (645)
+ .++|..++......++|.+++.|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 Y-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9 578888887666679999999999999999999998 89999999999999999999999999999865432221
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CCCchhHHHHHHHHhcCCcc-----ccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA-PQGQVSLLQWVWDLYGNGKL-----LEAVD 583 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~-~~~~~~l~~~~~~~~~~~~l-----~~~~d 583 (645)
......||..|+|||++.+..++.++|||||||+||||++|..|+.... ..........+......... .....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 1223569999999999999999999999999999999999886653222 11111001111111111100 00000
Q ss_pred c------------cccCCCCH-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 P------------RLCRDFDG-------QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~------------~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. ........ .....+..|+.+||+.||++|||+.|+|++.+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~ 459 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence 0 00000000 0112466788999999999999999999999885
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=337.81 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=199.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|...++||+|+||.||+|+...+++.||+|++... .......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999999999999999998653 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC--
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK-- 507 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~-- 507 (645)
||++|+|.+++.+. ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999988654 468899999999999999999998 899999999999999999999999999975321000
Q ss_pred --------------------------------------------CcceeecccCccccCccccccCCCCcchhHHHHHHH
Q 042831 508 --------------------------------------------GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIV 543 (645)
Q Consensus 508 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvl 543 (645)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000122468999999999999899999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH
Q 042831 544 ALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS---IRQVI 620 (645)
Q Consensus 544 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl 620 (645)
+|||++|+.||....+.+. ............ .+. ....+. .+.+++.+|+ .+|++|++ +.|++
T Consensus 238 l~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~--~p~-~~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET------QMKVINWQTSLH--IPP-QAKLSP----EASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH------HHHHHccCCCcC--CCC-cccCCH----HHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 9999999999975432211 111111000000 010 011222 2333344443 49999997 99999
Q ss_pred HHhccC
Q 042831 621 HVLNFE 626 (645)
Q Consensus 621 ~~L~~~ 626 (645)
+|.++.
T Consensus 304 ~hp~f~ 309 (382)
T cd05625 304 AHPFFK 309 (382)
T ss_pred cCCCcC
Confidence 998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.47 Aligned_cols=264 Identities=25% Similarity=0.303 Sum_probs=204.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-----eEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-----ELLLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-----~~~lV 427 (645)
.|...+++|.|.||.||+|+..++++.||||++-.+.+. --+|+++|+++.|||||+|+-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 456678999999999999999999999999998655331 136999999999999999999886432 45789
Q ss_pred EEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCcccc
Q 042831 428 YEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLV 503 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla~~~ 503 (645)
|||||. +|...+.. .+..++.-.++-+..||.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 78777753 35678888888999999999999999 999999999999999965 99999999999988
Q ss_pred cccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-------C
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-------N 575 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-------~ 575 (645)
..+... .....+..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+....++..++-.+...-. +
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 655433 445678899999988775 599999999999999999999999987665544333322211100 1
Q ss_pred CccccccCccccCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 GKLLEAVDPRLCRD-----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 ~~l~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+-.+...|.+... +........++++.++++.+|.+|.++.|++.|.-|+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 11112222222221 1222335677888999999999999999999999876
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.24 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=209.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||.|++|.||+|++..+++.||+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999999899999999987553 44556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 9999999998643 78999999999999999999998 899999999999999999999999999998765432 22
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....++..|+|||++.+..++.++||||||+++|||++|+.||....+.. . ... ...+ ..+.+...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~---~~~-~~~~-----~~~~~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---V---LFL-IPKN-----NPPSLEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---H---HHH-hhhc-----CCCCCccc-
Confidence 233567889999999998889999999999999999999999997543211 1 111 1111 11111111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+++..||+.+|++||++++++++.+..
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 0223567788999999999999999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.55 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=199.4
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-------- 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-------- 421 (645)
...+|...++||+|+||.||+|++..+++.||||++..... ...+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 34679999999999999999999998999999998854322 234799999999999999999876432
Q ss_pred CeEEEEEEecCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeec
Q 042831 422 KELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDF 497 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~Df 497 (645)
..+++||||+++ +|.+++. ..+..+++...+.++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999975 6766654 245679999999999999999999998 8999999999999999664 7999999
Q ss_pred cCcccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 498 GLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 498 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .......+..
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL---VRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCC
Confidence 9998654322 22335689999999988654 6899999999999999999999999765432211 1111111110
Q ss_pred ----------ccccc-----cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 577 ----------KLLEA-----VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 577 ----------~l~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+. ....+...++......+.+++.+||+.||.+|||+.|+++|.+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 00000 000111111111235678899999999999999999999999975
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=323.84 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
....++|+..+.||+|+||.||++..... ...+|+|.+... ..+...++.+|++++.++ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34456788889999999999999988643 378999998754 334556788999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeE
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 485 (645)
++..+++|||+++|+|..++... ...+++..++.++.|++.||.|||+ .+++||||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEE
Confidence 99999999999999999998532 3568999999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCch
Q 042831 486 LDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQV 563 (645)
Q Consensus 486 ld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~ 563 (645)
+++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 999999999999999865433221 1122234578999999988889999999999999999998 999986443211
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+......+... ..+......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus 243 -----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 243 -----LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred -----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11111122111 1111223567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.31 Aligned_cols=253 Identities=30% Similarity=0.463 Sum_probs=202.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...++||+|+||.||+|++.++ ..||+|+++... ...+++.+|++++.+++|+|++++++.+. ....++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 35688899999999999999998765 469999987532 23467899999999999999999999875 4567999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++|+|.+++.+. ...+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999753 3568999999999999999999998 89999999999999999999999999999866543322
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||+..++.++.++||||||+++|||++ |+.||...... .. ......+. ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~~-----~~---- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGY-----RM---- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcCC-----CC----
Confidence 2223446678999999988899999999999999999999 88888754321 11 11111111 00
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+....+.+++.+|++++|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1112334567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.43 Aligned_cols=247 Identities=24% Similarity=0.322 Sum_probs=197.0
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHH-HHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVK-IISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|++..+|+.||+|++.... ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999986432 223345556655 45779999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.. +..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 999988854 4568999999999999999999998 89999999999999999999999999998753221 222334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. +....+.. .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~----~~i~~~~~------~~~~~~--- 219 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY----DNILNKPL------RLKPNI--- 219 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH----HHHHcCCC------CCCCCC---
Confidence 57899999999999989999999999999999999999999754321 111 11111111 111122
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH----HHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI----RQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~~~ 626 (645)
...+.+++.+|++.||++||++ ++++++.++.
T Consensus 220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 220 -SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred -CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 3456778899999999999987 5888887753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.94 Aligned_cols=269 Identities=22% Similarity=0.245 Sum_probs=202.9
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-----
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK----- 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~----- 422 (645)
..++|...+.||+|+||.||++.+..+|+.||+|++... .......+.+|+.++.+++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999999999999999999998643 3344567889999999999999999999986443
Q ss_pred -eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 423 -ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 423 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999965 5555553 247889999999999999999998 899999999999999999999999999997
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh------------HHH--
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS------------LLQ-- 567 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~------------l~~-- 567 (645)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+... ...
T Consensus 172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 54321 22233568999999999999899999999999999999999999997543211100 000
Q ss_pred --HHHHHhcCC-cc-----ccccCcccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 568 --WVWDLYGNG-KL-----LEAVDPRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 568 --~~~~~~~~~-~l-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+....... .. .+....... ...+......+.+++.+||+.||++|||+.|+++|.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 000000000 00 000000000 0011112345778899999999999999999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.96 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=211.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|...+.||+|++|.||+|....+++.||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888999999999999999998889999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.+ ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~ 172 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-Cc
Confidence 99999998854 457899999999999999999998 8999999999999999999999999999876533221 22
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.......... . ....+ .+.+ ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~---~~~~~------~~~~--~~~ 238 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---L---IATNG------TPEL--QNP 238 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---e---eccCC------CCCC--CCc
Confidence 33468889999999998889999999999999999999999997543321110 0 00000 0010 011
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPL 629 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 629 (645)
......+.+++.+||+.+|++||++++++++.++....
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 12234567788999999999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.61 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=201.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCe--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNS--YIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
++|+..+.||+|+||.||+|.+..++. .+++|.++.. .....+.+.+|++++.++ +|||++++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468888999999999999999877654 4788888643 344567899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 428 YEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
+||+++++|.+++.+.. ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999986432 358899999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~ 571 (645)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |+.||...... .+.+
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~~~---- 229 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---ELYE---- 229 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----
Confidence 999999986432111 1111223457999999988889999999999999999997 99999754321 1111
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+. .+.... .....+.+++.+|++.+|.+||+++++++.|..
T Consensus 230 ~~~~~~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 230 KLPQGY-----RMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred HHhcCC-----CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111111 111111 122456788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.86 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=205.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...++||+|+||.||+|++..++. .||+|.+... .....+++.+|+.++..++|+|+++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4578888999999999999999876665 4899998754 334567888999999999999999999999754 578
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+++||+++|+|.+++.+....+++..+..++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 9999999999999997766779999999999999999999998 8999999999999999999999999999986643
Q ss_pred cCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+ ...+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~~--- 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERLP--- 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcCC---
Confidence 22211 112234678999999988889999999999999999998 99998643321 12221 11221110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
. +......+.+++.+||+.||++||++.++++.|.....
T Consensus 232 --~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 232 --Q----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --C----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 11123457788899999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=319.85 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=202.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+|...+.||+|+||.||+|+... ....+++|.+.... .....++.+|+.++.+++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998753 23579999887553 3445789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCC
Q 042831 427 VYEFMPNGSLDSHLFKE-----------------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 483 (645)
|+||+++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999987531 1357899999999999999999998 899999999999
Q ss_pred eEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042831 484 IMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQG 561 (645)
Q Consensus 484 ILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~ 561 (645)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999765332211 1222345678999999988889999999999999999998 99999654321
Q ss_pred chhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 562 QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 562 ~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+++....+.. .. .+......+.+++..|++++|++||++.|+++.|+.
T Consensus 237 ------~~~~~~~~~~~-----~~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 237 ------RLFNLLKTGYR-----ME----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ------HHHHHHhCCCC-----CC----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 12222222211 11 111223467788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=319.25 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=206.3
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
|+..+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.++.+++|+|++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999999999999999986432 23345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999988643 3468999999999999999999998 999999999999999999999999999987543222
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||............... ... ........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~~------~~~~~~~~ 227 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKE------VQEEYSEK 227 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hhh------hhhhcCcc
Confidence 222346899999999999989999999999999999999999999754332111111111 000 00111111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
+ ...+.+++..||+.||++||| ++|+++|.++.
T Consensus 228 ~----~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 228 F----SPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred C----CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 2 234678889999999999999 99999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=328.76 Aligned_cols=266 Identities=21% Similarity=0.240 Sum_probs=204.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...+.||+|+||.||++.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999999988999999998753 334456788999999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999965 6666663 247889999999999999999998 899999999999999999999999999997
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-------
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------- 574 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------- 574 (645)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+....+
T Consensus 175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHH
Confidence 65322 12233568999999999999999999999999999999999999997544221 1111111000
Q ss_pred -------------CCcccc----ccCccc----cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 575 -------------NGKLLE----AVDPRL----CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 575 -------------~~~l~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...... .+.+.. ...........+.+++.+|++.||++|||+.|+++|.++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000000 000000 00111112346778999999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.71 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=205.1
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
|...+.||+|+||+||+|.+..+++.+|+|.+.... ......+.+|++++.+++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999999999999999986542 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999888654 3469999999999999999999998 899999999999999999999999999987543221
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||........... +......+. ......
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~~------~~~~~~ 227 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLETE------EVYSAK 227 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhccc------cccCcc
Confidence 22335689999999999888899999999999999999999999975432211111 111111110 111111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
....+.+++..|++.||++||+ +++++.+.++.
T Consensus 228 ----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 228 ----FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred ----CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 2235667889999999999999 88999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=314.11 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=199.8
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCe--EEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------Ce
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNS--YIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------KE 423 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------~~ 423 (645)
|...+.||+|+||.||+|.+..++. .+|+|.++.. +....+.+..|++++.+++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457889999999999999877664 6999988654 345567899999999999999999999987532 24
Q ss_pred EEEEEEecCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 424 LLLVYEFMPNGSLDSHLFK-----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
.++++||+++|+|.+++.. ....+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 23458999999999999999999998 899999999999999999999999999
Q ss_pred CcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 499 LARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 499 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
+++......... .....++..|++||++....++.++||||||+++|||++ |+.||...... . ..+...++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcC
Confidence 998664322211 122345678999999999899999999999999999999 88998653321 1 12222233
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ... .....+.+++.+||++||++|||+.++++.|+.
T Consensus 231 ~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK-----QPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC-----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 2211 111 123457788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.41 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=204.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||++++..+++.||+|.+... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999999999999998642 2233456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999997766678999999999999999999998 9999999999999999999999999999976543332
Q ss_pred cceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 509 SQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.......|++.|+|||++.+ +.++.++|||||||+||||++|+.||...... +............ .+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~-~~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF-QFP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc-cCC
Confidence 23334579999999998875 46788999999999999999999999753321 1111111111000 011
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~ 626 (645)
+.+ . +..+.+.+++.+|++.++++ |++++++++|.+++
T Consensus 231 ~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~ 270 (331)
T cd05624 231 SHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270 (331)
T ss_pred Ccc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcC
Confidence 111 1 12345566677777765544 57999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=311.71 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=196.7
Q ss_pred ccCcCCcEEEEEEEEc--CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 359 KLGQGGFGGVYKGFFR--ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.||+|+||.||+|.+. +++..||+|.+.... ....+++.+|+.++++++|+||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999875 445679999987653 344567999999999999999999999886 457899999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc--eee
Q 042831 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ--TTV 513 (645)
Q Consensus 436 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~--~~~ 513 (645)
|.+++......+++..+++++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999997666789999999999999999999998 899999999999999999999999999997554322211 111
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
..++..|+|||.+....++.++|||||||++||+++ |+.||...... .. ......+... ..+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~ 221 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EV----MSFIEQGKRL---------DCPA 221 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHCCCCC---------CCCC
Confidence 223568999999988889999999999999999996 99999754322 11 1122222211 1111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++..||+.+|++||++.+|.+.|.
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22356677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.30 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=198.5
Q ss_pred CccCcCCcEEEEEEEE---cCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 358 QKLGQGGFGGVYKGFF---RETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~---~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
+.||+|+||.||+++. ..+|+.||+|++.... ......+..|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 3568899999987532 2234567789999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+|+|.+++.+ ...+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAY 156 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCcee
Confidence 9999998854 3468999999999999999999998 89999999999999999999999999998764332 12334
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
...|++.|+|||.+....++.++|||||||++|||++|+.||...... ..... ..++.. .+...
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~----i~~~~~------~~p~~--- 220 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTM----ILKAKL------GMPQF--- 220 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHH----HHcCCC------CCCCC---
Confidence 467899999999999888999999999999999999999999754321 11111 111111 11111
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhcc
Q 042831 593 QQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNF 625 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~ 625 (645)
....+..++.+||+.||++||+ +++++.+.++
T Consensus 221 -~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 221 -LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred -CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 1235667889999999999999 6678877665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=312.88 Aligned_cols=252 Identities=30% Similarity=0.459 Sum_probs=201.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|+..++||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 467888999999999999998764 56799999875433 3457899999999999999999999885 45688999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++++|.+++.+. ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999998754 3568999999999999999999998 899999999999999999999999999998654332222
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...... ...++. ..+. ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~----~~~~---------~~~ 223 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV----ERGY---------RMP 223 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcCC---------CCC
Confidence 222335668999999988889999999999999999999 89999653321 122211 1110 011
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+.+++.+|++++|++|||++++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112223567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.65 Aligned_cols=267 Identities=24% Similarity=0.306 Sum_probs=210.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-h-hHHHHHHHHHHHHhcCCCC-ccEEEeeeeeCC------
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-Q-GIKEYASEVKIISRLRHRN-LVQLLGWCHEKK------ 422 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~-~~~~~~~Ei~~l~~l~H~n-lv~l~~~~~~~~------ 422 (645)
..|...++||+|+||+||+|+...+|+.||+|+++...+ + .-....+|+.++.+++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345667789999999999999999999999999976644 2 2345679999999999999 999999998877
Q ss_pred eEEEEEEecCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN---SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
.+++|+||+ .-+|..++.... ..++...++.++.||++||+|||+ ++|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 789999999 668988887644 457778999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc-
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK- 577 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~- 577 (645)
|+....... ..+..+.|.+|.|||++.+. .|+...||||+||++.||++++..|....+ ..+...+++..+...
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCc
Confidence 996653322 24456789999999999887 699999999999999999999999986654 333444455543211
Q ss_pred --ccccc-----CccccCCC-----CHHH---HHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 578 --LLEAV-----DPRLCRDF-----DGQQ---IERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 578 --l~~~~-----d~~l~~~~-----~~~~---~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.... ++...... .... .....+++.+|++.+|.+|.|++.+++|..+.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 11100 10110000 0001 13677888999999999999999999997765
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.22 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=205.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.+|...+.||+|+||.||+|.+..+ +..+|+|.++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4677889999999999999988643 3479999886543 34457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++......+++.++..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999997766678999999999999999999998 899999999999999999999999999998664432
Q ss_pred Cccee--ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 508 GSQTT--VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 508 ~~~~~--~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..... ...++..|+|||.+.++.++.++|+||||++++|+++ |+.||...... ...... .++.- .
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~~-----~ 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAI----EEGYR-----L 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHH----hCCCc-----C
Confidence 22111 1223567999999998889999999999999999886 99999754322 112211 11110 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. .......+.+++.+|++.+|++||+|.++++.|+.
T Consensus 229 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 PA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred CC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00 11123456788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.57 Aligned_cols=265 Identities=28% Similarity=0.404 Sum_probs=201.0
Q ss_pred CCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLV 427 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV 427 (645)
...+.||+|+||.||++.. ..++..||+|.+.... ......+.+|++++++++||||++++++|... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 3467889999987543 34567788999999999999999999998653 468999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++.. ..+++.+++.++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999999854 358999999999999999999998 899999999999999999999999999998654322
Q ss_pred Ccc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 508 GSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 508 ~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
... .....++..|+|||.+....++.++||||||++++||++|+.|+....... .....+.........+.+.++..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhcC
Confidence 111 112235667999999988889999999999999999999999986433211 01111000000001111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.....+......+.+++..|++++|++|||++++++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111122234578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.99 Aligned_cols=262 Identities=27% Similarity=0.396 Sum_probs=207.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC----------------eEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN----------------SYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQ 413 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~ 413 (645)
..+|...++||+|+||.||++.+...+ ..||+|.+.... ....+++.+|++++.+++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457888999999999999999876533 568999987653 445678999999999999999999
Q ss_pred EEeeeeeCCeEEEEEEecCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCC
Q 042831 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKEN----------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483 (645)
Q Consensus 414 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 483 (645)
++++|..++..++|+||+++++|.+++.+.. ..+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999986533 268999999999999999999998 899999999999
Q ss_pred eEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 042831 484 IMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC--GRKPINPKAPQ 560 (645)
Q Consensus 484 ILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt--G~~pf~~~~~~ 560 (645)
|+++.++.++|+|||+++........ ......++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999998755332211 1223456778999999988889999999999999999998 6777764332
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..........+..+......+ .+......+.+++.+|++.||++|||+.|+++.|+
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 222333332222221111111 11112256888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.30 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=200.9
Q ss_pred CCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe-----
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE----- 423 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~----- 423 (645)
|...+.||+|+||.||+|.+..+ +..||+|+++.. .......+.+|++.+++++|+|++++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678999999999999998653 478999998754 33456789999999999999999999998866554
Q ss_pred -EEEEEEecCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 424 -LLLVYEFMPNGSLDSHLFKE-----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 424 -~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
.++|+||+++|+|..++... ...+++.....++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999888542 2468999999999999999999998 89999999999999999999999999
Q ss_pred cCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 498 GLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 498 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
|+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||...... .+.+++ ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hc
Confidence 999865433221 1122334678999999988889999999999999999999 88998653321 222222 12
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+... .. +......+.+++.+|++.||++||++.|+++.|..
T Consensus 231 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 2111 11 11223467888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=316.40 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=203.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.+|...++||+|+||.||++... .++..+|+|.+..........+.+|++++.+++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999999753 3467899999877766777889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 427 VYEFMPNGSLDSHLFKEN--------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999986532 358999999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~ 570 (645)
||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~-- 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIEC-- 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHH--
Confidence 99999998755322211 1122334678999999998899999999999999999998 99998644322 11111
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+.-.. .+ ..+ ...+.+++.+||+.||++||+++++++.|+
T Consensus 237 --~~~~~~~~--~~---~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 --ITQGRELE--RP---RTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --HHcCccCC--CC---CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111100 01 111 245678889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.96 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=207.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|++|.||++....++..++||.+... ......++.+|+.++.+++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999999888999999987643 2344568889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998853 34568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
... ......++..|+|||++.+..++.++|+||||+++|||++|..||...... ...... .. .....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~-----~~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KI-----EQCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhh----hh-----hcCCCCC
Confidence 221 222346888999999998888999999999999999999999999643321 111111 11 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+.. ......+.+++.+|++.||++||||.+|++.+.
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 111 123346778889999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.97 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=199.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhc---CCCCccEEEeeeee-----CC
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRL---RHRNLVQLLGWCHE-----KK 422 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~~-----~~ 422 (645)
+|...+.||+|+||.||+|.+..+++.||+|.++... ......+.+|++++.++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777899999999999999999999999999986532 22234556677777665 69999999998864 34
Q ss_pred eEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..++||||++ ++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999997 5888887653 3458999999999999999999998 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc---c
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK---L 578 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---l 578 (645)
...... ......++..|+|||++.+..++.++|||||||++|||++|+.||......+ ............. .
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhhC
Confidence 654322 2233467899999999998899999999999999999999999997543321 1111111111000 0
Q ss_pred c-------cccCcccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 L-------EAVDPRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 ~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ....+... .....+..+.+.+++.+||+.||++|||+.|++.+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00000000 00011123456788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.57 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=201.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+|...++||+|+||.||+|.+..+ +..||+|+++.... ...+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 456678899999999999987543 57899999975543 334678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 427 VYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
++||+++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999988521 2358889999999999999999998 89999999999999999999
Q ss_pred EEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHH
Q 042831 492 AKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~ 569 (645)
+||+|||+++........ ......+++.|+|||.+..+.++.++|||||||++|||++ |..||...... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~--- 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVI--- 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---
Confidence 999999998765432221 1223345778999999988889999999999999999998 88888653321 111
Q ss_pred HHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 570 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+...++.... .+......+..++..|++.+|++||+++++++.|+
T Consensus 237 -~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 237 -EMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -HHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 2222222111 11122345778889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.09 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=210.4
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEee-eee-----
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGW-CHE----- 420 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~-~~~----- 420 (645)
.....++++.+.|.+|||+.||.+.+...|..+|+|++-..+++..+...+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 344556778899999999999999999877999999987778889999999999999997 9999999993 221
Q ss_pred -CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 421 -KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 421 -~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
.-+.+|.||||++|.|-+++..+ ...|++.++++|+.|+++|+++||. +..+|||||||-+||||..+++.||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 23689999999999999999743 3459999999999999999999998 56789999999999999999999999999
Q ss_pred CcccccccCCcce--------eecccCccccCcccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 042831 499 LARLVEHAKGSQT--------TVLAGTMGYMAPECA---TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ 567 (645)
Q Consensus 499 la~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~ 567 (645)
.+.-.-....... -...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 9864332221110 112358899999976 567799999999999999999999999985422
Q ss_pred HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+++....-.-......++..||..||++||++||++-||++.+..
T Consensus 264 -----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 264 -----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred -----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 12223322222224577889999999999999999999999988863
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.84 Aligned_cols=240 Identities=27% Similarity=0.425 Sum_probs=191.1
Q ss_pred ccCcCCcEEEEEEEEcCC------------------------CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEE
Q 042831 359 KLGQGGFGGVYKGFFRET------------------------NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQL 414 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l 414 (645)
.||+|+||.||+|.+..+ ...|++|.+..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999986321 24589998876555556778899999999999999999
Q ss_pred EeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----
Q 042831 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---- 490 (645)
Q Consensus 415 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---- 490 (645)
+++|......++||||+++|+|..++.+....+++..+..++.||++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999987766789999999999999999999998 8999999999999997643
Q ss_pred ---cEEEeeccCcccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHH-cCCCCCCCCCCCCchhH
Q 042831 491 ---NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSL 565 (645)
Q Consensus 491 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~ell-tG~~pf~~~~~~~~~~l 565 (645)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-- 231 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH--
Confidence 3899999987643211 12346788999998865 56899999999999999995 699999754432211
Q ss_pred HHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 566 LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 566 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. .... ..+.... ...+.+++.+||+.+|++||++.++++.|.
T Consensus 232 -~~----~~~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 -RF----YEKK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HH----HHhc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 1110 0111111 135778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.86 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=211.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|++|.||+|.+..++..+|+|.+........+.+.+|++++++++|+|++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688889999999999999999888999999999877666778899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++.+.+..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-cc
Confidence 99999999987766779999999999999999999998 899999999999999999999999999987543322 22
Q ss_pred eeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 511 TTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....++..|++||.+. ...++.++|+||||+++|||++|+.||....... .+. . ...+.. +.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~----~-~~~~~~-----~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLL----K-ILKSEP-----PT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHH----H-HhcCCC-----CC
Confidence 23356889999999874 3446789999999999999999999997543211 111 1 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.. +......+.+++..||+.+|++||++++++++.+...
T Consensus 228 ~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 267 (280)
T cd06611 228 LDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267 (280)
T ss_pred cCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence 100 1112235667889999999999999999999988654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.82 Aligned_cols=254 Identities=30% Similarity=0.432 Sum_probs=201.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCe--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNS--YIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|+..+.||+|+||.||+|.+..++. .+++|.+... .....+++.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578888999999999999999877664 4688877643 344567889999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 427 VYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
||||+++++|.+++.+.. ..+++.+++.++.|++.||+|||+ .+++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 999999999999986432 357899999999999999999998 89999999999999999999
Q ss_pred EEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHH
Q 042831 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~ 570 (645)
+||+|||+++..... .......++..|+|||++....++.++|||||||+++||++ |..||...... ...+.
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~-- 235 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEK-- 235 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHH--
Confidence 999999998643211 11112234567999999988889999999999999999998 99999644321 11111
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+. .. .........+.+++.+|++.+|++||++.++++.|..
T Consensus 236 --~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 236 --LPQGY-----RL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred --HhcCC-----cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11110 00 0111122356788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.75 Aligned_cols=266 Identities=23% Similarity=0.254 Sum_probs=209.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|++|.||+|.+..+|+.|++|++.... ......+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999998889999999987553 34457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+ +++|.+++......+++.+++.++.||++||.|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999987766789999999999999999999998 899999999999999999999999999998665433222
Q ss_pred eeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc-----------
Q 042831 511 TTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL----------- 578 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l----------- 578 (645)
.....++..|+|||.+.+. .++.++||||+|++++||++|+.||...... ....++.........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcch
Confidence 3345688999999988654 4689999999999999999998888644321 222222221111000
Q ss_pred -ccccCcccc----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 -LEAVDPRLC----RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 -~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.....+.-. .+...+....+.+++.+|++++|++||+++++++|.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 000000000 00001123677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=312.02 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=195.7
Q ss_pred ccCcCCcEEEEEEEE--cCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 359 KLGQGGFGGVYKGFF--RETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+||+|+||.||+|.+ ..++..+|+|+++... ....+++.+|+.++.+++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999975 3567899999886443 345678999999999999999999999885 45679999999999
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc--ee
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ--TT 512 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~--~~ 512 (645)
+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998543 468999999999999999999998 899999999999999999999999999998664332211 11
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
...++..|+|||.+....++.++|+|||||++|||++ |+.||...... .+.+ ...++.... ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~~-----~~~~-- 222 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQ----MIESGERME-----CPQR-- 222 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCC-----CCCC--
Confidence 2234578999999988889999999999999999998 99999754321 1222 222222111 1111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
....+.+++.+|+++||++||++.+|.+.|+
T Consensus 223 --~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 223 --CPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred --CCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 2245678889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.49 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=194.8
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHH-HHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVK-IISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|++..+++.||+|.+.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999986432 223345556654 57889999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.. ...+++.....++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTST 155 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccc
Confidence 999888754 4568888899999999999999998 89999999999999999999999999998753221 122334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+ ....+.. .+ +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~----~i~~~~~------~~----~~~ 218 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD----NILHKPL------QL----PGG 218 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH----HHhcCCC------CC----CCC
Confidence 57899999999999888999999999999999999999999754311 1111 1111111 11 111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH----HHHHHHhcc
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI----RQVIHVLNF 625 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~~ 625 (645)
....+.+++.+||+.||++||+. .|++++.++
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence 23456788899999999999875 477777665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=314.54 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=204.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCe---EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+|...+.||+|+||.||+|.+..++. .||+|.+... .....++|..|+.++++++|||++++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999876554 6999998754 3445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++......+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999997666778999999999999999999998 8999999999999999999999999999876543222
Q ss_pred cce--eecc--cCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 509 SQT--TVLA--GTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 509 ~~~--~~~~--gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .... .+..|+|||.+..+.++.++|||||||++||+++ |+.||...... ....++. .+. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~~-----~ 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QDY-----R 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cCC-----c
Confidence 111 1111 1357999999998999999999999999999886 99999653321 2222221 110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..... +....+.+++..|++.+|++||++++++..|+.
T Consensus 230 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 230 LPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred CCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00011 123456788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.92 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=210.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||+|....+++.+++|.+........+.+.+|++++++++|||++++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999998888999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++....... ...
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-hcc
Confidence 9999999987665779999999999999999999998 899999999999999999999999999987654321 122
Q ss_pred eecccCccccCccccccC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 512 TVLAGTMGYMAPECATTG---KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....++..|+|||.+... .++.++|+||||+++|||++|+.||......... .. ...... ..+.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~-~~~~~~---~~~~~~- 227 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FL-ISKSNF---PPPKLK- 227 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhccC---CCcccc-
Confidence 335678899999998776 7899999999999999999999999754321111 00 001100 011111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
........+.+++.+|++.+|++|||+.+++.+-
T Consensus 228 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 228 -DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred -chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 1123345678899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.21 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=202.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||+|+||.||++....+++.||+|++... .......+.+|+.++.+++|+|++++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688889999999999999999999999999998643 2334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+. ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999998643 468999999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCC
Q 042831 509 ----------------------------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPI 554 (645)
Q Consensus 509 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf 554 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012346999999999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHhccCC
Q 042831 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP---SIRQVIHVLNFEA 627 (645)
Q Consensus 555 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L~~~~ 627 (645)
....... ... ..........+.+.. ..+ ..+.+++.+|+ .||++|+ +++|+++|.++..
T Consensus 237 ~~~~~~~---~~~----~i~~~~~~~~~p~~~--~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 237 CSETPQE---TYR----KVMNWKETLVFPPEV--PIS----EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCHHH---HHH----HHHcCCCceecCCCC--CCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 7544321 111 111111000111111 112 23444555555 4999998 5899999998753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.74 Aligned_cols=258 Identities=24% Similarity=0.308 Sum_probs=213.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+.|+..+.||+|.-|+||++.+.+++..+|+|++.+. .++...+...|-+||+.++||.++.|+..++.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4566688999999999999999999999999999765 3455667788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc--
Q 042831 429 EFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-- 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~-- 505 (645)
|||+||+|....+++ ++.+++..++-++..++-||+|||- .|||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999988754 6789999999999999999999999 9999999999999999999999999998653210
Q ss_pred -------------------------------c-C---------------------CcceeecccCccccCccccccCCCC
Q 042831 506 -------------------------------A-K---------------------GSQTTVLAGTMGYMAPECATTGKAS 532 (645)
Q Consensus 506 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~t 532 (645)
. . +..+..++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0111235799999999999999999
Q ss_pred cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC
Q 042831 533 KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL 612 (645)
Q Consensus 533 ~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~ 612 (645)
.+.|.|+|||+||||+.|+.||.+.+..+.. .. ...+ +.++.. .......+.+||+..|.+||++
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl--~N----Iv~~-------~l~Fp~--~~~vs~~akDLIr~LLvKdP~k 378 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETL--RN----IVGQ-------PLKFPE--EPEVSSAAKDLIRKLLVKDPSK 378 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhH--HH----HhcC-------CCcCCC--CCcchhHHHHHHHHHhccChhh
Confidence 9999999999999999999999876654321 11 1111 111111 1134566778999999999999
Q ss_pred CCC----HHHHHHHhccCC
Q 042831 613 RPS----IRQVIHVLNFEA 627 (645)
Q Consensus 613 RPs----~~evl~~L~~~~ 627 (645)
|-. +.||-+|.-|+.
T Consensus 379 Rlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 379 RLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred hhccccchHHhhcCccccC
Confidence 998 999999998763
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=323.58 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=202.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...++||+|+||.||++++..+++.+|+|.+... .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688899999999999999999999999999998642 2223455888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999997766779999999999999999999998 9999999999999999999999999999875533322
Q ss_pred cceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 509 SQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.......||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+............ .+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~-~~- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF-QF- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc-cC-
Confidence 2333457999999999886 34578999999999999999999999975432 11111111111000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCC--CCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAH--PDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~--~dP~~RPs~~evl~~L~~~ 626 (645)
+......+ ..+.+++.+|+. +++..||+++|+++|.++.
T Consensus 230 p~~~~~~s----~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~ 270 (332)
T cd05623 230 PAQVTDVS----EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFT 270 (332)
T ss_pred CCccccCC----HHHHHHHHHHccChhhhcCCCCHHHHhCCCCcC
Confidence 11111122 334455566554 4445579999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=320.68 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=209.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|++|.||++....+++.+|+|.+..... ...+.+..|++++.+++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999998899999999875432 35667899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||+.+++|.+++... +..+++..+..++.|+++||.|||. .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999988653 4578999999999999999999998 899999999999999999999999999987543221
Q ss_pred Cc----------------------------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 042831 508 GS----------------------------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559 (645)
Q Consensus 508 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~ 559 (645)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11124678899999999988899999999999999999999999975432
Q ss_pred CCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHhccC
Q 042831 560 QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS----IRQVIHVLNFE 626 (645)
Q Consensus 560 ~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~~L~~~ 626 (645)
.. .. .... .... .. .........+.+++.+|++.||++||+ ++|++.+.++.
T Consensus 238 ~~---~~---~~~~-~~~~------~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 238 DE---TF---SNIL-KKEV------TF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HH---HH---HHHh-cCCc------cC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 21 11 1111 1110 00 001113457788889999999999999 99999998765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.74 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=206.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555678999999999999998889999999987543 345567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++....... ...
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 99999988843 468999999999999999999998 899999999999999999999999999987654322 122
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||++.+..++.++|||||||+++||++|+.|+....+... . .. ...+ ..+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~~-~~~~-----~~~~~~---- 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---FL-IPKN-----SPPTLE---- 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---hh-hhcC-----CCCCCC----
Confidence 234578899999999988899999999999999999999999874432211 1 10 1111 112221
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+.+++.+|++.+|++||+|.+++++.+..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFIT 257 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHH
Confidence 22345677888999999999999999999988754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.73 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=202.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC--------------CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET--------------NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLL 415 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~ 415 (645)
.++|...++||+|+||.||++...++ ...||+|.++.. .......+.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35788899999999999999987543 235899998765 334456799999999999999999999
Q ss_pred eeeeeCCeEEEEEEecCCCChhhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCe
Q 042831 416 GWCHEKKELLLVYEFMPNGSLDSHLFKEN-----------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNI 484 (645)
Q Consensus 416 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 484 (645)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 99999999999999999999999885421 247899999999999999999998 8999999999999
Q ss_pred EECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCCCC
Q 042831 485 MLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC--GRKPINPKAPQG 561 (645)
Q Consensus 485 Lld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt--G~~pf~~~~~~~ 561 (645)
++++++.+||+|||++......... ......++..|+|||++..+.++.++|||||||+++||++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 9999999999999998755332211 1122345678999999998899999999999999999988 66777643322
Q ss_pred chhHHHHHHHHhcC-CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 562 QVSLLQWVWDLYGN-GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 562 ~~~l~~~~~~~~~~-~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
............ +.......+. .....+.+++.+|++.||++||+|.+|++.|.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 --QVIENTGEFFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHHhhhhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 122222221111 1111111111 12247888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.77 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=208.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|++|.||+|....+|+.||+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999999988999999988632 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||+++++|.+++.. .+..+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 34568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. +....+... .
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~-----~ 227 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEKCDYP-----P 227 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHH-hhhhcCCCC-----C
Confidence 221 223346888999999998888999999999999999999999999643321 11111 111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+. .......+.+++.+||+++|++||++.++++.|..
T Consensus 228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 10 11233467788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=323.98 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=216.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---hhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---QGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~l 426 (645)
...|...+.||+|.||.||+++.+.+|+.+|+|.+.+... .....+.+|+.+|+++. |||++++.+.++.....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4567888999999999999999999999999999976533 34568899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC----CCcEEEeeccCccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDFGLARL 502 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~----~~~~kl~DfGla~~ 502 (645)
|||++.+|.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+.. ++.+|++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999766 39999999999999999999999 99999999999999953 35799999999997
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
... .......+||+.|+|||++....++..+||||+||++|.|++|..||.......... ....++.
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~---- 255 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF---- 255 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC----
Confidence 765 456677899999999999999999999999999999999999999998765432211 1222322
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+..+.-....+.+..++..|+..||.+|+|+.++++|.|-.
T Consensus 256 --~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~ 297 (382)
T KOG0032|consen 256 --DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIK 297 (382)
T ss_pred --CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence 111222222345667788999999999999999999999854
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.65 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=203.4
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999999888999999998753 334456788999999999999999999988643
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++||||+++ +|...+. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999965 5655553 247899999999999999999998 999999999999999999999999999997
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HH--------------
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS-LL-------------- 566 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~-l~-------------- 566 (645)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64322 12233568999999999998889999999999999999999999997543211100 00
Q ss_pred -HHHHHHhcC-CccccccCcccc--------CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 -QWVWDLYGN-GKLLEAVDPRLC--------RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 -~~~~~~~~~-~~l~~~~d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+.....+ ........+... ..........+.+++.+|++.||++|||+.|++++.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 000000000 000000000000 001111235678899999999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.44 Aligned_cols=247 Identities=25% Similarity=0.288 Sum_probs=196.7
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHH-HHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVK-IISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+++...+|+.+|+|++... .....+++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999999999999998643 2233455666665 46778999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 999888754 4568999999999999999999998 89999999999999999999999999998743221 122334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... .+. .....+.+ .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~----~~~~~~~~------~~~~~~--- 219 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMY----DNILHKPL------VLRPGA--- 219 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHH----HHHHcCCc------cCCCCC---
Confidence 57899999999999999999999999999999999999999754321 111 11111111 111112
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHH----HHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIR----QVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~L~~~ 626 (645)
...+.+++..|++.+|++||+++ +++++.++.
T Consensus 220 -~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 220 -SLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred -CHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 23556788899999999999875 788877764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.80 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=205.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~~~lV~E 429 (645)
+|+..+.||+|++|.||++....+++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999999988999999998643 33455678899999999999999999998764 446899999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++++|.+++... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999998763 4568999999999999999999998 899999999999999999999999999998664322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......+++.|+|||.+.+..++.++||||||++++||++|+.||...... ...... ..+.+ +.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~-----~~~-- 222 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKL-----PPM-- 222 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCC-----CCC--
Confidence 2233456788999999999988999999999999999999999999743311 111111 12221 111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.......+.+++.+|++.+|++||++.+++++.+
T Consensus 223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred --ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 1123346778899999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=311.32 Aligned_cols=241 Identities=26% Similarity=0.452 Sum_probs=192.3
Q ss_pred CccCcCCcEEEEEEEEcCC------------CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 358 QKLGQGGFGGVYKGFFRET------------NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~------------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
+.||+|+||.||+|+.... ...|++|.+..........+.+|+.++.+++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 2368999876655555668889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc-------EEEeecc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN-------AKIGDFG 498 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-------~kl~DfG 498 (645)
+||||+++|+|+.++......+++..+..++.||++||.|||+ ++|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 9999999999999887666779999999999999999999998 89999999999999987664 8999999
Q ss_pred CcccccccCCcceeecccCccccCccccc-cCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECAT-TGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDV~SfGvll~ell-tG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
++...... ....++..|+|||++. ...++.++|||||||++|||+ .|+.|+......+. .. .. .+
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~---~~-~~ 224 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ER---FY-EG 224 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HH---HH-hc
Confidence 98654321 2235778899999887 456899999999999999998 58888764332111 11 11 11
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. ..... ....+..++.+||+.||++||+++++++.++
T Consensus 225 ~~------~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 QC------MLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred Cc------cCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11 01111 1245678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.07 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=209.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.|+..++||+|+||.||+|.+..++..||+|.+... .......+.+|+.++++++|+|++++++.+.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 466778999999999999999888999999998754 3455678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.. ..+++.+...++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 99999998853 468899999999999999999998 899999999999999999999999999997654322 122
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||++.+...+.++|+|||||++|||++|+.||....+.... .. . .........
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~---------~~~~~~~~~ 222 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL-I---------PKNNPPTLT 222 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh-h---------hcCCCCCCc
Confidence 3346788999999998888999999999999999999999999754322111 00 0 001111223
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+.+++..||+.+|++||++++++++.+..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 34456778899999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.35 Aligned_cols=265 Identities=24% Similarity=0.310 Sum_probs=201.0
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|++|.||+|+...+++.||+|.++... ....+.+.+|+.++.+++|||++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999999889999999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
++ ++|.+++... +..+++..+..++.||++||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 6888887542 3578999999999999999999998 899999999999999999999999999987553221
Q ss_pred cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC---C------cc
Q 042831 509 SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN---G------KL 578 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---~------~l 578 (645)
.......++..|+|||.+.+. .++.++|||||||+++||++|+.||........ +.... ..... . .+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIF-RILGTPTEDVWPGVTSL 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhcchhh
Confidence 112233568899999988654 478999999999999999999999975432111 10000 00000 0 00
Q ss_pred ---ccccCccccC---CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 ---LEAVDPRLCR---DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 ---~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+..... .........+.+++.+||+.||++|||+++++.+.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000000000 0000112456788999999999999999999988663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=324.84 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=202.0
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+|+..+.||+|+||.||++....+++.||+|++... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467788999999999999999999999999998753 2234566788999998886 577888999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++..... .
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-G 155 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC-C
Confidence 999999999888543 468999999999999999999998 89999999999999999999999999998753221 1
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.+.+. ++.. ....
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~----~~~~------~~p~ 222 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM----EHNV------SYPK 222 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCCC------CCCc
Confidence 2233456899999999999888999999999999999999999999754321 1222111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
. ....+.+++.+||+.+|.+|++ .+++++|.++.
T Consensus 223 ~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 223 S----LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred c----CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 1 2245677889999999999997 47788876654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.09 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=205.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||+|..... +..||+|.+.... ......+.+|+.++.+++|+|++++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45788889999999999999998643 3789999986553 34456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 425 LLVYEFMPNGSLDSHLFKE---------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998642 2347899999999999999999998 899999999999999999999999
Q ss_pred eccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHh
Q 042831 496 DFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 496 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|||+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |+.||...... ....+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~----~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKF----V 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHH----H
Confidence 9999876543322 12223456788999999988889999999999999999998 99998643321 12221 1
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.... .... ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLD-----LPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCC-----CCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1221111 1111 2356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.31 Aligned_cols=258 Identities=27% Similarity=0.390 Sum_probs=205.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEE-----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKK 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~ 422 (645)
..++|...+.||+|+||.||++.. ..++..||+|+++... ....+.+.+|+++++++ +|+||++++++|...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345788899999999999999975 2345689999987543 33456789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999987543 348999999999999999999998 899999999999999999999999999997
Q ss_pred cccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 502 LVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 502 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
........ ......++..|+|||.+....++.++|||||||++|||++ |+.||......+ .... ....+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~- 262 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGYR- 262 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCCc-
Confidence 65432211 1112345678999999999899999999999999999998 999987543221 1111 1111110
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+. ........+.+++.+|++++|++||++.|+++.|..
T Consensus 263 ----~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 263 ----MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ----CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00 011123467888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.22 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=201.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~ 424 (645)
.+|...+.||+|+||.||+|....++..|++|++... ..+..+.+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999999988999999988643 22345678899999999999999999998875 3578
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999998643 458999999999999999999998 899999999999999999999999999987653
Q ss_pred ccC--CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 505 HAK--GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 505 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~-----~ 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP-----T 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC-----C
Confidence 221 11122345788999999998888999999999999999999999999753221 1111111111 1
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.+.. ...+.+..++ .|+..+|++||+++|+++|.+++
T Consensus 227 ~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 NPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 122211 1122333343 68889999999999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.22 Aligned_cols=248 Identities=31% Similarity=0.493 Sum_probs=204.6
Q ss_pred CccCcCCcEEEEEEEEcCC---CeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|..... +..|++|.+...... ..+.+.+|++.+.+++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 889999998765433 367899999999999999999999999999999999999999
Q ss_pred CChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 434 GSLDSHLFKE--------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 434 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
++|.+++... ...+++..++.++.|++.||.|||+ ++++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765 4779999999999999999999998 9999999999999999999999999999987654
Q ss_pred cCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .......++..|+|||.+....++.++||||||++++||++ |+.||...... .+ .+...++...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV----LEYLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCC----
Confidence 321 12233457889999999988889999999999999999999 69999765321 11 1222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
. ........+.+++.+|++.+|++|||+.|++++|+
T Consensus 227 -~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -P----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -C----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 11112356778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.33 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=204.9
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCccEEEeeee
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNLVQLLGWCH 419 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~ 419 (645)
.....++|...++||+|+||.||+|++.+ +++.||+|++.... ....+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34445677888999999999999999643 45689999997543 333457889999999997 999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcC-------------------------------------------------------
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKEN------------------------------------------------------- 444 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------- 444 (645)
..+..++|+||+++|+|.+++++.+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999886421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 445 ------------------------------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 445 ------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
..+++.....++.||+.||.|||+ .+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence 246788889999999999999998 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQ 560 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~ 560 (645)
|||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532221 11122356788999999998889999999999999999998 89998643321
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+ ........+.. +. .+......+.+++..||+.+|++||+++++++.|+.
T Consensus 349 ~------~~~~~~~~~~~-----~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 349 E------QFYNAIKRGYR-----MA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H------HHHHHHHcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 11111112211 00 111123467788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.13 Aligned_cols=241 Identities=28% Similarity=0.474 Sum_probs=193.3
Q ss_pred CccCcCCcEEEEEEEEcCCCe-------EEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 358 QKLGQGGFGGVYKGFFRETNS-------YIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~-------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+.||+|+||.||+|.....+. .+++|.+........+.+.+|+.++.+++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999999865443 4888888665556667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc--------EEEeeccCccc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN--------AKIGDFGLARL 502 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--------~kl~DfGla~~ 502 (645)
+++|+|..++...+..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999997766678999999999999999999998 99999999999999987765 69999998864
Q ss_pred ccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCC-CCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGR-KPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~-~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... ... .....
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~~---- 221 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYEDR---- 221 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHcc----
Confidence 432 1234578899999999874 5799999999999999999985 5554322211 011 11110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+ +......+.+++..||+.||++|||++++++.|+
T Consensus 222 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011 1112245778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.90 Aligned_cols=249 Identities=30% Similarity=0.452 Sum_probs=204.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|++|.||+|... |+.||+|.+..... ..+++.+|+.++.+++|+|++++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457788899999999999999875 68899999976644 567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999986543 368999999999999999999998 9999999999999999999999999999986532211
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....+..|+|||.+..+.++.++||||||++++|+++ |+.||...... .+.. ....+.. ..
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~--- 219 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----HVEKGYR-----ME--- 219 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHhcCCC-----CC---
Confidence 2334667999999988899999999999999999997 99998754321 1111 1111110 01
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+.+++.+||+.+|++||+++++++.|+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111123567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.32 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=204.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC--CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
..+|...+.||+|+||.||++...+ ++..||+|.+... +...+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997643 4678999987543 23457999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|++. ++|.+++ .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9995 6888887 445679999999999999999999998 8999999999999999999999999999976543322
Q ss_pred -cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc-------
Q 042831 509 -SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE------- 580 (645)
Q Consensus 509 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~------- 580 (645)
.......||..|+|||++....++.++|||||||++|||++|+.||...........+..+...........
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 223346799999999999998999999999999999999999999976543322111111111111000000
Q ss_pred ------ccCccccCCCC-------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 581 ------AVDPRLCRDFD-------GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 581 ------~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.........+. ......+..++.+||+.||++|||+.|++.+.++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 00000000000 001234567788999999999999999999999864
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=318.16 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=209.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|+..+.||.|++|.||+|....+++.|++|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999998889999999987665555678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|..++.. ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 99999998853 358999999999999999999998 8999999999999999999999999999876543221 22
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||.+.+..++.++|||||||++|||++|+.||......... ... ...+ . +.+. ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---~~~---~~~~-~-----~~~~--~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLI---ATNG-T-----PELQ--NP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH---HhcC-C-----cccC--Cc
Confidence 2346888999999999888999999999999999999999999754432111 111 1111 0 0010 01
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......+.+++.+||+.||++||++.+++++-++..
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 112235667889999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.70 Aligned_cols=252 Identities=28% Similarity=0.510 Sum_probs=203.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.+|+..+.||+|+||.||++.+.. +..+|+|.+.... ....++.+|++++++++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 457778899999999999998864 6689999886442 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++......++++.+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999987666678999999999999999999998 8999999999999999999999999999875533222112
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... .+.+ . ..++. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~---~-~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE---T-INAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---H-HhCCC--CCCCCCC----
Confidence 22335678999999998889999999999999999998 99999743321 1111 1 11111 1111222
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=307.86 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=208.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|+||.||.++...+++.+++|.+... .....+++.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999999999999999987643 345567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++.+. ...+++.++..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998764 4568999999999999999999998 8999999999999999999999999999986543331
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......++..|+|||.+.+...+.++||||||++++||++|+.||...... +..... ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCCCCC--------
Confidence 223456889999999998888899999999999999999999999753321 111111 12222111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.......+.+++.+|++.+|++||++.++++++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 1122345778889999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.57 Aligned_cols=252 Identities=30% Similarity=0.461 Sum_probs=200.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...++||+|++|.||++.+..+ ..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4577788999999999999998764 469999876443 23467889999999999999999999875 45688999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++++|.+++.+. ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999754 3458999999999999999999998 899999999999999999999999999997654332222
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||...+..++.++||||||+++|||++ |+.||...... ....+ ...+.. + .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~----~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ----VERGYR-----M----P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC-----C----C
Confidence 222345678999999988899999999999999999999 89999754321 11111 111110 0 1
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+.+++.+||++||++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111233567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.04 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=208.0
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeee-
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCH- 419 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~- 419 (645)
+.++.+..+.++|+..+.||+|+||.||++.+..+++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445666778899999999999999999999999889999999876432 2235678899999999 6999999999874
Q ss_pred ----eCCeEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 420 ----EKKELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 420 ----~~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
.++..++||||+++++|.+++.. .+..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence 34578999999999999988753 34568999999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ 567 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~ 567 (645)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||........ +.
T Consensus 164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~- 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF- 239 (286)
T ss_pred EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh-
Confidence 999999987654322 12233468999999998753 3478899999999999999999999975432111 00
Q ss_pred HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ..+......++.. ....+..++.+|++.||++|||++|+++++++
T Consensus 240 ---~~-~~~~~~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 240 ---KI-PRNPPPTLHQPEL-------WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ---hc-cccCCCcccCCCC-------cCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 0111001111111 12357788899999999999999999998763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.30 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=191.6
Q ss_pred CCccCcCCcEEEEEEEEcC--CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeEEEEEEecC
Q 042831 357 DQKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKELLLVYEFMP 432 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~~lV~Ey~~ 432 (645)
.++||+|+||.||+|+..+ +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 5689999999999999753 56889999986442 23457789999999999999999998854 457899999985
Q ss_pred CCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----CCCCcEEEeeccCc
Q 042831 433 NGSLDSHLFKE--------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLA 500 (645)
Q Consensus 433 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kl~DfGla 500 (645)
++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5787776421 2358999999999999999999998 899999999999999 45678999999999
Q ss_pred ccccccCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc------hhHHHHHHH
Q 042831 501 RLVEHAKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQ------VSLLQWVWD 571 (645)
Q Consensus 501 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~------~~l~~~~~~ 571 (645)
+....... .......+|+.|+|||++.+. .++.++||||+||+++||++|+.||........ ....+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 87643221 122345789999999998764 589999999999999999999999975432211 111111111
Q ss_pred HhcCC---------------ccccccCccccCCC---------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNG---------------KLLEAVDPRLCRDF---------DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~---------------~l~~~~d~~l~~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+.. .............. ....-..+.+++.+||+.||++|||++|+++|.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11100 00000000000000 00001346788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.62 Aligned_cols=261 Identities=30% Similarity=0.383 Sum_probs=210.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||+|+||.||++....+++.||+|.+.... ....+++.+|++++..++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777899999999999999999889999999886543 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++.+ ...+++.....++.+++.||.|||+ ..+++||||||+||++++++.++|+|||++...... .
T Consensus 85 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~ 158 (284)
T cd06620 85 MDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---I 158 (284)
T ss_pred CCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---c
Confidence 999999988754 3468999999999999999999997 257999999999999999999999999998654221 1
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC-----chhHHHHHHHHhcCCccccccCcc
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG-----QVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~-----~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....|+..|+|||++.++.++.++|+|||||++|||++|+.||....... ...+.++........ .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 223568999999999988889999999999999999999999998544321 111222222211110 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.. .+....+.+++.+|+++||++|||+.|+++++++..
T Consensus 233 ~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 233 LPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 111 112345778889999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.28 Aligned_cols=248 Identities=29% Similarity=0.469 Sum_probs=198.1
Q ss_pred CccCcCCcEEEEEEEEcCCC---eEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETN---SYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
++||+|+||.||+|++...+ ..+|+|.+..... ...+++.+|+.+++++.|+|++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 7899999875543 35678899999999999999999999876 4568999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee-
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT- 512 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~- 512 (645)
++|.+++.... .+++..+..++.|++.||.|||. .+++|+||||+|||++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999996544 78999999999999999999998 89999999999999999999999999999866433322111
Q ss_pred -ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 513 -VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 513 -~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
...++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+..++ ..+.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~~---------~ 219 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERLP---------R 219 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcCC---------C
Confidence 1223467999999998899999999999999999998 9999975432 1222222 1111110 1
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.......+.+++.+|++++|++||++.++++.|+..
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 111234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=302.38 Aligned_cols=256 Identities=21% Similarity=0.326 Sum_probs=210.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+++|+..+.||+|.|+.||++.+..+|+.+|+|.+... +..+.+++.+|+.+.+.|+||||++|.+.+...+..+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677788999999999999999999999999987533 3346788899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl~DfGla~~~~~ 505 (645)
|+|.+++|-.-+.++ ...++......++||+++|.|+|. ++|||||+||+|++|- ..--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999997666443 456788888999999999999999 9999999999999994 33458999999998765
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.+......+||++|||||+++..+++..+|||+.||+||-|+.|+.||.+.... . +++.+..|... +++.
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---r----lye~I~~g~yd--~~~~ 234 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---R----LYEQIKAGAYD--YPSP 234 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---H----HHHHHhccccC--CCCc
Confidence 445556688999999999999999999999999999999999999999754322 1 23333333321 1221
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.-. ...+....|+.+||..||.+|.|+.|+|.|.|-
T Consensus 235 ~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 235 EWD----TVTPEAKSLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred ccC----cCCHHHHHHHHHHhccChhhhccHHHHhCCchh
Confidence 111 123455678899999999999999999999984
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.37 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=204.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...++||+|+||.||+|++..+++.||+|.++.........+.+|+.++..++|||++++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999999899999999987665555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.. ...+++.+...++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ...
T Consensus 89 ~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 89 GGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred CCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 99999998854 3468999999999999999999998 899999999999999999999999999987553221 222
Q ss_pred eecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 512 TVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....|+..|+|||++. .+.++.++|+|||||++|||++|+.||....+... +.... ..... .+....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~-~~~~~---~~~~~~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMT-KSNFQ---PPKLKD 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhh-ccCCC---CCcccc
Confidence 3456899999999874 45688999999999999999999999864432211 11110 11110 111111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. .....+.+++.+|++.+|++||++++++++.+
T Consensus 234 ~~--~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 KM--KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cC--CCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00 11235678889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.10 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=203.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
+|...+.||+|++|.||+|.+..+++.+|+|.+..... +..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 36677899999999999999988889999998864321 223568899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999998543 568899999999999999999998 89999999999999999999999999998866
Q ss_pred cccCC-----cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 504 EHAKG-----SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 504 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
..... .......|+..|+|||.+.+..++.++|+|||||++|||++|+.||...... ..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~--- 226 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIG-E--- 226 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHh-c---
Confidence 42211 1112245788999999999888999999999999999999999999753221 1111110 1
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+.+.. .....+..++.+||++||++||++.|++++.+
T Consensus 227 --~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 227 --NASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred --cCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 11122211 22356677889999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=315.60 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=204.0
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
...++|+..++||+|+||.||+|..++ .+..||+|.+.... ......+.+|+.++.+++|+||+++++++...+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346788999999999999999997652 35689999886543 234456889999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 423 ELLLVYEFMPNGSLDSHLFKE---------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999642 1345678889999999999999998 8999999999999999999999
Q ss_pred EeeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH
Q 042831 494 IGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~ 571 (645)
|+|||+++......... .....++..|+|||.+..+.++.++|||||||++|||++ |+.||...... ...+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~---- 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLK---- 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----
Confidence 99999987553322211 112234678999999998899999999999999999998 78888643321 1111
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+... ... ......+.+++.+|++.||++|||+.++++.|...
T Consensus 233 ~~~~~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGYL-----DQP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCCC-----CCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111111 111 11235788899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.29 Aligned_cols=266 Identities=24% Similarity=0.302 Sum_probs=206.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-----hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-----QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+|...+.||+|++|.||+|....+++.||+|.+..... .....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 46778899999999999999988899999999875432 2345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+ +++|.+++......+++..+..++.||++||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 999999986655579999999999999999999998 899999999999999999999999999998654332
Q ss_pred CcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC---------Cc
Q 042831 508 GSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN---------GK 577 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---------~~ 577 (645)
.......++..|+|||.+.+ ..++.++|||||||+++||++|..||....+.+ ........... ..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhccc
Confidence 12223346788999998855 457899999999999999999988876543221 11111111100 00
Q ss_pred cccccCccccCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 578 LLEAVDPRLCRDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 578 l~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+............+ ......+.+++.+||++||++|||+.|++++-++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 00111100011111 12245678899999999999999999999998876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.98 Aligned_cols=247 Identities=30% Similarity=0.447 Sum_probs=195.6
Q ss_pred CccCcCCcEEEEEEEEcCCCe--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNS--YIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||+|++.+++. .+++|.+... .....+.+.+|++++.++ +|||+++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999987764 5688888643 345567889999999999 799999999999999999999999999
Q ss_pred CChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 434 GSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 434 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
|+|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 357899999999999999999998 899999999999999999999999999
Q ss_pred CcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
++...... ........+..|+|||++....++.++|||||||+++||++ |+.||...... ...+ ....+.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~----~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE----KLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHH----HHhCCC
Confidence 98632211 11111223567999999988889999999999999999997 99999653321 1111 111111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. .. .......+.+++.+|++.+|.+|||+.++++.|..
T Consensus 229 ~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 RL-----EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CC-----CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 01 11122457788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.11 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=204.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||++.+.. ++..||+|.+.... ....+++.+|+.++++++|||+++++++|..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4678889999999999999998753 56889999987543 34557799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCC
Q 042831 425 LLVYEFMPNGSLDSHLFKEN---------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 483 (645)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986321 247889999999999999999998 899999999999
Q ss_pred eEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042831 484 IMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQG 561 (645)
Q Consensus 484 ILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~ 561 (645)
|++++++.+||+|||+++........ .......+..|+|||.+....++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999998754332211 1122234667999999988899999999999999999997 88888643321
Q ss_pred chhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 562 QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 562 ~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
... .....+..... +......+.+++.+|++.+|++|||+.|+++.|+
T Consensus 240 --~~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 --EVI----YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --HHH----HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 111 11222322111 1112346778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.25 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=204.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+|+..++||+|+||.||++.+..+++.+|+|.++.. .....+.+.+|+.++++++|+|++++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467789999999999999999989999999998643 3445677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++++|.+++.. ....+++.....++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 99999998865 34568999999999999999999998 899999999999999999999999999987654322 12
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||...... ...... ..+.... +
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~~-~-------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKV-CQGSYKP-L-------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHH-hcCCCCC-C--------
Confidence 23356888999999998888999999999999999999999999743321 111111 1221111 1
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
+......+.+++.+||+.||++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11122356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.06 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=202.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...++||+|+||.||+|...+ ++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4568888999999999999998754 67899999865433 3467899999999999999999999874 4578999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... +..+++.++..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999988653 4578999999999999999999998 89999999999999999999999999999766533222
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||++....++.++||||||++++||++ |+.||...... ..... ...+.. .....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~-----~~~~~ 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN----LERGYR-----MPRPD 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH----HHcCCC-----CCCCC
Confidence 2223345678999999998889999999999999999999 99999754321 11111 111111 01111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++.+|++.+|++||++++++..|+
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 227 ----NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 12246788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.19 Aligned_cols=269 Identities=22% Similarity=0.295 Sum_probs=205.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|++++.+++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788899999999999999999889999999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|..++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999888776643 3468999999999999999999999 9999999999999999999999999999986643321
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH-H-------HHHhcCCcc-c
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW-V-------WDLYGNGKL-L 579 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~-~-------~~~~~~~~l-~ 579 (645)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....... . .+.+..... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2233457889999998866 4578999999999999999999999975443221111100 0 000000000 0
Q ss_pred cccCccccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+......+. .....+.+++.+|++++|++||++.|++.+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000110000010 113567789999999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.48 Aligned_cols=254 Identities=31% Similarity=0.497 Sum_probs=205.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...++||+|+||.||+|.+.+ ++.+|||.+.... ...+++.+|++++++++|+|++++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678889999999999999999864 5779999987543 345678999999999999999999999998899999999
Q ss_pred ecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++++|.+++.+.. ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997643 578999999999999999999998 8999999999999999999999999999876643222
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......++..|+|||.+.+..++.++|+||||++++||++ |+.||...... ...+.. ..+. ...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~----~~~~-----~~~-- 224 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV----ERGY-----RMP-- 224 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HcCC-----CCC--
Confidence 22222334568999999998889999999999999999998 99999643321 112211 1110 000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+......+.+++.+|++.+|++||+++++++.|+
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 225 --RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 01111346788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.09 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=200.0
Q ss_pred CCCccCcC--CcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 356 DDQKLGQG--GFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 356 ~~~~LG~G--~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
..++||+| +|++||+++...+|+.||+|++.... ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999999999999999987542 334456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-c
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-S 509 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~ 509 (645)
++|+|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++++||+.......... .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 3458999999999999999999998 8999999999999999999999999986543221110 0
Q ss_pred -----ceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 510 -----QTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 510 -----~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .... .. .+.+...+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~----~~-~~~~~~~~ 231 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLE----KL-NGTVPCLL 231 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHH----Hh-cCCccccc
Confidence 1122346778999999876 358899999999999999999999997533211 0000 00 01110000
Q ss_pred -------------------Cccc-----------------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 -------------------DPRL-----------------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 -------------------d~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+..+ ...........+.+++.+||+.||++|||++|++++.++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 0000 0011112234677899999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.21 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=214.4
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcC----CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRE----TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
...+.....++||.|.||.||+|.+.. ..-.||||..+.+ .....+.|++|..+|+.++||||++|+|.|.+ ..
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 334455667899999999999999853 2357999999875 44567889999999999999999999999975 57
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.+||||.++-|.|..+|..++..|+......++.||..+|+|||+ ..+|||||..+|||+...-.+||+|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 899999999999999999988899999999999999999999999 99999999999999999999999999999998
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
+...........-...|||||.+.-..++.+||||.|||++||++. |..||..-...+... .+++|...
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGeRl--- 611 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGERL--- 611 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCCCC---
Confidence 8777666665556778999999999999999999999999999988 999998654432211 11233221
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..++.+...+..|..+||..||.+||.+.|+...|.
T Consensus 612 ------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 612 ------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 222233456778889999999999999999887765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.14 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=206.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcC----CCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRE----TNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHE--KKEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~ 424 (645)
+.|...+.||+|+||.||++.+.. ++..+|+|.+...... ..+++.+|++++++++|+|++++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 356677899999999999999753 4789999998765443 56789999999999999999999999987 5678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997766679999999999999999999998 899999999999999999999999999998765
Q ss_pred ccCCcc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch--------hHHHHHHHHhc
Q 042831 505 HAKGSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV--------SLLQWVWDLYG 574 (645)
Q Consensus 505 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~--------~l~~~~~~~~~ 574 (645)
...... .....++..|++||.+.+..++.++||||||++++||++|+.|+......... .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 322211 11234456799999998889999999999999999999999998643221100 00111111111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.. ...+......+.+++.+|++.+|++||+|+|+++.|..
T Consensus 241 ~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 241 EGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred cCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 1110 01111222567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.59 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=205.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||+|+||.||++.+..++..||+|.+... .......+.+|++++.+++|+|++++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3577889999999999999999988999999988654 334457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
+++++|..++... ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999888653 3478999999999999999999997 258999999999999999999999999998754321
Q ss_pred cceeecccCccccCccccccCC------CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGK------ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
......++..|+|||.+.+.. ++.++|+|||||++|||++|+.||....... ..... .....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~-~~~~~~~----- 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL-SAIVDGD----- 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH-HHHhhcC-----
Confidence 222345788999999886543 4889999999999999999999997543221 11111 1111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.+ +......+..++.+|++.+|++||++++++.+.++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~ 266 (286)
T cd06622 227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266 (286)
T ss_pred CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence 1111 122345567888999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=316.03 Aligned_cols=270 Identities=25% Similarity=0.342 Sum_probs=207.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..++||+|++|.||+|.+.++++.|++|.++.. .....+.+.+|++++++++|+|++++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3678889999999999999999988999999988643 23345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++++.+..+. .....+++..+..++.||+.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99987776554 344568999999999999999999998 89999999999999999999999999999876544332
Q ss_pred ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH--------HHh-cCCccc
Q 042831 510 QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW--------DLY-GNGKLL 579 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~--------~~~-~~~~l~ 579 (645)
......++..|+|||++.+. .++.++||||||+++|||++|+.||......+........+ ... .+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 33445678899999999888 78999999999999999999999997543221111100000 000 000000
Q ss_pred -----cccCcc-ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 -----EAVDPR-LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 -----~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..++. +...++......+.+++.+||+.+|++||++++++++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000 0000111124678899999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=305.16 Aligned_cols=247 Identities=30% Similarity=0.459 Sum_probs=200.3
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
++||+|++|.||++.+.. ++.|++|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999987 89999999876533 3567899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce-eecc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT-TVLA 515 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~-~~~~ 515 (645)
.+++......+++..+..++.+++.+|.|||+ ++++||||||+||+++.++.+||+|||+++.......... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99997666678999999999999999999998 8999999999999999999999999999975542211111 1122
Q ss_pred cCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 516 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
.+..|+|||.+.++.++.++|+|||||+++||++ |..||....... .... ...+. ....+...
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~----~~~~~---------~~~~~~~~ 220 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER----IESGY---------RMPAPQLC 220 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH----HhcCC---------CCCCCccC
Confidence 3567999999988889999999999999999999 888886543221 1111 11110 00111122
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 595 IERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+.+++.+|++.+|++||++.|+++.|+
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 346788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.11 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=203.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-------CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-------TNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
.++|...+.||+|+||.||++...+ ....+|+|.+... ......++..|++++.++ +|+||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3578889999999999999998643 2356999998754 334556788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999996532 358999999999999999999998 899999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVS 564 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~ 564 (645)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H
Confidence 999999999999987654322111 112234568999999988889999999999999999998 88888643221 1
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+......+... ..+......+.+++..|++.+|++||+|.++++.|+.
T Consensus 251 ----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 ----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred ----HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 11111122111 1111223466778899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.40 Aligned_cols=265 Identities=25% Similarity=0.323 Sum_probs=209.9
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
+...++..++++|...+.||+|+||.||++....+++.+|+|.+.... ....++.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677778899999999999999999999999889999999986532 2345677899999999 79999999999875
Q ss_pred C-----CeEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 421 K-----KELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 421 ~-----~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
. +..++|+||+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 368999999999999998753 34578999999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK-----ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ 567 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~ 567 (645)
||+|||+++....... ......++..|+|||.+.... ++.++|||||||++|||++|+.||....... .+.
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~- 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF- 243 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH-
Confidence 9999999876543221 122346788999999876543 6889999999999999999999997543211 111
Q ss_pred HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... ++......+ ..+....+..++.+|++.+|++||++.|++++.++
T Consensus 244 ---~~~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 244 ---KIP-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred ---HHh-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 111 111111111 11223467889999999999999999999998765
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.18 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=203.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...++||+|+||.||+|.+.+. ...|++|...... .+..+.+.+|+.++++++|||+++++++|.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34577889999999999999987643 3579999887654 4556789999999999999999999999875 45789
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999997666678999999999999999999998 89999999999999999999999999999865443
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........++..|+|||.+....++.++||||||++++|+++ |+.||...... ....+. .++... .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~~~~~-----~ 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----ENGERL-----P 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----HcCCcC-----C
Confidence 2222222334568999999988889999999999999999986 99999754322 111111 112111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ....+.+++.+|+.++|++|||+.++++.|+.
T Consensus 229 ~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 229 MPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 22457778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=306.62 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=200.9
Q ss_pred CccCcCCcEEEEEEEEcC-CC--eEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRE-TN--SYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~-~~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
++||+|++|.||+|.+.. .+ ..||+|.++.... ...+.+.+|+.++++++|+||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 23 3699999987655 667889999999999999999999999988 889999999999
Q ss_pred CChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc--c
Q 042831 434 GSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS--Q 510 (645)
Q Consensus 434 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~--~ 510 (645)
++|.+++.+.. ..+++...+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 578999999999999999999998 89999999999999999999999999999876442221 1
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||++....++.++|||||||++|||++ |+.||...... ....... ..+... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~~---------~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGERL---------E 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCCcC---------C
Confidence 122456788999999998899999999999999999998 99999643321 1111111 111100 0
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+......+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112346778899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.27 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=203.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|+||.||+|++..+|+.+|+|++.... ......+.+|++++++++|+|++++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999999999999999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ ++|.+++......+++.....++.||++||.|||+ .+++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-C 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-C
Confidence 96 57888876666679999999999999999999998 8999999999999999999999999999976543221 2
Q ss_pred eeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc------cccccC
Q 042831 511 TTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK------LLEAVD 583 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~------l~~~~d 583 (645)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.|+...... ............... +.+..+
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 22345788999999887654 789999999999999999999886543321 111111111111000 000000
Q ss_pred ----ccccCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 ----PRLCRD-----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ----~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..... ........+.+++.+||+.||++|||++|++++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000 011123567788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=323.69 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=193.8
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHH-HHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVK-IISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|+||.||++++..+++.||+|++.... .....++..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999986432 223344555544 56778999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|.+++... ..+++.....++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccc
Confidence 9999988653 457788888999999999999998 89999999999999999999999999998753221 122344
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.+ . .... .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~-~~~~------~~~~~~--- 219 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI---L-NKPL------QLKPNI--- 219 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH---H-hCCc------CCCCCC---
Confidence 57999999999999999999999999999999999999999754321 111111 1 1111 111112
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHH----HHHHHhcc
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIR----QVIHVLNF 625 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~----evl~~L~~ 625 (645)
...+.+++.+|++.||.+||++. +++++.++
T Consensus 220 -~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 220 -TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred -CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCccc
Confidence 23566788899999999999876 66666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.90 Aligned_cols=269 Identities=25% Similarity=0.331 Sum_probs=204.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++|||++++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999998889999999876432 2245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|..+... ...+++.++..++.||++||.|||+ .+++|+||+|+||++++++.+||+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 9999998876643 3458999999999999999999998 899999999999999999999999999987654332 2
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHHHH-------HHHhcCCcc-c
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS-LLQWV-------WDLYGNGKL-L 579 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~-l~~~~-------~~~~~~~~l-~ 579 (645)
......++..|+|||++.+ ..++.++||||||++++||++|+.||......+... +..+. ........+ .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233457889999998865 447889999999999999999999997443211100 00000 000000000 0
Q ss_pred cccCccccCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRDF-----DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+...... .......+.+++.+||+.+|++||++.+++++.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00001000000 01123567889999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.07 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=204.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEc-------CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFR-------ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
..++|...+.||+|+||.||+++.. ..+..||+|.+... .....+++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567888899999999999999753 23457999988654 344567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeE
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 485 (645)
.+..++||||+++|+|.+++.+. ...+++..+..++.||++||.|||+ .+++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999998653 2357889999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCch
Q 042831 486 LDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQV 563 (645)
Q Consensus 486 ld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~ 563 (645)
+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--- 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence 999999999999999866432222 1222345678999999988889999999999999999998 78888643211
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+ ..+...++.... ........+..++.+||+++|++||++.|+++.|..
T Consensus 247 ---~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 ---E-LFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---H-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 1 122222221110 011223467778899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.58 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=203.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh----------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK----------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
+|...+.||+|+||.||+|....+++.+|+|.++.... ...+.+.+|+.++.+++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46678899999999999999988899999998753211 12346788999999999999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999998654 578999999999999999999998 8999999999999999999999999999976
Q ss_pred ccccCC-cceeecccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 503 VEHAKG-SQTTVLAGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 503 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
...... .......++..|+|||.+.... ++.++|+||||++++|+++|+.||..... .....+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNK-RSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcc-ccC
Confidence 532211 1123346788999999987654 78999999999999999999999963321 1111221111 111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+++..... ....+.+++..|++++|++||++++|+++.+
T Consensus 231 ~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 231 PPIPPDVSMN----LSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred CcCCcccccc----CCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 1122222222 2356777889999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.08 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=206.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|+||.+|++....+++.||+|++... .....+++.+|+.++++++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999999988999999998643 334556889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++... ...+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 9999999988654 3468999999999999999999998 899999999999999999999999999997654322 1
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......|+..|+|||++.+...+.++|+|||||+++||++|+.||...... +.+.... .+.. +..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~-----~~~--- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-RGSY-----PPV--- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-cCCC-----CCC---
Confidence 222345788999999998888999999999999999999999999743321 1111111 1111 111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.......+.+++.+|++.+|++||+|++|+++.+
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred -cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 1122345778889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=311.04 Aligned_cols=262 Identities=25% Similarity=0.415 Sum_probs=202.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC----------------CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE----------------TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQ 413 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~----------------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~ 413 (645)
.++|+..++||+|+||.||++...+ ++..+|+|.+... ......++.+|++++.+++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3568889999999999999986432 3457999998754 3445678999999999999999999
Q ss_pred EEeeeeeCCeEEEEEEecCCCChhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCC
Q 042831 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKEN----------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483 (645)
Q Consensus 414 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~N 483 (645)
+++++...+..++||||+++++|.+++.... ..+++.+...++.|++.||.|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999886432 347888999999999999999998 899999999999
Q ss_pred eEECCCCcEEEeeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 042831 484 IMLDSNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC--GRKPINPKAPQ 560 (645)
Q Consensus 484 ILld~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt--G~~pf~~~~~~ 560 (645)
||+++++.++|+|||+++.+....... .....++..|++||....+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999997653322111 112234678999999888889999999999999999998 77888644322
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.........+......... +. +......+.+++.+||+.||++||++.++++.|.
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQGRQVYL-PK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhccccccC-CC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1122121211111111110 11 1112256778999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.05 Aligned_cols=267 Identities=23% Similarity=0.295 Sum_probs=203.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 578889999999999999999988899999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ ++|.+++......+++.....++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++....... .
T Consensus 85 ~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 85 LD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred CC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 97 48999887666678999999999999999999998 8999999999999999999999999999875432111 1
Q ss_pred eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC---cccc------
Q 042831 511 TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG---KLLE------ 580 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---~l~~------ 580 (645)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......++..+.. ....
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122346788999998865 45889999999999999999999999654321 11111122111110 0000
Q ss_pred -------cc-CccccCCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 581 -------AV-DPRLCRDF-DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 581 -------~~-d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ...+.... .......+.+++.+||+++|++|||+.|++++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 00000000 00112566788899999999999999999988764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.83 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=206.4
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLVYE 429 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV~E 429 (645)
|...++||+|++|.||+|+...+++.+|+|++.... ....+.+.+|++++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556788999999999999999889999999997653 34456788999999999999999999999887 89999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++ ++|.+++......+++..++.++.||++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 997 48888886665689999999999999999999998 89999999999999999999999999999876544322
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC---cc-------
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG---KL------- 578 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---~l------- 578 (645)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.+..... ..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccch
Confidence 2333456788999997765 457899999999999999999999997554321 111111111100 00
Q ss_pred -------ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 -------LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 -------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+...+...+...+.+++..|++.+|++||++++++++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000001111124678889999999999999999999988763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=307.05 Aligned_cols=239 Identities=28% Similarity=0.485 Sum_probs=193.3
Q ss_pred CccCcCCcEEEEEEEEcCCC----------eEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 358 QKLGQGGFGGVYKGFFRETN----------SYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~----------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.++++++|||+++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999998766 45888877654433 6788999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-------cEEEeeccCc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-------NAKIGDFGLA 500 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-------~~kl~DfGla 500 (645)
|||+++|+|.+++......+++..+..++.||+.||.|||+ ++++||||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999997666578999999999999999999998 8999999999999999887 7999999998
Q ss_pred ccccccCCcceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
..... .....++..|+|||++... .++.++||||||+++|||++ |..|+........ ..+ +....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~----~~~~~ 223 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERF----YQDQH 223 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHH----HhcCC
Confidence 76433 1223466789999998876 78999999999999999999 5777765432211 111 11110
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
. + .. .....+.+++.+|++.+|++||++.++++.|+
T Consensus 224 ~-------~-~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 R-------L-PM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------C-CC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0 00 01157778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=315.28 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=203.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~ 424 (645)
..|...++||+|+||.||++.+ ..++..||+|.++... ......+.+|++++++++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999985 3467899999987553 44457899999999999999999999998775 568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++.+....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 99999999999999987665678999999999999999999998 999999999999999999999999999998654
Q ss_pred ccCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCC---------CchhHHHHHHHHh
Q 042831 505 HAKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ---------GQVSLLQWVWDLY 573 (645)
Q Consensus 505 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~---------~~~~l~~~~~~~~ 573 (645)
..... ......++..|+|||++.+..++.++|||||||++|||++++.|....... .... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT-VTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc-HHHHHHHH
Confidence 33221 112345677899999998888999999999999999999988765321100 0000 11111111
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.++.... ........+.+++.+|++.+|++||++.++++.|+.
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 240 EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 1121110 111234578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=328.46 Aligned_cols=265 Identities=23% Similarity=0.295 Sum_probs=211.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-C-----CCccEEEeeeeeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-H-----RNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nlv~l~~~~~~~~~~~l 426 (645)
+|.+.+.||+|.||.|-+|.+..+++.||||+++.. +....+-..|+.+|.+|+ | -|+|++++++..++++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999999999999999999654 455677788999999997 4 389999999999999999
Q ss_pred EEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--CCcEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~~ 503 (645)
|+|.+ .-+|+++++.++ ..++...++.|+.||+.||.+||+ .+|||+||||+||||.+ ...+||+|||.++..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99998 679999998654 568999999999999999999998 99999999999999964 347999999999865
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH--------HHHHHhcC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ--------WVWDLYGN 575 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~--------~~~~~~~~ 575 (645)
...-. ....+..|+|||++.+.+|+.+.||||||||+.||.+|.+.|.+..+.++...+. |+.+...+
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 43322 3456788999999999999999999999999999999998888777655543332 11111100
Q ss_pred ---------Cccc-------------------------cccCc-c---ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 042831 576 ---------GKLL-------------------------EAVDP-R---LCRDFDGQQIERLMIVGLWCAHPDENLRPSIR 617 (645)
Q Consensus 576 ---------~~l~-------------------------~~~d~-~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 617 (645)
+... +..-| . +.......+-+.+++++.+|+..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0000 00001 0 00011112336678999999999999999999
Q ss_pred HHHHHhccC
Q 042831 618 QVIHVLNFE 626 (645)
Q Consensus 618 evl~~L~~~ 626 (645)
|+++|.+..
T Consensus 498 qal~Hpfl~ 506 (586)
T KOG0667|consen 498 QALNHPFLT 506 (586)
T ss_pred HHhcCcccc
Confidence 999999965
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.66 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=202.0
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578889999999999999999999899999999986532 23456678999999999999999999987543
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++++|++ +++|..++. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 4579999988 788887763 3468999999999999999999998 899999999999999999999999999997
Q ss_pred cccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC----
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG---- 576 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---- 576 (645)
.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ............
T Consensus 167 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPSPEV 239 (343)
T ss_pred ecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 6532 2233568999999999876 568999999999999999999999997543211 111111110000
Q ss_pred -------ccccccCccccCCCCH--------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 577 -------KLLEAVDPRLCRDFDG--------QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 -------~l~~~~d~~l~~~~~~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.....+. .+ ..... .....+.+++.+|++.||++|||+.|+++|.++..
T Consensus 240 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 240 LKKISSEHARKYIQ-SL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred HHhcchhhHHHHhh-cc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0000000 00 00000 01134678899999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.30 Aligned_cols=263 Identities=26% Similarity=0.385 Sum_probs=208.7
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
.++.++..+.+.|+..+.||+|+||.||+|.+..+++.+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 466677777889999999999999999999999889999999986543 3346788899999998 69999999999853
Q ss_pred ------CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 421 ------KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 421 ------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
....+++|||+++|+|.+++... ...+++..+..++.||++||.|||+ .+++|+||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988653 3568899999999999999999998 8999999999999999999999
Q ss_pred EeeccCcccccccCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW 568 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~ 568 (645)
|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.....
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---- 236 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---- 236 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----
Confidence 999999875532221 223356889999999875 3457889999999999999999999996543211110
Q ss_pred HHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 569 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. .....+.+.. ......+.+++.+||+.||.+||++.|++++.+
T Consensus 237 --~~------~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 237 --LI------PRNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred --hH------hhCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 00 0001111111 112346778889999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.95 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=206.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+|+..+.||+|++|.||+|....+++.+|+|.+.... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777899999999999999998889999999886432 2245788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEH 505 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~ 505 (645)
|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 9999999999998864 3468899999999999999999998 8999999999999998776 599999999876543
Q ss_pred cCC---cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 506 AKG---SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 506 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
... .......++..|+|||.+.+..++.++||||+|++++||++|+.||.......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~------- 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIASA------- 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhcc-------
Confidence 211 11223467889999999988889999999999999999999999997543322111 11111100
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
......+......+.+++.+|++.+|++||++.+++.+.++
T Consensus 227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 00112222334567788899999999999999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.65 Aligned_cols=254 Identities=25% Similarity=0.336 Sum_probs=205.8
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
|.....||+|+||.||++....++..||||.+........+.+.+|+.++.+++|+|++++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33356799999999999999888999999998766656667889999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
++|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||++++++.+||+|||++....... .....
T Consensus 104 ~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 177 (292)
T cd06658 104 GALTDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKS 177 (292)
T ss_pred CcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCce
Confidence 999998743 358999999999999999999998 899999999999999999999999999987543222 12233
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..++..|+|||.+.+..++.++||||||+++|||++|+.||....... ... . .. ..+.+.+... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~---~-~~-----~~~~~~~~~~--~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR---R-IR-----DNLPPRVKDS--HK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HH-----hcCCCccccc--cc
Confidence 568899999999988889999999999999999999999997533211 111 0 10 1111111111 01
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
....+..++..|++.||++|||++|++++.++..
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 2235667788999999999999999999988873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.47 Aligned_cols=251 Identities=31% Similarity=0.507 Sum_probs=203.6
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCC----eEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETN----SYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
|+..+.||+|+||.||++.+...+ ..||+|.+...... ..+.+..|+.++.+++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356788999999999999998765 88999999765433 6778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||+++++|.+++...... +++.++..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765444 8999999999999999999998 899999999999999999999999999998665432
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
........++..|+|||.+.+..++.++||||+|++++||++ |+.||..... ..+.+. ...+.... .
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~-----~ 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY----LKKGYRLP-----K 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCC-----C
Confidence 222212336789999999988889999999999999999998 8888865322 112221 11221111 0
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
.. .....+.+++.+|++.+|++|||+.|+++.|
T Consensus 226 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1234577788999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.04 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=194.4
Q ss_pred CccCcCCcEEEEEEEEcC---CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeee-eCCeEEEEEEecC
Q 042831 358 QKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCH-EKKELLLVYEFMP 432 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~-~~~~~~lV~Ey~~ 432 (645)
+.||+|+||.||+|.+.+ .+..||+|++... .....+.+.+|+.+++.++|||+++++++|. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 3467999998543 3445678889999999999999999999876 4556899999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC---c
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG---S 509 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~---~ 509 (645)
+|+|.+++.+....+++..+..++.|+++||.|||+ .+++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997666667888889999999999999998 8999999999999999999999999999875432111 1
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACG-RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||.+....++.++|||||||++|||++| ..||..... ..+...+. .+.. +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~~~-----~~~~~ 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QGRR-----LLQPE 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cCCC-----CCCCC
Confidence 11223456789999999888999999999999999999995 556653321 12222211 1110 11011
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ....+.+++..||+++|++||++.++++.|+.
T Consensus 226 ~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 226 Y----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred c----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1 12457788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=313.59 Aligned_cols=263 Identities=19% Similarity=0.290 Sum_probs=190.9
Q ss_pred CCccCcCCcEEEEEEEEcC--CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee--eCCeEEEEEEecC
Q 042831 357 DQKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH--EKKELLLVYEFMP 432 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~~lV~Ey~~ 432 (645)
..+||+|+||.||+|+..+ ++..||+|.+.... ....+.+|++++++++||||+++++++. .+...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4689999999999999764 56789999886543 2346778999999999999999999885 3567899999986
Q ss_pred CCChhhhhhh--------cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----CCCCcEEEeeccCc
Q 042831 433 NGSLDSHLFK--------ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLA 500 (645)
Q Consensus 433 ~gsL~~~l~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kl~DfGla 500 (645)
+ +|.+++.. ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 67666532 12358899999999999999999998 899999999999999 56778999999999
Q ss_pred ccccccCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc------hhHHHHHHH
Q 042831 501 RLVEHAKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQ------VSLLQWVWD 571 (645)
Q Consensus 501 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~------~~l~~~~~~ 571 (645)
+....... .......+|..|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 86643322 122345689999999998764 589999999999999999999999975432211 011111111
Q ss_pred HhcCCc---------------cccccC------cccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGK---------------LLEAVD------PRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~---------------l~~~~d------~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+... +..... +.+. ..........+.+++.+|++.||++|||++|++++.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 110000 000000 0000 00000112346778999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.83 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=199.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC-C
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK-K 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~-~ 422 (645)
.++|...+.||+|+||.||+|.+. .+++.||||+++... ......+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 457888999999999999999853 457889999997543 33456788999999999 689999999988654 5
Q ss_pred eEEEEEEecCCCChhhhhhhcC----------------------------------------------------------
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN---------------------------------------------------------- 444 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 444 (645)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6799999999999999885421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-cceeecc
Q 042831 445 --------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLA 515 (645)
Q Consensus 445 --------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~ 515 (645)
..+++..+..++.|+++||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 246888899999999999999998 8999999999999999999999999999876432211 1111233
Q ss_pred cCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHH
Q 042831 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ 594 (645)
Q Consensus 516 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~ 594 (645)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+ .....++..... +. ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~~~~~~~~--~~---~~---- 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMRA--PD---YT---- 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HH----HHHHhccCCCCC--CC---CC----
Confidence 5677999999988889999999999999999997 999986533211 11 111122211110 11 11
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 595 IERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 595 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+.+++..||++||++||++.|++++|..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1356788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.67 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=206.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~~lV~ 428 (645)
+|+..+.||+|+||.||++.+..+++.+|+|.+... .....+++.+|++++++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999999989999999998643 34456678899999999999999999998754 45689999
Q ss_pred EecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhc--CCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 429 EFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEW--EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
||+++++|.+++... ...+++..++.++.||+.||.|||..+ ..+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 467999999999999999999999322 389999999999999999999999999999876
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
..... ......++..|+|||.+....++.++|+||||+++++|++|+.||..... ..+.+ ....+..
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~----- 227 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKF----- 227 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCC-----
Confidence 54322 12334688999999999988899999999999999999999999975431 11111 1112211
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
+ ..+......+.+++.+|++.+|++||++++|+++.
T Consensus 228 ~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 228 R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 1 11223345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=305.70 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=209.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||.|+||.||+|....++..+++|++.... ....+.+.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999998889999999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
+++++|.+++... ...+++.....++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999998653 2578999999999999999999998 9999999999999999999999999999876654322
Q ss_pred c---ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 509 S---QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 509 ~---~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
. ......++..|+|||++... ..+.++|+|||||+++||++|+.||....... ... +.... ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~------~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN------DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC------CCC
Confidence 2 12334688899999998877 78999999999999999999999997543321 111 11111 011
Q ss_pred cccCCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFD-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+..... ......+.+++..|++.||++||++++++++.++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 1111110 1223567788899999999999999999998653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.83 Aligned_cols=269 Identities=22% Similarity=0.287 Sum_probs=204.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++++|...+.||+|+||.||+|....+++.||+|++..... .....+.+|+.++.+++|+|++++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45789999999999999999999998899999999865432 23346788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+. ++|.+++......+++..+..++.|+++||.|||+ .+++|+||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9995 77777776555668889999999999999999998 899999999999999999999999999987543221
Q ss_pred cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC---------cc
Q 042831 509 SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG---------KL 578 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---------~l 578 (645)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||+..... .......+...... .+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhc
Confidence 112233568899999998764 4788999999999999999999999754321 11111122211100 00
Q ss_pred ccccCccc----cCCC-----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 LEAVDPRL----CRDF-----DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 ~~~~d~~l----~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+... .... .......+.+++.+|++.||.+|||+.|++.+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000 0000 00113456678899999999999999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.51 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=202.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc-------CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR-------ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
.++|...++||+|+||.||++... .....+|+|.++.. ......++.+|++++.++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 356778899999999999999763 23457999998754 334567788999999999 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 9999999999999999998642 2358999999999999999999998 899999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVS 564 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~ 564 (645)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |+.||...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 999999999999998654322111 112234467999999988889999999999999999999 88998643321 1
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+...+ . +......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 245 ----~~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 245 ----LFKLLREGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred ----HHHHHHcCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 112222221111 1 11122456688899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=344.69 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=201.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...++||+|+||.||+|++..+++.||+|++... .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5788899999999999999999999999999998753 2234567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 429 EFMPNGSLDSHLFKE----------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
||+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988531 1345677889999999999999998 899999999999999999999999999
Q ss_pred CcccccccCC-----------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 042831 499 LARLVEHAKG-----------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG 561 (645)
Q Consensus 499 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~ 561 (645)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01122468999999999999999999999999999999999999997533211
Q ss_pred chhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhc
Q 042831 562 QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-SIRQVIHVLN 624 (645)
Q Consensus 562 ~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~ 624 (645)
. .. . ..+ .++.-... ..+....+.+++.+|++.||++|| +++++++.|.
T Consensus 239 i---~~---~----~~i---~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 I---SY---R----DVI---LSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred h---hh---h----hhc---cChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 00 0 000 01100000 011224567788999999999996 5666666554
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.26 Aligned_cols=274 Identities=23% Similarity=0.311 Sum_probs=207.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~l 426 (645)
.++|+..+.||+|+||.||+|.+..+|+.||+|.++.... .....+.+|+.++.+++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 3578889999999999999999999999999999864422 2234567899999999999999999998755 56899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+. ++|.+++......+++.++..++.||++||.|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 58888886656779999999999999999999999 89999999999999999999999999999866432
Q ss_pred CCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC--cc-----
Q 042831 507 KGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG--KL----- 578 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--~l----- 578 (645)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ....+.+..+.. ..
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 21 1222345778999998865 457899999999999999999999997544322 111111111100 00
Q ss_pred ----cccc--CccccCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC-CCCCCC
Q 042831 579 ----LEAV--DPRLCRDFD---GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE-APLPAL 632 (645)
Q Consensus 579 ----~~~~--d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~~ 632 (645)
.... ......... ......+.+++.+|++.||++|||++|++++.|+. .++|.-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 0000 000000000 01134567789999999999999999999999987 455543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.97 Aligned_cols=255 Identities=28% Similarity=0.483 Sum_probs=202.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...+.||+|+||.||+|.+..++. .||+|.+.... .....++.+|+.++.+++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 4567788999999999999999876665 57889886543 33345788999999999999999999998754 467
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+++||+++|+|.+++......+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999997766678999999999999999999998 8999999999999999999999999999986543
Q ss_pred cCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...+ ....+.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~~--~ 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPD----LLEKGERLP--Q 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHCCCCCC--C
Confidence 2221 1222345678999999988889999999999999999997 99999653321 1111 111221110 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+ .. ....+..++..|+..+|++||+++++++.|+.
T Consensus 233 ~---~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 233 P---PI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred C---CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 11 22456788899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.64 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=211.6
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChh
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD 437 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~ 437 (645)
-+||+|.||+||.|++..+...+|||.+.....+..+.+..|+.+-++|+|+|||+++|.|.+++.+-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 46999999999999999999999999998877777888999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEEeeccCcccccccCCcceeec
Q 042831 438 SHLFKENSLL--TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLARLVEHAKGSQTTVL 514 (645)
Q Consensus 438 ~~l~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl~DfGla~~~~~~~~~~~~~~ 514 (645)
++|...-+++ ++...--..+||++||.|||+ +.|||||||-.|||++ -.|.+||+|||-++.+. +-+..+..+
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCcccccc
Confidence 9998777777 778888899999999999998 8999999999999995 68899999999998764 234556678
Q ss_pred ccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 515 AGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 515 ~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
.||..|||||++..|+ |+.++|||||||.+.||+|||+||-...... . .++. -|- -+..+.++.
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-A----AMFk---VGm------yKvHP~iPe 802 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-A----AMFK---VGM------YKVHPPIPE 802 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-H----hhhh---hcc------eecCCCCcH
Confidence 8999999999998875 8999999999999999999999996433221 0 0110 010 011234556
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+...+...++++|..+||.+||++.++|+...
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccCcc
Confidence 66778888999999999999999999998653
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.76 Aligned_cols=247 Identities=31% Similarity=0.437 Sum_probs=198.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee-eCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH-EKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~-~~~~~~lV~Ey 430 (645)
++|...+.||+|+||.||++... +..+|+|..+... ..+.+.+|+.++++++|+|++++++++. .++..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46788899999999999999875 6779999886443 3467899999999999999999999764 45678999999
Q ss_pred cCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++.+.. ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999987643 458999999999999999999998 899999999999999999999999999987543221
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..++ ..+.. +..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~-----~~~-- 220 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYK-----MDA-- 220 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH----hcCCC-----CCC--
Confidence 12334568999999988889999999999999999997 9999864322 1112111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 221 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 --PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11223467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=310.20 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=204.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcC----CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRE----TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~ 423 (645)
..++|...+.||+|+||.||+|.+.. ++..|++|++... .....+.+.+|+.++.+++|+|++++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678889999999999999999875 3578999988654 34456778899999999999999999998876 467
Q ss_pred EEEEEEecCCCChhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN-------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
.++++||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999986532 468999999999999999999998 8999999999999999999999999
Q ss_pred ccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 497 FGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 497 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||..... ..+..++ .
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL----K 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH----H
Confidence 99998654322111 112345678999999988889999999999999999999 9999975432 1222211 1
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.. ...... ....+.+++.+|++.||++|||+.++++.|..
T Consensus 234 ~~~~-----~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 234 DGYR-----LAQPIN----CPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred cCCC-----CCCCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1110 000111 12457789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=312.04 Aligned_cols=252 Identities=28% Similarity=0.380 Sum_probs=204.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+.|...+.||+|+||.||+|....+++.||+|.+.... .+..+++.+|++++++++|||++++.++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999998889999999986432 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||++ |+|.+.+......+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9996 67777776555679999999999999999999998 89999999999999999999999999998754322
Q ss_pred cceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 509 SQTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
....++..|+|||++. .+.++.++||||||+++|||++|+.||...... .......... .+.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~------~~~ 233 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND------SPT 233 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCC------CCC
Confidence 2345788999999874 456889999999999999999999998643321 1111111110 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+. .....+.+..++.+||+.+|++||++++++.+.++..
T Consensus 234 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 234 LS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred CC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 11 1123456788899999999999999999999988753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.23 Aligned_cols=252 Identities=26% Similarity=0.463 Sum_probs=202.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...++||+|+||.||++.+.. +..+++|.+... ....+.+.+|++++++++|+|++++.+.+.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4578889999999999999998754 567999988654 3345688999999999999999999999887 778999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+++++|.+++.+. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999653 4568999999999999999999998 89999999999999999999999999999765432222
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||++..+.++.++|+|||||+++|+++ |+.||...... .+..+ ..++....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~~-------- 223 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRMP-------- 223 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCCCC--------
Confidence 2222345677999999988889999999999999999998 99999754321 11221 11221110
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
........+.+++.+|++++|++||++.++++.|+
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 11122346778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=324.12 Aligned_cols=246 Identities=25% Similarity=0.333 Sum_probs=195.0
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc---CCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL---RHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
||+|+||.||+|++..+++.||+|++.... ......+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986432 22334556677777665 699999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|..++.+ ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 999988854 4568999999999999999999998 899999999999999999999999999987533221 22334
Q ss_pred cccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 514 LAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
..||..|+|||++.+. .++.++|||||||++|||++|+.||...... ........+.. .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-------~~~~~i~~~~~------~~~~~--- 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-------QMYRNIAFGKV------RFPKN--- 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-------HHHHHHHcCCC------CCCCc---
Confidence 5799999999998765 4799999999999999999999999753321 11111222211 11110
Q ss_pred HHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHhccC
Q 042831 593 QQIERLMIVGLWCAHPDENLRP----SIRQVIHVLNFE 626 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RP----s~~evl~~L~~~ 626 (645)
.....+.+++.+||++||++|| ++.++++|.++.
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence 1123556788999999999998 789999998874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=345.97 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=205.9
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--C
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--K 421 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~ 421 (645)
+.....++|.+.++||+|+||.||++.+..++..+|+|.+... .......+..|+.++.+++||||+++++++.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3344557899999999999999999999999999999998643 33456778999999999999999999998854 3
Q ss_pred CeEEEEEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhc----CCCeeeccCCCCCeEECC------
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEW----EQCVVHRDIKSSNIMLDS------ 488 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~Dlkp~NILld~------ 488 (645)
..++|||||+++|+|.++|... ...+++..++.|+.||+.||.|||+.. .++|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5789999999999999998642 357999999999999999999999832 145999999999999964
Q ss_pred -----------CCcEEEeeccCcccccccCCcceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 042831 489 -----------NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPIN 555 (645)
Q Consensus 489 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~ 555 (645)
...+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 3348999999998653322 2234578999999999854 458899999999999999999999997
Q ss_pred CCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 556 PKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 556 ~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..... .. +......+. +..+ .. ....+..|+..||+.+|++||++.|++.+.+..
T Consensus 245 ~~~~~-----~q-li~~lk~~p-----~lpi-~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 245 KANNF-----SQ-LISELKRGP-----DLPI-KG----KSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cCCcH-----HH-HHHHHhcCC-----CCCc-CC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 43321 11 111111111 0001 11 124577888999999999999999999877654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.87 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=212.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||++....++..|++|.+........+.+.+|+.++++++|||++++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999988888999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.+ ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ ..
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~ 172 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 172 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cc
Confidence 99999998854 357899999999999999999998 8999999999999999999999999999875543222 22
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|++||.+..+.++.++||||||+++||+++|+.||.......... .....+. +... ..
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~~~~--~~ 238 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------PELQ--NP 238 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------CCCC--Cc
Confidence 33468889999999988889999999999999999999999997544321110 0000110 1110 11
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC--CCCCCCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA--PLPALPP 634 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~--~~p~~p~ 634 (645)
......+.+++..||+.+|++||++++++.+.++.. ++-.+||
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~ 283 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP 283 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence 122345778889999999999999999999988763 3445554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=309.56 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=204.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.+|...+.||+|+||.||+|.+..+|. .+|+|...... .....++.+|+.++.+++|+|+++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467778999999999999999876554 68999886553 3456788999999999999999999999987 78899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|+||+++|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 999999999999998776779999999999999999999998 99999999999999999999999999999866532
Q ss_pred CCcce-eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGSQT-TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..... ....++..|+|||.+....++.++|+||||++++|+++ |+.||...... .+.+. ...+... -.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~----~~~~~~~--~~~ 233 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDL----LEKGERL--PQP 233 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHH----HhCCCCC--CCC
Confidence 22111 11223567999999988889999999999999999998 99999754321 11221 1122110 001
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. .....+..++..||..+|++||++.++++.|..-
T Consensus 234 ~-------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 234 P-------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred C-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 1123567788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.64 Aligned_cols=252 Identities=28% Similarity=0.401 Sum_probs=192.4
Q ss_pred CccCcCCcEEEEEEEEcC--CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
+.||+|+||.||+|...+ ++..+|+|.++... ......+.+|+.++++++|||++++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998653 45679999887543 334467889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-
Q 042831 435 SLDSHLFKEN----SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS- 509 (645)
Q Consensus 435 sL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~- 509 (645)
+|.+++.... ...++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 356778888999999999999998 89999999999999999999999999998754322211
Q ss_pred ceeecccCccccCccccccC-------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 510 QTTVLAGTMGYMAPECATTG-------KASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-------~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
......++..|+|||++... .++.++|+||||+++|||++ |+.||......+ ..... ..+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYT----VREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----hhcccCCC
Confidence 11234567889999988542 35789999999999999996 999997543221 11111 11111222
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.++.+.... .+.+..++..|+ .+|++|||++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 233332222 223555677898 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.41 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=204.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
++|...+.||+|+||.||+|+... +.+.|++|.+...... ..+++.+|++++++++|+|++++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999999753 3467999988655443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 426 LVYEFMPNGSLDSHLFKEN--------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999986433 158999999999999999999998 89999999999999999999999999
Q ss_pred cCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 498 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 498 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
|+++..............++..|+|||.+.+...+.++||||||++++||++ |..||...... .... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH----HHHcC
Confidence 9987543322222333456778999999988889999999999999999998 88888643321 1111 11122
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+.... ... ....+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 ~~~~~~----~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV----PEG----CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC----CCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 211111 111 2246778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.85 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=204.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+|...+.||+|++|.||+|....++..|++|.+.... .+..+.+.+|+.++++++|+|++++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999998889999999886532 34567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
+||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998644 468999999999999999999998 899999999999999999999999999987654322
Q ss_pred CcceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
......++..|++||.+.... ++.++|+||||+++|||++|+.||..... .+..+........ +.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-----~~~ 223 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL-----PPI 223 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC-----CCc
Confidence 233456888999999987766 89999999999999999999999975431 1111111111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+......+.+++.+|++.+|++||++++++++.+
T Consensus 224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 1112245667889999999999999999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=305.68 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=201.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~ 424 (645)
++|...+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++.+++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999999999999999987532 123456788999999999999999999988763 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999988644 457889999999999999999998 899999999999999999999999999987553
Q ss_pred ccCC--cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 505 HAKG--SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 505 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-----~ 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQP-----T 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcCC-----C
Confidence 2211 1123345888999999998888999999999999999999999999743211 1111111111 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ...+......+..++..|+. +|++||+++|++++.+.
T Consensus 227 ~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 227 N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 1 11222334556677788884 99999999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.38 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=201.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+|...+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++|+|+++++++|.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4677889999999999999874 67889999886432 2334668899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999998643 467899999999999999999998 89999999999999999999999999998754321
Q ss_pred C-----CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 507 K-----GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 507 ~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
. ........++..|+|||.+.+..++.++||||||++++||++|+.||........ ........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~----- 225 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRG----- 225 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccC-----
Confidence 1 1112335688999999999988899999999999999999999999974332111 000000001
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+... ....+..++.+||+++|++||++.|++++.+
T Consensus 226 ~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 226 LMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred CCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 11222222 2345678889999999999999999998765
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=306.52 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=210.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||+|++|.||++.+..+++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999999889999999987653 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++......+++..+..++.|+++||.|||+ ..+++|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999999987655788999999999999999999997 37899999999999999999999999999875532211
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....++..|+|||.+.+..++.++||||||+++++|++|+.||....... ....+.+.... .+. .+.+...
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-~~~-----~~~~~~~- 227 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIV-NEP-----PPRLPSG- 227 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHh-cCC-----CCCCChh-
Confidence 11568889999999988899999999999999999999999997543211 11122211111 111 1111111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+++..|++.+|++|||+.+++.+.++.
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 1334577888999999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.43 Aligned_cols=269 Identities=22% Similarity=0.280 Sum_probs=205.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV 427 (645)
++|+..+.||+|+||.||+|.+..+++.+++|.++... ......+.+|+.++.+++|||++++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999999889999999986543 22334677899999999999999999998877 889999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||++ ++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 58988887656679999999999999999999998 899999999999999999999999999988654332
Q ss_pred CcceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HHH-------HHHHHhc----
Q 042831 508 GSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVS-LLQ-------WVWDLYG---- 574 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~-l~~-------~~~~~~~---- 574 (645)
.......++..|+|||.+.+.. .+.++|+||||++++||++|+.||.......... +.. ..|..+.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1222345788999999887644 6899999999999999999999997544221110 000 0011000
Q ss_pred --CCccccccCccccCCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 --NGKLLEAVDPRLCRDFDGQ-QIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 --~~~l~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...........+...+... ..+.+.+++..|++.+|++|||+.|++++-|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011111111111112111 24567788899999999999999999988664
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.75 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=203.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCC-------CeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRET-------NSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~-------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
...+|...+.||+|+||.||++..... +..||+|.+... .....+++.+|++++.++ +||||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 345688899999999999999986432 246899988754 344567899999999999 79999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeE
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 485 (645)
.+..++++||+++|+|.+++.+. ...+++.++..++.|++.||.|||+ .+++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEE
Confidence 99999999999999999998642 2358899999999999999999998 89999999999999
Q ss_pred ECCCCcEEEeeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCch
Q 042831 486 LDSNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQV 563 (645)
Q Consensus 486 ld~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~ 563 (645)
+++++.+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 243 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 243 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997654322111 122234567999999999899999999999999999998 88888643321
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+. ......+...+ .+......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 244 ---~~-~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~ 292 (334)
T cd05100 244 ---EL-FKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR 292 (334)
T ss_pred ---HH-HHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 11 11111211111 111223467788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=300.27 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=209.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
+|...+.||+|++|.||++....+++.+++|++........+++.+|++++++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 46778899999999999999988899999999977665567889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+++|.+++......+++..+..++.|+++||.|||. .+++|+||+|+||++++++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999999987665689999999999999999999998 9999999999999999999999999999876654322 33
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
...++..|++||.+.....+.++||||||++++||++|+.||...... ....... .... +.+... .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~~~~--~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIA-TNGP-----PGLRNP--E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHH-hcCC-----CCcCcc--c
Confidence 456888999999998888999999999999999999999999754321 1111110 1111 111100 0
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++..|++.||++|||+.|++++.|
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 01346778889999999999999999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.10 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=204.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|++|.||++....+++.+|+|.+... .....+.+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477789999999999999999989999999998654 334567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla~~~~~~~~ 508 (645)
+++++|.+++.+. ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999764 4568999999999999999999998 899999999999999854 468999999998654322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......++..|+|||.+.....+.++||||||+++++|++|+.||...... ...... . .+.... +
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~-~~~~~~-----~-- 221 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---M-SGTFAP-----I-- 221 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---H-hcCCCC-----C--
Confidence 222346788999999998888999999999999999999999999754322 111111 1 111111 1
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.......+..++..||+++|++|||++|++++..
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~ 255 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI 255 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence 1112345678889999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.57 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=208.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV~ 428 (645)
++|...+.||.|++|.||++.+..+++.+|+|.+.... .....++.+|++++++++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999999889999999987543 34567799999999999999999999998653 4789999
Q ss_pred EecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||+++++|.+++.. ....+++.....++.||+.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999987753 34568999999999999999999998 8999999999999999999999999999875432
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--CCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP--QGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~--~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.. .....++..|+|||.+.+..++.++|||||||++|||++|+.||..... .....+..+.. ..... .+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~-~~~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNP-ELK 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCch-hhc
Confidence 21 1234578899999999988999999999999999999999999986532 11122222221 11111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
... .......+.+.+++.+|++.+|++|||+.|++++.+..
T Consensus 230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~ 270 (287)
T cd06621 230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270 (287)
T ss_pred cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence 111 00112345678899999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=303.97 Aligned_cols=255 Identities=31% Similarity=0.472 Sum_probs=205.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|+||.||+|....+++.|++|.+..... ...+++.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 47778999999999999999988899999999876543 4678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999988653 458899999999999999999998 899999999999999999999999999988664332221
Q ss_pred e---eecccCccccCccccccCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 511 T---TVLAGTMGYMAPECATTGK---ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 511 ~---~~~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
. ....++..|++||++.... .+.++||||||++++|+++|+.||....... ....... .+ ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~-----~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AG-----HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cC-----CCC
Confidence 1 1356788999999988766 8899999999999999999999997443211 1111110 11 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+.... .....+.+++.+|++.+|++||++++++.+.+
T Consensus 226 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 226 PIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred CCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 111110 11345667889999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=304.88 Aligned_cols=253 Identities=28% Similarity=0.420 Sum_probs=202.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcC-CCeEEEEEEeccC----------ChhhHHHHHHHHHHHHh-cCCCCccEEEeeeee
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQG----------SKQGIKEYASEVKIISR-LRHRNLVQLLGWCHE 420 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~nlv~l~~~~~~ 420 (645)
+|+..+.||+|+||.||+|.+.. +++.+|+|.+... ......++.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778999999999999999987 6789999987532 22345667889998875 799999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 421 KKELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988743 34578999999999999999999995 267999999999999999999999999
Q ss_pred cCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 498 GLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 498 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
|++....... ......++..|++||.+.++.++.++||||||+++|||++|+.||...... ... .. ..++.
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~---~~-~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLA---TK-IVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHH---HH-Hhhcc
Confidence 9998654332 333456888999999999888999999999999999999999998643211 111 11 11111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.... . .......+.+++.+|++.||++||++.|+..++.
T Consensus 230 ~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPL----P----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcC----C----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111 0 0012245778889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.58 Aligned_cols=248 Identities=31% Similarity=0.477 Sum_probs=197.2
Q ss_pred CccCcCCcEEEEEEEEcCCC------eEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 358 QKLGQGGFGGVYKGFFRETN------SYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+.||+|+||.||+|+..+.. +.+|+|.+.... .....++.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999986433 689999886543 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-----cEEEeeccC
Q 042831 431 MPNGSLDSHLFKE------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-----NAKIGDFGL 499 (645)
Q Consensus 431 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-----~~kl~DfGl 499 (645)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 2357899999999999999999998 8999999999999999877 899999999
Q ss_pred cccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 500 ARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 500 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||..... ......+ ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHH----hcCC
Confidence 8755322211 1122345678999999999999999999999999999998 9999864332 1111111 1111
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. .........+.+++.+||+++|++||++.++++.|+
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 111122356778999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.94 Aligned_cols=250 Identities=29% Similarity=0.398 Sum_probs=207.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|++|.||++.+..+++.+|+|.+... ..+..+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4678889999999999999999988999999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998654 578999999999999999999998 99999999999999999999999999999865433
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||...... . .......+.. .+..
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~------~~~~ 219 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q----IYEKILEGKV------RFPS 219 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHhcCCc------cCCc
Confidence 23346889999999998888999999999999999999999999754311 1 1111111211 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
.. ...+.+++.+||+.||.+|| +++|++++.++.
T Consensus 220 ~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 258 (290)
T cd05580 220 FF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258 (290)
T ss_pred cC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence 11 34667788999999999999 899999998864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=294.88 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=208.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----h---hhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCC
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----K---QGIKEYASEVKIISRL-RHRNLVQLLGWCHEKK 422 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~ 422 (645)
+.|...+.||.|..+.|-++.++.+|...|+|++.... + +-.+.-.+|+.+|+++ .||+|+++.+.++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 45777889999999999999999999999999885421 1 1233456799999998 5999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.+++|+|.|+.|.|.++|. ..-.+++....+|++|+.+|+.|||. ++|+||||||+|||+|+|.++||+|||.++.
T Consensus 97 F~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 9999999999999999994 34568999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccCCcceeecccCccccCccccc------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECAT------TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
+.. +......+||++|+|||.+. ...|+...|+|++||++|-|+.|.+||-...+ .. +..++.+|
T Consensus 173 l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---ml----MLR~ImeG 243 (411)
T KOG0599|consen 173 LEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---ML----MLRMIMEG 243 (411)
T ss_pred cCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HH----HHHHHHhc
Confidence 654 45667789999999999874 23588999999999999999999999964221 11 12233344
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..- -.|.. .+......+|+.+||+.||.+|.|++|+|+|.++
T Consensus 244 kyqF-~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 244 KYQF-RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred cccc-CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 3321 11111 1234567788999999999999999999999997
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.73 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=189.7
Q ss_pred CccCcCCcEEEEEEEEcC--CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
++||+|+||.||+|.... ....+++|.+.... ......+.+|++.++.++|+||++++++|......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 34578999876443 344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-
Q 042831 435 SLDSHLFKEN----SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS- 509 (645)
Q Consensus 435 sL~~~l~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~- 509 (645)
+|.+++.... ...++.....++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999986543 235678889999999999999998 89999999999999999999999999998654322111
Q ss_pred ceeecccCccccCcccccc-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 510 QTTVLAGTMGYMAPECATT-------GKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||....+. .... ....++ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLK---QVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHH---HHhhcc-CccC
Confidence 1122345678999998743 356889999999999999999 78888644321 1111 111111 1122
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.++.+...++ ..+..++..|+ .||++|||+++|++.|.
T Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2232222222 34445667787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=312.83 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=202.7
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
...||+|+||.||++....+++.||+|.+........+.+.+|+.++..++|||++++++.+..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 45799999999999999888999999998765555567788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
..++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .......+
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~ 179 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVG 179 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceec
Confidence 987743 468999999999999999999998 899999999999999999999999999987543322 12233568
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
+..|+|||++.+..++.++|||||||+++||++|+.||...... .....+ ..... +.... ......
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~-----~~~~~--~~~~~~ 245 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRL----RDSPP-----PKLKN--AHKISP 245 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hccCC-----CCccc--cCCCCH
Confidence 89999999998888999999999999999999999999743321 111111 11110 00000 001123
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 597 RLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.+++..|++.+|++||++++++++.++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 567788999999999999999999987764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.64 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=212.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..+.||+|++|.||++++..+++.|++|++..... ...+.+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999999999999999876544 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999998654 6789999999999999999999962 78999999999999999999999999999866433222
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.||..........+..++. .+. .+.+...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~-----~~~~~~~- 226 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGP-----PPSLPAE- 226 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCC-----CCCCCcc-
Confidence 223457889999999999899999999999999999999999997654322222222221 111 1111111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.....+.+++.+|++++|++||+++|++++.+.
T Consensus 227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 227 --EFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 033567788899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.18 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=207.7
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
|...+.||+|++|.||++....+++.+++|++........+.+.+|+.++++++|+|++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567899999999999999888999999998766555667789999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....... .....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-ccccc
Confidence 999998865 568999999999999999999998 899999999999999999999999999887543322 12233
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|+..|+|||.+.+..++.++||||||++++||++|+.||...... ..... ...+. .+.+.. ...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~~--~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKR-IRDNL-----PPKLKN--LHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHhcC-----CCCCcc--ccc
Confidence 56889999999998888999999999999999999999999753321 11111 11111 111111 111
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
....+.+++.+||+.+|++||++.+++++.+...
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 2346788899999999999999999999988764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.85 Aligned_cols=269 Identities=19% Similarity=0.278 Sum_probs=202.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcC--CCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELL 425 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~ 425 (645)
+|...++||+|++|.||+|.... +++.||+|.+.... ....+.+.+|+.++.+++|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999999987 78999999987632 34456778899999999999999999999988 7899
Q ss_pred EEEEecCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC----CCcEEEeec
Q 042831 426 LVYEFMPNGSLDSHLFKE----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDF 497 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~----~~~~kl~Df 497 (645)
+||||+++ +|.+.+... ...+++..++.++.||+.||.|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666655321 2368999999999999999999998 89999999999999999 999999999
Q ss_pred cCcccccccCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc------hhHHHH
Q 042831 498 GLARLVEHAKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQ------VSLLQW 568 (645)
Q Consensus 498 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~------~~l~~~ 568 (645)
|+++....... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||........ ......
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 112234678899999987664 578999999999999999999999986554321 011111
Q ss_pred HHHHhcCC------------ccccccCccccCCCC----H-------HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 569 VWDLYGNG------------KLLEAVDPRLCRDFD----G-------QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 569 ~~~~~~~~------------~l~~~~d~~l~~~~~----~-------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+....... ......+......++ . .....+.+++.+||++||++|||+.|++++.++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 11111100 000000000000011 0 223467889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.33 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=193.7
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHH---hcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIIS---RLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~---~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
.||+|+||.||++....+++.+|+|.+.... ......+.+|..++. ..+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999889999999886532 122233445544433 3479999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+++|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||+++++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999888643 469999999999999999999998 899999999999999999999999999987543221 22
Q ss_pred ecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 513 VLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
...|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..........+.. .. ...+..+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~------~~~~~~~~---- 219 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MT------LTVNVELP---- 219 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hh------hcCCcCCc----
Confidence 3468999999998864 457899999999999999999999997544322211111 10 00111121
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
......+.+++..|++.||++|| +++|+++|.++..
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 12234667788999999999999 6999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=305.90 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcC---CCCccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLR---HRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.|+..+.||+|+||.||+|.+..+++.+|+|.+... ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999999888999999998654 3445677889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999998844 378999999999999999999998 899999999999999999999999999998665433
Q ss_pred cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......|+..|+|||.+.++ .++.++|+|||||++|||++|+.||....... +.. .... ...+.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~-----~~~~~~~ 223 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPK-----SKPPRLE 223 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-cccc-----CCCCCCC
Confidence 222334688899999988764 46899999999999999999999997543211 110 0001 1112222
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .....+.+++.+|++.||++||++.+++.+.+..
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 224 DN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred cc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 11 1234677888999999999999999999998864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=305.44 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=204.7
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCC-----
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKK----- 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~----- 422 (645)
.++++|+..+.||+|++|.||+|....+++.+++|.+..... ..+++.+|++++.++ +|+|++++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 356889999999999999999999988889999999875543 346789999999999 6999999999997644
Q ss_pred -eEEEEEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 423 -ELLLVYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 423 -~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
..++||||+++++|.+++... +..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 4678999999999999999999998 899999999999999999999999999
Q ss_pred CcccccccCCcceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
++....... .......++..|+|||.+.. ..++.++|||||||+++||++|+.||...... ..+. ..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~- 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF----KI- 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH----Hh-
Confidence 987553322 22233568889999998753 34678999999999999999999999743221 1111 11
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+ ..+.+. ......+.+.+++.+||..||++|||+.|++++.|
T Consensus 231 ~~~-----~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 231 PRN-----PPPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred hcc-----CCCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 111 111111 11123456778899999999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.84 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=205.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
-|...+.||+|+||.||+|.+..++..+|+|...... ....+.+.+|++++.+++|||++++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999998889999999886442 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++++|.+++.. ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 99999988843 468999999999999999999998 999999999999999999999999999987654322 122
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....++..|+|||.+.+...+.++|+|||||+++||++|+.||...... .+.... ..+. .+.+..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~-----~~~~~~--- 223 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI-PKNN-----PPTLEG--- 223 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH-hcCC-----CCCCCc---
Confidence 2346788999999998888999999999999999999999999643321 111111 1111 111212
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+++.+|++.+|++||++.+++++.++.
T Consensus 224 -~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 224 -NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred -ccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 2234567788999999999999999999987764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.32 Aligned_cols=267 Identities=26% Similarity=0.321 Sum_probs=201.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-------
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------- 422 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------- 422 (645)
++|+..++||+|+||.||+|....+++.||||.+.... ......+.+|++++++++|||+++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999999999999999886442 223345678999999999999999999987543
Q ss_pred -eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 423 -ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 423 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..++||||+. ++|.+.+......+++..++.++.||++||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999996 57888876665678999999999999999999998 899999999999999999999999999998
Q ss_pred cccccCCc---ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 502 LVEHAKGS---QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 502 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
........ ......++..|+|||.+.+. .++.++||||||++++||++|+.||...........+..+......+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 66432221 12234567889999987664 378899999999999999999999976543222222221110000000
Q ss_pred c-----cc-------------ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 L-----LE-------------AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l-----~~-------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. .+ .+...+... .+...+.+++.+||+.||++|||++|++++.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 00 000000000 012356689999999999999999999998774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.93 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=201.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|++|.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999999889999999886542 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
+. ++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6888888643 4678999999999999999999998 8999999999999999999999999999876543221
Q ss_pred ceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC------------
Q 042831 510 QTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG------------ 576 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------------ 576 (645)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||....... .+.+.. ...+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHHH
Confidence 222335678899999887654 6889999999999999999999997543211 111111 000000
Q ss_pred ----ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 ----KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ----~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.........+.. ........+.+++.+|++.||++||++++++++.++
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000000000000 000112346678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.15 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=204.7
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
|...+.||+|+||.||+++...++..+|+|++... ..+..+++.+|++++++++|+|++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66678899999999999999888999999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ |+|.+.+......+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 96 57877776666779999999999999999999998 8999999999999999999999999999865432
Q ss_pred eeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 511 TTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ... ......+. +..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~~~~------~~~- 244 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNES------PTL- 244 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHH---HHHHhccC------CCC-
Confidence 12345788999999873 456899999999999999999999998653211 111 11111110 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 631 (645)
........+.+++.+|++.+|++||++.+++++++.....|.
T Consensus 245 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 245 --QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred --CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 011233457788899999999999999999999987655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=308.42 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=199.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHH-HHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKI-ISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..+.||+|+||.||++++..+|+.||+|++.... .+...++..|+.. ++.++|||++++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999999999999999987542 2334566667665 556689999999999999999999999
Q ss_pred ecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 430 FMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 430 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
|++ |+|.+++.. .+..+++..++.++.||+.||.|||+ + +++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788777753 34578999999999999999999998 5 899999999999999999999999999876532
Q ss_pred cCCcceeecccCccccCcccccc----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATT----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
.. ......++..|+|||.+.. ..++.++|+|||||++|||++|+.||...... . +...... .+
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~~-~~----- 223 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F---QQLKQVV-EE----- 223 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H---HHHHHHH-hc-----
Confidence 21 1223457889999998754 44688999999999999999999999643221 1 1111111 11
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..+.+.. ....+.+..++.+||+.+|++||++++++++.++..
T Consensus 224 ~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 224 PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 1111110 012345778889999999999999999999988764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=310.89 Aligned_cols=268 Identities=25% Similarity=0.328 Sum_probs=204.5
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK---- 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~---- 422 (645)
...++|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678899999999999999999999889999999987543 233456778999999999999999999987654
Q ss_pred ------eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 423 ------ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 423 ------~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
..++|+||+++ +|...+......+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 6777776555679999999999999999999998 8999999999999999999999999
Q ss_pred ccCcccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 497 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 497 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
||++...............++..|+|||.+.+. ..+.++|||||||+++||++|+.||...... .....+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~ 236 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGS 236 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 999986654332222233467789999987653 5789999999999999999999999754322 111112221111
Q ss_pred Cc---cccc--------cCc------cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 576 GK---LLEA--------VDP------RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 576 ~~---l~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.. .... .++ ....... .....+.+++..||+.||++||++++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 0000 000 0000000 11356788899999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.05 Aligned_cols=267 Identities=21% Similarity=0.244 Sum_probs=204.9
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...+.||+|+||.||++++..+++.||+|.+... ......++.+|+.++.+++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999989999999998643 334456778899999999999999999988643
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++||||+. ++|.+.+... +++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999995 5787776432 8899999999999999999998 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-------
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------- 574 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------- 574 (645)
...... ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+... ....+....+
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 167 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSDEFM 241 (353)
T ss_pred eCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCHHHH
Confidence 654321 1233457889999999999899999999999999999999999997543211 1111110000
Q ss_pred ------------CCc------cccccCccc----cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 575 ------------NGK------LLEAVDPRL----CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 575 ------------~~~------l~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
+.. +.+.....+ ...........+.+++.+||+.||++|||+.|++++.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000 000111100 000011234567789999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.89 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=203.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||++.+..+++.|++|.+.... ......+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999999999999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999998554 568999999999999999999998 8999999999999999999999999999874211100
Q ss_pred --------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 509 --------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 509 --------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
.......++..|+|||.+....++.++|+|||||++|||++|+.||...... .+. ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~----~~~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELF----GQVI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHH
Confidence 0111235788999999998888999999999999999999999999743321 111 1111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS---IRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L~~ 625 (645)
.+.. ..+.... .....+..++.+|++.||++||+ +.+++++.++
T Consensus 230 ~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 230 SDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred hccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1111 0111111 12235678889999999999998 6777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=302.97 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=204.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|+||.||+|..+.+|..+|+|.+... .....+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 467788999999999999999999999999998653 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~~~ 508 (645)
+++++|.+++... ...+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 9999999998654 3468999999999999999999998 8999999999999999875 46999999987654322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......|+..|+|||++....++.++|+||||++++||++|+.||..... .+++.... .+.... ...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-----~~~ 224 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKIC-QGYFAP-----ISP 224 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHh-cccCCC-----CCC
Confidence 122334588899999999888899999999999999999999999964322 12222221 111111 111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+++.+|++.+|++|||+.+++++.+
T Consensus 225 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 225 ----NFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 12245778889999999999999999999866
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=303.52 Aligned_cols=274 Identities=26% Similarity=0.359 Sum_probs=209.9
Q ss_pred ChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCccEEEeeeee
Q 042831 343 PYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR--LRHRNLVQLLGWCHE 420 (645)
Q Consensus 343 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nlv~l~~~~~~ 420 (645)
++---+....+....+.||+|.||.||+|.++ |+.||||++....+ +.+.+|.++.+. |||+||+.+++.-..
T Consensus 202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 33334455567888999999999999999998 67899999975543 456677777765 699999999987543
Q ss_pred C----CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-----CCCeeeccCCCCCeEECCCCc
Q 042831 421 K----KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-----EQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 421 ~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~~~~ 491 (645)
+ .+++||.+|.++|||.++|.. ..++.+..++++.-+|.||++||.+. ++.|.|||||+.|||+..++.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 3 378999999999999999954 67899999999999999999999753 567999999999999999999
Q ss_pred EEEeeccCcccccccCCc---ceeecccCccccCccccccC------CCCcchhHHHHHHHHHHHHcC----------CC
Q 042831 492 AKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATTG------KASKESDVYSFGIVALEIACG----------RK 552 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~elltG----------~~ 552 (645)
+.|+|+|||.......+. .....+||.+|||||++... +.-..+||||||.++||++.. +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999866544322 23457899999999998653 224579999999999999752 35
Q ss_pred CCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 553 PINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 553 pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
||.+..+.+.. .+-+.+..--.++...++++. .+.+.+..+.+++..||+.+|..|-|+-.+-+.|..-..
T Consensus 435 Pyyd~Vp~DPs--~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 435 PYYDVVPSDPS--FEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CcccCCCCCCC--HHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 66654433221 111222222233443444333 345788899999999999999999999999888875443
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.45 Aligned_cols=262 Identities=23% Similarity=0.247 Sum_probs=200.3
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeC--CeEEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEK--KELLLVYE 429 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~--~~~~lV~E 429 (645)
|...++||+|+||.||+|....++..||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999999889999999987542 222334557899999985 99999999999887 88999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++ ++|.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 996 58888886656679999999999999999999998 89999999999999999 9999999999986543221
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-----------CCc
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-----------NGK 577 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-----------~~~ 577 (645)
.....++..|+|||++.. +.++.++|||||||++|||++|+.||...... ..+.+..+... ...
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccc
Confidence 223457889999997654 45789999999999999999999999754432 12222221111 011
Q ss_pred cccccCccccC----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCR----DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
......+.... .........+.+++.+||+++|++||++++++++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11110111000 0011234678899999999999999999999998763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=303.92 Aligned_cols=252 Identities=25% Similarity=0.290 Sum_probs=207.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+|...++||+|+||.||++.+..+++.||+|.+... .....+.+.+|++++++++|||++++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999999999999988999999998653 22456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++... ..+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998654 578999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... .++....... .. + .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~----~----~ 220 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--AD----V----L 220 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--cc----c----c
Confidence 2234567889999999988889999999999999999999999998654321 1111111111 00 1 1
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHhc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSI--RQVIHVLN 624 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~ 624 (645)
.+......+.+++.+|++.||.+||++ +|++++.+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 111223567788899999999999999 88887654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.68 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=197.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++.+++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 46789999986543 345788999999999999999999998654 479999999
Q ss_pred CCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999999754 3468999999999999999999998 899999999999999999999999999987543211
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....+..|+|||.+.++.++.++|+||||+++|||++ |+.||...... .. ......+... ++ ..
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~---~~--~~- 220 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EV----KECVEKGYRM---EP--PE- 220 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HH----HHHHhCCCCC---CC--CC-
Confidence 11234567999999988899999999999999999997 99999754321 11 1111222111 11 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+++.+|++.+|++||+++++++.|+.+
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 221 ---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254 (254)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence 1235667889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.13 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=190.9
Q ss_pred CccCcCCcEEEEEEEEcCC--CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 358 QKLGQGGFGGVYKGFFRET--NSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
++||+|+||.||+|....+ ...+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976433 3456777776543 345678999999999999999999999999999999999999999
Q ss_pred Chhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-cc
Q 042831 435 SLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQ 510 (645)
Q Consensus 435 sL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~~ 510 (645)
+|.+++.+. ....++.....++.||++||.|||+ .+++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 2346777888999999999999998 8999999999999999999999999999864321111 11
Q ss_pred eeecccCccccCcccccc-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 511 TTVLAGTMGYMAPECATT-------GKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..... .. .+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~~-~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNH---VI-KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HH-hhcccccC
Confidence 223457889999998743 235789999999999999997 56787643321 11111 11 22223334
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
++.+...++ ..+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 455444333 34555667898 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.29 Aligned_cols=259 Identities=26% Similarity=0.371 Sum_probs=211.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++.|+..+.||+|++|.||+|.+..++..+++|.+..... ..+.+.+|++++.+++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45678888999999999999999988889999999976554 56788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999997655579999999999999999999998 9999999999999999999999999999865433221
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......++..|++||.+.+..++.++|+||||+++|||++|+.||....... ... . ..........++
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~~---~-~~~~~~~~~~~~----- 239 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---ALF---L-ITTKGIPPLKNP----- 239 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhcCCCCCcch-----
Confidence 2223457889999999988889999999999999999999999997433211 111 1 111111110000
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......+..++.+|++.+|.+||++.+++++.+...
T Consensus 240 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 240 --EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred --hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 112245778889999999999999999999887653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.08 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=203.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+|+..++||+|++|.||+|++..+|+.||+|+++.... .....+.+|++++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47788999999999999999998999999999876533 23466778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 432 PNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 432 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
++ +|.+++.... ..+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 8888876543 568999999999999999999998 8999999999999999999999999999975543211
Q ss_pred ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH-----------hcCC-
Q 042831 510 QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL-----------YGNG- 576 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~-----------~~~~- 576 (645)
......++..|++||++.+. .++.++||||||+++|||++|+.||......+. .....+. +...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcCc
Confidence 12234568889999988664 478999999999999999999999976543221 1111111 1000
Q ss_pred ccccccCccc---cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRL---CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......... ...........+.+++.+|++.||++||++.|++++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000000000 000011123557788999999999999999999988654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.78 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=209.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~lV~ 428 (645)
+|...+.||+|++|.||+|....+++.|++|.+.... ....+.+.+|++++++++|+|++++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999999889999999987654 35677899999999999999999999999988 8999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++.+.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999986544 88999999999999999999998 8999999999999999999999999999886654332
Q ss_pred c-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 S-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
. ......++..|++||.+.....+.++||||||++++||++|+.||..... .....+.....+ ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---------~~ 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSG---------EP 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccC---------CC
Confidence 1 12345688899999999888899999999999999999999999975441 111111111101 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+......+.+++.+|++.+|++||++.+++++.++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 11222224577888899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.88 Aligned_cols=264 Identities=23% Similarity=0.286 Sum_probs=201.3
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
|+..++||.|++|.||+|.+..+|..||+|++.... ......+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999999889999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++|.+++.... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||+++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 468998886543 468999999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC-------------
Q 042831 511 TTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG------------- 576 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~------------- 576 (645)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+...........
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223468889999987664 47899999999999999999999997543211 1111111000000
Q ss_pred --ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 --KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 --~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.......+.. ..........+.+++.+|+++||++|||++|++++.|+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000000000 00011122467789999999999999999999988664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.47 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=219.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.-|...+.||+|-|..|-++++.-+|+.||||++.+.. .-...++.+|+..|+-++|||||+|+++......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 45777889999999999999999999999999997653 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE-CCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-DSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-d~~~~~kl~DfGla~~~~~~~~ 508 (645)
+=.+|+|.+|+.++..-+.+....+++.||..|+.|+|+ ..+|||||||+||.+ ..-|-+||+|||++..+..+
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 999999999999988889999999999999999999999 889999999999876 56788999999999876543
Q ss_pred cceeecccCccccCccccccCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKAS-KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t-~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.+....+|...|-|||++.+..|+ ++.|||||||+||-|+||+.||+..++.+. +..++|-..
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY- 236 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY- 236 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc-
Confidence 345567899999999999988875 688999999999999999999987665432 233345433
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
..+.....++.+|+..||..||++|-+.+|++.+-|-.+-
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 2344567788899999999999999999999999986543
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.72 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=201.9
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|+||.||++.+..+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555778999999999999999999999999987543 345567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhh---hh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 431 MPNGSLDSHL---FK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 431 ~~~gsL~~~l---~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
++ ++|.++. .. ....+++.....++.|++.||.|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 4554433 22 24678999999999999999999997 258999999999999999999999999998754322
Q ss_pred CCcceeecccCccccCccccccC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGSQTTVLAGTMGYMAPECATTG---KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+.+..... + ..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~-----~~ 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-G-----DP 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-C-----CC
Confidence 1 12233578899999998776 68999999999999999999999996432 11111111111 1 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.+...........+.+++.+|++.+|++|||+++++++.++..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 22222221223456788899999999999999999999988753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.91 Aligned_cols=266 Identities=21% Similarity=0.250 Sum_probs=199.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCe-----
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKE----- 423 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~----- 423 (645)
++|+..+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++.+++ |+|++++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999999899999999876542 223467888999999995 6999999999877655
Q ss_pred EEEEEEecCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeecc
Q 042831 424 LLLVYEFMPNGSLDSHLFKE----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFG 498 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfG 498 (645)
.++||||+++ +|.+++... ...+++..++.++.||+.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 788887543 2468999999999999999999998 89999999999999998 8999999999
Q ss_pred CcccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+ ..+........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~-~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QL-LHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HH-HHHHHHhCCCC
Confidence 9875533211 1222356788999998865 457899999999999999999999997543211 11 11111111000
Q ss_pred c---------ccccC-cccc----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 L---------LEAVD-PRLC----RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l---------~~~~d-~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ..... +... ..........+.+++..||++||++||+++|++.+.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 0 00000 0000 00001123567789999999999999999999998775
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=317.75 Aligned_cols=249 Identities=26% Similarity=0.377 Sum_probs=211.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|...+.||.|.||.||.+++..+.+.||||+++...+ +.+.+++.|+..|.+++|||.+.+.|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667889999999999999999999999999976543 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|| -||-.+.+.-.++.+-+..+..|+.+.+.||+|||+ .+.||||||+.||||++.|.+||+|||.|.+...
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 99 678888887777889999999999999999999999 8999999999999999999999999999976543
Q ss_pred ceeecccCccccCcccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 510 QTTVLAGTMGYMAPECA---TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~---~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
...++||+.|||||++ ..|+|+-++||||||++..||.-.++|+-..+. +..++.. ...-.|.+
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHI------AQNesPtL 245 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI------AQNESPTL 245 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHH------HhcCCCCC
Confidence 3457899999999987 457899999999999999999999999764331 1111111 11112333
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ..+....+..++-.||+.-|++|||.++++.|..-
T Consensus 246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 3 34677888999999999999999999999998754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.42 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=211.0
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCC----eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETN----SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
....++||+|+||+||+|.+...| .+||+|.+... +.+...++++|+.+|.+++||||++|+|+|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345789999999999999986544 47899987654 5566789999999999999999999999998776 88999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
+||+.|+|.++++.++..+-....+.|..|||+||.|||+ +.++||||..+|||+..-..+||.|||++++......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 9999999999999888889999999999999999999998 9999999999999999999999999999998765443
Q ss_pred cce-eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 509 SQT-TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 509 ~~~-~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.-. ....-.+.|||-|.+....++.++|||||||.+||++| |..|++....++.. ++++.|..+ --|.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~geRL--sqPpi 924 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKGERL--SQPPI 924 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhccccC--CCCCC
Confidence 322 22233567999999999999999999999999999998 99999876544333 333334321 11222
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
....+..++.+||..|++.||+++++......-+.-|
T Consensus 925 -------CtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 925 -------CTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred -------ccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 3345667788999999999999999998876544333
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.88 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=208.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...+.||+|++|.||++.+..++..+++|++.... ....+++.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999999889999999987653 35667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 431 MPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 431 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
+++++|.+++... ...+++..+..++.++++||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998764 4789999999999999999999998 899999999999999999999999999997654432
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......+++.|+|||.+....++.++|+||+|+++++|++|+.||...... +..... ..... +.+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~-~~~~~-----~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKI-LKGQY-----PPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHH-hcCCC-----CCCC
Confidence 2233356888999999998888999999999999999999999999654321 111111 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
. .....+..++.+||+.+|++||++++++++.+
T Consensus 225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 1 22345678889999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.56 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=203.1
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||.|++|.||++++..+++.+++|.+.... ....+.+.+|+.++++++|||++++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999999889999999986532 23456799999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
.+++.+. ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||+++...... ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9998653 458999999999999999999998 999999999999999999999999999998664332 2233467
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
+..|++||.+....++.++|+||||+++|||++|+.||.....+ ..... .... .+.. ...++.....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~---~~~~-~~~~--------~~~~~~~~~~ 221 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIY---NDIL-KGNG--------KLEFPNYIDK 221 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHH---HHHh-ccCC--------CCCCCcccCH
Confidence 88999999998888999999999999999999999999765431 11111 1111 1100 1111111235
Q ss_pred HHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 597 RLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.+..++..||+++|++||+ ++|++++.++.
T Consensus 222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred HHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 6788889999999999999 99999998875
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=303.10 Aligned_cols=263 Identities=23% Similarity=0.280 Sum_probs=205.3
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
|...+.||+|++|.||++....+++.+++|++..... .....+..|++++++++|+|++++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4567889999999999999988899999999875432 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++ +|..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 75 8888887666789999999999999999999998 899999999999999999999999999987664432 122
Q ss_pred eecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC--c-cccccC----
Q 042831 512 TVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG--K-LLEAVD---- 583 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~--~-l~~~~d---- 583 (645)
....++..|+|||.+.+. ..+.++|+||||+++++|++|+.||......+ ......+..... . .....+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhh
Confidence 234578889999998776 78999999999999999999999997544321 111111111110 0 000000
Q ss_pred --ccc-------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 584 --PRL-------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 584 --~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
... ...........+.+++..||++||.+||++++++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 000 00011123467889999999999999999999998876
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.09 Aligned_cols=267 Identities=23% Similarity=0.298 Sum_probs=201.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999999889999999886542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcccccccC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~~~ 507 (645)
|++ ++|.+++... ...+++.....++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 5787777543 3346888889999999999999998 89999999999999985 5679999999997653321
Q ss_pred CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc---------
Q 042831 508 GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK--------- 577 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--------- 577 (645)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||......+ .............
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccccc
Confidence 112234568899999988664 57899999999999999999999997543321 1111111111100
Q ss_pred cccc--cCccccCC----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 578 LLEA--VDPRLCRD----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 578 l~~~--~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.+. .-+..... ........+.+++.+|++.+|++||++.+++++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 0000 00000000 0011234577889999999999999999999998865
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=298.14 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=213.9
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
|.+.++||+|.||.||++.++++|+.+|||.+.-+ .+.+++..|+.+|.+.+.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55678999999999999999999999999998654 3567899999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+..+.+..+++.|++..+..|++.-++||+|||. ..-+|||||+.||||+.+|.+||+|||.|..+... -.....
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCc
Confidence 99999998889999999999999999999999998 66799999999999999999999999998754321 223345
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
+.||+.|||||++..-.|..++||||+|+...||.-|++||.+..+-.-.- -+.-.-.|.++ .+..
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------------MIPT~PPPTF~--KPE~ 254 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------------MIPTKPPPTFK--KPEE 254 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------------eccCCCCCCCC--ChHh
Confidence 789999999999999999999999999999999999999998655421100 00011122222 2345
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
....+-+++..||-..|++|-|+-++++|..
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 6678889999999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=294.27 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=206.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..+.||+|++|.||+++...+++.|++|.+..... .....+.+|++++.+++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 46778999999999999999998899999999876543 5667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999988644 578999999999999999999998 89999999999999999999999999999866543321
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....++..|+|||...+...+.++||||+|++++||++|+.||...... ...+.... .. .+.+..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~-----~~~~~~-- 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQ-DD-----HPPLPE-- 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-cC-----CCCCCC--
Confidence 23356788999999998888899999999999999999999999743311 11111111 10 011111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+..++.+||+.+|++||++.+++.+-+
T Consensus 222 --~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 253 (254)
T cd06627 222 --GISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253 (254)
T ss_pred --CCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence 12346678889999999999999999997643
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.73 Aligned_cols=267 Identities=22% Similarity=0.298 Sum_probs=202.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----CeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~~ 424 (645)
+++|...++||+|+||.||+|++..+|+.||+|+++.. .......+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999999999999999998643 234456788999999999999999999987644 358
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++|+||++ ++|...+. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 99999996 47777663 3468999999999999999999998 899999999999999999999999999987654
Q ss_pred ccCCc--ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc---
Q 042831 505 HAKGS--QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL--- 578 (645)
Q Consensus 505 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l--- 578 (645)
..... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .......+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence 32211 1223467899999998654 46899999999999999999999999653321 111111121111100
Q ss_pred ccccCcc---------ccCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 579 LEAVDPR---------LCRDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 579 ~~~~d~~---------l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+.. ...... ......+.+++.+||+.||++|||+.|++++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 0000000 000000 01235678899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.81 Aligned_cols=248 Identities=25% Similarity=0.310 Sum_probs=194.3
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHH---HHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVK---IISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~---~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
.||+|+||.||++....+++.||+|.+.... ......+..|.. .++...|||++++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999998889999999986542 122223444443 3444579999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+++|..++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 9999988854 4579999999999999999999998 899999999999999999999999999987543221 22
Q ss_pred ecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 513 VLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
...|+..|+|||.+.++ .++.++|||||||+++||++|+.||.......... ...... ..++.+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~------~~~~~~~~~-- 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TMAVELPDS-- 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhh------ccCCCCCCc--
Confidence 34689999999998755 58899999999999999999999997543322111 111110 011112111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
....+.+++.+|++.+|++|| ++.+++++.++..
T Consensus 222 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 222 --FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence 234677888999999999999 9999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=295.44 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=206.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|+..++||+|++|.||++....+++.+++|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477789999999999999999988999999998653 334456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 431 MPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 431 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
+++++|.+++.+ ....+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999998865 23578999999999999999999998 89999999999999999999999999999876543
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
......++..|++||.+.+..++.++|+||||++++||++|+.||...... .+.. ....+..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~----~~~~~~~--------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY----KVQRGKY--------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHhcCCC---------
Confidence 222345788999999998888999999999999999999999999754321 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
..........+..++.+|++.+|++||++.+++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 111223345688899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.09 Aligned_cols=267 Identities=25% Similarity=0.359 Sum_probs=202.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC--CeE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK--KEL 424 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~--~~~ 424 (645)
..++|...+.||+|+||.||+|.+..+++.+|+|++... .......+.+|+.++.++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346788889999999999999999888999999988542 334456677899999999 999999999998653 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||++ ++|..++... .+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999996 5888887543 78999999999999999999998 899999999999999999999999999998654
Q ss_pred ccCC----cceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-----
Q 042831 505 HAKG----SQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG----- 574 (645)
Q Consensus 505 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~----- 574 (645)
.... .......|+..|+|||.+.. ...+.++||||||+++|||++|+.||......+. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~ 235 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 3322 12233568899999998755 4578999999999999999999999975432211 111111100
Q ss_pred ------C---CccccccCcccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 ------N---GKLLEAVDPRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ------~---~~l~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ..+.+.+...-. ..........+.+++.+|++.||++|||+.+++++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 0 000000000000 00000123567888999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=299.31 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=200.5
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||+||++....+|+.+|+|.+.... ....+.+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999889999999986432 23345677899999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecc
Q 042831 437 DSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA 515 (645)
Q Consensus 437 ~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 515 (645)
.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99987644 468999999999999999999998 8999999999999999999999999999876543 22223345
Q ss_pred cCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHH
Q 042831 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595 (645)
Q Consensus 516 gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~ 595 (645)
++..|+|||.+.++.++.++||||||++++||++|+.||............ .. .... ..... +....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~----~~~~--~~~~~----~~~~~ 222 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KR----RTLE--MAVEY----PDKFS 222 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hh----cccc--ccccC----CccCC
Confidence 788999999998888999999999999999999999999754432111111 10 0000 01111 11123
Q ss_pred HHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 596 ERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 596 ~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
..+.+++.+||+.||++|| ++.+++.+.++.
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 4567888999999999999 888899988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.66 Aligned_cols=268 Identities=21% Similarity=0.307 Sum_probs=205.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeee----CCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHE----KKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~----~~~~ 424 (645)
..+|+..+.||+|++|.||+|....+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467888999999999999999999999999999987542 2345678889999999999999999998753 3568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999995 6888887543 458999999999999999999998 899999999999999999999999999997654
Q ss_pred ccCCcc---eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc------
Q 042831 505 HAKGSQ---TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------ 574 (645)
Q Consensus 505 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------ 574 (645)
...... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ +..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCChhHh
Confidence 322211 123468889999998765 4589999999999999999999999975433211 111111100
Q ss_pred -----CCccccccCc-cccCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 -----NGKLLEAVDP-RLCRDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 -----~~~l~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+.+..+. ....... ......+.+++..||+.+|++||++++++.+.|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 0001000000 0000011 11245688899999999999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=298.47 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=198.1
Q ss_pred CCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC------
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------ 422 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------ 422 (645)
|...+.||+|+||.||+|.+.. +++.||||.+... .....+++.+|++++++++|||++++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5567889999999999998653 4689999998654 3445678899999999999999999999886432
Q ss_pred eEEEEEEecCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 423 ELLLVYEFMPNGSLDSHLFKE-----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
..++++||+++|+|..++... ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998887532 2357899999999999999999998 89999999999999999999999999
Q ss_pred cCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 498 GLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 498 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
|+++........ ......++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence 999865432211 1122345678999999988889999999999999999999 8899864432 12222211 1
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+... ... ......+.+++.+|++.+|++||++.|+++.|+.
T Consensus 231 ~~~~-----~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRL-----KQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcC-----CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1110 011 1123578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.51 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=203.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----Ce
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~ 423 (645)
.++|...+.||+|+||.||++++..+++.||||.+... .......+.+|+.++.+++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999999999999999998653 333456778899999999999999999988644 35
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 899999995 688887754 3569999999999999999999998 89999999999999999999999999999865
Q ss_pred cccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc--------
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-------- 574 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-------- 574 (645)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .....+..+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLG 234 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhh
Confidence 4322 22233457889999998765 4688999999999999999999999975432111 111111110
Q ss_pred ---CCcccccc-------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 ---NGKLLEAV-------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ---~~~l~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+...+.+ ++.+.. ........+.+++.+||+.+|++|||++|++++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 01110000 000000 0012235678899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=297.35 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=200.4
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||.||++.+..+++.+++|.+..... ...+.+.+|++++.+++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999865433 4567888999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-------c
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-------S 509 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-------~ 509 (645)
.+++.+.+ .+++..+..++.||++||+|||+ .+++|+||+|+||++++++.+||+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99986544 78999999999999999999998 8999999999999999999999999999875443221 1
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......++..|++||.......+.++||||||++++||++|+.||...... .... . ...+.... +. .
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~~~---~~---~ 223 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---N-ILNGKIEW---PE---D 223 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhcCCcCC---Cc---c
Confidence 223355788999999998888999999999999999999999999754321 1111 1 11111110 00 0
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSI---RQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L~~~ 626 (645)
. .....+..++..|++.+|++|||+ .+++++.++.
T Consensus 224 ~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 224 V--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred c--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 0 013567788899999999999999 7777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.78 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=204.4
Q ss_pred CCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 355 NDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
...++||+|.||.|++|.|... -..||||+++.+... .+.+|++|+.+|.+|+|+|+++|+|...+ ....+|+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 3467899999999999999742 257999999877544 78899999999999999999999999987 778999999
Q ss_pred cCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
++.|+|.+.|.+ ....+.....+.++.|||.||.||.. +++|||||..+|+||-....+||+||||.+.+......
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999987 56678889999999999999999999 99999999999999999999999999999977654432
Q ss_pred ce--eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 510 QT--TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 510 ~~--~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.. ....-...|.|||.++..+++.+||||+|||.||||++ |+.||-+-.... +++.+|..-
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~e 332 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGE 332 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhccccc
Confidence 21 11233557999999999999999999999999999999 889987543321 112222211
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
.-..+..+.+.+.++++.||..+|++|||+..+.+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 112233456788999999999999999999999743
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.99 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=200.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~ 424 (645)
.+|...+.||+|+||.||+|.+..++..||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999999988999999987532 234456888999999999999999999998754 468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999988643 358899999999999999999998 899999999999999999999999999998653
Q ss_pred ccC--CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 505 HAK--GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 505 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
... ........++..|+|||++.+...+.++|+|||||+++||++|+.||...... . .+......+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~~~~-----~ 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---A---AIFKIATQP-----T 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---H---HHHHHHcCC-----C
Confidence 221 11223356888999999998888999999999999999999999999743221 1 111111111 1
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
.+. .+....+.+.+++..|++ +|.+||+..+++.|+
T Consensus 227 ~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 227 KPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred CCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 111 222233556777889998 579999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.26 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=201.5
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
|...++||+|+||.||+|+...+++.|++|++... .....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999999888999999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+. |+|.+.+......+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 67878776666779999999999999999999998 8999999999999999999999999999864321
Q ss_pred eeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 511 TTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ......... .. +...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~-----~~~~ 241 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-DS-----PTLQ 241 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-CC-----CCCC
Confidence 22346788999999874 456889999999999999999999998654321 111111111 11 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.......+..++.+||+.+|++||++.+++.+.++..
T Consensus 242 ---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 242 ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 1111234677889999999999999999999988764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.30 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=204.0
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
..+||+|+||.||++....+++.||+|++..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999999989999999998765555667899999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 105 ~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 178 (292)
T cd06657 105 TDIVTH--TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVG 178 (292)
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccccc
Confidence 987743 358999999999999999999998 899999999999999999999999999987553322 12233568
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
+..|++||.+.+..++.++|+||||+++|||++|+.||...... ........ ...+.+.. ......
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~---------~~~~~~~~--~~~~~~ 244 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD---------NLPPKLKN--LHKVSP 244 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---------hCCcccCC--cccCCH
Confidence 89999999998888999999999999999999999999743321 11111110 01111110 011223
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 597 RLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.+..++.+||+.+|.+||++.+++++-++...
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 45677889999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=325.84 Aligned_cols=271 Identities=20% Similarity=0.292 Sum_probs=193.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCC-eEEEEEE--------------ec---cCChhhHHHHHHHHHHHHhcCCCCc
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETN-SYIAVKR--------------VS---QGSKQGIKEYASEVKIISRLRHRNL 411 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vavK~--------------~~---~~~~~~~~~~~~Ei~~l~~l~H~nl 411 (645)
..++|...++||+|+||+||++.++... ...+.|. +. .........+.+|+.++.+++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999998765322 2222221 10 1122334568899999999999999
Q ss_pred cEEEeeeeeCCeEEEEEEecCCCChhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC
Q 042831 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487 (645)
Q Consensus 412 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld 487 (645)
+++++++...+..++|+|++ .++|.+++... ...........|+.||+.||.|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 99999999999999999998 45677766432 1223456677899999999999998 8999999999999999
Q ss_pred CCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCCCCchhHH
Q 042831 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK-PINPKAPQGQVSLL 566 (645)
Q Consensus 488 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~-pf~~~~~~~~~~l~ 566 (645)
.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+. |+..........+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999998765433333344679999999999999999999999999999999999875 44432222111111
Q ss_pred HHH-----------------HHHhcCCccc---cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 QWV-----------------WDLYGNGKLL---EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 ~~~-----------------~~~~~~~~l~---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+ ++++....+. ..+.+.+... .....+..++.+||+.||++|||+.|++++.++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~ 458 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS 458 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence 111 1111000000 0000000000 0112355678899999999999999999999875
Q ss_pred C
Q 042831 627 A 627 (645)
Q Consensus 627 ~ 627 (645)
.
T Consensus 459 ~ 459 (501)
T PHA03210 459 A 459 (501)
T ss_pred c
Confidence 4
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.72 Aligned_cols=264 Identities=21% Similarity=0.267 Sum_probs=199.0
Q ss_pred CccCcC--CcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQG--GFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G--~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
..||+| +||+||++.+..+|+.||+|.+... .....+.+.+|+.++..++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999999989999999998653 234457788999999999999999999999999999999999999
Q ss_pred CChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc--
Q 042831 434 GSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ-- 510 (645)
Q Consensus 434 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~-- 510 (645)
++|.+++.+. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999988654 3458999999999999999999998 899999999999999999999999998654332111110
Q ss_pred ----eeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH--------------
Q 042831 511 ----TTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW-------------- 570 (645)
Q Consensus 511 ----~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~-------------- 570 (645)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||....... .+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccch
Confidence 0112345679999998764 47899999999999999999999997543211 1111000
Q ss_pred --HHhc----------------CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 571 --DLYG----------------NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 571 --~~~~----------------~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... .+......+..+...........+.+++.+||+.||++|||+.|++++.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 0000 0000011111111222233456788999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.80 Aligned_cols=277 Identities=25% Similarity=0.334 Sum_probs=221.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.+.|..-+.||+||||.||-++.+.+|+.+|.|++.+. .+++....++|-.+|.+++.+.||.+--.++..+.+|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 46788899999999999999999999999999988643 345566788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 428 YEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
+..|.||+|.-+|.+. +..+++....-.+.+|+.||++||. .+||.|||||+|||||+.|+++|+|+|||..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999764 3578999999999999999999999 99999999999999999999999999999866543
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
......+||.+|||||++.++.|+...|.||+||+||||+.|+.||..........-++ ....+ |
T Consensus 341 --~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~-------~--- 405 (591)
T KOG0986|consen 341 --KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLE-------D--- 405 (591)
T ss_pred --CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhc-------c---
Confidence 33444589999999999999999999999999999999999999997544322211111 00000 1
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC-CCCCCCCCCCCCCCCCCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE-APLPALPPKMPVPTYLSPP 645 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~-~~~p~~p~~~p~~~~~~~p 645 (645)
..+++..-.+....+....|+.||++|- .+.+|.+|.-|. .+++.+-..+-.|++.|+|
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 1123333344555666778899999986 567899988765 4556665555555555544
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.33 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=202.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|...+.||+|++|.||+|+...++..+|+|.+... .....+++.+|++++++++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366678899999999999999988999999998642 33445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+. |+|.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 68887776656678999999999999999999998 89999999999999999999999999998754321
Q ss_pred ceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 510 QTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
....++..|+|||.+. .+..+.++|||||||++|||++|+.||...... ....... .+.. +..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~ 234 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNES-----PAL 234 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHh-hcCC-----CCc
Confidence 2345788999999874 356788999999999999999999998643221 1111111 1111 111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. .......+..++.+||+.+|++||++.+++++.+...
T Consensus 235 ~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 235 Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 1 1122345678889999999999999999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.99 Aligned_cols=266 Identities=21% Similarity=0.329 Sum_probs=200.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------C
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------K 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------~ 422 (645)
.++|...+.||+|+||.||+|++..+|+.||+|++... .......+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888899999999999999999888999999998643 223345688999999999999999999988654 3
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++|+||+.. +|..+. +..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 56999999964 666554 2368999999999999999999998 8999999999999999999999999999875
Q ss_pred ccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-------
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------- 574 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------- 574 (645)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+...+
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHH
Confidence 4321 123456888999998876 46889999999999999999999999754321 11111111100
Q ss_pred ----CCccccccC--ccc-cCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 575 ----NGKLLEAVD--PRL-CRDFD---GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 575 ----~~~l~~~~d--~~l-~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
.......+. +.. ..... ......+.+++..||++||++||++++++.+.+++.-.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000000000 000 00000 012245678999999999999999999999988875433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.73 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=196.1
Q ss_pred HHhhcCCCCCCcc--CcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeE
Q 042831 348 ALATNDFNDDQKL--GQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 348 ~~~~~~f~~~~~L--G~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~ 424 (645)
....++|...+.+ |+|+||.||++....++..+|+|.+....... .|+.....+ +|+|++++++++...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344566666666 99999999999999999999999986432111 122222222 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLV 503 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~ 503 (645)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999998654 378999999999999999999998 8999999999999999988 9999999998755
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... ....++..|+|||++.+..++.++||||||++++||++|+.||...... ......+.... ...
T Consensus 161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~------ 226 (267)
T PHA03390 161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ--QKK------ 226 (267)
T ss_pred CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh--ccc------
Confidence 322 2235788999999999888999999999999999999999999844322 11222222111 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPS-IRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~~ 626 (645)
... .......+.+++..||+++|++||+ ++|++++-|+.
T Consensus 227 ~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 227 LPF----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CCc----ccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 001 1123345677889999999999995 69999988764
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=302.73 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=201.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~ 428 (645)
-++|...+.||+|++|.||+|.+..+++.||||.+.... .....++..|+.++.+.. |+||++++++|..+...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356788899999999999999999889999999987543 334556777888777775 999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||++ ++|.+++......+++..+..++.|++.||+|||+ ..+++||||+|+||++++++.+||+|||++........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 57777765555689999999999999999999997 25899999999999999999999999999876533221
Q ss_pred cceeecccCccccCccccccCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 509 SQTTVLAGTMGYMAPECATTGK----ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||...... . +........ .. +
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~-~~-----~ 237 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F---EVLTKILQE-EP-----P 237 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H---HHHHHHhcC-CC-----C
Confidence 12235778999999987553 788999999999999999999999643221 1 111111111 11 0
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.. .....+.+.+++.+||+.||++||++++++++.+..
T Consensus 238 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 238 SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 1100 001234678888999999999999999999998865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=303.61 Aligned_cols=267 Identities=27% Similarity=0.319 Sum_probs=201.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEK------- 421 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------- 421 (645)
.++|...++||+|++|.||+|.+..+++.+|+|++..... .....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4688999999999999999999998899999998864422 2234677899999999999999999987543
Q ss_pred -CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 422 -KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 422 -~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
..+++|+||+.+ +|...+......+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 357999999964 6777776656679999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccCCc----------ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 042831 501 RLVEHAKGS----------QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 501 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~ 569 (645)
+........ ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~~ 239 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHLI 239 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence 765432211 11234567889999987654 57899999999999999999999997544321 11112
Q ss_pred HHHhcCC---------cccccc--------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 570 WDLYGNG---------KLLEAV--------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 570 ~~~~~~~---------~l~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.....- .+.... ++.+...+ ......+.+++.+|++.||++|||+.|++.+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2111100 000000 01110000 0112567889999999999999999999988764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.63 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=201.2
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEec
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
|...+.||+|++|.||+|+...+++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667899999999999999988899999999865422 23334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 432 PNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 432 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+|+|.+++.... ..+++.++..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++....... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 889998886654 578999999999999999999998 899999999999999999999999999997654322 2
Q ss_pred eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH----------HHHHHHhcCCccc
Q 042831 511 TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL----------QWVWDLYGNGKLL 579 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~----------~~~~~~~~~~~l~ 579 (645)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||......+..... .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 45799999999999999999999999655432111000 0100000000111
Q ss_pred cccCcccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 580 EAVDPRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 580 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+..... ..........+..++.+|++.+|++||+++|++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 01110000 0000111356889999999999999999999998865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.71 Aligned_cols=268 Identities=23% Similarity=0.256 Sum_probs=203.6
Q ss_pred cCCC-CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh--------------HHHHHHHHHHHHhcCCCCccEEEe
Q 042831 352 NDFN-DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG--------------IKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 352 ~~f~-~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
++|. ..+.||+|+||.||+|.+..+++.||+|.++...... ...+.+|++++.+++|+|++++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3567999999999999999889999999886432211 125778999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
++..++..++||||+. |+|.+++.. ...+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999996 688888743 4568999999999999999999998 8999999999999999999999999
Q ss_pred ccCcccccccC-------------CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 042831 497 FGLARLVEHAK-------------GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562 (645)
Q Consensus 497 fGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~ 562 (645)
||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-- 240 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI-- 240 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 99987654110 1111223467889999988764 4689999999999999999999999755432
Q ss_pred hhHHHHHHHHhcCCc---ccccc------------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 563 VSLLQWVWDLYGNGK---LLEAV------------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 563 ~~l~~~~~~~~~~~~---l~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.....+....+... ..+.. .+.... ........+.+++..|++.+|++||+++|++.+.++..
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 22222222222111 00000 000000 00112356778999999999999999999999999874
Q ss_pred C
Q 042831 628 P 628 (645)
Q Consensus 628 ~ 628 (645)
.
T Consensus 319 ~ 319 (335)
T PTZ00024 319 D 319 (335)
T ss_pred C
Confidence 3
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.95 Aligned_cols=266 Identities=24% Similarity=0.286 Sum_probs=207.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-----eEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-----ELL 425 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-----~~~ 425 (645)
+|...+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999998889999999987643 445678899999999999999999999988765 789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 5788887543 479999999999999999999998 8999999999999999999999999999987654
Q ss_pred cCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC-------
Q 042831 506 AKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN------- 575 (645)
Q Consensus 506 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~------- 575 (645)
... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+. ...+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHhh
Confidence 321 122334578899999999887 789999999999999999999999976543211 1111111100
Q ss_pred ----CccccccCc-cccCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 ----GKLLEAVDP-RLCRD-----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 ----~~l~~~~d~-~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+.+.. ..... ........+.+++.+||+.+|++||++++++++.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 293 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHH
Confidence 000000000 00000 0011235677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.99 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=213.7
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
|.+...||.|+||.||++..++++...|-|.+...+.+..++|+-|+++|....||+||+|++.|..++.+++..|||+|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44567899999999999999999988999999888888999999999999999999999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|-.+..+..-+..|.+.++.-+++|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+-.... .......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhhcc
Confidence 99999998888899999999999999999999999 9999999999999999999999999999753321 1223345
Q ss_pred cccCccccCcccc-----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 514 LAGTMGYMAPECA-----TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 514 ~~gt~~y~aPE~~-----~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
+.||+.|||||++ ...+|+.++||||||+.|.||+.+.+|...-++- ..++. +...-.|.+..
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllK----------iaKSePPTLlq 257 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----------IAKSEPPTLLQ 257 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHH----------HhhcCCCcccC
Confidence 7899999999976 4567999999999999999999999997643321 11111 11111233322
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+......+.++...||..||+.||++.++++|.+..
T Consensus 258 --PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 258 --PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred --cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 224455677888999999999999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.85 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=207.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV 427 (645)
++|...+.||+|++|.||++....+++.||+|.+... .....+.+..|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999999989999999998653 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++.+. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998654 479999999999999999999998 899999999999999999999999999987654322
Q ss_pred C-------------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH
Q 042831 508 G-------------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW 568 (645)
Q Consensus 508 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~ 568 (645)
. .......++..|+|||.+.....+.++|+||||++++|+++|+.||..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHH
Confidence 1 122334578899999999888899999999999999999999999975431 111111
Q ss_pred HHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHhcc
Q 042831 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSI----RQVIHVLNF 625 (645)
Q Consensus 569 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~~ 625 (645)
.. .. .. ..+....+.+.+++.+|++.+|++||++ ++++++.++
T Consensus 234 ~~----~~------~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 IL----KL------EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HH----hc------CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11 00 01 1111123567888999999999999999 999988763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.37 Aligned_cols=262 Identities=25% Similarity=0.324 Sum_probs=198.8
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhc---CCCCccEEEeeeeeCCe-----
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRL---RHRNLVQLLGWCHEKKE----- 423 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~~~~~----- 423 (645)
|+..+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999998889999999987432 22234566788877766 59999999999987766
Q ss_pred EEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.+++|||+. ++|.+++.... ..+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 57888886533 468999999999999999999998 8999999999999999999999999999976
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC-Ccc---
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN-GKL--- 578 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-~~l--- 578 (645)
..... ......++..|+|||.+.+..++.++|+|||||++|||++|+.||......+ ....+.+.... +..
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhcC
Confidence 64322 1122347888999999998889999999999999999999999997544321 11111111110 000
Q ss_pred ------ccccCcccc---CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 579 ------LEAVDPRLC---RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 579 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
......... .....+....+.+++.+||+.||++||+++|++++-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 000000000 0111123456778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.79 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=205.1
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
|+..+.||+|++|.||+|+...+++.+|+|.+.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999999889999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
+ ++|.+++.+....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++....... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 58999997665679999999999999999999999 8999999999999999999999999999976543221 22
Q ss_pred eecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC---------Cccc--
Q 042831 512 TVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN---------GKLL-- 579 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~---------~~l~-- 579 (645)
....++..|+|||.+.+. .++.++|||||||+++||++|+.||...... ..........+. ..+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 233457789999998776 7899999999999999999999999754421 111111111100 0000
Q ss_pred cccCccccCC----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRD----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..-+..... ........+.+++..||+.+|++||++++++.+.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000000000 000113568889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.63 Aligned_cols=276 Identities=22% Similarity=0.279 Sum_probs=207.3
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~ 419 (645)
...+++...+++|...+.||+|+||.||+|....+++.||+|++... .....+.+.+|++++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999999888999999998653 2334567889999999999999999999876
Q ss_pred eC------CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 420 EK------KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 420 ~~------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
.. ...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+ .+++||||||+||++++++.+|
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence 43 3468888887 7889887743 358999999999999999999998 8999999999999999999999
Q ss_pred EeeccCcccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH-H----
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL-Q---- 567 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~-~---- 567 (645)
|+|||+++.... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||............ .
T Consensus 161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999875432 2233467889999998866 46889999999999999999999999654321111000 0
Q ss_pred ---HHHHHhcCCcc---ccccCccccCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 568 ---WVWDLYGNGKL---LEAVDPRLCRDFD---GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 568 ---~~~~~~~~~~l---~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
........... ...++......+. ......+.+++..|++.||++||++.+++++.++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 00000000000 0000000000000 011245678899999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.20 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=206.4
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEecc--CChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCe
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKE 423 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~ 423 (645)
+......|++.++||+||.+.||++...+ .+.+|+|++.. .+.+...-|.+|++.|.+|+ |.+|++|++|-..++.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 33445679999999999999999998765 56678887653 35667888999999999996 9999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+|||||| .+-+|..+|.+....++.-.++.+.+||+.++.++|. .+|||.||||.|+|+- .|.+||+|||.|..+
T Consensus 435 lYmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 435 LYMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9999996 4779999998776666533788899999999999999 8999999999999884 568999999999876
Q ss_pred cccCCc-ceeecccCccccCccccccC-----------CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHH
Q 042831 504 EHAKGS-QTTVLAGTMGYMAPECATTG-----------KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 504 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~ 571 (645)
...... .....+||+.||+||.+... +.+++|||||+||+||+|+.|+.||..-. +..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~----- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI----- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH-----
Confidence 544332 23447899999999987432 25689999999999999999999996311 111
Q ss_pred HhcCCccccccCccccCCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQ-QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.++..+.||.-.-+|+.. +-..++.++..||+.||++||+.-|+|+|..-.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 134455666443333321 122278888999999999999999999987644
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.70 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=211.7
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKK 422 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~ 422 (645)
++++...| .+.||+|+++.|--++...+|..+|||++.+.......+..+|++++.+.+ |+||++|++||+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 55666655 467999999999999999999999999998887777888999999999986 999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEEeeccC
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKIGDFGL 499 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl~DfGl 499 (645)
.+|||||-|.+|+|..+++++ ..+++....++.++|+.||.|||. ++|.||||||+|||..... -+||+||.+
T Consensus 150 ~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred eEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999999999654 568999999999999999999999 9999999999999996544 489999988
Q ss_pred cccccc------cCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc------
Q 042831 500 ARLVEH------AKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ------ 562 (645)
Q Consensus 500 a~~~~~------~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~------ 562 (645)
..-... .........+|...|||||+.. ...|+.+.|.|||||+||-|++|.+||.+....+-
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 753321 1122334467889999999763 23488999999999999999999999986554321
Q ss_pred --hhHHHHHHHHhcCCccccccCccccCCCCHHH----HHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 563 --VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQ----IERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 563 --~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
..--+.+++.+.+|+. +|++.+ .....+++...+..|+.+|-++.+++.+.|...-.|
T Consensus 306 ~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred ccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 1111223333334432 222222 244556677788899999999999999999764333
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.52 Aligned_cols=251 Identities=27% Similarity=0.381 Sum_probs=202.2
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
....||.|..|.|++++.+.+|..+|||.+... +++..++++..+.++..-. +|.||+.+|||..+...++.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 356799999999999999999999999998765 6677888888888887765 899999999999999999999998 4
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
..++.++..-...+++...-++...+.+||.||.+ +++|+|||+||+|||+|+.|++|+||||.+..+-.. ...+.
T Consensus 175 ~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtr 250 (391)
T KOG0983|consen 175 TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTR 250 (391)
T ss_pred HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc--ccccc
Confidence 45666776667789999999999999999999998 578999999999999999999999999998755322 22344
Q ss_pred cccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 514 LAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.+|.+.|||||.+.- .+|+.++||||||+.|+||+||+.||..-..+ ...+..+. .-..|.+.++.
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvl---------n~ePP~L~~~~ 319 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVL---------NEEPPLLPGHM 319 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHH---------hcCCCCCCccc
Confidence 578999999998854 36889999999999999999999999864432 12222211 11223333221
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.++...||+.|+.+||...++++|..
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 13346677788999999999999999999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.92 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=193.0
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHH-HhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKII-SRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l-~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.||+|++|.||+|....+++.||+|.+.... ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999998889999999986542 22233455565544 445899999999999999999999999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999988543 468999999999999999999998 8999999999999999999999999999875432 223
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..++..|++||.+.+..++.++||||||+++|||++|+.||...... . .+.....+... ..+.... .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~--~~~~~~~----~ 219 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---A----VFDNILSRRIN--WPEEVKE----F 219 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---H----HHHHHHhcccC--CCCcccc----c
Confidence 45788999999998888999999999999999999999999754321 1 11111111111 0111111 1
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCH---HHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSI---RQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~---~evl~~L~~~ 626 (645)
....+.+++.+||+.+|++||++ +|++.+.++.
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 23567788999999999999955 6777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=297.01 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=195.2
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
+.+|.|++ ||.++...+++.||+|++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+
T Consensus 8 ~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33444444 555555557899999998754 44566789999999999999999999999999999999999999999
Q ss_pred hhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC------
Q 042831 436 LDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG------ 508 (645)
Q Consensus 436 L~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~------ 508 (645)
|.+++... ...+++.....++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99998753 4568999999999999999999998 8999999999999999999999999998875432111
Q ss_pred cceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH----hc-------C
Q 042831 509 SQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL----YG-------N 575 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~----~~-------~ 575 (645)
.......++..|+|||++... .++.++|||||||++|||++|+.||...... ..+.+..... .. .
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhc
Confidence 111234567789999998663 5789999999999999999999999754321 1111111000 00 0
Q ss_pred Ccccc----ccCccc----cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 GKLLE----AVDPRL----CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 ~~l~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.... ..++.. ...........+..++.+||+.||++|||++|++++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 00000 001100 0011122345678899999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=302.32 Aligned_cols=268 Identities=22% Similarity=0.248 Sum_probs=200.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC----------
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK---------- 421 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~---------- 421 (645)
.+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788899999999999999999999999999998776666677889999999999999999999776543
Q ss_pred ----CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEEee
Q 042831 422 ----KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKIGD 496 (645)
Q Consensus 422 ----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl~D 496 (645)
...++||||++ ++|.+++.. ..+++...+.++.||++||.|||+ .+++||||||+||+++ +++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 35799999996 588877743 468999999999999999999998 8999999999999997 556789999
Q ss_pred ccCcccccccCCc--ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH----
Q 042831 497 FGLARLVEHAKGS--QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV---- 569 (645)
Q Consensus 497 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~---- 569 (645)
||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+..........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765322111 1122357889999997654 45788999999999999999999999754421111000000
Q ss_pred ----HHHhcCCccccccC-ccccCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 570 ----WDLYGNGKLLEAVD-PRLCRDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 570 ----~~~~~~~~l~~~~d-~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... .+...+. .......+ ......+.+++..|+++||++|||+.|++++.++.
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 239 REEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred ChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 000000 0000000 00000000 01224577889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.89 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=202.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS----KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~ 424 (645)
+|+..+.||+|+||.||++... .+|..||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999874 368899999986532 22346778899999999 589999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++... ..+++.....++.|+++||.|||+ .+++||||+|+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998654 468899999999999999999998 899999999999999999999999999998654
Q ss_pred ccCCcceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
...........|+..|+|||.+... .++.++||||||+++|||++|+.||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~------- 227 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------- 227 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc-------
Confidence 4332333345688999999998753 467899999999999999999999964332211 11111111111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
.+.. +......+..++.+|++.||++|| ++++++.+.++.
T Consensus 228 ~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 272 (290)
T cd05613 228 EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272 (290)
T ss_pred CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccc
Confidence 0111 111234567888999999999997 899999988765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.53 Aligned_cols=272 Identities=26% Similarity=0.279 Sum_probs=205.5
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CC
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KK 422 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~ 422 (645)
++...+++|+..+.||+|+||.||++....+++.||+|++... .....+.+..|++++.+++|||++++.+++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3455778999999999999999999999989999999988643 23345678899999999999999999998865 56
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++|+||+ +++|..++.. ..+++.....++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999998 5688887743 457888889999999999999998 8999999999999999999999999999875
Q ss_pred ccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhH-HHH-------HHHHh
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL-LQW-------VWDLY 573 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l-~~~-------~~~~~ 573 (645)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||........... .++ +.+..
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4321 123456888999998766 5689999999999999999999999975432111000 000 00000
Q ss_pred cCCccccccCc-cccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 574 GNGKLLEAVDP-RLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 574 ~~~~l~~~~d~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..+...+.+.. ......+. .....+.+++.+|++.+|++||++.+++.+.+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 00000000000 00011111 12356788899999999999999999999988764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.41 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=200.6
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEecc----CChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--eEEEEEEe
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ----GSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--ELLLVYEF 430 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--~~~lV~Ey 430 (645)
..+||+|+|-+||||.+..+|..||--.++. .+....+.|..|+.+|+.|+||||++++.++.+.. ...+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 4679999999999999999998888654432 24556689999999999999999999999887654 48899999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~~~~~ 509 (645)
|..|+|..|..+. +.++......|++||++||.|||+. .++|||||||-+||+++. .|.+||+|+|||.+....
T Consensus 125 ~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 9999999999654 4578889999999999999999994 579999999999999975 589999999999876543
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
....+.|||.|||||.+. ..|++..||||||++++||+|+.-||..=... ..++.....|.....+..
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~------AQIYKKV~SGiKP~sl~k----- 267 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP------AQIYKKVTSGIKPAALSK----- 267 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH------HHHHHHHHcCCCHHHhhc-----
Confidence 334478999999999887 68999999999999999999999999632111 122333333332222211
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
... .++.+++.+|+.. ..+|||+.|+|.+.-++.
T Consensus 268 V~d---Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 268 VKD---PEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred cCC---HHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 111 2456788999999 999999999999887654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=288.50 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=198.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+|...++||+|+||.||++++...+..+++|.++.. ......++..|+.++.+++|||++++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477789999999999999998876666666665432 223345677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 428 YEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
|||+++++|.+++.. .+..+++..++.++.|+++||.|||+ .+++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988864 34679999999999999999999998 89999999999999975 469999999987653
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... .......++..|+|||.+....++.++|+||||+++|+|++|+.||..... ....... ..+. .+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~-~~~~-----~~ 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI-VEGP-----TP 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-HcCC-----CC
Confidence 322 122234578899999999888889999999999999999999999964321 1111111 1111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+ +......+.+++.+|++.+|++||++.|++++.+
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 11 2233356778889999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.09 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=210.9
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
....|.+...||+|.|+.|.+|++..++..||||.+++. +....+.+.+|+++|..++|||||+++.+......+++|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 346788899999999999999999999999999999765 334445689999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+.+|.+.+++.+++. +.+.....++.|+.++++|||. +.|+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--
Confidence 999999999999977655 4448888999999999999999 9999999999999999999999999999988763
Q ss_pred CcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......+|++.|.|||++.+.++ ++++|+||+|++||-|++|..||+...-.+-.. ..+..++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk~ 272 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGKY 272 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeeee
Confidence 345566889999999999988774 789999999999999999999998654321110 0011111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+-.+ --...+-+++++.+-++|.+|+++.+++++-|-..
T Consensus 273 rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 273 RIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred cccc--eeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 1111 01123446677888999999999999999998654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.32 Aligned_cols=257 Identities=19% Similarity=0.234 Sum_probs=186.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccCChhh-----------HHHHHHHHHHHHhcCCCCccEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGSKQG-----------IKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
.++|...++||+|+||.||+|.+.++ +..+|+|......... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36788999999999999999998876 5667777643332211 111223444556678999999999
Q ss_pred eeeeCC----eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 417 WCHEKK----ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 417 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
++.... ..++++|++. .++.+.+.. ....++..+..|+.|++.||.|||+ .+++||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 776543 3477788764 355555532 2346788899999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCC------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhH-
Q 042831 493 KIGDFGLARLVEHAKG------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL- 565 (645)
Q Consensus 493 kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l- 565 (645)
+|+|||+++....... .......||+.|+|||++.+..++.++|||||||+++||++|+.||...........
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999986542211 112234699999999999999999999999999999999999999986533221100
Q ss_pred --HHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 566 --LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 566 --~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.++ .....+++. . .... .+.+.+++..|++.+|++||++.++++.+.
T Consensus 246 ~~~~~-~~~~~~~~~----~---~~~~----~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDF-IKRLHEGKI----K---IKNA----NKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHH-HHHhhhhhh----c---cCCC----CHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 111112211 0 0111 245677888999999999999999998763
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=284.28 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=207.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...++||+|.||+|-+++-+.+++.+|+|++++. .+.....-+.|-++|...+||.+..|.-.++..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788899999999999999999999999999999875 344455667899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||..+|.|.-+|.+ .+.+++...+-....|..||.|||+ ++||.||||.+|.|||.+|++||+|||+++.- -..
T Consensus 247 MeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKY 321 (516)
T ss_pred EEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc-ccc
Confidence 999999999988854 5678888888889999999999999 99999999999999999999999999999742 223
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
+..+..++||+.|+|||++....|..+.|.|.+||++|||+|||.||...+.+.. ++++.-+.+ ++
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed~------kF- 387 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMEDL------KF- 387 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhhc------cC-
Confidence 4556779999999999999999999999999999999999999999987654322 222211111 11
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhcc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNF 625 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~ 625 (645)
+.....+...|....|..||.+|- .++||.++--+
T Consensus 388 ---Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF 427 (516)
T KOG0690|consen 388 ---PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFF 427 (516)
T ss_pred ---CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence 111112334455678899999995 57788877654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.07 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=197.2
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee------
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE------ 420 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~------ 420 (645)
..-..+|++.+.||+||||.||+++++-+|+.+|||++... +.+......+|+.++++|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34557899999999999999999999999999999998755 45566788899999999999999998753311
Q ss_pred --------------------------------------------------------------------------------
Q 042831 421 -------------------------------------------------------------------------------- 420 (645)
Q Consensus 421 -------------------------------------------------------------------------------- 420 (645)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 042831 421 -------------------------K--------KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467 (645)
Q Consensus 421 -------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 467 (645)
+ ..+||-||||+..+|++++.++...-.....++++++|++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 1357889999888888877554332246678899999999999999
Q ss_pred hhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc----------------ccC-CcceeecccCccccCccccccC-
Q 042831 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE----------------HAK-GSQTTVLAGTMGYMAPECATTG- 529 (645)
Q Consensus 468 ~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~----------------~~~-~~~~~~~~gt~~y~aPE~~~~~- 529 (645)
+ +++|||||||.||+||++.++||+|||+|.... .+. ....+..+||.-|+|||++.+.
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 999999999999999999999999999998621 011 1134567899999999998764
Q ss_pred --CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCC
Q 042831 530 --KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAH 607 (645)
Q Consensus 530 --~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 607 (645)
.|+.|+|+||+||+++||+. ||...- +-+..+ .-+++|.+... ..+...++..=.++++++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa~iL-~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSM-----ERASIL-TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchH-----HHHHHH-HhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999985 454211 111111 22334544332 22233344445678899999
Q ss_pred CCCCCCCCHHHHHHH
Q 042831 608 PDENLRPSIRQVIHV 622 (645)
Q Consensus 608 ~dP~~RPs~~evl~~ 622 (645)
.||.+|||+.|+|..
T Consensus 857 hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 857 HDPSKRPTATELLNS 871 (1351)
T ss_pred CCCccCCCHHHHhhc
Confidence 999999999999864
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.88 Aligned_cols=269 Identities=22% Similarity=0.303 Sum_probs=202.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK---- 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~---- 422 (645)
...++|...+.||+|+||.||++....++..||||++... .......+.+|+.++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567899999999999999999999988999999998543 2334567889999999999999999999887543
Q ss_pred --eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 423 --ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 423 --~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
..++||||+ +++|.+++.. ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 469999999 7788887743 468999999999999999999998 89999999999999999999999999998
Q ss_pred ccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHH-------HHHH
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQV-SLLQ-------WVWD 571 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~-~l~~-------~~~~ 571 (645)
...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||......... .... ....
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 755322 223457889999998876 45889999999999999999999999754321100 0000 0000
Q ss_pred HhcCCccccccC--ccccC----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 572 LYGNGKLLEAVD--PRLCR----DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 572 ~~~~~~l~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..........+. +.... .........+.+++.+|++.||++|||+.+++++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 000000000000 00000 000111235778899999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.00 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=198.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS----KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~ 424 (645)
+|...+.||+|++|.||+++.. .+++.||||.+.... ....+.+.+|++++.++ +|+|++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677889999999999999864 356889999886432 23346788999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++|+|.+++... ..+++.....++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999988643 468899999999999999999998 899999999999999999999999999987654
Q ss_pred ccCCcceeecccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
...........++..|+|||.+.+.. .+.++||||||++++||++|+.||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~------- 227 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS------- 227 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-------
Confidence 43332233356888999999987665 78899999999999999999999964322111 11111111110
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV---IHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev---l~~L~~~ 626 (645)
.+.....+ ...+.+++.+|++.||++|||++++ +++.++.
T Consensus 228 ~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~ 270 (288)
T cd05583 228 KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270 (288)
T ss_pred CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence 11111112 2346678899999999999997655 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=279.81 Aligned_cols=281 Identities=22% Similarity=0.311 Sum_probs=210.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCC----eEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETN----SYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~~ 424 (645)
..|+....||+|.+|.||++.-.+++ +.+|+|+++...+ .-.....+|+.++++++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999766543 3789999875532 223466789999999999999999998876 7889
Q ss_pred EEEEEecCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC----CcEEEee
Q 042831 425 LLVYEFMPNGSLDSHLFK----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN----FNAKIGD 496 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~----~~~kl~D 496 (645)
+|++||.+. +|+..++- ..+.++......|+.||+.|+.|||+ .-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999965 67776652 23578999999999999999999999 679999999999999776 8999999
Q ss_pred ccCcccccccCCc--ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCC------CchhHHH
Q 042831 497 FGLARLVEHAKGS--QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQ------GQVSLLQ 567 (645)
Q Consensus 497 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~------~~~~l~~ 567 (645)
+|+++++...-.. ....++-|.+|.|||.+.+. .||++.|||+.||++.||++-++-|...... -+.+.++
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999988643322 22335678999999998875 4999999999999999999999888654421 2334445
Q ss_pred HHHHHhcCCccccccCccccCCC------------CHH----H-------HHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDF------------DGQ----Q-------IERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~------------~~~----~-------~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+++..+-..-.++-+-.-.+++ +.- . ....+.|..++|+.||.+|.|++|++++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 55555443222111110000000 000 0 012566788999999999999999999998
Q ss_pred cC-CCCCCCCCCC
Q 042831 625 FE-APLPALPPKM 636 (645)
Q Consensus 625 ~~-~~~p~~p~~~ 636 (645)
|. .++|+.|.+.
T Consensus 340 F~~d~lpp~pt~~ 352 (438)
T KOG0666|consen 340 FTEDPLPPLPTSD 352 (438)
T ss_pred cccCCCCCCcccc
Confidence 75 5677665443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=307.36 Aligned_cols=202 Identities=34% Similarity=0.490 Sum_probs=175.6
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC------eEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------ELLL 426 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------~~~l 426 (645)
+...+.||+|+||.||+|+++.+|+.||||.++.. .....+...+|+++|++++|+|||++++.-+... ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34567899999999999999999999999998764 3345567789999999999999999999765443 5699
Q ss_pred EEEecCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC--C--CCcEEEeeccCc
Q 042831 427 VYEFMPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD--S--NFNAKIGDFGLA 500 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld--~--~~~~kl~DfGla 500 (645)
|||||.+|||+..|.+. ..-|++...+.+..++..||.|||+ .+|+||||||.||++- + .-.-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999753 4579999999999999999999998 9999999999999983 2 334799999999
Q ss_pred ccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQ 560 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~ 560 (645)
+.++. +.....++||..|++||.+.. +.++...|.|||||++||++||..||.+....
T Consensus 172 rel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 97654 447778899999999999984 88999999999999999999999999865543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.32 Aligned_cols=244 Identities=27% Similarity=0.351 Sum_probs=199.7
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
||+|+||.||++....+++.+++|.+.... ......+..|++++++++|+|++++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999998889999999987542 23556888999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeeccc
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g 516 (645)
.+++... ..+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 9998654 368999999999999999999998 999999999999999999999999999987654322 22334567
Q ss_pred CccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 517 t~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
+..|++||...+...+.++|+||||+++|||++|+.||..... ......+ .++. ..+.. ....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~~------~~~~~----~~~~ 218 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----LKDP------LRFPE----FLSP 218 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----hcCC------CCCCC----CCCH
Confidence 8899999999888899999999999999999999999964432 1111111 1111 11111 1134
Q ss_pred HHHHHHHHcCCCCCCCCCCH---HHHHHHhcc
Q 042831 597 RLMIVGLWCAHPDENLRPSI---RQVIHVLNF 625 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RPs~---~evl~~L~~ 625 (645)
.+.+++..|+..||++||++ ++++.+.++
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 56788899999999999999 788877654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=301.90 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=203.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe----
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE---- 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~---- 423 (645)
..++|...+.||+|++|.||+|++..+++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456788899999999999999999988999999988643 23345677889999999999999999988765554
Q ss_pred --EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 424 --LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 424 --~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 6799888754 468999999999999999999998 899999999999999999999999999997
Q ss_pred cccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc------
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG------ 574 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~------ 574 (645)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ......+..+
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHH
Confidence 65332 233457888999998865 367899999999999999999999997543221 1111111100
Q ss_pred -----CCccccc---cCccccCCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 575 -----NGKLLEA---VDPRLCRDFD---GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 575 -----~~~l~~~---~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
....... +...-...+. ......+.+++.+|++++|++|||+.|++++.++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 0000000 0000000000 012456788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.32 Aligned_cols=271 Identities=24% Similarity=0.292 Sum_probs=206.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
+|...++||+|.+|+||+|+..++++.||+|+++.+. +.--....+|+.++++++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556789999999999999999999999999987653 22345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
| .-+|..+...-++.++.+....++.|+++||.|+|+ +++.||||||.|.|++.||..|++|||+++.+.-.- ..
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv-rc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RC 157 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Ee
Confidence 9 557888887777889999999999999999999999 899999999999999999999999999999765322 22
Q ss_pred eeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc---cccccCcc
Q 042831 511 TTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK---LLEAVDPR 585 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~---l~~~~d~~ 585 (645)
....+-|.+|.+|+++.+.+ |++..|+||-||++.|+.. |++.|...+-.++...+-|+.....+.. +...-|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 23345689999999988765 8999999999999999998 6666765544433332322222122222 22222222
Q ss_pred ccCCCCHH-----HH----HHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 586 LCRDFDGQ-----QI----ERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 586 l~~~~~~~-----~~----~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
..+.++.. .. .+=.++....+.-+|.+|.++++.+++..+...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 22222211 01 112234445556699999999999999887644
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=332.79 Aligned_cols=258 Identities=28% Similarity=0.390 Sum_probs=210.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..+-++....+||.|.||.||-|...++|...|+|.+... .....+...+|..++..++|||+|+++|+-.+++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3445777889999999999999999999999999977543 34456778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
.||||.+|+|.+.+. .++.+++.....+..|++.|++|||+ .+||||||||.||+||.+|.+|++|||.|..+...
T Consensus 1312 FMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999999884 45567777778889999999999999 99999999999999999999999999999877543
Q ss_pred CC---cceeecccCccccCccccccC---CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH-hcCCccc
Q 042831 507 KG---SQTTVLAGTMGYMAPECATTG---KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL-YGNGKLL 579 (645)
Q Consensus 507 ~~---~~~~~~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~-~~~~~l~ 579 (645)
.. .......||+-|||||++.+. ....+.||||+|||++||+||++||...+.. |..-+ ...|..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC-
Confidence 21 223456899999999998653 3567899999999999999999999755432 22211 122322
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.++......-.+++..||..||++|-++.|++++--.+
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 222333444556788899999999999999999886543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=315.44 Aligned_cols=261 Identities=29% Similarity=0.440 Sum_probs=210.6
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcC-------CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEee
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRE-------TNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGW 417 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~ 417 (645)
++...++....+.||+|.||.|++|.... ....||||.++.. .....+.+..|+++|..+ +|+|++.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 44444555666799999999999998642 1467999998754 335678899999999998 59999999999
Q ss_pred eeeCCeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 418 CHEKKELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 418 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
|..++..++|+||+..|+|.++|...+ ..++....+.++.|||.|++||++ .+++||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999997665 348999999999999999999999 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccccCCcceeeccc--CccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG--TMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAP 559 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~ 559 (645)
|||+.++..+||+|||+++...+........-.+ ...|||||.+....++.+||||||||+|||+.+ |..|+.....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999655444333222222 446999999999999999999999999999999 8999975221
Q ss_pred CCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 560 QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 560 ~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. .-+++..++|...+. |.. ...++..+++.||+.+|++||++.|+++.+..
T Consensus 528 ~------~~l~~~l~~G~r~~~--P~~-------c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 T------EELLEFLKEGNRMEQ--PEH-------CSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H------HHHHHHHhcCCCCCC--CCC-------CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1 112334455544322 222 23466788899999999999999999998876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.37 Aligned_cols=265 Identities=24% Similarity=0.273 Sum_probs=197.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCC--CeEEEEEEeccC--ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeC----Ce
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRET--NSYIAVKRVSQG--SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEK----KE 423 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~----~~ 423 (645)
+|...+.||+|+||.||++....+ +..||+|++... .....+.+.+|++++.+++ ||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 467788999999999999999877 889999998643 2234567889999999994 99999999875432 45
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899885 688888743 4568999999999999999999998 89999999999999999999999999999865
Q ss_pred cccCCc---ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-----
Q 042831 504 EHAKGS---QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG----- 574 (645)
Q Consensus 504 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~----- 574 (645)
...... ......|+..|+|||.+.+ ..++.++|+|||||++++|++|+.||...... ..........+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPDEE 232 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 432211 1223468899999998765 46899999999999999999999999754321 11111111000
Q ss_pred ------CCcccc---cc---C-ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 ------NGKLLE---AV---D-PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ------~~~l~~---~~---d-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... .. . ..+. .........+..++.+|++.||++|||+.+++.+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~ 296 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhh
Confidence 000000 00 0 0000 00001124677889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=278.09 Aligned_cols=228 Identities=20% Similarity=0.166 Sum_probs=182.5
Q ss_pred CCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhh
Q 042831 363 GGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK 442 (645)
Q Consensus 363 G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 442 (645)
|.+|.||++++..+++.+|+|++.... .+..|...+....|||++++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 233455555566799999999999999999999999999999998865
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccC
Q 042831 443 ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522 (645)
Q Consensus 443 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 522 (645)
. ..+++..+..++.|+++||.|||+ ++++||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4 358999999999999999999998 89999999999999999999999999987654332 122345677999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHH
Q 042831 523 PECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602 (645)
Q Consensus 523 PE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~ 602 (645)
||.+....++.++||||+|++++||++|+.|+........ .. ....+.. .....+..++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~----~~~~~~~----~~~~~~~~li 209 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------TH----TTLNIPE----WVSEEARSLL 209 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------cc----cccCCcc----cCCHHHHHHH
Confidence 9999888899999999999999999999988753221100 00 0001111 1224567788
Q ss_pred HHcCCCCCCCCCCH-----HHHHHHhc
Q 042831 603 LWCAHPDENLRPSI-----RQVIHVLN 624 (645)
Q Consensus 603 ~~Cl~~dP~~RPs~-----~evl~~L~ 624 (645)
.+|++.||++||++ ++++.|.+
T Consensus 210 ~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 210 QQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred HHHccCCHHHhcCCCccchHHHHcCCC
Confidence 99999999999996 77777655
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=314.71 Aligned_cols=146 Identities=25% Similarity=0.416 Sum_probs=133.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...++||+|+||.||+|.+..+++.||||++... .......+..|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788899999999999999999988999999998653 2334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
||+++++|.+++... ..+++...+.|+.||+.||.|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999988543 468899999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.20 Aligned_cols=254 Identities=27% Similarity=0.347 Sum_probs=199.9
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
+.+..||.|+||+|+|-.++.+|+..|||+++.... ...++++.|.+...+- ++||||+++|.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 336689999999999999999999999999987643 6678899999877665 6899999999999999999999999
Q ss_pred CCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 433 NGSLDSHLFK----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 433 ~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
..||+.+... .+..+++...-+|......||.||.++ ..|||||+||+|||||..|.+||||||.+..+..+
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 6677765432 456799999999999999999999984 67999999999999999999999999998654321
Q ss_pred cceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 509 SQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
-..+.-+|...|||||.+... .++-+|||||||+.|+|++||+-|+..... +.+.+.... .|.- |.+
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdp-----p~l 290 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDP-----PIL 290 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCC-----Cee
Confidence 223345688899999988543 489999999999999999999999974331 222222221 2221 222
Q ss_pred cCCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 587 CRDFD-GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 587 ~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..... .+....+..++-.|+-+|-.+||+..+++++.-
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 22111 234456778888999999999999999987653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.98 Aligned_cols=268 Identities=25% Similarity=0.319 Sum_probs=215.8
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEee
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGW 417 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~ 417 (645)
.-...+++...++|.+.+.||+|+||.|..++++.+++.+|+|++++. .+....-|..|-.+|.--+.+=|++++-.
T Consensus 64 v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 64 VKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 344578888889999999999999999999999999999999999763 23445678899999998889999999999
Q ss_pred eeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 418 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
|++++++|+|||||+||+|..++.+.. .+++...+-++..|.-||.-||+ .|+|||||||+|||||..|++||+||
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999999997666 89999999999999999999998 99999999999999999999999999
Q ss_pred cCcccccccCCcceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH
Q 042831 498 GLARLVEHAKGSQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 498 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
|.+-.++....-.....+|||.|++||++.. +.|++.+|.||+||++|||+.|..||..+. ++.-....
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHH
Confidence 9998777555556667889999999999852 568999999999999999999999997432 22211111
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHhccC
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS---IRQVIHVLNFE 626 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~L~~~ 626 (645)
.........-+ +.+..+....|+.+.+. +|+.|-. .+++..|+.|.
T Consensus 294 m~hk~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 294 MNHKESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred hchhhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence 11111111110 01123344455555443 7778887 99999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=303.79 Aligned_cols=265 Identities=21% Similarity=0.236 Sum_probs=177.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCC----CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEee------ee
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRET----NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW------CH 419 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~------~~ 419 (645)
..++|...++||+|+||.||+|++..+ +..||+|++...... +....| .+.+..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999988 899999987643221 111111 1111222222222111 34
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCC
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKENSL-------------------LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIK 480 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 480 (645)
.+...++||||+++++|.+++...... ..+..+..++.||+.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 567899999999999999888643211 1233456799999999999998 899999999
Q ss_pred CCCeEECC-CCcEEEeeccCcccccccCCcceeecccCccccCccccccC----------------------CCCcchhH
Q 042831 481 SSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG----------------------KASKESDV 537 (645)
Q Consensus 481 p~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~sDV 537 (645)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 68999999999986654444444556789999999965322 23446799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC----ccccccCccc----cCCCC--HHHHHHHHHHHHHcCC
Q 042831 538 YSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----KLLEAVDPRL----CRDFD--GQQIERLMIVGLWCAH 607 (645)
Q Consensus 538 ~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----~l~~~~d~~l----~~~~~--~~~~~~l~~l~~~Cl~ 607 (645)
|||||+||||+++..+++.. +......+...+ .+...+++.. ...++ ........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999977664321 111110000000 0001111111 00000 0011234478899999
Q ss_pred CCCCCCCCHHHHHHHhccCCC
Q 042831 608 PDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 608 ~dP~~RPs~~evl~~L~~~~~ 628 (645)
.||++|||++|+++|.++...
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCC
Confidence 999999999999999998653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=268.65 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=201.7
Q ss_pred hhcCCCC-CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee----CCe
Q 042831 350 ATNDFND-DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE----KKE 423 (645)
Q Consensus 350 ~~~~f~~-~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~----~~~ 423 (645)
.+++|.+ .++||-|-.|+|-.+.++.+++.+|+|.+... ...++|+++--+. .|||||++++.+.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3455554 36799999999999999999999999988543 3346788877665 59999999998753 567
Q ss_pred EEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccC
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGL 499 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGl 499 (645)
+++|||.|+||.|...+.+++ ..+++.+...|++||+.|+.|||. .+|.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999999997654 579999999999999999999999 99999999999999964 55699999999
Q ss_pred cccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|+||.+||........ ..-+...++.|..
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gqy- 284 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQY- 284 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccCc-
Confidence 986543 2334456789999999999999999999999999999999999999986543211 1111111111111
Q ss_pred cccCccccCCCCHH----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQ----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+|+.+ ..+...++++.+|..+|.+|-|+.|++.+.|-.
T Consensus 285 ---------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 285 ---------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred ---------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 22222 245667788999999999999999999999854
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=291.85 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=198.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+..|.....+|.|+|+.|-++.+..+++..++|++.+... +-.+|+.++... +|||++++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5678888889999999999999999999999999976521 223577666655 69999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE-CCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-DSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-d~~~~~kl~DfGla~~~~~~~~ 508 (645)
++.++-|.+.+..... ....+..|+.+|+.++.|||+ ++|+||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999988877754332 226777899999999999999 999999999999999 58999999999999876543
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ ..+. ..+..++
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~~----------- 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMPK----------- 530 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCCc-----------
Confidence 22345688999999999989999999999999999999999999855433 1111 1112221
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.........+|+.+||+.||.+||+|.++..+.|+
T Consensus 531 -~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 -FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 222334456678899999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=268.86 Aligned_cols=242 Identities=26% Similarity=0.361 Sum_probs=197.2
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhh
Q 042831 364 GFGGVYKGFFRETNSYIAVKRVSQGSKQG-IKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK 442 (645)
Q Consensus 364 ~fG~Vy~g~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 442 (645)
+||.||+|...++++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997665444 68899999999999999999999999999999999999999999998865
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccC
Q 042831 443 ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522 (645)
Q Consensus 443 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 522 (645)
... +++..++.++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 433 8999999999999999999999 899999999999999999999999999998765432 3334567889999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHH
Q 042831 523 PECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602 (645)
Q Consensus 523 PE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~ 602 (645)
||.+.....+.++|||+||++++|+++|+.||..... .....++ ...+..... .........+.+++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~~~i 221 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKK----IGKPKPPFP-------PPEWKISPEAKDLI 221 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH----HhccCCCCc-------cccccCCHHHHHHH
Confidence 9999888899999999999999999999999975321 1112221 111111100 00000234677889
Q ss_pred HHcCCCCCCCCCCHHHHHHHhc
Q 042831 603 LWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 603 ~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+|+..+|++||++.+++++.+
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred HHHccCCchhccCHHHHhhCCC
Confidence 9999999999999999998654
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-33 Score=279.08 Aligned_cols=270 Identities=20% Similarity=0.285 Sum_probs=212.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC--C----CccEEEeeeeeCCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH--R----NLVQLLGWCHEKKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~----nlv~l~~~~~~~~~ 423 (645)
.+++|.+..++|+|.||.|-.+.+.+++..||||+++.-. ...+..+-|++++.++.+ | -.|++.+|+.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3788999999999999999999999999999999986443 334556679999999943 2 36888999999999
Q ss_pred EEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--------------
Q 042831 424 LLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-------------- 488 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------------- 488 (645)
.|||+|.+ |-|+.++|..+ -..++..++..|+.|++++++|||+ ..++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999998 77899999764 3578999999999999999999999 99999999999999832
Q ss_pred ------CCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc
Q 042831 489 ------NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562 (645)
Q Consensus 489 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~ 562 (645)
+..+||.|||.|..-... ....+.|..|.|||++.+-.++.++||||+||+|.|+.+|...|+..+..+.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 345899999999764322 2456789999999999999999999999999999999999999986654443
Q ss_pred hhHHHHH--------------HHHhcCCccc-----------cccCc----cccCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 042831 563 VSLLQWV--------------WDLYGNGKLL-----------EAVDP----RLCRDFDGQQIERLMIVGLWCAHPDENLR 613 (645)
Q Consensus 563 ~~l~~~~--------------~~~~~~~~l~-----------~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 613 (645)
..+++.+ ..+...|.+. ...++ ...-.....+...+.+|+..+|..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 3333221 1111112110 01110 00112344677889999999999999999
Q ss_pred CCHHHHHHHhccCCC
Q 042831 614 PSIRQVIHVLNFEAP 628 (645)
Q Consensus 614 Ps~~evl~~L~~~~~ 628 (645)
+|++|+++|..|...
T Consensus 398 iTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 398 ITLREALSHPFFARL 412 (415)
T ss_pred ccHHHHhcCHHhhcC
Confidence 999999999998754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=292.96 Aligned_cols=264 Identities=21% Similarity=0.276 Sum_probs=185.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEc----------------CCCeEEEEEEeccCChhhHHH--------------HHHH
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFR----------------ETNSYIAVKRVSQGSKQGIKE--------------YASE 399 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 399 (645)
..++|.+.++||+|+||.||+|.+. ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 234679999986544333333 3347
Q ss_pred HHHHHhcCCCCc-----cEEEeeeee--------CCeEEEEEEecCCCChhhhhhhcC----------------------
Q 042831 400 VKIISRLRHRNL-----VQLLGWCHE--------KKELLLVYEFMPNGSLDSHLFKEN---------------------- 444 (645)
Q Consensus 400 i~~l~~l~H~nl-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------- 444 (645)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888877654 677888753 356899999999999999886321
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCc
Q 042831 445 -SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523 (645)
Q Consensus 445 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 523 (645)
..++|..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 134678889999999999999998 8999999999999999999999999999976543322222223457899999
Q ss_pred cccccCCC----------------------CcchhHHHHHHHHHHHHcCCC-CCCCCCCCC------chhHHHHHHHHhc
Q 042831 524 ECATTGKA----------------------SKESDVYSFGIVALEIACGRK-PINPKAPQG------QVSLLQWVWDLYG 574 (645)
Q Consensus 524 E~~~~~~~----------------------t~~sDV~SfGvll~elltG~~-pf~~~~~~~------~~~l~~~~~~~~~ 574 (645)
|.+..... ..+.||||+||+++||++|.. |+....... ...+.. |..+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~--~r~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR--WRMYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH--HHhhc
Confidence 98754321 134699999999999999885 665321100 011111 22221
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHHHhccC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDE---NLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~L~~~ 626 (645)
.... +-... ........+++.+|+..+| .+|+|++|+++|.|+.
T Consensus 458 ~~~~----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 458 GQKY----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ccCC----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 1111 10011 1112345566677777655 7899999999999984
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=285.89 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=203.0
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
.+.||+|.||+||-|+++.+|+.||||.+.+. ..+...++++|+.+|..++||.||.+...|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999999999999999998754 4455688999999999999999999999999999999999999655
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC---CcEEEeeccCcccccccCCcce
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN---FNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kl~DfGla~~~~~~~~~~~ 511 (645)
-|.-.|....+.|++..-.-++.||+.||.|||. ++|+|+||||+||||... -++||||||.|++..... -.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 5555565667889999999999999999999999 999999999999999643 369999999999876433 33
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
..++||+.|+|||+++++.|...-|+||.||++|--++|.-||..+.+ ..+.++ +-.. +..+.--.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQ-------NAaF--MyPp~PW~--- 789 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQ-------NAAF--MYPPNPWS--- 789 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhh-------cccc--ccCCCchh---
Confidence 457899999999999999999999999999999999999999975432 122221 1111 11111111
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.....++++...|+..-++|-|..+.+.|.|-
T Consensus 790 -eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 790 -EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred -hcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 222445677777888899999999999988874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=272.63 Aligned_cols=262 Identities=25% Similarity=0.319 Sum_probs=209.9
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEee
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGW 417 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~ 417 (645)
.+++....+++....++.+|.||.||+|.+++. .+.|-+|.++.. +.-+...++.|...+..+.|||+.++.+.
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 456777778899999999999999999988653 245677777654 55567788999999999999999999999
Q ss_pred eeeC-CeEEEEEEecCCCChhhhhhh-----c--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC
Q 042831 418 CHEK-KELLLVYEFMPNGSLDSHLFK-----E--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489 (645)
Q Consensus 418 ~~~~-~~~~lV~Ey~~~gsL~~~l~~-----~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 489 (645)
+.++ ...+.+|.++.-|+|..+|.. . .+.++..+...++.|++.|++|||. .+|||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 8765 467899999999999999972 1 2467888899999999999999999 999999999999999999
Q ss_pred CcEEEeeccCcccccccCCccee-ecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHH
Q 042831 490 FNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQ 567 (645)
Q Consensus 490 ~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~ 567 (645)
.++||+|=.++|.+-..++.... .......||+||.+.+..++.++|||||||+||||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 99999999999876555443322 1234568999999999999999999999999999998 999998655432
Q ss_pred HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+..+..+|... ..|.- ...++..++.-||..+|++||+.+|++.-|.
T Consensus 507 -m~~ylkdGyRl--aQP~N-------CPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 507 -MEHYLKDGYRL--AQPFN-------CPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred -HHHHHhcccee--cCCCC-------CcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 22233344221 11221 2345666777899999999999999999885
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=267.29 Aligned_cols=271 Identities=24% Similarity=0.347 Sum_probs=206.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hh-hHHHHHHHHHHHHhcCCCCccEEEeeeee--------CC
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQ-GIKEYASEVKIISRLRHRNLVQLLGWCHE--------KK 422 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--------~~ 422 (645)
.|....++|+|.||.||+++.+.+|+.||+|++-.++ ++ .-...++|+.+|..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555778999999999999999999999999764432 22 23456789999999999999999999853 34
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.+++||++|+. +|.-.|......++...+.++++++..||.|+|. ..|+|||+|+.|+|++.++.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 58999999954 7777776666789999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccCC---cceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC---
Q 042831 503 VEHAKG---SQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN--- 575 (645)
Q Consensus 503 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~--- 575 (645)
+..... ...+..+-|.+|++||.+.+ ..++++.|||.-||++.||++|.+-++...+..+..++.....-+..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 754433 22344566999999998766 56999999999999999999999888776655444333322111111
Q ss_pred -----Ccccccc-------------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC-CCC
Q 042831 576 -----GKLLEAV-------------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA-PLP 630 (645)
Q Consensus 576 -----~~l~~~~-------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~-~~p 630 (645)
-.+.+.+ ..++.+...+ ...++|+..++..||.+|+.+.+++.|-+|.. |.|
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd---~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKD---DEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCC---hhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 1111111 1111111111 14556667788999999999999999998764 444
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=272.45 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=195.2
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCe
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~ 423 (645)
.....+|+...+||+|+||+|.++..+++.+.+|||+++++- ..+.+--+.|-++|.-. +-|.+++++.+++.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344568999999999999999999999999999999987652 11222223455666554 46899999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+++||||+.+|+|--++++- +.+.++...-.+..||-||-+||+ ++||.||||..|||||.+|++||+|||+++.-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999998888543 456777888899999999999999 99999999999999999999999999999742
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
- -....+..++||+.|+|||++...+|+...|.|||||+||||+.|++||+..+++ .+.+.+.+
T Consensus 501 i-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI~e------------ 564 (683)
T KOG0696|consen 501 I-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAIME------------ 564 (683)
T ss_pred c-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHH------------
Confidence 2 2334566789999999999999999999999999999999999999999865543 23332222
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 614 (645)
. .-.++.....+...+....+...|.+|-
T Consensus 565 h--nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 H--NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 1123333445556666777888888884
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=274.72 Aligned_cols=266 Identities=26% Similarity=0.368 Sum_probs=203.9
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--Ch-----hhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SK-----QGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~-----~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
+-....++|-.+++||+|||+.||++.+....+.||||+-..+ -+ ...+...+|..+-..|.||.||++++|+
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 3334455777889999999999999999988999999975322 11 1245677899999999999999999998
Q ss_pred ee-CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEE
Q 042831 419 HE-KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKI 494 (645)
Q Consensus 419 ~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl 494 (645)
.- .+.+|-|.|||++.+|+-+|.+ .+.+++...+.|+.||..||.||.+ .+.+|||-||||.||||- .-|.+||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEe
Confidence 74 5678999999999999988854 4678999999999999999999997 467999999999999994 4578999
Q ss_pred eeccCcccccccCCc------ceeecccCccccCccccccC----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 042831 495 GDFGLARLVEHAKGS------QTTVLAGTMGYMAPECATTG----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVS 564 (645)
Q Consensus 495 ~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~ 564 (645)
+|||++++++..... .+...+||.+|++||++.-+ +++.|.||||.||++|.++.|+.||...... ..
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH
Confidence 999999998754432 23457899999999988544 4788999999999999999999999864432 22
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+++ +..+..+-+-.+.. .+........++++||+..-++|....++..+..
T Consensus 693 ILq-------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy 743 (775)
T KOG1151|consen 693 ILQ-------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY 743 (775)
T ss_pred HHh-------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence 222 12222211111100 0112234456789999999999988888776554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=287.09 Aligned_cols=264 Identities=26% Similarity=0.391 Sum_probs=216.7
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE 420 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~ 420 (645)
..++.+...++-|++.+.||.|.+|.||+++...+++.+|+|+....... .++...|.++++.+ .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44556666778899999999999999999999999999999988655433 35667889999887 59999999999853
Q ss_pred -----CCeEEEEEEecCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEE
Q 042831 421 -----KKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494 (645)
Q Consensus 421 -----~~~~~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl 494 (645)
+++++||||||.+||..+++.. .+..+.|+.+..|+..++.||++||. ..++|||||-.|||++.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEE
Confidence 4689999999999999998864 26789999999999999999999998 88999999999999999999999
Q ss_pred eeccCcccccccCCcceeecccCccccCccccccC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 042831 495 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~ 569 (645)
+|||++..++..... .....||+.|||||++.-. .++.++|+||||++..||.-|.+|+.+..+- ..+
T Consensus 165 vDFGvSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raL 237 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 237 (953)
T ss_pred eeeeeeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhh
Confidence 999998876654433 3346799999999988532 4678999999999999999999999865542 111
Q ss_pred HHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 570 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+ .+...-.|.+.. +....+++.+++..||..|-++||++.++++|..
T Consensus 238 F------~IpRNPPPkLkr--p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 238 F------LIPRNPPPKLKR--PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred c------cCCCCCCccccc--hhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 1 122222344432 4467788999999999999999999999998864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=276.35 Aligned_cols=256 Identities=21% Similarity=0.361 Sum_probs=204.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.-|..++.||-|+||+|.+++..++...+|+|.+++. .+.......+|-.||.+...+=||+|+-.|++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4588899999999999999999999999999998765 3455667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc---
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH--- 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~--- 505 (645)
||++||++-.+|.+ .+.+++...+-.+..+..|+++.|. .|+|||||||+|||||.+|++||+||||+.-+.-
T Consensus 709 dYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999998864 3567888888888899999999998 9999999999999999999999999999863310
Q ss_pred ------c---CC-----------------------------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHH
Q 042831 506 ------A---KG-----------------------------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547 (645)
Q Consensus 506 ------~---~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~el 547 (645)
+ +. .....++||..|+|||++....++..+|.||.||+||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0 00 000125699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCCc-hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHh
Q 042831 548 ACGRKPINPKAPQGQ-VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP---SIRQVIHVL 623 (645)
Q Consensus 548 ltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~L 623 (645)
+.|+.||-...+.+. ..++.|- ..++-..++....+....+. ..|+ ++++|- -..||..|.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~~ls~e~~~li~---kLc~--sad~RLGkng~d~vKaHp 929 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWR----------NFLHIPYQGNLSKEALDLIQ---KLCC--SADSRLGKNGADQVKAHP 929 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehh----------hccccccccccCHHHHHHHH---HHhc--ChhhhhcccchhhhhcCc
Confidence 999999987776543 3334442 23333345555555444433 3466 444554 456688888
Q ss_pred ccC
Q 042831 624 NFE 626 (645)
Q Consensus 624 ~~~ 626 (645)
+|.
T Consensus 930 fFk 932 (1034)
T KOG0608|consen 930 FFK 932 (1034)
T ss_pred ccc
Confidence 764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=256.42 Aligned_cols=251 Identities=21% Similarity=0.331 Sum_probs=201.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~ 424 (645)
...++|...+.||+|.+.+|.+++++.+.+.+|+|++++. ..+.+.....|-.+..+. +||.+|-+..+++.+..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3446899999999999999999999999999999998764 445566677787777776 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++|.||+++|+|--+++ +.+.|+++..+-....|.-||.|||+ +|||.||||..|||+|.+|.+||+|+|+++.-
T Consensus 327 ffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC-
Confidence 99999999999987774 44578888888899999999999999 99999999999999999999999999999853
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CCCchhHHHHHHHHhcCCccccccC
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA-PQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~-~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
-..+..+..++||+.|+|||++++..|....|.|++||+++||+.||.||+.-. +..+.+.-++.++.+-+..+. +.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--ip 479 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--IP 479 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--cc
Confidence 234456677899999999999999999999999999999999999999997432 112233344555444332221 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 614 (645)
..+ ..+...+...-|++||.+|-
T Consensus 480 rsl--------svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 480 RSL--------SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cee--------ehhhHHHHHHhhcCCcHHhc
Confidence 111 12334455667789998874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=271.33 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=208.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.++.....||-||||.|=++..+.....+|+|++++. ...+.+....|-.+|.+.+.|.||+++--+.+.+..|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3455577899999999999998866556899988653 4455677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|-|-+|.|+..|.++ +.++.....-++..+.+|+.|||. ++||.|||||+|.+||.+|-+||.|||+|+.+.. +
T Consensus 500 EaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--G 573 (732)
T ss_pred HhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc--C
Confidence 999999999999554 567777788888999999999999 9999999999999999999999999999997754 3
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
..+-.++||+.|.|||++.+...+.++|.||||++++||++|++||...++-..- .++-+| +|..
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-------n~ILkG-----id~i--- 638 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-------NLILKG-----IDKI--- 638 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-------HHHHhh-----hhhh---
Confidence 4556689999999999999999999999999999999999999999865542111 111111 2211
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFEA 627 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~~ 627 (645)
+++........++++..+..+|.+|-. ..++-+|-|++.
T Consensus 639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 122223345566777788899999975 889999999753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=239.62 Aligned_cols=207 Identities=29% Similarity=0.412 Sum_probs=174.4
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeE
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~ 424 (645)
++...++......||+|++|.|-+-++..+|+..|+|++... +.+..++.++|+.+..+- .+|.+|.++|...++...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 344445555678899999999999999999999999999755 456677888999887765 699999999999999999
Q ss_pred EEEEEecCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 425 LLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
++.||.| ..||+.+.. +.+..+++...-+|+..+.+||.|||+ ...++|||+||+|||++..|++|+||||.+-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 667876654 467889999999999999999999999 4689999999999999999999999999987
Q ss_pred cccccCCcceeecccCccccCcccccc----CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT----GKASKESDVYSFGIVALEIACGRKPINPKA 558 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDV~SfGvll~elltG~~pf~~~~ 558 (645)
.+..+- ..+...|...|||||.+.. ..|+-+|||||||+.+.||++++.||+...
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 654321 1223467788999998753 368999999999999999999999997543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-31 Score=284.30 Aligned_cols=249 Identities=26% Similarity=0.373 Sum_probs=191.5
Q ss_pred CCCCCCccCcCCcEE-EEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEe
Q 042831 353 DFNDDQKLGQGGFGG-VYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~-Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
-|...+.+|.|..|+ ||+|... |+.||||++-... ..-..+|+..|+.- +||||+++++.-.++...||..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 356677899999886 6999986 6899999885332 23456899999887 599999999999999999999999
Q ss_pred cCCCChhhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-----CCcEEEeeccCccc
Q 042831 431 MPNGSLDSHLFKENS---LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-----NFNAKIGDFGLARL 502 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kl~DfGla~~ 502 (645)
| ..+|.+++..... ...-...+.+..|+++||++||+ .+||||||||.||||+. ...++|+|||+++.
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9 6799999976311 11113446788999999999999 89999999999999975 35799999999998
Q ss_pred ccccCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 503 VEHAKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 503 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
+...... ......||.||+|||++.....+.+.||||+||++|.+++ |..||.+....+ .+++. ++..+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~ 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLV 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Ccccee
Confidence 7655443 2345789999999999999988999999999999999999 589998544321 11110 011111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+... .++ ...+|+.+|++++|..||++.+|+.|.-|.
T Consensus 734 -----~L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 734 -----HLEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred -----eeccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 11111 111 566788999999999999999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=239.02 Aligned_cols=212 Identities=33% Similarity=0.539 Sum_probs=186.4
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChhh
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDS 438 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 438 (645)
||+|.+|.||++...++++.+++|++...... ..+.+.+|++.+.+++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888899999998765443 45688999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcccccccCCcceeecccC
Q 042831 439 HLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGT 517 (645)
Q Consensus 439 ~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt 517 (645)
++......+++..+..++.+++++|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 986554578999999999999999999999 89999999999999999 89999999999976543321 12334578
Q ss_pred ccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHH
Q 042831 518 MGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIE 596 (645)
Q Consensus 518 ~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~ 596 (645)
..|++||..... ..+.++|+|++|+++++| .
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~ 188 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------P 188 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------H
Confidence 889999998887 788999999999999999 4
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 597 RLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 597 ~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
.+.+++..|++.+|++||+++++++++
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 567788999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-31 Score=254.04 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-----eEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-----ELLLV 427 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-----~~~lV 427 (645)
+..+.||.|+||.||..++..+|+.||+|++..- +-...+.+.+|+++|+-++|.|++..++..+-.. ++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3467899999999999999999999999988643 3345678899999999999999999988765432 56788
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
.|.| ..+|.+.+.. ...++...++-+..||++||.|||+ .+|.||||||.|.|++.|...||||||+++..+...
T Consensus 136 TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8888 5567666643 3467778888899999999999999 999999999999999999999999999999877666
Q ss_pred CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc-----------C
Q 042831 508 GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-----------N 575 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-----------~ 575 (645)
....+..+-|..|.|||++.+. .|+.+.||||.||++.||+..|..|+...+-++..++ .++.+ +
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI---tdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI---IDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH---HHHhCCCcHHHHHHHhh
Confidence 6666666778899999999875 4899999999999999999999999877665544333 22222 2
Q ss_pred CccccccC-----ccc---cC--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVD-----PRL---CR--DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d-----~~l---~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
|....++. |.+ .. ..+..+ .+.+.+.+.+++.||++|.+..+.+.++..
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~-heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKN-HEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccc-hHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 22211111 111 11 111112 223345567889999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=248.25 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=196.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-----C---CCccEEEeeeee--
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-----H---RNLVQLLGWCHE-- 420 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~nlv~l~~~~~~-- 420 (645)
..+|...++||.|-|++||++.+..+.+.||+|+++.. ....+..+.||++|++++ | ..||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 36888999999999999999999999999999998643 334456778999999984 2 479999999975
Q ss_pred --CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC--------
Q 042831 421 --KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-------- 489 (645)
Q Consensus 421 --~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-------- 489 (645)
+.+.|||+|++ |.+|..++... -+-++...+++|++||+.||.|||.+ .+|||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhhh
Confidence 45899999999 66777777653 46799999999999999999999996 579999999999999421
Q ss_pred ---C-----------c----------------------------------------------------------------
Q 042831 490 ---F-----------N---------------------------------------------------------------- 491 (645)
Q Consensus 490 ---~-----------~---------------------------------------------------------------- 491 (645)
+ .
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence 0 0
Q ss_pred --------------------------------------------------------------------------------
Q 042831 492 -------------------------------------------------------------------------------- 491 (645)
Q Consensus 492 -------------------------------------------------------------------------------- 491 (645)
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence
Q ss_pred EEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc---hhHHHH
Q 042831 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ---VSLLQW 568 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~---~~l~~~ 568 (645)
+||+|||.|+...+ +.+.-..|..|+|||++.+..|++.+||||++|+++||+||...|++....+- .+=+..
T Consensus 393 vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 00001110000000 00001246789999999999999999999999999999999999986553321 111111
Q ss_pred HHHH--------h-----------cCCccccccC--c-----cc--cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 042831 569 VWDL--------Y-----------GNGKLLEAVD--P-----RL--CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620 (645)
Q Consensus 569 ~~~~--------~-----------~~~~l~~~~d--~-----~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 620 (645)
+.++ . +.|.+..+-. + -| .=+++.+++.++..++.-+|+.+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 1111 1 1233322211 0 00 1146778899999999999999999999999999
Q ss_pred HHhccC
Q 042831 621 HVLNFE 626 (645)
Q Consensus 621 ~~L~~~ 626 (645)
+|.|-.
T Consensus 549 ~hPwLn 554 (590)
T KOG1290|consen 549 KHPWLN 554 (590)
T ss_pred cCcccc
Confidence 999965
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=235.85 Aligned_cols=200 Identities=31% Similarity=0.493 Sum_probs=175.3
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
|...+.||+|++|.||++...++++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678899999999999999988899999999766544 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+++|.+++......+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999986544338999999999999999999998 79999999999999999999999999999876543211223
Q ss_pred ecccCccccCcccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 042831 513 VLAGTMGYMAPECA-TTGKASKESDVYSFGIVALEIACGRKPINP 556 (645)
Q Consensus 513 ~~~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~elltG~~pf~~ 556 (645)
...++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 35677889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=227.74 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=199.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeC--CeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEK--KELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~--~~~~lV 427 (645)
.++|++.+++|+|.++.||.|....+++.++||.++.-. .+.+.+|+.+|..|+ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 467888999999999999999998889999999986543 357789999999998 99999999998765 467899
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCccccccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~~ 506 (645)
+||+.+.+..... ..++...+...+.+++.||.|+|+ .||.|||+||.|+++|. +-..+|+|+|+|..+..+
T Consensus 114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999988776554 357777888899999999999999 99999999999999995 456999999999987654
Q ss_pred CCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH--H------HHHhcCCc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW--V------WDLYGNGK 577 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~--~------~~~~~~~~ 577 (645)
.. ....+.+..|--||.+..- .++-.-|+|||||+|.+|+..+.||-......+ .++.. + ..+..+-.
T Consensus 187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHHHHHHc
Confidence 43 3334567788999988664 478899999999999999999999875543221 12211 1 11111111
Q ss_pred cccccCccccC---------------CCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 578 LLEAVDPRLCR---------------DFDGQ-QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 578 l~~~~d~~l~~---------------~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+ .+||.+.. .-... ...+.++++-..|..|-++|||++|++.|..|.
T Consensus 264 i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 264 I--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA 326 (338)
T ss_pred c--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence 1 12222211 00001 114566777788899999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=234.26 Aligned_cols=267 Identities=23% Similarity=0.240 Sum_probs=200.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
...+|...+.+|.|.- .|-.+.+.-.++.||+|++... .....+...+|..++..++|+|+++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777889999998 7777887777899999987543 344567778999999999999999999988533
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
.+.++||||| ..+|...++ ..++-+....|..|++.|+.|||+ .+|+||||||+||++..++.+||.|||+++
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence 3679999999 667877765 345667888999999999999999 999999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH---------------
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL--------------- 566 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~--------------- 566 (645)
..+.. -..+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-++-..+
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 64432 2445567888999999999888999999999999999999999999755432221111
Q ss_pred -HHHHHHhcC------Ccccccc-CccccC--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 -QWVWDLYGN------GKLLEAV-DPRLCR--DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 -~~~~~~~~~------~~l~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.-+..+.+. -...+.+ |..+.. +.+.-.......++.++|-.+|++|.+.+++|+|....
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 001111110 0001111 110100 11112234556778999999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=251.31 Aligned_cols=197 Identities=27% Similarity=0.414 Sum_probs=170.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcC---CCCccEEEeeeee
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLR---HRNLVQLLGWCHE 420 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~ 420 (645)
.+|...+.+|+|+||.|+++.++.....|+||.+.+.. ....-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46889999999999999999999989999999886531 111123457999999997 9999999999999
Q ss_pred CCeEEEEEEecC-CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 421 KKELLLVYEFMP-NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 421 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
++.++|++|-.. +-+|.+++. .+..+++.....|++|++.|+.+||. ++|||||||-+||.+|.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999999764 446777773 45678999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCC
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPIN 555 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~ 555 (645)
+.+...+ ....+.||.+|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9766543 3455789999999999998875 677899999999999999998885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=224.46 Aligned_cols=257 Identities=23% Similarity=0.369 Sum_probs=192.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEee-eeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGW-CHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~-~~~~~~~~lV~ 428 (645)
.+.|.+.+.||+|.||.+-++.++++++.+++|-+... ....++|.+|...--.|. |.||+.-++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 35788899999999999999999999999999988543 334678999987766664 8999987764 66778889999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE-C-CCCcEEEeeccCccccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-D-SNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-d-~~~~~kl~DfGla~~~~~~ 506 (645)
||+|.|+|.+-+.. ..+-+..-.+++.|+++|+.|||+ +++||||||.+|||+ + +...+||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 99999999988744 346778888999999999999999 999999999999999 3 344799999999875432
Q ss_pred CCcceeecccCccccCccccccC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTG-----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
.......+..|.+||..... +..+.+|+|.||++++.+++|+.||+.....++ .-|-|..|.+++....
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNPAL 249 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCccC
Confidence 22223445678999976432 357789999999999999999999984333222 2344555555444321
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLR---PSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~~~ 626 (645)
|+.-..+. ++++.+-.+-+.+++++| -+.+.....+|.+
T Consensus 250 --P~~F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 250 --PKKFNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred --chhhcccC----HHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 22222333 355566677889999999 4445555555543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=254.09 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=206.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.+|+|.+|.|||++++.+++..|+|.++.......+-..+|+-+++..+|+||+.++|-+.....+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 57788899999999999999999999999999998877777777788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
.+|+|.+..+- ...+++.++..+++...+||.|||+ ++=+|||||-.|||+++.+.+|++|||.+-.+.. .-...
T Consensus 95 gggslQdiy~~-TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~Kr 169 (829)
T KOG0576|consen 95 GGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAKR 169 (829)
T ss_pred CCCcccceeee-cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhh-hhhhh
Confidence 99999987643 4578999999999999999999998 8889999999999999999999999999764432 22344
Q ss_pred eecccCccccCcccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 512 TVLAGTMGYMAPECA---TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~---~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
..+.||+.|||||+. +.+.|..++|||+.|+...|+.--+.|..+..+. +..+-+-..+ .-.|.+..
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~l~LmTkS~----~qpp~lkD 239 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RALFLMTKSG----FQPPTLKD 239 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HHHHHhhccC----CCCCcccC
Confidence 567899999999975 4567999999999999999998777765433221 1111110111 01122221
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.....+.+.+++..|+..+|++||+++.+++|.-
T Consensus 240 --k~kws~~fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 240 --KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred --CccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence 1234567888999999999999999998887543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=278.16 Aligned_cols=201 Identities=18% Similarity=0.272 Sum_probs=145.8
Q ss_pred hcCC-CCccEEEeee-------eeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeee
Q 042831 405 RLRH-RNLVQLLGWC-------HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476 (645)
Q Consensus 405 ~l~H-~nlv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 476 (645)
.++| +||++++++| .+...+++++||+ +++|.+++......+++..++.++.||++||.|||+ ++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3456 6888888887 2234678888987 669999997666779999999999999999999998 99999
Q ss_pred ccCCCCCeEECC-------------------CCcEEEeeccCcccccccCC---------------cceeecccCccccC
Q 042831 477 RDIKSSNIMLDS-------------------NFNAKIGDFGLARLVEHAKG---------------SQTTVLAGTMGYMA 522 (645)
Q Consensus 477 ~Dlkp~NILld~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y~a 522 (645)
|||||+||||+. ++.+|++|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 44566666666653211000 00112357889999
Q ss_pred ccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHH
Q 042831 523 PECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602 (645)
Q Consensus 523 PE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~ 602 (645)
||++.+..++.++|||||||+||||++|..|+.... ... .... .. .+++... ........++
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~---~~~~-~~----~~~~~~~-----~~~~~~~~~~ 245 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM---SSLR-HR----VLPPQIL-----LNWPKEASFC 245 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH---HHHH-Hh----hcChhhh-----hcCHHHHHHH
Confidence 999999999999999999999999999988865211 011 1110 00 1111111 1123345677
Q ss_pred HHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 603 LWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 603 ~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+||+++|.+||+|+|++++.+...
T Consensus 246 ~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHhCCCChhhCcChHHHhhchhhhh
Confidence 8999999999999999999998753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=243.77 Aligned_cols=287 Identities=21% Similarity=0.226 Sum_probs=212.4
Q ss_pred hhhhhcCCCCCccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC--
Q 042831 330 DDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-- 407 (645)
Q Consensus 330 ~~~~~~~~~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-- 407 (645)
.+.|....+- |.+.-.+....+|......|+|-|++|.+|.+..-|..||||++..+.. -.+.=+.|+++|.+|+
T Consensus 412 ~DNWdDaEGY--Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 412 QDNWDDAEGY--YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDA 488 (752)
T ss_pred ccCcccccce--EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhcc
Confidence 3444444433 3333344456789999999999999999999988888999999976532 2344568999999996
Q ss_pred ----CCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCC
Q 042831 408 ----HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKS 481 (645)
Q Consensus 408 ----H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 481 (645)
.-|.++|+-.|...+++|||+|-+ ..+|.+.|.+- +--|....+..+++|+.-||..|.. .+|+|.||||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKP 564 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKP 564 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCc
Confidence 247889999999999999999987 67899999764 3457788899999999999999998 8999999999
Q ss_pred CCeEECCCC-cEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 042831 482 SNIMLDSNF-NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ 560 (645)
Q Consensus 482 ~NILld~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~ 560 (645)
.|||+++.- .+||||||.|....... .+...-...|.|||++.+.+|+...|+||.||+||||.||+..|.+....
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred cceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 999998754 58999999997654322 12222345699999999999999999999999999999999999876543
Q ss_pred CchhHHHHH-----HHHhcCCcc---------------------------ccccCc------ccc--CCCC---HHHHHH
Q 042831 561 GQVSLLQWV-----WDLYGNGKL---------------------------LEAVDP------RLC--RDFD---GQQIER 597 (645)
Q Consensus 561 ~~~~l~~~~-----~~~~~~~~l---------------------------~~~~d~------~l~--~~~~---~~~~~~ 597 (645)
....+.--+ ..+++.|.. ...+.| .+. ..++ ...+..
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 322111100 011111111 111112 110 1122 234577
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 598 LMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 598 l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+..|.-.|+..||++|.|..|+|+|..+.
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 88899999999999999999999987643
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-26 Score=231.68 Aligned_cols=270 Identities=21% Similarity=0.307 Sum_probs=202.1
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKK 422 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~ 422 (645)
+....+.|...++||+|.|++||++.+.. .++.||+|.+...+.. ....+|+++|.++. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445678889999999999999999877 6789999998665433 45789999999996 899999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLAR 501 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~ 501 (645)
+.++|+||++.....+++. .++...+...+..+..||.++|. .|||||||||+|+|.+. .+.-.|.|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999998888874 46788899999999999999999 99999999999999974 5678999999997
Q ss_pred cccccC------C-------------------------------------cceeecccCccccCcccccc-CCCCcchhH
Q 042831 502 LVEHAK------G-------------------------------------SQTTVLAGTMGYMAPECATT-GKASKESDV 537 (645)
Q Consensus 502 ~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV 537 (645)
..+... . ......+||+||.|||++.. ...++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 221000 0 00012469999999998866 457999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHH----H-----hcCCc--ccc---------------ccC-ccccC--
Q 042831 538 YSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD----L-----YGNGK--LLE---------------AVD-PRLCR-- 588 (645)
Q Consensus 538 ~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~----~-----~~~~~--l~~---------------~~d-~~l~~-- 588 (645)
||.||+++.+++++.||-....+. ..+.+.+.- . ...|. +.+ -++ ..+.+
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999986544322 112211100 0 00122 111 000 00000
Q ss_pred -----CCC--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 -----DFD--GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 -----~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+ +.....++.+..+|+..||.+|.|++++|+|.-+.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 000 01123677888999999999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=209.48 Aligned_cols=166 Identities=21% Similarity=0.145 Sum_probs=126.8
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceee
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|+|.+++...+..+++.+++.|+.|+++||.|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 78999997767789999999999999999999998 44 999999999999999 99987654322
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... .....+...... .++.. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~------~~~~~-~~~~~~ 134 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPA------DDPRD-RSNLES 134 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhcc------CCccc-cccHHH
Confidence 258899999999999999999999999999999999999996433211 111111111100 01110 001111
Q ss_pred HH--HHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 594 QI--ERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 594 ~~--~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ..+.+++.+||+.+|++||++.|++++++.
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 22 258899999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=218.40 Aligned_cols=168 Identities=20% Similarity=0.222 Sum_probs=131.9
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcC-CCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccE-EEeeee
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQ-LLGWCH 419 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~-l~~~~~ 419 (645)
.....++|...+.||+|+||+||+|++.. +++.||||+.... .....+.+.+|+++|.+++|+|+++ ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34456789999999999999999998875 6788899986533 1223567899999999999999985 4432
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccC-CCCCeEECCCCcEEEeecc
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDI-KSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILld~~~~~kl~DfG 498 (645)
+..++||||+++++|.. + .... ...++.|++++|.|||+ ++|+|||| ||+|||++.++++||+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~-~-~~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-A-RPHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHH-h-Cccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 45799999999999963 2 1111 14678899999999999 99999999 9999999999999999999
Q ss_pred CcccccccCC-------cceeecccCccccCccccccC
Q 042831 499 LARLVEHAKG-------SQTTVLAGTMGYMAPECATTG 529 (645)
Q Consensus 499 la~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 529 (645)
+++.+..... ...+...++..|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987643221 111345678889999988654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-23 Score=202.59 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=187.2
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEecc--CChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecC
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
....+|.+...|..|+|++.+ ..++.|++.- ......++|..|.-.|+-+.||||++++|.|.....+.++..||+
T Consensus 193 nl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345678899999999999974 3466676643 234455789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 433 NGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 433 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
.|+|+..|++.. -..+..+..+++.++|+|++|||+. ++-|..--|.+..|++|++..++|.- +-++ ...+.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~k-----fsfqe 343 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTK-----FSFQE 343 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccce-----eeeec
Confidence 999999998754 4577889999999999999999983 44455567899999999999988851 1111 11112
Q ss_pred eecccCccccCccccccCCC---CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 512 TVLAGTMGYMAPECATTGKA---SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~---t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
....-.+.||+||.++..+. -.++|+|||.++||||.|...||.+..+-+...-+ ..+. ++.
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----------aleg----lrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----------ALEG----LRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------hhcc----ccc
Confidence 22345678999999987653 35799999999999999999999865543221111 0111 222
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+++.....+.+|+.-|++.||.+||.+..++-.|+.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 2333334566777788999999999999999988864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-21 Score=204.04 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=192.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCC-eEEEEEEeccCChhhHHHHHHHHHHHHhcCC----CCccEEEeee-eeCCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETN-SYIAVKRVSQGSKQGIKEYASEVKIISRLRH----RNLVQLLGWC-HEKKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~nlv~l~~~~-~~~~~~~l 426 (645)
+|...++||+|+||.||++....++ ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7889999999999999999987764 6789998765533333367789999988873 6889999888 47778899
Q ss_pred EEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-----CcEEEeeccCc
Q 042831 427 VYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-----FNAKIGDFGLA 500 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-----~~~kl~DfGla 500 (645)
||+.+ +.+|.++.... .+.++......|+.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 88999877544 3789999999999999999999998 999999999999999754 46999999999
Q ss_pred cccc--ccCC------cc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHH
Q 042831 501 RLVE--HAKG------SQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 501 ~~~~--~~~~------~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~ 571 (645)
+... .... .. .....||..|.++++..+...+.+.|+||++.++.|+..|..||............. .
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---K 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---H
Confidence 8322 1111 11 223569999999999999999999999999999999999999997554332211111 1
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+. .... + ......+...+. ..+-..+..++|....+...+..
T Consensus 252 ~~~~~----~~~~-~-~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 252 DPRKL----LTDR-F-GDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred Hhhhh----cccc-c-cCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHH
Confidence 10000 0010 1 122223333333 33445799999999999888753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=195.98 Aligned_cols=259 Identities=28% Similarity=0.368 Sum_probs=197.6
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh---hHHHHHHHHHHHHhcCCC-CccEEEeeeeeCCeEEEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ---GIKEYASEVKIISRLRHR-NLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-nlv~l~~~~~~~~~~~lV~E 429 (645)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566788999999999999987 67899988755322 477899999999999988 79999999977777899999
Q ss_pred ecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~ 506 (645)
|+.++++.+++.... ..++......+..|++.++.|+|. .+++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999996664433 278999999999999999999999 8899999999999999988 7999999999855433
Q ss_pred CCc-----ceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 507 KGS-----QTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 507 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
... ......|+..|++||.+.. .......|+|++|++++++++|+.||...... .......+.......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 322 2356789999999999987 57899999999999999999999997654321 001111111111110
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
. .................+..++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000111111002223466777888999999999999988775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=189.82 Aligned_cols=205 Identities=21% Similarity=0.284 Sum_probs=177.5
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~ 428 (645)
..-.|...++||+|.||.++.|+..-+++.||||.-...+ ...++..|....+.|. .++|...+-+-.++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 4557899999999999999999998889999999754433 3356778888888885 689999988888888999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-----CCcEEEeeccCcccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-----NFNAKIGDFGLARLV 503 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kl~DfGla~~~ 503 (645)
|.+ +.||++++.-.++.++...+..|+.|++.-++|+|+ +.+|.|||||+|.||.. ...+.|.|||+|+.+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 998 889999887778899999999999999999999999 99999999999999964 335899999999976
Q ss_pred ccc------CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 042831 504 EHA------KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ 560 (645)
Q Consensus 504 ~~~------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~ 560 (645)
... .......+.||.+||+-....+.+.+.+.|+-|+|.+++..+-|..||+....+
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 432 334456678999999999999999999999999999999999999999876543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=182.39 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=193.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCccEEEeeeeeCCeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nlv~l~~~~~~~~~~~lV~ 428 (645)
..+.|...++||+|+||.+|.|....+|+.||||.-+...+ ..++.-|..+...|++ ..|..+..+..++..-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34678899999999999999999999999999998654433 3567789999999985 67777888888888999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla~~~~~ 505 (645)
|.+ +.||++++.-..+.++....+.++-|++.-++|+|. ++++||||||+|.|..- ...+.++|||+++.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 889999887667789999999999999999999998 99999999999999953 34588999999987643
Q ss_pred c------CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 506 A------KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 506 ~------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
. .........||.+|.+-....+...+.+.|+-|+|.+|..+-.|..||++........-.+.+ .+.++
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK~- 241 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKKM- 241 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhhc-
Confidence 2 223345678999999988777778899999999999999999999999876654332222222 12222
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSI 616 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 616 (645)
...-..+|..++.+..- .+.-|-..--++-|..
T Consensus 242 s~~ie~LC~G~P~EF~m----yl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAM----YLNYCRGLGFEEKPDY 274 (341)
T ss_pred CCCHHHHhCCCcHHHHH----HHHHHhhcCCCCCCcH
Confidence 11223456666554322 2234555555555643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-22 Score=221.85 Aligned_cols=259 Identities=23% Similarity=0.230 Sum_probs=193.0
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEec----c-CC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS----Q-GS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~----~-~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
...+.+|.|++|.|+...........+.|.+. . .. .+....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988887776555555555432 1 11 122233667888888899999998888877766666669
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|||++ +|...+... ..+....+..+++|+..|+.|||. .|+.|||+|++|++++.++.+||+|||.+..+.....
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999888543 467888899999999999999999 9999999999999999999999999999987765444
Q ss_pred c---ceeecccCccccCccccccCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 509 S---QTTVLAGTMGYMAPECATTGKASK-ESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 509 ~---~~~~~~gt~~y~aPE~~~~~~~t~-~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
. ......|...|+|||.+...++.+ ..||||.|+++..|++|+.||......++.. .+ ..+.-...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~------~~~~~~~~~~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KT------NNYSDQRNIFE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hh------hcccccccccc
Confidence 3 345578899999999999988865 5799999999999999999998665543321 00 00000000000
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. ..........+...++..+|++||.+|.||++|++.-|+.
T Consensus 549 ~-~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~ 589 (601)
T KOG0590|consen 549 G-PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR 589 (601)
T ss_pred C-hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence 0 0011122335566778899999999999999999998865
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-19 Score=174.97 Aligned_cols=184 Identities=24% Similarity=0.230 Sum_probs=132.5
Q ss_pred CCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSK 124 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~ 124 (645)
..++.+. +|.+ .++.|+||+ ..++.|+++|+.|+++ .+|+|+|+|.|.+.. ..+||||||+++|...
T Consensus 19 ~~~w~~~G~a~~-~~~~i~LT~~~~~~~G~~~~~~pi~~--------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~- 87 (218)
T cd07308 19 IGNWTVGGSTVI-TKNYIRLTPDVPSQSGSLWSRVPIPA--------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPG- 87 (218)
T ss_pred cCCeEEcCCeEE-eCCEEEeCCCCCCCEeEEEeCCCccC--------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCC-
Confidence 4478888 8888 588999999 6779999999999998 589999999998764 5579999999999753
Q ss_pred CCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCc-c-----------cceeeecccCCCCce
Q 042831 125 IPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVK-S-----------KKNVSWWSDVKSGRR 192 (645)
Q Consensus 125 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~-s-----------~~~~~~~~~~~~g~~ 192 (645)
..|+.+|.-+ ..+-+||||||+.|. +-..++|.+-+|.-. + .....+... .+++.
T Consensus 88 ----~~g~~~G~~~-------~~~Glai~fdt~~n~-~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~-~~~~~ 154 (218)
T cd07308 88 ----SDGPLFGGPD-------KFKGLAIFFDTYDND-GKGFPSISVFLNDGTKSYDYETDGEKLELASCSLKFR-NSNAP 154 (218)
T ss_pred ----CCCcccccCC-------CCCEEEEEEEcCCCC-CCCCCeEEEEEeCCCceecccCCCccccccceeEecc-cCCCC
Confidence 2455555422 234499999999986 333445555444322 1 111122211 23789
Q ss_pred eEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeecc
Q 042831 193 NEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFN 260 (645)
Q Consensus 193 ~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~ 260 (645)
++++|.|+ .+.|.|.+...... ...++..++.. .+++..|+||||+||...+.|.|++|...
T Consensus 155 ~~~~I~y~--~~~l~v~i~~~~~~---~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 155 TTLRISYL--NNTLKVDITYSEGN---NWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred eEEEEEEE--CCEEEEEEeCCCCC---CccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 99999999 68999999754321 22344444432 45778999999999999999999999763
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.1e-20 Score=178.23 Aligned_cols=140 Identities=16% Similarity=0.105 Sum_probs=108.3
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh--h-------HH-----------------HHHHHHHHHHhcCCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ--G-------IK-----------------EYASEVKIISRLRHRN 410 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~H~n 410 (645)
...||+|++|.||+|.+. +|+.||||+++..... . .. ....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999987 7999999998654211 1 11 2234999999998877
Q ss_pred ccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhhcCCCeeeccCCCCCeEECCC
Q 042831 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL-QEEWEQCVVHRDIKSSNIMLDSN 489 (645)
Q Consensus 411 lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILld~~ 489 (645)
+.....+.. ...+|||||++++++...... ...+++.....++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 643322222 223899999998877654332 35688999999999999999999 56 7999999999999998 4
Q ss_pred CcEEEeeccCccccc
Q 042831 490 FNAKIGDFGLARLVE 504 (645)
Q Consensus 490 ~~~kl~DfGla~~~~ 504 (645)
+.++|+|||++...+
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=194.07 Aligned_cols=214 Identities=26% Similarity=0.383 Sum_probs=164.3
Q ss_pred HHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 403 ISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 403 l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+......++|.....++++|+.||.|||. ++-..|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 356889999999999999999999999999999999998888899999999999999999999998 344499999999
Q ss_pred CeEECCCCcEEEeeccCccccccc-CCcceeecccCccccCccccccCC-------CCcchhHHHHHHHHHHHHcCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPECATTGK-------ASKESDVYSFGIVALEIACGRKPI 554 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~t~~sDV~SfGvll~elltG~~pf 554 (645)
|.++|....+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765421 111111122345699999887641 467899999999999999999999
Q ss_pred CCCCCCCc-hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 555 NPKAPQGQ-VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 555 ~~~~~~~~-~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
........ ..++.++.. .....+.|.+.... +....++.++..||..+|++||++++|-..+..
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 86543322 234433322 11112223222111 233468889999999999999999999887764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-20 Score=179.26 Aligned_cols=171 Identities=13% Similarity=0.123 Sum_probs=131.0
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh---HHH------HHHHHHHHHhcCCCCccEEEeeeee
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG---IKE------YASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~---~~~------~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
..++|...+.||.|+||.||+... ++..+|+|.+....... ... +.+|+..+.+++|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 457899999999999999999654 36679999986542221 122 6799999999999999999888553
Q ss_pred C--------CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 421 K--------KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 421 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
. +..+|||||++|.+|.++.. ++. ....+++.+|..||. .+++|||++|+||+++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 2 35799999999999977631 222 345689999999998 9999999999999999888 9
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA 548 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ell 548 (645)
+|+|||........... ..++....+..++|+|+||+.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988654221111 01334445667899999999886553
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.1e-19 Score=170.57 Aligned_cols=142 Identities=18% Similarity=0.160 Sum_probs=111.2
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh--------------------------hHHHHHHHHHHHHhcCCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ--------------------------GIKEYASEVKIISRLRHRN 410 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~n 410 (645)
...||+|++|.||+|.+. +|+.||||+++..... ....+..|.+.+.+++|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 7999999998754211 0122357899999999998
Q ss_pred ccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC
Q 042831 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490 (645)
Q Consensus 411 lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 490 (645)
+.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ +.+|+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL-KDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh-hhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CC
Confidence 7544333322 2489999999886544322 23457788899999999999999997 37999999999999999 78
Q ss_pred cEEEeeccCcccccc
Q 042831 491 NAKIGDFGLARLVEH 505 (645)
Q Consensus 491 ~~kl~DfGla~~~~~ 505 (645)
.++|+|||++....+
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=176.04 Aligned_cols=230 Identities=19% Similarity=0.255 Sum_probs=150.2
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCC----------CCccEEEeeee--
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH----------RNLVQLLGWCH-- 419 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H----------~nlv~l~~~~~-- 419 (645)
...+.||.|+++.||.+++.++|+.+|+|.+... .....+++.+|.-....+.+ -.++--++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 4467899999999999999999999999987543 33456777777755555432 12222222221
Q ss_pred -------eC---C-----eEEEEEEecCCCChhhhhh---hcCC---CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeecc
Q 042831 420 -------EK---K-----ELLLVYEFMPNGSLDSHLF---KENS---LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478 (645)
Q Consensus 420 -------~~---~-----~~~lV~Ey~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 478 (645)
.. + ..+++|+-+ .++|.+.+. .... .+....+..+..|+++.+++||+ .|++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence 11 1 236778877 678877653 2222 34556777888999999999999 9999999
Q ss_pred CCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCcccccc--------CCCCcchhHHHHHHHHHHHHcC
Q 042831 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--------GKASKESDVYSFGIVALEIACG 550 (645)
Q Consensus 479 lkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDV~SfGvll~elltG 550 (645)
|+|+|++++.+|.++|+||+....... .......+..|.+||.... -.++.+.|.|++|+++|.|+||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999999988764332 1111345577999997643 2478899999999999999999
Q ss_pred CCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 042831 551 RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR 613 (645)
Q Consensus 551 ~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 613 (645)
+.||.......... | .+ ..+. +-.+.+..|+..+|+++|++|
T Consensus 247 ~lPf~~~~~~~~~~---~----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPE---W----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSG---G----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccccc---c----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99998544321110 0 11 1223 445667778899999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=203.36 Aligned_cols=251 Identities=20% Similarity=0.206 Sum_probs=178.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHH--HHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKI--ISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++...+.||++.|=+|.+|++.+ |. |+||++-+.. .-..+.|.++++- ...++|||.+++.-+....+..|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 56667899999999999999976 44 8899875543 3334444443333 455689999999888777777788888
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc--ccC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE--HAK 507 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~--~~~ 507 (645)
|. .-+|.+.+. .+..+...+.+-|+.|++.||..+|. .+|+|+|||.+|||++.-.-+.|+||..-+..- +..
T Consensus 102 yv-khnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HH-hhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 88 457888773 34567778888999999999999999 999999999999999999999999998765331 111
Q ss_pred Ccceeec----ccCccccCccccccC----------C-CCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH
Q 042831 508 GSQTTVL----AGTMGYMAPECATTG----------K-ASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 508 ~~~~~~~----~gt~~y~aPE~~~~~----------~-~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~ 571 (645)
......+ ..-.+|+|||.+... . .+++-||||+||++.||++ |++||+- .+ ...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQ-L~a 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQ-LLA 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HH-HHh
Confidence 1122222 233579999976431 1 5788999999999999988 8888861 21 111
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
++.|. ......-+ ..++. ..+..+++.|++.||.+|-++++.|+.-.+.
T Consensus 247 -Yr~~~-~~~~e~~L-e~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 -YRSGN-ADDPEQLL-EKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred -HhccC-ccCHHHHH-HhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 12221 00000001 11111 1456788999999999999999999986553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=165.00 Aligned_cols=187 Identities=13% Similarity=0.043 Sum_probs=139.7
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh----hHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ----GIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.....|++|+||+||.+.. .+..++.+.+.....- ....+.+|+++|.+|+ |+++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999997755 4677887777554331 1235789999999996 5889999887 34699999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccC-CCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDI-KSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-kp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+.+.+|...+.. ....++.|++++|.++|. ++|+|||| ||+|||++.++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999988654311 123577899999999999 99999999 79999999999999999999985543221
Q ss_pred c----c--------eeecccCccccCccccccC-CCC-cchhHHHHHHHHHHHHcCCCCCCCCC
Q 042831 509 S----Q--------TTVLAGTMGYMAPECATTG-KAS-KESDVYSFGIVALEIACGRKPINPKA 558 (645)
Q Consensus 509 ~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~~sDV~SfGvll~elltG~~pf~~~~ 558 (645)
. . ......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+.-.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0113367788888854332 223 56789999999999999998865433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.4e-18 Score=165.82 Aligned_cols=137 Identities=19% Similarity=0.217 Sum_probs=108.9
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-----CCCCccEEEeeeeeCC---e-E
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-----RHRNLVQLLGWCHEKK---E-L 424 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nlv~l~~~~~~~~---~-~ 424 (645)
++..++||+|+||.||. +..++.. +||++........+++.+|+.++.++ .||||++++|++..+. . +
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 44578899999999996 6666655 69988765455567899999999999 5799999999998763 4 3
Q ss_pred EEEEEe--cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhhcCCCeeeccCCCCCeEECC----CCcEEEeec
Q 042831 425 LLVYEF--MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL-LYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDF 497 (645)
Q Consensus 425 ~lV~Ey--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlkp~NILld~----~~~~kl~Df 497 (645)
.+|+|| +++++|.+++.+. .+++. ..++.+++.++ .|||+ .+|+||||||+|||++. +..++|+|+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 478999 5589999999543 35555 35677788777 99999 99999999999999974 347999995
Q ss_pred cCc
Q 042831 498 GLA 500 (645)
Q Consensus 498 Gla 500 (645)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-18 Score=185.50 Aligned_cols=187 Identities=27% Similarity=0.330 Sum_probs=151.9
Q ss_pred ccCcCCcEEEEEEEE---cCCCeEEEEEEeccCChh--hHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEecC
Q 042831 359 KLGQGGFGGVYKGFF---RETNSYIAVKRVSQGSKQ--GIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~---~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
.+|+|.||.|++++- .+.|..+|+|...+.... .......|..++...+ ||.++++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999987643 244677888877543211 1114456778888887 9999999999999999999999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
+|.|...+.+. ..............++-++.++|+ .+++|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99998888544 334555555666778889999998 99999999999999999999999999999865432222
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINP 556 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~ 556 (645)
+||..|||||++. ....++|.||||++++||++|..||..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7999999999998 567889999999999999999999975
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-17 Score=161.08 Aligned_cols=145 Identities=19% Similarity=0.224 Sum_probs=113.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEE-EcCCCeEEEEEEeccCChh------------------------hHHHHHHHHHHHHh
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGF-FRETNSYIAVKRVSQGSKQ------------------------GIKEYASEVKIISR 405 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~ 405 (645)
...|...+.||+|++|.||+|. +..+|+.||+|.++..... ....+..|+..+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357888999999999999998 6567999999998643210 01235689999999
Q ss_pred cCCC--CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC-eeeccCCCC
Q 042831 406 LRHR--NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC-VVHRDIKSS 482 (645)
Q Consensus 406 l~H~--nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dlkp~ 482 (645)
+.+. .+.+++++ ...++||||+++++|....... ..+.......++.|++.+|.+||. .+ ++||||||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~ 178 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY 178 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence 9753 34455543 2348999999998887655332 345566678999999999999998 88 999999999
Q ss_pred CeEECCCCcEEEeeccCccccc
Q 042831 483 NIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~ 504 (645)
||+++ ++.++|+|||.+....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=157.90 Aligned_cols=134 Identities=18% Similarity=0.278 Sum_probs=112.8
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+.||+|++|.||+|.+ .|..+++|....... .....+.+|++++..++|+++.....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 366789997653221 112457889999999999998877777777788899999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
|+++++|.+++.... + .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999885422 2 788999999999999998 8999999999999999 78999999999864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=182.95 Aligned_cols=201 Identities=17% Similarity=0.231 Sum_probs=161.5
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCccEEEeeeee
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR---HRNLVQLLGWCHE 420 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~ 420 (645)
..+.......|.+.+.||+|+||+||+|...+ |+.||+|.-+..+.. +|.--.+++.||+ -+.+..+.....-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34556666789999999999999999999987 999999987655432 2222334455555 1233344444445
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-------CCCcEE
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-------SNFNAK 493 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-------~~~~~k 493 (645)
.+..+||+||.+.|+|.+++. ..+.++|.....++.|++..+..||. .+|||+||||+|.||. ++.-++
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 677799999999999999995 66789999999999999999999999 9999999999999993 344589
Q ss_pred EeeccCcccccccC-CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCC
Q 042831 494 IGDFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK 552 (645)
Q Consensus 494 l~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~ 552 (645)
|+|||-+-.+..-. .......++|-.+-.+|...+...+.+.|.|.+..+++-|+.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986554332 335667889999999999999999999999999999999999973
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-16 Score=154.28 Aligned_cols=145 Identities=16% Similarity=0.180 Sum_probs=112.2
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh----------------------hhHHHHHHHHHHH
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK----------------------QGIKEYASEVKII 403 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l 403 (645)
++......|...+.||+|+||.||++... +|+.||||++..... .....+..|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 44444445778899999999999999885 689999998754320 0112356789999
Q ss_pred HhcCCC--CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCC
Q 042831 404 SRLRHR--NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKS 481 (645)
Q Consensus 404 ~~l~H~--nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp 481 (645)
.++.|+ .+.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+++||||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p 153 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE 153 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence 999877 44555443 345899999999998765421 3356788999999999998 8999999999
Q ss_pred CCeEECCCCcEEEeeccCcccccc
Q 042831 482 SNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 482 ~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||++++++.++|+|||++.....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=177.22 Aligned_cols=140 Identities=18% Similarity=0.274 Sum_probs=113.8
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEe-ccC-C------hhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQG-S------KQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~-~~~-~------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
.....|...++||+|+||.||+|.+.+.. +++|+. ... . ....+.+.+|++++.+++|++++....++..
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445667899999999999999886533 444432 111 1 1123568899999999999999988888887
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
....++||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||++
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 778899999999999998874 356799999999999998 899999999999999 6779999999999
Q ss_pred ccc
Q 042831 501 RLV 503 (645)
Q Consensus 501 ~~~ 503 (645)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=153.05 Aligned_cols=130 Identities=19% Similarity=0.295 Sum_probs=106.2
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.||+|++|.||+|.+. +..|++|...... .....++.+|++++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 5779999854321 11235677899999999988766555555666777999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
+++++|.+.+..... .++.+++.+|.+||+ .+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987743211 789999999999998 9999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-17 Score=173.30 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=131.0
Q ss_pred CeEEEEEEecCCCChhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE--NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
.++++.|++|...+|.++|..+ ....++.....++.|++.|+.| ++.+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 3579999999999999999643 4567888999999999999999 6799999999999999999999999999
Q ss_pred cccccccC-----CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHh
Q 042831 500 ARLVEHAK-----GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 500 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
........ ....+...||..||+||.+.+..|+.++||||||++|+||+. =..+++... ...-+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhh
Confidence 87665443 234456789999999999999999999999999999999986 222222100 11111
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 621 (645)
++|.+ +|....+++. =..+.++++++.|.+||+..++-.
T Consensus 473 r~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 473 RDGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred hcCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHhh
Confidence 22222 2222222221 124567899999999996555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=179.16 Aligned_cols=209 Identities=24% Similarity=0.281 Sum_probs=144.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
..+|+.++.+..|++|.||..+++.+.+.+|+|. .+++-- .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee------------------
Confidence 4689999999999999999999999999999953 222110 000 22222334433
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC---
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK--- 507 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~--- 507 (645)
|+-...+.. -+.++.. ++.+++|||+ .+|+|||+||+|.+++.-|.+|++|||+.+......
T Consensus 136 ---gDc~tllk~-~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ---GDCATLLKN-IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ---chhhhhccc-CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 444444422 2334333 2678999999 999999999999999999999999999987432111
Q ss_pred -----------CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 508 -----------GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 508 -----------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
.-....++||+.|+|||++....|....|.|++|+++||.+-|+.||..+.+++. ...+... ..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg~visd--~i 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FGQVISD--DI 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hhhhhhh--hc
Confidence 1112346899999999999999999999999999999999999999998766532 2211110 11
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 614 (645)
.+.+- |..+ ..+...++...|+.+|..|-
T Consensus 276 ~wpE~-dea~--------p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWPEE-DEAL--------PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccc-CcCC--------CHHHHHHHHHHHHhChHhhc
Confidence 11111 2222 22344556677888998885
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-14 Score=144.26 Aligned_cols=188 Identities=19% Similarity=0.194 Sum_probs=123.9
Q ss_pred CCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSK 124 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~ 124 (645)
.+++.+. +|.+ .++.|+||+ ..++.|++||+.|+++ .+|+|+|+|.|.+.....+||||||+++....
T Consensus 19 i~~w~~~G~a~v-~~~~IrLTp~~~~~~G~~w~~~p~~~--------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~- 88 (248)
T cd06901 19 MPLWDFLGSTMV-TSQYIRLTPDHQSKQGSIWNRVPCYL--------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM- 88 (248)
T ss_pred CCCEEEcceEEE-cCCeEEECCCCCCCEEEEeccCCccC--------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC-
Confidence 4578998 8888 467999999 5568999999999998 67999999999987666789999999998752
Q ss_pred CCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCC---CCCCceeeecCCC-ccc---------ceeeecccC-CCC
Q 042831 125 IPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWD---PTFSHVGIDINSV-KSK---------KNVSWWSDV-KSG 190 (645)
Q Consensus 125 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d---~~~~hvgidvns~-~s~---------~~~~~~~~~-~~g 190 (645)
..|..+|-.+.- + =+||-|||+.|... ...+-|.+-+|.- ... .-..+.... ..+
T Consensus 89 ----~~G~~fG~~~~f---~----Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~rn~~ 157 (248)
T cd06901 89 ----QPGPVFGSKDNF---H----GLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPFRNKD 157 (248)
T ss_pred ----ccCcccccCCCC---c----eEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeeccCCC
Confidence 234445532221 1 18999999988521 2223343333331 110 001122222 245
Q ss_pred ceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccC
Q 042831 191 RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261 (645)
Q Consensus 191 ~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~ 261 (645)
...+++|.|... .+.|.+...+..... ....+ -.-.||...|+||||+||...+.|.|++-.+..
T Consensus 158 ~~t~~rI~Y~~~--~l~v~vd~~~~~~w~---~Cf~~-~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~ 222 (248)
T cd06901 158 HDTFVAIRYSKG--RLTVMTDIDGKNEWK---ECFDV-TGVRLPTGYYFGASAATGDLSDNHDIISMKLYE 222 (248)
T ss_pred CCeEEEEEEECC--eEEEEEecCCCCcee---eeEEe-CCeecCCCCEEEEEecCCCCCCcEEEEEEEEec
Confidence 567899999964 577777643321111 22222 122356679999999999988999987665543
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.9e-16 Score=155.10 Aligned_cols=196 Identities=25% Similarity=0.296 Sum_probs=134.8
Q ss_pred CCCCccEEEeeeee---------------------------CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHH
Q 042831 407 RHRNLVQLLGWCHE---------------------------KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDL 459 (645)
Q Consensus 407 ~H~nlv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 459 (645)
+|||||++.+.|.+ ...+|+||.-+ .-+|..++..+ ..+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999887643 34678999887 45888888543 35566677889999
Q ss_pred HHHHHHHHhhcCCCeeeccCCCCCeEE--CCCC--cEEEeeccCccccccc-----CCcceeecccCccccCccccccCC
Q 042831 460 ASGLLYLQEEWEQCVVHRDIKSSNIML--DSNF--NAKIGDFGLARLVEHA-----KGSQTTVLAGTMGYMAPECATTGK 530 (645)
Q Consensus 460 a~gL~yLH~~~~~~ivH~Dlkp~NILl--d~~~--~~kl~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~ 530 (645)
++|+.|||. ++|.|||+|++|||+ |++. ...|+|||.+-.-+.. -.+......|...-||||+....+
T Consensus 351 LEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999 999999999999998 4444 4688999987532221 011223345777899999875432
Q ss_pred ------CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHH
Q 042831 531 ------ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLW 604 (645)
Q Consensus 531 ------~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~ 604 (645)
.-.|+|.|+.|.+.||++....||....+- ..+.-. +.+..+ |.+.. .....+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----Palp~----~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----PALPS----RVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----CCCcc----cCChHHHHHHHH
Confidence 246899999999999999999999752211 000000 111111 22222 222345677788
Q ss_pred cCCCCCCCCCCHHHHHHHh
Q 042831 605 CAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 605 Cl~~dP~~RPs~~evl~~L 623 (645)
.|++||.+||+.+-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999876555444
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.4e-15 Score=136.35 Aligned_cols=135 Identities=22% Similarity=0.163 Sum_probs=115.8
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCccEEEeeeeeCCeEEEEEEecCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH--RNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35779999999999999864 6799998865443 4678899999999986 5899999998888899999999988
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
+.+..+ +......++.+++++|.+||.....+++|+|++|+||+++..+.+++.|||.++.
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 5667788999999999999985556899999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=140.44 Aligned_cols=138 Identities=22% Similarity=0.251 Sum_probs=98.6
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh--hHHH----------------------HHHHHHHHHhcCCCC--
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ--GIKE----------------------YASEVKIISRLRHRN-- 410 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n-- 410 (645)
.+.||+|+||.||+|.+. +++.||||++...... .... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 6889999988653211 1111 134566666665432
Q ss_pred ccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC
Q 042831 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490 (645)
Q Consensus 411 lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~ 490 (645)
+.+.++. ...++||||++++.+......... .. .....++.+++.++.++|. +.+++|+||||+||+++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 4444443 245899999999654322111111 11 5677899999999999997 37899999999999999 89
Q ss_pred cEEEeeccCccccc
Q 042831 491 NAKIGDFGLARLVE 504 (645)
Q Consensus 491 ~~kl~DfGla~~~~ 504 (645)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.1e-14 Score=140.23 Aligned_cols=135 Identities=17% Similarity=0.178 Sum_probs=105.0
Q ss_pred CCccC-cCCcEEEEEEEEcCCCeEEEEEEeccCC-------------hhhHHHHHHHHHHHHhcCCCCc--cEEEeeeee
Q 042831 357 DQKLG-QGGFGGVYKGFFRETNSYIAVKRVSQGS-------------KQGIKEYASEVKIISRLRHRNL--VQLLGWCHE 420 (645)
Q Consensus 357 ~~~LG-~G~fG~Vy~g~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~nl--v~l~~~~~~ 420 (645)
...|| .||.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++.++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45687 8999999999875 5679999875321 1223567889999999998875 677776543
Q ss_pred CC----eEEEEEEecCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 421 KK----ELLLVYEFMPN-GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 421 ~~----~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
+. ..++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+ .+|+||||||.|||++.++.++|+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 32 23599999997 688888743 234443 35789999999999 999999999999999998899999
Q ss_pred eccCccc
Q 042831 496 DFGLARL 502 (645)
Q Consensus 496 DfGla~~ 502 (645)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.1e-13 Score=130.09 Aligned_cols=189 Identities=21% Similarity=0.148 Sum_probs=128.7
Q ss_pred CCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSK 124 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~ 124 (645)
.++..+. +|.+ .++.|+||. .+++.|.+|.+.|++. -+|+.+|+|.|.... ..+||||||.++....
T Consensus 21 i~~W~~~G~t~~-~~~~IrLTp~~~~~~G~iw~~~~~~~--------~~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~- 89 (225)
T cd06902 21 VPFWSHGGDAIA-SLEQVRLTPSLRSKKGSVWTKNPFSF--------ENWEVEVTFRVTGRG-RIGADGLAIWYTKERG- 89 (225)
T ss_pred CCceEecccEEe-cCCEEEECCCCCCCEEEEeeCCCcCC--------CCEEEEEEEEEecCC-CCCCCEEEEEEECCCC-
Confidence 4577888 7877 678999999 6789999999999973 469999999998764 3468999999998752
Q ss_pred CCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCc-ccc---------eeeecccCC-CCcee
Q 042831 125 IPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVK-SKK---------NVSWWSDVK-SGRRN 193 (645)
Q Consensus 125 ~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~-s~~---------~~~~~~~~~-~g~~~ 193 (645)
..|+.+|-.+.-+ =+||.|||+.|....+.+.|-+-+|.-. ... -..+..+.. ...+.
T Consensus 90 ----~~G~~~G~~~~f~-------Gl~I~~Dt~~n~~~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~p~ 158 (225)
T cd06902 90 ----EEGPVFGSSDKWN-------GVGIFFDSFDNDGKKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFRNKPYPV 158 (225)
T ss_pred ----CCCCccCCCCccc-------EEEEEEECCCCCCCCCCcEEEEEECCCCeeccccCCCcccccceEEEeccCCCCCe
Confidence 2455555433211 1899999998864444456655554321 111 112222333 35789
Q ss_pred EEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCc-CCCCceEEEEeecccceeeeEEEEEeeccC
Q 042831 194 EAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQ-HLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261 (645)
Q Consensus 194 ~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~-~l~~~~~vGfsastg~~~~~~~i~~wsf~~ 261 (645)
+++|.|.. ..|+|.+......+....-++. ++.. .||...|+||||+||...+.|.|++|.+.+
T Consensus 159 ~~rI~Y~~--~~l~V~~d~~~~~~~~~~~~Cf--~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~s 223 (225)
T cd06902 159 RAKITYYQ--NVLTVSINNGFTPNKDDYELCT--RVENMVLPPNGYFGVSAATGGLADDHDVLSFLTFS 223 (225)
T ss_pred EEEEEEEC--CeEEEEEeCCcCCCCCcccEEE--ecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEec
Confidence 99999997 5688888742221111111222 2222 357789999999999999999999998863
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-15 Score=168.79 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=193.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-CCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQGS--KQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~l 426 (645)
...|...+.||+|.|+.|-...... ....+|+|.+.... .........|..+-..+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3456677889999999998887643 34567777765443 233344455777777776 9999999999999999999
Q ss_pred EEEecCCCChhhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHH-hhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQ-EEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~ 503 (645)
+.||..++++.+.+ .......+....-..+.|+..++.|+| . .++.|+|+||+|.+++.++ ..+++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999998888 433325566667788999999999999 6 8999999999999999999 9999999999877
Q ss_pred cc--cCCcceeeccc-CccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 504 EH--AKGSQTTVLAG-TMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 504 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
.. +.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++....... ....|... .+...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~---~~~~~ 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSN---KGRFT 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeeccc---ccccc
Confidence 65 33334455678 9999999988774 457789999999999999999999875544321 11111110 00000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .-. .-....+.+..+++..+|..|.+.+++...-|..
T Consensus 252 ~~----~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 252 QL----PWN----SISDQAHDLLHKILKENPSNRLSIEELKLDNWLS 290 (601)
T ss_pred cC----ccc----cCChhhhhcccccccCCchhcccccccccccccc
Confidence 00 001 1123455666778889999999999988776643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.3e-14 Score=140.34 Aligned_cols=203 Identities=24% Similarity=0.358 Sum_probs=142.6
Q ss_pred HHHHHhcCCCCccEEEeeeeeCC-----eEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcC
Q 042831 400 VKIISRLRHRNLVQLLGWCHEKK-----ELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWE 471 (645)
Q Consensus 400 i~~l~~l~H~nlv~l~~~~~~~~-----~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 471 (645)
..-|-++-|.|||+++.|+.+.+ ...++.|||..|+|..+|++ ....+......+++.||..||.|||+ |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 34455667999999999886543 57899999999999999975 34578888889999999999999998 77
Q ss_pred CCeeeccCCCCCeEECCCCcEEEeeccCcc---cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHH
Q 042831 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLAR---LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA 548 (645)
Q Consensus 472 ~~ivH~Dlkp~NILld~~~~~kl~DfGla~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ell 548 (645)
+.|+|+++..+.|++..++-+|++----.. ..............+.++|.+||+=..-..+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999999999986321110 00011111222334678999999877777888999999999999998
Q ss_pred cCCCCCCCCCCCCc-hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 549 CGRKPINPKAPQGQ-VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 549 tG~~pf~~~~~~~~-~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
-|..--........ ..-+. .....+...+.. .++..|++.+|..||+|++++.|+
T Consensus 277 ilEiq~tnseS~~~~ee~ia---------~~i~~len~lqr-----------~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA---------NVIIGLENGLQR-----------GSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcceeehhhhhh---------hheeeccCcccc-----------CcCcccccCCCCCCcchhhhhcCc
Confidence 87754221111000 00000 001111111111 245679999999999999999876
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.5e-12 Score=141.86 Aligned_cols=144 Identities=20% Similarity=0.214 Sum_probs=100.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhH---------------------------------------
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI--------------------------------------- 393 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 393 (645)
.|+ .+.||.|++|.||+|++. +|+.||||+.+....+..
T Consensus 119 ~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 344 478999999999999986 488999999865421110
Q ss_pred -HHHHHHHHHHHhcC----CCCccEEEeee-eeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHH-HHHHH
Q 042831 394 -KEYASEVKIISRLR----HRNLVQLLGWC-HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS-GLLYL 466 (645)
Q Consensus 394 -~~~~~Ei~~l~~l~----H~nlv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-gL~yL 466 (645)
-+|.+|+..+.+++ |.+-+.+-..+ ...+..+|||||++|++|.+......... .+.+++..++. .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 12455666665553 32222222222 22345799999999999988764322222 24456666666 36677
Q ss_pred HhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 467 H~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
|. .+++|+|++|.||+++.++.+++.|||++..+.
T Consensus 274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 76 899999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.4e-13 Score=142.97 Aligned_cols=249 Identities=24% Similarity=0.278 Sum_probs=184.5
Q ss_pred CCCCCCccCc--CCcEEEEEEEE--cCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEE
Q 042831 353 DFNDDQKLGQ--GGFGGVYKGFF--RETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 353 ~f~~~~~LG~--G~fG~Vy~g~~--~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~ 425 (645)
.|...+.+|. |.+|.||.+.. ..++..+|+|+-+.. .......=.+|+....+++ |+|.++....+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999999 888899999974432 2222233345666666664 999999888899999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS----GLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLA 500 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla 500 (645)
+-.|++ +.+|..+.+.....++....+.+..+..+ ||.++|. .+++|-|+||.||++..+ ..++++|||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCccee
Confidence 999998 57888888777777888888888888888 9999998 999999999999999998 89999999998
Q ss_pred ccccccCCcc----eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 501 RLVEHAKGSQ----TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 501 ~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
..+....... .....|...|++||.. ++-++..+|+|++|.+.+|..+|..+....... . |...+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~--W~~~r~~ 341 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------S--WSQLRQG 341 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------C--ccccccc
Confidence 8765443211 1223678889999965 446789999999999999999988776533111 1 2222222
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
. +..+++.... ..+..+...+++.+|..|++.+.+..+
T Consensus 342 ~----ip~e~~~~~s----~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 Y----IPLEFCEGGS----SSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred c----CchhhhcCcc----hhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 2 1222222222 122236677899999999998877654
|
|
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.26 E-value=4e-10 Score=111.91 Aligned_cols=183 Identities=22% Similarity=0.266 Sum_probs=115.6
Q ss_pred CCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCC
Q 042831 48 DNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKI 125 (645)
Q Consensus 48 ~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~ 125 (645)
++..+. ++.+ .++.|+||. .+++.|.+|.+.|++. .+|+.+|+|.|........||||||.++.....
T Consensus 22 ~~W~~~G~t~i-~~~~IrLTp~~~~~~G~iws~~~~~~--------~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~~- 91 (229)
T PF03388_consen 22 PNWDIGGSTVI-TDNFIRLTPDRQSQSGSIWSRKPIPF--------DNWEIEFTFRISGQEKGLGGDGMAFWYTKDPGS- 91 (229)
T ss_dssp TTEEEEET-EE-ESSEEEEE-SSTTEEEEEEESS-BEE--------SEEEEEEEEEEESS-SSS-S-EEEEEEESSSSS-
T ss_pred CCEEECCeEEe-cCCEEEECCCcccCEEEEEEcCCCCc--------cCEEEEEEEEEeccccCcCCCeEEEEEEcCccc-
Confidence 367777 7777 588999999 6789999999999987 479999999999875566899999999976532
Q ss_pred CCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCC---CCCceeeecCCCc-c---------cceeeecccCC-CCc
Q 042831 126 PTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDP---TFSHVGIDINSVK-S---------KKNVSWWSDVK-SGR 191 (645)
Q Consensus 126 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~---~~~hvgidvns~~-s---------~~~~~~~~~~~-~g~ 191 (645)
.|..+|--+.- .| +||=||||.|...+ ....|.+-+|.-. + ..-..+..++. .+.
T Consensus 92 ----~G~~fG~~~~f-~G------l~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~~~ 160 (229)
T PF03388_consen 92 ----DGPVFGGPDKF-DG------LGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNSDV 160 (229)
T ss_dssp ----SCSBTTB-SS--EE------EEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE---BTESS
T ss_pred ----cccccCCCccc-ce------EEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccceeccCcCCC
Confidence 55556643221 11 89999999986433 3345555554321 1 01112223333 356
Q ss_pred eeEEEEEEcCCCceEEEEEecC--CCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEE
Q 042831 192 RNEAWISYNSSTHNLSVAFTGF--RNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYS 256 (645)
Q Consensus 192 ~~~~~I~Y~~~~~~l~v~l~~~--~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~ 256 (645)
..+++|.|.. +.+.|.+... .....-..++. ++ .-.||+..|+||||+||...+.|.|++
T Consensus 161 p~~~ri~Y~~--~~l~v~id~~~~~~~~~~~~Cf~--~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s 222 (229)
T PF03388_consen 161 PTRIRISYSK--NTLTVSIDSNYLKNQDDWELCFT--TD-GVDLPEGYYFGVSAATGELSDNHDILS 222 (229)
T ss_dssp EEEEEEEEET--TEEEEEEETSCCSECCTTEEEEE--ES-TEEGGSSBEEEEEEEESSSGGEEEEEE
T ss_pred CEEEEEEEEC--CeEEEEEecccccCCcCCcEEEE--cC-CeecCCCCEEEEEecCCCCCCcEEEEE
Confidence 7899999996 4677777632 11111122332 22 113577889999999999999999975
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.8e-11 Score=114.70 Aligned_cols=130 Identities=17% Similarity=0.103 Sum_probs=96.0
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCcc-EEEeeeeeCCeEEEEEEecCCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV-QLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv-~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 457899999999999875 67899998754432 223567899999988765554 444443 234579999999988
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc--CCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW--EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 436 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+.... .....+..+++++|+.||... ..+++|+|++|.||+++ ++.+++.|||.+.
T Consensus 78 l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76431 112345678999999999832 12369999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.5e-11 Score=135.65 Aligned_cols=149 Identities=15% Similarity=0.159 Sum_probs=95.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh----------------------------------HH--
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG----------------------------------IK-- 394 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~----------------------------------~~-- 394 (645)
...|+. +.||+|++|.||+|+++++|+.||||+.+....+. .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 78999999999999999889999999987542110 11
Q ss_pred ----HHHHHHHHHHhcC----CCCccEEEeeee-eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 042831 395 ----EYASEVKIISRLR----HRNLVQLLGWCH-EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465 (645)
Q Consensus 395 ----~~~~Ei~~l~~l~----H~nlv~l~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 465 (645)
+|.+|+..+.+++ +.+.+.+=..+. -.+..+|||||++|+.+.+.-.-.....+ +..++...+. .|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d---~~~la~~~v~--~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD---MKLLAERGVE--VF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC---HHHHHHHHHH--HH
Confidence 2344555554443 333333222222 24567899999999999764221111111 1122222222 12
Q ss_pred HHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCcccccc
Q 042831 466 LQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLARLVEH 505 (645)
Q Consensus 466 LH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla~~~~~ 505 (645)
+++....|++|+|++|.||+++.++ .+++.|||++..++.
T Consensus 273 ~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2222338999999999999999888 999999999876643
|
|
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-09 Score=107.17 Aligned_cols=178 Identities=19% Similarity=0.162 Sum_probs=117.4
Q ss_pred CCCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKI 125 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~ 125 (645)
..+..+. +|.+ .++.|+||..+++.|.+|-+.|+++-+ +|+.+|+|.|.... ..+||||||.++.....
T Consensus 20 i~~W~~~G~t~v-~~~~IrLTp~~s~~G~iWs~~pl~~~~-------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~- 89 (215)
T cd06903 20 IPNWQTSGNPKL-ESGRIILTPPGNQRGSLWLKKPLSLKD-------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNA- 89 (215)
T ss_pred CCCeEEcCcEEe-eCCeEEECCCCCceEeEeeCCcCCCCC-------CEEEEEEEEecccC-CcCCCEEEEEEECCCcc-
Confidence 4467788 8888 577899998766899999999998732 69999999998754 26799999999986532
Q ss_pred CCCCCC-CcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCc-cc--------ceeeeccc-CCCCceeE
Q 042831 126 PTNKGG-GSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVK-SK--------KNVSWWSD-VKSGRRNE 194 (645)
Q Consensus 126 ~~~~~g-~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~-s~--------~~~~~~~~-~~~g~~~~ 194 (645)
..| ..+|-.+.- .| +||.|||+.|.. ..|-+-+|.-. .. .-..+... ...+.+.+
T Consensus 90 ---~~g~~~fG~~~~f-~G------l~I~~Dt~~n~~----p~i~~~~NDGt~~yd~~~d~~~~~g~C~~~~rn~~~p~~ 155 (215)
T cd06903 90 ---DVGTSSIYGPSKF-DG------LQLLIDNNGGSG----GSLRGFLNDGSKDYKNEDVDSLAFGSCLFAYQDSGVPST 155 (215)
T ss_pred ---cCCccccCCCCCC-cE------EEEEEECCCCCC----ceEEEEECCCCeeccccCCcccccceeeEeccCCCCCEE
Confidence 112 233321111 11 899999998731 23333333211 11 11122222 24567899
Q ss_pred EEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCC-CceEEEEeecccceeeeEEEEEee
Q 042831 195 AWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLP-EFVTFGFSMATGVDFAIFSIYSWE 258 (645)
Q Consensus 195 ~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~-~~~~vGfsastg~~~~~~~i~~ws 258 (645)
++|.|....+.|+|.+... ++..++- -.|| ...++||||+||...+.|.|++-.
T Consensus 156 iri~Y~~~~~~l~v~vd~~---------~Cf~~~~-v~lP~~~y~fGiSAaTg~~~d~hdIl~~~ 210 (215)
T cd06903 156 IRLSYDALNSLFKVQVDNR---------LCFQTDK-VQLPQGGYRFGITAANADNPESFEILKLK 210 (215)
T ss_pred EEEEEECCCCEEEEEECCC---------EEEecCC-eecCCCCCEEEEEEcCCCCCCcEEEEEEE
Confidence 9999998778999988531 2222221 1234 557899999999988899987543
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=126.56 Aligned_cols=170 Identities=19% Similarity=0.212 Sum_probs=129.4
Q ss_pred EEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCH
Q 042831 370 KGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTW 449 (645)
Q Consensus 370 ~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~ 449 (645)
.|..+.++.+|.|+..+..+........+-++.|+.+|||||+++++....++.+|||.|-+. -|..++.+ +..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~ 103 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGK 103 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHH
Confidence 466777788999998877666445566778899999999999999999999999999999873 34455533 235
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccC
Q 042831 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529 (645)
Q Consensus 450 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 529 (645)
....-.+.||+.||.|||+ ..+++|++|.-..|++++.|..||++|.++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 5667788999999999997 37899999999999999999999999998764432221 11111222346666644332
Q ss_pred CCCcchhHHHHHHHHHHHHcC
Q 042831 530 KASKESDVYSFGIVALEIACG 550 (645)
Q Consensus 530 ~~t~~sDV~SfGvll~elltG 550 (645)
. -..|.|.|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=5e-10 Score=107.88 Aligned_cols=139 Identities=17% Similarity=0.100 Sum_probs=99.9
Q ss_pred CccCcCCcEEEEEEEEcC------CCeEEEEEEeccCC----------------------hhhHHHHH----HHHHHHHh
Q 042831 358 QKLGQGGFGGVYKGFFRE------TNSYIAVKRVSQGS----------------------KQGIKEYA----SEVKIISR 405 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~ 405 (645)
..||.|--+.||.|...+ .+..+|||..+... ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 24789999764210 00112223 79999999
Q ss_pred cCC--CCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhhcCCCeeeccCCCC
Q 042831 406 LRH--RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL-QEEWEQCVVHRDIKSS 482 (645)
Q Consensus 406 l~H--~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~ 482 (645)
++. -++.+.+++ ..-+|||||+.+..+.....+ ...++..+...+..+++.+|..| |. .+++|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHH
Confidence 864 466666664 456899999976544322211 12345556678889999999999 66 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccc
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~ 505 (645)
|||++ ++.+.|+|||.+...++
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCCC
Confidence 99997 46799999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-11 Score=129.67 Aligned_cols=257 Identities=22% Similarity=0.240 Sum_probs=177.4
Q ss_pred cChHH-HHHhhcCCCCCCccCcCCcEEEEEEEEc-CCCeEEEEEEeccCChhhH--HHHHHHHHHHHhc-CCCCccEEEe
Q 042831 342 FPYKE-LALATNDFNDDQKLGQGGFGGVYKGFFR-ETNSYIAVKRVSQGSKQGI--KEYASEVKIISRL-RHRNLVQLLG 416 (645)
Q Consensus 342 ~~~~e-l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l-~H~nlv~l~~ 416 (645)
|.-.+ ......+|.....||.|.|+.|++...+ .++..+++|.+........ ..-..|+.+...+ .|.+++.+..
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 33334 4455678999999999999999998866 6778899998765432222 2223456555555 4788887766
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEe
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIG 495 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~ 495 (645)
.+..-.+.++=-|||+++++.... .-...++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..+++
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred CccccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcc
Confidence 665556667889999999987666 233457778889999999999999998 999999999999999876 888999
Q ss_pred eccCcccccccCCcceeecccCcccc--CccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 496 DFGLARLVEHAKGSQTTVLAGTMGYM--APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|||.+..+.. .. ....+..++. +++......+..+.|++|||.-+.|.++|..--+... +| ..+
T Consensus 410 ~~~~~t~~~~---~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~--~~i 475 (524)
T KOG0601|consen 410 DFGCWTRLAF---SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS--LTI 475 (524)
T ss_pred ccccccccce---ec-ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc--eee
Confidence 9999864211 11 1122333344 5555566778999999999999999998875433211 11 011
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.|.. +.+... - +.+..+......+++..||.+.+...+..++
T Consensus 476 ~~~~~-----p~~~~~----~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 RSGDT-----PNLPGL----K-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ecccc-----cCCCch----H-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11111 111111 1 3334445567899999999999988877765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.9e-10 Score=109.33 Aligned_cols=143 Identities=21% Similarity=0.258 Sum_probs=111.7
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCC--CccEEEeeeeeC---CeEEEEEEe
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHR--NLVQLLGWCHEK---KELLLVYEF 430 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~--nlv~l~~~~~~~---~~~~lV~Ey 430 (645)
.+.|+.|..+.||++...+ |+.+++|....... ....++..|++++..+++. ++.+++.++... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3578999999999998854 57899998754322 2456788999999999763 467788877654 356899999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW---------------------------------------- 470 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 470 (645)
+++.++...+.. ..++..++..++.++++.|..||+..
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999988776532 35677888888999999999998520
Q ss_pred -------------CCCeeeccCCCCCeEECC--CCcEEEeeccCccc
Q 042831 471 -------------EQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARL 502 (645)
Q Consensus 471 -------------~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~ 502 (645)
...++|+|+.+.||+++. ++.+.|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256899999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-09 Score=112.85 Aligned_cols=167 Identities=19% Similarity=0.298 Sum_probs=131.3
Q ss_pred cEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee----eCCeEEEEEEecCC-CChhhh
Q 042831 365 FGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH----EKKELLLVYEFMPN-GSLDSH 439 (645)
Q Consensus 365 fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~----~~~~~~lV~Ey~~~-gsL~~~ 439 (645)
-.+.||+....+|..+++|++..+..+.......-++.++++.|.|+|++.+.+. .+..+++||+|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3678999999999999999995443333333345688999999999999999876 34578999999985 577665
Q ss_pred hhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 440 LFK--------------ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 440 l~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
.+. .+...+++..|.++.|++.||.++|+ .|+.-+-|.+++|+++.+.+++|+.+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432 23457889999999999999999999 8999999999999999999999999988766543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCC
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK 552 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~ 552 (645)
... |-+. --.+-|.=.||.+++.|.||..
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 321 1111 1235689999999999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1e-08 Score=95.24 Aligned_cols=142 Identities=19% Similarity=0.215 Sum_probs=104.6
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEe-ccC-------ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQG-------SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~-~~~-------~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
....+-+|+-+.|+++.+. |+.+.||.- .+. .+-..+.-.+|++.+.+++--.|..-.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4678999999999999886 677777742 221 122345677899999998755554444455566667899
Q ss_pred EEecCC-CChhhhhhhcCCCCCH-HHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEEeeccCccc
Q 042831 428 YEFMPN-GSLDSHLFKENSLLTW-EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKIGDFGLARL 502 (645)
Q Consensus 428 ~Ey~~~-gsL~~~l~~~~~~l~~-~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl~DfGla~~ 502 (645)
|||+++ .++.+++......-.. +....+++.|-+.+.-||. .+++|+||..+||+|..++ .+.+.|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 4778888654333233 3337888999999999998 8999999999999996444 458999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=95.50 Aligned_cols=131 Identities=21% Similarity=0.269 Sum_probs=99.1
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEe-ccC--C-----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRV-SQG--S-----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~-~~~--~-----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..+++|+-..+|.+.+. |..+++|.- ++. . +-....-.+|+.++.+++--.|.--.=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999775 445667642 221 1 1123445689999999876555555555667777899999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
|.++-.|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++.... +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888543 34667777777889998 9999999999999998764 99999999964
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=6.7e-10 Score=125.79 Aligned_cols=260 Identities=18% Similarity=0.190 Sum_probs=170.4
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
...+++.+.+-+.+|.++.++...-..+|...+.|...... +...+....+-.++-.-+||-++...--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45577888888999999999988877666555555432221 112222233333333334555555444445567889
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc-
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE- 504 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~- 504 (645)
||++|..+++|...|+.... .+.+.....+..+..+++|||. ..+.|+|++|.|++...++..+++|||......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999998876553 3333334445557788999998 668999999999999999999999998433211
Q ss_pred ------c--------------cCC---------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 042831 505 ------H--------------AKG---------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPIN 555 (645)
Q Consensus 505 ------~--------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~ 555 (645)
. ... .......+|+.|++||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 000 01123568999999999999999999999999999999999999998
Q ss_pred CCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHhccC
Q 042831 556 PKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR---QVIHVLNFE 626 (645)
Q Consensus 556 ~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~---evl~~L~~~ 626 (645)
...++... +-+.++.+ +. .....+.......++...+..+|.+|-.|. ++-.+--+.
T Consensus 1037 a~tpq~~f-------~ni~~~~~-----~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1037 AETPQQIF-------ENILNRDI-----PW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred Ccchhhhh-------hccccCCC-----CC--CCCccccChhhhhhhhhhhccCchhccCcccccccccCCccC
Confidence 66543221 10111111 10 011112223344455667788999998777 555554443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.3e-07 Score=94.36 Aligned_cols=139 Identities=12% Similarity=0.052 Sum_probs=99.3
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-hHH----------HHHHHHHHHHhcCCCC--ccEEEeeeee-----
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GIK----------EYASEVKIISRLRHRN--LVQLLGWCHE----- 420 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-~~~----------~~~~Ei~~l~~l~H~n--lv~l~~~~~~----- 420 (645)
.+-.-....|++.... |+.+.||+....... ..+ .+.+|...+.++...+ .++.+++...
T Consensus 29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3443444557776653 678999977433211 111 3778999888885433 3344555433
Q ss_pred CCeEEEEEEecCCC-Chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-------CCc
Q 042831 421 KKELLLVYEFMPNG-SLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-------NFN 491 (645)
Q Consensus 421 ~~~~~lV~Ey~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------~~~ 491 (645)
...-+||+|++++. +|.+++... ....+...+..++.+++..+.-||. .||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 788887431 2345667788999999999999999 99999999999999975 568
Q ss_pred EEEeeccCccc
Q 042831 492 AKIGDFGLARL 502 (645)
Q Consensus 492 ~kl~DfGla~~ 502 (645)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.6e-07 Score=88.75 Aligned_cols=126 Identities=21% Similarity=0.268 Sum_probs=80.8
Q ss_pred EEEEEEEcCCCeEEEEEEeccCC--------------h------------hhHHHHHHHHHHHHhcCCC--CccEEEeee
Q 042831 367 GVYKGFFRETNSYIAVKRVSQGS--------------K------------QGIKEYASEVKIISRLRHR--NLVQLLGWC 418 (645)
Q Consensus 367 ~Vy~g~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--nlv~l~~~~ 418 (645)
.||.|...+ |..+|||..+... + .......+|.+.|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998854 7899999864310 0 0123466899999999865 466666542
Q ss_pred eeCCeEEEEEEecC--CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 419 HEKKELLLVYEFMP--NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL-QEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
.-+|||||++ +..+.. +.... ++......++.+++..+..+ |. .+++|+||.+.||+++++ .+.|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~--~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVD--LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCG--GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred ----CCEEEEEecCCCccchhh-HHhcc--ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence 3379999998 444433 32211 11334566777888766664 55 899999999999999988 99999
Q ss_pred eccCccccc
Q 042831 496 DFGLARLVE 504 (645)
Q Consensus 496 DfGla~~~~ 504 (645)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.9e-06 Score=83.49 Aligned_cols=184 Identities=20% Similarity=0.183 Sum_probs=120.3
Q ss_pred eEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCCCC
Q 042831 50 ITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPT 127 (645)
Q Consensus 50 ~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~ 127 (645)
.... ||.. +.-.|+|+. -.++.|-+|-+.-+.+ ..|...-.|.|+... ..++|||||.-+...
T Consensus 56 W~~~GdAIa-s~eqvRlaPSmrsrkGavWtka~~~f--------e~weVev~~rVtGrG-RiGAdGlaiWYt~~~----- 120 (497)
T KOG3838|consen 56 WSHHGDAIA-SSEQVRLAPSMRSRKGAVWTKASVPF--------ENWEVEVQFRVTGRG-RIGADGLAIWYTRGR----- 120 (497)
T ss_pred eeecCcccc-cccceeeccccccccCceeecccCCc--------ccceEEEEEEecccc-cccCCceEEEEecCC-----
Confidence 3444 6665 667899999 4567899776665554 458889999999874 456999999988643
Q ss_pred CCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCc-c-cce--------eeecccCCC-CceeEEE
Q 042831 128 NKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVK-S-KKN--------VSWWSDVKS-GRRNEAW 196 (645)
Q Consensus 128 ~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~-s-~~~--------~~~~~~~~~-g~~~~~~ 196 (645)
+--|.-+|-.+.= +| +++=||.|-|..--|..-|.|-.|.-. + ... .++--++.| --+..|+
T Consensus 121 G~~GpVfGg~d~W-nG------igiffDSfdnD~qknnP~Is~~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRar 193 (497)
T KOG3838|consen 121 GHVGPVFGGLDSW-NG------IGIFFDSFDNDGQKNNPAISVLLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRAR 193 (497)
T ss_pred Ccccccccccccc-cc------eEEEeecccccCCcCCccEEEEecCCcccccCCCccHHHHHHHhhHHhccCCCCceEE
Confidence 1223333322111 11 799999998865556667777666532 1 111 122123444 2478899
Q ss_pred EEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeec
Q 042831 197 ISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF 259 (645)
Q Consensus 197 I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf 259 (645)
|+|= .++|+|-+.+.=++. ..+-++..++- -+||..-|.|.||+||....-|++++..-
T Consensus 194 ItY~--~nvLtv~innGmtp~-d~yE~C~rve~-~~lp~nGyFGvSAATGgLADDHDVl~Flt 252 (497)
T KOG3838|consen 194 ITYY--GNVLTVMINNGMTPS-DDYEFCVRVEN-LLLPPNGYFGVSAATGGLADDHDVLSFLT 252 (497)
T ss_pred EEEe--ccEEEEEEcCCCCCC-CCcceeEeccc-eeccCCCeeeeeecccccccccceeeeEE
Confidence 9998 588999987533322 34445554432 23477899999999999999999987653
|
|
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5.3e-07 Score=90.15 Aligned_cols=195 Identities=20% Similarity=0.229 Sum_probs=124.4
Q ss_pred eeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCC
Q 042831 35 LTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYAD 112 (645)
Q Consensus 35 ~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~ 112 (645)
++=.|.+=. ....+..+. ...+ ..--++||. .+++.|-++=..||.. -+|.-.+.|.+..+.....||
T Consensus 60 L~~Py~g~g-~r~~~W~~~Gstvv-~~~~irLT~d~qsk~GAv~n~~Pv~s--------~~wev~v~fkv~~~s~~lfgd 129 (351)
T KOG3839|consen 60 LSKPYQGVG-GRQPNWNLSGSTVV-TSNYIRLTPDEQSKSGAVWNRQPVFS--------RDWEVLVHFKVHGQSKNLFGD 129 (351)
T ss_pred ccccccccc-ccccCccccccEEE-EeeeeeccccccccccccccCCCccc--------cceeEEEEEEEecCCCccccc
Confidence 444444433 224456666 5555 456799999 7889999999999974 359999999999988888999
Q ss_pred eEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCC---CCceeeecCCC-ccc---------c
Q 042831 113 GLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPT---FSHVGIDINSV-KSK---------K 179 (645)
Q Consensus 113 GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~---~~hvgidvns~-~s~---------~ 179 (645)
|||+.++-...+ .|..+|-++.- +..||=.|||.|..-|. ..-|.+.+|.. .|. .
T Consensus 130 G~Aiw~t~Er~q-----~GPvFG~~dkF-------~GL~vfidtY~n~~g~~~~v~P~isvmv~~gs~sYD~~~Dg~~te 197 (351)
T KOG3839|consen 130 GMAIWYTKERAQ-----PGPVFGSKDKF-------TGLAVFIDTYGNHNGPHEHVFPYISVMVNIGSLSYDHSKDGTHTE 197 (351)
T ss_pred ceEEEeeccccc-----CCCCCCCcccc-------eeEEEEEeccCCcCCCcccceeeEEEEeccCCcccccCCCCCccc
Confidence 999999987633 55667755432 23899999998863222 12333333221 111 0
Q ss_pred eeeecccCCCC-ceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcC-CCCceEEEEeecccceeeeEEEEEe
Q 042831 180 NVSWWSDVKSG-RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQH-LPEFVTFGFSMATGVDFAIFSIYSW 257 (645)
Q Consensus 180 ~~~~~~~~~~g-~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~-l~~~~~vGfsastg~~~~~~~i~~w 257 (645)
-+.+..++++. ---.+-|.|+. ++|++..+..+.. ...--.++..+ +|.--++|+||+||+..+.|.+.+=
T Consensus 198 l~gc~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~~~-----~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~ 270 (351)
T KOG3839|consen 198 LAGCTANFRNLPHDTLVVIRYEK--KTLSISIDLEGPN-----EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSL 270 (351)
T ss_pred cccceeeeccCCCcceeEEEecC--CceEEEEecCCCc-----eeeeeeeecceecccceEEeeeeccCccchhhHHHHh
Confidence 01111112221 12346788987 6666665543321 23444555555 4777899999999999999998754
Q ss_pred e
Q 042831 258 E 258 (645)
Q Consensus 258 s 258 (645)
.
T Consensus 271 k 271 (351)
T KOG3839|consen 271 K 271 (351)
T ss_pred h
Confidence 3
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.4e-08 Score=108.30 Aligned_cols=155 Identities=19% Similarity=0.251 Sum_probs=103.0
Q ss_pred HHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc--------ceeecccCccccCcccccc
Q 042831 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS--------QTTVLAGTMGYMAPECATT 528 (645)
Q Consensus 457 ~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~ 528 (645)
.+++.||.|+|. ...+||++|.|++|.++.++..||+.|+.+......... ..........|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998 588999999999999999999999999987644331111 1111234567999999999
Q ss_pred CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCC
Q 042831 529 GKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAH 607 (645)
Q Consensus 529 ~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 607 (645)
...+.++|+||+||++|-+.. |+.-+......... ..+... +.... .......+ .++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~~~~-~~~~~---~~~s~~~p----~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFSRNL-LNAGA---FGYSNNLP----SELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhhhcc-ccccc---ccccccCc----HHHHHHHHHHhc
Confidence 889999999999999999995 44444432221111 011000 00000 00112222 334444456789
Q ss_pred CCCCCCCCHHHHHHHhccC
Q 042831 608 PDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 608 ~dP~~RPs~~evl~~L~~~ 626 (645)
.++..||++.++....-+.
T Consensus 251 ~~~~~rp~~~~l~~~~ff~ 269 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSIPFFS 269 (700)
T ss_pred CCcccCcchhhhhcccccC
Confidence 9999999999988877765
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=84.08 Aligned_cols=106 Identities=21% Similarity=0.255 Sum_probs=83.9
Q ss_pred HHHHHHHHHHHHhcCCC--CccEEEeeeeeC----CeEEEEEEecCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 042831 393 IKEYASEVKIISRLRHR--NLVQLLGWCHEK----KELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465 (645)
Q Consensus 393 ~~~~~~Ei~~l~~l~H~--nlv~l~~~~~~~----~~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~y 465 (645)
.....+|...+.+|+.. ...+.+++.... ...+||+|++++. +|.+++..... ++...+..++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 34677888888888543 345666666543 2458999999874 78888864322 6677788999999999999
Q ss_pred HHhhcCCCeeeccCCCCCeEECCCC---cEEEeeccCccc
Q 042831 466 LQEEWEQCVVHRDIKSSNIMLDSNF---NAKIGDFGLARL 502 (645)
Q Consensus 466 LH~~~~~~ivH~Dlkp~NILld~~~---~~kl~DfGla~~ 502 (645)
||. .+|+|+|++++|||++.+. .+.++||+-++.
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999 9999999999999998876 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-06 Score=87.69 Aligned_cols=192 Identities=16% Similarity=0.237 Sum_probs=129.1
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeee------eeCCe-EEEE
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWC------HEKKE-LLLV 427 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~------~~~~~-~~lV 427 (645)
..+.||+|+.+.+|-.--- ...+-|++.........+. ++.|... .||-+..=+.|= -+++. .-+.
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4678999999999964222 1234577765433322222 2223332 455443323331 12222 5667
Q ss_pred EEecCCCChhhhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 428 YEFMPNGSLDSHLFK------ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
|+.+++-.--..+.. +.....|...++.++.+|.+.+-||+ .|.+-+|++++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence 776655421111211 22467899999999999999999998 899999999999999999999999865544
Q ss_pred cccccCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcC-CCCCCCCC
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACG-RKPINPKA 558 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG-~~pf~~~~ 558 (645)
.. ..+......+|...|.+||.-. +..-+...|-|.+|+++++++.| +.||.+..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 32 2334455677899999999643 33457889999999999999985 99997543
|
|
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.1e-05 Score=78.02 Aligned_cols=189 Identities=20% Similarity=0.156 Sum_probs=107.9
Q ss_pred CCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCc
Q 042831 59 SNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLT 137 (645)
Q Consensus 59 ~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~ 137 (645)
.+|.||||+ ..++.|-+.|.++++--+ +. ...+|.+..-.. ...++||+||||+-..-....+..||.||+-
T Consensus 30 ~~g~LRLT~~~~nqata~~~~~~FPs~~----n~--v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa 102 (255)
T cd06900 30 VNNRLRLTDASGNQATAVTLQRLFPSAG----NY--VEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYA 102 (255)
T ss_pred ccCeEEeccCccCcceeEEEeeeeccCC----Ce--EEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccc
Confidence 468999999 778999999999997532 11 677788776654 4667999999998443221246678999997
Q ss_pred cCC-CCCCCCCCEEEEEEecccCCCCCCCC---ceeeecCCCc-----c--cceeee------c--ccCC------CCce
Q 042831 138 KDN-EPLNSSIPFVAVEFDVYVNSWDPTFS---HVGIDINSVK-----S--KKNVSW------W--SDVK------SGRR 192 (645)
Q Consensus 138 ~~~-~~~~~~~~~vaVEfDt~~n~~d~~~~---hvgidvns~~-----s--~~~~~~------~--~~~~------~g~~ 192 (645)
... ....-..-.++|-||-|-|.-.++.. -.|---|+|. + ..+... + ++.. .+-+
T Consensus 103 ~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~gt~~~~~~id~~~~~~~~~~hr 182 (255)
T cd06900 103 QRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITGTGVLPPGIDNNSTSTPAPGHR 182 (255)
T ss_pred cccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecccCCCCcccccCCCCCCCCceE
Confidence 654 22233456789999998775222221 1121112211 1 111111 0 0111 1233
Q ss_pred eEEEEEEcCC-CceEEEEEecCCCcccccceee--EeeccC--cCCCCceEEEEeecccceeeeEEEE
Q 042831 193 NEAWISYNSS-THNLSVAFTGFRNNLVVMQGLD--YQVDLR--QHLPEFVTFGFSMATGVDFAIFSIY 255 (645)
Q Consensus 193 ~~~~I~Y~~~-~~~l~v~l~~~~~~~~~~~~ls--~~vdl~--~~l~~~~~vGfsastg~~~~~~~i~ 255 (645)
.++.||=... ...|+|.-+-.+... -.+++. ..++.. ..+|+..+++|++|||...-.|.|-
T Consensus 183 Y~i~Ids~~~~~~~vsV~R~~~~gg~-~~~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEId 249 (255)
T cd06900 183 YRITIDSTNGDNAWLSVERDIGNGGA-YFVVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEID 249 (255)
T ss_pred EEEEEecCCCCceEEEEEEEccCCce-eEEeecceeeccccCCCCCCccEEEEEEecCCCcccceeec
Confidence 4444443322 233455444222111 011111 112333 6789999999999999988888773
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.9e-06 Score=79.55 Aligned_cols=137 Identities=20% Similarity=0.149 Sum_probs=103.2
Q ss_pred cCcCCcEEEEEEEEcCCCeEEEEEEeccC---C---hhhHHHHHHHHHHHHhcCCC--CccEEEeeee-e----CCeEEE
Q 042831 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQG---S---KQGIKEYASEVKIISRLRHR--NLVQLLGWCH-E----KKELLL 426 (645)
Q Consensus 360 LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~---~~~~~~~~~Ei~~l~~l~H~--nlv~l~~~~~-~----~~~~~l 426 (645)
-|+||-+.|++-.+. |..+-+|+-... + +-+...|.+|+..|.+|... .+.+.. ++. . .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467899999998765 346889976521 1 33567899999999998642 344555 332 1 124689
Q ss_pred EEEecCC-CChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc--EEEeeccCccc
Q 042831 427 VYEFMPN-GSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN--AKIGDFGLARL 502 (645)
Q Consensus 427 V~Ey~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kl~DfGla~~ 502 (645)
|+|-+++ -+|.+++.+. ....+..++..++.+++..+.-||. .++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9997753 5788887543 2356788889999999999999999 99999999999999986666 99999987653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.7e-06 Score=82.64 Aligned_cols=137 Identities=19% Similarity=0.198 Sum_probs=93.8
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--------------------C--hhhHHHHHHHHHHHHhcCCC--
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--------------------S--KQGIKEYASEVKIISRLRHR-- 409 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~Ei~~l~~l~H~-- 409 (645)
..+..+||-|--+.||.|.... |.++|||.=+.. + .-......+|.+.|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4457889999999999999874 788999942211 0 00123456799999998755
Q ss_pred CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC
Q 042831 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489 (645)
Q Consensus 410 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 489 (645)
.+.+.++| +.-++||||.++--|...-. +.+....|+..|++-+.-+-. .|+||+|+.+-||+++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 66666554 34589999998866644321 222233344444433333334 799999999999999999
Q ss_pred CcEEEeeccCccccc
Q 042831 490 FNAKIGDFGLARLVE 504 (645)
Q Consensus 490 ~~~kl~DfGla~~~~ 504 (645)
|.+.++||=.+...+
T Consensus 239 g~~~vIDwPQ~v~~~ 253 (304)
T COG0478 239 GDIVVIDWPQAVPIS 253 (304)
T ss_pred CCEEEEeCcccccCC
Confidence 999999997765443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.5e-06 Score=90.78 Aligned_cols=146 Identities=16% Similarity=0.261 Sum_probs=96.6
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh----------------------------------------
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG---------------------------------------- 392 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~---------------------------------------- 392 (645)
.|+ .+.|+.++-|.||+|+++. |+.||||+.+.+-++.
T Consensus 127 eF~-~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 127 EFE-PEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HcC-CCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 444 3789999999999999986 8999999876542211
Q ss_pred HHHHHHHHHHHHhcC-----CCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 042831 393 IKEYASEVKIISRLR-----HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467 (645)
Q Consensus 393 ~~~~~~Ei~~l~~l~-----H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH 467 (645)
+-++..|..-+.+++ .+++.=-.=|..-.+...|+|||++|-.+.+....+....+ +..++..++++ |+-
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~--f~~ 279 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRA--FLR 279 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHH--HHH
Confidence 012444555555553 23332112223335667999999999999887533333344 33444444433 222
Q ss_pred hhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 468 ~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+....++.|.|..|.||+++.++.+.+.|||+....+.
T Consensus 280 q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22236899999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.3e-05 Score=77.97 Aligned_cols=137 Identities=16% Similarity=0.197 Sum_probs=84.4
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.+||+|..+.||+. . +..+++|...... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57899999999984 2 3457788876433 2345678999999986443 4677888877778889999998863
Q ss_pred -hhhhh---------------------hhc-CCCCCHHHHH-HHHH----------HHHH-HHHHHHhh-cCCCeeeccC
Q 042831 436 -LDSHL---------------------FKE-NSLLTWEFRY-KIAQ----------DLAS-GLLYLQEE-WEQCVVHRDI 479 (645)
Q Consensus 436 -L~~~l---------------------~~~-~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH~Dl 479 (645)
+...+ +.- -.......+. .+.. .+.+ ...+|... ....++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 110 0011111100 0100 0111 11222211 1345789999
Q ss_pred CCCCeEECCCCcEEEeeccCcc
Q 042831 480 KSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 480 kp~NILld~~~~~kl~DfGla~ 501 (645)
.|.||++++++ +.|.||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.6e-07 Score=99.25 Aligned_cols=185 Identities=18% Similarity=0.130 Sum_probs=134.8
Q ss_pred CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-ccEEEeeeeeCCeEEEEEEecC
Q 042831 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN-LVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-lv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
+...+-+++++.++++|.+...+...+ ++.+... ....-++++|.+++||| .+..++-++.+....++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 334456889999999999876544333 6655433 34456899999999999 7777888888888999999998
Q ss_pred CC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 433 NG-SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 433 ~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
.+ +-....-.....+...+...+...-+++|+|||+ ..=+|+| ||+..+ ...|.+||+....+.... ..
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 77 2222211122234444555666677788999998 3347888 777665 578999999987654332 34
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPI 554 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf 554 (645)
....+++.++|||+...+.+..+.|+|+.|+---++.-|-.|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4567999999999999999999999999998777777776664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.8e-05 Score=75.42 Aligned_cols=141 Identities=20% Similarity=0.196 Sum_probs=85.1
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCC--CccEEEeeeee---CCeEEEEEEec
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHR--NLVQLLGWCHE---KKELLLVYEFM 431 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--nlv~l~~~~~~---~~~~~lV~Ey~ 431 (645)
.+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.++.. ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3568899999999998875 47899987544 4556777899998888633 35566665433 34579999999
Q ss_pred CCCChhh----------------hh---hhc---CCCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 042831 432 PNGSLDS----------------HL---FKE---NSLLTWEF---------RYKI------------AQDLAS-GLLYLQ 467 (645)
Q Consensus 432 ~~gsL~~----------------~l---~~~---~~~l~~~~---------~~~i------------~~~ia~-gL~yLH 467 (645)
++..+.. .+ ++. .....+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 01111110 0000 112222 333444
Q ss_pred hh----cCCCeeeccCCCCCeEEC-CCCcEEEeeccCcc
Q 042831 468 EE----WEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLAR 501 (645)
Q Consensus 468 ~~----~~~~ivH~Dlkp~NILld-~~~~~kl~DfGla~ 501 (645)
.. ....++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 346799999999999999 66667899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.00 E-value=8.6e-05 Score=72.30 Aligned_cols=137 Identities=12% Similarity=0.113 Sum_probs=90.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHH---------HHHHHHHHHhcCCC---CccEEEee
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE---------YASEVKIISRLRHR---NLVQLLGW 417 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~H~---nlv~l~~~ 417 (645)
..++|...+.+-......|.+-... |..+++|..+.......+. ..+++..+.+++.. ..+.++..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3467777777777776666665553 6789999876554333222 23445555555432 22232222
Q ss_pred ee-----eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 418 CH-----EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 418 ~~-----~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
+. -....+|+|||++|..|.+... ++. .+...+.+++.-||. .|+.|+|..|.|+++++++ +
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence 22 2345679999999988866531 222 345667778899998 9999999999999998654 9
Q ss_pred EEeeccCcc
Q 042831 493 KIGDFGLAR 501 (645)
Q Consensus 493 kl~DfGla~ 501 (645)
++.||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.1e-05 Score=84.24 Aligned_cols=141 Identities=16% Similarity=0.246 Sum_probs=93.5
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh-------------------------------------HHHHHHH
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG-------------------------------------IKEYASE 399 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E 399 (645)
.+.||.-..|.||+|++++ |+.||||+-+..-++. +-+|..|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4789999999999999987 8999999865432211 0124445
Q ss_pred HHHHHhc----CCCC------ccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh
Q 042831 400 VKIISRL----RHRN------LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469 (645)
Q Consensus 400 i~~l~~l----~H~n------lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 469 (645)
++-..+. +|-+ |.+++ ..-.....|+||||+|..+.+...-....++... |+..+.++ |++..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~---i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHD---ILNKLVEA--YLEQI 317 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHH---HHHHHHHH--HHHHH
Confidence 5444433 3444 22222 2234567999999999988876543444455443 33333332 33333
Q ss_pred cCCCeeeccCCCCCeEEC----CCCcEEEeeccCcccccc
Q 042831 470 WEQCVVHRDIKSSNIMLD----SNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 470 ~~~~ivH~Dlkp~NILld----~~~~~kl~DfGla~~~~~ 505 (645)
...|++|+|=.|.||+++ .++.+.+-|||+.....+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 447899999999999998 367899999999876544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00012 Score=72.13 Aligned_cols=154 Identities=19% Similarity=0.170 Sum_probs=96.6
Q ss_pred cChHHHHHhhcCCCCCCc---cCcCCcEEEEEEEEcCCCeEEEEEEeccCChhh-------------------H-----H
Q 042831 342 FPYKELALATNDFNDDQK---LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG-------------------I-----K 394 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~---LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~-------------------~-----~ 394 (645)
.+++.+.....+..+... |..|--..||+|... ++..+|+|++....... . .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 445556655555555555 456667789998763 47899999885431110 0 1
Q ss_pred HHHHHHHHHHhcC--CCCccEEEeeeeeCCeEEEEEEecCCCChh-hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcC
Q 042831 395 EYASEVKIISRLR--HRNLVQLLGWCHEKKELLLVYEFMPNGSLD-SHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471 (645)
Q Consensus 395 ~~~~Ei~~l~~l~--H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~-~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 471 (645)
....|+.-|.++. +=.+.+-+++. .-.|||||+....+. -.|.. -.+.......+..++++.+.-|-. .
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 1335666676664 33333444433 237999999654221 11211 122222456667777777776655 3
Q ss_pred CCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 472 ~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
.++||+||+.-|||+. ++.+.|+|+|.+....+
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 7899999999999999 78999999999876554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.4e-05 Score=73.57 Aligned_cols=103 Identities=23% Similarity=0.228 Sum_probs=83.8
Q ss_pred HHHHHHHhcCC-CCccEEEeeeeeCCeEEEEEEecCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCe
Q 042831 398 SEVKIISRLRH-RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF--KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474 (645)
Q Consensus 398 ~Ei~~l~~l~H-~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 474 (645)
.|.-++..+++ +++.+++|+|-+ ++|.||.+.+++...-. .+-...+|..|.+|+.++++.+.+|++.....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888888986 699999999943 77999998776643210 111346899999999999999999998665668
Q ss_pred eeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 475 vH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
.-.|++++|+-+++++++|+.|...+...+
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 899999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00015 Score=73.00 Aligned_cols=138 Identities=17% Similarity=0.153 Sum_probs=84.3
Q ss_pred ccCcCCc-EEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 359 KLGQGGF-GGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 359 ~LG~G~f-G~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
.|-.|.. ..||+.... +..+.+|+..... ..+..+|++++..+. +--+.+++++....+..++|||+++|.+|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3445555 788998764 3568888775432 345678998888874 44466788877776778999999998877
Q ss_pred hhhh-------------------hhc---CCCCCH--HHHHHHH-H-------------------HHHHHHHHHHh----
Q 042831 437 DSHL-------------------FKE---NSLLTW--EFRYKIA-Q-------------------DLASGLLYLQE---- 468 (645)
Q Consensus 437 ~~~l-------------------~~~---~~~l~~--~~~~~i~-~-------------------~ia~gL~yLH~---- 468 (645)
.... +.- ...... ..+.... . .+...+..|-.
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6431 100 001110 0000000 0 01111222211
Q ss_pred hcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 469 ~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
.....++|+|+.|.|||++++....|.||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 113569999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00026 Score=83.95 Aligned_cols=80 Identities=11% Similarity=0.256 Sum_probs=58.5
Q ss_pred CCccCcCCcEEEEEEEEcCCC--eEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCc--cEEEeeeeeC---CeEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETN--SYIAVKRVSQGS-KQGIKEYASEVKIISRLR-HRNL--VQLLGWCHEK---KELLLV 427 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nl--v~l~~~~~~~---~~~~lV 427 (645)
.+.++.|.+..+|+......+ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998775432 457777764432 123457889999999996 6665 7888888764 467899
Q ss_pred EEecCCCCh
Q 042831 428 YEFMPNGSL 436 (645)
Q Consensus 428 ~Ey~~~gsL 436 (645)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00046 Score=66.53 Aligned_cols=125 Identities=23% Similarity=0.316 Sum_probs=90.9
Q ss_pred cCCCCCCccCcCCc-EEEEEEEEcCCCeEEEEEEecc---CCh------------------hhHHHHHHHHHHHHhcC--
Q 042831 352 NDFNDDQKLGQGGF-GGVYKGFFRETNSYIAVKRVSQ---GSK------------------QGIKEYASEVKIISRLR-- 407 (645)
Q Consensus 352 ~~f~~~~~LG~G~f-G~Vy~g~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~-- 407 (645)
.+++..+.||.|.. |.||++... |+.+|+|.+.. ... .....|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67888999999999 999999986 67999999322 100 11235888999888885
Q ss_pred -CCCc--cEEEeeeeeC------------------CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 042831 408 -HRNL--VQLLGWCHEK------------------KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466 (645)
Q Consensus 408 -H~nl--v~l~~~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yL 466 (645)
+.++ |+.+||..-. ....||.||.+... .+. .+-+.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHH
Confidence 4566 8999997322 12467888876543 112 23345666777888
Q ss_pred HhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 467 H~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
|. .+|+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 88 99999999999975 4589999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0012 Score=63.95 Aligned_cols=133 Identities=21% Similarity=0.290 Sum_probs=90.7
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC----------------hhhHHHHHHHHHHHHhcC------CCCcc
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----------------KQGIKEYASEVKIISRLR------HRNLV 412 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nlv 412 (645)
+....||+|+.-.||.--. .....||+..... ....++..+|+.-..++. +.+|.
T Consensus 4 ~~~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CCCcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 3457899999999996533 3446788876554 223566777777776665 78999
Q ss_pred EEEeeeeeCCeEEEEEEecCC--C----ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 413 QLLGWCHEKKELLLVYEFMPN--G----SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 413 ~l~~~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+++|+.+.+...-+|+|.+.+ | +|.+++.+ ..++. ...+. +-+-..||-. ..|+.+|++|+||++
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEE
Confidence 999999999989999998643 2 56666633 23444 33333 3334456665 789999999999999
Q ss_pred CCC--C--cEEEee-ccC
Q 042831 487 DSN--F--NAKIGD-FGL 499 (645)
Q Consensus 487 d~~--~--~~kl~D-fGl 499 (645)
..+ + .+.|+| ||-
T Consensus 152 ~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EecCCCceEEEEEeCCCC
Confidence 532 2 466665 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00046 Score=69.09 Aligned_cols=73 Identities=15% Similarity=0.191 Sum_probs=46.7
Q ss_pred CccCcCCcE-EEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCC---CccEEEeeeeeC---CeEEEEEEe
Q 042831 358 QKLGQGGFG-GVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHR---NLVQLLGWCHEK---KELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nlv~l~~~~~~~---~~~~lV~Ey 430 (645)
+.|+.|+.. .||+. +..+++|..+.. ....++.+|.+++..+... -+.+.++.+... ...+++||+
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 567777776 48975 224667765432 2345788899999888632 344555544332 234889999
Q ss_pred cCCCChh
Q 042831 431 MPNGSLD 437 (645)
Q Consensus 431 ~~~gsL~ 437 (645)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00048 Score=80.42 Aligned_cols=201 Identities=19% Similarity=0.145 Sum_probs=134.7
Q ss_pred HHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE----EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 042831 393 IKEYASEVKIISRLRHRNLVQLLGWCHEKKEL----LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468 (645)
Q Consensus 393 ~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~----~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 468 (645)
.....-|++.+..++|+|++.++.|-.++... .+..|++..-++...+. +-...+.+..+.+..++.+||.|+|.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 33445677888889999999999987655432 23456777777777663 34567888888999999999999998
Q ss_pred hcCCCeeeccCCCC---CeEECCCCcEEEe--eccCcccccccCCcceeecccCccccCccccccCCCCc--chhHHHHH
Q 042831 469 EWEQCVVHRDIKSS---NIMLDSNFNAKIG--DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK--ESDVYSFG 541 (645)
Q Consensus 469 ~~~~~ivH~Dlkp~---NILld~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--~sDV~SfG 541 (645)
....|.-+..+ +.-.+.++...++ ||+..+....... ......+..+.+||......+.. ..|+|.+|
T Consensus 305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ---hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 45555555554 4445666777777 8888765433222 22223455678888776665544 47999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 042831 542 IVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621 (645)
Q Consensus 542 vll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 621 (645)
..+..+..|..+-..... . .+-+...... .+......|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------~----------------~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------P----------------VSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------h----------------hhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999988755321110 0 0001111111 3445567899999999999999999
Q ss_pred Hhcc
Q 042831 622 VLNF 625 (645)
Q Consensus 622 ~L~~ 625 (645)
+..-
T Consensus 434 ~~f~ 437 (1351)
T KOG1035|consen 434 HPFL 437 (1351)
T ss_pred chhc
Confidence 8753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0018 Score=67.34 Aligned_cols=78 Identities=9% Similarity=0.006 Sum_probs=57.1
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC---CCccEEEeeeeeC---CeEEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH---RNLVQLLGWCHEK---KELLLVY 428 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nlv~l~~~~~~~---~~~~lV~ 428 (645)
...+.||.|..+.||+....+ + .+.+|..+.. .....+..|.+.|+.|.. -.+.+++++|..+ +..+|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 345679999999999986543 3 3666764331 123578899999998853 3678899888643 6689999
Q ss_pred EecCCCCh
Q 042831 429 EFMPNGSL 436 (645)
Q Consensus 429 Ey~~~gsL 436 (645)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00095 Score=62.42 Aligned_cols=127 Identities=17% Similarity=0.251 Sum_probs=86.3
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCcc-EEEeeeeeCCeEEEEEEecCCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV-QLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv-~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
..+.|++|.+|.||+|.+. |..+|+|.-+.+++ ...+..|+++|..++-.++. +++.|-.+ ++.|||..|-
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 3577999999999999987 56899998765544 46788899999998866654 34444332 4459999887
Q ss_pred ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCC-CC-CeEECCCCcEEEeeccCccc
Q 042831 435 SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIK-SS-NIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 435 sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk-p~-NILld~~~~~kl~DfGla~~ 502 (645)
.|.+.-... +.. -...+++.-.-|-. .||-|..|. |. ||++.+ ..+.|+||..|..
T Consensus 98 ~L~~~~~~~----~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG----DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc----cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 886654211 222 22334444333333 788888886 34 555544 4999999998874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0014 Score=65.53 Aligned_cols=140 Identities=21% Similarity=0.280 Sum_probs=81.1
Q ss_pred CCccCcCCcEEEEEEEEcC-CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEEEecCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVYEFMPNG 434 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~Ey~~~g 434 (645)
.+.|..|-...+|+....+ .+..+++|........ ..+..+|+.++..+...++ +++++.+. . .++|||+++.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence 3567788888999987653 3467888876543221 1233478888888854333 44444332 2 4799999987
Q ss_pred Chhhh-----------------hhhcCCC----------C-CHHHHHHHHH----------------------HHHHHHH
Q 042831 435 SLDSH-----------------LFKENSL----------L-TWEFRYKIAQ----------------------DLASGLL 464 (645)
Q Consensus 435 sL~~~-----------------l~~~~~~----------l-~~~~~~~i~~----------------------~ia~gL~ 464 (645)
++... ++..... . .|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 1111001 1 1222111111 1111112
Q ss_pred HHHhh-----cCCCeeeccCCCCCeEECC-CCcEEEeeccCcc
Q 042831 465 YLQEE-----WEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLAR 501 (645)
Q Consensus 465 yLH~~-----~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~ 501 (645)
.|-.. ....++|+|+.+.|||+++ +..+.+.||..+.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 22111 2346999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0044 Score=66.58 Aligned_cols=77 Identities=13% Similarity=0.147 Sum_probs=54.6
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccC------C-hhhHHHHHHHHHHHHhcC---CCCccEEEeeeeeCCeEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG------S-KQGIKEYASEVKIISRLR---HRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~------~-~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~~~~~~l 426 (645)
.+.||.|.+..||++...++++.++||.-... + ......+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45799999999999998764468999974311 1 123456777888888763 2457777776 3355789
Q ss_pred EEEecCCCC
Q 042831 427 VYEFMPNGS 435 (645)
Q Consensus 427 V~Ey~~~gs 435 (645)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0014 Score=66.58 Aligned_cols=137 Identities=14% Similarity=0.071 Sum_probs=78.3
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEEEecCCCChh
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVYEFMPNGSLD 437 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~Ey~~~gsL~ 437 (645)
.+..|-...+|+... ++..+++|..........-+..+|.+++..+....+ .+++..+. -.+||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 356677889998873 356788887644322211235678888988864433 34444432 26899999987664
Q ss_pred hh-----------------hhhc---CCCCCHHHH-HHHHHHH---------HHHHHHHHhh-----cCCCeeeccCCCC
Q 042831 438 SH-----------------LFKE---NSLLTWEFR-YKIAQDL---------ASGLLYLQEE-----WEQCVVHRDIKSS 482 (645)
Q Consensus 438 ~~-----------------l~~~---~~~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivH~Dlkp~ 482 (645)
.. ++.. ...++...+ .....++ ...+..+-.. ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1111 111221111 1111111 1111112111 1246899999999
Q ss_pred CeEECCCCcEEEeeccCccc
Q 042831 483 NIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~ 502 (645)
||++++++ +.|.||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.01 Score=62.22 Aligned_cols=140 Identities=12% Similarity=0.133 Sum_probs=77.2
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEe------eeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLG------WCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~------~~~~~~~~~lV~ 428 (645)
.+.|+.|....+|+....+ | .+++|+...... .....|+.++..|...+ +.+.+. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCC-C-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4557777778999987643 3 588898752222 33344555565553222 333332 122355679999
Q ss_pred EecCCCChhh-----------h---hhhcC----------CCCCH-HHHHH------------HH-HHHHHHHHHHHh--
Q 042831 429 EFMPNGSLDS-----------H---LFKEN----------SLLTW-EFRYK------------IA-QDLASGLLYLQE-- 468 (645)
Q Consensus 429 Ey~~~gsL~~-----------~---l~~~~----------~~l~~-~~~~~------------i~-~~ia~gL~yLH~-- 468 (645)
||++|..+.. . ++... ..+.| ..... .. ..+...+..+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 9998875421 0 11100 01112 11111 11 111112222221
Q ss_pred --hcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 469 --EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 469 --~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
....+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 134689999999999999976556899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0051 Score=63.77 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=85.6
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEee------eeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLGW------CHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~~------~~~~~~~~lV~ 428 (645)
.+.|..|....+|+.... +..+++|+.... ...+...|++++..+++.+ +.+++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 566778888899998654 346888987542 2345667888888875432 4454432 12345668999
Q ss_pred EecCCCChhh----h----------hhh--cC--------CCCCHHHHH----------HHHHHHHHHHHHHHh----hc
Q 042831 429 EFMPNGSLDS----H----------LFK--EN--------SLLTWEFRY----------KIAQDLASGLLYLQE----EW 470 (645)
Q Consensus 429 Ey~~~gsL~~----~----------l~~--~~--------~~l~~~~~~----------~i~~~ia~gL~yLH~----~~ 470 (645)
+|++|..+.. . ++. .. ....|.... .....+...+.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877632 0 111 00 111222111 011123334445443 22
Q ss_pred CCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 471 ~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 4579999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0038 Score=64.93 Aligned_cols=139 Identities=24% Similarity=0.331 Sum_probs=82.9
Q ss_pred CccCcCCcEEEEEEEEcC------CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEEEe
Q 042831 358 QKLGQGGFGGVYKGFFRE------TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~Ey 430 (645)
+.|..|-...+|+....+ .++.+++|...... ....+..+|.+++..+....+ .++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899887653 25678899875543 223455678888888864333 355555532 358999
Q ss_pred cCCCChhhh-----------------hhhcC-C-------CCC--HHHHHH--------------------------HHH
Q 042831 431 MPNGSLDSH-----------------LFKEN-S-------LLT--WEFRYK--------------------------IAQ 457 (645)
Q Consensus 431 ~~~gsL~~~-----------------l~~~~-~-------~l~--~~~~~~--------------------------i~~ 457 (645)
++|..+... +++.. . ..+ |..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 11100 0 000 111111 111
Q ss_pred HHHHHHHHHHh------hcCCCeeeccCCCCCeEECCC----CcEEEeeccCcc
Q 042831 458 DLASGLLYLQE------EWEQCVVHRDIKSSNIMLDSN----FNAKIGDFGLAR 501 (645)
Q Consensus 458 ~ia~gL~yLH~------~~~~~ivH~Dlkp~NILld~~----~~~kl~DfGla~ 501 (645)
.+..-+.+|.. .....++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 134679999999999999975 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.032 Score=58.20 Aligned_cols=141 Identities=16% Similarity=0.194 Sum_probs=82.9
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEeee------eeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLGWC------HEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~~~------~~~~~~~lV~ 428 (645)
.+.++.|....+|+.... ++ .+++|....... ..+...|++++..|.... +.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC-CC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 556777777899988653 34 577887654321 234456777777774322 34444322 2245678999
Q ss_pred EecCCCChhhh--------------hhhcCC-----------CCCHHHHH------------HHHHHHHHHHHHHHh---
Q 042831 429 EFMPNGSLDSH--------------LFKENS-----------LLTWEFRY------------KIAQDLASGLLYLQE--- 468 (645)
Q Consensus 429 Ey~~~gsL~~~--------------l~~~~~-----------~l~~~~~~------------~i~~~ia~gL~yLH~--- 468 (645)
||++|..+... ++.... .-.|.... .....+.+.+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654210 111000 01121110 011123334555543
Q ss_pred -hcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 469 -EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 469 -~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
....+++|+|+.+.||++++++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.022 Score=60.49 Aligned_cols=140 Identities=18% Similarity=0.236 Sum_probs=82.0
Q ss_pred CccCcCCcEEEEEEEEcC----CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCcc-EEEeeeeeCCeEEEEEEecC
Q 042831 358 QKLGQGGFGGVYKGFFRE----TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV-QLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv-~l~~~~~~~~~~~lV~Ey~~ 432 (645)
+.|-.|-.-.+|+....+ .++.+.+|......... -+-.+|..++..+...++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557778899887542 23678889876543322 2236788888888654444 45555533 2 5899998
Q ss_pred CCChhhh-----------------hhhcC---C--CCCHHHHHHHHHHH-----------------HHHHHHHHh-----
Q 042831 433 NGSLDSH-----------------LFKEN---S--LLTWEFRYKIAQDL-----------------ASGLLYLQE----- 468 (645)
Q Consensus 433 ~gsL~~~-----------------l~~~~---~--~l~~~~~~~i~~~i-----------------a~gL~yLH~----- 468 (645)
+.+|... +|+.. . ...|....++..++ ...+..|..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 11111 0 11233332332211 111222221
Q ss_pred hcCCCeeeccCCCCCeEECC-CCcEEEeeccCccc
Q 042831 469 EWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARL 502 (645)
Q Consensus 469 ~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~ 502 (645)
.....++|+|+++.|||+++ ++.+.+.||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12347899999999999986 46899999988753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0029 Score=64.62 Aligned_cols=138 Identities=16% Similarity=0.134 Sum_probs=90.4
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---------Ch-----------h--hHHHHHHHHHHHHhcCC-C
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---------SK-----------Q--GIKEYASEVKIISRLRH-R 409 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---------~~-----------~--~~~~~~~Ei~~l~~l~H-~ 409 (645)
-++.+++||-|--+-||.+.+.+ |.+.++|.=+.. .+ . ..-...+|...|+.|.. .
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 46778999999999999998865 677888832110 00 0 01224468888888753 2
Q ss_pred -CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC
Q 042831 410 -NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 410 -nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 488 (645)
-+.+.++++ .-|+|||++.+-.|...- ...+.++++.-+.++ +--|.. .|+||+|..-=||++++
T Consensus 172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~----~v~d~~~ly~~lm~~---Iv~la~---~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDHN----RHCVVMELVDGYPLRQVR----HVEDPPTLYDDLMGL---IVRLAN---HGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCccccc----ceeeHHHhhcccceeeee----ecCChHHHHHHHHHH---HHHHHH---cCceecccchheeEEec
Confidence 244444443 458999999887765432 123344444333333 233333 89999999999999999
Q ss_pred CCcEEEeeccCcccccc
Q 042831 489 NFNAKIGDFGLARLVEH 505 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~ 505 (645)
++.++++||-......+
T Consensus 238 d~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTSH 254 (465)
T ss_pred CCCEEEeechHhhccCC
Confidence 99999999976554433
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.036 Score=56.91 Aligned_cols=31 Identities=23% Similarity=0.475 Sum_probs=25.8
Q ss_pred CCeeeccCCCCCeEECCCCc-EEEeeccCccc
Q 042831 472 QCVVHRDIKSSNIMLDSNFN-AKIGDFGLARL 502 (645)
Q Consensus 472 ~~ivH~Dlkp~NILld~~~~-~kl~DfGla~~ 502 (645)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.00054 Score=81.60 Aligned_cols=160 Identities=16% Similarity=0.014 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHhcCCCCccEEEeeee--eCCeEEEEEEecCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHh
Q 042831 394 KEYASEVKIISRLRHRNLVQLLGWCH--EKKELLLVYEFMPNGSLDSHLFKEN---SLLTWEFRYKIAQDLASGLLYLQE 468 (645)
Q Consensus 394 ~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~ 468 (645)
+....|..-+++..|+++.....=.. +..+.+.+++|+..|.+.+.+.+.. ..++........++......-+|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 34455666666678888776544332 2345688999999999999886532 233333333333333444444444
Q ss_pred h--cCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHH
Q 042831 469 E--WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546 (645)
Q Consensus 469 ~--~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~e 546 (645)
. .+.-.+|+++|+-|.+++.+.++|++++|+.+...+ .........+++.|+.|+....-.++.++|+|..|+.+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2 234478999999999999999999999999984332 2223334567888999999988899999999999999999
Q ss_pred HHcCCCCC
Q 042831 547 IACGRKPI 554 (645)
Q Consensus 547 lltG~~pf 554 (645)
..-|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98888776
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.061 Score=56.79 Aligned_cols=74 Identities=14% Similarity=0.171 Sum_probs=47.8
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEecc-------CChhhHHHHHHHHHHHHhcC--CCC-ccEEEeeeeeCCeEEEEE
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQ-------GSKQGIKEYASEVKIISRLR--HRN-LVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~-------~~~~~~~~~~~Ei~~l~~l~--H~n-lv~l~~~~~~~~~~~lV~ 428 (645)
.||.|....||++...++++.|+||.-.. .-+-...+..-|.+.|.... -|. +.+++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57999999999999865446899996321 11223445556777776653 343 444433 3455567999
Q ss_pred EecCCC
Q 042831 429 EFMPNG 434 (645)
Q Consensus 429 Ey~~~g 434 (645)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.099 Score=54.42 Aligned_cols=130 Identities=19% Similarity=0.231 Sum_probs=79.2
Q ss_pred EEEEEEEcCCCeEEEEEEec-cCChhhHHHHHHHHHHHHhcCC--CCccEEEeeeeeCC--eEEEEEEecCCCChhhhhh
Q 042831 367 GVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRH--RNLVQLLGWCHEKK--ELLLVYEFMPNGSLDSHLF 441 (645)
Q Consensus 367 ~Vy~g~~~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~~~~~~~--~~~lV~Ey~~~gsL~~~l~ 441 (645)
.+|+.... ++.+++.+-. ...........+|..+|+.+.- --+...+++|.++. ..+.||+|+++..+.+.+.
T Consensus 40 ~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 34444333 5667777221 1223344556678888887742 34456677787766 6799999998854443332
Q ss_pred hcCCCCCHHHHHHHH-HHHHHHHHHHH--------------------------------------------------hh-
Q 042831 442 KENSLLTWEFRYKIA-QDLASGLLYLQ--------------------------------------------------EE- 469 (645)
Q Consensus 442 ~~~~~l~~~~~~~i~-~~ia~gL~yLH--------------------------------------------------~~- 469 (645)
.... . .+++ ..+++.|.-|| ..
T Consensus 118 ~~~~----~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~ 191 (321)
T COG3173 118 PESL----G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR 191 (321)
T ss_pred cccc----h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence 1100 0 0111 23444444444 21
Q ss_pred ----cCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 470 ----WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 470 ----~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
....++|+|+.+.|++++.+..+=+.||+++..-+
T Consensus 192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 13469999999999999988889999999987544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.043 Score=56.57 Aligned_cols=75 Identities=17% Similarity=0.293 Sum_probs=48.7
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCccEEEeeeeeCCeEEEEEEec
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR---HRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+..+.++.|....+|+.. .+++.+-||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 345678889999999987 457789999765 333457888999888884 345778899888777779999999
Q ss_pred CCC
Q 042831 432 PNG 434 (645)
Q Consensus 432 ~~g 434 (645)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.0097 Score=64.31 Aligned_cols=165 Identities=24% Similarity=0.302 Sum_probs=90.4
Q ss_pred HHHHHHHHHHHhcCCCCccEEEeeeeeCC-eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCC
Q 042831 394 KEYASEVKIISRLRHRNLVQLLGWCHEKK-ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472 (645)
Q Consensus 394 ~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 472 (645)
.+......+++.+.|+|+..++++..... ...+|+|++ +-||++.+..+. +-.. +++ .+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~----------s~~-------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDE----------SLL-------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchh----------hhc-------cc
Confidence 45566778889999999999998876543 468889998 778888875432 1111 011 12
Q ss_pred CeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCC
Q 042831 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK 552 (645)
Q Consensus 473 ~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~ 552 (645)
++.|- |+ .+++| -++ .. | |- ...+|+|||++|.++.|+.-|..
T Consensus 87 ~~~~~-----~~-------~~~td-~~~---t~--------------~--~~-----~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL-----NI-------IYITD-HFL---TK--------------Y--PS-----PIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee-----hh-------hhccc-ccc---cc--------------C--CC-----CCCcchhhhhHHHHHHHHHHhhH
Confidence 33332 22 22233 000 00 0 10 11249999999999999999886
Q ss_pred CCCCCCCCCchhHHHHHHHHhc-CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 042831 553 PINPKAPQGQVSLLQWVWDLYG-NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621 (645)
Q Consensus 553 pf~~~~~~~~~~l~~~~~~~~~-~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 621 (645)
.+......+....+ ..++. .+......... .+..+.-++++++...|+-..|..||...+..+
T Consensus 130 l~~~~~~s~~l~~i---~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 130 LEAELTESEYLEIL---LKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHH---HHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 65433222111111 11111 01110000000 111223356778888999999998886555444
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.15 Score=54.81 Aligned_cols=73 Identities=10% Similarity=0.103 Sum_probs=49.8
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccC----Ch---hhHHHHHHHHHHHHhcC---CCCccEEEeeeeeCCeEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SK---QGIKEYASEVKIISRLR---HRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~----~~---~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~~~~~~l 426 (645)
.+.||.|....||+.... +..++||+-... +. -...+-..|.+.|..+. ..++.+++.+|.+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 567899999999998763 456889975411 11 12333445566666554 3478889998873 4578
Q ss_pred EEEecCC
Q 042831 427 VYEFMPN 433 (645)
Q Consensus 427 V~Ey~~~ 433 (645)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.051 Score=53.30 Aligned_cols=31 Identities=26% Similarity=0.446 Sum_probs=22.1
Q ss_pred CCeeeccCCCCCeEE-CCCCcEEEeeccCccc
Q 042831 472 QCVVHRDIKSSNIML-DSNFNAKIGDFGLARL 502 (645)
Q Consensus 472 ~~ivH~Dlkp~NILl-d~~~~~kl~DfGla~~ 502 (645)
..++|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8899999999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.11 Score=54.93 Aligned_cols=140 Identities=18% Similarity=0.243 Sum_probs=80.2
Q ss_pred CccCcCCcEEEEEEEEcCC---CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCcc-EEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRET---NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV-QLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv-~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
+.|..|=.-.+|+....+. +..|.+|........ .-+-.+|..++..+..-++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 4455566778898876432 237888887554332 22335788888888755553 5555553 22 58999977
Q ss_pred CChhhh-------h----------hhcC---C--CCCHHHHHHHHHHH----------------------HHHHHHHHhh
Q 042831 434 GSLDSH-------L----------FKEN---S--LLTWEFRYKIAQDL----------------------ASGLLYLQEE 469 (645)
Q Consensus 434 gsL~~~-------l----------~~~~---~--~l~~~~~~~i~~~i----------------------a~gL~yLH~~ 469 (645)
.+|... + |... . .-.|....++..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 1111 0 11233332222221 1112222211
Q ss_pred -----cCCCeeeccCCCCCeEECC-CCcEEEeeccCccc
Q 042831 470 -----WEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARL 502 (645)
Q Consensus 470 -----~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~ 502 (645)
....++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1235899999999999974 57899999998854
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.28 Score=51.39 Aligned_cols=143 Identities=17% Similarity=0.145 Sum_probs=91.4
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----C--------------------hhhH-HHHHHHHHHHHhcCCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----S--------------------KQGI-KEYASEVKIISRLRHR 409 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~--------------------~~~~-~~~~~Ei~~l~~l~H~ 409 (645)
+...|..|--..||.+.-.+ |..+|||+++.. . +.-. -....|+.-|.+|+.-
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45567889999999998755 777999987421 0 0001 1233577777777644
Q ss_pred CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC
Q 042831 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489 (645)
Q Consensus 410 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 489 (645)
.|..---... ..-.|||+|+.......-. -..-.++.......-+|++.-+.-|-+. .++||.||.--|+|+- +
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE-C
Confidence 4321100011 1237999999633221111 1233466666777778888888888774 5699999999999884 5
Q ss_pred CcEEEeeccCcccccc
Q 042831 490 FNAKIGDFGLARLVEH 505 (645)
Q Consensus 490 ~~~kl~DfGla~~~~~ 505 (645)
|.+.|+|-+.+...++
T Consensus 301 G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEHDH 316 (520)
T ss_pred CEEEEEEccccccCCC
Confidence 6899999988765544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 645 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 2e-27 | ||
| 2eig_A | 234 | Lotus Tetragonolobus Seed Lectin (Isoform) Length = | 1e-25 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 1e-25 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 4e-25 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 4e-25 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 2e-24 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 2e-24 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 4e-24 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 1e-23 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 4e-23 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 2e-22 | ||
| 1lul_A | 253 | Db58, A Legume Lectin From Dolichos Biflorus Length | 2e-22 | ||
| 3ujo_A | 281 | Galactose-Specific Seed Lectin From Dolichos Lablab | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 2pel_A | 236 | Peanut Lectin Length = 236 | 6e-22 | ||
| 1bjq_A | 253 | The Dolichos Biflorus Seed Lectin In Complex With A | 6e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-22 | ||
| 1bzw_A | 232 | Peanut Lectin Complexed With C-Lactose Length = 232 | 7e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-22 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 9e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-22 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 1e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 2e-21 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-21 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 3e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-21 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 6e-21 | ||
| 1n3o_A | 252 | Pterocarcpus Angolensis Lectin In Complex With Alph | 6e-21 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-21 | ||
| 1q8o_A | 252 | Pterocartpus Angolensis Lectin Pal In Complex With | 7e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-21 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 1e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 1loa_A | 181 | Three-Dimensional Structures Of Complexes Of Lathyr | 4e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-20 | ||
| 1lof_C | 181 | X-Ray Structure Of A Biantennary Octasaccharide-Lec | 4e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-20 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 7e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-20 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 9e-20 | ||
| 2lal_A | 181 | Crystal Structure Determination And Refinement At 2 | 1e-19 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 1e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 1fx5_A | 242 | Crystal Structure Analysis Of Ulex Europaeus Lectin | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 1ofs_A | 187 | Pea Lectin-sucrose Complex Length = 187 | 4e-19 | ||
| 1rin_A | 180 | X-Ray Crystal Structure Of A Pea Lectin-Trimannosid | 6e-19 | ||
| 2ltn_A | 181 | Design, Expression, And Crystallization Of Recombin | 6e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 1e-18 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2b7y_A | 182 | Fava Bean Lectin-Glucose Complex Length = 182 | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-18 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 9e-18 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 9e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 2e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 4e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 1h9p_A | 237 | Crystal Structure Of Dioclea Guianensis Seed Lectin | 1e-09 | ||
| 3rrd_A | 237 | Native Structure Of Dioclea Virgata Lectin Length = | 1e-09 | ||
| 1h9w_A | 237 | Native Dioclea Guianensis Seed Lectin Length = 237 | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2jdz_A | 239 | Crystal Structure Of Recombinant Dioclea Guianensis | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-09 | ||
| 2je7_A | 239 | Crystal Structure Of Recombinant Dioclea Guianensis | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 2zbj_A | 237 | Crystal Structure Of Dioclea Rostrata Lectin Length | 8e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 1avb_A | 226 | Arcelin-1 From Phaseolus Vulgaris L Length = 226 | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3a0k_A | 237 | Crystal Structure Of An Antiflamatory Legume Lectin | 1e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3u4x_A | 236 | Crystal Structure Of A Lectin From Camptosema Pedic | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2jec_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 2gdf_A | 237 | Crystal Structure Of Dioclea Violacea Seed Lectin L | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2je9_A | 239 | Crystal Structure Of Recombinant Dioclea Grandiflor | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3sh3_A | 237 | Crystal Structure Of A Pro-Inflammatory Lectin From | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 1mvq_A | 236 | Cratylia Mollis Lectin (Isoform 1) In Complex With | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 2d3p_A | 236 | Cratylia Floribunda Seed Lectin Crystallized At Bas | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 1qmo_A | 113 | Structure Of Fril, A Legume Lectin That Delays Hema | 7e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-08 | ||
| 1cn1_A | 237 | Crystal Structure Of Demetallized Concanavalin A. T | 9e-08 | ||
| 2cna_A | 237 | The Covalent And Three-Dimensional Structure Of Con | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1dgl_A | 237 | Lectin From Dioclea Grandiflora Complexed To Triman | 1e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 1azd_A | 237 | Concanavalin From Canavalia Brasiliensis Length = 2 | 2e-07 | ||
| 1ioa_A | 240 | Arcelin-5, A Lectin-Like Defense Protein From Phase | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2ctv_A | 237 | High Resolution Crystallographic Studies Of Native | 2e-07 | ||
| 2ow4_A | 237 | Crystal Structure Of A Lectin From Canavalia Mariti | 2e-07 | ||
| 2cwm_A | 237 | Native Crystal Structure Of No Releasing Inductive | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 1dhk_B | 223 | Structure Of Porcine Pancreatic Alpha-Amylase Lengt | 2e-07 | ||
| 2yz4_A | 237 | The Neutron Structure Of Concanavalin A At 2.2 Angs | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 1wuv_A | 237 | Crystal Structure Of Native Canavalia Gladiata Lect | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2ovu_A | 237 | Crystal Strucure Of A Lectin From Canavalia Gladiat | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1viw_B | 205 | Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Le | 4e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253 | Back alignment and structure |
|
| >pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PEL|A Chain A, Peanut Lectin Length = 236 | Back alignment and structure |
|
| >pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1BZW|A Chain A, Peanut Lectin Complexed With C-Lactose Length = 232 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|1N3O|A Chain A, Pterocarcpus Angolensis Lectin In Complex With Alpha-Methyl Glucose Length = 252 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1Q8O|A Chain A, Pterocartpus Angolensis Lectin Pal In Complex With The Dimmanoside Man(Alpha1-2)man Length = 252 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1LOA|A Chain A, Three-Dimensional Structures Of Complexes Of Lathyrus Ochrus Isolectin I With Glucose And Mannose: Fine Specificity Of The Monosaccharide-Binding Site Length = 181 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1LOF|C Chain C, X-Ray Structure Of A Biantennary Octasaccharide-Lectin Complex At 2.3 Angstroms Resolution Length = 181 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|2LAL|A Chain A, Crystal Structure Determination And Refinement At 2.3 Angstroms Resolution Of The Lentil Lectin Length = 181 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OFS|A Chain A, Pea Lectin-sucrose Complex Length = 187 | Back alignment and structure |
|
| >pdb|1RIN|A Chain A, X-Ray Crystal Structure Of A Pea Lectin-Trimannoside Complex At 2.6 Angstroms Resolution Length = 180 | Back alignment and structure |
|
| >pdb|2LTN|A Chain A, Design, Expression, And Crystallization Of Recombinant Lectin From The Garden Pea (Pisum Sativum) Length = 181 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B7Y|A Chain A, Fava Bean Lectin-Glucose Complex Length = 182 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1H9P|A Chain A, Crystal Structure Of Dioclea Guianensis Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|3RRD|A Chain A, Native Structure Of Dioclea Virgata Lectin Length = 237 | Back alignment and structure |
|
| >pdb|1H9W|A Chain A, Native Dioclea Guianensis Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDZ|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JE7|A Chain A, Crystal Structure Of Recombinant Dioclea Guianensis Lectin S131h Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ZBJ|A Chain A, Crystal Structure Of Dioclea Rostrata Lectin Length = 237 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3A0K|A Chain A, Crystal Structure Of An Antiflamatory Legume Lectin From Cymbosema Roseum Seeds Length = 237 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JEC|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Mutant E123a-H131n-K132q Complexed With 5-Bromo-4-Chloro-3- Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1QMO|A Chain A, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 113 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237 | Back alignment and structure |
|
| >pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1DGL|A Chain A, Lectin From Dioclea Grandiflora Complexed To Trimannoside Length = 237 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1AZD|A Chain A, Concanavalin From Canavalia Brasiliensis Length = 237 | Back alignment and structure |
|
| >pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237 | Back alignment and structure |
|
| >pdb|2OW4|A Chain A, Crystal Structure Of A Lectin From Canavalia Maritima Seeds (Conm) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|2CWM|A Chain A, Native Crystal Structure Of No Releasing Inductive Lectin From Seeds Of The Canavalia Maritima (Conm) Length = 237 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DHK|B Chain B, Structure Of Porcine Pancreatic Alpha-Amylase Length = 223 | Back alignment and structure |
|
| >pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VIW|B Chain B, Tenebrio Molitor Alpha-Amylase-Inhibitor Complex Length = 205 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 645 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-135 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-128 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-128 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 5e-83 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-66 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-65 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-63 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-63 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 8e-63 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-61 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-60 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-60 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-58 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-57 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-56 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-54 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 6e-53 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-52 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 2e-52 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-51 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 1e-51 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 4e-51 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 1e-49 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 2e-49 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 1e-48 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 1e-48 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 8e-48 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 9e-48 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 1e-47 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 2e-47 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 6e-47 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 8e-47 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-46 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 1e-46 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-46 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 2e-46 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-46 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 5e-46 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 6e-46 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-46 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-45 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-45 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-45 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-45 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-45 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-45 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-45 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-45 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 3e-45 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 4e-45 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 6e-45 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 7e-45 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 7e-45 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-44 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-44 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 2e-44 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 2e-44 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-44 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 5e-44 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 5e-44 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-44 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-44 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-44 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-43 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-43 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-43 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-43 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-43 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-43 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-43 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-43 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-43 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-42 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-42 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-42 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-42 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 4e-42 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-42 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-42 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 6e-42 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 8e-42 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 1e-41 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-41 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-41 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-41 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-41 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-41 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 7e-41 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-40 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-40 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-40 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-40 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-39 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-39 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-39 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-39 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-39 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-39 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-39 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-39 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-39 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-39 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-38 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-38 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-38 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-38 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-38 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-38 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-38 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 2e-38 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-38 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 7e-38 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-36 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-36 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-36 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-35 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-35 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-35 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-34 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-34 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-34 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-34 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-33 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-33 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-33 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-32 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-31 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-31 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-31 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-31 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-31 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-30 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-30 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-30 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-29 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 8e-29 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-28 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-28 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 5e-28 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-28 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 6e-28 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-28 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-27 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-27 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-27 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-27 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-27 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 6e-27 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 6e-27 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-27 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 9e-27 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 9e-27 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-26 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-26 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-26 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-26 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-26 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-26 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-26 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 8e-26 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-25 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-25 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-25 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-25 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-25 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-25 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-25 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-25 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-25 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-25 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 7e-25 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-25 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-24 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-24 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-24 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-24 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-24 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-24 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-24 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-24 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-24 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-24 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 6e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-23 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-23 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 3e-23 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 5e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-23 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-23 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 5e-23 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-23 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 6e-23 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-22 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-22 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-22 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-22 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-22 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-22 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 8e-22 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-22 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-21 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-21 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-21 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-20 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 1e-20 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-20 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-20 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-20 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-20 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-20 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 8e-20 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 9e-20 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-19 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-19 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-19 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-19 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-18 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 2e-18 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-18 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-17 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-17 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-17 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-17 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-17 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 9e-17 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-16 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-16 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-16 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-16 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 8e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-12 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 6e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 6e-11 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-05 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 397 bits (1022), Expect = e-135
Identities = 113/300 (37%), Positives = 179/300 (59%), Gaps = 8/300 (2%)
Query: 330 DDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS 389
D E G KRF +EL +A+++F++ LG+GGFG VYKG + +AVKR+ +
Sbjct: 9 DPEVHLG-QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEER 66
Query: 390 KQGIK-EYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENS 445
QG + ++ +EV++IS HRNL++L G+C E LLVY +M NGS+ S L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 446 LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
L W R +IA A GL YL + + ++HRD+K++NI+LD F A +GDFGLA+L+++
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ--V 563
TT + GT+G++APE +TGK+S+++DV+ +G++ LE+ G++ + V
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
LL WV L KL VD L ++ +++E+L+ V L C RP + +V+ +L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-128
Identities = 113/324 (34%), Positives = 177/324 (54%), Gaps = 12/324 (3%)
Query: 310 IGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVY 369
+G K + N S FE R P +L ATN+F+ +G G FG VY
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFES----YRVPLVDLEEATNNFDHKFLIGHGVFGKVY 56
Query: 370 KGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429
KG R+ + +A+KR + S QGI+E+ +E++ +S RH +LV L+G+C E+ E++L+Y+
Sbjct: 57 KGVLRD-GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115
Query: 430 FMPNGSLDSHLFKENSL---LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486
+M NG+L HL+ + ++WE R +I A GL YL ++HRD+KS NI+L
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILL 172
Query: 487 DSNFNAKIGDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVAL 545
D NF KI DFG+++ + +TV+ GT+GY+ PE G+ +++SDVYSFG+V
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 546 EIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWC 605
E+ C R I P+ V+L +W + + NG+L + VDP L + + + + C
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 606 AHPDENLRPSIRQVIHVLNFEAPL 629
RPS+ V+ L + L
Sbjct: 293 LALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-128
Identities = 109/307 (35%), Positives = 166/307 (54%), Gaps = 23/307 (7%)
Query: 335 RGAGPKRFPYKELALATNDFNDDQ------KLGQGGFGGVYKGFFRETNSYIAVKRVSQG 388
F + EL TN+F++ K+G+GGFG VYKG+ T +AVK+++
Sbjct: 8 SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT--VAVKKLAAM 65
Query: 389 ----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF--K 442
+++ +++ E+K++++ +H NLV+LLG+ + +L LVY +MPNGSL L
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 443 ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502
L+W R KIAQ A+G+ +L E +HRDIKS+NI+LD F AKI DFGLAR
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 503 VEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG 561
E + T+ + GT YMAPE G+ + +SD+YSFG+V LEI G ++
Sbjct: 183 SEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE-- 239
Query: 562 QVSLLQWVWDLYGNGKLLEA-VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
LL ++ K +E +D ++ D D +E + V C H +N RP I++V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 621 HVLNFEA 627
+L
Sbjct: 299 QLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 5e-83
Identities = 77/306 (25%), Positives = 118/306 (38%), Gaps = 28/306 (9%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK 401
+ L + + +G FG V+K N Y+AVK KQ + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 402 IISRLRHRNLVQLLGWC----HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQ 457
+ ++H N++Q +G +L L+ F GSL L +++W IA+
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAE 128
Query: 458 DLASGLLYLQEE-------WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS- 509
+A GL YL E+ + + HRDIKS N++L +N A I DFGLA E K +
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 510 QTTVLAGTMGYMAPECA-----TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS 564
T GT YMAPE A D+Y+ G+V E+A + + +
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 565 LLQWVWDLYGNGKLLEAV-----DPRLCRDFDGQQIERLMI-VGLWCAHPDENLRPSIRQ 618
+ + + E V P L + ++ C D R S
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 619 VIHVLN 624
V +
Sbjct: 309 VGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 6e-66
Identities = 85/280 (30%), Positives = 138/280 (49%), Gaps = 29/280 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
D N +K+G G FG V++ + ++ +AVK + + + + E+ EV I+ RLRH
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL--LTWEFRYKIAQDLASGLLYLQ 467
N+V +G + L +V E++ GSL L K + L R +A D+A G+ YL
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL- 153
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+VHR++KS N+++D + K+ DFGL+RL S + AGT +MAPE
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLR 212
Query: 528 TGKASKESDVYSFGIVALEIACGRKP---INPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584
++++SDVYSFG++ E+A ++P +NP Q V + K LE P
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------AQVVAAVGFKCKRLEI--P 261
Query: 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
R Q+ ++ C + RPS ++ +L
Sbjct: 262 RNLN----PQVAAII---EGCWTNEPWKRPSFATIMDLLR 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 1e-65
Identities = 69/321 (21%), Positives = 124/321 (38%), Gaps = 47/321 (14%)
Query: 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK 401
E +L ++ + +G+G +G VYKG E +AVK S ++Q + +E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFANRQ---NFINEKN 57
Query: 402 I--ISRLRHRNLVQLLGWCHE-----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK 454
I + + H N+ + + + E LLV E+ PNGSL +L W +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCR 115
Query: 455 IAQDLASGLLYLQEEWEQ------CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
+A + GL YL E + + HRD+ S N+++ ++ I DFGL+ + +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 509 SQ-------TTVLAGTMGYMAPE-------CATTGKASKESDVYSFGIVALEIACGRKPI 554
+ GT+ YMAPE A K+ D+Y+ G++ EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 555 NP--KAPQGQVSLLQWVWDLYGNGKLLEAVD-----PRLCRDFDGQQIERLMIVGL---- 603
P P+ Q++ V + + V P+ + + +
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 604 WCAHPDENLRPSIRQVIHVLN 624
W + R + + +
Sbjct: 296 WDQDAEA--RLTAQXAEERMA 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 1e-63
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 31/307 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+D + LG+G FG K RET + +K + + ++ + + EVK++ L H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
++ +G ++ K L + E++ G+L + +S W R A+D+ASG+ YL
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---S 126
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE-------------HAKGSQTTVLAGTM 518
++HRD+ S N ++ N N + DFGLARL+ + + G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578
+MAPE ++ DV+SFGIV EI P+ L
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLD 241
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL-NFEAPLPALPPKMP 637
P C + + C D RPS ++ H L L P P
Sbjct: 242 RYC--PPNCPP----SFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
Query: 638 VPTYLSP 644
L
Sbjct: 293 QLEQLDR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-63
Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 41/305 (13%)
Query: 338 GPKRFP-YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG---- 392
G FP + LA N+ ++++G+GGFG V+KG + S +A+K + G +G
Sbjct: 4 GGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 393 ---IKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTW 449
+E+ EV I+S L H N+V+L G +V EF+P G L L + + W
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKW 121
Query: 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-----NFNAKIGDFGLARLVE 504
+ ++ D+A G+ Y+ + +VHRD++S NI L S AK+ DFGL++
Sbjct: 122 SVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 505 HAKGSQTTVLAGTMGYMAPE--CATTGKASKESDVYSFGIVALEIACGRKP---INPKAP 559
H + L G +MAPE A ++++D YSF ++ I G P +
Sbjct: 181 H----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK- 235
Query: 560 QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
++++ + G P C ++ ++ C D RP +
Sbjct: 236 ------IKFINMIREEGLRPTI--PEDC----PPRLRNVI---ELCWSGDPKKRPHFSYI 280
Query: 620 IHVLN 624
+ L+
Sbjct: 281 VKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 8e-63
Identities = 75/298 (25%), Positives = 128/298 (42%), Gaps = 28/298 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+ ++ +G+G FG V K +R +A+K++ S+ K + E++ +SR+ H N+
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNI 63
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL--LTWEFRYKIAQDLASGLLYLQEE 469
V+L G C + LV E+ GSL + L L T + G+ YL
Sbjct: 64 VKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 470 WEQCVVHRDIKSSNIMLDSNFN-AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ ++HRD+K N++L + KI DFG A ++ + T G+ +MAPE
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ----THMTNNKGSAAWMAPEVFEG 177
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
S++ DV+S+GI+ E+ RKP + NG +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPL--IKNL- 229
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL-NFEAPLPALPPKMPVPTYLSPP 645
+ IE LM C D + RPS+ +++ ++ + P + P S P
Sbjct: 230 ---PKPIESLM---TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-61
Identities = 86/290 (29%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 353 DFND---DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SKQGIKEYASEVKIISR 405
DF + ++ +G GGFG VY+ F+ +AVK Q I+ E K+ +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
L+H N++ L G C ++ L LV EF G L+ L + + + A +A G+ Y
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNY 120
Query: 466 LQEEWEQCVVHRDIKSSNIMLD--------SNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
L +E ++HRD+KSSNI++ SN KI DFGLAR + AG
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---TTKMSAAGA 177
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEIACGRKP---INPKAPQGQVSLLQWVWDLYG 574
+MAPE SK SDV+S+G++ E+ G P I+ L + +
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------LAVAYGVAM 228
Query: 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
N L P C + +LM C +PD + RPS ++ L
Sbjct: 229 NKLALPI--PSTCP----EPFAKLM---EDCWNPDPHSRPSFTNILDQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-60
Identities = 85/315 (26%), Positives = 149/315 (47%), Gaps = 39/315 (12%)
Query: 315 KEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR 374
K+G + G + D ++E P ++ + Q++G G FG VYKG +
Sbjct: 2 KKGHHHHHHGSRDAAD-DWE-------IPDGQITVG-------QRIGSGSFGTVYKGKWH 46
Query: 375 ETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMP 432
+AVK ++ + Q ++ + +EV ++ + RH N++ +G+ +L +V ++
Sbjct: 47 GD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 102
Query: 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492
SL HL + + IA+ A G+ YL + ++HRD+KS+NI L +
Sbjct: 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTV 159
Query: 493 KIGDFGLARLVEHAKGSQT-TVLAGTMGYMAPE---CATTGKASKESDVYSFGIVALEIA 548
KIGDFGLA GS L+G++ +MAPE + S +SDVY+FGIV E+
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 549 CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHP 608
G+ P + + Q+ + + G G L + R ++++RLM C
Sbjct: 220 TGQLPYSNINNRDQI-----IEMV-GRGSLSPDLSK--VRSNCPKRMKRLM---AECLKK 268
Query: 609 DENLRPSIRQVIHVL 623
+ RPS +++ +
Sbjct: 269 KRDERPSFPRILAEI 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 69/332 (20%), Positives = 130/332 (39%), Gaps = 46/332 (13%)
Query: 330 DDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG- 388
F R A +E + + +G+G FG VY G + +A++ +
Sbjct: 11 ARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIER 67
Query: 389 -SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLL 447
++ +K + EV + RH N+V +G C L ++ +L S + +L
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 448 TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA- 506
+IAQ++ G+ YL + ++H+D+KS N+ D N I DFGL +
Sbjct: 128 DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183
Query: 507 ---KGSQTTVLAGTMGYMAPE---------CATTGKASKESDVYSFGIVALEIACGRKP- 553
+ + + G + ++APE SK SDV++ G + E+ P
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
Query: 554 --INPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDEN 611
+A Q+ G G + G++I ++ L+C ++
Sbjct: 244 KTQPAEAIIWQM----------GTGMKPN-LSQIGM----GKEISDIL---LFCWAFEQE 285
Query: 612 LRPSIRQVIHVLNFEAPLPALPPKMPVPTYLS 643
RP+ +++ +L LP ++ P +
Sbjct: 286 ERPTFTKLMDMLE---KLPKRNRRLSHPGHFW 314
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-57
Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
N KL + G ++KG ++ + I VK + S + +++ E + H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 410 NLVQLLGWCHE--KKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYL 466
N++ +LG C L+ +MP GSL + L + N ++ K A D+A G+ +L
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC- 525
E + + S ++M+D + A+I + Q+ ++APE
Sbjct: 128 -HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEAL 180
Query: 526 --ATTGKASKESDVYSFGIVALEIACGRKP---INPKAPQGQVSLLQWVWDLYGNGKLLE 580
+ +D++SF ++ E+ P ++ ++ + G
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVALEGLRPT 231
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P + +LM C + D RP ++ +L
Sbjct: 232 I--PPGI----SPHVSKLM---KICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 8e-56
Identities = 67/313 (21%), Positives = 121/313 (38%), Gaps = 45/313 (14%)
Query: 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASE 399
+R +++ L + +G+G +G V++G ++ +AVK S + K + E
Sbjct: 3 QRTVARDITL-------LECVGKGRYGEVWRGSWQGE--NVAVKIFSS---RDEKSWFRE 50
Query: 400 VKI--ISRLRHRNLVQLLGWC----HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY 453
++ LRH N++ + H +L L+ + GSL +L + +L
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTL-DTVSCL 108
Query: 454 KIAQDLASGLLYLQEEWEQC-----VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
+I +ASGL +L E + HRD+KS NI++ N I D GLA + +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 509 SQ---TTVLAGTMGYMAPE------CATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559
GT YMAPE + K D+++FG+V E+A
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 560 -----QGQVSL---LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDEN 611
V + + + + + R D + +LM C + + +
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPS 285
Query: 612 LRPSIRQVIHVLN 624
R + ++ L
Sbjct: 286 ARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 6e-53
Identities = 75/334 (22%), Positives = 128/334 (38%), Gaps = 53/334 (15%)
Query: 326 SEYIDDEFERGAGP------KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSY 379
+ I+ G+G +R K++ + +++G+G +G V+ G +R
Sbjct: 12 RDLIEQSQSSGSGSGLPLLVQRTIAKQIQM-------VKQIGKGRYGEVWMGKWRGEK-- 62
Query: 380 IAVKRVSQGSKQGIKEYASEVKI--ISRLRHRNLVQLLGWCHEKK----ELLLVYEFMPN 433
+AVK + + E +I +RH N++ + + +L L+ ++ N
Sbjct: 63 VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119
Query: 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE-----WEQCVVHRDIKSSNIMLDS 488
GSL +L K +L + K+A SGL +L E + + HRD+KS NI++
Sbjct: 120 GSLYDYL-KSTTL-DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177
Query: 489 NFNAKIGDFGLARLVEHAKGSQTTVL---AGTMGYMAPE------CATTGKASKESDVYS 539
N I D GLA GT YM PE ++ +D+YS
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 540 FGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV---------DPRLCRDF 590
FG++ E+A R + Q+ V + E V R D
Sbjct: 238 FGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDE 296
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+Q+ +LM C + R + +V L
Sbjct: 297 CLRQMGKLMT---ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 79/343 (23%), Positives = 137/343 (39%), Gaps = 51/343 (14%)
Query: 316 EGDEEDNQGFSEYIDDEFERGAG------PKRFPYKELALATNDFNDDQKLGQGGFGGVY 369
+ + I D G+G +R + + L + +G+G FG V+
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVL-------QESIGKGRFGEVW 59
Query: 370 KGFFRETNSYIAVKRVSQGSKQG-IKEYASEVKIISRLRHRNLVQLLGWCHEKK----EL 424
+G +R +AVK S ++ +E +E+ LRH N++ + ++ +L
Sbjct: 60 RGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC-----VVHRDI 479
LV ++ +GSL +L + +T E K+A ASGL +L E + HRD+
Sbjct: 116 WLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 480 KSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL---AGTMGYMAPE------CATTGK 530
KS NI++ N I D GLA + A + GT YMAPE +
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV-------- 582
+ K +D+Y+ G+V EIA R I Q+ V ++ + V
Sbjct: 234 SFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 292
Query: 583 -DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
R + + ++M C + + R + ++ L+
Sbjct: 293 IPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 86/260 (33%), Positives = 132/260 (50%), Gaps = 20/260 (7%)
Query: 26 LTIIPLASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATY 77
L +L+F++ +F + N+ ++ A+ N ++QL R T GR +
Sbjct: 3 LNRANSTDSLSFSFINFDRD-ERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILH 61
Query: 78 NQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLT 137
+ +RLW+K+T + + T FSF + S S ADG+AFF+AP + IP+ GG GL
Sbjct: 62 SAQVRLWEKSTNRVANLQTQFSFFLSS-PLSNPADGIAFFIAPPDTTIPSGSAGGLLGLF 120
Query: 138 KDNEPLNSSI-PFVAVEFDVY----VNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRR 192
LN S +AVEFD + N+WDP + H+GID+NS++S K V W + + G+
Sbjct: 121 NPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVRW--ERREGKT 178
Query: 193 NEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIF 252
++YN ST + V T L + VDL LPE+V GFS A+G F
Sbjct: 179 LNVLVTYNPSTRTIDVVATYPDGQ---RYQLSHVVDLTTILPEWVRVGFSAASGEQFQTH 235
Query: 253 SIYSWEFNSSLEMDDETTNP 272
++ SW F S+L + +
Sbjct: 236 NLESWSFTSTLLYTAQKEDE 255
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-51
Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 28/292 (9%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYA 397
+ P + L D +++G+G FG V+ G R N+ +AVK + ++
Sbjct: 101 HRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL 160
Query: 398 SEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQ 457
E +I+ + H N+V+L+G C +K+ + +V E + G + L E + L + ++
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
D A+G+ YL+ +C +HRD+ + N ++ KI DFG++R G
Sbjct: 221 DAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA---DGVYAASGGL 274
Query: 518 MGY----MAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDL 572
APE G+ S ESDV+SFGI+ E G P P Q ++V
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQT--REFV--- 328
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
G L P LC D + RLM C + RPS + L
Sbjct: 329 -EKGGRLPC--PELCPD----AVFRLM---EQCWAYEPGQRPSFSTIYQELQ 370
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 1e-51
Identities = 87/243 (35%), Positives = 127/243 (52%), Gaps = 18/243 (7%)
Query: 35 LTFNYTSFSPQYDDNITYER-AYPDSNRVIQL---PANRETAGRATYNQSMRLWDKATGN 90
++FNYT F D ++ ++ A ++ + + P T A Y + +WD ATGN
Sbjct: 1 VSFNYTRFKD--DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGN 58
Query: 91 LTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFV 150
+ F T FSF++ + DG+ FFLAP G++IP N GG G+T + NS FV
Sbjct: 59 VASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFV 115
Query: 151 AVEFDVYVNSW---DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLS 207
AVEFD + N W SH+GID+NS+ S K V+W + SG +A I Y+S T L+
Sbjct: 116 AVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNW--NRVSGSLEKATIIYDSDTKILT 173
Query: 208 VAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMAT-GVDFAIFSIYSWEFNSSLEMD 266
V T + + ++DL+ LPE V+ GFS T + IYSW F S+L+
Sbjct: 174 VVMTHQNGQITT---ISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFTSTLKEP 230
Query: 267 DET 269
+E
Sbjct: 231 EEQ 233
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 176 bits (446), Expect = 4e-51
Identities = 89/238 (37%), Positives = 115/238 (48%), Gaps = 13/238 (5%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL--PANRETAGRATYNQSMRLWDKATG 89
A ++FN+ SFS SN IQL + GR Y +R+W ATG
Sbjct: 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATG 60
Query: 90 NLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
N+ F T FSF + ADG+ FF+AP+ ++IP GG D + F
Sbjct: 61 NVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT---KGAGHF 117
Query: 150 VAVEFDVYVNSW--DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLS 207
V VEFD Y NS DP HVGID+NSV S K V W + SG + + Y+SST LS
Sbjct: 118 VGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW--NSVSGAVVKVTVIYDSSTKTLS 175
Query: 208 VAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD-FAIFSIYSWEFNSSLE 264
VA T ++ + VDL+ LPE V FGFS + + I I SW F S+L
Sbjct: 176 VAVTNDNGDITT---IAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLI 230
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 78/247 (31%), Positives = 115/247 (46%), Gaps = 17/247 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE-----TAGRATYNQSMRLWD 85
+ L+F + +FS +++++ A V+QL T G A Y + +W+
Sbjct: 1 SDDLSFKFKNFSQ-NGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN 59
Query: 86 KATGNLTDFTTHFSFVID-SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
TG L F T FSF ++ S N DGL FFLAP P + GG FGL D + +
Sbjct: 60 CNTGELASFITSFSFFMETSANPKAATDGLTFFLAP--PDSPLRRAGGYFGLFNDTKC-D 116
Query: 145 SSIPFVAVEFDVYVNS---WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
SS VAVEFD + WDP F H+GID+N VKS W I Y +
Sbjct: 117 SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIYEA 176
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIF-SIYSWEFN 260
S+ L+ + T + + VDL++ LPE+V+ GFS +T + + +W F
Sbjct: 177 SSKTLTASLTYPSDQ--TSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234
Query: 261 SSLEMDD 267
S+ +
Sbjct: 235 STFINTN 241
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 79/245 (32%), Positives = 123/245 (50%), Gaps = 19/245 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL------PANRETAGRATYNQSMRLW 84
+ L+F +F P + ++ ++ A S V+QL + + GRA Y +R+W
Sbjct: 1 SDELSFTINNFVP-NEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW 59
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
TG++ F+T F+FV+ + N +DGLAF+LAP S+IP+ GL ++ +
Sbjct: 60 GNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS-D 118
Query: 145 SSIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYN 200
SS VAVEFD Y WDP + H+GID+N ++S + D +G A I+Y
Sbjct: 119 SSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIES--IKTVQWDWINGGVAFATITYL 176
Query: 201 SSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS--IYSWE 258
+ L + N + VDL++ LPE+V GFS ATG + + + SW
Sbjct: 177 APNKTLIASLVYPSNQ--TTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234
Query: 259 FNSSL 263
F S+L
Sbjct: 235 FTSTL 239
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 84/256 (32%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
A ++F++ F P+ N+ + A S+ +QL + GRA Y+ + +
Sbjct: 1 AETVSFSWNKFVPK-QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHI 59
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
WDK TG++ F F+F + ++ ADGLAFFLAP G GL +NE
Sbjct: 60 WDKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAP--IDTKPQTHAGYLGLFNENESG 117
Query: 144 NSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
+ VAVEFD + NSWDP H+GI++NS++S K SW D+ + + + I+Y++ST
Sbjct: 118 D---QVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSW--DLANNKVAKVLITYDAST 172
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS--IYSWEFNS 261
L + L VDL+ LPE+V GFS ATG+D S + SW F S
Sbjct: 173 SLLVASLVYPSQR--TSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFAS 230
Query: 262 SLEMDDETTNPVSNPK 277
+L +P+
Sbjct: 231 NLPHASSNIDPLDLTS 246
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 89/251 (35%), Positives = 123/251 (49%), Gaps = 26/251 (10%)
Query: 33 SALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL------PANRETAGRATYNQSMRLWD 85
++FN+ F ++ + +R A SN V++L + GRA Y + +++WD
Sbjct: 2 KTISFNFNQFHQ-NEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWD 60
Query: 86 KATGNLTDFTTHFSFVIDSR-NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
TGN+ F T FSF I + ADGL FF+AP T +GGG FG+
Sbjct: 61 STTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAP--PNTQTGEGGGYFGIYNP----L 114
Query: 145 SSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTH 204
S PFVAVEFD + N+WDP H+GID+NSV S K V + + +G I Y++ST
Sbjct: 115 SPYPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPF--TLDNGGIANVVIKYDASTK 172
Query: 205 NLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS-------IYSW 257
L V + + VDL+Q LPE V GFS ATG I SW
Sbjct: 173 ILHVVLVFPSLG--TIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSW 230
Query: 258 EFNSSLEMDDE 268
F++SL +E
Sbjct: 231 SFSASLPGTNE 241
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-48
Identities = 85/246 (34%), Positives = 116/246 (47%), Gaps = 21/246 (8%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
A +F ++ F P + N+ + A V+QL + GRATY+ + +
Sbjct: 1 AEETSFVFSKFKPL-EPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINI 59
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
WD ATG + F T F F I + N + ADGLAFFLAP + GGG GL
Sbjct: 60 WDSATGLVASFATSFRFTIYAPNIATIADGLAFFLAP--VASAPDSGGGFLGLFDSAVS- 116
Query: 144 NSSIPFVAVEFDVYVN--SWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
S+ VAVEFD Y N DP ++H+G D+NS+ S K V W + +G + I+YNS
Sbjct: 117 GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW--SLANGEAAKVLITYNS 174
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWE 258
+ L + + L VDL LPE+V GFS ATG ++SW
Sbjct: 175 AVKLLVASLVYPSSK--TSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWS 232
Query: 259 FNSSLE 264
F S L
Sbjct: 233 FASKLA 238
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 9e-48
Identities = 80/254 (31%), Positives = 128/254 (50%), Gaps = 24/254 (9%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
A +F++ +F+ + + A S+ ++L + GRA Y+ +++
Sbjct: 1 ADIQSFSFKNFNS---SSFILQGDATVSSS-KLRLTKVKGNGLPTLSSLGRAFYSSPIQI 56
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
+DK+TG + + T F+ I + N S ADG+AF L P GS+ +N G +
Sbjct: 57 YDKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGFLGVFDSDVY--- 113
Query: 144 NSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSS 202
++S VAVEFD + N+ WDPT H+GID+NS+KS + SW + +G+ E I+YN++
Sbjct: 114 DNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--GLANGQNAEILITYNAA 171
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEF 259
T L + + +VD+ LPE+V+ GFS TG+ + SW F
Sbjct: 172 TSLLVASLVHPSRR--TSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229
Query: 260 NSSLEMDDETTNPV 273
S L DD TT P+
Sbjct: 230 ASKLP-DDSTTEPL 242
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-47
Identities = 87/242 (35%), Positives = 125/242 (51%), Gaps = 17/242 (7%)
Query: 33 SALTFNYTSFSPQYDDNITYERAYPDSNRVIQL------PANRETAGRATYNQSMRLWDK 86
+L+F++ F+P I A S V+QL + ++ GRA Y ++WD
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
TGN+ F T F+F+I + N + ADGLAFFLAP GG G+ KD N S
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAP--VDTQPLDLGGMLGIFKDGYF-NKS 118
Query: 147 IPFVAVEFDVY-VNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHN 205
VAVEFD + WDP H+GI++NS++S K V W + +G +ISY +ST +
Sbjct: 119 NQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW--NWTNGEVANVFISYEASTKS 176
Query: 206 LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNSS 262
L+ + +L +D VD++ LPE+V FGFS TG+D + SW F S+
Sbjct: 177 LTASLVY--PSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234
Query: 263 LE 264
L
Sbjct: 235 LP 236
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-47
Identities = 89/256 (34%), Positives = 128/256 (50%), Gaps = 26/256 (10%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
++ + FN+ F+ N+ +R A S+ ++L + GRA Y+ +++
Sbjct: 1 SNDIYFNFQRFNE---TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQI 57
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
WD TG + F T F+F I N++ ADGLAF L P GS GG GL +
Sbjct: 58 WDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGS--QPKDKGGFLGLFDGS--- 112
Query: 144 NSSIPFVAVEFD-VYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSS 202
NS+ VAVEFD +Y WDPT H+GID+NS++S K W D +G E I+Y+SS
Sbjct: 113 NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW--DFVNGENAEVLITYDSS 170
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEF 259
T+ L + + VDL+ LPE+V+ GFS TG++ + SW F
Sbjct: 171 TNLLVASLVYPSQK--TSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228
Query: 260 NSSLEMDDETTNPVSN 275
S L DETT+ N
Sbjct: 229 ASKL--SDETTSEGLN 242
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 23/240 (9%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL----PANRETAGRATYNQSMRLWDK 86
++ +FN +F+ N+ + A S + L ++ GRA Y+ +++ D+
Sbjct: 1 SNDASFNVETFNK---TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDR 57
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
NL F+T+F+F I+++N A GLAF L P G GL +
Sbjct: 58 TIDNLASFSTNFTFRINAKNIENSAYGLAFALVP--VGSRPKLKGRYLGLFNTTNY-DRD 114
Query: 147 IPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
VAV FD N + ID+NS++ S +G + E I+Y+S ++L
Sbjct: 115 AHTVAVVFDTVSN-------RIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSPKNDL 167
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNSSL 263
V+ + + V L + + ++V+ GFS +G + SW F+S+
Sbjct: 168 RVSLLY--PSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-47
Identities = 90/248 (36%), Positives = 132/248 (53%), Gaps = 18/248 (7%)
Query: 31 LASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL----PANRETAGRATYNQSMRLWD 85
L+ L+FN+ F P NI ++ A + V+Q+ + GRA Y +++WD
Sbjct: 2 LSDDLSFNFDKFVP-NQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 60
Query: 86 KATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNS 145
TG + F T FSFV+ + + S DGLAFFLAP S+IP+ G FGL ++ S
Sbjct: 61 SITGKVASFATSFSFVVKA-DKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDS-KS 118
Query: 146 SIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
S +AVEFD Y WDP F H+GID+NS+KS K V W D ++G + I+Y +
Sbjct: 119 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW--DWRNGEVADVVITYRA 176
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG--VDFAIFSIYSWEF 259
T +L+V + + + VDL+ LPE+V+ GFS G +F + SW F
Sbjct: 177 PTKSLTVCLSYPSDG--TSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234
Query: 260 NSSLEMDD 267
S+LE ++
Sbjct: 235 TSNLEANN 242
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 35/273 (12%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQL 414
D ++G+G F VYKG ET +A + + +K + + E +++ L+H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 415 LG----WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
KK ++LV E M +G+L ++L K ++ + + + GL +L
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLHTR- 148
Query: 471 EQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
++HRD+K NI + + KIGD GLA L + S + GT +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEEK 205
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL--- 586
+ DVY+FG+ LE+A P + Q+ + A ++
Sbjct: 206 -YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-------VTSGVKPASFDKVAIP 257
Query: 587 -CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
++ IE C +++ R SI+
Sbjct: 258 EVKEI----IEG-------CIRQNKDERYSIKD 279
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 79/240 (32%), Positives = 123/240 (51%), Gaps = 20/240 (8%)
Query: 34 ALTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE------TAGRATYNQSMRLWDK 86
+ +F++T+F+P +N+ + A +S ++L A + GRA Y + + D
Sbjct: 3 STSFSFTNFNP-NQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN 61
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
T L FTT FSFV+ + ++ ADGLAFFLAP ++ G + ++
Sbjct: 62 TT--LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGGFLGLFADRAHDASY-- 117
Query: 147 IPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
VAVEFD Y N+WDP ++H+GID N ++SKK + D+ G + I+Y +ST L
Sbjct: 118 -QTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF--DMVYGEKANIVITYQASTKAL 174
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNSSL 263
+ + + + +VDLR LPE+V GFS TG++ + I SW F SL
Sbjct: 175 AASLVFPVSQ--TSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 44/285 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
Q++G G FG V+ G++ + +A+K + +G+ +++ E +++ +L H LVQL G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C E+ + LV EFM +G L +L + L E + D+ G+ YL+ E CV+HR
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHR 128
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGKASKE 534
D+ + N ++ N K+ DFG+ R V Q T GT + +PE + + S +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 535 SDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD-------PRL 586
SDV+SFG++ E+ G+ P ++ N +++E + PRL
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP----------------YENRSNSEVVEDISTGFRLYKPRL 229
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAPL 629
+ ++M C RP+ +++ L E+ L
Sbjct: 230 AST----HVYQIM---NHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 78/257 (30%), Positives = 127/257 (49%), Gaps = 18/257 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLW 84
+ +++F + +F +D+I ++ + +QL + +AGRA Y+ ++LW
Sbjct: 2 SDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW 61
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
D T ++ F T F+F + + ADGLAFFLAP S + G K
Sbjct: 62 DNKTESVASFYTEFTFFLKITGNGP-ADGLAFFLAPPDSDVKDA-GEYLGLFNKSTATQP 119
Query: 145 SSIPFVAVEFDVY--VNSWDPTFSHVGIDINSVKSKKNVSWWS-DVKSGRRNEAWISYNS 201
S VAVEFD + N +P++ H+GI++NS+ S W D+ SG+ A ISY+
Sbjct: 120 SKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDG 179
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIF-SIYSWEFN 260
S L+V + + + L + VD+RQ+LPE V G S +TG + + I SW F+
Sbjct: 180 SAEILTVVLSYPDGSDYI---LSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFS 236
Query: 261 SSLEMDDETTNPVSNPK 277
S+L+ + P+
Sbjct: 237 SNLQ--STSVKAAMEPE 251
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 78/308 (25%), Positives = 143/308 (46%), Gaps = 45/308 (14%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+ +G G FG VYKG + ++ +A+K + G +++ ++ E I+ + H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
++L G + K ++++ E+M NG+LD L +++ + + + +A+G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATTG 529
VHRD+ + NI+++SN K+ DFGL+R++E + T G + APE +
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 530 KASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD----- 583
K + SDV+SFGIV E+ G +P + N ++++A++
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP----------------YWELSNHEVMKAINDGFRL 269
Query: 584 --PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAP--LPALPPKMP 637
P C I +LM + C + RP ++ +L+ AP L L P
Sbjct: 270 PTPMDCPS----AIYQLM---MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322
Query: 638 VPTYLSPP 645
+ P
Sbjct: 323 RVSIRLPS 330
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 5e-46
Identities = 83/307 (27%), Positives = 141/307 (45%), Gaps = 38/307 (12%)
Query: 336 GAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQGSKQ 391
G+ P +F + L Q+LG+G FG V + T +AVK++ +++
Sbjct: 1 GSDPTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 53
Query: 392 GIKEYASEVKIISRLRHRNLVQLLGWCHEKKE--LLLVYEFMPNGSLDSHLFKENSLLTW 449
++++ E++I+ L+H N+V+ G C+ L L+ E++P GSL +L K +
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509
+ + G+ YL + +HRD+ + NI++++ KIGDFGL +++ K
Sbjct: 114 IKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF 170
Query: 510 QTTVLAGTM--GYMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKA-------- 558
G + APE T K S SDV+SFG+V E+ K +P A
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 559 -PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR 617
QGQ+ + + +L N L P C D +I +M C + + N RPS R
Sbjct: 231 DKQGQMIVFH-LIELLKNNGRLPR--PDGCPD----EIYMIM---TECWNNNVNQRPSFR 280
Query: 618 QVIHVLN 624
+ ++
Sbjct: 281 DLALRVD 287
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 6e-46
Identities = 82/243 (33%), Positives = 124/243 (51%), Gaps = 18/243 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE-------TAGRATYNQSMRL 83
A+++ F +T F ++ ++ A SN+ +QL + GRA Y +RL
Sbjct: 1 ANSVCFTFTDFES-GQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRL 59
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
W + + F T F+F I +S+ AD L FF+A +KIP+ GG GL +
Sbjct: 60 WQS-SSLVASFETTFTFSISQGSSTP-ADALTFFIASPDTKIPSGSGGRLLGLFGSSNNA 117
Query: 144 NSSIPFVAVEFDVYVN--SWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
S V+VEFD Y N DP + H+GID+NS++SK W D ++G+ A ISYNS
Sbjct: 118 GSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW--DWQNGKTATAHISYNS 175
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261
++ LSV + ++ VV + + V+L P++V GFS TG +I +W F S
Sbjct: 176 ASKRLSVVSSYPNSSPVV---VSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232
Query: 262 SLE 264
SL
Sbjct: 233 SLM 235
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-46
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 42/278 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
++LG G FG V G ++ +AVK + +GS E+ E + + +L H LV+ G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C ++ + +V E++ NG L ++L L ++ D+ G+ +L+ +HR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGKASKE 534
D+ + N ++D + K+ DFG+ R V Q GT + APE K S +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 535 SDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD-------PRL 586
SDV++FGI+ E+ G+ P +DLY N +++ V P L
Sbjct: 186 SDVWAFGILMWEVFSLGKMP----------------YDLYTNSEVVLKVSQGHRLYRPHL 229
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
D I ++M C H RP+ +Q++ +
Sbjct: 230 ASD----TIYQIM---YSCWHELPEKRPTFQQLLSSIE 260
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-45
Identities = 75/305 (24%), Positives = 128/305 (41%), Gaps = 41/305 (13%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQGSKQGIK 394
P F + L +LG+G FG V + T + +AVK++ +
Sbjct: 17 PTIFEERHLKY-------ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR 69
Query: 395 EYASEVKIISRLRHRNLVQLLGWCHEKKE--LLLVYEFMPNGSLDSHLFKENSLLTWEFR 452
++ E++I+ L +V+ G + L LV E++P+G L L + + L
Sbjct: 70 DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL 129
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512
+ + G+ YL + VHRD+ + NI+++S + KI DFGLA+L+ K
Sbjct: 130 LLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV- 185
Query: 513 VLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLL 566
G + APE + S++SDV+SFG+V E+ K +P + ++
Sbjct: 186 --VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMM 241
Query: 567 QWVWDLYGNGKLLEAVD-------PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
D+ +LLE ++ P C ++ LM C P RPS +
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPA----EVHELM---KLCWAPSPQDRPSFSAL 294
Query: 620 IHVLN 624
L+
Sbjct: 295 GPQLD 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 69/285 (24%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY-------IAVKRVSQGSKQGIKEYASEVKIISRLRHR 409
++ LGQG F ++KG RE Y + +K + + + + + ++S+L H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+LV G C E +LV EF+ GSLD++L K + + ++ ++A+ LA+ + +L+
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-- 130
Query: 470 WEQCVVHRDIKSSNIMLDSNFN--------AKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
E ++H ++ + NI+L + K+ D G++ V Q + ++
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-----PWV 184
Query: 522 APECATTGKA-SKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579
PEC K + +D +SFG EI G KP+ + + Y + L
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL------SALDSQR-KLQFYEDRHQL 237
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
A P+ + L+ C + + RPS R +I LN
Sbjct: 238 PA--PKAAE------LANLI---NNCMDYEPDHRPSFRAIIRDLN 271
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 66/271 (24%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
++LG G FG V G +R +A+K + +GS E+ E K++ L H LVQL G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C +++ + ++ E+M NG L ++L + + ++ +D+ + YL+ + +HR
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGKASKE 534
D+ + N +++ K+ DFGL+R V + T G+ + PE K S +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 535 SDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593
SD+++FG++ EI G+ P + + + + G L P L +
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPY-ERFTNSET--AEHI----AQGLRLYR--PHLASE---- 248
Query: 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ +M C H + RP+ + ++ +
Sbjct: 249 KVYTIM---YSCWHEKADERPTFKILLSNIL 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 40/281 (14%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQ 413
D +LG G FG V +G +R I A+K + QG K +E E +I+ +L + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L+G C + + L+LV E G L L + + ++ ++ G+ YL+E +
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 130
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM--GYMAPECATTGKA 531
VHRD+ + N++L + AKI DFGL++ + T AG + APEC K
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 532 SKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD------- 583
S SDV+S+G+ E G+KP + +++ ++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP----------------YKKMKGPEVMAFIEQGKRMEC 234
Query: 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P C ++ LM C RP V +
Sbjct: 235 PPECPP----ELYALM---SDCWIYKWEDRPDFLTVEQRMR 268
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 64/284 (22%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 357 DQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+ LG G FG VYKG + + +A+K + + S + KE E +++ + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
+LLG C + L+ + MP G L ++ + + ++ +A G+ YL++
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 528
+ +VHRD+ + N+++ + + KI DFGLA+L+ + G +MA E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILH 193
Query: 529 GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD---- 583
+ +SDV+S+G+ E+ G KP +D ++ ++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILEKGER 237
Query: 584 ---PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P +C + +M C D + RP R++I +
Sbjct: 238 LPQPPICTI----DVYMIM---RKCWMIDADSRPKFRELIIEFS 274
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 82/307 (26%), Positives = 139/307 (45%), Gaps = 44/307 (14%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQGSKQGIK 394
P +F + L Q+LG+G FG V + T +AVK++ +++ ++
Sbjct: 35 PTQFEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 87
Query: 395 EYASEVKIISRLRHRNLVQLLGWCHEKKE--LLLVYEFMPNGSLDSHLFKENSLLTWEFR 452
++ E++I+ L+H N+V+ G C+ L L+ E++P GSL +L K +
Sbjct: 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512
+ + G+ YL + +HRD+ + NI++++ KIGDFGL +++ K
Sbjct: 148 LQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK- 203
Query: 513 VLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKA-------- 558
G + APE T K S SDV+SFG+V E+ K +P A
Sbjct: 204 --VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261
Query: 559 -PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR 617
QGQ+ + + +L N L P C D +I +M C + + N RPS R
Sbjct: 262 DKQGQMIVFH-LIELLKNNGRLPR--PDGCPD----EIYMIM---TECWNNNVNQRPSFR 311
Query: 618 QVIHVLN 624
+ ++
Sbjct: 312 DLALRVD 318
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 45/283 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ LG+G FG VY+G + +AVK + + +++ SE I+ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+L+G E++ ++ E P G L +L + + L + + + YL+
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTG 529
VHRDI NI++ S K+GDFGL+R +E + T +M+PE
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINFR 189
Query: 530 KASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD----- 583
+ + SDV+ F + EI G++P + N ++ ++
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP----------------FFWLENKDVIGVLEKGDRL 233
Query: 584 --PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P LC + LM C D + RP +++ L+
Sbjct: 234 PKPDLCPP----VLYTLM---TRCWDYDPSDRPRFTELVCSLS 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 48/285 (16%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYI--AVK--RVSQGSKQGIKEYASEVKIISRLRHRNLV 412
D++LG G FG V KG+++ AVK + E +E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+++G C E + +LV E G L+ +L ++N + + ++ ++ G+ YL+E
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE---S 136
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 527
VHRD+ + N++L + AKI DFGL++ + + A T G + APEC
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALR---ADENYYKAQTHGKWPVKWYAPECIN 193
Query: 528 TGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD--- 583
K S +SDV+SFG++ E G+KP + ++ ++
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGE 237
Query: 584 ----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P C ++ LM C D RP V L
Sbjct: 238 RMGCPAGCPR----EMYDLM---NLCWTYDVENRPGFAAVELRLR 275
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 74/244 (30%), Positives = 120/244 (49%), Gaps = 21/244 (8%)
Query: 33 SALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRLW 84
++F+++ F P +DN+T + A + V+QL ++ GR Y + + +W
Sbjct: 2 ETISFSFSEFEP-GNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW 60
Query: 85 DKATGNLTDFTTHFSFVIDS-RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
D TG + F T FSF I+ ADGL FF+ P +K +G G G+ +++
Sbjct: 61 DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGP--TKSKPAQGYGYLGVFNNSKQD 118
Query: 144 NSSIPFVAVEFDVYVNSW-DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSS 202
NS +AVEFD + N W P H+GID+NS++S K + + +G+ I Y++
Sbjct: 119 NSY-QTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF--QLDNGQVANVVIKYDAP 175
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEF 259
+ L V + + + VD++Q LP++V G S ATG +YSW F
Sbjct: 176 SKILHVVLVY--PSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSF 233
Query: 260 NSSL 263
+SL
Sbjct: 234 QASL 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 48/291 (16%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY---IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ +G G G V G R +A+K + G +++ +++ SE I+ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+L G + ++V E+M NGSLD+ L + T + + + +G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DL 170
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 527
VHRD+ + N+++DSN K+ DFGL+R++E T G + APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE---DDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 528 TGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD--- 583
S SDV+SFG+V E+ G +P + N ++ +V+
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP----------------YWNMTNRDVISSVEEGY 271
Query: 584 ----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAP 628
P C + +LM L C H D RP Q++ VL+ +P
Sbjct: 272 RLPAPMGCPH----ALHQLM---LDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 6e-45
Identities = 79/236 (33%), Positives = 123/236 (52%), Gaps = 13/236 (5%)
Query: 35 LTFNYTSFSPQYDDNITYERAYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATGNLTD 93
+F T FSP N+ ++ + + L A + T GRA Y+ + +WD+ TGN+ +
Sbjct: 4 TSFLITKFSPD-QQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVAN 62
Query: 94 FTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVE 153
F T F+FVI++ NS ADG FF+AP GGG G+ ++ + + VAVE
Sbjct: 63 FVTSFTFVINAPNSYNVADGFTFFIAP--VDTKPQTGGGYLGVF-NSAEYDKTTQTVAVE 119
Query: 154 FDVYVNSW---DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAF 210
FD + N+ H+GID+NS+KS SW +++G I++N++T+ L+V+
Sbjct: 120 FDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KLQNGEEANVVIAFNAATNVLTVSL 177
Query: 211 T---GFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSL 263
T V L V L+ +PE+V GFS TG ++A + SW F+S L
Sbjct: 178 TYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 233
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-45
Identities = 84/318 (26%), Positives = 132/318 (41%), Gaps = 54/318 (16%)
Query: 332 EFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQ 387
F+ P F + L + LG+G FG V + TN +AVK +
Sbjct: 18 LFQGPGDPTVFHKRYLKK-------IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA 70
Query: 388 G-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE--LLLVYEFMPNGSLDSHL---- 440
Q + E+ I+ L H ++++ G C + L LV E++P GSL +L
Sbjct: 71 DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS 130
Query: 441 FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500
LL + AQ + G+ YL Q +HRD+ + N++LD++ KIGDFGLA
Sbjct: 131 IGLAQLLLF------AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 501 RLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPI 554
+ V G + APEC K SDV+SFG+ E+
Sbjct: 182 KAVPEGHEYYR---VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238
Query: 555 NPKA--------PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCA 606
+P QGQ+++L+ + +L G+ L P C ++ LM C
Sbjct: 239 SPPTKFLELIGIAQGQMTVLR-LTELLERGERLPR--PDKCPA----EVYHLM---KNCW 288
Query: 607 HPDENLRPSIRQVIHVLN 624
+ + RP+ +I +L
Sbjct: 289 ETEASFRPTFENLIPILK 306
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 159 bits (402), Expect = 7e-45
Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 29/255 (11%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
A+ +FN+ +F DD + + A S +QL ++ GRA Y+ +++
Sbjct: 1 ATETSFNFPNFHT--DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQI 58
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
D + N+ F T+F+F+I ++N S A GLAF L P P K G+ N P
Sbjct: 59 KD--SNNVASFNTNFTFIIRAKNQSISAYGLAFALVP--VNSPPQKKQEFLGIFNTNNP- 113
Query: 144 NSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
+ VAV F+ + N + D N +K N + +G + + I+Y+SS
Sbjct: 114 EPNARTVAVVFNTFKN-------RIDFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSN 166
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFN 260
++L V V + V L + + E+V+ GFS +G+ + SW F+
Sbjct: 167 NDLRVFLHF--TVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFS 224
Query: 261 SSLEMDDETTNPVSN 275
S ++ +N + N
Sbjct: 225 SKFR--NKLSNILLN 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 78/288 (27%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 358 QKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
+ LG+G FG V + T +AVK + I + E++I+ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 413 QLLGWCHEKKE--LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+ G C E + L+ EF+P+GSL +L K + + + + K A + G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPEC 525
+ VHRD+ + N++++S KIGDFGL + +E K T + APEC
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWYAPEC 200
Query: 526 ATTGKASKESDVYSFGIVALEIA-CGRKPINPKA--------PQGQVSLLQWVWDLYGNG 576
K SDV+SFG+ E+ +P A GQ+++ + + + G
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-LVNTLKEG 259
Query: 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
K L P C D ++ +LM C + R S + +I
Sbjct: 260 KRLPC--PPNCPD----EVYQLM---RKCWEFQPSNRTSFQNLIEGFE 298
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-44
Identities = 83/307 (27%), Positives = 140/307 (45%), Gaps = 50/307 (16%)
Query: 357 DQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
D+ +G G FG V G + + +A+K + G +++ +++ E I+ + H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
+L G + K +++V E+M NGSLDS L K ++ T + + +ASG+ YL +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DM 166
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECAT 527
VHRD+ + NI+++SN K+ DFGL R++E G + +PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 528 TGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD--- 583
K + SDV+S+GIV E+ G +P + N +++AVD
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP----------------YWEMSNQDVIKAVDEGY 267
Query: 584 ----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAP--LPALPPK 635
P C + +LM L C D N RP Q++ +L+ P L +
Sbjct: 268 RLPPPMDCPA----ALYQLM---LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
Query: 636 MPVPTYL 642
P+ L
Sbjct: 321 AARPSNL 327
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 80/247 (32%), Positives = 117/247 (47%), Gaps = 25/247 (10%)
Query: 35 LTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRLWDK 86
+FN+ F + +R A SN V++L ++ GRA Y + +++WD
Sbjct: 3 QSFNFDHFEE-NSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDS 61
Query: 87 ATGNLTDFTTHFSFVIDS-RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNS 145
TGN+ F T FSF I ADGL FF+ P S P + GG+ G+ K
Sbjct: 62 TTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNS--PQGEDGGNLGVFKPP----E 115
Query: 146 SIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHN 205
AVEFD + N+WDP H+GID+NS+ S K + + +++G I Y+S T
Sbjct: 116 GDNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF--QLENGGVANVVIKYDSPTKI 173
Query: 206 LSVAFTGFRNNLVVMQGLDYQVDLRQHLP--EFVTFGFSMATGVDFAIFS---IYSWEFN 260
L+V +++ + L VDL+Q P E+V G S TG I SW F
Sbjct: 174 LNVVLAF--HSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFT 231
Query: 261 SSLEMDD 267
SSL+ +
Sbjct: 232 SSLQETN 238
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 157 bits (397), Expect = 2e-44
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 38/249 (15%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATG 89
A+ +F +F+ N+ + A SN +QL + ++ RA Y+ +++ D TG
Sbjct: 1 ATETSFIIDAFNK---TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTG 57
Query: 90 NLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
N+ F T+F+ I + + A GL F L P S
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQP--------------------ESKGDT 97
Query: 150 VAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVA 209
V VEFD +++ + ID+N+ K+V W G+ E I+YNSST SV+
Sbjct: 98 VTVEFDTFLS-------RISIDVNNNDI-KSVPWDVHDYDGQNAEVRITYNSSTKVFSVS 149
Query: 210 FTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEFNSSLEMD 266
+ + V+L + + ++V+ GFS +G + + SW F+S
Sbjct: 150 LSNPSTG--KSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFINL 207
Query: 267 DETTNPVSN 275
+ + SN
Sbjct: 208 KDQKSERSN 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 48/291 (16%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
+LG+G FG V+ + +AVK + + S+ +++ E ++++ L+H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHL--------------FKENSLLTWEFRYKIAQD 458
+ G C E + LL+V+E+M +G L+ L L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+A+G++YL VHRD+ + N ++ KIGDFG++R + S G
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY----STDYYRVGGR 219
Query: 519 G-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDL 572
+M PE K + ESDV+SFG+V EI G++P Q+S + D
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW------YQLSNTE-AIDC 272
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
G+ LE PR C ++ +M C + R SI+ V L
Sbjct: 273 ITQGRELER--PRACPP----EVYAIM---RGCWQREPQQRHSIKDVHARL 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 85/343 (24%), Positives = 136/343 (39%), Gaps = 59/343 (17%)
Query: 324 GFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNS 378
G + I D E P K + L + LG G FG VY+G +
Sbjct: 16 GKTSSISDLKE-------VPRKNITL-------IRGLGHGAFGEVYEGQVSGMPNDPSPL 61
Query: 379 YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD 437
+AVK + + S+Q ++ E IIS+ H+N+V+ +G + ++ E M G L
Sbjct: 62 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLK 121
Query: 438 SHL------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---S 488
S L + S L +A+D+A G YL+ E +HRDI + N +L
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 178
Query: 489 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-----MAPECATTGKASKESDVYSFGIV 543
AKIGDFG+AR + + S G M PE G + ++D +SFG++
Sbjct: 179 GRVAKIGDFGMARDIY--RASYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 544 ALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602
EI G P S + V + +G ++ P+ C + R+M
Sbjct: 235 LWEIFSLGYMPY-----PS-KSNQE-VLEFVTSGGRMDP--PKNCPG----PVYRIM--- 278
Query: 603 LWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
C RP+ ++ + + P + +P P
Sbjct: 279 TQCWQHQPEDRPNFAIILERIEYCTQDPDV-INTALPIEYGPL 320
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-44
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 358 QKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQ 413
+ +G+G FG V++G + + +A+K S +++ E + + H ++V+
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L+G + + ++ E G L S L L A L++ L YL+ +
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 136
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGK 530
VHRDI + N+++ SN K+GDFGL+R +E S + +MAPE +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWMAPESINFRR 193
Query: 531 ASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD------ 583
+ SDV+ FG+ EI G KP + N ++ ++
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKP----------------FQGVKNNDVIGRIENGERLP 237
Query: 584 -PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAP 628
P C + LM C D + RP ++ L+ E
Sbjct: 238 MPPNCPP----TLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 85/317 (26%), Positives = 139/317 (43%), Gaps = 58/317 (18%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAV 382
Y+ DE+E +++ + ++LGQG FG VY+G + E + +A+
Sbjct: 15 YVPDEWE-------VAREKITM-------SRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 383 KRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL- 440
K V++ S + E+ +E ++ ++V+LLG + + L++ E M G L S+L
Sbjct: 61 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 441 --------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492
+ + ++A ++A G+ YL VHRD+ + N M+ +F
Sbjct: 121 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV 177
Query: 493 KIGDFGLARLVEHAKGSQTTVLAGTMGY-----MAPECATTGKASKESDVYSFGIVALEI 547
KIGDFG+ R + G G M+PE G + SDV+SFG+V EI
Sbjct: 178 KIGDFGMTRDIY----ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233
Query: 548 A-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCA 606
A +P QG +S Q V G LL+ P C D + LM C
Sbjct: 234 ATLAEQPY-----QG-LSNEQ-VLRFVMEGGLLDK--PDNCPD----MLFELM---RMCW 277
Query: 607 HPDENLRPSIRQVIHVL 623
+ +RPS ++I +
Sbjct: 278 QYNPKMRPSFLEIISSI 294
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-44
Identities = 71/268 (26%), Positives = 131/268 (48%), Gaps = 22/268 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
KLG G +G VY+G +++ + +AVK + + + + ++E+ E ++ ++H NLVQLLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
C + ++ EFM G+L +L + N ++ +A ++S + YL+ ++ +H
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
R++ + N ++ N K+ DFGL+RL+ + + + APE K S +SD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 537 VYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595
V++FG++ EIA G P P QV + + +E P C + ++
Sbjct: 402 VWAFGVLLWEIATYGMSP-YPGIDLSQV--YELL----EKDYRMER--PEGCPE----KV 448
Query: 596 ERLMIVGLWCAHPDENLRPSIRQVIHVL 623
LM C + + RPS ++
Sbjct: 449 YELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-44
Identities = 76/271 (28%), Positives = 134/271 (49%), Gaps = 28/271 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
KLG G +G VY+G +++ + +AVK + + + + ++E+ E ++ ++H NLVQLLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
C + ++ EFM G+L +L + N ++ +A ++S + YL+ ++ +H
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT---MGYMAPECATTGKASK 533
RD+ + N ++ N K+ DFGL+RL+ G T AG + + APE K S
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 534 ESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
+SDV++FG++ EIA G P P QV + + +E P C +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPY-PGIDLSQV--YELL----EKDYRMER--PEGCPE--- 239
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
++ LM C + + RPS ++
Sbjct: 240 -KVYELM---RACWQWNPSDRPSFAEIHQAF 266
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 35/280 (12%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV---SQGSKQGIKEYASEVKIISRLRH 408
+F ++K+G+G F VY+ +A+K+V + + E+ ++ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL---------FKENSLLTWEFRYKIAQDL 459
N+++ E EL +V E G L + E ++ + Q L
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-L 145
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 519
S L ++ + V+HRDIK +N+ + + K+GD GL R + +++ GT
Sbjct: 146 CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 201
Query: 520 YMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579
YM+PE + +SD++S G + E+A + P SL + K+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCK---------KIE 251
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ P L D +++ +L+ C +PD RP + V
Sbjct: 252 QCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDVTYV 288
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLV 412
++LG+G FG V+ + +AVK + + K++ E ++++ L+H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHL---------------FKENSLLTWEFRYKIAQ 457
+ G C + L++V+E+M +G L+ L + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
+ASG++YL Q VHRD+ + N ++ +N KIGDFG++R V V T
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGHT 195
Query: 518 M---GYMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLY 573
M +M PE K + ESDV+SFG++ EI G++P + +V ++ +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEV--IECI---- 248
Query: 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
G++LE PR+C ++ +M L C + R +I+++ +L
Sbjct: 249 TQGRVLER--PRVCPK----EVYDVM---LGCWQREPQQRLNIKEIYKIL 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 32/279 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ +G+G FG VY G + + + AVK +++ + ++ +E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 413 QLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
LLG C + L+V +M +G L + + E T + +A G+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 210
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 526
+ VHRD+ + N MLD F K+ DFGLAR + +V T +MA E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEFDSVHNKTGAKLPVKWMALESL 268
Query: 527 TTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585
T K + +SDV+SFG++ E+ G P L G+ L P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRRLLQ--PE 319
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
C D + +M L C HP +RPS +++ ++
Sbjct: 320 YCPD----PLYEVM---LKCWHPKAEMRPSFSELVSRIS 351
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 32/279 (11%)
Query: 357 DQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
D+ +G+G FG VY G + + A+K +S+ Q ++ + E ++ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 413 QLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
L+G + ++ +M +G L + T + +A G+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE--- 142
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 526
Q VHRD+ + N MLD +F K+ DFGLAR + +V + A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTALESL 200
Query: 527 TTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585
T + + +SDV+SFG++ E+ G P P L G+ L P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------QGRRLPQ--PE 251
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
C D + ++M C D +RP+ R ++ +
Sbjct: 252 YCPD----SLYQVM---QQCWEADPAVRPTFRVLVGEVE 283
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 67/307 (21%), Positives = 131/307 (42%), Gaps = 47/307 (15%)
Query: 357 DQKLGQGGFGGVYKGFFR----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNL 411
+ LG G FG VYKG + + +A+K + + + + KE E +++ + + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
+LLG C + L+ + MP G L ++ + + ++ +A G+ YL++
Sbjct: 80 CRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED--- 135
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 528
+ +VHRD+ + N+++ + + KI DFGLA+L+ + G +MA E
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILH 193
Query: 529 GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD---- 583
+ +SDV+S+G+ E+ G KP +D ++ ++
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP----------------YDGIPASEISSILEKGER 237
Query: 584 ---PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAPLPALPPKMPV 638
P +C + +M + C D + RP R++I + P L +
Sbjct: 238 LPQPPICTI----DVYMIM---VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 290
Query: 639 PTYLSPP 645
+L P
Sbjct: 291 RMHLPSP 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY---IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLV 412
++ +G+G FG VY G + + AVK +++ + ++ +E I+ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 413 QLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
LLG C + L+V +M +G L + + E T + +A G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS--- 146
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECA 526
+ VHRD+ + N MLD F K+ DFGLAR + +V T +MA E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMALESL 204
Query: 527 TTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585
T K + +SDV+SFG++ E+ G P L G+ L P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRRLLQ--PE 255
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
C D + +M L C HP +RPS +++ ++
Sbjct: 256 YCPD----PLYEVM---LKCWHPKAEMRPSFSELVSRIS 287
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 44/284 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSY---IAVKRVSQG---SKQGIKEYASEVKIISRLRHRN 410
+KLG G FG V +G + + +AVK + + + ++ EV + L HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
L++L G + +V E P GSL L K + A +A G+ YL+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-- 139
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATT 528
+ +HRD+ + N++L + KIGDFGL R + + + APE T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 529 GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD---- 583
S SD + FG+ E+ G++P W ++L +D
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHKIDKEGE 242
Query: 584 ----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
P C I +M + C RP+ + L
Sbjct: 243 RLPRPEDCPQ----DIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 89/306 (29%), Positives = 135/306 (44%), Gaps = 54/306 (17%)
Query: 327 EYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS 386
E+ + KEL L Q +G+G FG V G +R +AVK +
Sbjct: 10 EFYRSGWA-------LNMKELKL-------LQTIGKGEFGDVMLGDYRGNK--VAVKCIK 53
Query: 387 QGSKQGIKEYASEVKIISRLRHRNLVQLLGWC-HEKKELLLVYEFMPNGSLDSHL-FKEN 444
+ + + +E ++++LRH NLVQLLG EK L +V E+M GSL +L +
Sbjct: 54 NDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 445 SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504
S+L + K + D+ + YL+ VHRD+ + N+++ + AK+ DFGL +
Sbjct: 112 SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168
Query: 505 HAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKA 558
+ G + APE K S +SDV+SFGI+ EI GR P P+
Sbjct: 169 STQ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRI 218
Query: 559 PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
P V + V G ++A P C + +M C H D +RPS Q
Sbjct: 219 PLKDV--VPRV----EKGYKMDA--PDGCPP----AVYEVM---KNCWHLDAAMRPSFLQ 263
Query: 619 VIHVLN 624
+ L
Sbjct: 264 LREQLE 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 86/343 (25%), Positives = 137/343 (39%), Gaps = 59/343 (17%)
Query: 324 GFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNS 378
G + I D E P K + L + LG G FG VY+G +
Sbjct: 57 GKTSSISDLKE-------VPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPL 102
Query: 379 YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLD 437
+AVK + + S+Q ++ E IIS+ H+N+V+ +G + ++ E M G L
Sbjct: 103 QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLK 162
Query: 438 SHL------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---S 488
S L + S L +A+D+A G YL+ E +HRDI + N +L
Sbjct: 163 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 219
Query: 489 NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY-----MAPECATTGKASKESDVYSFGIV 543
AKIGDFG+AR + + G M PE G + ++D +SFG++
Sbjct: 220 GRVAKIGDFGMARDIY--RAGYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 544 ALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVG 602
EI G P P +V L++V G ++ P+ C + R+M
Sbjct: 276 LWEIFSLGYMPY-PSKSNQEV--LEFVTS----GGRMDP--PKNCPG----PVYRIM--- 319
Query: 603 LWCAHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
C RP+ ++ + + P + +P P
Sbjct: 320 TQCWQHQPEDRPNFAIILERIEYCTQDPDV-INTALPIEYGPL 361
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 30/272 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
++LG G FG V+ G++ +AVK + QGS + +E ++ +L+H+ LV+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV 76
Query: 418 CHEKKELLLVYEFMPNGSLDSHL-FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
++ + ++ E+M NGSL L LT +A +A G+ +++E + +H
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIH 132
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATTGKASK 533
RD++++NI++ + KI DFGLARL+E ++ T G + APE G +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 534 ESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
+SDV+SFGI+ EI GR P P +V +Q + G + P C +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPY-PGMTNPEV--IQNL----ERGYRMVR--PDNCPE--- 237
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ +LM C RP+ + VL
Sbjct: 238 -ELYQLM---RLCWKERPEDRPTFDYLRSVLE 265
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 73/303 (24%), Positives = 120/303 (39%), Gaps = 58/303 (19%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+DF + LGQG FG V K + Y A+K++ +++ + SEV +++ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 411 LVQLLG-WCHE------------KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQ 457
+V+ W K L + E+ NG+L + EN + +++ +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH------------ 505
+ L Y+ Q ++HRD+K NI +D + N KIGDFGLA+ V
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 506 -AKGSQTTVLAGTMGYMAPE-CATTGKASKESDVYSFGIVALEIACG------RKPINPK 557
T GT Y+A E TG +++ D+YS GI+ E+ R I K
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 558 APQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR 617
+ D ++ + I L+ D N RP R
Sbjct: 241 LRSVSIEFPPDFDDNK----------MKVEKKI----IRLLIDH-------DPNKRPGAR 279
Query: 618 QVI 620
++
Sbjct: 280 TLL 282
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-42
Identities = 91/309 (29%), Positives = 137/309 (44%), Gaps = 44/309 (14%)
Query: 318 DEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETN 377
E E+ + KEL L Q +G+G FG V G +R
Sbjct: 173 MEGTVAAQDEFYRSGWA-------LNMKELKL-------LQTIGKGEFGDVMLGDYRGNK 218
Query: 378 SYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC-HEKKELLLVYEFMPNGSL 436
+AVK + + + + +E ++++LRH NLVQLLG EK L +V E+M GSL
Sbjct: 219 --VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 437 DSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495
+L S+L + K + D+ + YL+ VHRD+ + N+++ + AK+
Sbjct: 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVS 331
Query: 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA-CGRKPI 554
DFGL + E + T L + + APE K S +SDV+SFGI+ EI GR P
Sbjct: 332 DFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP- 386
Query: 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614
P+ P V + V G ++A P C + +M C H D RP
Sbjct: 387 YPRIPLKDV--VPRV----EKGYKMDA--PDGCPP----AVYDVM---KNCWHLDAATRP 431
Query: 615 SIRQVIHVL 623
+ Q+ L
Sbjct: 432 TFLQLREQL 440
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-42
Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 40/281 (14%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQ 413
D +LG G FG V +G +R I A+K + QG K +E E +I+ +L + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L+G C + + L+LV E G L L + + ++ ++ G+ YL+E +
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KN 456
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY--MAPECATTGKA 531
VHR++ + N++L + AKI DFGL++ + T AG APEC K
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 532 SKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD------- 583
S SDV+S+G+ E G+KP + +++ ++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP----------------YKKMKGPEVMAFIEQGKRMEC 560
Query: 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
P C ++ LM C RP V +
Sbjct: 561 PPECPP----ELYALM---SDCWIYKWEDRPDFLTVEQRMR 594
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 71/307 (23%), Positives = 131/307 (42%), Gaps = 47/307 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYI----AVKRVSQGS-KQGIKEYASEVKIISRLRHRNL 411
+ LG G FG V+KG + I +K + S +Q + + I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+LLG C L LV +++P GSL H+ + L + +A G+ YL+E
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE--- 133
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM---GYMAPECATT 528
+VHR++ + N++L S ++ DFG+A L+ + + + +MA E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP--PDDKQLLYSEAKTPIKWMALESIHF 191
Query: 529 GKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD---- 583
GK + +SDV+S+G+ E+ G +P + ++ + ++
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP----------------YAGLRLAEVPDLLEKGER 235
Query: 584 ---PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAPLPALPPKMPV 638
P++C + +M + C DEN+RP+ +++ + P L K
Sbjct: 236 LAQPQICTI----DVYMVM---VKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRES 288
Query: 639 PTYLSPP 645
++P
Sbjct: 289 GPGIAPG 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 5e-42
Identities = 65/307 (21%), Positives = 115/307 (37%), Gaps = 45/307 (14%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY---IAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLV 412
+ LG+G FG V + ++ + +AVK + + I+E+ E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 413 QLLGWC------HEKKELLLVYEFMPNGSLDSHL-----FKENSLLTWEFRYKIAQDLAS 461
+L+G +++ FM +G L + L + L + + D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-- 519
G+ YL + +HRD+ + N ML + + DFGL+R + S G
Sbjct: 149 GMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY----SGDYYRQGCASKL 201
Query: 520 ---YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGN 575
++A E + SDV++FG+ EI G+ P + L
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-------G 254
Query: 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALPPK 635
G L+ P C + ++ LM C D RPS + L ++
Sbjct: 255 GNRLKQ--PPECME----EVYDLM---YQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
Query: 636 MPVPTYL 642
P Y+
Sbjct: 306 SQDPLYI 312
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 72/285 (25%), Positives = 108/285 (37%), Gaps = 30/285 (10%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEY 396
P P + + F +LG G +G V+K +E AVKR +
Sbjct: 44 PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK 103
Query: 397 ASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR-YK 454
+EV ++ +H V+L E L L E SL H + L E + +
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP-EAQVWG 161
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514
+D L +L Q +VH D+K +NI L K+GDFGL + A +
Sbjct: 162 YLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE- 217
Query: 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574
G YMAPE G +DV+S G+ LE+AC + P +G W
Sbjct: 218 -GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL--PHGGEG--------WQQLR 265
Query: 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
G L L + + + +M+ PD LR + +
Sbjct: 266 QGYLPPEFTAGLSSEL--RSVLVMML------EPDPKLRATAEAL 302
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 18/235 (7%)
Query: 326 SEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV 385
S +E + + + Y+ ++ D LG+G +G VY G IA+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYE-----YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 386 SQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-FKEN 444
+ + + E+ + L+H+N+VQ LG E + + E +P GSL + L K
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 445 SLLTWE--FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLAR 501
L E + Q L GL YL + +VHRDIK N+++++ + KI DFG ++
Sbjct: 116 PLKDNEQTIGFYTKQIL-EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171
Query: 502 LVEHAKGSQTTVLAGTMGYMAPE---CATTGKASKESDVYSFGIVALEIACGRKP 553
+ T GT+ YMAPE G +D++S G +E+A G+ P
Sbjct: 172 RLAGINPCTETF-TGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPP 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 8e-42
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 19/211 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
+ QK+G+G FG E +K ++ S + +E EV +++ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHL-------FKENSLLTWEFRYKIAQDLASG 462
N+VQ E L +V ++ G L + F+E+ +L W Q +
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW-----FVQ-ICLA 137
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L ++ + + ++HRDIKS NI L + ++GDFG+AR++ GT Y++
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLS 193
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKP 553
PE + +SD+++ G V E+ +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-41
Identities = 74/245 (30%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 33 SALTFNYTSFSP---QYDDNITYERAYPDSNRVIQLPANRE-------TAGRATYNQSMR 82
+ + F Y F + IT+ +QL +AG+A+Y++ +
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 83 LWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEP 142
LWD +TG F T F+F++ + + ADGLAFFLAP S + GG +
Sbjct: 62 LWD-STGKAASFYTSFTFLLKNYGAPT-ADGLAFFLAPVDSSVKD-YGGFLGLFRHETAA 118
Query: 143 LNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSW-WSDVKSGRRNEAWISY 199
S VAVEFD ++N DP + H+GID+NS+ S W D A I+Y
Sbjct: 119 DPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITY 178
Query: 200 NSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF 259
++ + L+V + + L + VDL + LP+ V GFS G + I SW F
Sbjct: 179 DARSKILTVLLSYEHGRDYI---LSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSWHF 234
Query: 260 NSSLE 264
S+L+
Sbjct: 235 FSTLD 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 44/288 (15%)
Query: 358 QKLGQGGFGGVYKGFFRETNSY---IAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLV 412
+ LG+G FG V +G ++ + +AVK + S++ I+E+ SE + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 413 QLLGWC-----HEKKELLLVYEFMPNGSLDSHLFK-----ENSLLTWEFRYKIAQDLASG 462
+LLG C + +++ FM G L ++L + + K D+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG--- 519
+ YL + +HRD+ + N ML + + DFGL++ + S G +
Sbjct: 160 MEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----SGDYYRQGRIAKMP 212
Query: 520 --YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNG 576
++A E + +SDV++FG+ EIA G P G V + ++D +G
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-----PG-VQNHE-MYDYLLHG 265
Query: 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
L+ P C D ++ +M C D RP+ + L
Sbjct: 266 HRLKQ--PEDCLD----ELYEIM---YSCWRTDPLDRPTFSVLRLQLE 304
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 50/294 (17%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
++LG+ FG VYKG E +A+K + +E+ E + +RL+H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL---------------FKENSLLTWEFRYKIA 456
V LLG + + L +++ + +G L L S L +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
+A+G+ YL VVH+D+ + N+++ N KI D GL R V +
Sbjct: 135 AQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYKLL 187
Query: 517 TMG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVW 570
+MAPE GK S +SD++S+G+V E+ G +P V ++ +
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDV--VEMI- 243
Query: 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
N ++L P C + LM + C + + RP + + L
Sbjct: 244 ---RNRQVLPC--PDDCPA----WVYALM---IECWNEFPSRRPRFKDIHSRLR 285
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
KLGQG FG V+ G + T +A+K + G+ + + E +++ +LRH LVQL
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
E+ + +V E+M GSL L E L +A +ASG+ Y++ VH
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD++++NI++ N K+ DFGLARL+E + + + + APE A G+ + +SD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 537 VYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595
V+SFGI+ E+ GR P P +V L V G + P C + +
Sbjct: 364 VWSFGILLTELTTKGRVP-YPGMVNREV--LDQV----ERGYRMPC--PPECPE----SL 410
Query: 596 ERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
LM C + RP+ + L
Sbjct: 411 HDLM---CQCWRKEPEERPTFEYLQAFLE 436
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 73/272 (26%), Positives = 130/272 (47%), Gaps = 30/272 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G FG V+ + + +AVK + GS + + +E ++ L+H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAV 251
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
K+ + ++ EFM GSL L E S + +A G+ ++++ + +H
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG---YMAPECATTGKASK 533
RD++++NI++ ++ KI DFGLAR++E ++ T G + APE G +
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 534 ESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
+SDV+SFGI+ +EI GR P P +V ++ + G + P C +
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP-YPGMSNPEV--IRAL----ERGYRMPR--PENCPE--- 412
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ +M + C RP+ + VL+
Sbjct: 413 -ELYNIM---MRCWKNRPEERPTFEYIQSVLD 440
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 63/293 (21%), Positives = 118/293 (40%), Gaps = 59/293 (20%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
DF + + +G GGFG V+K R +KRV +++ +E VK +++L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66
Query: 412 VQLLG----------------WCHEKKELLLVYEFMPNGSLDSHL-------FKENSLLT 448
V G + K L + EF G+L+ + + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 449 WEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
Q + G+ Y+ + +++RD+K SNI L KIGDFGL +++
Sbjct: 127 L-----FEQ-ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW 568
+ GT+ YM+PE ++ KE D+Y+ G++ E+ + L+
Sbjct: 178 RTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFTDLR- 232
Query: 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+G + + D + + +++L+ RP+ +++
Sbjct: 233 ------DGIISDIFDKKE-KTL----LQKLL-------SKKPEDRPNTSEILR 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-41
Identities = 82/346 (23%), Positives = 145/346 (41%), Gaps = 70/346 (20%)
Query: 312 RKRKEGDEEDNQGFSEY---IDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGV 368
R D G SEY D ++E FP +L L + LG+G FG V
Sbjct: 52 RLSSTADTPMLAGVSEYELPEDPKWE-------FPRDKLTL-------GKPLGEGCFGQV 97
Query: 369 YKG-------FFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCH 419
+ +AVK + +++ + + SE++++ + +H+N++ LLG C
Sbjct: 98 VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157
Query: 420 EKKELLLVYEFMPNGSLDSHL---------------FKENSLLTWEFRYKIAQDLASGLL 464
+ L ++ E+ G+L +L +T++ LA G+
Sbjct: 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 217
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG----- 519
YL Q +HRD+ + N+++ N KI DFGLAR + + T G
Sbjct: 218 YLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NIDYYKKTTNGRLPVK 270
Query: 520 YMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKL 578
+MAPE + +SDV+SFG++ EI G P G + + + ++ L G
Sbjct: 271 WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-----PG-IPVEE-LFKLLKEGHR 323
Query: 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ P C + ++ +M C H + RP+ +Q++ L+
Sbjct: 324 MDK--PANCTN----ELYMMM---RDCWHAVPSQRPTFKQLVEDLD 360
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 63/326 (19%), Positives = 112/326 (34%), Gaps = 48/326 (14%)
Query: 336 GAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE 395
G F + + + QKLG+GGF V + A+KR+ +Q +E
Sbjct: 13 GRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREE 72
Query: 396 YASEVKIISRLRHRNLVQLLGWCHEKK----ELLLVYEFMPNGSLDSHL---------FK 442
E + H N+++L+ +C ++ E L+ F G+L + +
Sbjct: 73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 443 ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502
E+ +L + + GL + + HRD+K +NI+L + D G
Sbjct: 133 EDQIL------WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 503 VEHAKGSQTTVLA--------GTMGYMAPE---CATTGKASKESDVYSFGIVALEIACGR 551
L T+ Y APE + + +DV+S G V + G
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 552 KPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDEN 611
P + +G S+ V +L PR ++ + P +
Sbjct: 244 GPYDMVFQKGD-SVALAV-----QNQLSIPQSPRHSSAL------WQLLNSMMTVDPHQ- 290
Query: 612 LRPSIRQVI-HVLNFEAPLPALPPKM 636
RP I ++ + + P P
Sbjct: 291 -RPHIPLLLSQLEALQPPAPGQHTTQ 315
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-40
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 24/269 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
KLGQG FG V+ G + T +A+K + G+ + + E +++ +LRH LVQL
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
E+ + +V E+M GSL L E L +A +ASG+ Y++ VH
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD++++NI++ N K+ DFGLARL+E + + + + APE A G+ + +SD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 537 VYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQI 595
V+SFGI+ E+ GR P P +V L V G + P C + +
Sbjct: 447 VWSFGILLTELTTKGRVP-YPGMVNREV--LDQV----ERGYRMPC--PPECPE----SL 493
Query: 596 ERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
LM C + RP+ + L
Sbjct: 494 HDLM---CQCWRKEPEERPTFEYLQAFLE 519
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 82/335 (24%), Positives = 136/335 (40%), Gaps = 72/335 (21%)
Query: 325 FSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSY 379
F D ++E FP K L L + LG+G FG V K +
Sbjct: 10 FKILEDPKWE-------FPRKNLVL-------GKTLGEGEFGKVVKATAFHLKGRAGYTT 55
Query: 380 IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDS 438
+AVK + + S +++ SE ++ ++ H ++++L G C + LLL+ E+ GSL
Sbjct: 56 VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 439 HL-----------------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
L + LT A ++ G+ YL E +V
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV 172
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGK 530
HRD+ + NI++ KI DFGL+R V + + + + G +MA E
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVY----EEDSYVKRSQGRIPVKWMAIESLFDHI 228
Query: 531 ASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
+ +SDV+SFG++ EI G P G + + +++L G +E P C +
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPY-----PG-IPPER-LFNLLKTGHRMER--PDNCSE 279
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ RLM L C + + RP + L
Sbjct: 280 ----EMYRLM---LQCWKQEPDKRPVFADISKDLE 307
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 76/323 (23%), Positives = 127/323 (39%), Gaps = 62/323 (19%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAV 382
++++E FP L + LG G FG V + + +AV
Sbjct: 36 PYNEKWE-------FPRNNLQF-------GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV 81
Query: 383 KRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL 440
K + + SE+KI+S L +H N+V LLG C +L++ E+ G L + L
Sbjct: 82 KMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 441 -------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
NS + + +A G+ +L + +HRD+ + N++L
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT 198
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVYSFGI 542
+ AKIGDFGLAR + + + + +MAPE + +SDV+S+GI
Sbjct: 199 NGHVAKIGDFGLARDIM----NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 543 VALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIV 601
+ EI G P G + + + L +G + P I +M
Sbjct: 255 LLWEIFSLGLNPY-----PGILVNSK-FYKLVKDGYQMAQ--PAFAPK----NIYSIM-- 300
Query: 602 GLWCAHPDENLRPSIRQVIHVLN 624
C + RP+ +Q+ L
Sbjct: 301 -QACWALEPTHRPTFQQICSFLQ 322
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 80/326 (24%), Positives = 129/326 (39%), Gaps = 65/326 (19%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAV 382
Y ++E FP L L + LG+G FG V + T +AV
Sbjct: 17 YDASKWE-------FPRDRLKL-------GKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 383 KRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWC-HEKKELLLVYEFMPNGSLDSH 439
K + +G + + SE+KI+ + H N+V LLG C L+++ EF G+L ++
Sbjct: 63 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 122
Query: 440 L---------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNI 484
L LT E + +A G+ +L + +HRD+ + NI
Sbjct: 123 LRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 179
Query: 485 MLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVYS 539
+L KI DFGLAR + + +MAPE + +SDV+S
Sbjct: 180 LLSEKNVVKICDFGLARDIY----KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 235
Query: 540 FGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERL 598
FG++ EI G P G V + + G + A P ++ +
Sbjct: 236 FGVLLWEIFSLGASPY-----PG-VKIDEEFCRRLKEGTRMRA--PDYTTP----EMYQT 283
Query: 599 MIVGLWCAHPDENLRPSIRQVIHVLN 624
M L C H + + RP+ +++ L
Sbjct: 284 M---LDCWHGEPSQRPTFSELVEHLG 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 58/301 (19%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNL 411
+ +G+G FG V++ E + +AVK + + S ++ E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHL-----------------------FKENSLLT 448
V+LLG C K + L++E+M G L+ L L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 449 WEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
+ IA+ +A+G+ YL E + VHRD+ + N ++ N KI DFGL+R + A
Sbjct: 173 CAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD- 228
Query: 509 SQTTVLAGTMGY-----MAPECATTGKASKESDVYSFGIVALEIA-CGRKPINPKAPQGQ 562
A M PE + + ESDV+++G+V EI G +P
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY------YG 279
Query: 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
++ + V +G +L P C ++ LM C RPS + +
Sbjct: 280 MAHEE-VIYYVRDGNILAC--PENCPL----ELYNLM---RLCWSKLPADRPSFCSIHRI 329
Query: 623 L 623
L
Sbjct: 330 L 330
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 80/335 (23%), Positives = 143/335 (42%), Gaps = 70/335 (20%)
Query: 323 QGFSEY---IDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKG-------F 372
G SEY D ++E FP +L L + LG+G FG V
Sbjct: 17 AGVSEYELPEDPKWE-------FPRDKLTL-------GKPLGEGAFGQVVMAEAVGIDKD 62
Query: 373 FRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEF 430
+ +AVK + +++ + + SE++++ + +H+N++ LLG C + L ++ E+
Sbjct: 63 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 122
Query: 431 MPNGSLDSHL---------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
G+L +L +T++ LA G+ YL Q +
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCI 179
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGK 530
HRD+ + N+++ N KI DFGLAR + + T G +MAPE
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDIN----NIDYYKKTTNGRLPVKWMAPEALFDRV 235
Query: 531 ASKESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
+ +SDV+SFG++ EI G P G + + + ++ L G ++ P C +
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPY-----PG-IPVEE-LFKLLKEGHRMDK--PANCTN 286
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ +M C H + RP+ +Q++ L+
Sbjct: 287 ----ELYMMM---RDCWHAVPSQRPTFKQLVEDLD 314
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 67/317 (21%), Positives = 127/317 (40%), Gaps = 53/317 (16%)
Query: 320 EDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSY 379
++ ++ ++E + + L + +G+G FG V++G + +
Sbjct: 372 DEEDTYTMPSTRDYE-------IQRERIEL-------GRCIGEGQFGDVHQGIYMSPENP 417
Query: 380 ---IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGS 435
+A+K S +++ E + + H ++V+L+G + + ++ E G
Sbjct: 418 AMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGE 476
Query: 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495
L S L L A L++ L YL+ + VHRDI + N+++ SN K+G
Sbjct: 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLG 533
Query: 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIA-CGRKPI 554
DFGL+R +E + + + + +MAPE + + SDV+ FG+ EI G KP
Sbjct: 534 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP- 592
Query: 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVD-------PRLCRDFDGQQIERLMIVGLWCAH 607
+ N ++ ++ P C + LM C
Sbjct: 593 ---------------FQGVKNNDVIGRIENGERLPMPPNCPP----TLYSLM---TKCWA 630
Query: 608 PDENLRPSIRQVIHVLN 624
D + RP ++ L+
Sbjct: 631 YDPSRRPRFTELKAQLS 647
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 10/205 (4%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEY-ASEVKIISRLRH 408
DF + LG+G FG VY +++ +A+K + +Q K G++ EV+I S LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
N+++L G+ H+ + L+ E+ P G++ L K + I + LA+ L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHS 127
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ V+HRDIK N++L S KI DFG + HA S+ T L GT+ Y+ PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 529 GKASKESDVYSFGIVALEIACGRKP 553
++ D++S G++ E G+ P
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 58/301 (19%), Positives = 125/301 (41%), Gaps = 37/301 (12%)
Query: 337 AGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIK 394
G + ++ +++ ++ +++G GG V++ E A+K V+ + Q +
Sbjct: 13 LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLD 71
Query: 395 EYASEVKIISRLRHRNL--VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR 452
Y +E+ +++L+ + ++L + + + +V E N L+S L K+ S+ WE +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK 130
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQT 511
+++ + + + +VH D+K +N ++ K+ DFG+A +
Sbjct: 131 S-YWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 185
Query: 512 TVLAGTMGYMAPE-----------CATTGKASKESDVYSFGIVALEIACGRKPINPKAPQ 560
GT+ YM PE + K S +SDV+S G + + G+ P
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QII 243
Query: 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
Q+S L + D + + + +D ++ + D R SI +++
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEK-DLQDV----LKCCLKR-------DPKQRISIPELL 291
Query: 621 H 621
Sbjct: 292 A 292
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-39
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 22/217 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
D+ +G G +G K + + K + G ++ + SEV ++ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 410 NLVQLLGWCHEK--KELLLVYEFMPNGSLDSHL---------FKENSLLTWEFRYKIAQD 458
N+V+ ++ L +V E+ G L S + E +L + Q
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-----MTQ- 119
Query: 459 LASGLLYL--QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
L L + + V+HRD+K +N+ LD N K+GDFGLAR++ H S G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFVG 178
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T YM+PE +++SD++S G + E+ P
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 57/296 (19%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLV 412
+G+G FG V K ++ + A+KR+ + SK +++A E++++ +L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHL---------------FKENSLLTWEFRYKIAQ 457
LLG C + L L E+ P+G+L L S L+ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
D+A G+ YL ++ +HRD+ + NI++ N+ AKI DFGL+R E T
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-------KKT 199
Query: 518 MG-----YMAPECATTGKASKESDVYSFGIVALEIA-CGRKP---INPKAPQGQVSLLQW 568
MG +MA E + SDV+S+G++ EI G P +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----------AE 249
Query: 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+++ G LE P C D ++ LM C RPS Q++ LN
Sbjct: 250 LYEKLPQGYRLEK--PLNCDD----EVYDLM---RQCWREKPYERPSFAQILVSLN 296
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 73/326 (22%), Positives = 125/326 (38%), Gaps = 66/326 (20%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKG-----FFRETNSYIAV 382
D ++E FP L+ + LG G FG V + + +AV
Sbjct: 13 PYDHKWE-------FPRNRLSF-------GKTLGAGAFGKVVEATAYGLIKSDAAMTVAV 58
Query: 383 KRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL 440
K + + SE+K++S L H N+V LLG C L++ E+ G L + L
Sbjct: 59 KMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 441 -----------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483
+ L E + +A G+ +L + +HRD+ + N
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175
Query: 484 IMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVY 538
I+L KI DFGLAR ++ + + + +MAPE + ESDV+
Sbjct: 176 ILLTHGRITKICDFGLARDIK----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 539 SFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIER 597
S+GI E+ G P G + + + + G + + P ++
Sbjct: 232 SYGIFLWELFSLGSSPY-----PG-MPVDSKFYKMIKEGFRMLS--PEHAPA----EMYD 279
Query: 598 LMIVGLWCAHPDENLRPSIRQVIHVL 623
+M C D RP+ +Q++ ++
Sbjct: 280 IM---KTCWDADPLKRPTFKQIVQLI 302
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 16/253 (6%)
Query: 307 LAGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFG 366
LA + + G + + E D+E + E + ++G+G FG
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFG 72
Query: 367 GVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425
V++ ++T AVK+V + + E+ + L +V L G E +
Sbjct: 73 EVHRMKDKQTGFQCAVKKVRLEVFRV------EELVACAGLSSPRIVPLYGAVREGPWVN 126
Query: 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485
+ E + GSL + + L Y + Q L GL YL + ++H D+K+ N++
Sbjct: 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-EGLEYLH---TRRILHGDVKADNVL 182
Query: 486 LDSN-FNAKIGDFGLARLVEHAKGSQTTV----LAGTMGYMAPECATTGKASKESDVYSF 540
L S+ A + DFG A ++ ++ + + GT +MAPE + D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 541 GIVALEIACGRKP 553
+ L + G P
Sbjct: 243 CCMMLHMLNGCHP 255
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 74/327 (22%), Positives = 135/327 (41%), Gaps = 67/327 (20%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKG-------FFRETNSYI 380
D +E P L L + LG+G FG V + +
Sbjct: 59 PEDPRWE-------LPRDRLVL-------GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV 104
Query: 381 AVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDS 438
AVK + +++ + + SE++++ + +H+N++ LLG C + L ++ E+ G+L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 439 HL---------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483
+L L+ + A +A G+ YL + +HRD+ + N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221
Query: 484 IMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVY 538
+++ + KI DFGLAR + T G +MAPE + +SDV+
Sbjct: 222 VLVTEDNVMKIADFGLARDIH----HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 277
Query: 539 SFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIER 597
SFG++ EI G P G V + + ++ L G ++ P C + ++
Sbjct: 278 SFGVLLWEIFTLGGSPY-----PG-VPVEE-LFKLLKEGHRMDK--PSNCTN----ELYM 324
Query: 598 LMIVGLWCAHPDENLRPSIRQVIHVLN 624
+M C H + RP+ +Q++ L+
Sbjct: 325 MM---RDCWHAVPSQRPTFKQLVEDLD 348
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 57/284 (20%), Positives = 117/284 (41%), Gaps = 37/284 (13%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHR 409
++ +++G GG V++ E A+K V+ + Q + Y +E+ +++L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 410 NL--VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+ ++L + + + +V E N L+S L K+ S+ WE + +++ + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKS-YWKNMLEAVHTIH 125
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPE-- 524
+ +VH D+K +N ++ K+ DFG+A + GT+ YM PE
Sbjct: 126 Q---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 525 ---------CATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575
+ K S +SDV+S G + + G+ P Q+S L + D
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHE 239
Query: 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ + + +D ++ + D R SI ++
Sbjct: 240 IEFPDIPEK-DLQDV----LKCCLKR-------DPKQRISIPEL 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKE-YASEVKIISRLRHRNLVQLLG 416
LG+GGF ++ +T A K V S K +E + E+ I L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+ + + +V E SL + +L E RY + Q + G YL V+H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQYLHR---NRVIH 164
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+K N+ L+ + KIGDFGLA VE+ + L GT Y+APE + S E D
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVD 223
Query: 537 VYSFGIVALEIACGRKP 553
V+S G + + G+ P
Sbjct: 224 VWSIGCIMYTLLVGKPP 240
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKE-YASEVKIISRLRHRNLVQLLG 416
LG+G F GVY+ T +A+K + K G+ + +EVKI +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLT-WEFRYKIAQDLASGLLYLQEEWEQCVV 475
+ + + LV E NG ++ +L + E R+ + Q + +G+LYL ++
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ-IITGMLYLHS---HGIL 134
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
HRD+ SN++L N N KI DFGLA ++ T L GT Y++PE AT ES
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLES 193
Query: 536 DVYSFGIVALEIACGRKP 553
DV+S G + + GR P
Sbjct: 194 DVWSLGCMFYTLLIGRPP 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 62/197 (31%), Positives = 93/197 (47%), Gaps = 8/197 (4%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKE-YASEVKIISRLRHRNLVQLLG 416
LG+GGF ++ +T A K V S K +E + E+ I L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476
+ + + +V E SL + +L E RY + Q + G YL V+H
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ-IVLGCQYLHR---NRVIH 138
Query: 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESD 536
RD+K N+ L+ + KIGDFGLA VE+ + L GT Y+APE + S E D
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVD 197
Query: 537 VYSFGIVALEIACGRKP 553
V+S G + + G+ P
Sbjct: 198 VWSIGCIMYTLLVGKPP 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 56/280 (20%), Positives = 113/280 (40%), Gaps = 37/280 (13%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNL--VQ 413
+++G GG V++ E A+K V+ + Q + Y +E+ +++L+ + ++
Sbjct: 62 KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
L + + + +V E N L+S L K+ S+ WE + + + + +
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN-MLEAVHTIHQ---HG 175
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPE-------- 524
+VH D+K +N ++ K+ DFG+A + G + YM PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 525 ---CATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
+ K S +SDV+S G + + G+ P Q+S L + D + +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHEIEFPDI 292
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+ +D ++ + D R SI +++
Sbjct: 293 PEK-DLQDV----LKCCLKR-------DPKQRISIPELLA 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 29/224 (12%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRN 410
DF Q LG+GGFG V++ + + A+KR+ +++ +E EVK +++L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 411 LVQLLGWCHEKKE------------LLLVYEFMPNGSLDSHLFKENSLLTWEFRY--KIA 456
+V+ EK L + + +L + ++ E I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA- 515
+A + +L + ++HRD+K SNI + K+GDFGL ++ + QT +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 516 ----------GTMGYMAPECATTGKASKESDVYSFGIVALEIAC 549
GT YM+PE S + D++S G++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 62/181 (34%), Positives = 97/181 (53%), Gaps = 10/181 (5%)
Query: 35 LTFNYTSFSPQYDDNITYERAYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATGNLTD 93
+F T FSP N+ ++ + + L A + T GRA Y+ + +WD+ TGN+ +
Sbjct: 4 TSFLITKFSPD-QQNLIFQGDGYTTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVAN 62
Query: 94 FTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVE 153
F T F+FVI++ NS ADG FF+AP GGG G+ E + + VAVE
Sbjct: 63 FVTSFTFVINAPNSYNVADGFTFFIAP--VDTKPQTGGGYLGVFNSAEY-DKTTQTVAVE 119
Query: 154 FDVYVNSW---DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAF 210
FD + N+ H+GID+NS+KS SW +++G I++N++T+ L+V+
Sbjct: 120 FDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KLQNGEEANVVIAFNAATNVLTVSL 177
Query: 211 T 211
T
Sbjct: 178 T 178
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 79/332 (23%), Positives = 133/332 (40%), Gaps = 71/332 (21%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAV 382
D ++E FP + L + LG G FG V + +AV
Sbjct: 35 EYDLKWE-------FPRENLEF-------GKVLGSGAFGKVMNATAYGISKTGVSIQVAV 80
Query: 383 KRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL 440
K + + + SE+K++++L H N+V LLG C + L++E+ G L ++L
Sbjct: 81 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 441 ----------------------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
++ ++LT+E A +A G+ +L+ + VHRD
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRD 197
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASK 533
+ + N+++ KI DFGLAR + S + + +MAPE G +
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIM----SDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 534 ESDVYSFGIVALEIA-CGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
+SDV+S+GI+ EI G P G + + + L NG ++ P +
Sbjct: 254 KSDVWSYGILLWEIFSLGVNPY-----PG-IPVDANFYKLIQNGFKMDQ--PFYATE--- 302
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+I +M C D RPS + L
Sbjct: 303 -EIYIIM---QSCWAFDSRKRPSFPNLTSFLG 330
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEY-ASEVKIISRLRH 408
+DF+ + LG+G FG VY ++ +A+K + SQ K+G++ E++I S LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
N++++ + H++K + L+ EF P G L L K + + LA L Y E
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHE 132
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ V+HRDIK N+++ KI DFG + HA + + GT+ Y+ PE
Sbjct: 133 ---RKVIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEG 186
Query: 529 GKASKESDVYSFGIVALEIACGRKP 553
++ D++ G++ E G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-36
Identities = 77/303 (25%), Positives = 121/303 (39%), Gaps = 32/303 (10%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEY-ASEVKIISRLRHRNLVQLL 415
++LG GGFG V + ++T +A+K+ Q +E E++I+ +L H N+V
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 416 ------GWCHEKKELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYL 466
LL E+ G L +L + L R + D++S L YL
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYL 137
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNA---KIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
E ++HRD+K NI+L KI D G A+ ++ +G T GT+ Y+AP
Sbjct: 138 ---HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVGTLQYLAP 192
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAP---------QGQVSLLQWVWDLYG 574
E K + D +SFG +A E G +P P + + DL G
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 575 NGKL-LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPALP 633
K P ++ER + L + R + Q +V F+A L
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPNVGCFQALDSILS 309
Query: 634 PKM 636
K+
Sbjct: 310 LKL 312
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 64/259 (24%), Positives = 115/259 (44%), Gaps = 9/259 (3%)
Query: 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKII 403
K L +DF +LG G G V+K + + +A K + + + E++++
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
+V G + E+ + E M GSLD + K+ + + K++ + GL
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGL 144
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA-RLVEHAKGSQTTVLAGTMGYMA 522
YL+E+ + ++HRD+K SNI+++S K+ DFG++ +L++ S GT YM+
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMS 198
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582
PE S +SD++S G+ +E+A GR PI P + + +
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 583 DPRLCRDFDGQQIERLMIV 601
P + G M +
Sbjct: 259 TPGRPLNKFGMDSRPPMAI 277
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 3e-36
Identities = 44/351 (12%), Positives = 84/351 (23%), Gaps = 59/351 (16%)
Query: 308 AGIGRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGG 367
IG R+E +E E + L+ + L G
Sbjct: 20 ELIGYCREEALKEPAA-MVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSV 77
Query: 368 VYKGFFRETNSYIAVKRVSQGSKQGIKEYAS---EVKIISRLRHRNLVQLLGWCH----- 419
V+ E A+K + G++ E +RL + +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137
Query: 420 ---------------------EKKELLLVYEFM-----PNGSLDSHLFKENSLLTWEFRY 453
LL+ S ++ +
Sbjct: 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALH 197
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513
+ L LQ + +VH N+ + + +GD G++
Sbjct: 198 ILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPA 250
Query: 514 LAGTMGYMAPECATTGKA--SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWD 571
+ + Y E A + + + G+ + C P P + S +
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 572 LYGNGKLLEAVDPRL---CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ G L L + I R + + D R +
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTL----IGRFL-------NFDRRRRLLPLEA 350
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLL 415
LGQG V++G ++T A+K + S + + E +++ +L H+N+V+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 416 G--WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTW---EFRYKIAQDLASGLLYLQEEW 470
+ +L+ EF P GSL + L + ++ EF + +D+ G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHL---R 129
Query: 471 EQCVVHRDIKSSNIML----DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-- 524
E +VHR+IK NIM D K+ DFG AR +E Q L GT Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 525 -----CATTGKA-SKESDVYSFGIVALEIACGRKP 553
K D++S G+ A G P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 65/303 (21%), Positives = 107/303 (35%), Gaps = 69/303 (22%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRL-R 407
T +F++ +K+G G FG V+K R A+KR + + EV + L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL---------FKENSLLTWEFRYKIAQD 458
H ++V+ E +L+ E+ GSL + FKE L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL------LLQ 123
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-------------------FNAKIGDFGL 499
+ GL Y+ +VH DIK SNI + KIGD G
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 500 ARLVEHAKGSQTTVLAGTMGYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINPKA 558
+ S V G ++A E ++D+++ + + A P+
Sbjct: 181 V-----TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--PRN 233
Query: 559 PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF--DGQQIERLMIVGLWCAHPDENLRPSI 616
W G+L PR+ + + ++ ++MI HPD RPS
Sbjct: 234 GDQ--------WHEIRQGRL-----PRIPQVLSQEFTELLKVMI------HPDPERRPSA 274
Query: 617 RQV 619
+
Sbjct: 275 MAL 277
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 33/228 (14%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYAS----------- 398
ND+ + L QG F + + N + A+K+ S K+ ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 399 ----EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY- 453
E++II+ +++ + G E+ ++YE+M N S+ L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 454 ------KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507
I + + + Y+ E + + HRD+K SNI++D N K+ DFG + E+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGES---EYMV 203
Query: 508 GSQTTVLAGTMGYMAPE-CATTGK-ASKESDVYSFGIVALEIACGRKP 553
+ GT +M PE + + D++S GI + P
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 62/340 (18%), Positives = 116/340 (34%), Gaps = 56/340 (16%)
Query: 336 GAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE 395
G F + + L + L +GGF VY+ + A+KR+ ++ +
Sbjct: 12 GRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA 71
Query: 396 YASEVKIISRLR-HRNLVQLLGWC--------HEKKELLLVYEFMPNGSLD-------SH 439
EV + +L H N+VQ + E LL+ E ++
Sbjct: 72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131
Query: 440 LFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499
+++L KI + ++ + + ++HRD+K N++L + K+ DFG
Sbjct: 132 PLSCDTVL------KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184
Query: 500 ARLVEHAKGSQTTVLA-----------GTMGYMAPE-CATTGKA--SKESDVYSFGIVAL 545
A + H + T Y PE ++ D+++ G +
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244
Query: 546 EIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWC 605
+ + P ++ ++ NGK F + R M+
Sbjct: 245 LLCFRQHPFE---DGAKLRIV--------NGKYSIPPHDTQYTVF--HSLIRAMLQ---- 287
Query: 606 AHPDENLRPSIRQVIHVLNFEAPLPALPPKMPVPTYLSPP 645
+ R SI +V+H L A + PK P+ L
Sbjct: 288 --VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQN 325
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 6/203 (2%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+ +K+GQG G VY T +A+++++ + + +E+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V L EL +V E++ GSL + + E + + + ++ L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAA-VCRECLQALEFLH--- 133
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
V+HRDIKS NI+L + + K+ DFG + + ++T+ GT +MAPE T
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKA 192
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
+ D++S GI+A+E+ G P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 24/215 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEY-ASEVKIISRLRHRNLVQLL 415
LGQG V++G ++T A+K + S + E +++ +L H+N+V+L
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 416 GW--CHEKKELLLVYEFMPNGSLDSHLFKENSLLTW---EFRYKIAQDLASGLLYLQEEW 470
+ +L+ EF P GSL + L + ++ EF + +D+ G+ +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVVGGMNHL---R 129
Query: 471 EQCVVHRDIKSSNIML----DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-- 524
E +VHR+IK NIM D K+ DFG AR +E Q L GT Y+ P+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 525 -----CATTGKA-SKESDVYSFGIVALEIACGRKP 553
K D++S G+ A G P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 6/200 (3%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
+ K+G+G G V + + +AVK + +Q + +EV I+ +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
+ +EL ++ EF+ G+L + + + L + + + + L YL Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIAT-VCEAVLQALAYLH---AQG 161
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
V+HRDIKS +I+L + K+ DFG + + ++ GT +MAPE + +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSLYAT 220
Query: 534 ESDVYSFGIVALEIACGRKP 553
E D++S GI+ +E+ G P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 54/211 (25%), Positives = 106/211 (50%), Gaps = 12/211 (5%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
+ +LG G FG VYK +ET + A K + S++ +++Y E++I++ H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
LLG + +L ++ EF P G++D+ + + + LT + + + L +L +
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
++HRD+K+ N+++ + ++ DFG++ + + + GT +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 534 ES-----DVYSFGIVALEIACGRKP---INP 556
D++S GI +E+A P +NP
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 7/202 (3%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRNL 411
F +K+G+G FG V+KG T +A+K + + ++ I++ E+ ++S+ +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
+ G + +L ++ E++ GS L + L + I +++ GL YL
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIAT-ILREILKGLDYLHS--- 137
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+ +HRDIK++N++L + K+ DFG+A + + + T GT +MAPE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 196
Query: 532 SKESDVYSFGIVALEIACGRKP 553
++D++S GI A+E+A G P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 15/221 (6%)
Query: 343 PYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVK 401
P + D D ++G+G +G V K + + +AVKR+ S ++ K+ ++
Sbjct: 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLD 72
Query: 402 IISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR----YKIA 456
++ R +VQ G + + + E M + S D S+L KI
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
L +L+E + ++HRDIK SNI+LD + N K+ DFG++ + + G
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--G 187
Query: 517 TMGYMAPE---CATTGKA-SKESDVYSFGIVALEIACGRKP 553
YMAPE + + + SDV+S GI E+A GR P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS---QGSKQGIKEYASEVKIISRLRHRN 410
F+D +++G G FG VY + +A+K++S + S + ++ EV+ + +LRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+Q G + LV E+ + D + L E + GL YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-VTHGALQGLAYLHS-- 172
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
++HRD+K+ NI+L K+GDFG A + + GT +MAPE
Sbjct: 173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMD 226
Query: 531 AS---KESDVYSFGIVALEIACGRKP---INP 556
+ DV+S GI +E+A + P +N
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVKIISR 405
+ + +D +LG+G +G V K + +AVKR+ + + Q K ++ I R
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 406 L-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDS---HLFKENSLLTWEFRYKIAQDLAS 461
V G + ++ + E M + SLD + + + + KIA +
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL-ARLVEHAKGSQTTVLAGTMGY 520
L +L + V+HRD+K SN+++++ K+ DFG+ LV ++ AG Y
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDID-AGCKPY 175
Query: 521 MAPE---CATTGKA-SKESDVYSFGIVALEIACGRKPINP 556
MAPE K S +SD++S GI +E+A R P +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 66/206 (32%), Positives = 110/206 (53%), Gaps = 9/206 (4%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ 413
F+ +KLG+G +G VYK +ET +A+K+V + ++E E+ I+ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVK 88
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
G + +L +V E+ GS+ + N LT + I Q GL YL
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MR 145
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
+HRDIK+ NI+L++ +AK+ DFG+A + + TV+ GT +MAPE +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 534 ESDVYSFGIVALEIACGRKP---INP 556
+D++S GI A+E+A G+ P I+P
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHP 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 12/222 (5%)
Query: 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV-SQGSKQGIKEYASEVKII 403
+ ND + ++G G G V+K FR+T IAVK++ G+K+ K ++ ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 404 SRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+ +VQ G ++ + E M + + + K+ +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L YL+E+ V+HRD+K SNI+LD K+ DFG++ + K + G YMA
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMA 192
Query: 523 PECATTGKASKE-----SDVYSFGIVALEIACGRKPINPKAP 559
PE +K +DV+S GI +E+A G+ P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 22/219 (10%)
Query: 351 TNDFNDDQKLGQG--GFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRL 406
+ +G+G V ++ T Y+ V+R++ S + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIA---QDLASGL 463
H N+V EL +V FM GS L + + IA Q + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTHFMDGMNELA-IAYILQGVLKAL 141
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL------AGT 517
Y+ VHR +K+S+I++ + + + Q V
Sbjct: 142 DYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 518 MGYMAPE---CATTGKASKESDVYSFGIVALEIACGRKP 553
+ +++PE G +K SD+YS GI A E+A G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVP 236
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHR 409
F + +G G +G VYKG +T A+K + + +E E+ ++ + HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 410 NLVQLLG------WCHEKKELLLVYEFMPNGSLDS--HLFKENSLLTWEFRYKIAQDLAS 461
N+ G +L LV EF GS+ K N+L Y I +++
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILR 140
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
GL +L + V+HRDIK N++L N K+ DFG++ ++ G + T GT +M
Sbjct: 141 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 196
Query: 522 APECATTGKASKES-----DVYSFGIVALEIACGRKP 553
APE + + D++S GI A+E+A G P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQG-IKEYASEVKIISRLRHRNLVQ 413
KLG GG VY N +A+K + K+ +K + EV S+L H+N+V
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
++ E LV E++ +L ++ + + L+ + + G+ + +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
+VHRDIK NI++DSN KI DFG+A+ + +QT + GT+ Y +PE A +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 534 ESDVYSFGIVALEIACGRKP 553
+D+YS GIV E+ G P
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP 211
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 47/378 (12%), Positives = 93/378 (24%), Gaps = 67/378 (17%)
Query: 311 GRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN---DFNDDQKLGQGGFGG 367
R + ++ D P++ + LGQ
Sbjct: 34 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 93
Query: 368 VYKGFFRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLR----------------- 407
+ +ET V + IK+ EV + LR
Sbjct: 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 408 --------HRNLVQLLGW--CHEKKELLLVYEFMPN-----GSLDSHLFKENSLLTWEFR 452
+ ++++ +Y M + G + + L R
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512
++ + L L +VH ++ +I+LD + F + S
Sbjct: 214 LQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG 270
Query: 513 VLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ 567
A + D ++ G+ I C P A G +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG---GSE 327
Query: 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627
W++ P+ R +E + ++ R Q + +E
Sbjct: 328 WIFR-------SCKNIPQPVRAL----LEGFLRY-----PKED--RLLPLQAMETPEYEQ 369
Query: 628 PLPALPPKMPVPTYLSPP 645
L +P+ P
Sbjct: 370 LRTELSAALPLYQTDGEP 387
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 37/236 (15%), Positives = 75/236 (31%), Gaps = 24/236 (10%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEY 396
P P E L + LG+G F VY+ + N ++ E+
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111
Query: 397 ASEVKIISRLR---HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL----FKENSLLTW 449
+++ RL+ ++ + +LV E G+L + + ++
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-----------DSNFNAKIGDFG 498
A + + + + ++H DIK N +L D + + D G
Sbjct: 172 GLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 499 LAR-LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
+ + KG+ T T G+ E + + + D + + G
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 55/287 (19%), Positives = 100/287 (34%), Gaps = 50/287 (17%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNL 411
F LG G G + N +AVKR+ + EV+++ H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNV 80
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
++ +++ + E +L ++ +++ + Q SGL +L
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 472 QCVVHRDIKSSNIML-----DSNFNAKIGDFGLARLVEHAKGSQTTV--LAGTMGYMAPE 524
+VHRD+K NI++ A I DFGL + + + S + + GT G++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 525 ---CATTGKASKESDVYSFGIVALEIACGRKP---------INPKAPQGQVSLLQWVWDL 572
+ D++S G V + N + L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH- 255
Query: 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ + R+ IE+++ D RPS + V
Sbjct: 256 ----------EDVIAREL----IEKMI-------AMDPQKRPSAKHV 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISRLRHRN 410
+D+ + +G G V + +A+KR++ + + + E E++ +S+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK--------IAQDLASG 462
+V K EL LV + + GS+ + K I +++ G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG----LARLVEHAKGSQTTVLAGTM 518
L YL + +HRD+K+ NI+L + + +I DFG LA + + GT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 519 GYMAPECATTGKA-SKESDVYSFGIVALEIACGRKP 553
+MAPE + ++D++SFGI A+E+A G P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 59/338 (17%), Positives = 112/338 (33%), Gaps = 86/338 (25%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRN 410
DF Q +G+GGFG V++ + + A+KR+ +++ +E EVK +++L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 411 LVQLLG------WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR-----------Y 453
+V+ ++E+ ++ + + + R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 454 KIAQDLASGLLYLQEEW---------------------------------------EQCV 474
++ LY+Q + + +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA-----------GTMGYMAP 523
+HRD+K SNI + K+GDFGL ++ + QT + GT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583
E S + D++S G++ E+ + ++ +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIIT---------DVRNLKF 291
Query: 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
P L Q E +M+ P RP +I
Sbjct: 292 PLLFTQKYPQ--EHMMV--QDMLSPSPTERPEATDIIE 325
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-30
Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 11/249 (4%)
Query: 311 GRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFND----DQKLGQGGFG 366
G E + + + + K++ + + + + D ++LG G FG
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFG 171
Query: 367 GVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426
V++ R T + A K V + + E++ +S LRH LV L + E+++
Sbjct: 172 VVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486
+YEFM G L + E++ ++ + + + + GL ++ E VH D+K NIM
Sbjct: 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 288
Query: 487 DSNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVA 544
+ + K+ DFGL ++ V GT + APE A +D++S G+++
Sbjct: 289 TTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
Query: 545 LEIACGRKP 553
+ G P
Sbjct: 347 YILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 54/248 (21%), Positives = 104/248 (41%), Gaps = 17/248 (6%)
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFND----DQKLGQGGFGG 367
+ R + D + ++ +D + K++ + + + D ++LG G FG
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIW------KKYVPQPVEVKQGSVYDYYDILEELGSGAFGV 66
Query: 368 VYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427
V++ + T K ++ +E+ I+++L H L+ L +K E++L+
Sbjct: 67 VHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
EF+ G L + E+ ++ + GL ++ E +VH DIK NIM +
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCE 183
Query: 488 SNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVAL 545
+ + KI DFGLA + V T + APE +D+++ G++
Sbjct: 184 TKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241
Query: 546 EIACGRKP 553
+ G P
Sbjct: 242 VLLSGLSP 249
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIIS 404
++ +KLG G +G V + T+ A+K + + S + EV ++
Sbjct: 32 KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY------KIAQD 458
L H N+++L + +K+ LV E G L + ++ I +
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-------KFNEVDAAVIIKQ 144
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLA 515
+ SG+ YL + +VHRD+K N++L+S + KI DFGL+ + E +
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERL 199
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG 561
GT Y+APE K ++ DV+S G++ + G P + Q
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQ---GSKQGIKEYASEVKII 403
T F+D + LG+G FG V + T AVK +S+ K + EV+++
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY------KIAQ 457
+L H N+++L + +K LV E G L + R+ +I +
Sbjct: 81 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-------RFSEVDAARIIR 133
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVL 514
+ SG+ Y+ + +VHRD+K N++L+S + N +I DFGL+ E +
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDK 188
Query: 515 AGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GT Y+APE G ++ DV+S G++ + G P
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 21/207 (10%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS----------EVKIISRL 406
+ +G+GG G VY+ +A+K +S+ +S E + RL
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSE-------TLSSDPVFRTRMQREARTAGRL 91
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466
+ ++V + + +L + + L + L + L I + + S L
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
HRD+K NI++ ++ A + DFG+A K +Q GT+ YMAPE
Sbjct: 151 HA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 527 TTGKASKESDVYSFGIVALEIACGRKP 553
+ A+ +D+Y+ V E G P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 339 PKRFPYKELALATNDFNDD------QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG 392
P F ++ + N + LG G FG V+K T +A K + +
Sbjct: 70 PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 393 IKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFR 452
+E +E+ ++++L H NL+QL K +++LV E++ G L + E+ LT
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA--KIGDFGLARLVEHAKGSQ 510
+ + G+ ++ + ++H D+K NI+ + KI DFGLAR + +
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REK 244
Query: 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVA 544
V GT ++APE S +D++S G++A
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 50/376 (13%), Positives = 96/376 (25%), Gaps = 78/376 (20%)
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATN---DFNDDQKLGQGGFGGV 368
R + ++ D P++ + LGQ
Sbjct: 30 RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89
Query: 369 YKGFFRETNSYIAVKRVSQGSKQG---IKEYASEVKIISRLR------------------ 407
+ +ET V + IK+ EV + LR
Sbjct: 90 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149
Query: 408 -------HRNLVQLLGWCHEK--KELLLVYEFM--PNGSLDSHLF---KENSLLTWEFRY 453
+ ++++ + +Y M + L + L R
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209
Query: 454 KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV 513
++ + L L +VH ++ +I+LD + F + V
Sbjct: 210 QLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVV 261
Query: 514 LAGTMGYMAPE-----------CATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562
+ + G+ PE + D ++ G+V I C PI A G
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321
Query: 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622
W + P+ R +E + + R Q +
Sbjct: 322 SE-----WIFRSCKNI-----PQPVRAL----LEGFL-------RYPKEDRLLPLQAMET 360
Query: 623 LNFEAPLPALPPKMPV 638
+E L +P+
Sbjct: 361 PEYEQLRTELSAALPL 376
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVS-------------QGSKQGI 393
+ +KLG G +G V + +S A+K + + ++
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 394 KEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY 453
+E +E+ ++ L H N+++L +KK LV EF G L + + ++
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-------KF 143
Query: 454 ------KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVE 504
I + + SG+ YL + +VHRDIK NI+L++ N KI DFGL+
Sbjct: 144 DECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
K + GT Y+APE K +++ DV+S G++ + CG P
Sbjct: 201 --KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 13/206 (6%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQG-IKEYASEVKIISRLRHRNLVQ 413
+ LG GG V+ + +AVK R + E + + L H +V
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 414 LL--GWCHEKKELL--LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
+ G L +V E++ +L + +T + ++ D L
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQAL---NFS 132
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS--QTTVLAGTMGYMAPECAT 527
+ ++HRD+K +NIM+ + K+ DFG+AR + + S QT + GT Y++PE A
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 528 TGKASKESDVYSFGIVALEIACGRKP 553
SDVYS G V E+ G P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 51/258 (19%), Positives = 95/258 (36%), Gaps = 58/258 (22%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVK-----RVSQGSKQGIKEYASEVK 401
+ +GQG +G V +T + A+K ++ Q + + ++ +EV+
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 402 IISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL------------------------- 436
++ +L H N+ +L +++ + LV E G L
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 437 --------DSHLFKENSLLTWEFRY------KIAQDLASGLLYLQEEWEQCVVHRDIKSS 482
+ + +F I + + S L YL Q + HRDIK
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 483 NIMLDSNFNA--KIGDFGLARLVEHAKGSQTTVL---AGTMGYMAPE--CATTGKASKES 535
N + +N + K+ DFGL++ + + AGT ++APE T +
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 536 DVYSFGIVALEIACGRKP 553
D +S G++ + G P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYA---SEVKIISR 405
DF + LG+G F V T+ A+K + K+ I + E ++SR
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE---KRHIIKENKVPYVTRERDVMSR 86
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
L H V+L + ++L + NG L ++ K S R+ A+ + S L Y
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-IVSALEY 145
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTV-LAGTMGYMAPE 524
L + ++HRD+K NI+L+ + + +I DFG A+++ GT Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKP 553
T A K SD+++ G + ++ G P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIIS 404
F + LG+G FG V K R T AVK + + + EV+++
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY------KIAQD 458
+L H N+++L + +V E G L + K R+ +I +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-------RFSEHDAARIIKQ 129
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLA 515
+ SG+ Y+ + +VHRD+K NI+L+S + + KI DFGL+ + + ++
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GT Y+APE G ++ DV+S G++ + G P
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 14/243 (5%)
Query: 318 DEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETN 377
F ++I+ + + + L NDF+ + +G+GGFG VY +T
Sbjct: 155 QNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTG 214
Query: 378 SYIAVKRVSQG---SKQGIKEYASEVKI---ISRLRHRNLVQLLGWCHEKKELLLVYEFM 431
A+K + + KQG +E + +S +V + H +L + + M
Sbjct: 215 KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 274
Query: 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491
G L HL + + R+ A+ + GL ++ + VV+RD+K +NI+LD + +
Sbjct: 275 NGGDLHYHLSQHGVFSEADMRFYAAE-IILGLEHMHN---RFVVYRDLKPANILLDEHGH 330
Query: 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACG 550
+I D GLA + +K + GT GYMAPE G A +D +S G + ++ G
Sbjct: 331 VRISDLGLA--CDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
Query: 551 RKP 553
P
Sbjct: 388 HSP 390
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 26/216 (12%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL 406
T + + LG G F V+ R T A+K + + +E+ ++ ++
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY------KIAQDLA 460
+H N+V L LV + + G L + + Y + Q +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-------YTEKDASLVIQQVL 116
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
S + YL E +VHRD+K N++ + N I DFGL+++ + + GT
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGT 170
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GY+APE SK D +S G++ + CG P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 339 PKRFPYKELA-----LATNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVK-----R 384
K F + +L + D+ + LG G G V F R+T +A++ +
Sbjct: 113 NKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172
Query: 385 VSQGSKQGIKEYAS---EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF 441
+ GS + + E++I+ +L H ++++ + + ++ +V E M G L +
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV 231
Query: 442 KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFG 498
L + + + YL E ++HRD+K N++L S + KI DFG
Sbjct: 232 GNKRLKEATCK-LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 499 LARLVEHAKGSQTTVLAGTMGYMAPE---CATTGKASKESDVYSFGIVALEIACGRKP 553
++++ + S L GT Y+APE T ++ D +S G++ G P
Sbjct: 288 HSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIIS 404
F + LG+G FG V K R T AVK + + + EV+++
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLAS 461
+L H N+++L + +V E G LF + + +I + + S
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
G+ Y+ + +VHRD+K NI+L+S + + KI DFGL+ + + ++ GT
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTA 187
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
Y+APE G ++ DV+S G++ + G P
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 63/305 (20%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRN 410
N ++ LG G G V +AVKR+ E+K+++ H N
Sbjct: 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPN 70
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLD-----SHLFKENSLLTWEFRYK-IAQDLASGLL 464
+++ + L + E N +L ++ EN L E+ + + +ASG+
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDS-------------NFNAKIGDFGLARLVEHAKGSQT 511
+L ++HRD+K NI++ + N I DFGL + ++ + S
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 512 TVL---AGTMGYMAPE-------CATTGKASKESDVYSFGIVALEIACGRKP-------I 554
T L +GT G+ APE T + ++ D++S G V I K
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614
+G SL + L+ + EA D I +++ D RP
Sbjct: 247 ESNIIRGIFSLDEMKC-LHDRSLIAEA------TDL----ISQMI-------DHDPLKRP 288
Query: 615 SIRQV 619
+ +V
Sbjct: 289 TAMKV 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 351 TNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVKRVS-QGSKQGIKEYASEVKIISR 405
+D +KLG G FG V+ R + +K ++ S+ +++ +E++++
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRY------KIAQD 458
L H N++++ + + +V E G L + + + ++ +
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR----GKALSEGYVAELMKQ 132
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLA 515
+ + L Y Q VVH+D+K NI+ + KI DFGLA L + +T A
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA 187
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GT YMAPE + + D++S G+V + G P
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 20/213 (9%)
Query: 351 TNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL 406
D N + +G+G +G V + T A K++ + + + + E++I+ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGL 463
H N+++L + ++ LV E G LF + +I +D+ S +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY 520
Y + V HRD+K N + + + K+ DFGLA + G GT Y
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYY 174
Query: 521 MAPECATTGKASKESDVYSFGIVALEIACGRKP 553
++P+ G E D +S G++ + CG P
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 43/198 (21%), Positives = 79/198 (39%), Gaps = 12/198 (6%)
Query: 353 DFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH 408
+ + + LG+G FG V++ + K V E+ I++ RH
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARH 60
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
RN++ L +EL++++EF+ + + L + L +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
+ H DI+ NI+ + ++ KI +FG AR ++ G +L Y APE
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVH 175
Query: 527 TTGKASKESDVYSFGIVA 544
S +D++S G +
Sbjct: 176 QHDVVSTATDMWSLGTLV 193
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 350 ATNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVK-----RVSQGSKQGIKE----Y 396
+T+ F ++ + LG+G V + + T AVK S + ++E
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 397 ASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKI 455
EV I+ ++ H N++QL LV++ M G L +L ++ +L E R KI
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-KI 129
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA 515
+ L + L + +VHRD+K NI+LD + N K+ DFG + ++ G + +
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVC 184
Query: 516 GTMGYMAPE------CATTGKASKESDVYSFGIVALEIACGRKP 553
GT Y+APE KE D++S G++ + G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVK-----RVSQGSKQGIKEYASEVKIISRLRHRNLVQL 414
+G+G F V T +A+K +++ S Q + EV+I+ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79
Query: 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
+K L L+ E+ G + +L + E R + + S + Y + + +
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR-SKFRQIVSAVQYCHQ---KRI 135
Query: 475 VHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK--AS 532
VHRD+K+ N++LD++ N KI DFG + G Y APE GK
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPE-LFQGKKYDG 192
Query: 533 KESDVYSFGIVALEIACGRKP 553
E DV+S G++ + G P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-27
Identities = 50/141 (35%), Positives = 71/141 (50%), Gaps = 12/141 (8%)
Query: 149 FVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
VAVEFD Y+N DP + H+GID+NS++SK W D ++G+ A ISYNS + L
Sbjct: 3 VVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW--DWQNGKIATAHISYNSVSKRL 60
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMD 266
SV + L Y ++L LPE+V G S +TG D +++SW F SSL
Sbjct: 61 SVTSYYAGSKPAT---LSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLW-- 115
Query: 267 DETTNPVSNPKRRRKNRTALV 287
TN + ++
Sbjct: 116 ---TNVAKKENENKYITRGVL 133
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 18/218 (8%)
Query: 345 KELALATNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEV 400
++L + F D + +G G + + + TN AVK + + SK+ E E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---EI 66
Query: 401 KIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDL 459
+I+ R +H N++ L + K + +V E M G L + ++ E + +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-AVLFTI 125
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA----KIGDFGLARLVEHAKGSQTTVLA 515
+ YL Q VVHRD+K SNI+ +I DFG A+ + G T
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-C 181
Query: 516 GTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T ++APE D++S G++ + G P
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 12/246 (4%)
Query: 313 KRKEGDEEDNQGFSEYID-DEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKG 371
R + F++Y+D F R K + + N F + LG+GGFG V
Sbjct: 146 TRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTK--NTFRQYRVLGKGGFGEVCAC 203
Query: 372 FFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428
R T A K++ + ++G +E +I+ ++ R +V L K L LV
Sbjct: 204 QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 429 EFMPNGSLDSHLFKENSLLTWEFRYKI-AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
M G L H++ E R A ++ GL L + +V+RD+K NI+LD
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLD 320
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
+ + +I D GLA V +G GT+GYMAPE + + D ++ G + E+
Sbjct: 321 DHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 548 ACGRKP 553
G+ P
Sbjct: 379 IAGQSP 384
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEY------ASEVKIISR 405
+ F + +G+G FG V +T A+K ++ KQ E E++I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN---KQKCVERNEVRNVFKELQIMQG 71
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
L H LV L +++++ +V + + G L HL + + I + L L Y
Sbjct: 72 LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-LVMALDY 130
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
LQ Q ++HRD+K NI+LD + + I DF +A ++ + +Q T +AGT YMAPE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPYMAPEM 185
Query: 526 ATTGKA---SKESDVYSFGIVALEIACGRKP 553
++ K S D +S G+ A E+ GR+P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 29/256 (11%)
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFND----DQKLGQGGFGG 367
G E + G Y + +D + +LG+G
Sbjct: 9 SGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSI 68
Query: 368 VYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427
VY+ + T A+K + + K +E+ ++ RL H N+++L E+ LV
Sbjct: 69 VYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 428 YEFMPNGSL-DSHLFKENSLLTWEFRY------KIAQDLASGLLYLQEEWEQCVVHRDIK 480
E + G L D + K Y + + + YL E +VHRD+K
Sbjct: 127 LELVTGGELFDRIVEKG--------YYSERDAADAVKQILEAVAYLHE---NGIVHRDLK 175
Query: 481 SSNIML---DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
N++ + KI DFGL+++VEH + GT GY APE E D+
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233
Query: 538 YSFGIVALEIACGRKP 553
+S GI+ + CG +P
Sbjct: 234 WSVGIITYILLCGFEP 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 26/211 (12%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS---------EVKIISRLRH 408
LG GGFG VY G N +A+K V K I ++ EV ++ ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVE---KDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 409 R--NLVQLLGWCHEKKELLLVYEF-MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
+++LL W +L+ E P L + + +L R + + +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRH 164
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
V+HRDIK NI++D N K+ DFG L+ K + T GT Y PE
Sbjct: 165 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPE 218
Query: 525 CATTGK--ASKESDVYSFGIVALEIACGRKP 553
+ + V+S GI+ ++ CG P
Sbjct: 219 -WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIIS 404
+ F+D+ ++LG+G F V + + T A K + + S + ++ E +I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLAS 461
+L+H N+V+L E+ LV++ + G LF + Q +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+ Y +VHR++K N++L S K+ DFGLA V AGT
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTP 171
Query: 519 GYMAPECATTGKASKESDVYSFGIV 543
GY++PE SK D+++ G++
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 350 ATNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-------- 397
A +F +G+G V + R T AVK + +++ E
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 398 SEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRY-- 453
E I+ ++ H +++ L+ + LV++ M G L D K
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--------ALSE 199
Query: 454 ----KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509
I + L + +L +VHRD+K NI+LD N ++ DFG + +E G
Sbjct: 200 KETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGE 254
Query: 510 QTTVLAGTMGYMAPE------CATTGKASKESDVYSFGIVALEIACGRKP 553
+ L GT GY+APE T KE D+++ G++ + G P
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 349 LATNDFNDD-------QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK 401
+ + F + LG+G F K +++N AVK +S+ + ++ E+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EIT 57
Query: 402 IISRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRY------K 454
+ H N+V+L H++ LV E + G L + K+ +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-------FSETEASY 110
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAKGSQT 511
I + L S + ++ + VVHRD+K N++ + N KI DFG ARL
Sbjct: 111 IMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T T+ Y APE + D++S G++ + G+ P
Sbjct: 168 TP-CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-26
Identities = 69/247 (27%), Positives = 113/247 (45%), Gaps = 27/247 (10%)
Query: 321 DNQGFSEYID-DEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSY 379
F E++D F R K + + + F D + LG+GGFG V+ + T
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGE--DWFLDFRVLGRGGFGEVFACQMKATGKL 212
Query: 380 IAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSL 436
A K++++ ++G + E KI++++ R +V L K +L LV M G +
Sbjct: 213 YACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI 272
Query: 437 DSHL---------FKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
H+ F+E + AQ + SGL +L + + +++RD+K N++LD
Sbjct: 273 RYHIYNVDEDNPGFQEP-----RAIFYTAQ-IVSGLEHLHQ---RNIIYRDLKPENVLLD 323
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTT-VLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546
+ N +I D GLA VE G T AGT G+MAPE + D ++ G+ E
Sbjct: 324 DDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 547 IACGRKP 553
+ R P
Sbjct: 382 MIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-----------SEVKIISRL 406
LG G FG V+ +E N + VK + K+ + E E+ I+SR+
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIK---KEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGS-LDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
H N++++L + LV E +G L + + + L Y Q L S + Y
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ-LVSAVGY 145
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L+ + ++HRDIK NI++ +F K+ DFG A +E K T GT+ Y APE
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPE- 199
Query: 526 ATTGK--ASKESDVYSFGIVALEIACGRKP 553
G E +++S G+ + P
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 21/220 (9%)
Query: 336 GAGPKRFPYKELALATNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGS 389
G + + A+ F+D+ ++LG+G F V + + T A K + + S
Sbjct: 9 GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 390 KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSL 446
+ ++ E +I +L+H N+V+L E+ LV++ + G LF
Sbjct: 69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREF 124
Query: 447 LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLV 503
+ Q + + Y +VHR++K N++L S K+ DFGLA V
Sbjct: 125 YSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181
Query: 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIV 543
AGT GY++PE SK D+++ G++
Sbjct: 182 N--DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-------EVKIISRLRHRNLV 412
LG+G +G V + ET AVK + K+ ++ + E++++ RLRH+N++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILK---KKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 413 QLLG--WCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQ 467
QL+ + EK+++ +V E+ G + + E + Q L GL YL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQ-LIDGLEYLH 126
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPE 524
Q +VH+DIK N++L + KI G+A + +T+ G+ + PE
Sbjct: 127 S---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPE 181
Query: 525 CATTGK--ASKESDVYSFGIVALEIACGRKP 553
A + + D++S G+ I G P
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 351 TNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVKRVS------QGSKQGIKEYASEV 400
D ++LG G F V K + T A K + +E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLA 460
I+ ++ H N++ L + +++L+ E + G L L ++ SL E I Q +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-IL 125
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDFGLARLVEHAKGSQTTVLAG 516
G+ YL + + H D+K NIML + K+ DFGLA +E G + + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVA 544
T ++APE E+D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 6/152 (3%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYAS-EVKIISRLRHR 409
+ K+G+G +G V+K R+T +A+K+ + IK+ A E++++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
NLV LL K+ L LV+E+ + ++ L + + I + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
+HRD+K NI++ + K+ DFG AR
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYAS-EVKIISRLRHR 409
+ + +G+G +G V K ++T +A+K+ + + +K+ A E+K++ +LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 410 NLVQLLGWCHEKKELLLVYEFMPN---GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466
NLV LL C +KK LV+EF+ + L+ N L + + Q + +G+ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQ-IINGIGFC 140
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
++HRDIK NI++ + K+ DFG AR
Sbjct: 141 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHRNLVQLLGWC 418
LG+G +G V R T +AVK V E E+ I L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
E L E+ G L + + + + + Q L +G++YL + HRD
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLHG---IGITHRD 130
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA---GTMGYMAPECATTGK--ASK 533
IK N++LD N KI DFGLA + + ++ +L GT+ Y+APE + ++
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPE-LLKRREFHAE 187
Query: 534 ESDVYSFGIVALEIACGRKP 553
DV+S GIV + G P
Sbjct: 188 PVDVWSCGIVLTAMLAGELP 207
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 65/308 (21%), Positives = 117/308 (37%), Gaps = 55/308 (17%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS---------EVKIISRLR- 407
LG+GGFG V+ G +A+K + + + ++ EV ++ ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIP---RNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 408 ---HRNLVQLLGWCHEKKELLLVYEF-MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
H +++LL W ++ +LV E +P L ++ ++ L R + + +
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAI 152
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ + VVHRDIK NI++D AK+ DFG L+ T GT Y
Sbjct: 153 QHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSP 206
Query: 523 PECATTGK-ASKESDVYSFGIVALEIACGRKPIN--PKAPQGQVSLLQWVWDLYGNGKLL 579
PE + + + + V+S GI+ ++ CG P + + ++ V
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV---------- 256
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV--LNFEAPLPALPPKMP 637
C I R + P RPS+ +++ + A L P
Sbjct: 257 ----SPDCCAL----IRRCLAP-----KPSS--RPSLEEILLDPWMQTPAEDVPLNPSKG 301
Query: 638 VPTYLSPP 645
P L+
Sbjct: 302 GPAPLAWS 309
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 351 TNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVK------RVSQGSKQGIKEYASEV 400
D ++LG G F V K + T A K + +E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLA 460
I+ ++ H N++ L + +++L+ E + G L L ++ SL E I Q +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-IL 125
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDFGLARLVEHAKGSQTTVLAG 516
G+ YL + + H D+K NIML + K+ DFGLA +E G + + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFG 180
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVA 544
T ++APE E+D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 17/176 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRNLVQLLG 416
+KLG G + VYKG + T Y+A+K V S++G A E+ ++ L+H N+V+L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 417 WCHEKKELLLVYEFMPN---GSLDSH--LFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
H + +L LV+EFM N +DS L +Y Q L GL + E
Sbjct: 71 VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ-LLQGLAFCHENK- 128
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGYMAPE 524
++HRD+K N++++ K+GDFGLAR A G + T+ Y AP+
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLAR----AFGIPVNTFSSEVVTLWYRAPD 178
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVK-----RVSQGSKQGIKEYAS---EVKIISRLRH 408
+ LG G G V F R+T +A+K + + GS + + E++I+ +L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSL-----DSHLFKENSLLTWEFRYKIAQDLASGL 463
++++ + + ++ +V E M G L + KE + + +
Sbjct: 75 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAV 127
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY 520
YL E ++HRD+K N++L S + KI DFG ++++ + S L GT Y
Sbjct: 128 QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTY 182
Query: 521 MAPE---CATTGKASKESDVYSFGIVALEIACGRKP 553
+APE T ++ D +S G++ G P
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 23/211 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK-----RVSQGSKQGIKEYASEVKIISRLRHRNLV 412
+ +G+G F V + RET AVK + + ++ E I L+H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 413 QLLGWCHEKKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRY------KIAQDLASGLLY 465
+LL L +V+EFM L + + ++ F Y + + L Y
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA----GFVYSEAVASHYMRQILEALRY 145
Query: 466 LQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ ++HRD+K ++L S + K+G FG+A + + GT +MA
Sbjct: 146 CH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMA 201
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKP 553
PE K DV+ G++ + G P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 12/177 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRN 410
+ KLG+G + VYKG + T++ +A+K + ++G A EV ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V L H +K L LV+E++ L +L +++ L GL Y +
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGYMAPE 524
V+HRD+K N++++ K+ DFGLAR AK T T+ Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYDNEVVTLWYRPPD 170
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHRNLVQLLGWC 418
LG+G +G V R T +AVK V E E+ I L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478
E L E+ G L + + + + + Q L +G++YL + HRD
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ-LMAGVVYLHG---IGITHRD 130
Query: 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLA---GTMGYMAPECATTGK--ASK 533
IK N++LD N KI DFGLA + + ++ +L GT+ Y+APE + ++
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRY--NNRERLLNKMCGTLPYVAPE-LLKRREFHAE 187
Query: 534 ESDVYSFGIVALEIACGRKP 553
DV+S GIV + G P
Sbjct: 188 PVDVWSCGIVLTAMLAGELP 207
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 51/234 (21%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK--------RVSQGSKQGIKEYAS----------- 398
++G+G +G V + N+Y A+K R + ++
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 399 -------EVKIISRLRHRNLVQLLGWCHE------KKELLLVYEFMPNGSLDSHLF---K 442
E+ I+ +L H N+V+L E + L +V+E + G +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGP----VMEVPT 130
Query: 443 ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502
L + R QDL G+ YL Q ++HRDIK SN+++ + + KI DFG++
Sbjct: 131 LKPLSEDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 503 VEHAKGSQTTVLAGTMGYMAPE-CATTGK--ASKESDVYSFGIVALEIACGRKP 553
+ + + GT +MAPE + T K + K DV++ G+ G+ P
Sbjct: 187 FKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 41/212 (19%), Positives = 73/212 (34%), Gaps = 20/212 (9%)
Query: 357 DQKLGQGGFGGVYKGF-FRETNSYIAVKRV-SQGSKQGIKEYASEVKIISRLRHRNLVQL 414
+ GG G +Y + +K + G + +E + ++ + H ++VQ+
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 415 L-----GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
H +V E++ SL L ++ L YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHS- 200
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
+V+ D+K NIML K+ D G + + L GT G+ APE
Sbjct: 201 --IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLYGTPGFQAPEIVR-T 251
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQG 561
+ +D+Y+ G + N + G
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G V+K RET+ +A+KRV +G+ A E+ ++ L+H+N+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475
H K+L LV+EF L + N L E L GL + V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT---TVLAGTMGYMAPECATTGKA- 531
HRD+K N++++ N K+ +FGLAR A G + T+ Y P+ K
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 532 SKESDVYSFGIVALEIACGRKPINP 556
S D++S G + E+A +P+ P
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFP 204
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 353 DFND----DQKLGQGGFGGVYKGFFRETNSYIAVK------RVSQGSKQGIKEYASEVKI 402
D ++LG G F V K + T A K S +E EV I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 403 ISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+ +RH N++ L K +++L+ E + G L L ++ SL E + + + G
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-QFLKQILDG 120
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+ YL + + H D+K NIML N K+ DFG+A +E G++ + GT
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTP 175
Query: 519 GYMAPECATTGKASKESDVYSFGIVA 544
++APE E+D++S G++
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 24/223 (10%)
Query: 351 TNDFNDD-----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR 405
+ F D LG+G V T+ AVK + + EV+++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 406 LR-HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
+ HRN+++L+ + E+ LV+E M GS+ SH+ K E + QD+AS L
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-VVVQDVASALD 125
Query: 465 YLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAKGSQTTV------LA 515
+L + + HRD+K NI+ + KI DF L ++
Sbjct: 126 FLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 516 GTMGYMAPE-----CATTGKASKESDVYSFGIVALEIACGRKP 553
G+ YMAPE K D++S G++ + G P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 20/215 (9%)
Query: 351 TNDFNDD----QKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIIS 404
F ++ ++LG+G F V + A + S + ++ E +I
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 405 RLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLAS 461
L+H N+V+L E+ L+++ + G L F + Q +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQILE 121
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
+L+ + VVHR++K N++L S K+ DFGLA VE + + AGT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GY++PE K D+++ G++ + G P
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/206 (21%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 351 TNDFND-----DQKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKII 403
+FN+ ++LG+G F V + + T A K + + + E E+ ++
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 404 SRLRHR-NLVQLLGWCHEKKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRYKIAQDLAS 461
+ ++ L E++L+ E+ G + L + +++ ++ + +
Sbjct: 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
G+ YL + +VH D+K NI+L + KI DFG++R + H + + GT
Sbjct: 143 GVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTP 197
Query: 519 GYMAPECATTGKASKESDVYSFGIVA 544
Y+APE + +D+++ GI+A
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 25/217 (11%)
Query: 351 TNDFNDD-----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR 405
DD Q LG G G V + F R T A+K + ++ EV +
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--SPKARQ---EVDHHWQ 77
Query: 406 L-RHRNLVQLLGWC----HEKKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRYKIAQDL 459
++V +L H K+ LL++ E M G L + + T +I +D+
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAKGSQTTVLAG 516
+ + +L + HRD+K N++ + + K+ DFG A+ + T
Sbjct: 138 GTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTP-CY 191
Query: 517 TMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T Y+APE K K D++S G++ + CG P
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS------EVKIISRLRHRNLVQ 413
LG G FG V G + T +AVK ++ +Q I+ E++ + RH ++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 414 LLGWCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
L ++ + +V E++ G L ++ K + E R Q + S + Y
Sbjct: 76 L----YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ-ILSAVDYCHR- 129
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
VVHRD+K N++LD++ NAKI DFGL+ ++ + +T+ G+ Y APE +G
Sbjct: 130 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISG 184
Query: 530 K--ASKESDVYSFGIVALEIACGRKP 553
+ A E D++S G++ + CG P
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-----EVKIISRL 406
+ LG+G F VYK + TN +A+K++ G + K+ + E+K++ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYL 466
H N++ LL K + LV++FM L+ + + +LT GL YL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
+ W ++HRD+K +N++LD N K+ DFGLA+
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 59/246 (23%), Positives = 111/246 (45%), Gaps = 21/246 (8%)
Query: 314 RKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFF 373
+K ++E + F ++F + +L + F+ + LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 374 RETNSYIAVKRVSQGSKQGI---KEYA---SEVKIISRLRHRNLVQLLGWCHEKKELLLV 427
+E+ ++ A+K + KQ + K+ +E +I+ + LV+L + L +V
Sbjct: 63 KESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
E++ G + SHL + R+ AQ + YL +++RD+K N+++D
Sbjct: 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
++ DFG A+ V+ +T L GT +APE + +K D ++ G++ E+
Sbjct: 176 QQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 548 ACGRKP 553
A G P
Sbjct: 232 AAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 14/177 (7%)
Query: 334 ERGAGPKRFPYKELALATN--DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-K 390
+ GP AT+ + KLG+G +G VYK TN +A+KR+ +
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73
Query: 391 QGIKEYAS-EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTW 449
+G+ A EV ++ L+HRN+++L H L L++E+ N L ++ K +
Sbjct: 74 EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR 132
Query: 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA-----KIGDFGLAR 501
+ + Q L +G+ + +HRD+K N++L + + KIGDFGLAR
Sbjct: 133 VIKSFLYQ-LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G VYK + T +A+K++ + +G+ A E+ ++ L H N+V+LL
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 416 GWCHEKKELLLVYEFMPN---GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
H + +L LV+EF+ +D+ + + + Q L GL +
Sbjct: 69 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQ-LLQGLAFCHSHR-- 123
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
V+HRD+K N+++++ K+ DFGLAR
Sbjct: 124 -VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 351 TNDFND----DQKLGQGGFGGVYKGFFRETNSYIAVKRV------SQGSKQGIKEYASEV 400
+ +D ++LG G F V K + T A K + S ++ EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQ 457
I+ ++H N++ L K +++L+ E + G LF E LT E + +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLK 121
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDS----NFNAKIGDFGLARLVEHAKGSQTTV 513
+ +G+ YL + H D+K NIML KI DFGLA ++ G++
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKN 176
Query: 514 LAGTMGYMAPECATTGKASKESDVYSFGIVA 544
+ GT ++APE E+D++S G++
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 339 PKRFPYKELAL--ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKE 395
K++ E + + K+GQG FG V+K R+T +A+K+V + K+G
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61
Query: 396 YAS-EVKIISRLRHRNLVQLLGWCHEKKE--------LLLVYEFMPN---GSLDSHLFKE 443
A E+KI+ L+H N+V L+ C K + LV++F + G L + L K
Sbjct: 62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK- 120
Query: 444 NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
T ++ Q L +GL Y+ ++HRD+K++N+++ + K+ DFGLAR
Sbjct: 121 ---FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 504 EHAKGSQTTVLAG---TMGYMAPE 524
AK SQ T+ Y PE
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPE 198
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 98.0 bits (243), Expect = 3e-23
Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 7/135 (5%)
Query: 148 PFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHN 205
VAVE D Y N+ DP++ H+GIDI SV+SKK W ++++G+ A I YNS
Sbjct: 3 TIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW--NMQNGKVGTAHIIYNSVDKR 60
Query: 206 LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEM 265
LS + + + Y VDL LPE+V G S +TG+ +I SW F S L+
Sbjct: 61 LSAVVSYPNADSAT---VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKS 117
Query: 266 DDETTNPVSNPKRRR 280
+ + +
Sbjct: 118 NSTHETNALHFMFNQ 132
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 79.9 bits (196), Expect = 5e-17
Identities = 33/129 (25%), Positives = 55/129 (42%), Gaps = 9/129 (6%)
Query: 19 TITISFCLTIIPLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRET 71
+ T +AL F + FS D I A ++ ++L +
Sbjct: 110 SFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSS 169
Query: 72 AGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGG 131
GRA + + +W+ ++ + F F+F+I S +S ADG+AFF++ S IP+ G
Sbjct: 170 VGRALFYAPVHIWE-SSAVVASFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTG 227
Query: 132 GSFGLTKDN 140
GL D
Sbjct: 228 RLLGLFPDA 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 331 DEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK 390
E+ A P K++ L DF + +G+G FG V + + A+K ++ K
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN---K 109
Query: 391 QGI---KEYA---SEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKEN 444
+ E A E ++ + + L + L LV ++ G L + L K
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 445 SLLTWEF-RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
L E R+ +A+ + + + + VHRDIK NI++D N + ++ DFG +
Sbjct: 170 DRLPEEMARFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225
Query: 504 EHAKGSQTTVLAGTMGYMAPE-----CATTGKASKESDVYSFGIVALEIACGRKP 553
Q++V GT Y++PE G+ E D +S G+ E+ G P
Sbjct: 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 15/234 (6%)
Query: 331 DEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-- 388
+F + A P KE+ L +DF + +G+G F V ++T A+K +++
Sbjct: 40 ADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM 99
Query: 389 -SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLL 447
+ + + E ++ R + QL ++ L LV E+ G L + L K +
Sbjct: 100 LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERI 159
Query: 448 TWEF-RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506
E R+ +A+ + + + VHRDIK NI+LD + ++ DFG +
Sbjct: 160 PAEMARFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 507 KGSQTTVLAGTMGYMAPE-------CATTGKASKESDVYSFGIVALEIACGRKP 553
++ V GT Y++PE TG E D ++ G+ A E+ G+ P
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 347 LALATNDFNDD-----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK 401
L + N DD Q LG G G V + F + T A+K + K EV+
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVE 106
Query: 402 IISRL-RHRNLVQLLGWCHE----KKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRYKI 455
+ R + ++V+++ +K LL+V E + G L + + T +I
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHAKGSQTT 512
+ + + YL + HRD+K N++ S N K+ DFG A+ T
Sbjct: 167 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 223
Query: 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
T Y+APE K K D++S G++ + CG P
Sbjct: 224 C--YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 26/206 (12%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS------EVKIISRLRHRNLVQ 413
LG G FG V G T +AVK ++ +Q I+ E++ + RH ++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 414 LLGWCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
L ++ ++ +V E++ G L ++ K L E R Q + SG+ Y
Sbjct: 81 L----YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ-ILSGVDYCHR- 134
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
VVHRD+K N++LD++ NAKI DFGL+ ++ + +T+ G+ Y APE +G
Sbjct: 135 --HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE-VISG 189
Query: 530 K--ASKESDVYSFGIVALEIACGRKP 553
+ A E D++S G++ + CG P
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 20/234 (8%)
Query: 331 DEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-- 388
D F ++L + D+ + +G+G FG V + T A+K +S+
Sbjct: 48 DNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM 107
Query: 389 -SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHL----FKE 443
+ + E I++ +VQL + + L +V E+MP G L + + E
Sbjct: 108 IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE 167
Query: 444 NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503
R+ A+ + L + +HRD+K N++LD + + K+ DFG +
Sbjct: 168 KWA-----RFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 504 EHAKGSQTTVLAGTMGYMAPE----CATTGKASKESDVYSFGIVALEIACGRKP 553
+ GT Y++PE G +E D +S G+ E+ G P
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEY-ASEVKIISRLRHRNLVQLLGWC 418
+G G FG + T +AVK + +G I E E+ LRH N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRF---- 81
Query: 419 HE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCV 474
E L ++ E+ G L + E R+ Q L SG+ Y +
Sbjct: 82 KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ-LLSGVSYCHS---MQI 137
Query: 475 VHRDIKSSNIMLDSNF--NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK-- 530
HRD+K N +LD + KI DFG ++ ++TV GT Y+APE +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE-VLLRQEY 194
Query: 531 ASKESDVYSFGIVALEIACGRKP 553
K +DV+S G+ + G P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYP 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 3e-22
Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 13/149 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLRHRNLVQLL 415
+K+G+G +G VYK A+K++ +GI E+ I+ L+H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 416 GWCHEKKELLLVYEFMPN---GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
H KK L+LV+E + LD E L + + + Q L +G+ Y +
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQ-LLNGIAYCHDRR-- 120
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
V+HRD+K N++++ KI DFGLAR
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 360 LGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS------EVKIISRLRHRNLVQ 413
LG+G FG V +T +A+K +S +Q +K+ E+ + LRH ++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS---RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 414 LLGWCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
L ++ ++++V E+ G L ++ ++ + E R Q + + Y
Sbjct: 74 L----YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ-IICAIEYCHR- 126
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
+VHRD+K N++LD N N KI DFGL+ ++ +T+ G+ Y APE G
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VING 181
Query: 530 K--ASKESDVYSFGIVALEIACGRKP 553
K A E DV+S GIV + GR P
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYA---SEVKIISR 405
DF + LG G FG V+ R Y A+K + K+ + K+ E ++S
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK---KEIVVRLKQVEHTNDERLMLSI 62
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
+ H ++++ G + +++ ++ +++ G L S L K ++ A+ + L Y
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-VCLALEY 121
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L + +++RD+K NI+LD N + KI DFG A+ V T L GT Y+APE
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEV 174
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKP 553
+T +K D +SFGI+ E+ G P
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-22
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHRNLV 412
+ D + +G G FG VY+ ++ +A+K+V Q K + + E++I+ +L H N+V
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 413 QLLGWCHEKKE------LLLVYEFMP---NGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
+L + + E L LV +++P + + +L + + Q L L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ-LFRSL 169
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
Y+ + HRDIK N++LD + K+ DFG A+ + + + + + + Y A
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 224
Query: 523 PE---CATTGKASKESDVYSFGIVALEIACGRKPINP 556
PE AT + DV+S G V E+ +PI P
Sbjct: 225 PELIFGAT--DYTSSIDVWSAGCVLAEL-LLGQPIFP 258
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 49/218 (22%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+ F ++ GQG FG V G + T +A+K+V Q + +E ++ ++ L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPN 80
Query: 411 LVQLLGWCH-----EKKE--LLLVYEFMP---NGSLDSHLFKENSLLTWEFRYKIAQDLA 460
+VQL + + ++++ L +V E++P + ++ ++ + + + Q L
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ-LI 139
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 519
+ L V HRDIK N++++ ++ K+ DFG A+ + ++ + + +
Sbjct: 140 RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--SRY 196
Query: 520 YMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
Y APE + D++S G + E+ +PI
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPIFR 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLRHR 409
+ +K+G+G +G VYK +A+KR+ + +GI A E+ ++ L H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
N+V L+ H ++ L LV+EFM L L + + L L G+ + +
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
++HRD+K N++++S+ K+ DFGLAR
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 21/215 (9%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRH 408
+ +G G +G V + + +A+K++S+ S+ K E+ ++ ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 409 RNLVQLL------GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
N++ LL + LV FM D + +Y + Q L G
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQYLVYQML-KG 138
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
L Y+ VVHRD+K N+ ++ + KI DFGLAR + ++ T T Y A
Sbjct: 139 LKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRA 191
Query: 523 PE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
PE + ++ D++S G + E+ K +
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFK 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRH 408
+ D Q +G G +G V T + +A+K++ + S+ K E++++ +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 409 RNLVQLL------GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWE-FRYKIAQDLAS 461
N++ LL + + LV FM D ++ L + ++ + Q L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRIQFLVYQML-K 139
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
GL Y+ ++HRD+K N+ ++ + KI DFGLAR + S+ T T Y
Sbjct: 140 GLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYR 192
Query: 522 APE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
APE + ++ D++S G + E+ K +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFK 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 15/247 (6%)
Query: 313 KRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGF 372
K++ E D + S + E P + + N+F + LG+G FG V
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM--NEFEYLKLLGKGTFGKVILVK 168
Query: 373 FRETNSYIAVKRVSQGSKQGIKEY------ASEVKIISRLRHRNLVQLLGWCHEKKELLL 426
+ T Y A+K + K+ I +E +++ RH L L L
Sbjct: 169 EKATGRYYAMKILK---KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225
Query: 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486
V E+ G L HL +E R+ A+ + S L YL E + VV+RD+K N+ML
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGAE-IVSALDYLHSE--KNVVYRDLKLENLML 282
Query: 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALE 546
D + + KI DFGL + G+ GT Y+APE + D + G+V E
Sbjct: 283 DKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 547 IACGRKP 553
+ CGR P
Sbjct: 342 MMCGRLP 348
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS----EVKIISRL 406
+ + +G+G +G V + +A+K++S Q Y E+KI+ R
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ---TYCQRTLREIKILLRF 82
Query: 407 RHRNLVQLL-----GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLA 460
RH N++ + + K++ +V + M D + L K L Y + Q L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICYFLYQIL- 138
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTM 518
GL Y+ V+HRD+K SN++L++ + KI DFGLAR+ +H T T
Sbjct: 139 RGLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 519 GYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
Y APE + +K D++S G + E+ +PI P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFP 233
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 18/214 (8%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRH 408
+ + + +G G G V + +A+K++S+ ++ K E+ ++ + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 409 RNLVQLL------GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+N++ LL E +++ +V E M + + L Y + Q L G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---NLCQVIQMELDHERMSYLLYQML-CG 139
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ +L ++HRD+K SNI++ S+ KI DFGLAR T T Y A
Sbjct: 140 IKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 194
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKPINP 556
PE + D++S G + E+ + P
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFP 227
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 90.7 bits (224), Expect = 1e-20
Identities = 37/242 (15%), Positives = 68/242 (28%), Gaps = 26/242 (10%)
Query: 30 PLASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATG 89
+ Y SF + + A++ + +Q +W K
Sbjct: 25 LPHRRFEYKY-SFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLKSQRGSVWTKTKA 83
Query: 90 NLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
++ +F + R ADGLA + G FG
Sbjct: 84 AFENWEVEVTFRVTGRGRI-GADGLAIWYTENQGLD-----GPVFG-------SADMWNG 130
Query: 150 VAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVA 209
V + FD + N + + N+ + N +D + + + + +
Sbjct: 131 VGIFFDSFDNDGKKNNPAIVVVGNN--GQINYDHQNDGATQALASCQRDFRNKPYPVRAK 188
Query: 210 FTGFRNNLVVMQGLDYQVDLRQ----------HLPEFVTFGFSMATGVDFAIFSIYSWEF 259
T ++ L VM + D +P FG S ATG + S+
Sbjct: 189 ITYYQKTLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 248
Query: 260 NS 261
Sbjct: 249 FQ 250
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 2e-20
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 18/214 (8%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRH 408
+ + + +G G G V + + +A+K++S+ ++ K E+ ++ + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 409 RNLVQLL------GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+N++ LL E +++ LV E M + + L Y + Q L G
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQML-CG 176
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ +L ++HRD+K SNI++ S+ KI DFGLAR T T Y A
Sbjct: 177 IKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 231
Query: 523 PECATTGKASKESDVYSFGIVALEIACGRKPINP 556
PE + D++S G + E+ K + P
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 264
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 43/239 (17%), Positives = 94/239 (39%), Gaps = 26/239 (10%)
Query: 313 KRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQK------LGQGGFG 366
++ + S + +R P + +D+ + +G G +G
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 367 GVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS----EVKIISRLRHRNLVQLL-----GW 417
V + + + +A+K++ + + I E+ I++RL H ++V++L
Sbjct: 68 HVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRLNHDHVVKVLDIVIPKD 125
Query: 418 CHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWE-FRYKIAQDLASGLLYLQEEWEQCVV 475
+ EL +V E D LF+ LT + + L G+ Y+ ++
Sbjct: 126 VEKFDELYVVLEIAD---SDFKKLFRTPVYLTELHIKTLLYNLL-VGVKYVHS---AGIL 178
Query: 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKE 534
HRD+K +N +++ + + K+ DFGLAR V++ + + + + +
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHRNLV 412
+ + + +G G FG V++ E++ +A+K+V Q K + + E++I+ ++H N+V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-----KRFKNRELQIMRIVKHPNVV 95
Query: 413 QLL------GWCHEKKELLLVYEFMP---NGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
L G ++ L LV E++P + + + ++ + + Q L L
Sbjct: 96 DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ-LLRSL 154
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
Y+ + HRDIK N++LD K+ DFG A+++ + + + + + Y A
Sbjct: 155 AYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209
Query: 523 PE---CATTGKASKESDVYSFGIVALEIACGRKPINP 556
PE AT + D++S G V E+ +P+ P
Sbjct: 210 PELIFGAT--NYTTNIDIWSTGCVMAEL-MQGQPLFP 243
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 29/226 (12%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+ + D + LG GG G V+ + + +A+K++ Q +K E+KII RL H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 411 LVQLL--------------GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKI 455
+V++ G E + +V E+M D + ++ LL R +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGPLLEEHARLFM 126
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVL 514
Q L GL Y+ V+HRD+K +N+ +++ + KIGDFGLAR+++ S L
Sbjct: 127 YQLL-RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD-PHYSHKGHL 181
Query: 515 AG---TMGYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
+ T Y +P + +K D+++ G + E+ K +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFA 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 48/203 (23%)
Query: 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYAS----EVKIIS 404
AT+ + ++G G +G VYK + ++A+K V + G EV ++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 405 RLR---HRNLVQLLGWCHEKKE-----LLLVYEFM-----------PNGSLDSHLFKENS 445
RL H N+V+L+ C + + LV+E + P L + K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIK--- 123
Query: 446 LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
+ + GL +L +VHRD+K NI++ S K+ DFGLAR
Sbjct: 124 --------DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---- 168
Query: 506 AKGSQTT----VLAGTMGYMAPE 524
Q V+ T+ Y APE
Sbjct: 169 IYSYQMALTPVVV--TLWYRAPE 189
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS----EVKIISRL 406
++DF LG+G +G V + T +A+K++ K +A E+KI+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHF 66
Query: 407 RHRNLVQLL-----GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLA 460
+H N++ + E+ ++ E M D H + L +Y I Q L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHIQYFIYQTL- 122
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG---- 516
+ L V+HRD+K SN++++SN + K+ DFGLAR+++ + +
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 517 -----TMGYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
T Y APE T+ K S+ DV+S G + E+ R+PI P
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 8e-20
Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 24/186 (12%)
Query: 357 DQKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHRNLVQ 413
K+G+G +G VYK ++ + A+K++ GI A E+ ++ L+H N++
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVIS 82
Query: 414 LLGWCHEKKE--LLLVYEFMPN---GSLDSHLFKENSLLTWEFRY----KIAQDLASGLL 464
L + + L++++ + + H + + + + + G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNA----KIGDFGLARLVEHAKGSQTTVLAG--TM 518
YL W V+HRD+K +NI++ KI D G ARL + T
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 519 GYMAPE 524
Y APE
Sbjct: 200 WYRAPE 205
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 88.4 bits (218), Expect = 9e-20
Identities = 38/245 (15%), Positives = 66/245 (26%), Gaps = 20/245 (8%)
Query: 41 SFSPQYDDNITYERAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSF 100
S Y + D L + ++ +W+ L D+ H F
Sbjct: 11 SLIKPYQGVGSSSMPLWDFQGSTILTSQYVRLTPDERSKEGSIWNHQPCFLKDWEMHVHF 70
Query: 101 VIDSRNSSY-YADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVN 159
+ + DG+A + G FG + +A+ D Y N
Sbjct: 71 KVHGTGKKNLHGDGIALWYTRD-----RLVPGPVFGSK-------DNFHGLAIFLDTYPN 118
Query: 160 SWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVV 219
I + + D + + + H+ +A R L V
Sbjct: 119 DETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRGRLTV 178
Query: 220 MQGLDYQVDLRQ-------HLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDETTNP 272
M L+ + + + LP FG S TG I S + +
Sbjct: 179 MTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLMVEHTPDEEN 238
Query: 273 VSNPK 277
+ K
Sbjct: 239 IDWTK 243
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRH 408
+ + +G G +G V F +T +AVK++S+ S K E++++ ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 409 RNLVQLL------GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLAS 461
N++ LL E ++ LV M D + + K L ++ I Q L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQIL-R 143
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
GL Y+ ++HRD+K SN+ ++ + KI DFGLAR + T T Y
Sbjct: 144 GLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYVATRWYR 196
Query: 522 APE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
APE ++ D++S G + E+ + + P
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFP 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/253 (22%), Positives = 106/253 (41%), Gaps = 30/253 (11%)
Query: 318 DEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVY---KGFFR 374
+ G + + + E +++ + +F + LG G +G V+ K
Sbjct: 22 SADGGDGGEQLLTVKHELRTANLTGHAEKVGI--ENFELLKVLGTGAYGKVFLVRKISGH 79
Query: 375 ETNSYIAVKRVSQGSKQGIKEYASEV-------KIISRLRHRN-LVQLLGWC----HEKK 422
+T A+K + K I + A +++ +R LV L K
Sbjct: 80 DTGKLYAMKVLK---KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL--HYAFQTETK- 133
Query: 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482
L L+ +++ G L +HL + E + + + + L +L + +++RDIK
Sbjct: 134 -LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE-IVLALEHLHK---LGIIYRDIKLE 188
Query: 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA--SKESDVYSF 540
NI+LDSN + + DFGL++ + + GT+ YMAP+ G + K D +S
Sbjct: 189 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248
Query: 541 GIVALEIACGRKP 553
G++ E+ G P
Sbjct: 249 GVLMYELLTGASP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR 405
NDF+ + LG+G FG V + T Y A+K + K+ I E A E +++
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR---KEVIIAKDEVAHTVTESRVLQN 61
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
RH L L L V E+ G L HL +E R+ A+ + S L Y
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L + VV+RDIK N+MLD + + KI DFGL + + G+ GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAPEV 176
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKP 553
+ D + G+V E+ CGR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 352 NDFNDDQKLGQGGFGGVY---KGFFRETNSYIAVKRVSQGSKQGIK-----EYASEVKII 403
+ F + LGQG FG V+ K + A+K + K +K E I+
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 404 SRLRHRNLVQLLGWC---HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLA 460
+ H +V+L + K L L+ +F+ G L + L KE + ++ +A+ LA
Sbjct: 81 VEVNHPFIVKLH-YAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LA 136
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL-VEHAKGSQTTVLAGTMG 519
L +L +++RD+K NI+LD + K+ DFGL++ ++H + GT+
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVE 191
Query: 520 YMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
YMAPE ++ +D +SFG++ E+ G P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 352 NDFNDDQKLGQGGFGGVY---KGFFRETNSYIAVKRVSQGSKQGIKEYASEV-------K 401
F + LG+GG+G V+ K T A+K + K I A +
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK---KAMIVRNAKDTAHTKAERN 73
Query: 402 IISRLRHRNLVQLLGWC---HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD 458
I+ ++H +V L+ + K L L+ E++ G L L +E + + +A+
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGK--LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE- 129
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
++ L +L + + +++RD+K NIML+ + K+ DFGL + G+ T GT+
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTI 185
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
YMAPE ++ D +S G + ++ G P
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HR 409
+D+ +KLG+G + V++ N + VK + K+ IK E+KI+ LR
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGP 91
Query: 410 NLVQLLGWCH--EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
N++ L + LV+E + N +L ++ R+ + + L L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEIL-KALDYCH 147
Query: 468 EEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA 526
++HRD+K N+M+D + ++ D+GLA G + V + + PE
Sbjct: 148 ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELL 202
Query: 527 TTGKA-SKESDVYSFGIVALEIACGRKPI 554
+ D++S G + + ++P
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 31/223 (13%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-----------SEVKI 402
+ + + G +G V G +A+KRV G E+++
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 403 ISRLRHRNLVQLL-----GWCHEKKELLLVYEFMPNGSLDSH--LFKENSLLTWE-FRYK 454
++ H N++ L +L LV E M D + + +++ + +Y
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYF 139
Query: 455 IAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVL 514
+ L GL L E VVHRD+ NI+L N + I DF LAR E + T
Sbjct: 140 MYHIL-LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHY 193
Query: 515 AGTMGYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
Y APE +K D++S G V E+ RK +
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 46/199 (23%)
Query: 352 NDFNDDQKLGQGGFGGVYKGF-FRETNSYIAVKRVSQGS-KQGIKEYA-SEVKIISRLR- 407
+ ++G+G +G V+K + ++A+KRV + ++G+ EV ++ L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 408 --HRNLVQLLGWCH-----EKKELLLVYEFM-----------PNGSLDSHLFKENSLLTW 449
H N+V+L C + +L LV+E + P + + K
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------- 123
Query: 450 EFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509
+ L GL +L VVHRD+K NI++ S+ K+ DFGLAR
Sbjct: 124 ----DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR----IYSF 172
Query: 510 QTT----VLAGTMGYMAPE 524
Q V+ T+ Y APE
Sbjct: 173 QMALTSVVV--TLWYRAPE 189
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-18
Identities = 38/113 (33%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLW 84
A +L+F++T F P +++ ++ +N V+Q+ +AGR Y+ +RLW
Sbjct: 1 AQSLSFSFTKFDP-NQEDLIFQGHATSTNNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW 59
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLT 137
+ + LT F T +F I + +S ADGLAFF+AP S I GG GL
Sbjct: 60 ED-SAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISY--HGGFLGLF 109
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 48/244 (19%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLRHRNL 411
+ +G+G +G VY + + T +A+K+V++ K E+ I++RL+ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 412 VQLL-----GWCHEKKELLLVYEFMPNGSLDSH-LFKENSLLTWE-FRYKIAQDLASGLL 464
++L + EL +V E + D LFK LT E + + L G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKTPIFLTEEHIKTILYNLL-LGEN 143
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAG-------- 516
++ E ++HRD+K +N +L+ + + K+ DFGLAR + K +
Sbjct: 144 FIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 517 -------------TMGYMAPE-CATTGKASKESDVYSFG-IVA---------LEIACGRK 552
T Y APE +K D++S G I A + R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 553 PINP 556
P+ P
Sbjct: 261 PLFP 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 56/252 (22%), Positives = 100/252 (39%), Gaps = 60/252 (23%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS-EVKIISRLRHR 409
+ ++ + LG G FG V + F E+ A+K+V Q Y + E+ I+ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60
Query: 410 NLVQLL--------------------------------------GWCHEKKELLLVYEFM 431
N+++L+ + K L ++ E++
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 432 P---NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488
P + L S + S+ I Q L + ++ + HRDIK N++++S
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVNS 176
Query: 489 NFNA-KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CATTGKASKESDVYSFGIVA 544
N K+ DFG A+ + ++ S + + Y APE AT + + D++S G V
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGAT--EYTPSIDLWSIGCVF 232
Query: 545 LEIACGRKPINP 556
E+ KP+
Sbjct: 233 GEL-ILGKPLFS 243
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 1e-17
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 16/246 (6%)
Query: 315 KEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR 374
K + QG + + ++ + DFN LG+G FG V +
Sbjct: 305 KFERAKIGQGTKAPEEKTANTISKFDNNGNRD-RMKLTDFNFLMVLGKGSFGKVMLSERK 363
Query: 375 ETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR-LRHRNLVQLLGWCHEKKELLLV 427
T+ AVK + K + + E ++++ + L QL L V
Sbjct: 364 GTDELYAVKILK---KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420
Query: 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD 487
E++ G L H+ + + A+ +A GL +LQ + +++RD+K N+MLD
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLD 476
Query: 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547
S + KI DFG+ + G T GT Y+APE K D ++FG++ E+
Sbjct: 477 SEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 535
Query: 548 ACGRKP 553
G+ P
Sbjct: 536 LAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 15/222 (6%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KE 395
K P ++ L DF + LG+G FG V+ F++TN + A+K + K + +
Sbjct: 4 NKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK---KDVVLMDDD 60
Query: 396 YAS---EVKIISR-LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEF 451
E +++S H L + K+ L V E++ G L H+ +
Sbjct: 61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA 120
Query: 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511
+ A+ + GL +L + +V+RD+K NI+LD + + KI DFG+ + ++T
Sbjct: 121 TFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKT 175
Query: 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
GT Y+APE K + D +SFG++ E+ G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 37/294 (12%), Positives = 76/294 (25%), Gaps = 50/294 (17%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQ 413
G ++ + +A+ V ++E S +SR+ + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
+L H + L+V E++ GSL + S + Q LA+
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVG-AIRAMQSLAAAADAAHRAG--- 149
Query: 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASK 533
V S + + + + + M A+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------ANP 181
Query: 534 ESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593
+ D+ G + R P+ + ++ D G +D +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERDTAGQPIEPADIDRDIPFQISA- 238
Query: 594 QIERLMIVGLWCAHPDENLRPS---IRQVIHVLNFEAPLPALPPKMPVPTYLSP 644
V D +R + + + L P P +P
Sbjct: 239 -------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVSAAP 285
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 75/375 (20%), Positives = 119/375 (31%), Gaps = 115/375 (30%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGF-----FRETNSYIAV 382
Y ++E FP L L + LG+G FG V + T +AV
Sbjct: 12 YDASKWE-------FPRDRLKL-------GKPLGRGAFGQVIEADAFGIDKTATCRTVAV 57
Query: 383 KRVSQGSKQG-IKEYASEVK---------------------------IISRLRHRNLVQL 414
K + +G+ + SE+K I+ + NL
Sbjct: 58 KMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY 117
Query: 415 L------------------------GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWE 450
L G + L S S +E SL E
Sbjct: 118 LRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
Query: 451 FRY----------------KIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494
+ +A G+ +L + +HRD+ + NI+L KI
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKI 234
Query: 495 GDFGLARLVEHAKGSQTTVLAGTMG-----YMAPECATTGKASKESDVYSFGIVALEIAC 549
DFGLAR + + +MAPE + +SDV+SFG++ EI
Sbjct: 235 CDFGLARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 550 -GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHP 608
G P P V + + G + A P ++ + M L C H
Sbjct: 291 LGASPY-P-----GVKIDEEFCRRLKEGTRMRA--PDYTTP----EMYQTM---LDCWHG 335
Query: 609 DENLRPSIRQVIHVL 623
+ + RP+ +++ L
Sbjct: 336 EPSQRPTFSELVEHL 350
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 15/209 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR 405
++F + LG+G FG V +ET AVK + K I + E +I+S
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 406 -LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
H L QL L V EF+ G L H+ K R+ A+ + S L+
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
+L + + +++RD+K N++LD + K+ DFG+ + G T GT Y+APE
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCGTPDYIAPE 194
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKP 553
D ++ G++ E+ CG P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 56/244 (22%), Positives = 107/244 (43%), Gaps = 18/244 (7%)
Query: 318 DEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETN 377
+ I++E E + +L DF+ + +G+G + V ++T+
Sbjct: 19 NLYFQGAMGSGIEEEKEAMNTRESGKASS-SLGLQDFDLLRVIGRGSYAKVLLVRLKKTD 77
Query: 378 SYIAVKRVSQGSKQGI---KEYAS---EVKIISR-LRHRNLVQLLGWCHEKKE-LLLVYE 429
A++ V K+ + ++ E + + H LV L C + + L V E
Sbjct: 78 RIYAMRVVK---KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIE 133
Query: 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489
++ G L H+ ++ L R+ A+ ++ L YL E + +++RD+K N++LDS
Sbjct: 134 YVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSE 189
Query: 490 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC 549
+ K+ D+G+ + G T+ GT Y+APE D ++ G++ E+
Sbjct: 190 GHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 550 GRKP 553
GR P
Sbjct: 249 GRSP 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 67/250 (26%), Positives = 105/250 (42%), Gaps = 19/250 (7%)
Query: 311 GRKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYK 370
G + + E N + + GP P +DF+ + +G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNP----HAKPSDFHFLKVIGKGSFGKVLL 56
Query: 371 GFFRETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR-LRHRNLVQLLGWCHEKKE 423
+ + AVK + K+ I KE E ++ + ++H LV L +
Sbjct: 57 ARHKAEEVFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113
Query: 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSN 483
L V +++ G L HL +E L R+ A+ +AS L YL +V+RD+K N
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE-IASALGYLHS---LNIVYRDLKPEN 169
Query: 484 IMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIV 543
I+LDS + + DFGL + S T+ GT Y+APE + D + G V
Sbjct: 170 ILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 228
Query: 544 ALEIACGRKP 553
E+ G P
Sbjct: 229 LYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR 405
DF+ + +G+G + V ++T+ A+K V K+ + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK---KELVNDDEDIDWVQTEKHVFEQ 65
Query: 406 -LRHRNLVQLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
H LV L C + + L V E++ G L H+ ++ L R+ A+ ++ L
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE-ISLAL 123
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
YL E + +++RD+K N++LDS + K+ D+G+ + G T+ GT Y+AP
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAP 179
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKP 553
E D ++ G++ E+ GR P
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 15/209 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGI---KEYAS---EVKIISR 405
DFN LG+G FG V + T+ AVK + K + + E ++++
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 406 -LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
+ L QL L V E++ G L H+ + + A+ +A GL
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-IAIGLF 135
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
+LQ + +++RD+K N+MLDS + KI DFG+ + G T GT Y+APE
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPE 191
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKP 553
K D ++FG++ E+ G+ P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 13/182 (7%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ--GSKQGIKEYASEVKIISRLR-HRN 410
+ +KLG+G +G V+K R T +AVK++ + + E+ I++ L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 411 LVQLLGWCH--EKKELLLVYEFMPNGSLDSH-LFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+V LL +++ LV+++M D H + + N L +Y + Q + + YL
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET---DLHAVIRANILEPVHKQYVVYQLI-KVIKYLH 126
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
++HRD+K SNI+L++ + K+ DFGL+R + + +
Sbjct: 127 S---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 528 TG 529
Sbjct: 184 QP 185
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 22/171 (12%)
Query: 347 LALATNDFNDD-----QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVK 401
L + N DD Q LG G G V + F + T A+K + + EV+
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARR---EVE 62
Query: 402 IISRL-RHRNLVQLLGWCHE----KKELLLVYEFMPNGSL-DSHLFKENSLLTWEFRYKI 455
+ R + ++V+++ +K LL+V E + G L + + T +I
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLV 503
+ + + YL + HRD+K N++ S N K+ DFG A+
Sbjct: 123 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 44/227 (19%), Positives = 87/227 (38%), Gaps = 52/227 (22%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLR------- 407
+KLG G F V+ N+++A+K ++ E+K++ R+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTKE 80
Query: 408 ----HRNLVQLLGW--------CHEKKELLLVYEFMPNGSLDSHLF---KENSL--LTWE 450
++++LL H +++V+E L +L K+ +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVH----VVMVFE-----VLGENLLALIKKYEHRGIPLI 131
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD------SNFNAKIGDFGLARLVE 504
+ +I++ L GL Y+ ++H DIK N++++ + KI D G A +
Sbjct: 132 YVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551
T + T Y +PE +D++S + E+ G
Sbjct: 190 E---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-12
Identities = 34/211 (16%), Positives = 63/211 (29%), Gaps = 56/211 (26%)
Query: 338 GPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------- 390
GP F + L T +K+G+G FG V++ ++ +A+K ++
Sbjct: 9 GPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSH 63
Query: 391 -QGIKEYASEVKIISRL---------RHRNLVQLLGWCH--------------------- 419
+ +E E+ I L R + L
Sbjct: 64 QKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKG 123
Query: 420 ---------EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+ +L +V EF G + + L + I L + L +
Sbjct: 124 SANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASL 181
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501
HRD+ N++L K+ +
Sbjct: 182 R--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 6e-12
Identities = 17/47 (36%), Positives = 25/47 (53%)
Query: 223 LDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDDET 269
L V L+ +PE+V GFS TG ++A + SW F+S L +
Sbjct: 6 LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSGTSSS 52
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 51/259 (19%), Positives = 98/259 (37%), Gaps = 52/259 (20%)
Query: 333 FERGAGPKRFPYKELALATNDFNDDQ-------------------KLGQGGFGGVYKGFF 373
+ G K+ ++DDQ +G+G FG V K +
Sbjct: 59 YFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYD 118
Query: 374 RETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLRHR------NLVQLLGWCHEKKEL 424
+ + ++A+K + +Q + E++I+ LR + N++ +L + +
Sbjct: 119 HKVHQHVALKMVRNEKRFHRQAAE----EIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174
Query: 425 LLVYEFMPNGSLDSHLF---KENSL--LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDI 479
+ +E L +L+ K+N + K A + L L + ++H D+
Sbjct: 175 CMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDL 226
Query: 480 KSSNIMLDSNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDV 537
K NI+L + K+ DFG + T + + Y APE + D+
Sbjct: 227 KPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFYRAPEVILGARYGMPIDM 282
Query: 538 YSFGIVALEIACGRKPINP 556
+S G + E+ G P+ P
Sbjct: 283 WSLGCILAELLTG-YPLLP 300
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLRHR----- 409
+G+G FG V K + R ++A+K Q EV+++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI----EVRLLELMNKHDTEMK 115
Query: 410 -NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSL--LTWEFRYKIAQDLASGL 463
+V L + L LV+E L +L+ + + ++ K AQ + + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
L+L E ++H D+K NI+L + + KI DFG + + + + Y
Sbjct: 171 LFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI---YQYIQ-SRFYR 225
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINP 556
+PE D++S G + +E+ G +P+
Sbjct: 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFS 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 61/458 (13%), Positives = 133/458 (29%), Gaps = 132/458 (28%)
Query: 223 LDYQVDLRQH---------LPEFVTFGFSMATGVDFAIFSIYSWEFN--SSLEMDDETTN 271
+D++ Q+ FV +F + + S E+D +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVD---------NFDCKDVQDMPKSILSKEEIDHIIMS 57
Query: 272 PVSNPKRRRKNRTALVVGLSLGGG-----VLVGGVVLI--IWLAGIGRKRKEGDEEDNQG 324
+ T + L V V+ I +L + + +
Sbjct: 58 K------DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 325 FSEYID------DEFERGAGPKRFPYKELALATNDFNDDQKL---GQGGFGGVYKGFFRE 375
+ E D F + + PY +L A + + + G G G K
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K----- 163
Query: 376 TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL-----LVYEF 430
+++A+ Q + ++ ++ L C+ + +L L+Y+
Sbjct: 164 --TWVALDVCLSYKVQ--CKMDFKIFWLN----------LKNCNSPETVLEMLQKLLYQI 209
Query: 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC-VVHRDIKSSNIMLDS- 488
PN + S L + ++ + L + +E C +V +++++ ++
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRR------LLKSKPYENCLLVLLNVQNAKA-WNAF 262
Query: 489 NFNAKI----GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVA 544
N + KI + + A + ++ +M E ++
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE--------------VKSLLL 308
Query: 545 --LEIACGRKP-----INPKAPQGQVSLL---------QW-VWDLYGNGKL-------LE 580
L+ P NP+ +S++ W W KL L
Sbjct: 309 KYLDCRPQDLPREVLTTNPRR----LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 581 AVDPRLCRD-------F-DGQQIERLMIVGLWCAHPDE 610
++P R F I +++ +W
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 50/280 (17%), Positives = 86/280 (30%), Gaps = 98/280 (35%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR--------HR 409
+KLG G F V+ + + ++A+K V + ++ + E++++ +R
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 410 NLVQLLGW--------CHEKKELLLVYEFM-----------PNGSLDSHLFKENSLLTWE 450
+VQLL H + +V+E + L K+
Sbjct: 102 MVVQLLDDFKISGVNGTH----ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK------- 150
Query: 451 FRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML------------------------ 486
I Q + GL YL + ++H DIK NI+L
Sbjct: 151 ----IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 487 -------------------------DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
KI D G A V T T Y
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYR 260
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG 561
+ E + +D++S +A E+A G P + +
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 43/177 (24%), Positives = 67/177 (37%), Gaps = 20/177 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLL 415
+K+G G FG +Y G +A+K +K E KI ++ + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIR 71
Query: 416 GWCHEKKELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-EQC 473
E ++V E + G SL LF S +F K LA ++ E +
Sbjct: 72 WCGAEGDYNVMVMELL--GPSL-EDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKN 125
Query: 474 VVHRDIKSSNIMLDSNFNAK---IGDFGLARLV------EHAKGSQTTVLAGTMGYM 521
+HRD+K N ++ I DFGLA+ +H + L GT Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 39/193 (20%), Positives = 66/193 (34%), Gaps = 37/193 (19%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIA---VKRVSQGSKQGIKEY-----ASEVKIISRLRHR 409
+K+G GGFG +Y F A VK Q + E ++ I + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 410 NLVQLLG-----WC--HEKKELLLVYEFM------PNGSLDSHLFKENSLLTWEFRYKIA 456
+ LG E K Y FM L + +N ++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRS--YRFMVMERLGI--DLQ-KISGQNGTFKKSTVLQLG 157
Query: 457 QDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI--GDFGLARLV------EHAKG 508
+ L Y+ E VH DIK++N++L ++ D+GL+ + +
Sbjct: 158 IRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214
Query: 509 SQTTVLAGTMGYM 521
+ GT+ +
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 37/182 (20%), Positives = 72/182 (39%), Gaps = 28/182 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLL 415
+++G+G FG +++G N +A+K + S E + L + +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVY 72
Query: 416 GWCHEKKELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYK----IAQDLASGLLYLQEEW 470
+ E +LV + + G SL L +F K A+ + + + +
Sbjct: 73 YFGQEGLHNVLVIDLL--GPSL-EDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH--- 123
Query: 471 EQCVVHRDIKSSNIMLDSNFNAK-----IGDFGLARL------VEHAKGSQTTVLAGTMG 519
E+ +V+RDIK N ++ + + DFG+ + +H + L+GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 520 YM 521
YM
Sbjct: 184 YM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 28/182 (15%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLL 415
+K+G G FG + G TN Y+A+K S+ E + +L + Q+
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVY 71
Query: 416 GWCHEKKELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYK----IAQDLASGLLYLQEEW 470
+ K +V E + G SL LF F K IA L S + Y+ +
Sbjct: 72 YFGPCGKYNAMVLELL--GPSL-EDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSK- 124
Query: 471 EQCVVHRDIKSSNIML--DSNFNAKIG---DFGLARL------VEHAKGSQTTVLAGTMG 519
+++RD+K N ++ N ++ DF LA+ +H + L GT
Sbjct: 125 --NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 520 YM 521
YM
Sbjct: 183 YM 184
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 49/177 (27%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLG 416
+K+G G FG +Y G +TN +A+K + +K Y E KI L+ + +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVR 69
Query: 417 WC-HEKKELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-EQC 473
W E +LV + + G SL LF S + K LA ++ E +
Sbjct: 70 WFGVEGDYNVLVMDLL--GPSL-EDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKS 123
Query: 474 VVHRDIKSSNIMLDSNFNAK---IGDFGLARLV------EHAKGSQTTVLAGTMGYM 521
+HRDIK N ++ A I DFGLA+ +H + L GT Y
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 38/197 (19%), Positives = 70/197 (35%), Gaps = 42/197 (21%)
Query: 358 QKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEY-----ASEVKIISRLR 407
+GQGGFG +Y +++ VK + E A++ + I +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 408 HRNLVQLLG-----WCHEKKELLLVYEFM------PNGSLDSHLFKEN----SLLTWEFR 452
++ LG + Y FM L +++ N S T
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQ-KIYEANAKRFSRKT---V 154
Query: 453 YKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI--GDFGLA------RLVE 504
+++ + L Y+ E VH DIK+SN++L+ ++ D+GLA + +
Sbjct: 155 LQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 505 HAKGSQTTVLAGTMGYM 521
GT+ +
Sbjct: 212 AYAADPKRCHDGTIEFT 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 30/150 (20%), Positives = 57/150 (38%), Gaps = 35/150 (23%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLRHR----- 409
+K+G G FG V + Y AVK + + ++ E I+ ++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNN 96
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRY-------KIAQDL 459
N+V+ G + L++E L L+ N+ + ++
Sbjct: 97 NIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNN-----YNGFHIEDIKLYCIEI 146
Query: 460 ASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489
L YL++ + H D+K NI+LD
Sbjct: 147 LKALNYLRKM---SLTHTDLKPENILLDDP 173
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 27/168 (16%), Positives = 58/168 (34%), Gaps = 30/168 (17%)
Query: 358 QKLGQGGFGGVYKGF--------FRETNSYIAVKRVSQGSK----QGIKEYASEVKIISR 405
+ G +Y+ ++K ++ + Q + A++ +++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 406 LRHRNLVQLLG-----WC--HEKKELLLVYEFMPNG-SLDSHLFKENS--LLTWEFRYKI 455
+ LL H+ K LV + G SL + +L+ ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSL-QSALDVSPKHVLSERSVLQV 164
Query: 456 AQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI--GDFGLAR 501
A L L +L E VH ++ + NI +D +++ +G A
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 30/168 (17%), Positives = 62/168 (36%), Gaps = 27/168 (16%)
Query: 358 QKLGQGGFGGVYKGF-FRETNSYIAVK---RVSQGSKQGIKEYASEVKIISRLRHR---- 409
LG+G FG V + S +A+K V + + E + ++ +++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80
Query: 410 --NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSL--LTWEFRYKIAQDLASG 462
V + W + + + +E L + F KEN+ +A L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510
L +L E + H D+K NI+ ++ + + + + K +
Sbjct: 136 LRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 32/173 (18%), Positives = 59/173 (34%), Gaps = 37/173 (21%)
Query: 358 QKLGQGGFGGVYKGFFRETNS-YIAVK---RVSQGSKQGIKEYASEVKIISRLRHR---- 409
LG+G FG V + + ++AVK V + + E++++ L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS----EIQVLEHLNTTDPNS 75
Query: 410 --NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---KENSLLTWEFRY-------KIAQ 457
VQ+L W + +V+E L + KEN F K+A
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENG-----FLPFRLDHIRKMAY 125
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510
+ + +L + H D+K NI+ + + + + R
Sbjct: 126 QICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.98 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.36 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.46 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.06 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.88 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.51 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.23 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.35 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.47 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.56 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-64 Score=502.72 Aligned_cols=241 Identities=34% Similarity=0.576 Sum_probs=204.0
Q ss_pred HHHHHHHHHHHHhhcCCCCceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCC------ceEEEEeCCceeccc
Q 042831 14 LLSFFTITISFCLTIIPLASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRE------TAGRATYNQSMRLWD 85 (645)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~------~~G~~~y~~pv~l~~ 85 (645)
++++++++++++++.++++.+++|+|++|.. .++.++ ||.+. +|.|+||+ ... +.|||+|++||+|||
T Consensus 6 ~~~~~~~~fl~l~~~~~sa~~~sF~f~~F~~---~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d 81 (281)
T 3ujo_A 6 FTMKRIVLFLILLTKAASANLISFTFKKFNE---TNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWD 81 (281)
T ss_dssp ------------------CEEEEEEESSCCS---TTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBC
T ss_pred HHHHHHHHHHHHHcccCcCCcceEEcCCCCc---cCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEccc
Confidence 3445555666667788889999999999973 479999 99995 99999999 433 899999999999999
Q ss_pred CCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCC
Q 042831 86 KATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPT 164 (645)
Q Consensus 86 ~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~ 164 (645)
+.+|+++||+|+|+|.|.+++...+||||||||+|.++. |. +.||||||+|..++ +.++|+|||||||++|. |||+
T Consensus 82 ~~tg~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~-p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~Dp~ 158 (281)
T 3ujo_A 82 NTTGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQ-PK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGWDPT 158 (281)
T ss_dssp SSSCCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCC-CC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSSCCS
T ss_pred CCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCC-CC-CCcceeeeccccCC-CccCcEEEEEEeccccccCCCC
Confidence 999999999999999999887778899999999999864 54 68999999998766 77899999999999994 9999
Q ss_pred CCceeeecCCCcccceeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeec
Q 042831 165 FSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMA 244 (645)
Q Consensus 165 ~~hvgidvns~~s~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsas 244 (645)
+|||||||||+.|.++++|+ +.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.|||+++|||+|||||||+
T Consensus 159 ~nHVGIDvNSi~S~~t~~~~--l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~VGFSAs 234 (281)
T 3ujo_A 159 ERHIGIDVNSIKSIKTTSWD--FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVSVGFSAT 234 (281)
T ss_dssp SSEEEEEESSSCCSCEEECC--CCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEEEEEEEE
T ss_pred CCeEEEEcCCCCcccccccc--ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEEEEEEee
Confidence 99999999999999999985 67999999999999999999999998764 447899999999999999999999999
Q ss_pred ccc---eeeeEEEEEeeccCcccc
Q 042831 245 TGV---DFAIFSIYSWEFNSSLEM 265 (645)
Q Consensus 245 tg~---~~~~~~i~~wsf~~~~~~ 265 (645)
||. ..|.|+|++|+|++.+..
T Consensus 235 TG~~~~~~e~H~IlsWSFss~l~~ 258 (281)
T 3ujo_A 235 TGLSKGYVETNEVLSWSFASKLSI 258 (281)
T ss_dssp ECSSTTSCCCCEEEEEEEEEEECS
T ss_pred cCCCCcccceeEEEEEEEEEEcCC
Confidence 996 589999999999988765
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=495.45 Aligned_cols=233 Identities=36% Similarity=0.654 Sum_probs=209.1
Q ss_pred hhcCCCCceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEE
Q 042831 26 LTIIPLASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTH 97 (645)
Q Consensus 26 ~~~~~~~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~ 97 (645)
+++++++.+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ .. .+.|||+|++||+|||+.+|+++||+|+
T Consensus 3 ~~~~~sa~~~sF~f~~F~~~-~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~ 81 (261)
T 3zyr_A 3 LNRANSTDSLSFSFINFDRD-ERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQ 81 (261)
T ss_dssp -----CCEEEEEEESSCCSC-CTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEE
T ss_pred ccccCcCcccEEEcCCCCCC-CCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEE
Confidence 34677889999999999865 5689999 99997899999999 43 5899999999999999999999999999
Q ss_pred EEEEEeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCC-CCCCEEEEEEecc---cC-CCCCCCCceeeec
Q 042831 98 FSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN-SSIPFVAVEFDVY---VN-SWDPTFSHVGIDI 172 (645)
Q Consensus 98 F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEfDt~---~n-~~d~~~~hvgidv 172 (645)
|+|.|.+. ...+||||||||+|.++.+|.+++||||||+|..++++ ..||+|||||||+ +| +|||++|||||||
T Consensus 82 F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~Dp~~nHVGIdv 160 (261)
T 3zyr_A 82 FSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDV 160 (261)
T ss_dssp EEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEE
T ss_pred EEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCCCCCCCeEEEEc
Confidence 99999987 56789999999999988778889999999999877644 5689999999999 88 4999999999999
Q ss_pred CCCcccceeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeE
Q 042831 173 NSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIF 252 (645)
Q Consensus 173 ns~~s~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~ 252 (645)
||+.|.+++.|. +.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.|||+++|+|+|||||||+||...|.|
T Consensus 161 Nsi~S~~s~~~~--l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h 235 (261)
T 3zyr_A 161 NSIRSSKVVRWE--RREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTH 235 (261)
T ss_dssp SSSSCSEEEECC--CCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEE
T ss_pred CCCCcccccccc--ccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechHHhCcCcEEEEEEecCCCccceE
Confidence 999999999984 67999999999999999999999998663 2789999999999999999999999999999999
Q ss_pred EEEEeeccCcccc
Q 042831 253 SIYSWEFNSSLEM 265 (645)
Q Consensus 253 ~i~~wsf~~~~~~ 265 (645)
+|++|+|++.+.+
T Consensus 236 ~IlsWsF~s~l~~ 248 (261)
T 3zyr_A 236 NLESWSFTSTLLY 248 (261)
T ss_dssp EEEEEEEEEEECC
T ss_pred EEEEEEEEEEcCC
Confidence 9999999988765
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=485.62 Aligned_cols=225 Identities=38% Similarity=0.655 Sum_probs=205.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCC------ceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRE------TAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~------~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ ..+ ++|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 2 ~~~sF~f~~F~~~-~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~ 80 (251)
T 3ipv_A 2 EETSFVFSKFKPL-EPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYA 80 (251)
T ss_dssp EEEEEEESSCCSS-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred cceEEEeCCCCCC-CCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeC
Confidence 4689999999865 5689999 99997899999999 443 8999999999999999999999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-C-CCCCCceeeecCCCcccceee
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-W-DPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~-d~~~~hvgidvns~~s~~~~~ 182 (645)
++...+||||||||+|.+.. |. +.||||||+|..++ +..+|+|||||||++|. | ||++|||||||||+.|.+++.
T Consensus 81 ~~~~~~gdGlAF~lap~~~~-~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~ 157 (251)
T 3ipv_A 81 PNIATIADGLAFFLAPVASA-PD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK 157 (251)
T ss_dssp SSTTSCCEEEEEEEEETTCC-CC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCCceEEEEecCCCC-CC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCcccccce
Confidence 87778899999999999865 54 57999999998765 77899999999999995 6 999999999999999999999
Q ss_pred ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeec
Q 042831 183 WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEF 259 (645)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf 259 (645)
|+ +.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|+|+|||||||+||.. .|.|+|++|+|
T Consensus 158 ~~--l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF 233 (251)
T 3ipv_A 158 WS--LANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233 (251)
T ss_dssp CC--CCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEE
T ss_pred eE--ecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEE
Confidence 84 78999999999999999999999998664 4578999999999999999999999999998 89999999999
Q ss_pred cCcccc
Q 042831 260 NSSLEM 265 (645)
Q Consensus 260 ~~~~~~ 265 (645)
++.+..
T Consensus 234 ~s~l~~ 239 (251)
T 3ipv_A 234 ASKLAG 239 (251)
T ss_dssp EEEECC
T ss_pred EEECCC
Confidence 988664
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-61 Score=477.39 Aligned_cols=224 Identities=36% Similarity=0.653 Sum_probs=205.8
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ . ..+.|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 80 (239)
T 1dbn_A 2 DELSFTINNFVPN-EADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEcCCCCCC-CCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 4689999999865 5689999 99997789999998 4 4689999999999999999999999999999999988
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccC---C-CCCCCCceeeecCCCccccee
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVN---S-WDPTFSHVGIDINSVKSKKNV 181 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n---~-~d~~~~hvgidvns~~s~~~~ 181 (645)
+...+||||||||+|.++.+|.++.||||||+|..+ ++..+|+|||||||++| . |||++|||||||||++|++++
T Consensus 81 ~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~~Dp~~nHVGIdvNs~~S~~~~ 159 (239)
T 1dbn_A 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV 159 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccccCCCCCcEEEecCCccccceE
Confidence 767789999999999987788889999999998764 46789999999999999 6 999999999999999999999
Q ss_pred eecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce--eeeEEEEEeec
Q 042831 182 SWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD--FAIFSIYSWEF 259 (645)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf 259 (645)
.|+ +.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|+|+|||||||+||.. .|.|+|++|+|
T Consensus 160 ~~~--l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF 235 (239)
T 1dbn_A 160 QWD--WINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235 (239)
T ss_dssp ECC--CCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEE
T ss_pred ccc--ccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEEe
Confidence 984 88999999999999999999999998654 4578999999999999999999999999999 99999999999
Q ss_pred cCc
Q 042831 260 NSS 262 (645)
Q Consensus 260 ~~~ 262 (645)
++.
T Consensus 236 ~s~ 238 (239)
T 1dbn_A 236 TST 238 (239)
T ss_dssp EEE
T ss_pred Eec
Confidence 865
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=472.23 Aligned_cols=227 Identities=40% Similarity=0.734 Sum_probs=207.2
Q ss_pred CCceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C---CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 31 LASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N---RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 31 ~~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~---~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
++.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 s~~~~~F~f~~F~~~-~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~ 80 (242)
T 1qnw_A 2 LSDDLSFNFDKFVPN-QKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD 80 (242)
T ss_dssp -CCSEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS
T ss_pred CccceEEEcCCCCCC-CCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC
Confidence 456789999999965 5689999 99997789999999 4 5689999999999999999999999999999999987
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecc----cCCCCCCCCceeeecCCCccccee
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVY----VNSWDPTFSHVGIDINSVKSKKNV 181 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~----~n~~d~~~~hvgidvns~~s~~~~ 181 (645)
...+||||||||+|.++.+|.++.||||||+|..+ ++..+|+|||||||+ +|.|||++|||||||||+.|.+++
T Consensus 81 -~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~~Dp~~nHVGIdvNs~~S~~~~ 158 (242)
T 1qnw_A 81 -KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTV 158 (242)
T ss_dssp -SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred -CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCCCCCCCCcEEEecCCcccccee
Confidence 67789999999999987788889999999998764 577899999999999 998999999999999999999999
Q ss_pred eecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce--eeeEEEEEeec
Q 042831 182 SWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD--FAIFSIYSWEF 259 (645)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf 259 (645)
.| ++.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|+|+|||||||+||.. .|.|+|++|+|
T Consensus 159 ~~--~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF 234 (242)
T 1qnw_A 159 KW--DWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYF 234 (242)
T ss_dssp EC--CCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEE
T ss_pred cc--cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CcceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEEe
Confidence 98 488999999999999999999999998654 5578999999999999999999999999999 99999999999
Q ss_pred cCccc
Q 042831 260 NSSLE 264 (645)
Q Consensus 260 ~~~~~ 264 (645)
++.+.
T Consensus 235 ~s~l~ 239 (242)
T 1qnw_A 235 TSNLE 239 (242)
T ss_dssp EEEC-
T ss_pred EeecC
Confidence 88753
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-61 Score=471.51 Aligned_cols=222 Identities=39% Similarity=0.698 Sum_probs=201.0
Q ss_pred eeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCC
Q 042831 34 ALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRN 106 (645)
Q Consensus 34 ~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (645)
+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ . ..+.|||+|++||+|||+.+|+++||+|+|+|.|.++.
T Consensus 3 ~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (237)
T 1fny_A 3 SLSFSFPKFAPN-QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEcCCCCCC-CCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 578999999965 5689999 99997789999998 4 46899999999999999999999999999999999887
Q ss_pred CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceeeecc
Q 042831 107 SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWS 185 (645)
Q Consensus 107 ~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~~~~ 185 (645)
...+||||||||+|.... | ++.||||||+|..+ ++..+|+|||||||++|. |||++|||||||||+.|.++++|
T Consensus 82 ~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~Dp~~nHVGIdvNsi~S~~~~~~-- 156 (237)
T 1fny_A 82 PATTADGLAFFLAPVDTQ-P-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW-- 156 (237)
T ss_dssp TTSCCEEEEEEEEETTCC-C-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC--
T ss_pred CCCCCCCEEEEeccCCCC-C-CCCCCcccccccCC-CCccccEEEEEeecccCcccCCCCCceEEecCCccccccccc--
Confidence 777899999999998753 4 48899999998764 577899999999999998 99999999999999999999998
Q ss_pred cCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeeccCc
Q 042831 186 DVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFNSS 262 (645)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~~~ 262 (645)
++.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|+|+|||||||+||.. .|.|+|++|+|++.
T Consensus 157 ~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 157 NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEe
Confidence 488999999999999999999999998654 5578999999999999999999999999998 99999999999876
Q ss_pred c
Q 042831 263 L 263 (645)
Q Consensus 263 ~ 263 (645)
+
T Consensus 235 l 235 (237)
T 1fny_A 235 L 235 (237)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-60 Score=463.23 Aligned_cols=220 Identities=42% Similarity=0.664 Sum_probs=202.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCCC--CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPAN--RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSY 109 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~~--~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+. ..+.|||+|++||+|||+.+|+++||+|+|+|.|.+++...
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~ 80 (232)
T 1v6i_A 2 ETVSFNFNSFSEG-NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYD 80 (232)
T ss_dssp EEEEEEESSCCTT-CTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSB
T ss_pred cceEEEcCCCCCC-CCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCC
Confidence 4689999999865 5689999 999977899999984 46899999999999999999999999999999999887677
Q ss_pred CCCeEEEEEccCCCCCCCCC-CCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeeccc
Q 042831 110 YADGLAFFLAPQGSKIPTNK-GGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSD 186 (645)
Q Consensus 110 ~g~GlaF~l~p~~~~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~~~ 186 (645)
+||||||||+|.++.+|.++ .||||||+|. +..+|+|||||||++|. |||++|||||||||++|.+++.|+
T Consensus 81 ~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~~-- 154 (232)
T 1v6i_A 81 PADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWN-- 154 (232)
T ss_dssp CCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEECC--
T ss_pred CCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCcccccccccc--
Confidence 89999999999987788888 9999999985 56789999999999997 999999999999999999999984
Q ss_pred CCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc--eeeeEEEEEeeccCcc
Q 042831 187 VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV--DFAIFSIYSWEFNSSL 263 (645)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~--~~~~~~i~~wsf~~~~ 263 (645)
+.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.|||+++|+|+|||||| +||. ..|.|+|++|+|++.+
T Consensus 155 l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~l 229 (232)
T 1v6i_A 155 SVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTSTL 229 (232)
T ss_dssp CCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred ccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEeec
Confidence 88999999999999999999999998 4 36689999999999999999999999 9999 6899999999998765
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=462.41 Aligned_cols=219 Identities=40% Similarity=0.694 Sum_probs=201.3
Q ss_pred eeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCCC---CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 35 LTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPAN---RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 35 ~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~~---~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
++|+|++|. + ..++.++ ||.+.++|.|+||+. .++.|||+|++||+|||+.+|+++||+|+|+|.|.++....+
T Consensus 1 ~sF~f~~F~-~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~ 78 (234)
T 2eig_A 1 VSFNYTRFK-D-DGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPP 78 (234)
T ss_dssp CEEEESSCC-S-SSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCC
T ss_pred CeEEcCCCC-C-CCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCC
Confidence 479999998 2 4589999 999977899999984 468999999999999999999999999999999999877778
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCC---CceeeecCCCcccceeeecccC
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTF---SHVGIDINSVKSKKNVSWWSDV 187 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~---~hvgidvns~~s~~~~~~~~~~ 187 (645)
||||||||+|.++.+|.++.||||||+|.. +..+|+|||||||++|.|||++ |||||||||+.|.+++.| ++
T Consensus 79 gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~Dp~~~~~nHVGIdvNsi~S~~~~~~--~l 153 (234)
T 2eig_A 79 TDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNW--NR 153 (234)
T ss_dssp CCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCTTSCTTTCSSEEEEEESSSSCSEEEEC--CC
T ss_pred CCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCccCCCCCCCCceEEecCCccccceecc--cc
Confidence 999999999998778888999999999864 5678999999999999999999 999999999999999998 48
Q ss_pred CCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecc--cceeeeEEEEEeeccCccc
Q 042831 188 KSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMAT--GVDFAIFSIYSWEFNSSLE 264 (645)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsast--g~~~~~~~i~~wsf~~~~~ 264 (645)
.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|+|+|||||||+| |.. |.|+|++|+|++.+.
T Consensus 154 ~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l~ 228 (234)
T 2eig_A 154 VSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTLK 228 (234)
T ss_dssp CTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEECC
T ss_pred cCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEecCC
Confidence 8999999999999999999999998 4 36678999999999999999999999999 998 999999999988764
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=464.08 Aligned_cols=223 Identities=35% Similarity=0.636 Sum_probs=202.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C---CCceEE-EEeCCceecccCCCCCccceeEEEEEEEeeC-
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N---RETAGR-ATYNQSMRLWDKATGNLTDFTTHFSFVIDSR- 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~---~~~~G~-~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~- 105 (645)
.+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ . ..+.|| |+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~ 80 (242)
T 1fx5_A 2 DDLSFKFKNFSQN-GKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSA 80 (242)
T ss_dssp CEEEEEESSCCTT-CSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESS
T ss_pred cceEEEcCCCCCC-CCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCC
Confidence 4689999999865 5689999 99997789999999 4 468999 9999999999999999999999999999987
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC---CCCCCCceeeecCCCcccceee
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS---WDPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~---~d~~~~hvgidvns~~s~~~~~ 182 (645)
....+||||||||+|.... | ++.||||||+|..+ ++..+|+|||||||++|. |||++|||||||||+.|.+++.
T Consensus 81 ~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~ 157 (242)
T 1fx5_A 81 NPKAATDGLTFFLAPPDSP-L-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAER 157 (242)
T ss_dssp CGGGCCCEEEEEEECTTCC-C-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEE
T ss_pred CCCCCCCcEEEEEecCCCC-C-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceec
Confidence 5667899999999998753 4 47899999999764 577899999999999997 8999999999999999999999
Q ss_pred ecccCCCC--ceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecc--cceeeeEEEEEee
Q 042831 183 WWSDVKSG--RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMAT--GVDFAIFSIYSWE 258 (645)
Q Consensus 183 ~~~~~~~g--~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsast--g~~~~~~~i~~ws 258 (645)
| ++.+| +.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|+|+|||||||+| |.. |.|+|++|+
T Consensus 158 ~--~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWs 232 (242)
T 1fx5_A 158 W--NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWY 232 (242)
T ss_dssp C--CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEE
T ss_pred c--cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEE
Confidence 8 47899 9999999999999999999998654 5578999999999999999999999999 999 999999999
Q ss_pred ccCccc
Q 042831 259 FNSSLE 264 (645)
Q Consensus 259 f~~~~~ 264 (645)
|++.+.
T Consensus 233 F~s~l~ 238 (242)
T 1fx5_A 233 FTSTFI 238 (242)
T ss_dssp EEEESS
T ss_pred eEeecc
Confidence 988754
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=465.65 Aligned_cols=223 Identities=37% Similarity=0.650 Sum_probs=203.0
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~ 80 (253)
T 1sbf_A 2 ETVSFSWNKFVPK-QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA 80 (253)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCC-CCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeC
Confidence 4689999999865 5689999 99997789999999 4 358999999999999999999999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeec
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
++...+||||||||+|.... | ++.||||||+|.. +..+|+|||||||++|.|||++|||||||||+.|.++..|+
T Consensus 81 ~~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~~Dp~~nHVGIdvNs~~S~~t~~~~ 155 (253)
T 1sbf_A 81 PDTKRLADGLAFFLAPIDTK-P-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSWD 155 (253)
T ss_dssp SSTTSCCEEEEEEEEETTCC-C-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEECC
T ss_pred CCCCCCCCcEEEEEecCCCC-C-CCCCCccccccCC---CcccceEEEEeccccCCCCCCCCcEEEEcCCccccceeccc
Confidence 87677899999999998753 4 5889999999864 66889999999999999999999999999999999999984
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce--eeeEEEEEeeccCc
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD--FAIFSIYSWEFNSS 262 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~~~ 262 (645)
+.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|||+|||||||+||.. .+.|+|++|+|++.
T Consensus 156 --l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~ 231 (253)
T 1sbf_A 156 --LANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231 (253)
T ss_dssp --CCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEE
T ss_pred --ccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEee
Confidence 88999999999999999999999998654 5578999999999999999999999999999 99999999999887
Q ss_pred ccc
Q 042831 263 LEM 265 (645)
Q Consensus 263 ~~~ 265 (645)
+..
T Consensus 232 l~~ 234 (253)
T 1sbf_A 232 LPH 234 (253)
T ss_dssp ECC
T ss_pred cCC
Confidence 643
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=464.42 Aligned_cols=223 Identities=35% Similarity=0.671 Sum_probs=201.0
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . ..+.|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~ 80 (239)
T 1gzc_A 2 ETISFSFSEFEPG-NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQ 80 (239)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred eeEEEEeCCCCCC-CCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeC
Confidence 3678999999965 5689999 99997789999999 4 358999999999999999999999999999999998
Q ss_pred CC-CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCC-CCCCceeeecCCCcccceee
Q 042831 105 RN-SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWD-PTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 105 ~~-~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d-~~~~hvgidvns~~s~~~~~ 182 (645)
+. ...+||||||||+|.... | ++.||||||+|..+ ++..+|+|||||||++|.|| |++|||||||||+.|.+++.
T Consensus 81 ~~~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~dDp~~nHVGIdvns~~S~~~~~ 157 (239)
T 1gzc_A 81 PYTRPLPADGLVFFMGPTKSK-P-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQP 157 (239)
T ss_dssp CCSSSCCCEEEEEEEECSSCC-C-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCTTSCSSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCCCcEEEEEecCCCC-C-CCCCCcccccccCC-CCccccEEEEEEecccccCCCCCCCeEEEecCCcccccccc
Confidence 76 677899999999998753 4 48899999998764 57789999999999999865 99999999999999999999
Q ss_pred ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc---eeeeEEEEEeec
Q 042831 183 WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEF 259 (645)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf 259 (645)
| ++.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|+|+|||||||+||. ..|.|+|++|+|
T Consensus 158 ~--~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF 233 (239)
T 1gzc_A 158 F--QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSF 233 (239)
T ss_dssp C--CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEE
T ss_pred c--cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEe
Confidence 8 488999999999999999999999998654 457899999999999999999999999997 489999999999
Q ss_pred cCcc
Q 042831 260 NSSL 263 (645)
Q Consensus 260 ~~~~ 263 (645)
++.+
T Consensus 234 ~s~l 237 (239)
T 1gzc_A 234 QASL 237 (239)
T ss_dssp EEEE
T ss_pred EEec
Confidence 8764
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-59 Score=457.40 Aligned_cols=221 Identities=38% Similarity=0.690 Sum_probs=200.4
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . .++.|||+|++||+|||+.+ ++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~--~~sFsT~F~F~I~~~ 78 (233)
T 1n47_A 2 ESTSFSFTNFNPN-QNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT--LASFTTSFSFVMAAP 78 (233)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC--BCEEEEEEEEECCCS
T ss_pred cceEEEcCCCCCC-CCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC--cCCEEEEEEEEEeCC
Confidence 4689999999965 5689999 99997789999999 4 36899999999999999877 999999999999988
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeecc
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWS 185 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~~ 185 (645)
+...+||||||||+|.... |. +.||||||++..+ ++..+|+|||||||++|.|||++|||||||||+.|.++..|
T Consensus 79 ~~~~~gdGlAF~l~p~~~~-p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~Dp~~nHvGIdvns~~S~~~~~~-- 153 (233)
T 1n47_A 79 AAAAVADGLAFFLAPPDTQ-PQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF-- 153 (233)
T ss_dssp STTSCCEEEEEEEECTTCC-CC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred CCCCCCCcEEEEEecCCCC-CC-CCCCcccccccCC-CCccCceEEEEeccccCCCCCCCCcEEEccCCccccccccc--
Confidence 7677899999999999865 65 8899999999764 57789999999999999999999999999999999999988
Q ss_pred cCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeeccCc
Q 042831 186 DVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFNSS 262 (645)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~~~ 262 (645)
++.+|+.++|||+||+.+++|+|+|.+.+.. ..|+|++.+||+++|||+|||||||+||.. .|.|+|++|+|++.
T Consensus 154 ~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 154 DMVYGEKANIVITYQASTKALAASLVFPVSQ--TSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCTTSCEEEEEEEETTTTEEEEEEEETTTT--EEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred cccCCCEEEEEEEEeCCCCEEEEEEecCCCC--CcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEee
Confidence 4779999999999999999999999986543 478999999999999999999999999998 99999999999875
Q ss_pred c
Q 042831 263 L 263 (645)
Q Consensus 263 ~ 263 (645)
+
T Consensus 232 l 232 (233)
T 1n47_A 232 L 232 (233)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-59 Score=459.00 Aligned_cols=221 Identities=39% Similarity=0.678 Sum_probs=200.6
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ ..+|.++ ||.+.++|.|+||+ . ..+.|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 80 (242)
T 1wbf_A 2 KTISFNFNQFHQN-EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQP 80 (242)
T ss_dssp CEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEcCCCCCC-CCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCC
Confidence 3678999999865 5689999 99997789999999 4 4689999999999999999999999999999999987
Q ss_pred -CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeec
Q 042831 106 -NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 106 -~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
....+||||||||+|.... .++.||||||+|.. ..+|+|||||||++|.|||++|||||||||+.|.++..|
T Consensus 81 ~~~~~~gdGlAF~l~p~~~~--~~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~~Dp~~nHVGIdvNs~~S~~~~~~- 153 (242)
T 1wbf_A 81 FPRPHPADGLVFFIAPPNTQ--TGEGGGYFGIYNPL----SPYPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPF- 153 (242)
T ss_dssp CCSSCCCEEEEEEEECSSCC--CCCCGGGTTTCCTT----SCCCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCCcEEEEEecCCCC--CCCCCCccccccCC----CcCcEEEEEeccccCCCCCCCCeEEEECCCccccceeee-
Confidence 5677899999999998753 44789999999864 578999999999999999999999999999999999988
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecc----cce---eeeEEEEEe
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMAT----GVD---FAIFSIYSW 257 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsast----g~~---~~~~~i~~w 257 (645)
++.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++|+|+|||||||+| |.. .|.|+|++|
T Consensus 154 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsW 230 (242)
T 1wbf_A 154 -TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSW 230 (242)
T ss_dssp -CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEE
T ss_pred -EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEE
Confidence 488999999999999999999999998654 4578999999999999999999999999 988 899999999
Q ss_pred eccCccc
Q 042831 258 EFNSSLE 264 (645)
Q Consensus 258 sf~~~~~ 264 (645)
+|++.+.
T Consensus 231 sF~s~l~ 237 (242)
T 1wbf_A 231 SFSASLP 237 (242)
T ss_dssp EEEEECC
T ss_pred EeEecCC
Confidence 9988754
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=456.03 Aligned_cols=224 Identities=38% Similarity=0.737 Sum_probs=203.0
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
.+++|+|++|.++ ..++.++ ||. .++|.|+||+ ..++.|||+|++||+|||+.+|+++||+|+|+|.|.++....+
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~ 79 (234)
T 2bqp_A 2 ETTSFLITKFSPD-QQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNV 79 (234)
T ss_dssp EEEEEEESSBCTT-CTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSC
T ss_pred cceEEEcCCCCCC-CCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCC
Confidence 4689999999865 5689999 999 5889999999 6679999999999999999999999999999999998876778
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCC--CCceeeecCCCcccceeeecccC
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPT--FSHVGIDINSVKSKKNVSWWSDV 187 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~--~~hvgidvns~~s~~~~~~~~~~ 187 (645)
||||||||+|.... |. +.||||||++..+ ++..+|+|||||||++|. |||+ +|||||||||+.|.++..| ++
T Consensus 80 gdGlAF~l~p~~~~-p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~~Dp~~~~nHVgIdvns~~S~~s~~~--~l 154 (234)
T 2bqp_A 80 ADGFTFFIAPVDTK-PQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW--KL 154 (234)
T ss_dssp CCEEEEEEEETTCC-CC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEEC--CC
T ss_pred CCcEEEEEecCCCC-CC-CCCCccccccccC-CCCCCcEEEEEEecccCcccCCCCCCCceeEeeCCccccceEee--EE
Confidence 99999999999865 65 8899999998764 567899999999999997 8999 9999999999999999998 47
Q ss_pred CCCceeEEEEEEcCCCceEEEEEecCCCc---ccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcc
Q 042831 188 KSGRRNEAWISYNSSTHNLSVAFTGFRNN---LVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSL 263 (645)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~---~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~ 263 (645)
.+|+.++|||+||+.+++|+|+|.+.+.. +|..|+|++.+||+.+|||+|||||||+||...+.|+|++|+|++.+
T Consensus 155 ~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~l 233 (234)
T 2bqp_A 155 QNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL 233 (234)
T ss_dssp CTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred cCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEEeec
Confidence 79999999999999999999999987665 67789999999999999999999999999999999999999998753
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=455.95 Aligned_cols=220 Identities=35% Similarity=0.634 Sum_probs=199.6
Q ss_pred eeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 34 ALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 34 ~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.++
T Consensus 2 ~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~ 80 (238)
T 1f9k_A 2 TQSFNFDHFEEN-SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP 80 (238)
T ss_dssp EEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred CeEEEcCCCCCC-CCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecC
Confidence 578999999865 5689999 99997789999999 4 4689999999999999999999999999999999987
Q ss_pred -CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeec
Q 042831 106 -NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 106 -~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
....+||||||||+|.... | ++.||||||+|.. +. +|+|||||||++|.|||++|||||||||+.|.++..|
T Consensus 81 ~~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~~Dp~~nHVgIdvns~~S~~s~~~- 153 (238)
T 1f9k_A 81 YAYPEPADGLTFFMVPPNSP-Q-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF- 153 (238)
T ss_dssp CSSSCCCEEEEEEEECTTCC-C-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCCcEEEEEccCCCC-C-CCCCCcccccccC---CC-CcEEEEEEecccCCCCCCCCeEEEecCCccccceEee-
Confidence 6677899999999998753 4 5789999999865 45 8999999999999999999999999999999999988
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCC--ceEEEEeecccce---eeeEEEEEeec
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPE--FVTFGFSMATGVD---FAIFSIYSWEF 259 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~--~~~vGfsastg~~---~~~~~i~~wsf 259 (645)
++.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.|||+++||| +|||||||+||.. .|.|+|++|+|
T Consensus 154 -~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF 230 (238)
T 1f9k_A 154 -QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSF 230 (238)
T ss_dssp -CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEe
Confidence 488999999999999999999999998654 557899999999999999 9999999999999 99999999999
Q ss_pred cCccc
Q 042831 260 NSSLE 264 (645)
Q Consensus 260 ~~~~~ 264 (645)
++.+.
T Consensus 231 ~s~~~ 235 (238)
T 1f9k_A 231 TSSLQ 235 (238)
T ss_dssp EEEC-
T ss_pred Eeecc
Confidence 88753
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-58 Score=453.54 Aligned_cols=223 Identities=35% Similarity=0.603 Sum_probs=200.6
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ .. ++.|||+|++||+|||+ +|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~-~g~~~sFst~F~F~I~~ 79 (240)
T 2fmd_A 2 NSVCFTFTDFESG-QQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQS-SSLVASFETTFTFSISQ 79 (240)
T ss_dssp CEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TCSEEEEEEEEEEECCB
T ss_pred cceEEEcCCCCCC-CCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCC-CCCcCcEEEEEEEEEec
Confidence 4689999999865 5689999 99997789999999 44 68999999999999999 99999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCC-CCCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCccccee
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTN-KGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNV 181 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~ 181 (645)
+ ...+||||||||+|.... |.+ +.||||||++.+++++..+|+|||||||++|. |||++|||||||||+.|.++.
T Consensus 80 ~-~~~~gdGlAF~l~p~~~~-p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~ 157 (240)
T 2fmd_A 80 G-SSTPADALTFFIASPDTK-IPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAAS 157 (240)
T ss_dssp S-SSSCCCEEEEEEECTTCC-CCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEE
T ss_pred C-CCCCCCcEEEEEecCCCC-CCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeecccccccccee
Confidence 7 677899999999999865 655 88999999998766778899999999999996 899999999999999999999
Q ss_pred eecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccC
Q 042831 182 SWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261 (645)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~ 261 (645)
.| ++.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+.+||++|||||||+||...+.|+|++|+|++
T Consensus 158 ~~--~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s 232 (240)
T 2fmd_A 158 KW--DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRS 232 (240)
T ss_dssp EC--CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEE
T ss_pred EE--EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEe
Confidence 88 477999999999999999999999998664 4789999999999999999999999999999999999999988
Q ss_pred ccc
Q 042831 262 SLE 264 (645)
Q Consensus 262 ~~~ 264 (645)
.+.
T Consensus 233 ~~~ 235 (240)
T 2fmd_A 233 SLM 235 (240)
T ss_dssp EEE
T ss_pred cCC
Confidence 764
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-58 Score=459.13 Aligned_cols=222 Identities=33% Similarity=0.593 Sum_probs=201.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.. .++.++ ||.+. +|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~---~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~ 77 (253)
T 1g7y_A 2 DIQSFSFKNFNS---SSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFA 77 (253)
T ss_dssp EEEEEEESSCCS---SCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred cceEEEcCCCCc---CCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEec
Confidence 468999999984 479999 99995 89999999 4 358999999999999999999999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceeee
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~~ 183 (645)
+....+||||||||+|.... | ++.||||||++..+ ++..+|+|||||||++|. |||++|||||||||+.|.++..|
T Consensus 78 ~~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~Dp~~nHVGIdvns~~S~~t~~~ 154 (253)
T 1g7y_A 78 PNKSSSADGIAFALVPVGSE-P-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW 154 (253)
T ss_dssp SSGGGCCCEEEEEEEETTCC-C-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCCcEEEEEecCCCC-C-CCCCCcccccccCC-CCccCceEEEEecceeccCcCCCCCcEeeccCCccccceecc
Confidence 76667899999999998753 4 58899999998764 467899999999999997 99999999999999999999998
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeecc
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFN 260 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ 260 (645)
+ +.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|||+|||||||+||.. .+.|+|++|+|+
T Consensus 155 ~--l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~ 230 (253)
T 1g7y_A 155 G--LANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFA 230 (253)
T ss_dssp C--CCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEE
T ss_pred c--cCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEE
Confidence 4 78999999999999999999999997654 5578999999999999999999999999998 999999999998
Q ss_pred Ccccc
Q 042831 261 SSLEM 265 (645)
Q Consensus 261 ~~~~~ 265 (645)
+.+..
T Consensus 231 s~l~~ 235 (253)
T 1g7y_A 231 SKLPD 235 (253)
T ss_dssp EEECS
T ss_pred eeCCC
Confidence 87643
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=458.30 Aligned_cols=226 Identities=35% Similarity=0.590 Sum_probs=200.1
Q ss_pred ceeeEEeCCCC-CCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 33 SALTFNYTSFS-PQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 33 ~~~~f~f~~f~-~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
.+++|+|++|. ++ ..++.++ ||.+. +|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.
T Consensus 3 ~~~~F~f~~F~~~~-~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~ 80 (257)
T 1hql_A 3 DSVSFTFPNFWSDV-EDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLK 80 (257)
T ss_dssp -CCEEEESCSCSCG-GGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCC-CCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEe
Confidence 46789999998 43 4589999 99995 89999999 4 35899999999999999999999999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCC-CCCCCCCEEEEEEecccCC-C-CCCCCceeeecCCCcccce
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNE-PLNSSIPFVAVEFDVYVNS-W-DPTFSHVGIDINSVKSKKN 180 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEfDt~~n~-~-d~~~~hvgidvns~~s~~~ 180 (645)
++ ...+||||||||+|.... .++.||||||++.++ +++..+|+|||||||++|. | ||++|||||||||+.|.++
T Consensus 81 ~~-~~~~gdGlAF~l~p~~~~--~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s 157 (257)
T 1hql_A 81 IT-GNGPADGLAFFLAPPDSD--VKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVAT 157 (257)
T ss_dssp EC-SSCCCCEEEEEEECTTCC--CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEE
T ss_pred cC-CCCCCCcEEEEEecCCCC--CCCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccce
Confidence 87 677899999999998753 458899999998765 3677899999999999997 6 9999999999999999999
Q ss_pred eeeccc-CCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc-ceeeeEEEEEee
Q 042831 181 VSWWSD-VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG-VDFAIFSIYSWE 258 (645)
Q Consensus 181 ~~~~~~-~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg-~~~~~~~i~~ws 258 (645)
..|++. +.+|+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+|+|+|||||||+|| ...+.|+|++|+
T Consensus 158 ~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWs 234 (257)
T 1hql_A 158 KRWEDSDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWR 234 (257)
T ss_dssp EECCHHHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEE
T ss_pred eccCcccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEE
Confidence 998654 55699999999999999999999998654 4689999999999999999999999999 899999999999
Q ss_pred ccCccccc
Q 042831 259 FNSSLEMD 266 (645)
Q Consensus 259 f~~~~~~~ 266 (645)
|++.+...
T Consensus 235 F~s~~~~~ 242 (257)
T 1hql_A 235 FSSNLQST 242 (257)
T ss_dssp EEEEC---
T ss_pred eEecCCCC
Confidence 98876543
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=458.36 Aligned_cols=221 Identities=38% Similarity=0.637 Sum_probs=200.3
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.. .++.++ ||.+.++|.|+||+ . .++.|||+|++||+|||+.+|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~---~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~ 78 (252)
T 1fat_A 2 NDIYFNFQRFNE---TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQV 78 (252)
T ss_dssp CCEEEEESSCCG---GGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCC
T ss_pred cceEEEcCCCCc---CCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeC
Confidence 468899999984 489999 99997789999999 4 358999999999999999999999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceeee
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~~ 183 (645)
++...+||||||||+|.... | ++.||||||+|.. +..+|+|||||||++|. |||++|||||||||+.|.++..|
T Consensus 79 ~~~~~~gdGlAF~l~p~~~~-~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~~Dp~~nHVGIdvNs~~S~~~~~~ 153 (252)
T 1fat_A 79 PNNAGPADGLAFALVPVGSQ-P-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW 153 (252)
T ss_dssp CSSCBCCEEEEEEEEETTCC-C-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCCcEEEEEccCCCC-C-CCCCccccccccC---CccCcEEEEEeecccCCCCCCCCCeEEEecCCccccceecc
Confidence 76677899999999998753 4 5789999999864 56899999999999998 99999999999999999999998
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeecc
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFN 260 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ 260 (645)
+ +.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|||+|||||||+||.. .+.|+|++|+|+
T Consensus 154 ~--l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~ 229 (252)
T 1fat_A 154 D--FVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFA 229 (252)
T ss_dssp C--CCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEE
T ss_pred c--ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEE
Confidence 4 78999999999999999999999998654 5578999999999999999999999999999 999999999998
Q ss_pred Ccccc
Q 042831 261 SSLEM 265 (645)
Q Consensus 261 ~~~~~ 265 (645)
+.+..
T Consensus 230 s~l~~ 234 (252)
T 1fat_A 230 SKLSD 234 (252)
T ss_dssp EEEC-
T ss_pred eeCCC
Confidence 87653
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=450.51 Aligned_cols=220 Identities=35% Similarity=0.587 Sum_probs=197.4
Q ss_pred ceeeEEeCCC----CCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEE
Q 042831 33 SALTFNYTSF----SPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSF 100 (645)
Q Consensus 33 ~~~~f~f~~f----~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f 100 (645)
.+++|+|++| .++ ..++.++ ||.+. +|.|+||+ . .++.|||+|++||+||| .+|+++||+|+|+|
T Consensus 2 ~~~~F~f~~F~~~~~~~-~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~-~tg~vasFsT~F~F 78 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKN-GTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWD-STGKAASFYTSFTF 78 (243)
T ss_dssp CCCEEEESCCCCTTCCT-TSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBC-TTSCBCEEEEEEEE
T ss_pred cceEEEcCCCccccCCC-CCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccC-CCCCcCceEEEEEE
Confidence 3578999999 543 4689999 99995 89999999 4 35899999999999999 99999999999999
Q ss_pred EEeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCC-CCCCCCEEEEEEecccCC-C-CCCCCceeeecCCCcc
Q 042831 101 VIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEP-LNSSIPFVAVEFDVYVNS-W-DPTFSHVGIDINSVKS 177 (645)
Q Consensus 101 ~i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEfDt~~n~-~-d~~~~hvgidvns~~s 177 (645)
.|.++ ...+||||||||+|.... .++.||||||++.+++ ++..+|+|||||||++|. | ||++|||||||||+.|
T Consensus 79 ~I~~~-~~~~gdGlAF~l~p~~~~--~~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S 155 (243)
T 1gsl_A 79 LLKNY-GAPTADGLAFFLAPVDSS--VKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVS 155 (243)
T ss_dssp EEEES-SSSCBCEEEEEEEETTCC--CCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSC
T ss_pred EEecC-CCCCCCCEEEEEecCCCC--CCCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccc
Confidence 99987 667899999999998753 4588999999988653 677899999999999997 6 9999999999999999
Q ss_pred cceeeecccCCC---CceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEE
Q 042831 178 KKNVSWWSDVKS---GRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSI 254 (645)
Q Consensus 178 ~~~~~~~~~~~~---g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i 254 (645)
.++..|+ +.+ |+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+|||+|||||||+|| ..+.|+|
T Consensus 156 ~~~~~~~--l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~I 229 (243)
T 1gsl_A 156 VATTRWE--NDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYI 229 (243)
T ss_dssp SEEEECC--HHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEE
T ss_pred cceeeeE--EeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEEEEEeccC-CcceeEE
Confidence 9999884 666 99999999999999999999998654 3689999999999999999999999999 9999999
Q ss_pred EEeeccCccc
Q 042831 255 YSWEFNSSLE 264 (645)
Q Consensus 255 ~~wsf~~~~~ 264 (645)
++|+|++.+.
T Consensus 230 lsWsF~s~l~ 239 (243)
T 1gsl_A 230 LSWHFFSTLD 239 (243)
T ss_dssp EEEEEEEECT
T ss_pred EEEEEEeecc
Confidence 9999988754
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=445.56 Aligned_cols=216 Identities=28% Similarity=0.467 Sum_probs=196.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCCC----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPAN----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNS 107 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~~----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (645)
.+++|+|++|.. .++.++ ||.+.++|.|+||+. .++.|||+|++||+|||+.+|+++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~---~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~ 78 (226)
T 1avb_A 2 NDASFNVETFNK---TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNI 78 (226)
T ss_dssp EEEEEEESSCCG---GGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESST
T ss_pred cceEEEcCCCCc---cCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCC
Confidence 467899999984 489999 999977899999983 358999999999999999999999999999999999877
Q ss_pred CCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeecccC
Q 042831 108 SYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDV 187 (645)
Q Consensus 108 ~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~~~~ 187 (645)
..+||||||||+|.++. |. +.||||||+|.. +++..+|+|||||||+ +|||||||||+.|.+++.|+..+
T Consensus 79 ~~~gdGlAF~l~p~~~~-p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~-------~nHVGIdvNs~~S~~t~~~~~~l 148 (226)
T 1avb_A 79 ENSAYGLAFALVPVGSR-PK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV-------SNRIEIDVNSIRPIATESCNFGH 148 (226)
T ss_dssp TSCCEEEEEEEEETTCC-CC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT-------TTEEEEEESSSSCSEEEECCSGG
T ss_pred CCCCCcEEEEEecCCCC-CC-CCCCcccccccC-CCCCcccEEEEEecCc-------CCccceeecCcccCccccCCccc
Confidence 78899999999999865 65 889999999875 4567899999999999 69999999999999999998888
Q ss_pred CCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeeccCcc
Q 042831 188 KSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFNSSL 263 (645)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~~~~ 263 (645)
.+|+.++|||+||+.+++|+|+|++.+.. ..|+|++.+||+++|||+|||||||+||.. .|.|+|++|+|++.+
T Consensus 149 ~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~l 225 (226)
T 1avb_A 149 NNGEKAEVRITYDSPKNDLRVSLLYPSSE--EKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSNF 225 (226)
T ss_dssp GTTCEEEEEEEEEGGGTEEEEEEEETTTT--EEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEEE
T ss_pred cCCCeEEEEEEEeCCCcEEEEEEeecCCC--ccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEeec
Confidence 89999999999999999999999986643 378999999999999999999999999999 999999999998754
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=441.56 Aligned_cols=215 Identities=28% Similarity=0.468 Sum_probs=194.1
Q ss_pred ceeeEEeCCCCCCCCCC-eEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 33 SALTFNYTSFSPQYDDN-ITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~-~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
.+++|+|++|.. .+ +.++ ||.+.++|.|+||+ .. .+.|||+|++||+|||+. +++||+|+|+|.|.
T Consensus 2 ~~~~F~f~~F~~---~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~--~vaSFsT~F~F~I~ 76 (240)
T 1ioa_A 2 TETSFNFPNFHT---DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN--NVASFNTNFTFIIR 76 (240)
T ss_dssp CCCEEEESSCCT---TSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS--CBEEEEEEEEEECC
T ss_pred cceEEEcCCCCC---CCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC--ccccEEEEEEEEEe
Confidence 457899999984 37 9999 99997789999999 43 589999999999999986 89999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeee
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~ 183 (645)
+++...+||||||||+|.++. |. +.||||||+|.. +++..+|+|||||||+ +|||||||||+.|.+++.|
T Consensus 77 ~~~~~~~gdGlAF~l~p~~~~-p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~-------~nHVGIdvNs~~S~~t~~~ 146 (240)
T 1ioa_A 77 AKNQSISAYGLAFALVPVNSP-PQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF-------KNRIDFDKNFIKPYVNENC 146 (240)
T ss_dssp BSCTTSCCEEEEEEEEETTCC-CC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT-------TTEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCCCcEEEEEecCCCC-CC-CCCCcccccccC-CCCCcCcEEEEEecCc-------CCceeeeeCCccccccccC
Confidence 887777899999999999865 66 889999999875 4567899999999999 5999999999999999999
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeecc
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFN 260 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~ 260 (645)
+..+.+|+.++|||+||+.+++|+|+|++.+.. ..|+|++.|||+++|||+|||||||+||.. .|.|+|++|+|+
T Consensus 147 ~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~ 224 (240)
T 1ioa_A 147 DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVSQ--VKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFS 224 (240)
T ss_dssp CHHHHCSSCEEEEEEEETTTTEEEEEEEETTTC--CEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEE
T ss_pred CccccCCCEEEEEEEEeCCCcEEEEEEecCCCC--ccceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEE
Confidence 877779999999999999999999999986643 378999999999999999999999999999 999999999998
Q ss_pred Cccc
Q 042831 261 SSLE 264 (645)
Q Consensus 261 ~~~~ 264 (645)
+.+.
T Consensus 225 s~~~ 228 (240)
T 1ioa_A 225 SKFR 228 (240)
T ss_dssp EEEC
T ss_pred eeCC
Confidence 7653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=447.33 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=207.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|...++||+|+||.||+|++. .+++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999975 3578999999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 427 VYEFMPNGSLDSHLFKEN--------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
|||||++|+|.+++.+.. ..++|.+++.|+.|||+||.|||+ ++|+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999996532 369999999999999999999998 899999999999999999999
Q ss_pred EEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~ 570 (645)
||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||..... ..+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~--- 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAID--- 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHHH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence 99999999876543322 2344679999999999999999999999999999999999 9999975432 12222
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.+.++.. +.....+ ...+.+|+.+||+.||++||||+||+++|+.-..
T Consensus 272 -~i~~g~~-----~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 -CITQGRE-----LERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HHHHTCC-----CCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHcCCC-----CCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 2222221 1111122 2457788899999999999999999999986433
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-54 Score=443.12 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=211.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|...++||+|+||+||+|++. .++..||||+++..+.+..++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45677889999999999999875 3578999999988777778899999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEE
Q 042831 427 VYEFMPNGSLDSHLFKE------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl 494 (645)
|||||++|+|.++|... ...++|.+++.|+.|||+||.|||+ ++|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 2479999999999999999999999 89999999999999999999999
Q ss_pred eeccCcccccccCCcc-eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHH
Q 042831 495 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
+|||+++......... .....||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+.. .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~~----~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIE----C 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH----H
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----H
Confidence 9999998765433322 223568999999999999999999999999999999998 9999975432 12222 2
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..++.... .... ..+.+.+|+.+||+.||++||||+||++.|+.
T Consensus 243 i~~~~~~~-----~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 ITQGRVLQ-----RPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCC-----CCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22332211 1112 23467788899999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=438.15 Aligned_cols=266 Identities=28% Similarity=0.474 Sum_probs=208.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
...+++...++||+|+||+||+|++.+ .||||+++.. +.+..++|.+|++++++++|||||+++|+|.+ +.++|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344677788999999999999998753 4999998643 45567889999999999999999999999865 56899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||||++|+|.++|......++|.++..|+.|||+||.|||+ ++||||||||+||||++++++||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999998777789999999999999999999998 89999999999999999999999999999876543
Q ss_pred CC-cceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 507 KG-SQTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 507 ~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.. .......||+.|||||++.. +.++.++|||||||+||||+||+.||...... ..+......+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~---- 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA---- 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----
Confidence 32 23455789999999999863 46899999999999999999999999754432 112222222221
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc-CCCCCCC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF-EAPLPAL 632 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~-~~~~p~~ 632 (645)
.|.+. .........+.+|+.+||+.||++||||.||+++|+. +.++|.+
T Consensus 256 ~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~ 305 (307)
T 3omv_A 256 SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305 (307)
T ss_dssp CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC-
T ss_pred CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCC
Confidence 11111 1111223467788899999999999999999999874 3455554
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=408.25 Aligned_cols=199 Identities=29% Similarity=0.497 Sum_probs=175.2
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
.+++|+|++|.. .++.++ ||.+.++|.|+||+ ..++.|||+|++||+|||+.+|+++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~---~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 78 (223)
T 1dhk_B 2 TETSFIIDAFNK---TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANS 78 (223)
T ss_dssp CCCEEEESSCCG---GGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---C
T ss_pred cceEEEcCCCCc---CCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCC
Confidence 457899999984 489999 99997789999999 6678999999999999999999999999999999998876778
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeecccCCCC
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSG 190 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~~~~~~g 190 (645)
||||||||+|.... |. +++|||||||+ +|||||||||+ |.++++|+..+.+|
T Consensus 79 gdGlAF~l~p~~~~-p~-------------------~~~vAVEFDT~-------~nHVGIdvNsi-S~~~~~~~~~l~~g 130 (223)
T 1dhk_B 79 AVGLDFVLVPVQPE-SK-------------------GDTVTVEFDTF-------LSRISIDVNNN-DIKSVPWDVHDYDG 130 (223)
T ss_dssp CSEEEEEEEEC--------------------------CCEEEEEETT-------TTEEEEEETTE-EEEEEECCGGGTTT
T ss_pred CCceEEEEecCCCC-CC-------------------ccEEEEEecCC-------CCcccccCCcc-ccccccCCccccCC
Confidence 99999999998643 22 23799999999 59999999999 99999998888899
Q ss_pred ceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeeccCccc
Q 042831 191 RRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFNSSLE 264 (645)
Q Consensus 191 ~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~~~~~ 264 (645)
+.++|||+||+.+++|+|+|++.+.. .+|+|++.+||+++|||+|||||||+||.. .+.|+|++|+|++.+.
T Consensus 131 ~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~~ 205 (223)
T 1dhk_B 131 QNAEVRITYNSSTKVFSVSLSNPSTG--KSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSKFI 205 (223)
T ss_dssp SCEEEEEEEETTTTEEEEEEECTTTC--CEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC-
T ss_pred CEEEEEEEEeCCCCEEEEEEecCCCC--ccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEeccc
Confidence 99999999999999999999987543 378999999999999999999999999999 9999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=438.89 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=208.8
Q ss_pred CCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+...++||+|+||+||+|++. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999974 356899999997543 34467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 428 YEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
||||++|+|.++|... ...++|..+..|+.|||+||.|||+ ++||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 9999999999999643 2368999999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHH
Q 042831 493 KIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 493 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~ 570 (645)
||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||..... ..+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~~---- 257 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVV---- 257 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHHH----
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHHH----
Confidence 9999999987654332 23345679999999999999999999999999999999998 8999975432 2222
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....++..... +......+.+|+.+||+.||++||||+||+++|+.
T Consensus 258 ~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 258 EMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22333332211 11223467788899999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=437.91 Aligned_cols=256 Identities=25% Similarity=0.331 Sum_probs=215.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
..|+..++||+|+||.||+|+++.+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45788899999999999999999999999999997665555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++.+ ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 99999998864 458999999999999999999999 999999999999999999999999999998765432 234
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
...+||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+...+ .++ ..+.+.. .
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i----~~~-----~~~~~~~--~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI----RDN-----LPPRLKN--L 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH----HHS-----SCCCCSC--G
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHH----HcC-----CCCCCCc--c
Confidence 457899999999999999999999999999999999999999975432 1222211 111 1111110 0
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......+.+|+.+||+.||++|||++|+++|.|+..
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 112245677889999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=439.28 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=208.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...++||+|+||.||+|++..+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999999999999999999754 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||++|+|.+++... ...+++.+.+.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999754 4567999999999999999999999 999999999999999999999999999998764321
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......+||+.|||||++.+..++.++|||||||+||||++|+.||..... ..+... +.++.. +.+..
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~----i~~~~~-----~~~~~ 247 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---KNLVLK----IISGSF-----PPVSL 247 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHH----HHHTCC-----CCCCT
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHH----HHcCCC-----CCCCc
Confidence 223446799999999999999999999999999999999999999975432 122211 112221 11112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+ ...+.+|+.+||+.||++|||++|+++|.|+
T Consensus 248 ~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 248 HY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred cC----CHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence 22 2456788899999999999999999998765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=420.37 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=204.4
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----CCeEEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE----KKELLLVY 428 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~----~~~~~lV~ 428 (645)
...++||+|+||.||+|.+..++..||+|++... .....+.|.+|++++++++|||||+++++|.. ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799999999999999999999999998643 44556789999999999999999999999865 35689999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEECC-CCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~ 505 (645)
|||++|+|.+++.+. ..+++..+..++.||+.||.|||+ ++ |+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999654 568999999999999999999998 66 999999999999984 79999999999985432
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
......+||+.|||||++.+ .++.++|||||||+||||+||+.||...... ..+......+.... .
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~~~~~~i~~~~~~~----~ 250 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIYRRVTSGVKPA----S 250 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHHHHHTTTCCCG----G
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------HHHHHHHHcCCCCC----C
Confidence 33455789999999998864 6999999999999999999999999743321 11222222322111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+....+ ..+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 251 ~~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 251 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 111222 3467788999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=426.85 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=214.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..++||+|+||+||+|++..+|+.||||++... .....+.+.+|+++|++++|||||++++++++++.++|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999999999999999999653 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC-
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK- 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~- 507 (645)
|||++|+|.+++.+. +.+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999654 569999999999999999999999 999999999999999999999999999999765432
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......+||+.|||||++.+..++.++||||+||+||||++|+.||...+. ..+... +.++.. .+.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~----i~~~~~------~~p 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAK----IIKLEY------DFP 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHTCC------CCC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHcCCC------CCC
Confidence 2344567899999999999999999999999999999999999999975432 222221 222221 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQ------VIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e------vl~~L~~~ 626 (645)
..++ ..+.+|+.+||+.||++|||++| +++|.|+.
T Consensus 255 ~~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 255 EKFF----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp TTCC----HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred cccC----HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 2222 35677889999999999999998 57888875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=417.14 Aligned_cols=256 Identities=23% Similarity=0.373 Sum_probs=201.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||+|+||.||+|++..+|+.||||+++.. .....+.+.+|++++++++||||+++++++.+++.+++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999754 2334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+ +|+|.+++.+. ..+++.....++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-- 165 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence 999 68999988654 569999999999999999999999 99999999999999999999999999999865432
Q ss_pred cceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||+.|||||++.+..+ +.++||||+||++|||++|+.||..... ..+.. ...++.. .+.
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~----~i~~~~~------~~p 232 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFK----NISNGVY------TLP 232 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCC------CCC
T ss_pred CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCC------CCC
Confidence 23345689999999999988775 5899999999999999999999975321 11221 2222221 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 631 (645)
...+ ..+.+++.+||+.||++|||++|+++|.|+...+|.
T Consensus 233 ~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 233 KFLS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred CCCC----HHHHHHHHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 1222 356678899999999999999999999999776654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=438.70 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=215.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+.|+..++||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888999999999999999999999999999998766556677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++.. ..+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.+.... ...
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 99999998854 358999999999999999999999 999999999999999999999999999998765432 234
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+... +.++ ..+.+.. .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~----i~~~-----~~~~~~~--~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKM----IRDN-----LPPRLKN--L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH----HHHS-----CCCCCSC--T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHH----HHcC-----CCCCCcc--c
Confidence 457899999999999999999999999999999999999999975432 122221 1111 1111111 0
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......+.+|+.+||+.||++|||++|+++|.|+..
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 111245677889999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=425.55 Aligned_cols=252 Identities=19% Similarity=0.187 Sum_probs=205.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.+.|...++||+|+||.||+|+++.+|+.||||+++.... ..+|+.++++++|||||++++++.+++.++|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3467778899999999999999999999999999975432 24699999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~~~~ 509 (645)
|++|+|.+++.+. ..+++.....++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+|+........
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999654 469999999999999999999998 9999999999999999987 5999999999876543221
Q ss_pred ----ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 510 ----QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 510 ----~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||......... ..+. ....-.. .
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~---~~~~~~~----~ 277 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIA---SEPPPIR----E 277 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHH---HSCCGGG----G
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHH---cCCCCch----h
Confidence 123367999999999999999999999999999999999999999865543321 1111 1111000 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+...+ ...+.+++.+||+.||++|||+.|++++|..
T Consensus 278 ~~~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSC----APLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11222 2456778899999999999999999999864
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=376.48 Aligned_cols=174 Identities=38% Similarity=0.741 Sum_probs=158.7
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
.+++|+|++|.++ ..+|.++ ||. .++|.|+||+ ...+.|||+|++||+|||+.+|+++||+|+|+|.|.+.....+
T Consensus 2 ~~~sF~f~~F~~~-~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~ 79 (181)
T 2ltn_A 2 ETTSFLITKFSPD-QQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNV 79 (181)
T ss_dssp EEEEEEESSCCSS-CTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSC
T ss_pred cceEEEcCCCCCC-CCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 4689999999965 5689999 999 5899999999 6678999999999999999999999999999999998876778
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCC--CCceeeecCCCcccceeeecccC
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPT--FSHVGIDINSVKSKKNVSWWSDV 187 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~--~~hvgidvns~~s~~~~~~~~~~ 187 (645)
||||||||+|.++. |. +.||||||+|.. +++..+|+|||||||++|. |||+ +|||||||||+.|++++.|+ +
T Consensus 80 gdGlAF~l~p~~~~-p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~~Dp~~~~nHVGIdvNs~~S~~t~~~~--l 154 (181)
T 2ltn_A 80 ADGFTFFIAPVDTK-PQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWK--L 154 (181)
T ss_dssp CCEEEEEEEETTCC-CC-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTTTSCTTCCCEEEEEESSSSCSEEEECC--C
T ss_pred CCceEEEEecCCCC-CC-CCCccccccccC-CCCccccEEEEEeccccccccCCCCCCCEEEEEcCCccccceeccc--c
Confidence 99999999999865 65 889999999876 3577899999999999998 9999 99999999999999999984 7
Q ss_pred CCCceeEEEEEEcCCCceEEEEEecC
Q 042831 188 KSGRRNEAWISYNSSTHNLSVAFTGF 213 (645)
Q Consensus 188 ~~g~~~~~~I~Y~~~~~~l~v~l~~~ 213 (645)
.+|+.++|||+||+.+++|+|+|++.
T Consensus 155 ~~G~~~~v~I~Yd~~~~~L~V~l~~~ 180 (181)
T 2ltn_A 155 QNGEEANVVIAFNAATNVLTVSLTYP 180 (181)
T ss_dssp CTTCCEEEEEEEETTTTEEEEEEEEC
T ss_pred CCCCEEEEEEEEECCCCEEEEEEecC
Confidence 89999999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=429.11 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=215.5
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCC-CCccEEEe
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGS-KQGIKEYASEVKIISRLRH-RNLVQLLG 416 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H-~nlv~l~~ 416 (645)
..+++...++|...++||+|+||.||+|.+..+ ++.||||++.... ....++|.+|+++|.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 345666778899999999999999999998653 3689999997653 3456789999999999976 89999999
Q ss_pred eeeeC-CeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCC
Q 042831 417 WCHEK-KELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIK 480 (645)
Q Consensus 417 ~~~~~-~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 480 (645)
+|.+. +.++||||||++|+|.++|... ...++|..+..++.|||+||.|||+ ++|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccC
Confidence 99764 5789999999999999999642 2458999999999999999999999 999999999
Q ss_pred CCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q 042831 481 SSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKA 558 (645)
Q Consensus 481 p~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~ 558 (645)
|+|||+++++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543332 3344678999999999999999999999999999999998 999997644
Q ss_pred CCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 559 PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 559 ~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... .+.....++... ...... ...+.+++..||+.||++|||+.|++++|+.
T Consensus 293 ~~~------~~~~~i~~g~~~-----~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 293 IDE------EFCRRLKEGTRM-----RAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CSH------HHHHHHHHTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH------HHHHHHHcCCCC-----CCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 321 122222233211 111112 2456778899999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=415.60 Aligned_cols=265 Identities=26% Similarity=0.311 Sum_probs=200.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----eEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK----ELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~----~~~lV 427 (645)
++|...++||+|+||+||+|++. |+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++ .++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35667889999999999999984 789999999654322 222345666667899999999999998654 68999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-----CCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-----EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
||||++|+|.+++.. ..++|+.+.+++.|+++||+|||+.+ .++|+||||||+|||||.++++||+|||+++.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999965 35899999999999999999999742 34899999999999999999999999999987
Q ss_pred ccccCCc---ceeecccCccccCccccccC------CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc--------hhH
Q 042831 503 VEHAKGS---QTTVLAGTMGYMAPECATTG------KASKESDVYSFGIVALEIACGRKPINPKAPQGQ--------VSL 565 (645)
Q Consensus 503 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~--------~~l 565 (645)
....... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6544322 22346799999999998754 367899999999999999999887753322110 001
Q ss_pred HHHHHHHhcCCccccccCccccCC-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 566 LQWVWDLYGNGKLLEAVDPRLCRD-FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 566 ~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+.....++.+ +|.+... .+.+..+.+.+|+.+||+.||++||||.||++.|+.
T Consensus 238 ~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1222222222222 2222111 123566778899999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=420.87 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=203.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|+..+.||+|+||+||+|+.. .+++.||||+++... ......+.+|++++++++|||||++++++.+++.++|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56889999999999999999874 467899999986542 2234468899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||||++|+|.+++.+. ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999654 469999999999999999999999 99999999999999999999999999999865332
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
. ......+||+.|||||++.+..++.++|||||||+||||++|+.||...+. ..+...+ .++.. .+
T Consensus 180 ~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~~~~~~i----~~~~~------~~ 245 (304)
T 3ubd_A 180 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---KETMTMI----LKAKL------GM 245 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCC------CC
T ss_pred C-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---HHHHHHH----HcCCC------CC
Confidence 2 233456899999999999999999999999999999999999999975432 1222211 12211 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.... ...+.+++.+||+.||++||| ++|+++|.|+.
T Consensus 246 p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 246 PQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred CCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 1122 235677889999999999998 58999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=401.87 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=195.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--------
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-------- 422 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-------- 422 (645)
++|+..+.||+|+||.||+|+++.+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999999999999999999999999997543 345578999999999999999999999987543
Q ss_pred ----eEEEEEEecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 423 ----ELLLVYEFMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 423 ----~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
.+++|||||++|+|.+++.... ...++...+.|+.||++||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999997543 245677889999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCc-----------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 042831 497 FGLARLVEHAKGS-----------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL 565 (645)
Q Consensus 497 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l 565 (645)
||+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 1234579999999999999999999999999999999996 77521 111
Q ss_pred HHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 566 LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 566 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... ..+.... +. ..+....+..++.+||++||++|||+.|+++|.+++
T Consensus 234 ~~~~~~-~~~~~~p----~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~ 284 (299)
T 4g31_A 234 VRTLTD-VRNLKFP----PL-----FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284 (299)
T ss_dssp HHHHHH-HHTTCCC----HH-----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHH-HhcCCCC----CC-----CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence 111111 1121111 10 112223456788999999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=402.93 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=209.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee------CCe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE------KKE 423 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~------~~~ 423 (645)
++|...++||+|+||.||+|++..+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788899999999999999999999999999999754 33456788999999999999999999998764 367
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+|||||||+ |+|.+++.+ ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999995 789888854 4579999999999999999999999 99999999999999999999999999999866
Q ss_pred cccC---CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 504 EHAK---GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 504 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...... .....+..........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCCChH
Confidence 4322 2234457899999999998775 5699999999999999999999999765432 2222222222111100
Q ss_pred c--------------ccCccccCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 E--------------AVDPRLCRDFDGQ-----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 ~--------------~~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. .+.+. ...+.+ ....+.+|+.+||+.||++|||++|+++|.|+..
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp GTC-----CHHHHHHSSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred HhhhhhhhhhhhhhhcCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 0 00000 000111 1245678899999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=389.93 Aligned_cols=284 Identities=37% Similarity=0.703 Sum_probs=250.6
Q ss_pred CCccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 339 ~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
..++++.++..++++|...+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||++++++|
T Consensus 26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred ceeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356778888889999999999999999999999975 5889999998877667778899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKEN---SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
.+.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999996543 358999999999999999999999 899999999999999999999999
Q ss_pred eccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 496 DFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 496 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
|||+++....... .......||+.|+|||++.++.++.++|||||||++|||++|+.||....+.+......|......
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence 9999986543222 223345689999999999988999999999999999999999999987777666777888877777
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.+...+++.+......+....+.+++.+||+.||++|||++|++++|+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8888888888888788888999999999999999999999999999999854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=391.00 Aligned_cols=294 Identities=37% Similarity=0.666 Sum_probs=253.3
Q ss_pred CCCccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEe
Q 042831 338 GPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 338 ~~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
...+|+++++....++|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++.+++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3578999999999999999999999999999999865 588999999875532 23347899999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
+|...+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 999999999999999999999999753 34599999999999999999999994334999999999999999999999
Q ss_pred EeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--CCCchhHHHHHHH
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA--PQGQVSLLQWVWD 571 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~--~~~~~~l~~~~~~ 571 (645)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||+... ........+|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998776555555556679999999999988899999999999999999999999996321 2234456677777
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCCC
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPAL 632 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~ 632 (645)
......+....+..+...+..++...+.+++.+||+.||++|||++|++++|+.+......
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 7777778888888888888899999999999999999999999999999999987554443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=419.42 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=218.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++........+.+.+|+++|++++|||||++++++.+++.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999999999999999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC--CcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN--FNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~--~~~kl~DfGla~~~~~~~~ 508 (645)
|++|+|.+++......+++.....++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-- 310 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-- 310 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence 99999999997766789999999999999999999999 999999999999999854 89999999999876533
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .+.. .+..+... +++....
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~----~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLR----NVKSCDWN--MDDSAFS 381 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHTTCCC--CCSGGGT
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHH----HHHhCCCC--CCccccc
Confidence 3344568999999999999999999999999999999999999999754321 1221 11122110 1111112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+ ..+.+|+.+||+.||++|||+.|+++|.|+.
T Consensus 382 ~~s----~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~ 415 (573)
T 3uto_A 382 GIS----EDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415 (573)
T ss_dssp TSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred CCC----HHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence 222 3566788999999999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=391.53 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=205.4
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
.+....++|...++||+|+||+||+|+++ .+++.||+|++..... ..++.+|+++|.++ +||||+++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33345678999999999999999999875 4578999999865432 35678999999998 699999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLA 500 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla 500 (645)
+++++|||||++|+|.+++. .+++.+...++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999999883 48999999999999999999999 999999999999999876 79999999999
Q ss_pred ccccccCC---------------------------cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCC
Q 042831 501 RLVEHAKG---------------------------SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRK 552 (645)
Q Consensus 501 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~ 552 (645)
+....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 85532211 112345799999999998775 48999999999999999999999
Q ss_pred CCCCCCCCCchhHHHHHHHHhcC----------Cc-c--------------------ccccCccccCC---------CCH
Q 042831 553 PINPKAPQGQVSLLQWVWDLYGN----------GK-L--------------------LEAVDPRLCRD---------FDG 592 (645)
Q Consensus 553 pf~~~~~~~~~~l~~~~~~~~~~----------~~-l--------------------~~~~d~~l~~~---------~~~ 592 (645)
||...... ...+..+....+. +. . .+...|.+... ...
T Consensus 246 Pf~~~~~~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 246 PFYKASDD--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp SSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCH--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 99654322 1111111111100 00 0 00000000000 000
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~ 357 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFK 357 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGT
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccC
Confidence 1124567889999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=414.24 Aligned_cols=255 Identities=25% Similarity=0.313 Sum_probs=207.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHH---HHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEY---ASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
-++|...++||+|+||.||+|+++.+|+.||||++.+.. ....... ..++.+++.++|||||++++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999999999999999986431 1222233 3446677788999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
|||||||+||+|.+++.+. ..+++.....++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999654 569999999999999999999998 999999999999999999999999999998664
Q ss_pred ccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.. .....+||+.|||||++.. ..++.++|+|||||+||||++|+.||......+...+..... ...
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~~------ 410 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TMA------ 410 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HCC------
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CCC------
Confidence 32 2345689999999999975 469999999999999999999999997544333222222111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
..+...+ ...+..|+..||+.||++|++ ++||++|.|+.
T Consensus 411 ~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 411 VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred CCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 1111222 235677889999999999998 79999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=370.67 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=214.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...++||+|+||.||+|.+..+++.||+|++........+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 45778889999999999999999999999999999777777888999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++|+|.+++......+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999998777789999999999999999999999 899999999999999999999999999998664332211
Q ss_pred -------------eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 511 -------------TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 511 -------------~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+............. ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~------- 237 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VR------- 237 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HH-------
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hh-------
Confidence 114579999999999999999999999999999999999999987544322110000 00
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+......+ ...+.+++.+||+.||++|||++|+++.|+.
T Consensus 238 --~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~ 279 (310)
T 3s95_A 238 --GFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279 (310)
T ss_dssp --HHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --ccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00011111111 1346778899999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=367.70 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=215.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...++||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45789999999999999999999999999999999766555667889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++|+|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....... ..
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 9999999998653 58999999999999999999999 899999999999999999999999999998654332 23
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.. ....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~-~~~~------- 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQN------- 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCSC-------
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC-CCCC-------
Confidence 34467999999999999999999999999999999999999999754321 111111111111 0000
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
+......+.+++.+||+.||++|||++|++++.++...
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 11123457788899999999999999999999998743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=367.28 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=212.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.++|...+.||+|+||.||+|++..+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788999999999999999999999999999998654 4455678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 999999999998654 458999999999999999999999 89999999999999999999999999999865432
Q ss_pred cceeecccCccccCccccccCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKAS-KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t-~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+.. ....+.. .+.
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~----~i~~~~~------~~p 234 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELRE----RVLRGKY------RIP 234 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CCC
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC------CCC
Confidence 233456799999999999887764 8999999999999999999999754321 1111 1112211 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.. ....+.+++.+||+.||++|||++|+++|.|+..
T Consensus 235 ~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 235 FY----MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp TT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred CC----CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 11 1235667889999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=384.96 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=220.1
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
+.++++....++|...++||+|+||+||+|++..+++.||+|++.... ......+.+|..++.+++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677788899999999999999999999999999999999986532 12233488999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
.+++.+++|||||++|+|.+++.+....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999999997766789999999999999999999999 999999999999999999999999999
Q ss_pred CcccccccCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||...... .....+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~ 297 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHK 297 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh---HHHHhhhhcc
Confidence 99866544433444568999999999987 456899999999999999999999999754321 1222111100
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFE 626 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~ 626 (645)
.. ..-|......+ ..+.+++.+||+.+|++ ||+++|+++|.++.
T Consensus 298 ~~-----~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 298 ER-----FQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp HH-----CCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred cc-----ccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 00 00111111222 35667788899888888 99999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=362.54 Aligned_cols=267 Identities=24% Similarity=0.311 Sum_probs=220.4
Q ss_pred CccChHHHHHhhcC----------CCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCC
Q 042831 340 KRFPYKELALATND----------FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHR 409 (645)
Q Consensus 340 ~~~~~~el~~~~~~----------f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ 409 (645)
..++++++..+++. |...++||+|+||.||+|++..+|+.||||++........+.+.+|+.++.+++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888877764 66677999999999999999988999999999877666678899999999999999
Q ss_pred CccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC
Q 042831 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN 489 (645)
Q Consensus 410 nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~ 489 (645)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999998853 468999999999999999999999 899999999999999999
Q ss_pred CcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH
Q 042831 490 FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV 569 (645)
Q Consensus 490 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~ 569 (645)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 178 ~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~- 252 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKR- 252 (321)
T ss_dssp CCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHH-
T ss_pred CcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-
Confidence 999999999998664322 223446799999999999999999999999999999999999999975432 111111
Q ss_pred HHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 570 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... ..+.+.. .......+.+++.+||+.||++|||++|++++.++.
T Consensus 253 ---~~~~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 253 ---LRDS-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp ---HHHS-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred ---HhcC-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 1111 1111110 011124567788999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=364.15 Aligned_cols=252 Identities=27% Similarity=0.346 Sum_probs=204.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...++||+|+||+||+|++..+++.||||++... ......++..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999999989999999998653 334445566677666665 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+ +++|.+++...+..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 779999988777789999999999999999999999 89999999999999999999999999998765432
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||++|+|||++.+ .++.++|||||||++|||++|+.|+.... .+....++... +.+.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~----~~~~ 274 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLP----PEFT 274 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCC----HHHH
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCC----cccc
Confidence 22344569999999998875 79999999999999999999977764211 12222222221 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
... ...+.+++.+||++||++|||++|++++.|+..
T Consensus 275 ~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 275 AGL----SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cCC----CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 112 246778889999999999999999999999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.93 Aligned_cols=278 Identities=38% Similarity=0.655 Sum_probs=230.1
Q ss_pred CCccChHHHHHhhcCCCCC------CccCcCCcEEEEEEEEcCCCeEEEEEEeccC----ChhhHHHHHHHHHHHHhcCC
Q 042831 339 PKRFPYKELALATNDFNDD------QKLGQGGFGGVYKGFFRETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLRH 408 (645)
Q Consensus 339 ~~~~~~~el~~~~~~f~~~------~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H 408 (645)
...|++.++..++++|... +.||+|+||.||+|.. +++.||+|++... .....+.+.+|+.++.+++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4679999999999999888 8999999999999987 3788999998643 23456789999999999999
Q ss_pred CCccEEEeeeeeCCeEEEEEEecCCCChhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 409 ~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
|||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999999864 34569999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL 565 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l 565 (645)
+.++.+||+|||+++........ ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-- 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-- 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--
Confidence 99999999999999866543222 2234578999999998764 5889999999999999999999999865443221
Q ss_pred HHHHHHHhc-CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 566 LQWVWDLYG-NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 566 ~~~~~~~~~-~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+...... ...+.+.+++.+ ........+.+.+++..||+.||++|||+++++++|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 222222221 223344455544 34566778889999999999999999999999999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=365.06 Aligned_cols=264 Identities=30% Similarity=0.463 Sum_probs=203.1
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
.+...++....++|...+.||+|+||.||+|++. ++.||||++.... ....+++.+|++++.+++||||+++++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3444555566778999999999999999999874 7889999987543 44567899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEECCCCcEEE
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLDSNFNAKI 494 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld~~~~~kl 494 (645)
...+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL 180 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKV 180 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEE
Confidence 99999999999999999999996543 248999999999999999999998 78 999999999999999999999
Q ss_pred eeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 495 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+. .
T Consensus 181 ~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~~---~ 253 (309)
T 3p86_A 181 CDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAVG---F 253 (309)
T ss_dssp CCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHHH---H
T ss_pred CCCCCCcccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h
Confidence 999999754332 22234467999999999999999999999999999999999999999754321 1111111 0
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ..+...+ ...+.+++.+||+.||++|||++|+++.|+.
T Consensus 254 ~~~~-----~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 254 KCKR-----LEIPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp SCCC-----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC-----CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111 1111222 2457788899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=365.46 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=209.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC---eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN---SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+|.+..++ ..||||++... .....+.+.+|++++.+++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999997544 46999999765 44556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 999999999999997777789999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~----~~~~~~~----- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS----SVEEGYR----- 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH----HHHTTCC-----
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHcCCC-----
Confidence 2222 223346778999999998899999999999999999999 99999754321 1111 1112211
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..... .....+.+++..||+.||++|||++|+++.|+.-
T Consensus 273 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 LPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111 2234677888999999999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=370.25 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=217.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||+|.+..+++.||+|.+..........+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999877666667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--CCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~~~~~~~ 508 (645)
+++|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 99999999997766689999999999999999999999 89999999999999974 577999999999876432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. .... ..++....
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~i~----~~~~--~~~~~~~~ 275 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVK----RCDW--EFDEDAFS 275 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH----HCCC--CCCSSTTT
T ss_pred cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---HHHHHHHH----hCCC--CCCccccc
Confidence 223445799999999999999999999999999999999999999975432 11221111 1111 01111112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.. ...+.+++.+||+.||++|||++|++++.++...
T Consensus 276 ~~----s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 276 SV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 22 2457788899999999999999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.34 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=209.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999999999999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-c
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-S 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~ 509 (645)
+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 87 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 87 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999999854 4569999999999999999999998 9999999999999999999999999999986543222 2
Q ss_pred ceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|. ..... .++ ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~---~~~--~~ 232 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTY---LNP--WK 232 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTT---STT--GG
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----ccccc---CCc--cc
Confidence 2334679999999999987775 7899999999999999999999976543321 111111 11100 010 01
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.....+.+++.+||+.||++|||++|++++.|+..+
T Consensus 233 ----~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 233 ----KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 122456678899999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.41 Aligned_cols=259 Identities=19% Similarity=0.255 Sum_probs=215.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467888999999999999999999999999999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--CCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~~~~~~~ 508 (645)
+++|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-- 157 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence 99999999997766689999999999999999999999 89999999999999987 789999999999876432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ .++... .++....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i----~~~~~~--~~~~~~~ 228 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENI----MNAEYT--FDEEAFK 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH----HHTCCC--CCHHHHT
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHH----HcCCCC--CChhhhc
Confidence 2344567999999999999888999999999999999999999999754321 112111 111110 0111111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.. ...+.+++.+||+.||++|||+.|+++|.|+...
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 11 2457788899999999999999999999997644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.24 Aligned_cols=254 Identities=28% Similarity=0.377 Sum_probs=211.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+++...+|+.||+|+++.. .......+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35788899999999999999999999999999999654 233456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++|+|..++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999988643 468999999999999999999999 89999999999999999999999999999754322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+.. .+.
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~----~i~~~~~------~~p 225 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFE----LILMEEI------RFP 225 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCC------CCC
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCC------CCC
Confidence 2234456799999999999999999999999999999999999999975332 11111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
... ...+..++.+||+.||++|| +++|+++|.++.
T Consensus 226 ~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~ 265 (337)
T 1o6l_A 226 RTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred CCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence 122 24567788999999999999 999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=352.80 Aligned_cols=272 Identities=25% Similarity=0.306 Sum_probs=212.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...++||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688899999999999999999999999999998754 33445788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++ +|.+.+......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9965 6666666666789999999999999999999999 89999999999999999999999999999866432 22
Q ss_pred ceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc------cc
Q 042831 510 QTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE------AV 582 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~------~~ 582 (645)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .......+........... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 334457899999999987766 79999999999999999998888643322 2223333333322111000 00
Q ss_pred C-------c--cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 583 D-------P--RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 583 d-------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
+ + .............+.+++.+||+.||++|||++|+++|.|+..-.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 0 0 0000111122346678889999999999999999999999875433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.51 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=210.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc-------CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR-------ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
.++|...+.||+|+||.||+|.+. .++..||||+++.. .....+++.+|++++.++ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999874 24568999999765 344567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997543 358999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 042831 487 DSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVS 564 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~ 564 (645)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999986543322 22233457889999999999999999999999999999999 99999754322 1
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.. ....+.. +.... .....+.+++.+||+.||++||+++|+++.|+.
T Consensus 314 ~~~----~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 LFK----LLKEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHH----HHHTTCC-----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----HHhcCCC-----CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 221 1222211 11111 223467788899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=358.64 Aligned_cols=272 Identities=24% Similarity=0.285 Sum_probs=211.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...++||+|+||.||+|++.. ++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34678889999999999999999864 8899999986542 23356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||++ ++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 98 FEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99997 58888887777779999999999999999999999 899999999999999999999999999998654322
Q ss_pred CcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc---c-
Q 042831 508 GSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA---V- 582 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~---~- 582 (645)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+............ .
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTT
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhc
Confidence 22334578999999999876 5689999999999999999999999986554432 2222222221110000 0
Q ss_pred -----Cccc--cCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 583 -----DPRL--CRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 583 -----d~~l--~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
+... ...... .....+.+++.+||+.||++|||++|+++|.++..--|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 0000 000000 11246778899999999999999999999999875433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.07 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=208.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEE----EcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGF----FRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~ 424 (645)
.++|...++||+|+||.||+|+ ...+++.||||++........+.+.+|++++.+++||||++++++|.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3567889999999999999998 456789999999988777778899999999999999999999999864 3568
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++|+|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999998776679999999999999999999998 899999999999999999999999999998764
Q ss_pred ccCC--cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---------CCchhHHHHHHHHh
Q 042831 505 HAKG--SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP---------QGQVSLLQWVWDLY 573 (645)
Q Consensus 505 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~---------~~~~~l~~~~~~~~ 573 (645)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... ...........+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 3322 122334577789999999999999999999999999999999999863211 00111111122222
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+... ..+......+.+++..||+.||++|||++|+++.|+.
T Consensus 246 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 246 KNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 221111 1111223567788899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=374.42 Aligned_cols=270 Identities=21% Similarity=0.238 Sum_probs=219.0
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEee
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGW 417 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~ 417 (645)
.+.++++....++|...+.||+|+||.||+++++.+|+.||||++.... ....+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3556777778899999999999999999999999999999999996532 2234568899999999999999999999
Q ss_pred eeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 418 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
+.+.+.+++||||+++|+|.+++.+.+..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++++||+||
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999998766689999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCcceeecccCccccCccccc-------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH
Q 042831 498 GLARLVEHAKGSQTTVLAGTMGYMAPECAT-------TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 498 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~ 570 (645)
|+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||...... .....+.
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~ 283 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIV 283 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999876543333334468999999999987 356899999999999999999999999754321 1111111
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHhccC
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR---PSIRQVIHVLNFE 626 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~L~~~ 626 (645)
.... .+ .-|.....+ ...+.+++.+||+ +|++| |+++|+++|.++.
T Consensus 284 ~~~~--~~---~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~ 332 (412)
T 2vd5_A 284 HYKE--HL---SLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332 (412)
T ss_dssp THHH--HC---CCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGT
T ss_pred hccc--Cc---CCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcC
Confidence 1000 00 011111122 2456778899999 99998 6999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.90 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=200.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+|++. .++..||||+++.. .....++|.+|+.++.+++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457999999999999999999986 45678999999765 34556789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++.+....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999998777789999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCcc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ....+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~----~i~~~~~----- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIK----AVDEGYR----- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHH----HHHTTEE-----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC-----
Confidence 2211 122345778999999999999999999999999999998 99999754321 1111 1112211
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..........+.+++..||+.||++||+++|+++.|+.
T Consensus 269 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 269 ----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 01111223567888999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.28 Aligned_cols=254 Identities=27% Similarity=0.486 Sum_probs=209.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||+|.+.. ++.||+|++..... ..+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4578888999999999999999874 67899999975432 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++......+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999998777789999999999999999999998 899999999999999999999999999998654333223
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ....+. ....+ ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~----~~~~~~--~~~~~---~~ 231 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE----DISTGF--RLYKP---RL 231 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTC--CCCCC---TT
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhcCc--cCCCC---Cc
Confidence 333456788999999999999999999999999999999 99999754321 1111 111111 01111 11
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ...+.+++..||+.||++|||++|++++|+.
T Consensus 232 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 232 A----STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1 2457788899999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=375.45 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=211.6
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
....++|...+.||+|+||.||+|++..+++.||||.+.... ....++|.+|++++++++||||++++++|..++..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567888999999999999999999889999999987543 3445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++...+..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999998766779999999999999999999999 89999999999999999999999999999754322
Q ss_pred CCcce-eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGSQT-TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..... ....++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .+.+....+.... .+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~--~~ 337 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLP--CP 337 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCC--CC
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC--CC
Confidence 11111 11235678999999998899999999999999999998 99999754321 1122222222111 01
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+ ...+.+++..||+.||++|||++++++.|+.
T Consensus 338 ---~~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 338 ---ELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp ---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 112 2456788899999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.56 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=212.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh------hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ------GIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||++++..+|+.||+|.+...... ..+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45788899999999999999999999999999998754321 357889999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLA 500 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla 500 (645)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999854 4579999999999999999999999 8999999999999998877 7999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+..+..
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~----~i~~~~~-- 235 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NITAVSY-- 235 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHTTCC--
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhcCC--
Confidence 866432 2234467999999999999989999999999999999999999999754321 1111 1111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..++...... ...+.+++..||+.||++|||+.|+++|.|+.
T Consensus 236 ~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 236 DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 0111111111 24567888999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.88 Aligned_cols=272 Identities=24% Similarity=0.284 Sum_probs=216.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--eEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--ELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--~~~lV 427 (645)
.++|...++||+|+||.||+|++..+++.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888999999999999999999999999999997543 334677889999999999999999999988655 78999
Q ss_pred EEecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----CCCCcEEEeeccCcc
Q 042831 428 YEFMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLAR 501 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kl~DfGla~ 501 (645)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997543 349999999999999999999999 899999999999999 888899999999998
Q ss_pred cccccCCcceeecccCccccCccccc--------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHHHH
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECAT--------TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ-VSLLQWVWDL 572 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~-~~l~~~~~~~ 572 (645)
...... ......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ......+...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 764432 233456999999999886 56789999999999999999999999975443222 2222222211
Q ss_pred hcCCcccccc-----------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 573 YGNGKLLEAV-----------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 573 ~~~~~l~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.....+.... +-.............+..++..||+.||++|||++|+++++..++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111111000 001112345677788889999999999999999999999998664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.72 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=210.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...+.||+|+||.||+|.+.. +..||+|++..... ..+++.+|++++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 45678889999999999999998864 67899999975432 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999998776779999999999999999999999 89999999999999999999999999999866543333
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... . ....+.. ...+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~-~~~~~~~--~~~~~~-- 229 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVV---L-KVSQGHR--LYRPHL-- 229 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH---H-HHHTTCC--CCCCTT--
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHH---H-HHHcCCC--CCCCCc--
Confidence 3334456778999999998889999999999999999999 99999754321 111 1 1111111 111111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. ...+.+++..||+.||++|||++|++++|+.-
T Consensus 230 -~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 230 -A----SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp -S----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred -C----hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 23577888999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.21 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=202.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeE----EEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...++||+|+||.||+|++..+++. ||+|.+... .....+++.+|+.++.+++||||++++++|...+ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35688899999999999999998776654 588877543 3355678999999999999999999999998754 78
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+++|+|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999998877889999999999999999999999 8999999999999999999999999999987654
Q ss_pred cCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||....... +.. ....+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~---- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL---- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC----
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCC----
Confidence 3322 2233456889999999999999999999999999999999 999997544322 111 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+......+..++.+||+.||++||+++|++++|+.
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 239 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1111223467788899999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=368.56 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=210.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...++||+|+||.||++++..+++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 45788899999999999999999999999999999754 233445688899999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|..++.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 99999999999988654 468999999999999999999999 8999999999999999999999999999985322
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc--hhHHHHHHHHhcCCccccccCc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ--VSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~--~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ....+.+......+..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 22334557899999999999999999999999999999999999999974432211 1111222222222211
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSI------RQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~~ 626 (645)
.+.... ...+..++..||+.||++||++ +|+++|.++.
T Consensus 280 ~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 280 RIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred CCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 111122 2456788899999999999984 8999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=367.21 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=214.5
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEE-----cCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEE
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQL 414 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l 414 (645)
+...++....++|...+.||+|+||.||+|.+ ..+++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566777788999999999999999999994 456789999999764 344567899999999999 78999999
Q ss_pred EeeeeeCC-eEEEEEEecCCCChhhhhhhcCC------------------------------------------------
Q 042831 415 LGWCHEKK-ELLLVYEFMPNGSLDSHLFKENS------------------------------------------------ 445 (645)
Q Consensus 415 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 445 (645)
+++|.+.+ ..++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 48999999999999999975422
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 446 -----------------LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 446 -----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 28999999999999999999999 8999999999999999999999999999986543322
Q ss_pred -cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 509 -SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 509 -~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ + ......+.. ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~----~~~~~~~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H----HHHHHHTCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--H----HHHHHcCCC-----CCC
Confidence 23344568899999999999999999999999999999998 9999976543211 1 111111111 111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ...+.+++..||+.||++|||++|++++|+.
T Consensus 318 ~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1112 2457788899999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=354.08 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=207.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788899999999999999999999999999998543 344567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999998654 468999999999999999999999 899999999999999999999999999998765444
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+ .... ......
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~-~~~~~~ 237 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPN-VTTDVR 237 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCC-HHHHSC
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCC-cchhcc
Confidence 44445567999999999999999999999999999999999999999754321 111111111 1110 011111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRP-SIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 626 (645)
... ...+..++.+|++.||++|| +++++.+.|..-
T Consensus 238 ~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 238 KDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred cCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 222 24677888999999999999 899999888753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=359.62 Aligned_cols=272 Identities=27% Similarity=0.348 Sum_probs=209.6
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC---
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--- 422 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--- 422 (645)
++....++|...++||+|+||.||+|++. ++.||||++.... .....+..|+.++.+++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 34445578899999999999999999886 7899999996543 33445667999999999999999999998743
Q ss_pred -eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh-------cCCCeeeccCCCCCeEECCCCcEEE
Q 042831 423 -ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE-------WEQCVVHRDIKSSNIMLDSNFNAKI 494 (645)
Q Consensus 423 -~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivH~Dlkp~NILld~~~~~kl 494 (645)
.+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +..+|+||||||+|||++.++.+||
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 47999999999999999965 3489999999999999999999982 1129999999999999999999999
Q ss_pred eeccCcccccccCCc-ceeecccCccccCccccccC-----CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH-
Q 042831 495 GDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTG-----KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ- 567 (645)
Q Consensus 495 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~- 567 (645)
+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 23335799999999998763 45678999999999999999999998655432221111
Q ss_pred --------HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 568 --------WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 568 --------~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..............+..... .......+.+++.+||+.||++|||++|+++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111111111111111111 12455678899999999999999999999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=350.23 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=202.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------------------------hhHHHHHHHHHHHH
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------------------------QGIKEYASEVKIIS 404 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~ 404 (645)
.++|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3678889999999999999999999999999999865421 12356889999999
Q ss_pred hcCCCCccEEEeeeee--CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 405 RLRHRNLVQLLGWCHE--KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 405 ~l~H~nlv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||+.||.|||+ .+|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 9999999999999986 56899999999999998865 33579999999999999999999999 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK---ASKESDVYSFGIVALEIACGRKPINPKAP 559 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~elltG~~pf~~~~~ 559 (645)
|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 9999999999999999998664322 2234467999999999987765 37889999999999999999999975321
Q ss_pred CCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 560 QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 560 ~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+. .....+.... + ..... ...+.+++.+||+.||++|||+.|+++|.|+
T Consensus 246 ---~~~~----~~~~~~~~~~---~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 246 ---MCLH----SKIKSQALEF---P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp ---HHHH----HHHHHCCCCC---C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred ---HHHH----HHHhcccCCC---C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 1111 1111111110 0 01122 2457788899999999999999999998875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=375.38 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=215.7
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
++++....++|...++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4566677889999999999999999999999999999999986421 2223457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
++.+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecccee
Confidence 9999999999999999998854 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGK----ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
+..............||+.|+|||++.... ++.++|||||||++|||++|+.||...... .....+. ++
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~----~~ 288 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIM----NH 288 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----TH
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHH----hc
Confidence 876544333344578999999999997655 789999999999999999999999754321 1111111 11
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHHhccCC
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL--RPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L~~~~ 627 (645)
... ..-|. ...+ ...+..++.+||+.+|++ ||+++|+++|.++..
T Consensus 289 ~~~-~~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 289 KNS-LTFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp HHH-CCCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred ccc-ccCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 000 00010 0112 245667888999999988 999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.64 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=208.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEE-----cCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||+|++ ..+++.||||++... ......++.+|+.++.+++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678889999999999999994 346789999999654 445567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEEe
Q 042831 425 LLVYEFMPNGSLDSHLFKEN------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKIG 495 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl~ 495 (645)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 468999999999999999999999 8999999999999999555 59999
Q ss_pred eccCcccccccC-CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHh
Q 042831 496 DFGLARLVEHAK-GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 496 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~----~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE----FV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HH
Confidence 999998654322 223344568899999999999999999999999999999998 99999754321 1221 22
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+... .....+ ...+.+++.+||+.||++|||+.|++++|+.-
T Consensus 300 ~~~~~~-----~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 TSGGRM-----DPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HTTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCC-----CCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222111 111122 24577888999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=366.57 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=212.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35788899999999999999999999999999998643 233457888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 999999999999864 4569999999999999999999999 89999999999999999999999999999865432
Q ss_pred CcceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 508 GSQTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+..... ... .
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~------~ 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTV------V 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCC------C
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcc------c
Confidence 33445679999999999864 458999999999999999999999997654433322222111 111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPS-IRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~~~ 626 (645)
.. +......+..++..||+.||++||+ ++++++|.++.
T Consensus 238 ~~----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~ 276 (384)
T 4fr4_A 238 TY----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276 (384)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred CC----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence 11 1112346778889999999999998 99999988875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=359.53 Aligned_cols=257 Identities=23% Similarity=0.296 Sum_probs=211.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.++.+++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3568889999999999999999999999999999875432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLA 500 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla 500 (645)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999854 4568999999999999999999998 8999999999999999887 8999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+...... ......||+.|+|||++....++.++|||||||++|||++|+.||...... .....+. ....
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----~~~~-- 234 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVS----AVNY-- 234 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH----HTCC--
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHH----hcCC--
Confidence 8764322 233457999999999999889999999999999999999999999754321 1111111 1100
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+...... ...+.+++.+||+.||++|||++|+++|.++.
T Consensus 235 ~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 276 (326)
T 2y0a_A 235 EFEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276 (326)
T ss_dssp CCCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTS
T ss_pred CcCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcCCCcc
Confidence 0011111111 24567888999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.46 Aligned_cols=272 Identities=19% Similarity=0.256 Sum_probs=211.2
Q ss_pred hhcCCCCCCccCcC--CcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQG--GFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G--~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|...++||+| +||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678889999999 9999999999999999999999754 3445677889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 426 LVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
+|||||++|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999754 3569999999999999999999999 899999999999999999999999999986543
Q ss_pred ccCC------cceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc--
Q 042831 505 HAKG------SQTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-- 574 (645)
Q Consensus 505 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-- 574 (645)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcc
Confidence 2111 11222468999999999987 57899999999999999999999999765433211 100000000
Q ss_pred --------------------CCccccccC---ccc------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 575 --------------------NGKLLEAVD---PRL------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 575 --------------------~~~l~~~~d---~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+.+.+. +.. ...........+.+++.+||+.||++|||++|+++|.++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 000000000 000 000111223567889999999999999999999999987
Q ss_pred C
Q 042831 626 E 626 (645)
Q Consensus 626 ~ 626 (645)
.
T Consensus 338 ~ 338 (389)
T 3gni_B 338 K 338 (389)
T ss_dssp G
T ss_pred H
Confidence 5
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=353.09 Aligned_cols=258 Identities=24% Similarity=0.392 Sum_probs=208.5
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+....++|...+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 3345567888999999999999999887 477899999975532 34678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++......+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999997766679999999999999999999999 89999999999999999999999999999866433
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ....++. ...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~-----~~~ 241 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGL-----RLY 241 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HHHHTTC-----CCC
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHH----HHHhccc-----CCC
Confidence 2222333456788999999998899999999999999999998 99999754321 111 1111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..... .+.+.+++.+||+.||++|||++|++++|+.
T Consensus 242 ~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 242 RPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11111 2467788899999999999999999999963
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=362.10 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=210.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57888999999999999999999999999999986432 223457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+ +|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999 78998888654 468999999999999999999999 899999999999999999999999999998654332
Q ss_pred cceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ..+....
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~~~- 224 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNSCV- 224 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCSSC-
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHcCC-
Confidence 2334579999999999988775 78999999999999999999999754322111 0011000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 631 (645)
...+......+.+++.+||+.||++|||++|++++.|+...+|.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 00111122456788899999999999999999999998765554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=382.82 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=214.8
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+.....+|...++||+|+||.||+|++..++..||||.++... ...++|.+|+.++.+++||||++++++|...+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 3445567888999999999999999999889999999997543 346789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 427 VYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
|||||++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999764 4569999999999999999999999 8999999999999999999999999999987643
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..........++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+.+ ....+...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~----- 438 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYRM----- 438 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCC-----
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC-----
Confidence 32222233446778999999999899999999999999999999 99999764432 1121 12222110
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+......+.+++.+||+.||++|||++++++.|+.-
T Consensus 439 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 ----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11112234677888999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=366.41 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=207.4
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|...+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 346899999999999999999999999999999999754 233456788999999998 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||+++|+|..++.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999998654 568999999999999999999999 8999999999999999999999999999975332
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.++.. .
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~----~i~~~~~------~ 242 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFE----AILNDEV------V 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------C
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCC------C
Confidence 222344567999999999999888999999999999999999999999754321 1221 1111211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSI------RQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~~ 626 (645)
+... ....+..++..||+.||++||++ +|+++|.++.
T Consensus 243 ~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 243 YPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp CCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred CCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 1111 22456778899999999999998 8999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=352.61 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=217.3
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
+++....++|...+.||+|+||.||+|.+..++..||+|.+... ....+.+.+|++++++++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 34455677899999999999999999999999999999999654 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 425 LLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999763 4569999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+. ...+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~----~~~~~----- 229 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYEL----LEKDY----- 229 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHH----HHTTC-----
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhccC-----
Confidence 5544444444567889999999999999999999999999999999 999997544321 1111 11111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....... ....+.+++..|++.||++|||++|+++.|+.
T Consensus 230 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 230 RMERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1111111 23467788899999999999999999998863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.83 Aligned_cols=276 Identities=24% Similarity=0.261 Sum_probs=219.0
Q ss_pred CCccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-----CCCccE
Q 042831 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-----HRNLVQ 413 (645)
Q Consensus 339 ~~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nlv~ 413 (645)
...+++++.....++|...++||+|+||.||+|++..+++.||||++... ....+.+..|++++.+++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 35677777888889999999999999999999999999999999998643 445567788999999997 999999
Q ss_pred EEeeeeeCCeEEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC----
Q 042831 414 LLGWCHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---- 488 (645)
Q Consensus 414 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---- 488 (645)
+++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 999999999999999999 999999997643 469999999999999999999998 99999999999999976
Q ss_pred ---------------------CCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHH
Q 042831 489 ---------------------NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEI 547 (645)
Q Consensus 489 ---------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~el 547 (645)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999976432 22345789999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCCCchhHHHHHHHHhcC-----------CccccccCc-cc----cCC-CCHH---------------HH
Q 042831 548 ACGRKPINPKAPQGQVSLLQWVWDLYGN-----------GKLLEAVDP-RL----CRD-FDGQ---------------QI 595 (645)
Q Consensus 548 ltG~~pf~~~~~~~~~~l~~~~~~~~~~-----------~~l~~~~d~-~l----~~~-~~~~---------------~~ 595 (645)
++|+.||......+ ....+...... ......++. .+ ... .... ..
T Consensus 253 l~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 253 YTGSLLFRTHEHME---HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHSSCSCCCSSHHH---HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHCCCCCCCCcHHH---HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 99999997544222 11111111100 000000000 00 000 0000 11
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 596 ERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 596 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.+.+++.+||+.||++|||++|+++|.|++
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 5677899999999999999999999998863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.99 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=206.2
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
..+.||+|+||.||+|.+..+|+.||+|++........+++.+|++++.+++||||+++++++...+..++||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35679999999999999999999999999987766677889999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE--CCCCcEEEeeccCcccccccCCcceee
Q 042831 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML--DSNFNAKIGDFGLARLVEHAKGSQTTV 513 (645)
Q Consensus 436 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl--d~~~~~kl~DfGla~~~~~~~~~~~~~ 513 (645)
|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cccc
Confidence 999997766779999999999999999999999 899999999999999 677899999999998764332 2334
Q ss_pred cccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHH
Q 042831 514 LAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQ 593 (645)
Q Consensus 514 ~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~ 593 (645)
..||+.|+|||++....++.++|||||||++|||++|+.||...... .... ..... ... +.+.....+
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~---~i~~~-~~~--~~~~~~~~~--- 315 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLN---NILAC-RWD--LEDEEFQDI--- 315 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHT-CCC--SCSGGGTTS---
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhc-cCC--CChhhhccC---
Confidence 56999999999999889999999999999999999999999754321 1111 11111 110 111111122
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 594 QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 594 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+.+++.+||+.||++|||++|++++.++.
T Consensus 316 -~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 316 -SEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred -CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 24577888999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.86 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=211.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
++|...+.||+|+||.||++++..+++.||+|++... .....+.+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999999999999999999754 344566788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~- 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 163 (345)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-
T ss_pred EeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC-
Confidence 9999999999998654 468999999999999999999999 89999999999999999999999999999753322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc--hhHHHHHHHHhcCCccccccCcc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ--VSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~--~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............+.. .
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 237 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 237 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------C
T ss_pred CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------C
Confidence 2234456899999999999999999999999999999999999999975322111 0111222222222211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSI------RQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~~L~~~ 626 (645)
+.... ...+..++.+||+.||++||++ +|+++|.++.
T Consensus 238 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 238 IPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred CCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 11122 2456778899999999999985 8999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=351.81 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=198.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...++||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999999999999999999975533 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 430 FMPNGSLDSHLFKE-----NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 430 y~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
|++ |+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 6999888643 2468999999999999999999999 899999999999999999999999999998654
Q ss_pred ccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc--cc--
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK--LL-- 579 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--l~-- 579 (645)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.+..+... ..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 322 222345689999999998764 6899999999999999999999999754432 22233332221110 00
Q ss_pred --------------------cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 --------------------EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 --------------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.+.+...... ...+.+++.+||+.||++|||++|++++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hhhhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 00001111111 246778899999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=354.75 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=212.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...+.||+|+||.||+|++..+++.||||.+..... .+++.+|++++.++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678899999999999999999999999999999865432 24678999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc-----EEEeeccCccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN-----AKIGDFGLARLVE 504 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-----~kl~DfGla~~~~ 504 (645)
|+ +++|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 999999998766789999999999999999999999 89999999999999999887 9999999998654
Q ss_pred ccCCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 505 HAKGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 505 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP- 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence 33221 12456799999999999999999999999999999999999999987654433333322211110000
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+.++... ..+.+++..|++.||.+||+++++++.|+
T Consensus 241 ----~~~~~~~~-----p~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 241 ----IEVLCENF-----PEMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp ----HHHHTTTC-----HHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ----HHHHhccC-----hHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 01111111 16778889999999999999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=360.28 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=204.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeE----EEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
++|...+.||+|+||.||+|++..+++. ||+|.+.... ....+.+.+|+.++.+++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5678889999999999999999877764 7888775432 334456788999999999999999999986 466899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 999999999999997766789999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......++..|+|||++.++.++.++|||||||++|||++ |+.||....... +.+ ....+.... .+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~--~~ 239 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERLA--QP 239 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBCC--CC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCCC--CC
Confidence 322 2344567889999999999999999999999999999999 999998654332 111 122221111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. ....+..++.+||+.||++|||++|++++|+.-
T Consensus 240 ~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 240 QI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp TT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred Cc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 112356788999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=350.72 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=198.9
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
...++|...+.||+|+||.||+|.+..+ +..||+|.+... .....+.+.+|+.++.+++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 3456788899999999999999998643 567999998754 3445678999999999999999999999984 5678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999998777789999999999999999999999 899999999999999999999999999998765
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
...........+++.|+|||.+....++.++||||||+++|||++ |+.||......+ .... ...+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~----i~~~~~----- 235 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR----IENGER----- 235 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCC-----
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHH----HHcCCC-----
Confidence 443333344557789999999998899999999999999999996 999997544321 2221 112211
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+.... ...+.+++..||+.||++|||+.|+++.|+.
T Consensus 236 ~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 236 LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1111222 2456788899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.54 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=210.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+++...+|+.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999999999999999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999999865 3568999999999999999999998 8999999999999999999999999999986532
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... ... ++.. .+..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~---~i~-~~~~------~~p~ 224 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---MKTYE---KIL-NAEL------RFPP 224 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHH---HHH-HCCC------CCCT
T ss_pred -ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---HHH-hCCC------CCCC
Confidence 23346799999999999999999999999999999999999999975332 11111 111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
.+ ...+.+++.+||+.||++|| +++|+++|.++.
T Consensus 225 ~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~ 263 (318)
T 1fot_A 225 FF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263 (318)
T ss_dssp TS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred CC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence 22 24567788999999999999 999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=348.19 Aligned_cols=266 Identities=25% Similarity=0.324 Sum_probs=206.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688889999999999999998 5688999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++ +|.+++......+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 9975 8999887766789999999999999999999999 899999999999999999999999999998654322 2
Q ss_pred ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc--------c
Q 042831 510 QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL--------E 580 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~--------~ 580 (645)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.......... .
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhccc
Confidence 23345689999999998764 5899999999999999999999999754321 2222222222111000 0
Q ss_pred ccCccccC-------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCR-------DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..++.+.. .+.......+.+++.+||+.||++|||++|+++|.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 285 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 01111100 00011234567888999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=359.98 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=214.9
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
.++....++|...+.||+|+||.||+|++. .+++.||||.+... .....+.+.+|+.++.+++||||++++++|
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556688999999999999999999997 34589999999765 344567899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCee
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKEN-----------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 475 (645)
.+.+..++||||+++|+|.+++.... ..+++..++.++.||++||.|||+ .+|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 99999999999999999999997532 568999999999999999999999 8999
Q ss_pred eccCCCCCeEECCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCC
Q 042831 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKP 553 (645)
Q Consensus 476 H~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~p 553 (645)
||||||+|||++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986543322 22334567899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 554 INPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 554 f~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
|...... . ......++.... ....+ ...+.+++..||+.||++||++.+++++|+.-
T Consensus 277 ~~~~~~~---~----~~~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 277 YYGMAHE---E----VIYYVRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp TTTSCHH---H----HHHHHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCChH---H----HHHHHhCCCcCC-----CCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 9754321 1 112222332211 11122 24677888999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=345.55 Aligned_cols=260 Identities=17% Similarity=0.239 Sum_probs=213.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467889999999999999999998899999999986543 234678899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc-----EEEeeccCccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN-----AKIGDFGLARLVE 504 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-----~kl~DfGla~~~~ 504 (645)
|+ +++|.+++...+..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 999999998777779999999999999999999998 89999999999999987776 9999999998765
Q ss_pred ccCCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 505 HAKGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 505 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 234467999999999999999999999999999999999999999875544333333222211111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.+...+ .+.+.+++..||+.||++||+++++++.|+.
T Consensus 243 -----~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 243 -----RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred -----HHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 1111222 2467788899999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=361.81 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=212.0
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
...++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3456799999999999999999999999999999999754 34456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl~DfGla~~~ 503 (645)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++..
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999999998864 3568999999999999999999999 8999999999999998654 5999999999866
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+.... ..
T Consensus 182 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~~~~~----~i~~~~~~~-~~ 251 (362)
T 2bdw_A 182 NDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYA----QIKAGAYDY-PS 251 (362)
T ss_dssp TTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCCCC-CT
T ss_pred cCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHhCCCCC-Cc
Confidence 432 223346799999999999998999999999999999999999999975332 12221 122221110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+. ... ....+.+++.+||+.||++|||+.|++++.|..
T Consensus 252 ~~-~~~----~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 252 PE-WDT----VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp TG-GGG----SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred cc-ccC----CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 10 011 124567888999999999999999999998763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=362.49 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=211.5
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCe
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~ 423 (645)
....++|...+.||+|+||.||+|+++.+|+.||||+++... ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999999999999999997542 23456778899999887 89999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999998653 468999999999999999999999 89999999999999999999999999999754
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+.
T Consensus 169 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~----~i~~~~------ 234 (345)
T 1xjd_A 169 MLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFH----SIRMDN------ 234 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCC------
T ss_pred ccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHhCC------
Confidence 322 2234456899999999999999999999999999999999999999975432 11221 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIR-QVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~~ 626 (645)
+.+.... ...+..++.+||+.||++||++. ++++|.++.
T Consensus 235 ~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~ 274 (345)
T 1xjd_A 235 PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274 (345)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHcCcccc
Confidence 1111112 24567788999999999999998 999998875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.84 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=188.3
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.++||+|+||.||+|.+..+++.||||++... ....+.+|+.++.+++ ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999999999999998643 3457788999999997 9999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEEEeeccCcccccccCCccee
Q 042831 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 436 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~kl~DfGla~~~~~~~~~~~~ 512 (645)
|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...... ....
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 167 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLK 167 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cccc
Confidence 99999654 579999999999999999999998 8999999999999997655 89999999998654322 2234
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCH
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~ 592 (645)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+.... +.... .
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~----~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEAW----K 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHHH----H
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Ccccc----c
Confidence 45689999999999999999999999999999999999999986543221111122222333332210 00000 1
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 593 QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 593 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.....+.+++..||+.||++|||++|++++.|+..
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhcc
Confidence 12356778889999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.38 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=201.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...+.||+|+||.||++++..+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3467899999999999999999999999999999997543 233678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc--EEEeeccCcccccccC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN--AKIGDFGLARLVEHAK 507 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kl~DfGla~~~~~~~ 507 (645)
|+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999998654 468999999999999999999998 99999999999999987765 999999999743322
Q ss_pred CcceeecccCccccCccccccCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKE-SDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~-sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ........ ..... +...
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~-~~~~~--~~~~- 244 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRIL-SVKYS--IPDD- 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHH-TTCCC--CCTT-
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHh-cCCCC--CCCc-
Confidence 22334579999999999988877655 89999999999999999999865433221 11111111 11110 0000
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPL 629 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 629 (645)
.. ....+.+++.+||+.||++|||++|+++|.|+...+
T Consensus 245 -~~----~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 245 -IR----ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp -SC----CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred -CC----CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 01 124567888999999999999999999999985443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=368.51 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=211.0
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...++||+|+||.||++.+..+|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467888999999999999999999999999999987543 34566789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEEeeccCccccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKIGDFGLARLVE 504 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl~DfGla~~~~ 504 (645)
|||+++|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999988654 569999999999999999999999 8999999999999998 56789999999997664
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ....+... ...+
T Consensus 165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~~~~~----~i~~~~~~-~~~~ 235 (444)
T 3soa_A 165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---HRLYQ----QIKAGAYD-FPSP 235 (444)
T ss_dssp TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHH----HHHHTCCC-CCTT
T ss_pred CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---HHHHH----HHHhCCCC-CCcc
Confidence 322 223446799999999999998999999999999999999999999975332 12222 12222211 0011
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. .... ...+.+++..||+.||++|||+.|+++|.|..
T Consensus 236 ~-~~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~ 272 (444)
T 3soa_A 236 E-WDTV----TPEAKDLINKMLTINPSKRITAAEALKHPWIS 272 (444)
T ss_dssp T-TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred c-cccC----CHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 1 1112 24567888999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=363.95 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=209.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 356888999999999999999999999999999985321 224578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc---EEEeeccC
Q 042831 426 LVYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFGL 499 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kl~DfGl 499 (645)
+||||+++++|.+++.+. +..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887642 3468999999999999999999999 89999999999999986655 99999999
Q ss_pred cccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+. .....+...
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~----~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF----EGIIKGKYK 250 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH----HHHHHTCCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH----HHHHcCCCC
Confidence 98664322 22344579999999999999899999999999999999999999997532 1111 111112111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.++...... ...+.+++.+||+.||++|||+.|+++|.|+.
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 111111112 24577888999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=351.28 Aligned_cols=268 Identities=22% Similarity=0.271 Sum_probs=205.8
Q ss_pred cCCCC-CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFND-DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~-~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
+.|.. .+.||+|+||.||+|++..+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 47899999999999999989999999999876666677899999999995 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc---EEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kl~DfGla~~~~~~ 506 (645)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999654 468999999999999999999999 89999999999999998776 999999998765422
Q ss_pred CC------cceeecccCccccCcccccc-----CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch--------hHHH
Q 042831 507 KG------SQTTVLAGTMGYMAPECATT-----GKASKESDVYSFGIVALEIACGRKPINPKAPQGQV--------SLLQ 567 (645)
Q Consensus 507 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~--------~l~~ 567 (645)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.. ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223569999999999875 45789999999999999999999999865433210 0011
Q ss_pred HHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCC
Q 042831 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPL 629 (645)
Q Consensus 568 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 629 (645)
.......++... ......... ...+.+++.+||+.||++|||++|+++|.++....
T Consensus 248 ~~~~~i~~~~~~--~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 248 MLFESIQEGKYE--FPDKDWAHI----SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHCCCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHhccCcc--cCchhcccC----CHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 111222222110 000000111 24577889999999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=345.01 Aligned_cols=254 Identities=31% Similarity=0.544 Sum_probs=206.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-------hHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-------GIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
..++|...+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|++++.+++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346788899999999999999999999999999998654221 1267899999999999999999999997665
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEECCCCc-----EEEe
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLDSNFN-----AKIG 495 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld~~~~-----~kl~ 495 (645)
++||||+++|+|.+++.+....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 69999999999999998777789999999999999999999998 78 999999999999988776 9999
Q ss_pred eccCcccccccCCcceeecccCccccCccccc--cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECAT--TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...... .
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~---~ 243 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMI---R 243 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHH---H
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHH---h
Confidence 9999974322 334467999999999984 44578999999999999999999999975543321 111111 1
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+ ..+.+...+ ...+.+++..||+.||++|||++|+++.|+.
T Consensus 244 ~~~-----~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG-----LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC-----CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC-----CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 111 111222222 3467788899999999999999999999863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=363.50 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=211.6
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcC-------CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeee
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRE-------TNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCH 419 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~-------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~ 419 (645)
...++|...++||+|+||.||+|.+.. .+..||||++... .....+++.+|++++.++ +||||++++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345678889999999999999999753 2368999999765 345567899999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCe
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNI 484 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 484 (645)
.++..++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+ .+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceE
Confidence 9999999999999999999997543 359999999999999999999999 8999999999999
Q ss_pred EECCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 042831 485 MLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQ 562 (645)
Q Consensus 485 Lld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~ 562 (645)
|++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999986654322 22333567889999999999999999999999999999999 99999754321
Q ss_pred hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 563 ~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. +.....++... .....+ ...+.+++.+||+.||++|||++|++++|+.
T Consensus 301 -~----~~~~~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 301 -E----LFKLLKEGHRM-----DKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp -H----HHHHHHTTCCC-----CCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -H----HHHHHHcCCCC-----CCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 22222222211 111122 2467788899999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.27 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=206.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...++||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999999999999999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-D 157 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-c
Confidence 9999999887743 4568999999999999999999999 899999999999999999999999999998654322 2
Q ss_pred ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHH--------HHHhcCCcccc
Q 042831 510 QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWV--------WDLYGNGKLLE 580 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~--------~~~~~~~~l~~ 580 (645)
......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+... ...+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2334578999999999876 56899999999999999999999999765432221111100 00111111000
Q ss_pred ---ccCccccCCC---CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 581 ---AVDPRLCRDF---DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 581 ---~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..++.-.... .......+.+++..||+.||++|||++|+++|.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0011000000 0012245778899999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.45 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=203.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCccEEEeeeee----CCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR--LRHRNLVQLLGWCHE----KKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nlv~l~~~~~~----~~~~ 424 (645)
.++|...+.||+|+||.||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999988 4789999998643 34556677777776 789999999998754 3468
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-----CCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-----EQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
++||||+++|+|.+++. ...+++..++.++.||+.||.|||... +++|+||||||+|||++.++.+||+|||+
T Consensus 82 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999999994 356999999999999999999999211 28999999999999999999999999999
Q ss_pred cccccccCCcc---eeecccCccccCccccccC------CCCcchhHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 042831 500 ARLVEHAKGSQ---TTVLAGTMGYMAPECATTG------KASKESDVYSFGIVALEIACG----------RKPINPKAPQ 560 (645)
Q Consensus 500 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~~sDV~SfGvll~elltG----------~~pf~~~~~~ 560 (645)
++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98655433221 2234799999999999876 455799999999999999999 8888654433
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... ................+.+ ..........+.+++.+||+.||++|||++|+++.|+.
T Consensus 240 ~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 240 DPS--FEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCC--HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred Ccc--hhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 221 1111121111111111111 11223466788999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.17 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=203.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--------
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-------- 422 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-------- 422 (645)
++|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888999999999999999999899999999997543 345678999999999999999999999986543
Q ss_pred -------------------------------------------------eEEEEEEecCCCChhhhhhhcC--CCCCHHH
Q 042831 423 -------------------------------------------------ELLLVYEFMPNGSLDSHLFKEN--SLLTWEF 451 (645)
Q Consensus 423 -------------------------------------------------~~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~ 451 (645)
..++||||+++++|.+++.... ...++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3899999999999999997643 3467778
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-----------cceeecccCccc
Q 042831 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-----------SQTTVLAGTMGY 520 (645)
Q Consensus 452 ~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y 520 (645)
++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999998 8999999999999999999999999999987654321 122335699999
Q ss_pred cCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHH
Q 042831 521 MAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMI 600 (645)
Q Consensus 521 ~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~ 600 (645)
+|||++.+..++.++|||||||++|||++|..|+.. ... .......+... . ........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~~-----~----~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKFP-----L----LFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCCC-----H----HHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCCC-----c----ccccCChhHHH
Confidence 999999999999999999999999999998776421 111 11111111110 0 01123345678
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 601 VGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 601 l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
++.+||+.||++|||++|++++.+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHHHccCCCCcCCCHHHHhhchhhh
Confidence 89999999999999999999998875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=360.19 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=211.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||++++..+|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999999999999999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999999654 458999999999999999999998 99999999999999999999999999999865432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ..+..+.. .+..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~----~~i~~~~~------~~p~ 259 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIY----EKIVSGKV------RFPS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCC------CCCT
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---HHHH----HHHHcCCC------CCCC
Confidence 2345799999999999999999999999999999999999999975432 1111 11222221 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.+ ...+..++.+||+.||++||+ ++|+++|.++.
T Consensus 260 ~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~ 298 (350)
T 1rdq_E 260 HF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp TC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred CC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence 22 245678889999999999998 99999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=352.69 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=211.7
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK 421 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~ 421 (645)
....++|...+.||+|+||.||+|.+. .+++.||+|.+... .....+.+.+|++++.+++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 344567888999999999999999873 44589999999754 345567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeecc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN-----------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 478 (645)
+..++||||+++++|.+++.... ..+++..++.++.||++||.|||+ .+|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccc
Confidence 99999999999999999997543 248999999999999999999999 8999999
Q ss_pred CCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 042831 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINP 556 (645)
Q Consensus 479 lkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~ 556 (645)
|||+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999866433221 2233457788999999998889999999999999999999 9999976
Q ss_pred CCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 557 KAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 557 ~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..... +.. ....+.. +..... ....+.+++.+||+.||++||++.|++++|+.
T Consensus 256 ~~~~~---~~~----~~~~~~~-----~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 256 IPPER---LFN----LLKTGHR-----MERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CCGGG---HHH----HHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHH---HHH----HhhcCCc-----CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 54321 111 1222211 111112 23467788899999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=355.59 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=197.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++.+++||||++++++|...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4567888999999999999999999999999999987543 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla~~~~~~ 506 (645)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999998864 3568999999999999999999999 89999999999999975 889999999999865432
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . .......++... ... ..
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~----~~~~~i~~~~~~-~~~-~~ 274 (349)
T 2w4o_A 205 --VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--Q----FMFRRILNCEYY-FIS-PW 274 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--H----HHHHHHHTTCCC-CCT-TT
T ss_pred --cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--H----HHHHHHHhCCCc-cCC-ch
Confidence 2233457899999999999999999999999999999999999999754322 1 111112122111 011 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
... ....+.+++.+||+.||++|||+.|++++.++...
T Consensus 275 ~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 275 WDE----VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp TTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred hhh----CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 112 23457788899999999999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=375.29 Aligned_cols=261 Identities=26% Similarity=0.457 Sum_probs=212.0
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
..++....++|...++||+|+||.||+|.+.. +..||||+++... ...++|.+|++++++++||||+++++++. .+.
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34555667788999999999999999999864 6789999997643 34678999999999999999999999986 567
Q ss_pred EEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.++|||||++|+|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 89999999999999999754 3468999999999999999999999 8999999999999999999999999999987
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
.............++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+... ...+...
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~~-- 404 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRM-- 404 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH----HHHTCCC--
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC--
Confidence 64322222233446788999999999999999999999999999999 99999754321 22221 1112110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+ . .....+.+++.+||+.||++|||++++++.|+.-
T Consensus 405 ~~~---~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 405 PRP---E----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp CCC---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCC---C----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 011 1 1234677888999999999999999999999854
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.65 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=213.2
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCe-----EEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEee
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNS-----YIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGW 417 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~-----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~ 417 (645)
+++....++|...+.||+|+||.||+|.+..+++ .||+|.+.... ....+.+.+|+.++.++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456667889999999999999999999876553 79999997653 34567899999999999 89999999999
Q ss_pred eeeCCeEEEEEEecCCCChhhhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCe
Q 042831 418 CHEKKELLLVYEFMPNGSLDSHLFKE-------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNI 484 (645)
Q Consensus 418 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 484 (645)
|...+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceE
Confidence 99999999999999999999998643 3468999999999999999999999 8999999999999
Q ss_pred EECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 042831 485 MLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQ 562 (645)
Q Consensus 485 Lld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~ 562 (645)
|++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999999865443322 2233456889999999999999999999999999999998 9999975443211
Q ss_pred hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 563 ~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ......+. ........ ...+..++..||+.||++|||++|++++|+.
T Consensus 276 --~----~~~~~~~~-----~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 276 --F----YKLVKDGY-----QMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp --H----HHHHHHTC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --H----HHHHhcCC-----CCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1 11111111 01111111 2467788899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.51 Aligned_cols=251 Identities=26% Similarity=0.382 Sum_probs=208.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+.|...+.||+|+||.||+|++..+++.||||++.... ....+++.+|++++.+++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45778899999999999999999899999999987542 334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+. |+|.+++......+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence 9996 78888887667789999999999999999999999 8999999999999999999999999999976542
Q ss_pred cceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 509 SQTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....||+.|+|||++. .+.++.++|||||||++|||++|+.||..... ........... .+.
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~------~~~ 272 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE------SPA 272 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCC
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC------CCC
Confidence 22357999999999884 56789999999999999999999999975432 11222222111 111
Q ss_pred cc-CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LC-RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+. ... .+.+.+++.+||+.||++|||+++++++.+...
T Consensus 273 ~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 273 LQSGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred CCCCCC----CHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 11 112 245677889999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.26 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=210.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|...+.||+|+||.||+|++..+++.||+|+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346789999999999999999999998999999998754 223456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999998654 468999999999999999999999 8999999999999999999999999999985332
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+ .++.. .
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~i----~~~~~------~ 239 (353)
T 2i0e_A 174 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSI----MEHNV------A 239 (353)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH----HHCCC------C
T ss_pred C-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HHHHHHH----HhCCC------C
Confidence 2 2234456799999999999999999999999999999999999999975432 1222211 11111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
+.... ...+..++.+||+.||++||+ ++++++|.++.
T Consensus 240 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 240 YPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 11122 245678889999999999994 69999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.71 Aligned_cols=263 Identities=27% Similarity=0.380 Sum_probs=211.6
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeee
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWC 418 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~ 418 (645)
++....++|...+.||+|+||.||+|.+. .++..||+|.+... .....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456678999999999999999999973 45678999999754 334557899999999999 899999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhhcCCCeee
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKENS----------------------LLTWEFRYKIAQDLASGLLYLQEEWEQCVVH 476 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 476 (645)
...+..++||||+++|+|.+++..... .+++..++.++.||+.||.|||+ .+|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 999999999999999999999975432 37999999999999999999999 89999
Q ss_pred ccCCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCC
Q 042831 477 RDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPI 554 (645)
Q Consensus 477 ~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf 554 (645)
|||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999866543322 2233557889999999999999999999999999999998 99999
Q ss_pred CCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 555 NPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 555 ~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....... . .......+.. +..... ....+..++..||+.||++|||+.|++++|+..
T Consensus 276 ~~~~~~~--~----~~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 276 PGIPVDA--N----FYKLIQNGFK-----MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TTCCCSH--H----HHHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCcHH--H----HHHHHhcCCC-----CCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 7654321 1 1112222211 111111 234677888999999999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=345.31 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=191.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 356888999999999999999998889999999986432 22346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++......+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 99999999999998766789999999999999999999999 899999999999999999999999999998654322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... . .-... +..+.
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-------~~~~~---~~~~~ 232 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---N-------KVVLA---DYEMP 232 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS---CCCCC
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---H-------HHhhc---ccCCc
Confidence 1 223456899999999999888999999999999999999999999754432110 0 00000 11111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..+ ...+.+++.+||+.||++|||+++++++.++..
T Consensus 233 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 268 (278)
T 3cok_A 233 SFL----SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268 (278)
T ss_dssp TTS----CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-
T ss_pred ccc----CHHHHHHHHHHcccCHhhCCCHHHHhcCccccC
Confidence 112 245678889999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.53 Aligned_cols=262 Identities=22% Similarity=0.382 Sum_probs=194.6
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCe---EEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeee
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~ 419 (645)
+++....++|...+.||+|+||.||+|.+..++. .||||.+... .....+++.+|++++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 3455566789999999999999999999877664 8999998754 4456788999999999999999999999998
Q ss_pred eCCeE------EEEEEecCCCChhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC
Q 042831 420 EKKEL------LLVYEFMPNGSLDSHLFKEN-----SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 420 ~~~~~------~lV~Ey~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 488 (645)
..+.. ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcC
Confidence 77655 99999999999999986422 268999999999999999999999 89999999999999999
Q ss_pred CCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHH
Q 042831 489 NFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLL 566 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~ 566 (645)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~ 249 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY 249 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH
Confidence 99999999999986643322 12233456788999999999999999999999999999999 999997644321 11
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ...+.. ..... .....+.+++.+||+.||++|||+.++++.|+.
T Consensus 250 ~~----~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 250 NY----LIGGNR-----LKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp HH----HHTTCC-----CCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HH----HhcCCC-----CCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 111111 11111 123467788999999999999998888877764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.99 Aligned_cols=269 Identities=25% Similarity=0.304 Sum_probs=205.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----hhhHHHHHHHHHHHHhc---CCCCccEEEeeeeeC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----KQGIKEYASEVKIISRL---RHRNLVQLLGWCHEK 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~~~ 421 (645)
..++|...++||+|+||.||+|++..+++.||||++.... ......+.+|++++.++ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999999999999999986432 11234566777777766 499999999999875
Q ss_pred C-----eEEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 422 K-----ELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 422 ~-----~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
. ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999996 69999987643 349999999999999999999999 899999999999999999999999
Q ss_pred eccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+....
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~ 237 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIGL 237 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHCC
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 99999865432 2234467899999999999999999999999999999999999999754422 222333332221
Q ss_pred Cccccc---c---Ccccc--CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 576 GKLLEA---V---DPRLC--RDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 576 ~~l~~~---~---d~~l~--~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.....+ . ...+. .... .+..+.+.+++.+||+.||++|||+.|+++|.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 110000 0 00000 0000 012256778889999999999999999999998763
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.20 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=206.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC-------eEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN-------SYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
.++|...+.||+|+||.||+|.+..++ ..||+|.+........+.+.+|++++.+++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 356788899999999999999998766 5799999977766777889999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc--------EEEe
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN--------AKIG 495 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--------~kl~ 495 (645)
.++||||+++|+|.+++......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999998766669999999999999999999999 89999999999999998887 9999
Q ss_pred eccCcccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
|||++..... .....++..|+|||++.+ ..++.++|||||||++|||++|..|+...... ..... ....
T Consensus 164 Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~---~~~~ 233 (289)
T 4fvq_A 164 DPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQ---FYED 233 (289)
T ss_dssp CCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHH---HHHT
T ss_pred cCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHH---Hhhc
Confidence 9999865432 123457889999999987 67999999999999999999965554322211 11111 1111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...+. +.. ...+.+++.+||+.||++|||++|++++|+.--
T Consensus 234 ~~~~~----~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 234 RHQLP----APK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TCCCC----CCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred cCCCC----CCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111 111 124567889999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=377.80 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=215.0
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..++|...+.||+|+||.||+|++..+|+.||+|++... .......+.+|++++.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 346788999999999999999999999999999998653 22345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 427 VYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||||+++|+|.+++...+ ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999987543 459999999999999999999999 8999999999999999999999999999986543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ....... ...
T Consensus 339 ~--~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i---~~~i~~~------~~~ 407 (576)
T 2acx_A 339 G--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEV------PEE 407 (576)
T ss_dssp T--CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH---HHHHHHC------CCC
T ss_pred C--ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH---HHHhhcc------ccc
Confidence 2 2334458999999999999988999999999999999999999999865433222111 1111111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
+...+ ...+..++.+||+.||++|| +++|+++|.++..
T Consensus 408 ~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 408 YSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 11222 24567888999999999999 8999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=353.33 Aligned_cols=271 Identities=23% Similarity=0.278 Sum_probs=207.5
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-----hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-----QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
...++|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|++++.+++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999999999999999999865322 123468899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++ +|..++......+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999975 8988887777789999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc-
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA- 581 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~- 581 (645)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ......+............
T Consensus 163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSS
T ss_pred cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCChhhhh
Confidence 4322 233445789999999998764 589999999999999999999999975432 2222222322221111000
Q ss_pred --------cCccccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 582 --------VDPRLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 582 --------~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+...-....+. .....+.+++.+||+.||++|||++|++++.++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 00000011111 12256788999999999999999999999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.18 Aligned_cols=254 Identities=27% Similarity=0.476 Sum_probs=209.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||+|.+. +++.||+|.+..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 457888899999999999999986 478899999976533 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 99999999998777789999999999999999999999 899999999999999999999999999998654322222
Q ss_pred eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 511 TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ....+.. ...+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~i~~~~~--~~~~~---~ 229 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE----DISTGFR--LYKPR---L 229 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCC--CCCCT---T
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH----HHhcCCc--CCCCc---c
Confidence 233456788999999998899999999999999999999 89999754321 1111 1112211 01111 1
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+.+++.+||+.||++|||++|++++|+.
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 12457788899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=346.81 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=211.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35688899999999999999999999999999998654 334567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++... ..+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999987543 468999999999999999999999 899999999999999999999999999998654322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +.. .....+.. .+.
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~-~~~~~~~~------~~~ 235 (294)
T 2rku_A 170 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETY-LRIKKNEY------SIP 235 (294)
T ss_dssp -CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHTTCC------CCC
T ss_pred -cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHhhccC------CCc
Confidence 2234457899999999999888999999999999999999999999754321 111 11111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+ ..+.+++.+||+.||++|||++|++++.++.
T Consensus 236 ~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 236 KHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred cccC----HHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 1222 3567788999999999999999999998875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=353.19 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=208.8
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-----SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
++....++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|++++.+++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3455667899999999999999999999999999999998643 33456789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKE---------------------------------------NSLLTWEFRYKIAQDLAS 461 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~ 461 (645)
.+..++||||+++|+|.+++... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988420 112467788899999999
Q ss_pred HHHHHHhhcCCCeeeccCCCCCeEECCCC--cEEEeeccCcccccccCC---cceeecccCccccCcccccc--CCCCcc
Q 042831 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNF--NAKIGDFGLARLVEHAKG---SQTTVLAGTMGYMAPECATT--GKASKE 534 (645)
Q Consensus 462 gL~yLH~~~~~~ivH~Dlkp~NILld~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~~ 534 (645)
||.|||+ .+|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.. ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 899999999986543222 12345679999999999875 678999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 042831 535 SDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP 614 (645)
Q Consensus 535 sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 614 (645)
+|||||||++|||++|+.||...... .. .......... ...+.. ... ...+.+++.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~---~~---~~~~~~~~~~--~~~~~~-~~~----~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA---DT---ISQVLNKKLC--FENPNY-NVL----SPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHHHHHCCCC--TTSGGG-GGS----CHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH---HH---HHHHHhcccc--cCCccc-ccC----CHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999754321 11 1111111110 001111 111 24567888999999999999
Q ss_pred CHHHHHHHhccCC
Q 042831 615 SIRQVIHVLNFEA 627 (645)
Q Consensus 615 s~~evl~~L~~~~ 627 (645)
++.|++++.++..
T Consensus 324 s~~~~l~hp~~~~ 336 (345)
T 3hko_A 324 DAMRALQHPWISQ 336 (345)
T ss_dssp CHHHHHHSHHHHT
T ss_pred CHHHHhcChhhcc
Confidence 9999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=350.35 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=212.3
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEE-----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeee
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFF-----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCH 419 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~ 419 (645)
+....++|...+.||+|+||.||+|.+ ..+++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 334456888899999999999999985 3567899999997653 34567899999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKENS-----------------LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
..+..++||||+++|+|.+++..... .+++..++.++.||++||.|||+ .+++||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence 99999999999999999999975432 48999999999999999999999 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQ 560 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~ 560 (645)
||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876543322 1223457789999999999999999999999999999999 99999765432
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ... ....+. .+..... ....+.+++.+||+.||++|||++|++++|+.
T Consensus 255 ~~--~~~----~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 255 SK--FYK----MIKEGF-----RMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HH--HHH----HHHHTC-----CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hH--HHH----HhccCC-----CCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11 111 111111 1111111 22467788899999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.80 Aligned_cols=262 Identities=25% Similarity=0.371 Sum_probs=212.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee--eCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH--EKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~~ 425 (645)
++|...++||+|+||.||++++ ..+++.||||++........+.+.+|++++.+++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5778899999999999999994 5678999999998877777788999999999999999999999886 456789
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||+++++|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999997766679999999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC--------chhHHHHHHHHhcC
Q 042831 506 AKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG--------QVSLLQWVWDLYGN 575 (645)
Q Consensus 506 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~--------~~~l~~~~~~~~~~ 575 (645)
.... ......++..|+|||++.+..++.++||||||+++|||++|+.||....... .......+......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3322 1233457888999999998889999999999999999999999986322100 00001111111111
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+. ....+......+.+++.+||+.||++|||++|++++|+.
T Consensus 260 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 300 (327)
T 3lxl_A 260 GQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300 (327)
T ss_dssp TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 111122233567788899999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=344.93 Aligned_cols=259 Identities=20% Similarity=0.309 Sum_probs=212.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||+|.+..++..||+|++........+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 45688899999999999999999999999999999876556678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCcccccccC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~~~~~ 507 (645)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999988654 458999999999999999999999 899999999999999 788999999999998654332
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... .... ...++... ......
T Consensus 164 --~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~--~~~~~~ 231 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVML----KIREGTFT--FPEKDW 231 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCCC--CCHHHH
T ss_pred --chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhCCCC--CCchhh
Confidence 2334569999999998865 4899999999999999999999999754321 1111 11111110 000000
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPL 629 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 629 (645)
... ...+.+++..||+.||++|||+.|++++.++...+
T Consensus 232 ~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 232 LNV----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp TTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred hcC----CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 111 24677888999999999999999999999876433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=341.23 Aligned_cols=262 Identities=26% Similarity=0.360 Sum_probs=213.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35688899999999999999999988999999998644 33456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG- 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~- 508 (645)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998853 4568999999999999999999998 8999999999999999999999999999986543221
Q ss_pred cceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......|+..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....| ...... ..+ .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~~--~~~--~ 231 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKTY--LNP--W 231 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCTT--STT--G
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhcccc--cCc--h
Confidence 22334578999999999987765 7899999999999999999999976543321 11111 111100 000 0
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
... ...+.+++..||+.||++|||++|++++.++..+..
T Consensus 232 ~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 232 KKI----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp GGS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred hhc----CHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 111 235677889999999999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=366.20 Aligned_cols=250 Identities=30% Similarity=0.434 Sum_probs=205.3
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC-eEEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK-ELLLV 427 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~-~~~lV 427 (645)
...++|...++||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++.+++||||++++++|.+.+ ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 44567888999999999999999986 6799999997553 4578999999999999999999999987665 79999
Q ss_pred EEecCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 428 YEFMPNGSLDSHLFKENS-LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||++|+|.+++...+. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999986543 47999999999999999999999 89999999999999999999999999999854321
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ... ...++... .
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~-----~ 406 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKM-----D 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCCC-----C
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC-----C
Confidence 122357889999999999999999999999999999998 999998654332 111 12222111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ....+.+++..||+.||++|||++++++.|+.
T Consensus 407 ~p~~----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 APDG----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112 23467788899999999999999999998863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.84 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=202.0
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCC--CCccEEEeeeeeCCeE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRH--RNLVQLLGWCHEKKEL 424 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~~~~~~~~~ 424 (645)
...++|...+.||+|+||.||++.+. +++.||||++... ..+..+.+.+|+.++.+++| +||+++++++..++..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34567889999999999999999885 5889999998654 44556789999999999987 9999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||| +.+++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++...
T Consensus 85 ~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEC-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEEEe-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99999 568899999965 4568999999999999999999999 8999999999999997 5789999999998765
Q ss_pred ccCCc-ceeecccCccccCcccccc-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH
Q 042831 505 HAKGS-QTTVLAGTMGYMAPECATT-----------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 505 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH
Confidence 33222 2334679999999999865 67899999999999999999999999743221 1111111
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. ++.....++......+.+++..||+.||++|||+.|+++|.|+..
T Consensus 234 ~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 234 I---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp H---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred h---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1 111111111112245678889999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.26 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=207.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
+.++|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999999999999999986432 2235678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999998654 468999999999999999999998 8999999999999999999999999999864432
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ..... ...+
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~------~~~~ 226 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYK----RISRV------EFTF 226 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHT------CCCC
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---HHHH----HHHhC------CCCC
Confidence 2233457899999999999999999999999999999999999999753321 1111 11111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
... ....+.+++..||+.||++|||++|+++|.++..
T Consensus 227 ~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~ 263 (279)
T 3fdn_A 227 PDF----VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263 (279)
T ss_dssp CTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred CCc----CCHHHHHHHHHHhccChhhCCCHHHHhhCccccC
Confidence 111 2245677889999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.72 Aligned_cols=257 Identities=22% Similarity=0.287 Sum_probs=211.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||+|++..+|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4568889999999999999999999999999999875422 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLA 500 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla 500 (645)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999854 4568999999999999999999999 8999999999999999887 7999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... . ...+..
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~---~-i~~~~~-- 235 (321)
T 2a2a_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA---N-ITSVSY-- 235 (321)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHTTCC--
T ss_pred eecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHHH---H-HHhccc--
Confidence 8654322 233456899999999999999999999999999999999999999754321 1111 1 111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..++...... ...+.+++.+||+.||++|||++|+++|.++.
T Consensus 236 ~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~ 277 (321)
T 2a2a_A 236 DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (321)
T ss_dssp CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 1111111122 24577888999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=344.19 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=205.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|...+.||+|+||.||+|++.. ++..||+|.+... .....+.+.+|+.++.+++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678889999999999999998754 3456999998765 34456789999999999999999999999865 4568
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 9999999999999998777789999999999999999999999 8999999999999999999999999999987654
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+ ..+...
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~~----- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDRL----- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCCC-----
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCCC-----
Confidence 43333344567889999999998899999999999999999998 999997544322 22111 111110
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...... ...+.+++.+||+.||++|||+.|++++|+.
T Consensus 234 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 234 PKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 111112 2457788899999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.89 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=211.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeee--eCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCH--EKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~~l 426 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45788899999999999999999999999999999754 3445678999999999999999999999885 4578999
Q ss_pred EEEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCC-----eeeccCCCCCeEECCCCcEEEeecc
Q 042831 427 VYEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQC-----VVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
||||+++++|.+++... ...+++..++.++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998653 3459999999999999999999999 66 9999999999999999999999999
Q ss_pred CcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
+++...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.. ...++..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~----~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAG----KIREGKF 233 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHTCC
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHH----HHhhccc
Confidence 998654322 122335689999999999998999999999999999999999999975432 11221 1222222
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCC
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 631 (645)
. .+...+ ...+.+++.+||+.||++|||++|+++++++.++.+.
T Consensus 234 ~-----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 277 (279)
T 2w5a_A 234 R-----RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH 277 (279)
T ss_dssp C-----CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred c-----cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence 1 111122 2467788899999999999999999999998766554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.31 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=206.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCccEEEeeee--eCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----KQGIKEYASEVKIISRLRHRNLVQLLGWCH--EKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~ 424 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|++++.+++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999986532 244678999999999999999999999984 45688
Q ss_pred EEEEEecCCCChhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 425 LLVYEFMPNGSLDSHLFK-ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
++||||++++ |.+++.. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999877 6666654 35679999999999999999999999 89999999999999999999999999999866
Q ss_pred cccC-CcceeecccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 504 EHAK-GSQTTVLAGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 504 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
.... ........|+..|+|||++.+.. .+.++||||||+++|||++|+.||..... ..+ ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~i~~~~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---YKL----FENIGKGSY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHH----HHHHHHCCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---HHH----HHHHhcCCC--
Confidence 4322 22334467899999999987654 47899999999999999999999975331 111 112222211
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPA 631 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 631 (645)
.+...+ ...+.+++.+||+.||++|||++|++++.++....|.
T Consensus 231 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 231 ----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp ----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred ----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 111222 2456778899999999999999999999987654443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=342.22 Aligned_cols=250 Identities=31% Similarity=0.475 Sum_probs=194.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+|.+. ++.||||++.... ....+.+.+|++++.+++||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 457888999999999999999985 7889999986542 2335788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC---eeeccCCCCCeEECC--------CCcEEEe
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC---VVHRDIKSSNIMLDS--------NFNAKIG 495 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivH~Dlkp~NILld~--------~~~~kl~ 495 (645)
||||+++++|.+++. +..+++..++.++.|+++||.|||+ ++ ++||||||+|||++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999884 4578999999999999999999999 66 999999999999986 7789999
Q ss_pred eccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 496 DFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 496 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
|||+++...... .....|++.|+|||.+.+..++.++||||||++++||++|+.||...... ........
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~- 228 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAM- 228 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHT-
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhc-
Confidence 999997654322 22456899999999999999999999999999999999999999754321 11111111
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ..... .....+.+++.+||+.||++|||++|++++|+.
T Consensus 229 ~~~~----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLA----LPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCCC----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC----CCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1111 11111 223467788899999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.99 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=200.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS----KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
.++|...+.||+|+||.||+++.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 457888999999999999999985 578999999987542 2345667899999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999998654 468999999999999999999999 89999999999999999999999999999754
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+. ++..
T Consensus 172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~----~~~~----- 238 (327)
T 3a62_A 172 IHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTIDKIL----KCKL----- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH----HTCC-----
T ss_pred ccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHHHHHH----hCCC-----
Confidence 322 1223345799999999999999999999999999999999999999975432 11222111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
.+.... ...+.+++.+||+.||++|| +++|+++|.++.
T Consensus 239 -~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 239 -NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp -CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred -CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 111112 24567788999999999999 889999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.56 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=211.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++.+++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46788999999999999999999999999999998654 3445678889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc---EEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kl~DfGla~~~~~ 505 (645)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999888654 568999999999999999999999 89999999999999986655 99999999976543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... ....+... ...+.
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~----~~~~~~~~-~~~~~ 230 (284)
T 3kk8_A 161 S--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYD-YPSPE 230 (284)
T ss_dssp S--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC-CCTTT
T ss_pred C--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHH----HHHhcccc-CCchh
Confidence 2 2233467899999999999999999999999999999999999999754321 1111 11111111 00111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... ...+.+++.+||+.||++|||++|++++.++.
T Consensus 231 -~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 231 -WDTV----TPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp -TTTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred -hccc----CHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 1112 24567888999999999999999999998864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=358.39 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=204.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|...++||+|+||.||+|++..+++.||+|++...... ....+.+|++++.+++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688899999999999999999989999999998654322 222456799999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ 510 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~ 510 (645)
++ |+|.+++...+..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 96 69999988777789999999999999999999998 899999999999999999999999999997554322 22
Q ss_pred eeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc---cccccC---
Q 042831 511 TTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK---LLEAVD--- 583 (645)
Q Consensus 511 ~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---l~~~~d--- 583 (645)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+....+... +.....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhcchh
Confidence 334568999999999876 56899999999999999999999999764432 22333333222111 000000
Q ss_pred ------ccccCCC----CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 584 ------PRLCRDF----DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 584 ------~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+...... .......+.+++.+||+.||++|||++|+++|.|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 287 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence 0000000 0011245678899999999999999999999999863
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=371.96 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=202.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..++|...++||+|+||.||+|++..+|+.||||++... .......+.+|+.++.+++||||++++++|...+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346788999999999999999999999999999998653 33445678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999988654 468999999999999999999996 278999999999999999999999999999754322
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+...+ ..+.. .+
T Consensus 303 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i----~~~~~------~~ 368 (446)
T 4ejn_A 303 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI----LMEEI------RF 368 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHCCC------CC
T ss_pred -CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH----HhCCC------CC
Confidence 22334567999999999999999999999999999999999999999754321 122111 11111 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
.... ...+.+++..||+.||++|| +++|+++|.++..
T Consensus 369 p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 369 PRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp CTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 1122 24567888999999999999 9999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=344.82 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=204.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...++||+|+||.||++....++..||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356888999999999999999999999999999987543 3356789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCcccc
Q 042831 430 FMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLV 503 (645)
Q Consensus 430 y~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~ 503 (645)
|+++|+|.+++.. .+..+++..++.++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999998864 34679999999999999999999999 899999999999999 45678999999999865
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .......|++.|+|||.+. +.++.++||||||+++|||++|+.||...... ....... .......
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~~~~~~~--~~~~~~~---- 245 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---EVQQKAT--YKEPNYA---- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH--HCCCCCC----
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---HHHhhhc--cCCcccc----
Confidence 432 2234457899999999875 56899999999999999999999999754321 1111110 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... ...+.+++.+||+.||++|||++|++++.++.
T Consensus 246 -~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~ 283 (285)
T 3is5_A 246 -VECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283 (285)
T ss_dssp -C--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred -cccCcC----CHHHHHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence 001112 24566788999999999999999999998875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=343.97 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=207.5
Q ss_pred hcCCCCCC-ccCcCCcEEEEEEEEc--CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQ-KLGQGGFGGVYKGFFR--ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+ .||+|+||.||+|.+. .++..||+|.+... .....+++.+|++++.+++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34555555 8999999999999864 46788999999765 345677899999999999999999999999 5567999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++......+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 999999999999997777789999999999999999999999 89999999999999999999999999999876433
Q ss_pred CCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+.. ....+..
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~i~~~~~----- 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKR----- 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCC-----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHhcCCc-----
Confidence 221 1223456889999999988889999999999999999998 99999754432 1221 1222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..... ....+.+++..||+.||++||++++++++|+.
T Consensus 232 ~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 MECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp CCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCC----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111112 23467788899999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=358.39 Aligned_cols=267 Identities=22% Similarity=0.295 Sum_probs=211.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC--------CCCccEEEeeee---
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR--------HRNLVQLLGWCH--- 419 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nlv~l~~~~~--- 419 (645)
.++|...++||+|+||.||+|++..+++.||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 57899999999999999999999999999999999644 345677889999999986 788999999987
Q ss_pred -eCCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCC------
Q 042831 420 -EKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNF------ 490 (645)
Q Consensus 420 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~------ 490 (645)
.....++||||+ +++|.+.+... ...+++..++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence 556899999999 56666666543 4679999999999999999999998 7 999999999999999775
Q ss_pred -------------------------------------------cEEEeeccCcccccccCCcceeecccCccccCccccc
Q 042831 491 -------------------------------------------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527 (645)
Q Consensus 491 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 527 (645)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865432 23356899999999999
Q ss_pred cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch---hHHHHHHHHhcC--------Cccc-cccCc--------cc-
Q 042831 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV---SLLQWVWDLYGN--------GKLL-EAVDP--------RL- 586 (645)
Q Consensus 528 ~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~---~l~~~~~~~~~~--------~~l~-~~~d~--------~l- 586 (645)
+..++.++|||||||++|||++|+.||......... .....+....+. +... +.... ..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999865543321 111212221111 0000 00000 00
Q ss_pred ----------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 587 ----------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 587 ----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+......+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 0123556778899999999999999999999999998864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=352.64 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=207.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
.++|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4678999999999999999999999999999999875421 13346778999999999999999999999999
Q ss_pred eEEEEEEecCCC-ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 423 ELLLVYEFMPNG-SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 423 ~~~lV~Ey~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
..++||||+.+| +|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999877 99888854 4569999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ...
T Consensus 179 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~ 239 (335)
T 3dls_A 179 YLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEA 239 (335)
T ss_dssp ECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTT
T ss_pred ECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------Hhh
Confidence 765332 2334579999999999988776 88999999999999999999999642110 000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
...+ ...+ ...+.+++..||++||++|||++|++++.|+..+
T Consensus 240 ~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 AIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 0011 0111 2357788899999999999999999999997653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.14 Aligned_cols=250 Identities=27% Similarity=0.487 Sum_probs=197.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...+.||+|+||.||+|++. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46778899999999999999885 688999998643 345789999999999999999999999874 479999999
Q ss_pred CCCChhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc-EEEeeccCcccccccCC
Q 042831 432 PNGSLDSHLFKENS--LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN-AKIGDFGLARLVEHAKG 508 (645)
Q Consensus 432 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~-~kl~DfGla~~~~~~~~ 508 (645)
++|+|.+++..... .+++..++.++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999975442 4789999999999999999999865578999999999999988886 799999999754322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+... .+.. +.+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~~~-----~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH-TTCC-----CCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh-cCCC-----CCccc
Confidence 223468999999999999999999999999999999999999997543321 11112111 1111 11222
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+ ..+.+++.+||+.||++|||++|+++.|+.
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 222 356778899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=354.02 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=208.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeee--------C
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHE--------K 421 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--------~ 421 (645)
++|...++||+|+||.||+|++..+|+.||+|++.... ......+.+|++++.+++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999999999999999986543 2335678899999999999999999999976 4
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+..++||||++ ++|...+......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 56899999996 57888777666779999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCC---cceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 502 LVEHAKG---SQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 502 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......-.
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCC
Confidence 7653222 22344678999999998876 45899999999999999999999999864432 22222222211100
Q ss_pred --cccccC---------ccccCCCC-HHH------HHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 578 --LLEAVD---------PRLCRDFD-GQQ------IERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 578 --l~~~~d---------~~l~~~~~-~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+ ........ .+. ...+.+++.+||+.||++|||++|+++|.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 000000 00000001 111 13477899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=350.41 Aligned_cols=266 Identities=22% Similarity=0.268 Sum_probs=209.9
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE---- 420 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~---- 420 (645)
+.+....++|...+.||+|+||.||++....+++.||||++........+.+.+|++++.+++||||+++++++..
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 3344556789999999999999999999988999999999977777777889999999999999999999999873
Q ss_pred CCeEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 421 KKELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
....++||||+++|+|.+++.. .+..+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEec
Confidence 3578999999999999998875 35679999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccCCc--------ceeecccCccccCccccccCC---CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH
Q 042831 498 GLARLVEHAKGS--------QTTVLAGTMGYMAPECATTGK---ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566 (645)
Q Consensus 498 Gla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~ 566 (645)
|++......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||......... ..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~ 257 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VA 257 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hh
Confidence 998754321111 112345799999999987554 689999999999999999999999532111110 11
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. ..... . .......+ ...+.+++.+||+.||++|||+++++++|+.-.
T Consensus 258 ~----~~~~~-~----~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 258 L----AVQNQ-L----SIPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp H----HHHCC-------CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred H----Hhhcc-C----CCCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1 01110 0 00001112 246778889999999999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=359.50 Aligned_cols=268 Identities=24% Similarity=0.329 Sum_probs=199.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCC--eE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKK--EL 424 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~--~~ 424 (645)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++.+++ ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999999999999999998643 4455677889999999997 999999999997544 78
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++|||||+ ++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 689888854 468999999999999999999999 899999999999999999999999999998653
Q ss_pred ccC--------------------CcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 505 HAK--------------------GSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 505 ~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
... ........||+.|+|||++.+ ..++.++|||||||+++||++|+.||......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-- 238 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-- 238 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 211 112334679999999999876 678999999999999999999999997644221
Q ss_pred hHHHHHHHHhcCCccccc--c-------------------CccccCCCC------------HHHHHHHHHHHHHcCCCCC
Q 042831 564 SLLQWVWDLYGNGKLLEA--V-------------------DPRLCRDFD------------GQQIERLMIVGLWCAHPDE 610 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~--~-------------------d~~l~~~~~------------~~~~~~l~~l~~~Cl~~dP 610 (645)
....+............ + .......++ ......+.+|+.+||+.||
T Consensus 239 -~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 239 -QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp -HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred -HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 12212111111000000 0 000000000 0112457788999999999
Q ss_pred CCCCCHHHHHHHhccC
Q 042831 611 NLRPSIRQVIHVLNFE 626 (645)
Q Consensus 611 ~~RPs~~evl~~L~~~ 626 (645)
++|||++|+++|.++.
T Consensus 318 ~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 318 NKRISANDALKHPFVS 333 (388)
T ss_dssp GGSCCHHHHTTSTTTT
T ss_pred ccCCCHHHHhCCHHHH
Confidence 9999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=362.22 Aligned_cols=271 Identities=21% Similarity=0.290 Sum_probs=193.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-----CCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-----KKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-----~~~ 423 (645)
.++|...+.||+|+||.||+|++..+++.||||++... .....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36789999999999999999999999999999998653 34456789999999999999999999999843 357
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 89999998 5789888854 4569999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCC--------------------------cceeecccCccccCcccc-ccCCCCcchhHHHHHHHHHHHHc-------
Q 042831 504 EHAKG--------------------------SQTTVLAGTMGYMAPECA-TTGKASKESDVYSFGIVALEIAC------- 549 (645)
Q Consensus 504 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~ellt------- 549 (645)
..... .......||+.|+|||++ ....++.++|||||||+||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 43221 123445789999999976 45679999999999999999999
Q ss_pred ----CCCCCCCCCCC-----------------CchhHHHHHHHHhcCCccc--------------cccC----ccccCCC
Q 042831 550 ----GRKPINPKAPQ-----------------GQVSLLQWVWDLYGNGKLL--------------EAVD----PRLCRDF 590 (645)
Q Consensus 550 ----G~~pf~~~~~~-----------------~~~~l~~~~~~~~~~~~l~--------------~~~d----~~l~~~~ 590 (645)
|+.+|...... .....+..+.+..+..... ..+. ..+...+
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 56666443210 0011112222222111000 0000 0000000
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......+.+|+.+||+.||++|||++|+++|.++..
T Consensus 367 -~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 367 -PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred -CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 011345778899999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.46 Aligned_cols=256 Identities=26% Similarity=0.464 Sum_probs=202.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC----eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN----SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...+.||+|+||.||+|.+..++ ..||||.+... .......+.+|+.++.+++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 346677889999999999999987543 46999999765 3445668999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||||+++|+|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 9999999999999998777789999999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 506 AKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 506 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.... ......++..|+|||.+....++.++|||||||++|||++ |+.||..... ..+. ....++...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~----~~~~~~~~~--- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVM----KAINDGFRL--- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----HHHHTTCCC---
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHHCCCcC---
Confidence 3221 1222346788999999999999999999999999999999 9999965432 1111 122222111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... .....+.+++.+||+.||++||++.++++.|+.
T Consensus 270 --~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 270 --PTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp --CCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 123467788899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=351.35 Aligned_cols=267 Identities=27% Similarity=0.435 Sum_probs=216.5
Q ss_pred ccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEE
Q 042831 341 RFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQL 414 (645)
Q Consensus 341 ~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l 414 (645)
.+..+++....++|...+.||+|+||.||+|++. .+++.||+|.+... .......+.+|+.++.+++||||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3455566777889999999999999999999876 35788999999754 33455678999999999999999999
Q ss_pred EeeeeeCCeEEEEEEecCCCChhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeE
Q 042831 415 LGWCHEKKELLLVYEFMPNGSLDSHLFKEN---------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485 (645)
Q Consensus 415 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 485 (645)
++++.+.+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence 999999999999999999999999986422 457999999999999999999999 89999999999999
Q ss_pred ECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCch
Q 042831 486 LDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQV 563 (645)
Q Consensus 486 ld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~ 563 (645)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---
Confidence 999999999999999865433221 1223456889999999999999999999999999999999 89999754321
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+ .....++.... .... ....+.+++.+||+.||++|||+.|++++|+..
T Consensus 248 ~~----~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 248 QV----LRFVMEGGLLD-----KPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HH----HHHHHTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HH----HHHHHcCCcCC-----CCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 11 12222222211 1112 224577888999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=357.83 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=209.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEc---CCCeEEEEEEeccCC----hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFR---ETNSYIAVKRVSQGS----KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKK 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~ 422 (645)
.++|...++||+|+||.||+++.. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357888999999999999999984 478999999986432 23345677899999999 6999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999654 468999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccCCcceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
.............||+.|+|||++.++ .++.++|||||||++|||++|+.||.......... .........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~----- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS----- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-----
Confidence 654333344456799999999999863 47899999999999999999999997554332211 111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccCC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFEA 627 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~~ 627 (645)
.+.+... ....+.+++.+||+.||++|| +++|+++++++..
T Consensus 282 --~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 --EPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp --CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred --CCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 1111122 224567888999999999999 9999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=352.29 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=211.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||++.+..+++.||+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35688889999999999999999999999999998654 334567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999987543 568999999999999999999999 899999999999999999999999999998664322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||...... +... ....+.. .+.
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~-~~~~~~~------~~~ 261 (335)
T 2owb_A 196 -ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYL-RIKKNEY------SIP 261 (335)
T ss_dssp -CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-HHHHTCC------CCC
T ss_pred -ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHH-HHhcCCC------CCC
Confidence 2234467899999999999988999999999999999999999999753321 1111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+ ..+.+++.+||+.||++|||++|++++.++.
T Consensus 262 ~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 262 KHIN----PVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp TTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccCC----HHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 1222 3566788999999999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=369.31 Aligned_cols=260 Identities=29% Similarity=0.461 Sum_probs=205.5
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
..+....++|...++||+|+||.||+|.+.. +..||||+++... ...++|.+|++++.+++||||+++++++.+ +..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3344556778889999999999999999976 5679999997543 235689999999999999999999999876 678
Q ss_pred EEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 425 LLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
++||||+++|+|.+++... +..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999999999999999753 4568999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
............++..|+|||++..+.++.++|||||||++|||++ |+.||...... ... .....+...
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~~--- 400 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRM--- 400 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHHHTTCCC---
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCC---
Confidence 5433223334457789999999999999999999999999999999 99999754321 111 222222111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. .+....+.+.+++.+||+.||++|||++++++.|+.-
T Consensus 401 --~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 401 --P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp --C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 1112234677888999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=349.94 Aligned_cols=259 Identities=21% Similarity=0.292 Sum_probs=201.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----e
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK----E 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~----~ 423 (645)
.++|...+.||+|+||.||++++..+++.||||++... .....+.+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788899999999999999999999999999999764 3344567899999999999999999999987654 3
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998654 468999999999999999999999 89999999999999999999999999999866
Q ss_pred cccCC--cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 504 EHAKG--SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 504 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~- 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP- 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCH-
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCc-
Confidence 44322 2233457899999999999999999999999999999999999999754321 11122222211110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+ ...+..++.+||+.||++||++.+++++.+..
T Consensus 240 --~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 240 --SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp --HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0001112 24567888999999999999888888776643
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=351.47 Aligned_cols=256 Identities=24% Similarity=0.407 Sum_probs=202.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeE----EEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
.++|...++||+|+||.||+|.+..+++. ||+|.+... .....+.+.+|+.++.+++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46788899999999999999999877764 577777543 3456678999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|+||+++|+|.+++......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 9999999999999998877789999999999999999999999 8999999999999999999999999999987643
Q ss_pred cCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 506 AKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 506 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +... ...+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~~~~---- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGERL---- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCCC----
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCC----
Confidence 322 12233456788999999999999999999999999999999 999997654332 1111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... .....+.+++.+||+.||++||+++|+++.|+.-
T Consensus 239 -~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 239 -PQPP----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -CCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111 1223577888999999999999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=353.51 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=207.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...+.||+|+||.||++.+..+++.||||.+..... ...+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4578889999999999999999999999999999975532 234688888888 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC----CcEEEeeccCcccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN----FNAKIGDFGLARLVEH 505 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~----~~~kl~DfGla~~~~~ 505 (645)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+.++ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999988644 568999999999999999999999 899999999999998433 3599999999986543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. ....+... ....
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~i~~~~~~--~~~~ 245 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA----RIGSGKFS--LSGG 245 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH----HHHHCCCC--CCST
T ss_pred CC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH----HHccCCcc--cCcc
Confidence 32 23344678999999999988889999999999999999999999998543332222222 22222221 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... ....+.+++.+||+.||++|||+.|+++|.|+.
T Consensus 246 ~~~~----~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 246 YWNS----VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp TTTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred cccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 1111 224567888999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.09 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=212.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999999999999999986542 22356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++|+|.+++.+ ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999864 4569999999999999999999998 89999999999999999999999999999876432
Q ss_pred CcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+.. ...++... .
T Consensus 170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~----~i~~~~~~------~ 235 (476)
T 2y94_A 170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFK----KICDGIFY------T 235 (476)
T ss_dssp -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHH----HHHTTCCC------C
T ss_pred -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHhcCCcC------C
Confidence 22344579999999999988765 78999999999999999999999754321 1221 12222110 1
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
....+ ..+.+++.+||+.||++|||++|+++|.++....|
T Consensus 236 p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 275 (476)
T 2y94_A 236 PQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP 275 (476)
T ss_dssp CTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred CccCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence 11122 35677889999999999999999999998865444
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.35 Aligned_cols=261 Identities=26% Similarity=0.377 Sum_probs=206.7
Q ss_pred cCCCCCCccCcCCcEEEEEEE----EcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGF----FRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KEL 424 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~----~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~ 424 (645)
++|...++||+|+||.||+|+ ...+++.||+|++... .....+.+.+|++++.+++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457788999999999999999 4567899999999754 334567899999999999999999999999876 678
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 99999999999999997777789999999999999999999999 899999999999999999999999999998765
Q ss_pred ccCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CCCchhHHHHHHHHhc
Q 042831 505 HAKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA--------PQGQVSLLQWVWDLYG 574 (645)
Q Consensus 505 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~--------~~~~~~l~~~~~~~~~ 574 (645)
..... ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... +...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 43321 2234567888999999999899999999999999999999999864221 0000011111111111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+.. . ..+......+.+++.+||+.||++|||++|+++.|+
T Consensus 258 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 258 EGKR-----L----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp TTCC-----C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ccCC-----C----CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 1111 1 111122356778899999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.25 Aligned_cols=265 Identities=15% Similarity=0.159 Sum_probs=206.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCC-----CeEEEEEEeccCChhh-----------HHHHHHHHHHHHhcCCCCccE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRET-----NSYIAVKRVSQGSKQG-----------IKEYASEVKIISRLRHRNLVQ 413 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nlv~ 413 (645)
..++|...++||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998764 5789999987654321 123445666777888999999
Q ss_pred EEeeeeeC----CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC--
Q 042831 414 LLGWCHEK----KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-- 487 (645)
Q Consensus 414 l~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-- 487 (645)
+++++... ...++||||+ +++|.+++......+++..++.|+.||+.||.|||+ .+|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 99998764 4589999999 999999998777789999999999999999999999 8999999999999998
Q ss_pred CCCcEEEeeccCcccccccCCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 042831 488 SNFNAKIGDFGLARLVEHAKGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG 561 (645)
Q Consensus 488 ~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~ 561 (645)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999876433211 1233569999999999999999999999999999999999999998533221
Q ss_pred chhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 562 QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 562 ~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
....+..... ...+.+.+++.+.... ....+..++..|++.||++||+++++++.|+
T Consensus 269 --~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 269 --KYVRDSKIRY-RENIASLMDKCFPAAN---APGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp --HHHHHHHHHH-HHCHHHHHHHHSCTTC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred --HHHHHHHHHh-hhhHHHHHHHhccccc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 1222221111 1122333333322111 1245677888999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=353.19 Aligned_cols=259 Identities=23% Similarity=0.290 Sum_probs=193.4
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeee----
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCH---- 419 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~---- 419 (645)
+.+.....+|...++||+|+||.||+|++..+++.||||++........+.+.+|+.++.+++ ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 344555668899999999999999999999899999999997777777788999999999996 999999999984
Q ss_pred ----eCCeEEEEEEecCCCChhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEECCCCc
Q 042831 420 ----EKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 420 ----~~~~~~lV~Ey~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld~~~~ 491 (645)
.....++||||+. |+|.+++.. ....+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCC
Confidence 3456899999995 799988864 45679999999999999999999998 77 999999999999999999
Q ss_pred EEEeeccCcccccccCCc-----------ceeecccCccccCcccc---ccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 042831 492 AKIGDFGLARLVEHAKGS-----------QTTVLAGTMGYMAPECA---TTGKASKESDVYSFGIVALEIACGRKPINPK 557 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~~sDV~SfGvll~elltG~~pf~~~ 557 (645)
+||+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876432221 11234689999999998 5667899999999999999999999999743
Q ss_pred CCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 558 APQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 558 ~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... .. .+...... ... ....+..++..||+.||++|||++|++++|+.-
T Consensus 257 ~~~~---~~--------~~~~~~~~----~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 257 AKLR---IV--------NGKYSIPP----HDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp --------------------CCCCT----TCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHH---hh--------cCcccCCc----ccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3211 00 01110000 011 112366788999999999999999999999853
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=360.14 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=202.5
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcC--CCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLR--HRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nlv~l~~~~~~~~~~~ 425 (645)
...+|...+.||+|+||.||++.+.. ++.||||++... .....+.+.+|+.++.+++ ||||+++++++..++..+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34569999999999999999999875 889999998654 3456678999999999997 599999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+||| +.+++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++....
T Consensus 133 lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999 6689999998654 478999999999999999999998 8999999999999996 57899999999987643
Q ss_pred cCCc-ceeecccCccccCcccccc-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 506 AKGS-QTTVLAGTMGYMAPECATT-----------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 506 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh
Confidence 3222 2344679999999999865 46899999999999999999999999743321 11111111
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
++.....++......+.+++.+||+.||++|||+.|++++.++..
T Consensus 282 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 282 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 111111111111245678889999999999999999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.44 Aligned_cols=261 Identities=20% Similarity=0.288 Sum_probs=206.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeee-eeCCeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC-HEKKELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~-~~~~~~~lV~ 428 (645)
..++|...+.||+|+||.||+|++..+++.||||.+..... .+++.+|++++.+++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999998754432 23578899999999988877766665 5677889999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~~~ 505 (645)
||+ +++|.+++......+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 999999997667789999999999999999999999 899999999999999 7899999999999987654
Q ss_pred cCC------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 506 AKG------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 506 ~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence 332 122346789999999999999999999999999999999999999986554433333322221110000
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.+...++ ..+.+++..||+.||++|||++++++.|+.
T Consensus 239 ---~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 239 ---IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp ---HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ---hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 011112222 467788899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.14 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=213.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|++++.+++||||+++++++...+.+++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888999999999999999999999999999996532 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 428 YEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
|||+++|+|..++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999998653 3469999999999999999999999 899999999999999999999999999998664
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc-hhHHHHHHHHhcCCccccccC
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ-VSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~-~~l~~~~~~~~~~~~l~~~~d 583 (645)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+... ...+..
T Consensus 341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~----i~~~~~----- 410 (543)
T 3c4z_A 341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----VLEQAV----- 410 (543)
T ss_dssp TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH----HHHCCC-----
T ss_pred CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH----Hhhccc-----
Confidence 332 223345799999999999999999999999999999999999999986543222 111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHhccCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSI-----RQVIHVLNFEA 627 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~~~ 627 (645)
.+...+ ...+..++.+||+.||++||++ +++++|.++..
T Consensus 411 -~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 411 -TYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp -CCCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred -CCCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 111122 2456778899999999999964 88999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=336.47 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=205.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----CCeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE----KKELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~----~~~~~l 426 (645)
.|...+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++.+++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 466778899999999999999999999999998654 44556789999999999999999999998865 456899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEEC-CCCcEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLD-SNFNAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld-~~~~~kl~DfGla~~~ 503 (645)
||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+ ++||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999999653 568999999999999999999998 77 99999999999998 7899999999999754
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.. .......|++.|+|||++. +.++.++||||||+++|||++|+.||...... . . .......+.....
T Consensus 183 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~---~-~~~~~~~~~~~~~-- 250 (290)
T 1t4h_A 183 RA---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--A---Q-IYRRVTSGVKPAS-- 250 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--H---H-HHHHHTTTCCCGG--
T ss_pred cc---cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--H---H-HHHHHhccCCccc--
Confidence 32 2334467999999999876 46899999999999999999999999753321 1 1 1122222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..... ...+.+++..||+.||++|||++|+++|.++..
T Consensus 251 --~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 251 --FDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --GGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --cCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 11111 235778889999999999999999999998763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.52 Aligned_cols=250 Identities=23% Similarity=0.359 Sum_probs=205.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||+|++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46788899999999999999999989999999998754 344567888999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC----------------
Q 042831 428 YEFMPNGSLDSHLFKE---NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---------------- 488 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---------------- 488 (645)
|||+++++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753 3678999999999999999999999 89999999999999984
Q ss_pred ---CCcEEEeeccCcccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 042831 489 ---NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVS 564 (645)
Q Consensus 489 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~ 564 (645)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||+++||++|+.++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 4479999999998654322 23589999999998776 56789999999999999999998764221
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. +....++.. +.+...++ ..+.+++.+||+.||++|||++|++++.++..
T Consensus 236 ~----~~~~~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 236 Q----WHEIRQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp H----HHHHHTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred H----HHHHHcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 1 112222222 12222222 45678889999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=341.98 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=207.5
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.....++|...+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++.+++||||+++++++.. +..++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 3444567888999999999999999986 46789999986543 345688999999999999999999999864 56899
Q ss_pred EEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 427 VYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999996532 368999999999999999999999 8999999999999999999999999999987654
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
..........++..|+|||.+.++.++.++||||||++++||++ |+.||...... .+.. ...++. ..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~-----~~ 229 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ----NLERGY-----RM 229 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTC-----CC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH----HHhccc-----CC
Confidence 33222333456788999999998889999999999999999999 99999754321 1111 111221 11
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.....+ .+.+.+++..|++.||++|||+.++++.|+.
T Consensus 230 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 230 VRPDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111122 2467788899999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=347.65 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=214.1
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEE
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQL 414 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l 414 (645)
+...++....++|...+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445566667789999999999999999999853 467899999997653 34567899999999999 69999999
Q ss_pred EeeeeeCC-eEEEEEEecCCCChhhhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhhcCCCeeecc
Q 042831 415 LGWCHEKK-ELLLVYEFMPNGSLDSHLFKENS---------------LLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRD 478 (645)
Q Consensus 415 ~~~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 478 (645)
++++...+ ..++||||+++|+|.+++..... .+++..++.++.||++||.|||+ .+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence 99987754 58999999999999999975433 28999999999999999999999 8999999
Q ss_pred CCCCCeEECCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCC
Q 042831 479 IKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINP 556 (645)
Q Consensus 479 lkp~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~ 556 (645)
|||+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543322 22334567889999999999999999999999999999998 9999975
Q ss_pred CCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 557 KAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 557 ~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..... .+ ......+.. ....... ...+.+++.+||+.||++|||++|++++|+.
T Consensus 254 ~~~~~--~~----~~~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 254 VKIDE--EF----CRRLKEGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCCSH--HH----HHHHHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhH--HH----HHHhccCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 44321 11 111111211 1111112 2457788899999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.51 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=209.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeee-eeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWC-HEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~-~~~~~~~lV~E 429 (645)
.++|...+.||+|+||.||+|++..+++.||||++..... .+++.+|+.++.+++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4688999999999999999999988999999999865433 24688999999999998876666655 56778899999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~~~~ 506 (645)
|+ +++|.+++......+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999997667789999999999999999999999 899999999999999 48889999999999876543
Q ss_pred CCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 507 KGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 507 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 321 12446799999999999999999999999999999999999999986554333333322221111000
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.+...++ ..+.+++.+||+.||++|||++++++.|+.
T Consensus 239 --~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 239 --IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp --HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred --hHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 011112222 457788899999999999999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.49 Aligned_cols=271 Identities=23% Similarity=0.269 Sum_probs=201.4
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
....++|...++||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445689999999999999999999999999999999875432 33567789999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE-----CCCCcEEEeeccCc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML-----DSNFNAKIGDFGLA 500 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl-----d~~~~~kl~DfGla 500 (645)
+||||++ |+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 110 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999997 5999988654 458999999999999999999999 899999999999999 45566999999999
Q ss_pred ccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+........-.
T Consensus 185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchh
Confidence 8664322 223445689999999998875 4899999999999999999999999754322 1222222221110000
Q ss_pred c---------c--cCccccCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 E---------A--VDPRLCRDFDGQ-----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 ~---------~--~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. . ..+......... ....+.+++.+||+.||++|||++|+++|.++..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 324 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence 0 0 000000000000 1256778899999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.92 Aligned_cols=260 Identities=28% Similarity=0.493 Sum_probs=197.7
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
...++|...++||+|+||.||+|++.. .||+|.+... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 345678999999999999999998753 4999998654 345567899999999999999999999976 4566899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999997777789999999999999999999999 89999999999999999999999999999765432
Q ss_pred C-CcceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 507 K-GSQTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 507 ~-~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
. ........||+.|+|||.+. ...++.++||||||+++|||++|+.||......+ . +......+......
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhcccccCcch
Confidence 2 22234457899999999986 5668899999999999999999999997544321 1 22222222221111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. .+... ....+.+++..||+.||++|||++|+++.|+.-
T Consensus 248 ~-~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 S-KVRSN----CPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp T-SSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred h-hcccc----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1 11122 235677888999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.75 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=207.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34678889999999999999999999999999999987766677889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++......+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 999999999987767789999999999999999999999 899999999999999999999999999876432111 1
Q ss_pred ceeecccCccccCcccc-----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 510 QTTVLAGTMGYMAPECA-----TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~-----~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
......|+..|+|||++ ....++.++||||||+++|||++|+.||...... ......... .......+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~~ 245 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS-DPPTLLTP 245 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCCCCSSG
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhcc-CCcccCCc
Confidence 12335689999999988 3667899999999999999999999999754321 111111111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. .....+..++.+||+.||++|||++|++++.++..
T Consensus 246 ---~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 246 ---S----KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp ---G----GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred ---c----ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence 1 11245778889999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.89 Aligned_cols=265 Identities=21% Similarity=0.231 Sum_probs=203.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...++||+|+||.||+|++..+++.||||++... .....+++.+|+.++++++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999999999999999999754 445567889999999999999999999998654
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++||||++++ |.+.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred CeEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 4679999999764 555553 248999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC-----
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----- 576 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----- 576 (645)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.+..+..
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHH
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHH
Confidence 65432 2334567999999999999999999999999999999999999999754422 1111111111110
Q ss_pred ---------------c-----cccccCccccCCC---CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 577 ---------------K-----LLEAVDPRLCRDF---DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 577 ---------------~-----l~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. +.......+.... .......+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0 0000000000000 111246688999999999999999999999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.41 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=209.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999999999999999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999999998654 468999999999999999999998 89999999999999999999999999998754322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....... ..+..
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~~~~~~------~~~~~ 233 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETH----RRIVNVD------LKFPP 233 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHTTC------CCCCT
T ss_pred -ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHH----HHHhccc------cCCCC
Confidence 223457899999999999989999999999999999999999999753321 111 1111111 11112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.. ...+.+++.+||+.||++||+++|++++.++..
T Consensus 234 ~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 234 FL----SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp TS----CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred cC----CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 22 245678889999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.78 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=206.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|.....||+|+||.||+|.+..+++.||+|.+........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34566779999999999999999999999999998776666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcccccccCC
Q 042831 432 PNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 432 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~~~~~~~~ 508 (645)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999997643 356789999999999999999999 89999999999999987 8999999999998654321
Q ss_pred cceeecccCccccCccccccCC--CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGK--ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~--~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.......|++.|+|||++..+. ++.++||||||+++|||++|+.||........ ... ..... ...+.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-~~~~~-------~~~~~~ 247 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMF-KVGMF-------KVHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHH-HHHHH-------CCCCCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHH-hhccc-------cccccc
Confidence 2233457899999999987654 88999999999999999999999964322111 010 00000 111222
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.... ...+.+++.+||+.||++||+++|++++.++..
T Consensus 248 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 284 (295)
T 2clq_A 248 PESM----SAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284 (295)
T ss_dssp CTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC
T ss_pred cccC----CHHHHHHHHHHccCChhhCCCHHHHhcChhhhh
Confidence 2222 245677889999999999999999999998864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.10 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=208.9
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEc-------CCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeee
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFR-------ETNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCH 419 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~ 419 (645)
...++|...+.||+|+||.||+|.+. .++..||+|++... .....+.+.+|++++.++ +||||++++++|.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578888999999999999999975 35678999999765 345567899999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCe
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNI 484 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NI 484 (645)
..+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceE
Confidence 9999999999999999999997543 248999999999999999999999 8999999999999
Q ss_pred EECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCc
Q 042831 485 MLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQ 562 (645)
Q Consensus 485 Lld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~ 562 (645)
|++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 266 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 266 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--
Confidence 9999999999999999866543221 2233456788999999988889999999999999999999 99999754321
Q ss_pred hhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 563 VSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 563 ~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.. ....+.. +.....+ ...+.+++.+||+.||++|||++|+++.|+.
T Consensus 267 -~~~~----~~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 267 -ELFK----LLKEGHR-----MDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp -HHHH----HHHHTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHH----HHhcCCC-----CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1121 1112211 1111122 2457788899999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.65 Aligned_cols=272 Identities=22% Similarity=0.281 Sum_probs=204.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----Ce
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~ 423 (645)
.++|...+.||+|+||.||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46788999999999999999999999999999999753 344567899999999999999999999999766 57
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999999985 699988854 4569999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCC---------------------cceeecccCccccCcccc-ccCCCCcchhHHHHHHHHHHHHcCCCCCCCC----
Q 042831 504 EHAKG---------------------SQTTVLAGTMGYMAPECA-TTGKASKESDVYSFGIVALEIACGRKPINPK---- 557 (645)
Q Consensus 504 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDV~SfGvll~elltG~~pf~~~---- 557 (645)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..||...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 259 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence 43321 123556899999999986 5567999999999999999999865554321
Q ss_pred -------CCC--------------CchhHHHHHHHHhcCCccc-----------cccCc-cccCCCCH-----HHHHHHH
Q 042831 558 -------APQ--------------GQVSLLQWVWDLYGNGKLL-----------EAVDP-RLCRDFDG-----QQIERLM 599 (645)
Q Consensus 558 -------~~~--------------~~~~l~~~~~~~~~~~~l~-----------~~~d~-~l~~~~~~-----~~~~~l~ 599 (645)
..- .....+..+.+..+..... ..+.. ......+. .....+.
T Consensus 260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 339 (432)
T 3n9x_A 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI 339 (432)
T ss_dssp CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence 100 0011112222222211100 00000 00000000 1124567
Q ss_pred HHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 600 IVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 600 ~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+|+.+||+.||++|||++|+++|.++..
T Consensus 340 dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 340 NLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred HHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 8889999999999999999999999763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=342.59 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=211.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.+.|...+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888999999999999999999899999999987543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999999998853 568999999999999999999999 899999999999999999999999999997654322 2
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...+. .+.+...
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~-----~~~~~~~ 242 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLFL----IPKNN-----PPTLEGN 242 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHH----HHHSC-----CCCCCSS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHHH----hhcCC-----CCCCccc
Confidence 233457899999999999999999999999999999999999999753321 11111 11111 1222222
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
++ ..+..++..||+.||++|||++|++++.++.
T Consensus 243 ~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 243 YS----KPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CC----HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred cC----HHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 33 3577888999999999999999999998763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.89 Aligned_cols=271 Identities=25% Similarity=0.348 Sum_probs=206.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.++|...+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999999999999999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+++++|..++. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 104 EFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp ECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 9999998887764 34569999999999999999999999 899999999999999999999999999997654322
Q ss_pred cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHH--------HHHHHhcC-Ccc
Q 042831 509 SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ--------WVWDLYGN-GKL 578 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~--------~~~~~~~~-~~l 578 (645)
.......|+..|+|||++.+. .++.++|||||||++|||++|+.||......+...... .....+.. ...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 223345689999999998775 68999999999999999999999997644321111000 00111111 111
Q ss_pred ccccCccccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 579 LEAVDPRLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 579 ~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+...... ...+.+.+++.+||+.||++|||++|++++.++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~ 311 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhc
Confidence 11111111111111 1235678899999999999999999999998874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.01 Aligned_cols=274 Identities=24% Similarity=0.321 Sum_probs=206.8
Q ss_pred CccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc--CCCCccEEEee
Q 042831 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL--RHRNLVQLLGW 417 (645)
Q Consensus 340 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~H~nlv~l~~~ 417 (645)
...+........++|...++||+|+||.||+|++. ++.||||++.... ...+..|.+++..+ +||||++++++
T Consensus 25 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 25 SGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp SSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 34455555566789999999999999999999886 7899999985432 23445566666554 89999999999
Q ss_pred eeeC----CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-----CCCeeeccCCCCCeEECC
Q 042831 418 CHEK----KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-----EQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 418 ~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~ 488 (645)
+... ...++||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 9877 7899999999999999999543 6899999999999999999999821 129999999999999999
Q ss_pred CCcEEEeeccCcccccccCCcc---eeecccCccccCccccccCCCCcc------hhHHHHHHHHHHHHcC---------
Q 042831 489 NFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECATTGKASKE------SDVYSFGIVALEIACG--------- 550 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~~------sDV~SfGvll~elltG--------- 550 (645)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997654332221 224579999999999987766655 9999999999999999
Q ss_pred -CCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 551 -RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 551 -~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.||......... ...................... ..+....+.+++.+||+.||++|||+.|++++|+.
T Consensus 258 ~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 258 YQLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNRWS---SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGGGG---GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred ccccHhhhcCCCCc--hhhhHHHHhhhccCccccccch---hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 6666544332211 1111122211221111111111 12566778899999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.49 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=200.6
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..++|...+.||+|+||.||+|....+|+.||+|++... .....+.+.+|+.++.+++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 345788999999999999999999888999999998753 34456788999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999998864 35678999999999999999999999 89999999999999999999999999999765
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... .....+......
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~- 259 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHTTCSCCCC-
T ss_pred cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhcccCCCCc-
Confidence 4322 2223456899999999999999999999999999999999999999754322 11111 112222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+ ...+.+++.+||+.||++|||++++++.|+.-
T Consensus 260 ---~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 260 ---SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1112 24577888999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.96 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=197.0
Q ss_pred cCCCCC-CccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHh-cCCCCccEEEeeeee----CCeEE
Q 042831 352 NDFNDD-QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR-LRHRNLVQLLGWCHE----KKELL 425 (645)
Q Consensus 352 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~H~nlv~l~~~~~~----~~~~~ 425 (645)
++|... +.||+|+||.||++.+..+++.||||++... ..+.+|++++.+ .+||||+++++++.. .+.++
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345554 6899999999999999999999999998633 356788888754 589999999999875 56789
Q ss_pred EEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCcc
Q 042831 426 LVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLAR 501 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla~ 501 (645)
+|||||++|+|.+++.... ..+++..+..|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999997643 469999999999999999999998 89999999999999997 7899999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch-hHHHHHHHHhcCCcccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV-SLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~-~l~~~~~~~~~~~~l~~ 580 (645)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ...+...
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~- 285 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE- 285 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-
Confidence 65422 2234467899999999999999999999999999999999999999765433211 11111 1111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+. ...+ ...+.+++..||+.||++|||++|+++|.|+.
T Consensus 286 ~~~~~-~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~ 326 (400)
T 1nxk_A 286 FPNPE-WSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326 (400)
T ss_dssp CCTTT-TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCCcc-cccC----CHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 00010 0112 24577888999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=352.62 Aligned_cols=269 Identities=24% Similarity=0.310 Sum_probs=209.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...++||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++.+++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 45788899999999999999999999999999999765 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++++|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999654 468999999999999999999998 5 8999999999999999999999999999755322
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHH---------HHHHhc-----
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW---------VWDLYG----- 574 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~---------~~~~~~----- 574 (645)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....... .+....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 22345789999999999999999999999999999999999999975432111000000 000000
Q ss_pred ---------CCccccccC----ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 ---------NGKLLEAVD----PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ---------~~~l~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.++ ..............+.+++.+||+.||++|||++|+++|.++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 329 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 329 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 000000000 0000000011224577888999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=376.49 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=202.9
Q ss_pred cCCCCCC-ccCcCCcEEEEEEEEc--CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQ-KLGQGGFGGVYKGFFR--ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~-~LG~G~fG~Vy~g~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
+++...+ +||+|+||.||+|.+. .++..||||+++... ....+++.+|++++.+++||||++++++|.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3344344 7999999999999876 346789999997653 3467889999999999999999999999976 568999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||||++|+|.+++......+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 99999999999998777789999999999999999999999 899999999999999999999999999998764332
Q ss_pred Ccc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 508 GSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 508 ~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... .....+++.|+|||++.++.++.++|||||||+||||++ |+.||...... .+. ..+.++....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~---- 559 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRME---- 559 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH----HHHHTTCCCC----
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCCCC----
Confidence 211 122345689999999999999999999999999999998 99999865432 122 2222332111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+......+.+++..||+.||++||+++++++.|+.
T Consensus 560 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 560 -----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111223467788899999999999999999998874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.09 Aligned_cols=258 Identities=23% Similarity=0.354 Sum_probs=209.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||.||++++..+|+.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45788899999999999999999989999999999866555556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCcccccccC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~~~~~ 507 (645)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999988654 468999999999999999999999 899999999999999 78899999999999754322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ..+.. ...++... .+....
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~----~i~~~~~~--~~~~~~ 231 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---SKLFE----KIKEGYYE--FESPFW 231 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHCCCC--CCTTTT
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHcCCCC--CCcccc
Confidence 22335689999999999999999999999999999999999999975432 11111 12222111 111111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
... ...+.+++.+||+.||++|||++|++++.++...
T Consensus 232 ~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 232 DDI----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTS----CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 122 2467788899999999999999999999987643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.74 Aligned_cols=256 Identities=23% Similarity=0.307 Sum_probs=206.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
++|...+.||+|+||.||++++..+++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 568889999999999999999998999999999865421 13678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCcc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLAR 501 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla~ 501 (645)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999998643 468999999999999999999998 8999999999999998877 89999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
...... ......|++.|+|||++....++.++||||||+++|||++|+.||...... .... ....... .
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~--~ 229 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETLT----NISAVNY--D 229 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHTTCC--C
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHHH----HhHhccc--C
Confidence 654322 233456899999999999999999999999999999999999999754321 1111 1111110 0
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.++...... ...+.+++.+||+.||++|||+.|++++.++.
T Consensus 230 ~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 270 (283)
T 3bhy_A 230 FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK 270 (283)
T ss_dssp CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence 111111112 24577888999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=346.74 Aligned_cols=266 Identities=24% Similarity=0.401 Sum_probs=191.2
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
...++|...+.||+|+||.||+|.+..+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999998889999999886543 34456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 428 YEFMPNGSLDSHLFK-------ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999864 24569999999999999999999999 89999999999999999999999999998
Q ss_pred ccccccCC----cceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 501 RLVEHAKG----SQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 501 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
........ .......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ . ......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhcc
Confidence 76543211 12234578999999999876 5689999999999999999999999976443211 1 111111
Q ss_pred C--ccc-cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 576 G--KLL-EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 576 ~--~l~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. ... ...++.+...++ ..+.+++.+||+.||++|||++|++++.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 293 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293 (303)
T ss_dssp SCCCTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTSTTC--
T ss_pred CCCccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhChhhhc
Confidence 1 010 111122222232 45677889999999999999999999998763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.96 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=204.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCe---EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE-EEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL-LLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~-~lV 427 (645)
.|...++||+|+||.||+|.+..++. .||+|.+... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35556899999999999999765443 7999998754 345567899999999999999999999999876655 999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+.+|+|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 99999999999998777789999999999999999999999 899999999999999999999999999997654322
Q ss_pred ---CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 508 ---GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 508 ---~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
........++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..+...+ ..+.. .
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~----~~~~~-----~ 247 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFL----AQGRR-----L 247 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHH----HTTCC-----C
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHh----hcCCC-----C
Confidence 12233456788999999999999999999999999999999966554432221 1122211 11111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...... ...+.+++.+||+.||++|||++++++.|+.
T Consensus 248 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 248 PQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111112 2467788899999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.64 Aligned_cols=267 Identities=19% Similarity=0.270 Sum_probs=211.3
Q ss_pred cChHHHHHhhcCCCCC-CccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcC-CCCccEEEee
Q 042831 342 FPYKELALATNDFNDD-QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLR-HRNLVQLLGW 417 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~ 417 (645)
..++......+.|... ++||+|+||.||+|++..+++.||+|++.... ......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445556667766 88999999999999999999999999987542 334678899999999995 6999999999
Q ss_pred eeeCCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEE
Q 042831 418 CHEKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAK 493 (645)
Q Consensus 418 ~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~k 493 (645)
+.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998643 4679999999999999999999999 89999999999999987 78999
Q ss_pred EeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~-- 247 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---ETYLNISQ-- 247 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH--
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHHHh--
Confidence 99999998664322 233457999999999999999999999999999999999999999754321 11111110
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..... ....... ....+.+++.+||+.||++|||++|++++.++.
T Consensus 248 ~~~~~----~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 248 VNVDY----SEETFSS----VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp TCCCC----CTTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred ccccc----Cchhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 01100 1111111 234577888999999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.67 Aligned_cols=257 Identities=19% Similarity=0.205 Sum_probs=200.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 467889999999999999999999899999999987542 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999998654 468999999999999999999999 899999999999999999999999999998665443
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc-cccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK-LLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~-l~~~~d~~l 586 (645)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||..... . .......... .... .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~---~~~~~~~~~~~~~~~----~ 257 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S---VMGAHINQAIPRPST----V 257 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H---HHHHHHHSCCCCGGG----T
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H---HHHHHhccCCCCccc----c
Confidence 3334456789999999999998999999999999999999999999974321 1 1111111111 1111 1
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRP-SIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 626 (645)
...++ ..+.+++.+||+.||++|| +++++++.|+..
T Consensus 258 ~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 258 RPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp STTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred CCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 11222 3567788999999999999 999999999854
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=355.01 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=199.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~ 421 (645)
..++|...++||+|+||.||+|.+..+++.||||++.... ......+.+|++++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4568999999999999999999999999999999986431 122335789999999999999999999975 4
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC---CcEEEeecc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN---FNAKIGDFG 498 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kl~DfG 498 (645)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecc
Confidence 568999999999999998854 4568999999999999999999998 899999999999999754 459999999
Q ss_pred CcccccccCCcceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ +.+. ...
T Consensus 288 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~----i~~ 359 (419)
T 3i6u_A 288 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ----ITS 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH----HHT
T ss_pred cceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH----Hhc
Confidence 99876432 23344679999999999853 5688999999999999999999999975443221 1111 112
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.... .+..... ....+.+++.+||+.||++|||++|+++|.|+..
T Consensus 360 ~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 360 GKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 21110 0111111 1246778899999999999999999999999753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.45 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=204.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEE--EEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYI--AVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~v--avK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
++|...+.||+|+||.||+|++..++..+ |+|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67888999999999999999998888755 99988753 344556789999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 428 YEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999996543 479999999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~ 571 (645)
||+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE 252 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHHH
Confidence 999999987433211 2233456889999999988889999999999999999998 99999754321 1112
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
....+. ....... ....+.+++.+||+.||++|||++|++++|+.
T Consensus 253 ~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 KLPQGY-----RLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp HGGGTC-----CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCC-----CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 222221 1111111 22467788899999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=357.75 Aligned_cols=260 Identities=13% Similarity=0.061 Sum_probs=190.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhc--CCCCccEEE-------eee
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRL--RHRNLVQLL-------GWC 418 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l--~H~nlv~l~-------~~~ 418 (645)
..+|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++..+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999999999999999998653 23456677886555555 699988865 344
Q ss_pred eeC-----------------CeEEEEEEecCCCChhhhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhhcCCCee
Q 042831 419 HEK-----------------KELLLVYEFMPNGSLDSHLFKENSLLTWEFR------YKIAQDLASGLLYLQEEWEQCVV 475 (645)
Q Consensus 419 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 475 (645)
... ...++||||++ |+|.+++...+..+++..+ ..++.||+.||.|||+ ++|+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCc
Confidence 332 34899999998 8999999865555666777 8888999999999998 8999
Q ss_pred eccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCC
Q 042831 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKP 553 (645)
Q Consensus 476 H~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~p 553 (645)
||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999986532 2224557799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 554 INPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 554 f~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
|.......... +............+...........+.+++.+||+.||++|||+.|+++|.++.
T Consensus 293 f~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 357 (371)
T 3q60_A 293 FGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357 (371)
T ss_dssp TTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred CCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence 98654321110 000000000011110000012234677888999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.51 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=202.3
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
++++....++|...+.||+|+||.||+|.+.. ++..||+|.+... .....+.+.+|+.++.+++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 44555667889999999999999999998764 4568999998754 345567899999999999999999999999
Q ss_pred eeCC-----eEEEEEEecCCCChhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC
Q 042831 419 HEKK-----ELLLVYEFMPNGSLDSHLFK-----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 419 ~~~~-----~~~lV~Ey~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~ 488 (645)
...+ ..++||||+++|+|.+++.. ....+++..++.++.||++||.|||+ .+|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcC
Confidence 8654 35999999999999999853 34579999999999999999999998 89999999999999999
Q ss_pred CCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHH
Q 042831 489 NFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLL 566 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~ 566 (645)
++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH
Confidence 99999999999986543322 22233557889999999999999999999999999999999 88999754432 112
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. ...+.. +.....+ ...+.+++..||+.||++|||+++++++|+.
T Consensus 260 ~~----~~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 260 DY----LLHGHR-----LKQPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp HH----HHTTCC-----CCCBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HH----HHcCCC-----CCCCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 112211 1111222 2467788899999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=357.70 Aligned_cols=272 Identities=20% Similarity=0.264 Sum_probs=209.0
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc------CCCCccEEEeeeeeCCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL------RHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~nlv~l~~~~~~~~~ 423 (645)
...+|...++||+|+||.||+|.+..+++.||||++... ....+++.+|+.++..+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346799999999999999999999999999999999654 34456778899888887 56799999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc--EEEeeccCc
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN--AKIGDFGLA 500 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~--~kl~DfGla 500 (645)
.++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999995 68998887643 459999999999999999999999 89999999999999999887 999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC----
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG---- 576 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~---- 576 (645)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+.+..+..
T Consensus 250 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~---~l~~i~~~~~~p~~~~ 322 (429)
T 3kvw_A 250 CYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD---QLACMIELLGMPSQKL 322 (429)
T ss_dssp EETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred eecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHH
Confidence 75432 2234578999999999999999999999999999999999999997654322 111111111100
Q ss_pred -----ccccccCcc---------------------------cc---CCCCH------HHHHHHHHHHHHcCCCCCCCCCC
Q 042831 577 -----KLLEAVDPR---------------------------LC---RDFDG------QQIERLMIVGLWCAHPDENLRPS 615 (645)
Q Consensus 577 -----~l~~~~d~~---------------------------l~---~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs 615 (645)
.....++.. +. ..... .....+.+++.+||+.||++|||
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt 402 (429)
T 3kvw_A 323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402 (429)
T ss_dssp HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence 000000000 00 00000 01245778999999999999999
Q ss_pred HHHHHHHhccCCCCCCCC
Q 042831 616 IRQVIHVLNFEAPLPALP 633 (645)
Q Consensus 616 ~~evl~~L~~~~~~p~~p 633 (645)
++|+++|.|+....|..|
T Consensus 403 a~e~L~Hpw~~~~~~~~~ 420 (429)
T 3kvw_A 403 PGQALRHPWLRRRLPKPP 420 (429)
T ss_dssp HHHHHTSTTTC-------
T ss_pred HHHHhCChhhccCCCCCC
Confidence 999999999987666544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.62 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=202.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC--CeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK--KELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~--~~~~l 426 (645)
.++|...+.||+|+||.||+|++. ++.||||++... .....+.+.+|+.++.+++||||+++++++... +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357888999999999999999985 788999998754 345567899999999999999999999999877 78899
Q ss_pred EEEecCCCChhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFKENS-LLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+ .+ ++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999976543 68999999999999999999998 77 999999999999999999999999987543
Q ss_pred cccCCcceeecccCccccCccccccCCCC---cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKAS---KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t---~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
.. ....||+.|+|||.+.+...+ .++||||||+++|||++|+.||...... +........+.
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~--- 228 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGL--- 228 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCC---
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCC---
Confidence 22 224689999999998875544 4899999999999999999999754321 11111111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+.+.... ...+.+++..||+.||++|||++|+++.|+.
T Consensus 229 --~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 229 --RPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp --CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11222222 2457788899999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.47 Aligned_cols=267 Identities=24% Similarity=0.304 Sum_probs=212.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--eEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--ELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--~~~lV 427 (645)
.++|...++||+|+||.||+|++..+++.||||++.... ....+.+.+|++++.+++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888999999999999999999999999999997543 334577889999999999999999999998755 78999
Q ss_pred EEecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----CCCCcEEEeeccCcc
Q 042831 428 YEFMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGDFGLAR 501 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kl~DfGla~ 501 (645)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997532 349999999999999999999999 899999999999999 788889999999998
Q ss_pred cccccCCcceeecccCccccCcccccc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC-chhHHHHHHHH
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT--------GKASKESDVYSFGIVALEIACGRKPINPKAPQG-QVSLLQWVWDL 572 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~-~~~l~~~~~~~ 572 (645)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..... ...
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~---~~~ 239 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM---YKI 239 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH---HHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH---HHH
Confidence 654322 2334579999999998865 467889999999999999999999997544322 22222 222
Q ss_pred hcCC---cccccc-----------CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 573 YGNG---KLLEAV-----------DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 573 ~~~~---~l~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... .+.... +..............+..++..||+.||++||+++|+++.++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 2111 100000 0011123446677888899999999999999999999988864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=341.13 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=205.1
Q ss_pred HHHHhhcCCCCCC-ccCcCCcEEEEEEEE--cCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 346 ELALATNDFNDDQ-KLGQGGFGGVYKGFF--RETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 346 el~~~~~~f~~~~-~LG~G~fG~Vy~g~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
++....++|...+ .||+|+||.||+|.+ ..+++.||||++.... ....+++.+|++++.+++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3334456677777 899999999999955 4567899999987542 33467899999999999999999999999 5
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 6778999999999999999965 3568999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCcc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCc
Q 042831 501 RLVEHAKGSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGK 577 (645)
Q Consensus 501 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~ 577 (645)
+......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . +......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~----~~~~~~~~~ 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGE 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---H----HHHHHHcCC
Confidence 8765433221 122346788999999988889999999999999999999 99999754321 1 112222222
Q ss_pred cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 578 l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. +..... ....+.+++..||+.||++||++.++++.|+.
T Consensus 238 ~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 238 R-----MGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp C-----CCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 111112 23467788899999999999999999999873
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=343.63 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=193.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hh-hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQ-GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~-~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...+.||+|+||.||+|.+..+++.||+|++.... .. ..+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 4567888999999999999999999899999999997542 22 233444555567888999999999999999999999
Q ss_pred EEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 428 YEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
|||++ |+|.+++.. .+..+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 588777753 45689999999999999999999998 6 9999999999999999999999999999865
Q ss_pred cccCCcceeecccCccccCcccc----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECA----TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... . ...........
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~~~~-- 231 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--F---QQLKQVVEEPS-- 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--H---HHHHHHHHSCC--
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--H---HHHHHHhccCC--
Confidence 4322 22334689999999996 5567899999999999999999999999743321 1 11111111111
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.... ......+.+++.+||+.||++|||++|+++|.++.
T Consensus 232 ----~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 232 ----PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271 (290)
T ss_dssp ----CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred ----CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence 11110 11224577888999999999999999999998864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.52 Aligned_cols=270 Identities=21% Similarity=0.280 Sum_probs=210.1
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----C
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----K 422 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~ 422 (645)
...++|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++.+++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34568999999999999999999999999999999997543 34457889999999999999999999998754 4
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||++ |+|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 6899999996 689888854 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccccCCc--ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 503 VEHAKGS--QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 503 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ...+....+.....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHH
Confidence 6533221 12445799999999987654 489999999999999999999999976543322 22222111111000
Q ss_pred ---cccC--------c-cccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 580 ---EAVD--------P-RLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 580 ---~~~d--------~-~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...+ . .-....+. .....+.+++.+||+.||++|||++|+++|.++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000 0 00000000 11245778899999999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=341.44 Aligned_cols=257 Identities=27% Similarity=0.386 Sum_probs=207.5
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...+.||+|+||.||+|.+..+|+.||+|.+.... ..+++.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3467888999999999999999999999999999987543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+++++|.+++......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... .
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 999999999997667789999999999999999999999 899999999999999999999999999997654322 2
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ......+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~~~~~~---- 249 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNP-PPTFRKPE---- 249 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCCSSGG----
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCC-CcccCCcc----
Confidence 233456899999999999989999999999999999999999999753321 1111111111 00000111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.....+.+++.+||+.||++|||+.+++++.++.
T Consensus 250 ---~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 250 ---LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp ---GSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 1124677888999999999999999999998865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=362.47 Aligned_cols=247 Identities=16% Similarity=0.174 Sum_probs=194.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHH---HHHHhcCCCCccEEE-------e
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEV---KIISRLRHRNLVQLL-------G 416 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~nlv~l~-------~ 416 (645)
..++|...+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+ +.+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788899999999999999999888999999998743 344567899999 455566899999998 5
Q ss_pred eeeeCC-----------------eEEEEEEecCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhhcCCC
Q 042831 417 WCHEKK-----------------ELLLVYEFMPNGSLDSHLFKEN------SLLTWEFRYKIAQDLASGLLYLQEEWEQC 473 (645)
Q Consensus 417 ~~~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 473 (645)
++...+ ..++||||+ +|+|.+++...+ ..+++..++.|+.||+.||.|||+ .+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 655443 278999999 689999997532 234468899999999999999999 89
Q ss_pred eeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccC-----------CCCcchhHHHHHH
Q 042831 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-----------KASKESDVYSFGI 542 (645)
Q Consensus 474 ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDV~SfGv 542 (645)
|+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999998532 23345567 999999999887 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 042831 543 VALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV 622 (645)
Q Consensus 543 ll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 622 (645)
++|||++|+.||.......... .+.+. ...++ ..+.+++.+||+.||++|||+.|++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~----------------~~~~~-~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE----------------WIFRS-CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CCSG----------------GGGSS-CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccchh----------------hhhhh-ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 9999999999997544322111 00010 12222 456778899999999999999999998
Q ss_pred hccC
Q 042831 623 LNFE 626 (645)
Q Consensus 623 L~~~ 626 (645)
.++.
T Consensus 361 p~f~ 364 (377)
T 3byv_A 361 PEYE 364 (377)
T ss_dssp HHHH
T ss_pred hHHH
Confidence 8753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=353.47 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=196.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCeEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKELLLV 427 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~~~lV 427 (645)
.|...++||+|+||.||+|.+..+ +..||+|.+... .....+++.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 456678999999999999997543 246899998654 34566889999999999999999999998754 5678999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++|+|.+++......+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998777789999999999999999999999 899999999999999999999999999998654322
Q ss_pred Cc---ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 508 GS---QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 508 ~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.. ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ... ..++.. ...
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~----~~~~~~--~~~ 317 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY----LLQGRR--LLQ 317 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHH----HHTTCC--CCC
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHH----HHcCCC--CCC
Confidence 11 1233457789999999999999999999999999999999 6777765443321 111 112211 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+ ..+ ...+.+++.+||+.||++|||++|+++.|+.
T Consensus 318 p---~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 318 P---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp C---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 112 2457788899999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.17 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=203.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467888999999999999999999889999999986532 23456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999998654 458999999999999999999999 899999999999999999999999999998654322
Q ss_pred CcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
......+++.|+|||.+.+..+ +.++||||||++++||++|+.||..... ..+. .....+.. .+
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~----~~~~~~~~------~~ 230 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---PTLF----KKIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHHCCC------CC
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHH----HHhhcCcc------cC
Confidence 2234568999999999988765 6899999999999999999999975321 1111 11111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
.... ...+..++.+||+.||++|||++|++++.++...+|
T Consensus 231 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 231 PEYL----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred chhc----CHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 1112 235677889999999999999999999998865544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=350.32 Aligned_cols=264 Identities=21% Similarity=0.227 Sum_probs=199.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------ 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------ 422 (645)
.++|...+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46889999999999999999999999999999998753 3445677889999999999999999999987654
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||++ ++|.+.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999996 57877774 348999999999999999999999 8999999999999999999999999999986
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH----------
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL---------- 572 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~---------- 572 (645)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHHHHT
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHH
Confidence 5432 2233457899999999999989999999999999999999999999754321 111111100
Q ss_pred ---------hcCC-c-----cccccCccccCCC---CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 573 ---------YGNG-K-----LLEAVDPRLCRDF---DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 573 ---------~~~~-~-----l~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+. . +...+.....+.. .......+.+++.+||+.||++|||++|+++|.++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 0000 0 0000000000000 112356788999999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=348.22 Aligned_cols=265 Identities=18% Similarity=0.199 Sum_probs=200.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccCChh-----------hHHHHHHHHHHHHhcCCCCccEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQGSKQ-----------GIKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
.++|...+.||+|+||.||+|.+.. ++..+|+|+....... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4678899999999999999999986 6789999998765322 1234678889999999999999999
Q ss_pred eeee----CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC--
Q 042831 417 WCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-- 490 (645)
Q Consensus 417 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-- 490 (645)
++.. ....++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 9987 67899999999 999999986544 79999999999999999999999 8999999999999998877
Q ss_pred cEEEeeccCcccccccCC------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 042831 491 NAKIGDFGLARLVEHAKG------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVS 564 (645)
Q Consensus 491 ~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~ 564 (645)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~ 269 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-A 269 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-H
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-H
Confidence 999999999987643221 112345799999999999999999999999999999999999999964322211 1
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......... ..+...+...... ......+.+++..||+.||++||+++++++.|+..
T Consensus 270 -~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 -VQTAKTNLL-DELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -HHHHHHHHH-HTTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -HHHHHHhhc-ccccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111110 0111111000000 01224677888999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.80 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=210.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC--eE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK--EL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~--~~ 424 (645)
.++|...+.||+|+||.||++++ ..+++.||||++........+.+.+|++++.+++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35678889999999999999984 5678999999998777777788999999999999999999999987654 78
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++||||+++++|.+++......+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 99999999999999998777789999999999999999999999 899999999999999999999999999998765
Q ss_pred ccCCcc--eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---------CCCchhHHHHHHHHh
Q 042831 505 HAKGSQ--TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA---------PQGQVSLLQWVWDLY 573 (645)
Q Consensus 505 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~---------~~~~~~l~~~~~~~~ 573 (645)
...... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..........+.+..
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 433211 123456778999999998889999999999999999999999886321 000011111112222
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+... .... .....+.+++.+||+.||++|||++|+++.|+.
T Consensus 277 ~~~~~~-----~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 277 KNNGRL-----PRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HTTCCC-----CCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCC-----CCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 221111 1111 223467788899999999999999999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=338.61 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=202.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeee-eCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCH-EKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~-~~~~~~l 426 (645)
.+|...++||+|+||.||+|.+..+ ...||+|.+... .....+.+.+|+.++++++||||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4677889999999999999997543 346999998764 3455678999999999999999999999865 4567899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999998777789999999999999999999999 89999999999999999999999999999865432
Q ss_pred CC---cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 507 KG---SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 507 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ ..... ..+.. ..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~----~~~~~--~~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRR--LL 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHH----HTTCC--CC
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHH----hcCCC--CC
Confidence 21 12334567889999999999999999999999999999999 556665443322 11111 11111 01
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.+ ... ...+.+++.+||+.||++|||++|+++.|+.
T Consensus 253 ~~---~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 253 QP---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp CC---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC---ccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 111 2357788899999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.74 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=200.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHH-HHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKI-ISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+.||+|+||.||+++++.+++.||||++.... ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467888999999999999999999999999999997542 2334566777776 467899999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999998654 468899999999999999999998 89999999999999999999999999999854322
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+. +.++.+ .+
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~~~~~----i~~~~~------~~ 258 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDN----ILNKPL------QL 258 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HHHHHH----HHHSCC------CC
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHHHHH----HHhccc------CC
Confidence 2234456899999999999999999999999999999999999999975332 111111 111111 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSI----RQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~~L~~~ 626 (645)
...++ ..+..++.+||+.||++||++ +++++|.++.
T Consensus 259 ~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 259 KPNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp CSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred CCCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 12222 356778899999999999987 5888888764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.55 Aligned_cols=258 Identities=28% Similarity=0.418 Sum_probs=204.4
Q ss_pred hhcCCCCCCccCcCCcEEEEEEE-----EcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGF-----FRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~-----~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
..++|...+.||+|+||.||+|+ ...+++.||||.+... ......++.+|+.++.+++||||+++++++...+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 34678899999999999999999 4456789999999754 44556789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEE
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKI 494 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl 494 (645)
.++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999997643 458999999999999999999999 89999999999999984 456999
Q ss_pred eeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHH
Q 042831 495 GDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 495 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE----F 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----H
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH----H
Confidence 99999976543222 22234567889999999999999999999999999999998 99999754321 1222 2
Q ss_pred hcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 573 YGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 573 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+... .....+ ...+.+++..||+.||++||++.+++++|+.-
T Consensus 258 ~~~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 VTSGGRM-----DPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHTTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCC-----CCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2222111 111122 24577888999999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=340.46 Aligned_cols=274 Identities=26% Similarity=0.350 Sum_probs=213.2
Q ss_pred CccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCccEEEee
Q 042831 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISR--LRHRNLVQLLGW 417 (645)
Q Consensus 340 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nlv~l~~~ 417 (645)
...+........++|...+.||+|+||.||+|++. ++.||||++... ..+.+.+|++++.. ++||||++++++
T Consensus 30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~ 104 (342)
T 1b6c_B 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA 104 (342)
T ss_dssp SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred CCCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence 34555555566789999999999999999999984 899999998643 34577889999988 789999999999
Q ss_pred eeeCC----eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-----CCCeeeccCCCCCeEECC
Q 042831 418 CHEKK----ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW-----EQCVVHRDIKSSNIMLDS 488 (645)
Q Consensus 418 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlkp~NILld~ 488 (645)
+.... ..++||||+++|+|.+++.+ ..+++..++.++.|++.||.|||... +.+|+||||||+|||++.
T Consensus 105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp EECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred ecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 98775 89999999999999999964 35899999999999999999999211 289999999999999999
Q ss_pred CCcEEEeeccCcccccccCCc---ceeecccCccccCccccccCC------CCcchhHHHHHHHHHHHHcC---------
Q 042831 489 NFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATTGK------ASKESDVYSFGIVALEIACG--------- 550 (645)
Q Consensus 489 ~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~elltG--------- 550 (645)
++.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876543322 123457899999999987753 34789999999999999999
Q ss_pred -CCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 551 -RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 551 -~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.||......... ... .............+.... ...+....+.+++.+||+.||++|||++|++++|+.
T Consensus 263 ~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 263 YQLPYYDLVPSDPS-VEE-MRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCTTTTTSCSSCC-HHH-HHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCccccCcCccc-HHH-HHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 7788654432211 111 122222222211111111 123566788999999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=349.03 Aligned_cols=276 Identities=22% Similarity=0.233 Sum_probs=208.2
Q ss_pred ChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-----------hhhHHHHHHHHHHHHhcCCCCc
Q 042831 343 PYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-----------KQGIKEYASEVKIISRLRHRNL 411 (645)
Q Consensus 343 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~nl 411 (645)
..+++....++|...+.||+|+||.||+|.+.. |+.||||++.... ....+.+.+|++++.+++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 456788889999999999999999999999865 8999999985432 1224789999999999999999
Q ss_pred cEEEeeeee-----CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 412 VQLLGWCHE-----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 412 v~l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+++++++.. ....++||||++ |+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILL 167 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEE
Confidence 999999843 346899999997 68888887777789999999999999999999999 899999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhH
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL 565 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l 565 (645)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~ 242 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQ 242 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH
T ss_pred cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 99999999999999754322 22344578999999999877 67899999999999999999999999754321 22
Q ss_pred HHHHHHHhcCCccc-----------cccCccccC--C-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 566 LQWVWDLYGNGKLL-----------EAVDPRLCR--D-----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 566 ~~~~~~~~~~~~l~-----------~~~d~~l~~--~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...+.+........ +.+...+.. . ........+.+++.+||+.||++|||++|+++|.++..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 22222221111110 000000000 0 00011245778899999999999999999999999875
Q ss_pred C
Q 042831 628 P 628 (645)
Q Consensus 628 ~ 628 (645)
-
T Consensus 323 ~ 323 (362)
T 3pg1_A 323 L 323 (362)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.80 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=205.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeee--CCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHE--KKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~--~~~~~lV~ 428 (645)
++|...++||+|+||.||+|++..+++.||||++.... .+.+.+|++++.+++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 67888999999999999999999999999999986443 467889999999997 9999999999987 66789999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~~ 507 (645)
||+++++|.+++. .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999998884 38899999999999999999998 8999999999999999776 89999999998654332
Q ss_pred CcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc-----
Q 042831 508 GSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA----- 581 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~----- 581 (645)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..............+.+.
T Consensus 186 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 186 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhc
Confidence 2334578999999999877 668999999999999999999999996443221 111111111000000000
Q ss_pred --cCc----------------cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 582 --VDP----------------RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 582 --~d~----------------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.++ .............+.+++.+||+.||++|||++|+++|.++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~ 325 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence 000 0001111112356788899999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=372.78 Aligned_cols=260 Identities=29% Similarity=0.458 Sum_probs=210.5
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
..+....++|...++||+|+||.||+|.+.. +..||||+++... ...++|.+|+++|.+++||||++++++|.+ +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 3444556778889999999999999999976 5679999997543 335689999999999999999999999876 678
Q ss_pred EEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 425 LLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+||||||++|+|.+++... +..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999999753 4568999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
............++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+. .....+....
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~----~~i~~~~~~~-- 484 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL----DQVERGYRMP-- 484 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHH----HHHHTTCCCC--
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC--
Confidence 4322112223456788999999999999999999999999999999 99999754321 112 2222221111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
... .....+.+++..||+.||++|||++++++.|+.-
T Consensus 485 ---~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 485 ---CPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ---CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ---CCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1234677888999999999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.39 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=202.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------C
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------K 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------~ 422 (645)
.++|...+.||+|+||.||+|++..+|+.||||++... .....+.+.+|++++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788899999999999999999999999999998543 344567889999999999999999999998765 3
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 569999999 8899998865 468999999999999999999999 8999999999999999999999999999986
Q ss_pred ccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc----
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK---- 577 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~---- 577 (645)
... ......+|+.|+|||++.+ ..++.++||||+||+++||++|+.||...... .....+....+...
T Consensus 178 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred ccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCHHHH
Confidence 542 2334578999999999877 67999999999999999999999999754422 12221211111100
Q ss_pred --------------cccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 578 --------------LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 578 --------------l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+.......+. .........+.+++.+||+.||++|||++|+++|.++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 0000000000 000112345778889999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.18 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=210.9
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------hhHHHHHHHHHHHHhc-CCCCccEEEe
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------QGIKEYASEVKIISRL-RHRNLVQLLG 416 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~nlv~l~~ 416 (645)
......++|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 334455679999999999999999999998899999999865431 2245678999999999 7999999999
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999998643 468999999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCcceeecccCccccCcccccc------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH
Q 042831 497 FGLARLVEHAKGSQTTVLAGTMGYMAPECATT------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 497 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~ 570 (645)
||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ......
T Consensus 244 fG~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~-- 316 (365)
T 2y7j_A 244 FGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---ILMLRM-- 316 (365)
T ss_dssp CTTCEECCTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH--
T ss_pred cCcccccCCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH---HHHHHH--
Confidence 9999866532 22344679999999998863 3578899999999999999999999975321 111111
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+.... ..+.. ... ...+..++.+||+.||++|||++|++++.+++
T Consensus 317 --i~~~~~~~-~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 317 --IMEGQYQF-SSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp --HHHTCCCC-CHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --HHhCCCCC-CCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 11111110 00000 111 24577888999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=349.29 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=203.6
Q ss_pred CCCCCccCcCCcEEEEEEEE----cCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeEEE
Q 042831 354 FNDDQKLGQGGFGGVYKGFF----RETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKELLL 426 (645)
Q Consensus 354 f~~~~~LG~G~fG~Vy~g~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~~l 426 (645)
|...++||+|+||.||++.+ ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999988865 3468999999997653 4556789999999999999999999999987 467899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999653 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC--------chhHHHHHHHHhcCC
Q 042831 507 KGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQG--------QVSLLQWVWDLYGNG 576 (645)
Q Consensus 507 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~--------~~~l~~~~~~~~~~~ 576 (645)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .........+....+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 321 2233567888999999999889999999999999999999999986422100 000001111111111
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. ....+......+.+++.+||+.||++|||++|+++.|+.
T Consensus 268 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 268 E---------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c---------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1 111112223567888899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.56 Aligned_cols=277 Identities=21% Similarity=0.268 Sum_probs=215.2
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CC-----CccEEE
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HR-----NLVQLL 415 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nlv~l~ 415 (645)
+..++.....++|...++||+|+||.||+|++..+++.||||++... ....+++..|+.++..++ |+ ++++++
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 33444455678999999999999999999999999999999999643 344567788999998885 55 499999
Q ss_pred eeeeeCCeEEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC--CCCcE
Q 042831 416 GWCHEKKELLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD--SNFNA 492 (645)
Q Consensus 416 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~ 492 (645)
+++...+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||.. +.+|+||||||+|||++ .++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence 99999999999999995 59999987653 5699999999999999999999951 37899999999999994 57889
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 201 kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~ 273 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV---DQMNKIVEV 273 (382)
T ss_dssp EECCCTTCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH
T ss_pred EEEeccCceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence 9999999986542 223457899999999999999999999999999999999999999854422 222222221
Q ss_pred hcCC---------cccccc----C-----------------ccc--------------------cCCCCHHHHHHHHHHH
Q 042831 573 YGNG---------KLLEAV----D-----------------PRL--------------------CRDFDGQQIERLMIVG 602 (645)
Q Consensus 573 ~~~~---------~l~~~~----d-----------------~~l--------------------~~~~~~~~~~~l~~l~ 602 (645)
.+.. ...+.+ + +.. .......+...+.+|+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 353 (382)
T 2vx3_A 274 LGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLI 353 (382)
T ss_dssp HCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHH
T ss_pred hCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHH
Confidence 1100 000000 0 000 0012234456788999
Q ss_pred HHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 603 LWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 603 ~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.+||+.||++|||++|+++|.|+...
T Consensus 354 ~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 354 LRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHhcCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=376.28 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=212.5
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~ 425 (645)
..++|...+.||+|+||.||+|++..+++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999999999999999998753 233456788899999987 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
|||||+++|+|..++... ..+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999654 468999999999999999999999 8999999999999999999999999999985432
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
. ........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ..+.+ .+.++.. .
T Consensus 495 ~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~----~i~~~~~------~ 560 (674)
T 3pfq_A 495 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQ----SIMEHNV------A 560 (674)
T ss_dssp T-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHSSCC------C
T ss_pred C-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHH----HHHhCCC------C
Confidence 2 2234557899999999999999999999999999999999999999975432 12221 1222211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSI-----RQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~L~~~ 626 (645)
+... ....+..|+..||+.||++||++ +||++|.++.
T Consensus 561 ~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~ 602 (674)
T 3pfq_A 561 YPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602 (674)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred CCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence 1111 23457788899999999999997 9999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.49 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=205.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE---------- 420 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~---------- 420 (645)
.++|...+.||+|+||.||+|.+..+++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 456888999999999999999999889999999997654 246689999999999999999998854
Q ss_pred ------CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEE
Q 042831 421 ------KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493 (645)
Q Consensus 421 ------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~k 493 (645)
....++||||+++++|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 4679999999999999999999999 8999999999999999999999
Q ss_pred EeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+... ...+...
T Consensus 163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~ 231 (284)
T 2a19_B 163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDL 231 (284)
T ss_dssp ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHH
T ss_pred ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHh
Confidence 99999998664332 223456899999999999999999999999999999999999887421 1111222
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
..+.+ ...++ ..+.+++.+||+.||++|||+.|++++|+.-..
T Consensus 232 ~~~~~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 232 RDGII--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HTTCC--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hcccc--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 22222 12222 346678899999999999999999999986543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=346.98 Aligned_cols=269 Identities=21% Similarity=0.313 Sum_probs=207.3
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----Ce
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KE 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~ 423 (645)
..++|...+.||+|+||.||+|++..+|+.||||++... .......+.+|++++.+++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356888999999999999999999999999999999754 334566788999999999999999999988754 67
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 899999996 689888854 468999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCc---------ceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 504 EHAKGS---------QTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 504 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~ 239 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFGII 239 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHh
Confidence 432211 1223578999999998765 67899999999999999999999999754321 1111222221
Q ss_pred cCCccc---cccC-c-------cc--cCCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 574 GNGKLL---EAVD-P-------RL--CRDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 574 ~~~~l~---~~~d-~-------~l--~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+..... ..+. + .+ ..... ......+.+++.+||+.||++|||++|+++|.++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 111000 0000 0 00 00000 011245678899999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.52 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=210.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---------hhhHHHHHHHHHHHHhcC-CCCccEEEeeeee
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---------KQGIKEYASEVKIISRLR-HRNLVQLLGWCHE 420 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~ 420 (645)
.++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|++++.+++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999999999999999986542 123467889999999996 9999999999999
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999998653 568999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCcceeecccCccccCccccc------cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECAT------TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG 574 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~ 574 (645)
....... ......|++.|+|||++. ...++.++||||||++++||++|+.||..... ..... ...
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~ 242 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLR----MIM 242 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHH
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHH----HHh
Confidence 8654322 233457899999999885 45688999999999999999999999975332 11111 111
Q ss_pred CCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 575 NGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 575 ~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.+.... ..+. .. .....+.+++.+||+.||++|||+.|++++.++...
T Consensus 243 ~~~~~~-~~~~-~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 243 SGNYQF-GSPE-WD----DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HTCCCC-CTTT-GG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCCccc-Cccc-cc----ccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 111110 0011 01 123467788899999999999999999999998643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=354.75 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=210.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|...++||+|+||.||+|++..+++.||||++..... ..++..|++++..++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999999999999998765433 2357889999999987 566666677778889999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~~~~ 506 (645)
|+ +++|.+++......+++..++.|+.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 999999997767789999999999999999999999 899999999999999 68899999999999876543
Q ss_pred CCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 507 KGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 507 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
... ......||..|+|||++.+..++.++|||||||+||||++|+.||..............+........+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 237 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-- 237 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH--
Confidence 321 223567999999999999999999999999999999999999999876554433333322221111111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
+.++..++ ..+.+++..||+.||++||++++|++.|+
T Consensus 238 ---~~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 238 ---EALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp ---HHHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred ---HHHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11112222 46778889999999999999999999886
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.73 Aligned_cols=266 Identities=20% Similarity=0.272 Sum_probs=202.4
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-------
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE------- 420 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~------- 420 (645)
....++|...+.||+|+||.||+|++..+|+.||||++...... ..+|++++++++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45567899999999999999999999999999999998654322 2369999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 042831 421 -------------------------------KKELLLVYEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYL 466 (645)
Q Consensus 421 -------------------------------~~~~~lV~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yL 466 (645)
....++||||++ |+|.+.+.. .+..+++..++.++.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999997 588777753 457899999999999999999999
Q ss_pred HhhcCCCeeeccCCCCCeEEC-CCCcEEEeeccCcccccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHH
Q 042831 467 QEEWEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVA 544 (645)
Q Consensus 467 H~~~~~~ivH~Dlkp~NILld-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll 544 (645)
|+ .+|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++|||||||++
T Consensus 158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 98 8999999999999997 68899999999998654332 23345689999999988765 489999999999999
Q ss_pred HHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC----------ccccccCccccC-----CCCHHHHHHHHHHHHHcCCCC
Q 042831 545 LEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----------KLLEAVDPRLCR-----DFDGQQIERLMIVGLWCAHPD 609 (645)
Q Consensus 545 ~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----------~l~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~d 609 (645)
|||++|+.||......+ ....+....+.. ...+..-+.+.. .++......+.+++.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 99999999997644321 111111111111 000000011100 011112345788899999999
Q ss_pred CCCCCCHHHHHHHhccC
Q 042831 610 ENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 610 P~~RPs~~evl~~L~~~ 626 (645)
|++|||+.|+++|.+++
T Consensus 310 P~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 310 PDLRINPYEAMAHPFFD 326 (383)
T ss_dssp GGGSCCHHHHHTSGGGH
T ss_pred hhhCCCHHHHhcCHHHH
Confidence 99999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.94 Aligned_cols=258 Identities=27% Similarity=0.410 Sum_probs=201.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE---------- 420 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~---------- 420 (645)
.++|...+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788899999999999999999988999999998643 3456788999999999999999999998865
Q ss_pred ---CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 421 ---KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 421 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
.+..++||||+++|+|.+++......+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeC
Confidence 457899999999999999998777778999999999999999999999 89999999999999999999999999
Q ss_pred cCcccccccC-------------CcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 498 GLARLVEHAK-------------GSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 498 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
|+++...... ........|+..|+|||++.+. .++.++|||||||++|||++ ||....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----- 232 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----- 232 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-----
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-----
Confidence 9998654221 1122345689999999998764 68999999999999999998 553211
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...... ....... ..+...+.......+.+++.+||+.||++|||++|++++.|+..
T Consensus 233 ~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 233 ERVNIL-KKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHH-HHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred hHHHHH-Hhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 111111 1111111 11112222333456778899999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.58 Aligned_cols=268 Identities=19% Similarity=0.252 Sum_probs=189.1
Q ss_pred CCC-CCccCcCCcEEEEEEEEc--CCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee--eCCeEEEEE
Q 042831 354 FND-DQKLGQGGFGGVYKGFFR--ETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH--EKKELLLVY 428 (645)
Q Consensus 354 f~~-~~~LG~G~fG~Vy~g~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~--~~~~~~lV~ 428 (645)
|.. .++||+|+||.||+|++. .+++.||||++..... ...+.+|+.++.+++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 568999999999999976 4678999999865432 346789999999999999999999995 467899999
Q ss_pred EecCCCChhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----CCCCcEEEee
Q 042831 429 EFMPNGSLDSHLFKE--------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML----DSNFNAKIGD 496 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl----d~~~~~kl~D 496 (645)
||++ ++|.+++... ...+++..++.|+.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5787777421 1259999999999999999999999 899999999999999 7789999999
Q ss_pred ccCcccccccCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCC------chhHHH
Q 042831 497 FGLARLVEHAKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQG------QVSLLQ 567 (645)
Q Consensus 497 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~------~~~l~~ 567 (645)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653222 223446789999999998874 58999999999999999999999997544321 112222
Q ss_pred HHHHHhcCCccccc--c-------------CccccCCCCHH---------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 568 WVWDLYGNGKLLEA--V-------------DPRLCRDFDGQ---------QIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 568 ~~~~~~~~~~l~~~--~-------------d~~l~~~~~~~---------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
.+....+...-..+ + ........... ....+.+|+.+||+.||++|||++|+++|.
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 23322221110000 0 00000000000 023567889999999999999999999999
Q ss_pred ccCC
Q 042831 624 NFEA 627 (645)
Q Consensus 624 ~~~~ 627 (645)
|+..
T Consensus 336 ~f~~ 339 (405)
T 3rgf_A 336 YFLE 339 (405)
T ss_dssp GGTS
T ss_pred hhcc
Confidence 9864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.60 Aligned_cols=255 Identities=15% Similarity=0.140 Sum_probs=205.6
Q ss_pred ChHHHHHhhcCCCCCCccCcCCcEEEEEEE-----EcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCccEE
Q 042831 343 PYKELALATNDFNDDQKLGQGGFGGVYKGF-----FRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR---HRNLVQL 414 (645)
Q Consensus 343 ~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~-----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nlv~l 414 (645)
+..++....++|...++||+|+||.||+|. ...+++.||||++.... ..++..|++++.+++ |+|++++
T Consensus 56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 445566677889999999999999999994 56678999999997554 346777888888887 9999999
Q ss_pred EeeeeeCCeEEEEEEecCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--
Q 042831 415 LGWCHEKKELLLVYEFMPNGSLDSHLFK----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-- 488 (645)
Q Consensus 415 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-- 488 (645)
++++...+..++|||||++|+|.+++.. ....+++..++.|+.||+.||.|||+ .+|+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccc
Confidence 9999999999999999999999999974 35679999999999999999999998 89999999999999998
Q ss_pred ---------CCcEEEeeccCccccccc-CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 042831 489 ---------NFNAKIGDFGLARLVEHA-KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKA 558 (645)
Q Consensus 489 ---------~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~ 558 (645)
++.+||+|||+++..... .........||++|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 899999999999765432 2234455779999999999999999999999999999999999999986432
Q ss_pred CCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHhc
Q 042831 559 PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR-PSIRQVIHVLN 624 (645)
Q Consensus 559 ~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~ 624 (645)
... ..++..+...... +.+.+++..|++.+|.+| |+++++.+.|+
T Consensus 290 ~~~------------------~~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 290 GGE------------------CKPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp TTE------------------EEECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CCc------------------eeechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 210 0011222222222 344566778999999998 57777777665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=343.53 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=195.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHH--HHhcCCCCccEEEeeee-----eCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKI--ISRLRHRNLVQLLGWCH-----EKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~H~nlv~l~~~~~-----~~~~ 423 (645)
.++|...++||+|+||.||+|+. +++.||||++..... ..+..|.++ +..++||||+++++++. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999977 478999999865432 344444444 44589999999998553 2346
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc------CCCeeeccCCCCCeEECCCCcEEEeec
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW------EQCVVHRDIKSSNIMLDSNFNAKIGDF 497 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlkp~NILld~~~~~kl~Df 497 (645)
+++||||+++|+|.+++... ..++..++.++.||++||.|||+.+ ..+|+||||||+|||++.++.+||+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 79999999999999999553 3589999999999999999999821 119999999999999999999999999
Q ss_pred cCcccccccCC-------cceeecccCccccCcccccc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc-
Q 042831 498 GLARLVEHAKG-------SQTTVLAGTMGYMAPECATT-------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQ- 562 (645)
Q Consensus 498 Gla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~- 562 (645)
|+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99986643221 12234579999999999876 3567789999999999999999877654332111
Q ss_pred hhHH----------HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 563 VSLL----------QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 563 ~~l~----------~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ...............+.+... ........+.+++.+||+.||++|||++|+++.|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 0000 111111111111111111111 122355678899999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.76 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=206.8
Q ss_pred CccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeee
Q 042831 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWC 418 (645)
Q Consensus 340 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~ 418 (645)
..+.+.++....++|...+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34555666677889999999999999999999999889999999986543 3346788999999999 799999999999
Q ss_pred ee------CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc
Q 042831 419 HE------KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN 491 (645)
Q Consensus 419 ~~------~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~ 491 (645)
.. .+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+ .+++||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCC
Confidence 76 46889999999999999999754 3578999999999999999999999 89999999999999999999
Q ss_pred EEEeeccCcccccccCCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH
Q 042831 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~ 566 (645)
+||+|||++....... .......|++.|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 168 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~- 242 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RA- 242 (326)
T ss_dssp EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HH-
T ss_pred EEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HH-
Confidence 9999999997654322 1223456899999999986 566899999999999999999999999653321 11
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... ....... ...+ ...+..++.+||+.||++||+++|++++.++.
T Consensus 243 --~~~~~~-~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 243 --LFLIPR-NPAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp --HHHHHH-SCCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred --HHHhhc-CccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 111111 1111111 1112 24567888999999999999999999998875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.13 Aligned_cols=267 Identities=21% Similarity=0.273 Sum_probs=201.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeee-----------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCH----------- 419 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~----------- 419 (645)
.++|...+.||+|+||.||+|.+..+++.||+|++........+++.+|++++.+++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467888999999999999999999999999999998777777889999999999999999999999873
Q ss_pred ---eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEEe
Q 042831 420 ---EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKIG 495 (645)
Q Consensus 420 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl~ 495 (645)
+.+..++||||++ |+|.+++.+ ..+++..++.++.|++.||.|||+ .+|+||||||+|||++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4468899999997 699998843 568999999999999999999999 8999999999999997 57799999
Q ss_pred eccCcccccccCC--cceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHH
Q 042831 496 DFGLARLVEHAKG--SQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDL 572 (645)
Q Consensus 496 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~ 572 (645)
|||+++....... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .....+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHh
Confidence 9999986643211 12233567899999998865 67899999999999999999999999754421 111111111
Q ss_pred hcC----------CccccccCcccc-CCCC-----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 573 YGN----------GKLLEAVDPRLC-RDFD-----GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 573 ~~~----------~~l~~~~d~~l~-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
... ..+...+..... .... ......+.+++.+||+.||++|||++|++++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 000 000000000000 0000 01134677889999999999999999999999876
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.37 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=192.5
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------ 421 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------ 421 (645)
..++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347889999999999999999999999999999998653 344567888999999999999999999998654
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 5689999999 7899988854 569999999999999999999998 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc--
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL-- 578 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l-- 578 (645)
.... ......||+.|+|||++.+ ..++.++|||||||+++||++|+.||...... .....+....+....
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAEL 253 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHHH
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 6432 2334578999999999877 67899999999999999999999999754422 222222222211100
Q ss_pred ccccCc--------cc--cCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 579 LEAVDP--------RL--CRDFDGQ-----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 579 ~~~~d~--------~l--~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...+.. .+ ....... ....+.+|+.+||+.||++|||++|+++|.++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~ 317 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence 000000 00 0001111 1245778899999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.60 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=205.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...++||+|+||.||+|++..++..||+|++.... ......+.+|+.++++++||||++++++|.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456888999999999999999999999999999987542 33457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC---CcEEEeeccCccccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN---FNAKIGDFGLARLVE 504 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kl~DfGla~~~~ 504 (645)
||||++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++...
T Consensus 115 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999988654 468999999999999999999999 899999999999999764 459999999998765
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
.. .......||+.|+|||++. +.++.++|||||||++|||++|+.||...... .+.. ....+... .+.
T Consensus 191 ~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~~--~~~ 258 (494)
T 3lij_A 191 NQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILR----KVEKGKYT--FDS 258 (494)
T ss_dssp TT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC--CCS
T ss_pred CC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCCC--CCc
Confidence 33 2334467999999999876 56999999999999999999999999754321 1221 11122111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... ...+.+++.+||+.||++|||+.|+++|.|..
T Consensus 259 ~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~ 296 (494)
T 3lij_A 259 PEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIK 296 (494)
T ss_dssp GGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred hhcccC----CHHHHHHHHHHCCCChhhCccHHHHhcCcccc
Confidence 111112 24567888999999999999999999998863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=370.67 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=197.4
Q ss_pred CccCcCCcEEEEEEEEc--CCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFR--ETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
++||+|+||.||+|.+. .+++.||||+++... ....+++.+|++++.+++||||++++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999654 557899999997543 3446789999999999999999999999964 568899999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC--cce
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG--SQT 511 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~--~~~ 511 (645)
|+|.+++.. ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999954 4578999999999999999999999 8999999999999999999999999999987654322 122
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....+|+.|+|||++....++.++|||||||++|||++ |+.||...... .+......+.... ....
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~-----~p~~- 596 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG-----CPAG- 596 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----CCTT-
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----CCCC-
Confidence 33456789999999999999999999999999999998 99999754321 1222222332111 1111
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
....+.+++..||+.||++||++++|++.|+
T Consensus 597 ---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 597 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2346778889999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=356.93 Aligned_cols=258 Identities=25% Similarity=0.359 Sum_probs=208.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-------------hhHHHHHHHHHHHHhcCCCCccEEEe
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-------------QGIKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
..++|...++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999865321 33567899999999999999999999
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC---cEE
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF---NAK 493 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~---~~k 493 (645)
++.+.+..++|||||++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999988654 468999999999999999999999 8999999999999998775 699
Q ss_pred EeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 494 IGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 494 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
|+|||+++..... .......||+.|+|||++. +.++.++|||||||++|||++|+.||...... .+.. ..
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIK----KV 259 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HH
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHH----HH
Confidence 9999999876433 2334457999999999886 56899999999999999999999999754321 1221 11
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..+.... +....... ...+.+++.+||+.||++|||++|+++|.|...
T Consensus 260 ~~~~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp HHCCCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HcCCCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 1222110 00000111 245778889999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.90 Aligned_cols=272 Identities=21% Similarity=0.243 Sum_probs=198.2
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe-
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE- 423 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~- 423 (645)
.+.....++|...+.||+|+||.||+|++..+++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999999999999999986543 233456778888999999999999999865433
Q ss_pred ------EEEEEEecCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hhcCCCeeeccCCCCCeEECC-CCc
Q 042831 424 ------LLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQ--EEWEQCVVHRDIKSSNIMLDS-NFN 491 (645)
Q Consensus 424 ------~~lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlkp~NILld~-~~~ 491 (645)
.++||||+++ +|...+. .....+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence 7899999976 5544443 34567899999999999999999999 6 89999999999999996 899
Q ss_pred EEEeeccCcccccccCCcceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHH
Q 042831 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~ 570 (645)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....+.
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHH
Confidence 9999999998665322 233457899999999986654 8999999999999999999999997644221 121111
Q ss_pred HHhcCC--ccccccCcc----------------ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 571 DLYGNG--KLLEAVDPR----------------LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 571 ~~~~~~--~l~~~~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... .....+++. ............+.+++.+||+.||++|||+.|+++|.|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~ 319 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFD 319 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccc
Confidence 111100 000000000 00111112346788899999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.32 Aligned_cols=267 Identities=21% Similarity=0.299 Sum_probs=209.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEE-cCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCC------CccEEEeeeeeCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFF-RETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHR------NLVQLLGWCHEKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~------nlv~l~~~~~~~~~ 423 (645)
.++|...+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|++++.+++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46788999999999999999998 557899999998644 34557788999999998765 49999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--------------
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-------------- 488 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------------- 488 (645)
.++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 899999987654 468999999999999999999999 89999999999999987
Q ss_pred -----CCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 489 -----NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 489 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 67899999999976432 223457899999999999999999999999999999999999999754432211
Q ss_pred hHHHHH--------HHHhcCCccc------------------cccCccc-cCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 042831 564 SLLQWV--------WDLYGNGKLL------------------EAVDPRL-CRDFDGQQIERLMIVGLWCAHPDENLRPSI 616 (645)
Q Consensus 564 ~l~~~~--------~~~~~~~~l~------------------~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 616 (645)
..+... +......... ....+.. .........+.+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111110 0000000000 0000000 001123456778899999999999999999
Q ss_pred HHHHHHhccC
Q 042831 617 RQVIHVLNFE 626 (645)
Q Consensus 617 ~evl~~L~~~ 626 (645)
+|++++.++.
T Consensus 324 ~ell~hp~f~ 333 (339)
T 1z57_A 324 REALKHPFFD 333 (339)
T ss_dssp HHHTTSGGGG
T ss_pred HHHhcCHHHH
Confidence 9999998875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.17 Aligned_cols=249 Identities=30% Similarity=0.435 Sum_probs=196.9
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-CeEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-KELLLVY 428 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-~~~~lV~ 428 (645)
..++|...+.||+|+||.||++.+. |+.||||.+.... ..+.+.+|++++.+++||||+++++++.+. +..++||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3467888999999999999999875 7899999986543 456789999999999999999999997654 5789999
Q ss_pred EecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999997543 348999999999999999999999 89999999999999999999999999998754332
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. ....+. .+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~-----~~~~ 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTC-----CCCC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCC-----CCCC
Confidence 122357889999999999999999999999999999998 99999754322 1111 111221 1111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+ ...+.+++..||+.||++|||++|+++.|+.
T Consensus 236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 236 PDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 1222 3467788899999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.20 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=208.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
.++|...++||+|+||.||+|++..+++.||||++... .......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45788899999999999999999999999999998643 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl~DfGla~~~~~ 505 (645)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999988654 468999999999999999999999 8999999999999995 456799999999986543
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
. .......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+... ...+...... +.
T Consensus 177 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----i~~~~~~~~~-~~ 245 (486)
T 3mwu_A 177 N--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKR----VETGKYAFDL-PQ 245 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCCCSCS-GG
T ss_pred C--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCCCCC-cc
Confidence 2 23344579999999999875 6999999999999999999999999754321 12211 1122211100 11
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
. .. ....+.+++.+||+.||++|||+.|+++|.|+..
T Consensus 246 ~-~~----~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 246 W-RT----ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp G-GG----SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred c-CC----CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 11 1245678889999999999999999999998753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.35 Aligned_cols=259 Identities=17% Similarity=0.145 Sum_probs=204.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC--------CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccE---------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE--------TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ--------- 413 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~--------- 413 (645)
.++|...+.||+|+||.||+|++.. .++.||+|.+... +.+.+|++++.+++|||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999987 3789999998654 35788999999999999887
Q ss_pred ------EEeeeee-CCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeE
Q 042831 414 ------LLGWCHE-KKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIM 485 (645)
Q Consensus 414 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NIL 485 (645)
+++++.. ++..++||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 6677765 67899999999 99999999764 4679999999999999999999999 89999999999999
Q ss_pred ECCCC--cEEEeeccCcccccccCCc------ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Q 042831 486 LDSNF--NAKIGDFGLARLVEHAKGS------QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPK 557 (645)
Q Consensus 486 ld~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~ 557 (645)
++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999866533211 123357999999999999999999999999999999999999999865
Q ss_pred CCCCchhHHHHHHHHhcCCccccccCcccc-CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 558 APQGQVSLLQWVWDLYGNGKLLEAVDPRLC-RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 558 ~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ..+.......... .....++... ..+ ...+.+++.+||+.||++|||++++++.|+.
T Consensus 272 ~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 272 LPNT-EDIMKQKQKFVDK--PGPFVGPCGHWIRP----SETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp TTCH-HHHHHHHHHHHHS--CCCEECTTSCEECC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CcCH-HHHHHHHHhccCC--hhhhhhhccccCCC----cHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 4221 1222222111111 1111111110 111 2467778899999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.63 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=202.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~ 422 (645)
.++|...+.||+|+||.||+|++..+++.||||.+.... ......+.+|++++.+++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457888999999999999999999999999999986432 122345889999999999999999999987655
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc---EEEeeccC
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFGL 499 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kl~DfGl 499 (645)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 8999999999999998854 4578999999999999999999998 89999999999999987664 99999999
Q ss_pred cccccccCCcceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...+ ..+
T Consensus 164 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~~ 235 (322)
T 2ycf_A 164 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TSG 235 (322)
T ss_dssp CEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----HHT
T ss_pred ceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----HhC
Confidence 9865422 2223456899999999874 56789999999999999999999999975443321 12211 111
Q ss_pred ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 ~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
... ..+...... ...+.+++.+||+.||++||++.|++++.++
T Consensus 236 ~~~--~~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 236 KYN--FIPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp CCC--CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ccc--cCchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 110 011111112 2467788899999999999999999998875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.40 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=208.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-----------CCCccEEEeeee
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-----------HRNLVQLLGWCH 419 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nlv~l~~~~~ 419 (645)
.++|...+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46788999999999999999999999999999998643 344567889999999886 899999999987
Q ss_pred eCC----eEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEEC------
Q 042831 420 EKK----ELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLD------ 487 (645)
Q Consensus 420 ~~~----~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld------ 487 (645)
..+ ..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+ + +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 654 789999999 99999998763 4569999999999999999999998 7 999999999999994
Q ss_pred CCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc---hh
Q 042831 488 SNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ---VS 564 (645)
Q Consensus 488 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~---~~ 564 (645)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4558999999999865432 2334789999999999999999999999999999999999999986543211 11
Q ss_pred HHHHHHHHhcC--------C----------ccccccCc-c---------ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 042831 565 LLQWVWDLYGN--------G----------KLLEAVDP-R---------LCRDFDGQQIERLMIVGLWCAHPDENLRPSI 616 (645)
Q Consensus 565 l~~~~~~~~~~--------~----------~l~~~~d~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 616 (645)
....+.+..+. + .....+.. . -...++......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11111111110 0 00000000 0 0113456677889999999999999999999
Q ss_pred HHHHHHhccCCC
Q 042831 617 RQVIHVLNFEAP 628 (645)
Q Consensus 617 ~evl~~L~~~~~ 628 (645)
+|+++|.++...
T Consensus 329 ~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 GGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhhChhhhcc
Confidence 999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=361.39 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=210.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..++|...++||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3457888999999999999999999999999999986542 3456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE---CCCCcEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---d~~~~~kl~DfGla~~~ 503 (645)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++..
T Consensus 104 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999988644 568999999999999999999999 899999999999999 56789999999999866
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ..+... ...+......
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~----i~~~~~~~~~- 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKK----VEKGKYTFEL- 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCCCCCCS-
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH---HHHHHH----HHcCCCCCCC-
Confidence 4332 2334579999999998865 699999999999999999999999975432 122221 1222211110
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.. .. ....+.+++.+||+.||++|||++|+++|.|+.
T Consensus 249 ~~~-~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 249 PQW-KK----VSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp GGG-GG----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ccc-cc----CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 110 11 224567888999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=335.15 Aligned_cols=270 Identities=25% Similarity=0.303 Sum_probs=207.2
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEc-CCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhc---CCCCccEEEeeee---
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFR-ETNSYIAVKRVSQGS--KQGIKEYASEVKIISRL---RHRNLVQLLGWCH--- 419 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~--- 419 (645)
.+.++|...+.||+|+||.||+|.+. .+++.||+|++.... ......+.+|+.++.++ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45678999999999999999999995 678999999986432 22233566777777666 8999999999987
Q ss_pred --eCCeEEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 420 --EKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 420 --~~~~~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
.....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999997 6999998764 3459999999999999999999999 8999999999999999999999999
Q ss_pred ccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC
Q 042831 497 FGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576 (645)
Q Consensus 497 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~ 576 (645)
||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+....+..
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcCCC
Confidence 99998654322 23345789999999999999999999999999999999999999975432 22222222222111
Q ss_pred ccccc----------cCc---cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 577 KLLEA----------VDP---RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 ~l~~~----------~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
..... ... .....+.......+.+++.+||+.||++|||++|+++|.++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 302 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccc
Confidence 00000 000 0000011112345678889999999999999999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.85 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=198.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcC-CC--eEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRE-TN--SYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~-~~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||.||+|++.. ++ ..||+|+++.. .....+.+.+|++++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4578889999999999999998643 23 36999988654 3345678999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE 504 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~ 504 (645)
++|+||+++++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999998766779999999999999999999999 899999999999999999999999999998764
Q ss_pred ccCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 505 HAKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 505 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .+. ......+..
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~~~~~~--- 243 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGER--- 243 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCCC---
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH---HHHHccCCC---
Confidence 43322 1233457888999999988889999999999999999999 99999754321 111 111111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...... ....+.+++.+||+.||++|||+.+++++|+..
T Consensus 244 --~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 244 --LPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp --CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 111111 234677888999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.18 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=199.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------CeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------KELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------~~~~ 425 (645)
.+|...+.||+|+||.||+|++..+|+.||||++..... ...+|++++++++||||++++++|... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 357788999999999999999999999999999865432 234699999999999999999998532 2467
Q ss_pred EEEEecCCCChhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC-CcEEEeeccCcc
Q 042831 426 LVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLAR 501 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~-~~~kl~DfGla~ 501 (645)
+||||+++ +|.+.+. .....+++..++.++.||++||.|||+ .+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 5655553 345679999999999999999999998 899999999999999955 678999999998
Q ss_pred cccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC-----
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN----- 575 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~----- 575 (645)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+..+....+.
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence 654322 22345789999999998765 68999999999999999999999997643221 11111111111
Q ss_pred -----CccccccCccccCC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 -----GKLLEAVDPRLCRD-----FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 -----~~l~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+..-+.+... +.......+.+|+.+||+.||++|||+.|+++|.+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 11111111111100 1111235678899999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=342.85 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=202.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE----
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL---- 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~---- 424 (645)
.++|...+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.++.+++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46888899999999999999999999999999999754 344567889999999999999999999999876654
Q ss_pred --EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 425 --LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 425 --~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
++||||+. ++|.+.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 68877763 348999999999999999999999 8999999999999999999999999999975
Q ss_pred ccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc--cc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK--LL 579 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--l~ 579 (645)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+....+... ..
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHH
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcHHHH
Confidence 432 2334578999999999877 67999999999999999999999999754321 11111111111000 00
Q ss_pred c------------ccCccccCCC---CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 E------------AVDPRLCRDF---DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~------------~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. .+.......+ .......+.+++.+||+.||++|||++|++++.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 0000000000 001135678889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.72 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=185.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHH-HHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVK-IISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...+.||+|+||.||+|.+..+|+.||||++.... .....++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3467888999999999999999999899999999997653 344556666766 66778999999999999999999999
Q ss_pred EEecCCCChhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 428 YEFMPNGSLDSHLFK----ENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
|||+++ +|.+++.. ....+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 78777642 25679999999999999999999998 6 999999999999999999999999999976
Q ss_pred ccccCCcceeecccCccccCcccc----ccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECA----TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||....... +. . ..+
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~--~~~ 242 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----L--TQV 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----H--HHH
Confidence 54322 22334689999999998 45668999999999999999999999997533210 00 0 011
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.....+.+...........+.+++.+||+.||++|||++|++++.++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 11111111111111123467788899999999999999999998875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.27 Aligned_cols=264 Identities=20% Similarity=0.289 Sum_probs=209.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-----------------hHHHHHHHHHHHHhcCCCCccE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-----------------GIKEYASEVKIISRLRHRNLVQ 413 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~Ei~~l~~l~H~nlv~ 413 (645)
.++|...+.||+|+||.||+|.+ +++.||+|++...... ..+.+.+|+.++.+++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 6899999998643211 1278999999999999999999
Q ss_pred EEeeeeeCCeEEEEEEecCCCChhhh------hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 414 LLGWCHEKKELLLVYEFMPNGSLDSH------LFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 414 l~~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+++++.+.+..++||||+++++|.++ +... ...+++..++.++.||+.||.|||+ ..+++||||||+||++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEE
Confidence 99999999999999999999999998 5432 5679999999999999999999997 3799999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCcceeecccCccccCccccccC-CCCc-chhHHHHHHHHHHHHcCCCCCCCCCCCCchh
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG-KASK-ESDVYSFGIVALEIACGRKPINPKAPQGQVS 564 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~sDV~SfGvll~elltG~~pf~~~~~~~~~~ 564 (645)
+.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999865432 33446789999999999887 5666 999999999999999999999864432 11
Q ss_pred HHHHHHHHhcCCccccccCc-----ccc----CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 565 LLQWVWDLYGNGKLLEAVDP-----RLC----RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~-----~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+. .....+......+. .+. ..........+.+++.+||+.||++|||++|++++.++..
T Consensus 261 ~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 261 LF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 12 22222221111000 000 0000112356778889999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.39 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=197.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC------eEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------ELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------~~~ 425 (645)
.+|...++||+|+||.||+|++..+++ ||+|++...... ..+|++++++++||||+++++++...+ ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468889999999999999999987655 888887654321 236999999999999999999986443 378
Q ss_pred EEEEecCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEEeeccCccc
Q 042831 426 LVYEFMPNGSLDSHLF--KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKIGDFGLARL 502 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl~DfGla~~ 502 (645)
+||||++++.+..... .....+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999997754443332 235679999999999999999999999 8999999999999999 799999999999987
Q ss_pred ccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC-----
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----- 576 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----- 576 (645)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ...+....+..
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 64322 23345789999999998765 589999999999999999999999976442211 11111111110
Q ss_pred -----ccccccCccccC-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 577 -----KLLEAVDPRLCR-----DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 -----~l~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
...+..-+.... .+.......+.+++.+||+.||++|||+.|+++|.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE 327 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence 000000011000 011112346788899999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.27 Aligned_cols=262 Identities=22% Similarity=0.287 Sum_probs=203.2
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe-----
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE----- 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~----- 423 (645)
.++|...+.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.++.+++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 45788899999999999999999999999999999654 33446788999999999999999999999987653
Q ss_pred -EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 424 -LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 424 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred eEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999996 68888773 348999999999999999999999 8999999999999999999999999999976
Q ss_pred ccccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC-----
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG----- 576 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~----- 576 (645)
... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+....+..
T Consensus 176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCBCCHHHH
T ss_pred CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence 432 2234578999999999877 67899999999999999999999999754321 1111111111100
Q ss_pred -------------ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 577 -------------KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 577 -------------~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+.....+.+. .........+.+++.+||+.||++|||++|+++|.++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 311 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000000110 111122356778889999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.87 Aligned_cols=267 Identities=21% Similarity=0.324 Sum_probs=205.9
Q ss_pred CccChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcC--CCCccEEE
Q 042831 340 KRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLR--HRNLVQLL 415 (645)
Q Consensus 340 ~~~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nlv~l~ 415 (645)
..+.++.+....++|...+.||+|+||.||++.+.. ++.||||.+... .....+.+.+|++++.+++ |+||++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence 455666777778889999999999999999999864 889999998654 3456678999999999997 59999999
Q ss_pred eeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEe
Q 042831 416 GWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIG 495 (645)
Q Consensus 416 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~ 495 (645)
+++..++..++||| +.+++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||+++ +.+||+
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence 99999999999999 6689999998654 578999999999999999999999 89999999999999965 899999
Q ss_pred eccCcccccccCCc-ceeecccCccccCcccccc-----------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 496 DFGLARLVEHAKGS-QTTVLAGTMGYMAPECATT-----------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 496 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
|||+++........ ......|++.|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence 99999866433221 2234568999999999865 46889999999999999999999999753321
Q ss_pred hHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......... +.....++......+.+++.+||+.||++||+++|++++.++..
T Consensus 246 --~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 246 --ISKLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp --HHHHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred --HHHHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence 111111111 11111111111245677889999999999999999999998764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=366.86 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=208.1
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcC---CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRE---TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE 420 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~ 420 (645)
.+.....++|...+.||+|+||.||+|.+.. .+..||+|.+... .....+.+.+|+.++.+++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3444556778889999999999999999864 3568999998754 3445578999999999999999999999985
Q ss_pred CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 421 KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 421 ~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
++..++||||+++|+|.+++......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 456899999999999999998776779999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
+..............+++.|+|||++....++.++|||||||++|||++ |+.||...... ..... ...+..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~----i~~~~~- 610 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGER- 610 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHHTCC-
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCC-
Confidence 8765443333344567889999999998999999999999999999997 99999754321 12221 111211
Q ss_pred cccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 580 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+...+ ...+.+++.+||+.||++|||+.|+++.|+.
T Consensus 611 ----~~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 611 ----LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1111222 2467788899999999999999999998863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=337.73 Aligned_cols=265 Identities=19% Similarity=0.270 Sum_probs=207.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC-eEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC------ccEEEeeeeeCCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN-SYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN------LVQLLGWCHEKKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------lv~l~~~~~~~~~ 423 (645)
.++|...+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|++++.+++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999998766 79999998643 344567889999999997665 8999999999999
Q ss_pred EEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE----------------
Q 042831 424 LLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML---------------- 486 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl---------------- 486 (645)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 66777776554 3579999999999999999999998 899999999999999
Q ss_pred ---CCCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch
Q 042831 487 ---DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV 563 (645)
Q Consensus 487 ---d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~ 563 (645)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH- 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 5678999999999976432 22345789999999999999999999999999999999999999975443221
Q ss_pred hHHHHHHHHhcC-----------Cccc------------------cccCc-cccCCCCHHHHHHHHHHHHHcCCCCCCCC
Q 042831 564 SLLQWVWDLYGN-----------GKLL------------------EAVDP-RLCRDFDGQQIERLMIVGLWCAHPDENLR 613 (645)
Q Consensus 564 ~l~~~~~~~~~~-----------~~l~------------------~~~d~-~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 613 (645)
...+...... .... +...+ ......+..+...+.+++.+||+.||++|
T Consensus 248 --~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 248 --LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp --HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred --HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 1111111110 0000 00000 00001122345678899999999999999
Q ss_pred CCHHHHHHHhccCC
Q 042831 614 PSIRQVIHVLNFEA 627 (645)
Q Consensus 614 Ps~~evl~~L~~~~ 627 (645)
||++|+++|.++..
T Consensus 326 pt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 326 ITLAEALLHPFFAG 339 (355)
T ss_dssp CCHHHHTTSGGGGG
T ss_pred cCHHHHhcChhhcC
Confidence 99999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=336.03 Aligned_cols=263 Identities=23% Similarity=0.406 Sum_probs=206.1
Q ss_pred cChHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeee
Q 042831 342 FPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~ 419 (645)
...++.....++|...+.||+|+||.||+|.+.+ .+|+|.+... .....+.+.+|+.++.+++||||+++++++.
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 3455666667889999999999999999999864 3999988643 2333456778999999999999999999999
Q ss_pred eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 420 EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 420 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
..+..++||||+++++|.+++......+++..++.++.||+.||.|||+ .+++||||||+||+++ ++.+||+|||+
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999999997766789999999999999999999999 8999999999999998 67999999999
Q ss_pred cccccccC----CcceeecccCccccCcccccc---------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH
Q 042831 500 ARLVEHAK----GSQTTVLAGTMGYMAPECATT---------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566 (645)
Q Consensus 500 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~ 566 (645)
++...... ........|++.|+|||++.. ..++.++||||||+++|||++|+.||...... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~- 251 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI- 251 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH-
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH-
Confidence 87553211 122334568999999999864 45789999999999999999999999754321 11
Q ss_pred HHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 567 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+ ....+........ .+ ...+.+++..||+.||++|||++++++.|+.-
T Consensus 252 --~~-~~~~~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l 300 (319)
T 2y4i_B 252 --IW-QMGTGMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300 (319)
T ss_dssp --HH-HHHTTCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred --HH-HhccCCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 1122211111111 11 12467788999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.82 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=197.7
Q ss_pred HHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhc----CCCCccEEEe
Q 042831 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRL----RHRNLVQLLG 416 (645)
Q Consensus 347 l~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l----~H~nlv~l~~ 416 (645)
.....++|...+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34456789999999999999999999998999999999865432 1233456799999998 8999999999
Q ss_pred eeeeCCeEEEEEEe-cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEE
Q 042831 417 WCHEKKELLLVYEF-MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKI 494 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl 494 (645)
++...+..++|+|| +.+++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999999 7899999999654 468999999999999999999999 8999999999999999 8899999
Q ss_pred eeccCcccccccCCcceeecccCccccCccccccCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 495 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKAS-KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
+|||+++..... ......|+..|+|||++.+..+. .++||||||+++|||++|+.||.... ...
T Consensus 182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~------- 246 (312)
T 2iwi_A 182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL------- 246 (312)
T ss_dssp CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-------
T ss_pred EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh-------
Confidence 999999866432 23345689999999998877664 58999999999999999999996321 100
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCCC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPAL 632 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~ 632 (645)
... ..+.... ...+.+++.+||+.||++|||++|++++.++..+...+
T Consensus 247 -~~~------~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~ 294 (312)
T 2iwi_A 247 -EAE------LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV 294 (312)
T ss_dssp -HTC------CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-----
T ss_pred -hhc------cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhcc
Confidence 000 1111122 24567888999999999999999999999987654433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.64 Aligned_cols=257 Identities=25% Similarity=0.350 Sum_probs=207.7
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++.+++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 346789999999999999999999988999999998654 234567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCC---CcEEEeeccCccccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN---FNAKIGDFGLARLVE 504 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~---~~~kl~DfGla~~~~ 504 (645)
+||+++++|.+++... ..+++..++.++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999888654 468999999999999999999999 899999999999999754 469999999998654
Q ss_pred ccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 505 HAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 505 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||...... .+. .....+...... +
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~~~~-~ 244 (287)
T 2wei_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYAFDL-P 244 (287)
T ss_dssp CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCCCCS-G
T ss_pred CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCCCCCc-h
Confidence 322 2233458899999998865 5899999999999999999999999754321 111 112222211100 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....+ ...+.+++.+||+.||++|||+.|++++.++.
T Consensus 245 -~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~ 281 (287)
T 2wei_A 245 -QWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (287)
T ss_dssp -GGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred -hhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcCHHHh
Confidence 01122 24577888999999999999999999988764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.34 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=178.1
Q ss_pred hhcCCCCCC-ccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----CCeE
Q 042831 350 ATNDFNDDQ-KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE----KKEL 424 (645)
Q Consensus 350 ~~~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~----~~~~ 424 (645)
..++|...+ .||+|+||.||+|++..+++.||||++.... ... .+....+..++|||++++++++.. +...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788744 6999999999999999999999999986532 111 222334566799999999999876 4568
Q ss_pred EEEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCc
Q 042831 425 LLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLA 500 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla 500 (645)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999997653 479999999999999999999999 89999999999999976 455999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+.... .......||+.|+|||++....++.++|||||||++|||++|+.||.......... ........+.. .
T Consensus 179 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-~ 251 (336)
T 3fhr_A 179 KETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY-G 251 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C
T ss_pred eeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc-c
Confidence 76542 22234568999999999988889999999999999999999999997544321110 00000000100 0
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
........ ....+.+++.+||+.||++|||++|++++.++..
T Consensus 252 -~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 252 -FPNPEWSE----VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -CCTTTSTT----CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred -cCchhhcc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 00000111 2345778889999999999999999999998753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=327.13 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=186.1
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-hhH-HHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-QGI-KEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-~~~-~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
..++|...+.||+|+||.||+|.+..+|+.||||++..... ... +.+.++..++..++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 34678888999999999999999998899999999976532 233 3344555677888999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCC-CeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ-CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||+ ++.+..+.......+++..+..++.||+.||.|||+ + +++||||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 555655554456779999999999999999999998 5 8999999999999999999999999999765432
Q ss_pred CCcceeecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 507 KGSQTTVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
. ......|++.|+|||++. ...++.++|||||||++|||++|+.||...... .... ....... ...
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~---~~~~~~~-~~~- 249 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL---TKVLQEE-PPL- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH---HHHHHSC-CCC-
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH---HHHhccC-CCC-
Confidence 2 223456899999999984 456889999999999999999999999753321 1111 1111111 100
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. +. ...++ ..+.+++.+||+.||++||+++|++++.++
T Consensus 250 ~-~~-~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 250 L-PG-HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp C-CS-SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred C-Cc-cCCCC----HHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 0 00 01122 356778899999999999999999998875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=337.30 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=205.8
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhcC--CCCccEEEe
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRLR--HRNLVQLLG 416 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nlv~l~~ 416 (645)
++.....++|...+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++.+++ |+|++++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3344456789999999999999999999999999999999865421 12345678999999996 599999999
Q ss_pred eeeeCCeEEEEEEecCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC-CCCcEEE
Q 042831 417 WCHEKKELLLVYEFMPN-GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD-SNFNAKI 494 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld-~~~~~kl 494 (645)
++...+..++|+||+.+ ++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++ +++.+||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999999976 8999998653 568999999999999999999998 8999999999999999 7899999
Q ss_pred eeccCcccccccCCcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHh
Q 042831 495 GDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLY 573 (645)
Q Consensus 495 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~ 573 (645)
+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .. .
T Consensus 192 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~-------~ 256 (320)
T 3a99_A 192 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------I 256 (320)
T ss_dssp CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------H
T ss_pred eeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh-------h
Confidence 999999866432 2334568999999999887765 788999999999999999999996321 00 0
Q ss_pred cCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 574 GNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 574 ~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+.. .+...++ ..+.+++.+||+.||++|||++|++++.++..
T Consensus 257 -~~~~------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 257 -RGQV------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -HCCC------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -cccc------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 0110 1112222 35678889999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=337.64 Aligned_cols=254 Identities=22% Similarity=0.248 Sum_probs=189.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEEEEec
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
.|...+.||+|+||+||.+.. .+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344567899999999987543 45899999998643 234678899999986 8999999999999999999999999
Q ss_pred CCCChhhhhhhcCCC------CCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-------------CCcE
Q 042831 432 PNGSLDSHLFKENSL------LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-------------NFNA 492 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-------------~~~~ 492 (645)
. |+|.+++...... .++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 7999999654321 1333457899999999999998 89999999999999965 4589
Q ss_pred EEeeccCcccccccCCc---ceeecccCccccCcccccc-------CCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 042831 493 KIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPECATT-------GKASKESDVYSFGIVALEIAC-GRKPINPKAPQG 561 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~ 561 (645)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 2234579999999999865 568999999999999999999 999997543211
Q ss_pred chhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 562 QVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 562 ~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... .+... .+.+....+......+.+++.+||+.||++|||+.|+++|.++.
T Consensus 248 ----~~i~-----~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 248 ----SNII-----RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp ----HHHH-----HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred ----HHHh-----cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 1111 11100 01111122345567888999999999999999999999998874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.86 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=193.3
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~l 426 (645)
.....+|...+.||+|+||+||... ..+++.||||++..... ..+.+|++++.++ +||||+++++++.+.+..++
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 3445578889999999999965433 34578999999865432 2356799999999 79999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-----CCcEEEeeccCcc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-----NFNAKIGDFGLAR 501 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kl~DfGla~ 501 (645)
|||||+ |+|.+++......+.+..+..++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 999995 69999997766556666778999999999999999 89999999999999943 3468899999998
Q ss_pred cccccCC--cceeecccCccccCccccc---cCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 502 LVEHAKG--SQTTVLAGTMGYMAPECAT---TGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 502 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||...... .. ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~---~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QA---NILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HH---HHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HH---HHHhcc
Confidence 7653321 2234467999999999987 4567889999999999999999 99999643221 11 111111
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. ..... ........+.+++.+||+.||++|||++|+++|.++.
T Consensus 245 ~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~ 288 (432)
T 3p23_A 245 CS-LDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288 (432)
T ss_dssp CC-CTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTC
T ss_pred CC-ccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcccc
Confidence 11 11111 1123344567889999999999999999999998874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=349.75 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=205.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee------CCe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE------KKE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~------~~~ 423 (645)
.++|...++||+|+||.||+|.+..+|+.||||++... .....+.+.+|++++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999999988999999998754 44556789999999999999999999999765 677
Q ss_pred EEEEEEecCCCChhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCc---EEEeecc
Q 042831 424 LLLVYEFMPNGSLDSHLFKEN--SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFN---AKIGDFG 498 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~---~kl~DfG 498 (645)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997533 368999999999999999999999 89999999999999987664 9999999
Q ss_pred CcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCC--
Q 042831 499 LARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG-- 576 (645)
Q Consensus 499 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~-- 576 (645)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...|.......+
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccch
Confidence 998764332 23446799999999999999999999999999999999999999975321 111110000000
Q ss_pred --ccccccC------c--cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 577 --KLLEAVD------P--RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 577 --~l~~~~d------~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...+... . .............+..++..||+.||++|||++|++++.++
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 0000000 0 00112334456778899999999999999999998777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.89 Aligned_cols=229 Identities=15% Similarity=0.143 Sum_probs=183.8
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
.++|...+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+..+.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999999999999999997542 34457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||+++++|.+++.. . .......+|+.||+.||.|||+ ++|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999843 2 3555788999999999999999 899999999999999999999998443
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc-cc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP-RL 586 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~-~l 586 (645)
|++ .++.++|||||||++|||++|+.||............. . ...+.. ..+ .+
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~-~~~~~~---~~~~~~ 228 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---R-DTAGQP---IEPADI 228 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---B-CTTSCB---CCHHHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---H-HhccCC---CChhhc
Confidence 333 36889999999999999999999998654322110000 0 000000 000 11
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.... ...+..++.+||+.||++| |+.|+++.|+.
T Consensus 229 ~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 229 DRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp CTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred ccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 1122 2457788899999999999 99999999985
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.90 Aligned_cols=114 Identities=41% Similarity=0.619 Sum_probs=106.2
Q ss_pred CCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceee
Q 042831 147 IPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLD 224 (645)
Q Consensus 147 ~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls 224 (645)
||+|||||||++|. |||++|||||||||+.|.++++|+ +.+|+.++|||+||+.+++|+|+|++.+. + .|+|+
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~~--l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~-~--~p~ls 75 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWD--WQNGKIATAHISYNSVSKRLSVTSYYAGS-K--PATLS 75 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECC--CCTTSCEEEEEEEETTTTEEEEEEECSSS-C--CEEEE
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeeeE--EcCCCEEEEEEEEeCCCcEEEEEEccCCC-c--cceEE
Confidence 57899999999997 999999999999999999999984 78999999999999999999999998664 3 78999
Q ss_pred EeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcccc
Q 042831 225 YQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEM 265 (645)
Q Consensus 225 ~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~~~ 265 (645)
+.+||+++|+|+||||||||||...|.|+|++|+|++.+.+
T Consensus 76 ~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l~~ 116 (133)
T 1qmo_E 76 YDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLWT 116 (133)
T ss_dssp EECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEEEE
T ss_pred EeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeCCC
Confidence 99999999999999999999999999999999999887643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=332.84 Aligned_cols=246 Identities=17% Similarity=0.162 Sum_probs=186.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---hhHHHHHHHHHHHHhcCC-CCccE------------
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---QGIKEYASEVKIISRLRH-RNLVQ------------ 413 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~nlv~------------ 413 (645)
.+.+|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++..++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34557778899999999999999999999999999874322 336789999999999987 32211
Q ss_pred ---------EEeeeee-----CCeEEEEEEecCCCChhhhhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC
Q 042831 414 ---------LLGWCHE-----KKELLLVYEFMPNGSLDSHLF------KENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473 (645)
Q Consensus 414 ---------l~~~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 473 (645)
+..++.. ....+++|+++ +++|.+++. ..+..+++..++.|+.||++||.|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 1111111 12457777765 789998884 224568899999999999999999998 99
Q ss_pred eeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCcccc----------ccCCCCcchhHHHHHHH
Q 042831 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECA----------TTGKASKESDVYSFGIV 543 (645)
Q Consensus 474 ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~sDV~SfGvl 543 (645)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998764432 344567 999999998 55568899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 042831 544 ALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623 (645)
Q Consensus 544 l~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 623 (645)
+|||++|+.||.......... ..+.. ...++ +.+.+++..||+.||++||++.|++++.
T Consensus 307 l~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~~ 365 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE---------------WIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETP 365 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred HHHHHHCCCCCCCcchhhhHH---------------HHHhh--cccCC----HHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 999999999997543221110 01110 11222 4577888999999999999998888775
Q ss_pred cc
Q 042831 624 NF 625 (645)
Q Consensus 624 ~~ 625 (645)
++
T Consensus 366 ~~ 367 (413)
T 3dzo_A 366 EY 367 (413)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=308.32 Aligned_cols=231 Identities=22% Similarity=0.310 Sum_probs=182.6
Q ss_pred cCCCCC-CccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHH-HhcCCCCccEEEeeeee----CCeEE
Q 042831 352 NDFNDD-QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKII-SRLRHRNLVQLLGWCHE----KKELL 425 (645)
Q Consensus 352 ~~f~~~-~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~nlv~l~~~~~~----~~~~~ 425 (645)
++|... +.||+|+||.||++.+..+++.||+|++... ..+.+|++++ ..++||||+++++++.. .+..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456655 7799999999999999999999999998643 3567888888 55689999999999876 67899
Q ss_pred EEEEecCCCChhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCcc
Q 042831 426 LVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLAR 501 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla~ 501 (645)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999997653 479999999999999999999999 89999999999999998 7899999999986
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
... +..++.++|||||||++|||++|+.||......... ......
T Consensus 169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~ 213 (299)
T 3m2w_A 169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTR 213 (299)
T ss_dssp ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCS
T ss_pred ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHH
Confidence 432 234678999999999999999999999754322100 000000
Q ss_pred cCccccCCCCH----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDG----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+.... ...+. .....+..++.+||+.||++|||++|+++|.++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~ 261 (299)
T 3m2w_A 214 IRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261 (299)
T ss_dssp SCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred Hhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence 00000 00111 1235677888999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=347.19 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=192.2
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcC-CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe----
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRE-TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE---- 423 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~---- 423 (645)
..++|...++||+|+||.||+|.+.. +++.||||++... .......+.+|++++.+++||||++++++|...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34789999999999999999999976 6899999998654 34556788999999999999999999999987655
Q ss_pred -EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 424 -LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 424 -~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.+|||||+++++|.+++.. .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++.
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999987643 69999999999999999999999 899999999999999986 899999999986
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.... ....||++|+|||++.++. +.++|||||||+++||++|..||....... +
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------------~ 284 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------------L 284 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------------------C
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------------------c
Confidence 5432 3456999999999987654 899999999999999999998876321110 0
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHh
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPS-IRQVIHVL 623 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L 623 (645)
.. ..........+..++.+||+.||++||+ ++++.+.|
T Consensus 285 ~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 285 PE---DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp CT---TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cc---cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence 00 0000112356778899999999999995 44454444
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.85 Aligned_cols=244 Identities=18% Similarity=0.194 Sum_probs=188.1
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcC---------CCCccE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLR---------HRNLVQ 413 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nlv~ 413 (645)
.++|...++||+|+||.||+|++ +|+.||||++.... ....+.+.+|+.++++++ |||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45688899999999999999998 57999999997542 223478889999999886 777777
Q ss_pred EEeeee------------------------------eCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHH
Q 042831 414 LLGWCH------------------------------EKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463 (645)
Q Consensus 414 l~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL 463 (645)
+.+.+. ..+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776532 26789999999999987777643 5689999999999999999
Q ss_pred HHHH-hhcCCCeeeccCCCCCeEECCCC--------------------cEEEeeccCcccccccCCcceeecccCccccC
Q 042831 464 LYLQ-EEWEQCVVHRDIKSSNIMLDSNF--------------------NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522 (645)
Q Consensus 464 ~yLH-~~~~~~ivH~Dlkp~NILld~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 522 (645)
.||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 7 8999999999999999887 8999999999866432 2479999999
Q ss_pred ccccccCCCCcchhHHHHHHH-HHHHHcCCCCCCCCCCCCchhHHHHH---HHHhcCCccccccCccccCCCCHHHHHHH
Q 042831 523 PECATTGKASKESDVYSFGIV-ALEIACGRKPINPKAPQGQVSLLQWV---WDLYGNGKLLEAVDPRLCRDFDGQQIERL 598 (645)
Q Consensus 523 PE~~~~~~~t~~sDV~SfGvl-l~elltG~~pf~~~~~~~~~~l~~~~---~~~~~~~~l~~~~d~~l~~~~~~~~~~~l 598 (645)
||++.+.. +.++||||++++ .+++++|..||.. ..|. .+...+... ................+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhc---cCcccchhhhhhcCHHH
Confidence 99998665 899999998777 7778889999842 1111 111100000 00111111123456778
Q ss_pred HHHHHHcCCCCCCCCCCHHHHH-HHhcc
Q 042831 599 MIVGLWCAHPDENLRPSIRQVI-HVLNF 625 (645)
Q Consensus 599 ~~l~~~Cl~~dP~~RPs~~evl-~~L~~ 625 (645)
.+++.+||+.| |++|++ +|.++
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~Hp~f 335 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQHSLF 335 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHCGGG
T ss_pred HHHHHHHhccC-----CHHHHHhcCCCc
Confidence 89999999866 999999 99876
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=288.81 Aligned_cols=190 Identities=18% Similarity=0.195 Sum_probs=149.1
Q ss_pred CCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCC-CCCCCeEEEEEccCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNS-SYYADGLAFFLAPQGS 123 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~-~~~g~GlaF~l~p~~~ 123 (645)
..++.++ +|.+ .+|.|+||+ ..++.|||||+.|+++ +||+|+|+|.|.+... ..+||||||+|+|...
T Consensus 24 i~~~~l~G~a~i-~~g~l~LT~~~~~~~G~~w~~~pi~~--------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~ 94 (253)
T 2dur_A 24 MPLWDFQGSTIL-TSQYVRLTPDERSKEGSIWNHQPCFL--------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL 94 (253)
T ss_dssp CCSEEEEETCEE-CSSCEEEECSSSSEEEEEEESSCBCC--------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS
T ss_pred cCCEEEccceEE-ECCEEEECCCCCCCEEEEEeCCCCcc--------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC
Confidence 3589999 9999 689999999 6678999999999986 6899999999998765 5689999999999863
Q ss_pred CCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeee--------------cccC-C
Q 042831 124 KIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSW--------------WSDV-K 188 (645)
Q Consensus 124 ~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~--------------~~~~-~ 188 (645)
..|++||+.+ .++.|||||||++|.++|+ |+++|||++.+..+..| ..++ .
T Consensus 95 -----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~--~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n 160 (253)
T 2dur_A 95 -----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE--RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRN 160 (253)
T ss_dssp -----CEETBTEECS-------SCEEEEEEEECSCCCTTCC--SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBT
T ss_pred -----CCCcccCcCC-------CCCEEEEEEECCCCCCCCC--CCCcEEEEEecCCceeeeccCCCcccccccccHhhcc
Confidence 2578999643 2567999999999986654 56666665555444433 2244 3
Q ss_pred CCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcccc
Q 042831 189 SGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEM 265 (645)
Q Consensus 189 ~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~~~ 265 (645)
.|+.++|||+||+. +|+|++++.+.. +..++ ..++ ...||+++||||||+||...+.|+|++|+|.+...+
T Consensus 161 ~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~~~--~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl~~~ 231 (253)
T 2dur_A 161 RDHDTFLAVRYSRG--RLTVMTDLEDKN-EWKNC--IDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLMVE 231 (253)
T ss_dssp CSSCEEEEEEEETT--EEEEEEECSSSS-CCEEE--EEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEECCCC
T ss_pred CCCCeEEEEEEECC--EEEEEEeCCCCC-CceEE--EEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEecccC
Confidence 48899999999975 899999975542 32333 3445 345899999999999999999999999999765443
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=285.89 Aligned_cols=205 Identities=19% Similarity=0.174 Sum_probs=160.1
Q ss_pred eeeEEeCCCCCC--CCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCC
Q 042831 34 ALTFNYTSFSPQ--YDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSY 109 (645)
Q Consensus 34 ~~~f~f~~f~~~--~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (645)
..||..+....+ ...++.++ ||.+ ++|.|+||+ ..++.||+||+.|++ ++||+|+|+|.|.+++ ..
T Consensus 33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i-~~~~IrLT~~~~~~~G~~w~~~p~~--------~~sF~t~F~F~I~~~~-~~ 102 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPFWAHAGNAIP-SADQIRIAPSLKSQRGSVWTKTKAA--------FENWEVEVTFRVTGRG-RI 102 (260)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEE-CSSCEEEECSSTTCEEEEEESSCBC--------CSSEEEEEEEEEECSS-SC
T ss_pred ceeEcCccccCCCCccCCeEEcccEEe-eCCEEEeCCCCCCCEEEEEECCCcc--------ccCEEEEEEEEEecCC-CC
Confidence 345555554422 24589999 9988 789999999 667999999999995 4899999999999864 36
Q ss_pred CCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCC---CC------CCCceeeecCC-Ccccc
Q 042831 110 YADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSW---DP------TFSHVGIDINS-VKSKK 179 (645)
Q Consensus 110 ~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~---d~------~~~hvgidvns-~~s~~ 179 (645)
+||||||+|+|.... .|++||+.+ .++.||||||||.|.+ +| |++|+|||+|+ +.|..
T Consensus 103 ~gdGlAF~l~~~~~~-----~g~~~G~~~-------~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~ 170 (260)
T 1gv9_A 103 GADGLAIWYTENQGL-----DGPVFGSAD-------MWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQA 170 (260)
T ss_dssp CCCEEEEEEESSCCC-----EEEETTECS-------CCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHC
T ss_pred CCCeEEEEEecCCCC-----CCCccCCCC-------CCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccce
Confidence 799999999998642 578889742 3457999999999874 34 46788888886 66666
Q ss_pred eeeecccCC-CCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEee
Q 042831 180 NVSWWSDVK-SGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWE 258 (645)
Q Consensus 180 ~~~~~~~~~-~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~ws 258 (645)
...|..++. +|+.++|||+|++. +|+|++.+........+.+++.+| +..||+++||||||+||...+.|+|++|+
T Consensus 171 ~~~c~~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~e~hdIlsw~ 247 (260)
T 1gv9_A 171 LASCQRDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFL 247 (260)
T ss_dssp SEEECCCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEE
T ss_pred eeccChhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCcceEEEEEEE
Confidence 666655554 59999999999986 899999863211122357888999 67899999999999999999999999999
Q ss_pred ccCcc
Q 042831 259 FNSSL 263 (645)
Q Consensus 259 f~~~~ 263 (645)
|....
T Consensus 248 ~~~l~ 252 (260)
T 1gv9_A 248 TFQLT 252 (260)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 97543
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=270.22 Aligned_cols=115 Identities=40% Similarity=0.636 Sum_probs=106.5
Q ss_pred CCCEEEEEEecccCC-C-CCCCCceeeecCCCcccceeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCccccccee
Q 042831 146 SIPFVAVEFDVYVNS-W-DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGL 223 (645)
Q Consensus 146 ~~~~vaVEfDt~~n~-~-d~~~~hvgidvns~~s~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~l 223 (645)
+||+|||||||++|. | ||++|||||||||+.|.+++.|+ +.+|+.++|||+||+.+++|+|+|++.+. ..|+|
T Consensus 1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~~--l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~l 75 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWN--MQNGKVGTAHIIYNSVDKRLSAVVSYPNA---DSATV 75 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECC--CCTTCEEEEEEEEETTTTEEEEEEECTTS---CCEEE
T ss_pred CCCEEEEEEeCCCCcccCCCCCCeeeEecCCcccccccccc--ccCCCEEEEEEEEeCCCCEEEEEEecCCC---CcceE
Confidence 378999999999997 6 99999999999999999999984 78999999999999999999999997654 47899
Q ss_pred eEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcccc
Q 042831 224 DYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEM 265 (645)
Q Consensus 224 s~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~~~ 265 (645)
++.|||+++|+|+|||||||+||...|.|+|++|+|++.+..
T Consensus 76 s~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~a 117 (237)
T 1nls_A 76 SYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKS 117 (237)
T ss_dssp EEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEE
T ss_pred EEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecccc
Confidence 999999999999999999999999999999999999887653
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=211.57 Aligned_cols=103 Identities=35% Similarity=0.683 Sum_probs=91.8
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..+|.++ ||.+.+ |.|+||+ +. .++|||+|++||||||+ +|+++||+|+|+|.|.+
T Consensus 2 ~~~~F~f~~F~~~-~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~-tg~vaSFsT~F~F~I~~ 78 (113)
T 1qmo_A 2 QSLSFSFTKFDPN-QEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWED-SAVLTSFDTIINFEIST 78 (113)
T ss_dssp EEEEEEESSCCSS-CTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEEEEC
T ss_pred cceEEEcCCCCCC-CCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCC-CCCEEeeEEEEEEEEec
Confidence 4689999999965 5689999 999965 9999999 43 58999999999999999 99999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCC
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDN 140 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~ 140 (645)
.....+||||||||+|..+. |. +.||||||+|.+
T Consensus 79 ~~~~~~gdGlAF~lap~~~~-p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 79 PYTSRIADGLAFFIAPPDSV-IS-YHGGFLGLFPNA 112 (113)
T ss_dssp SSSSCCCCEEEEEEECTTCC-CC-CCGGGTTTCSSC
T ss_pred CCCCCCCCeEEEEecCCCCC-CC-CCccccccccCC
Confidence 87777899999999999865 76 899999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-29 Score=279.77 Aligned_cols=186 Identities=19% Similarity=0.105 Sum_probs=132.9
Q ss_pred ccCcCCcEEEEEEEEcCCCeEEEEEEeccC----------ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 359 KLGQGGFGGVYKGFFRETNSYIAVKRVSQG----------SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 359 ~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
..+.|+.|.+..++....|+.+++|.+... .....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 466777777777776667888999998653 123456799999999999 699999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
|||++|++|.+++.+. ..++.. +|+.||+.||.|||+ ++||||||||+|||+++++++||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999654 456654 589999999999999 999999999999999999999999999998664322
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCC
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~p 553 (645)
......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 23345679999999998865 567789999999998887665443
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=216.90 Aligned_cols=187 Identities=16% Similarity=0.212 Sum_probs=147.0
Q ss_pred CCCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKI 125 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~ 125 (645)
..++.++ +|.+ .++.|+||+..++.|++|.+.|+++ .++|+|+|+|.|.... ..+||||||+++|....
T Consensus 30 i~~w~~~G~a~v-~~~~IrLTp~~~s~G~iW~~~p~~~-------~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~- 99 (256)
T 2a6y_A 30 PNNWQTGEQASL-EEGRIVLTSNQNSKGSLWLKQGFDL-------KDSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI- 99 (256)
T ss_dssp CTTEEEEETCEE-ETBEEECCCSTTCEEEEEESSCEEE-------SSCEEEEEEEEEESCC-SCCSCEEEEEEEECSSS-
T ss_pred cCCeEEccceEE-eCCEEEECCCCCceEEEeeCCCCcc-------cCCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCc-
Confidence 5589999 9999 7899999996567999777777764 4789999999999764 33799999999997642
Q ss_pred CCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCC------CCceeeecCCCcccceeeecccCC-CCceeEEEEE
Q 042831 126 PTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPT------FSHVGIDINSVKSKKNVSWWSDVK-SGRRNEAWIS 198 (645)
Q Consensus 126 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~------~~hvgidvns~~s~~~~~~~~~~~-~g~~~~~~I~ 198 (645)
| ..|+.+|..+. ..-+||||||+.|. .|. +.|+++|.+++.+.....|..++. +|..++|||+
T Consensus 100 ~--~~g~~~G~~~~-------f~GlaV~fDT~~n~-~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~~~~rn~~~~~~v~I~ 169 (256)
T 2a6y_A 100 P--RDKQLYNGPVN-------YDGLQLLVDNNGPL-GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVT 169 (256)
T ss_dssp C--CCCTBTTBCTT-------CEEEEEEEESCSTT-CSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTCSSCEEEEEE
T ss_pred c--cCCcccCcCCC-------CCEEEEEEECCCCC-CceEEEEECCCceecccCCCcccceecceeecccCCCcEEEEEE
Confidence 2 56778887742 22489999999873 343 679999998866666677754454 7899999999
Q ss_pred Ec-CCCceEEEEEecCCCcccccceeeEeeccCcC-CCCce-EEEEeeccc---ceeeeEEEEEeeccCccc
Q 042831 199 YN-SSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQH-LPEFV-TFGFSMATG---VDFAIFSIYSWEFNSSLE 264 (645)
Q Consensus 199 Y~-~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~-l~~~~-~vGfsastg---~~~~~~~i~~wsf~~~~~ 264 (645)
|+ +..+.|+|.+.+ .. -+++..+ ||+++ ++||||+|| ...+.|.|++|+|.....
T Consensus 170 Y~~~~~~~L~V~i~~-------~~----c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~~~ 230 (256)
T 2a6y_A 170 YDLEDDNLLKVQVDN-------KV----CFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNGVI 230 (256)
T ss_dssp EEGGGTSEEEEEETT-------EE----EEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEESCS
T ss_pred EecCCCcEEEEEEcC-------EE----EEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEeccc
Confidence 99 888999999976 11 1223334 78887 699999999 889999999999987554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.3e-26 Score=252.33 Aligned_cols=185 Identities=12% Similarity=0.137 Sum_probs=146.3
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
...++||+|+||.||+|... +..+++|+..... ....+++.+|++++++++||||+++..++...+..+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999544 6789999864321 1124568999999999999999977777777788899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++++|.+++.+ +..++.|+++||.|||+ ++|+||||||+|||++. ++||+|||+++.....
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999999854 56899999999999998 89999999999999999 9999999999876543
Q ss_pred CCcc------eeecccCccccCcccccc--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 042831 507 KGSQ------TTVLAGTMGYMAPECATT--GKASKESDVYSFGIVALEIACGRKPIN 555 (645)
Q Consensus 507 ~~~~------~~~~~gt~~y~aPE~~~~--~~~t~~sDV~SfGvll~elltG~~pf~ 555 (645)
.... .....||+.|+|||++.. ..|+...|+|+..+-.++-+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2211 235679999999999977 567888999999999988888877663
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=7.2e-25 Score=214.99 Aligned_cols=106 Identities=28% Similarity=0.578 Sum_probs=94.1
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
+..++|+|++|.++ ..+|.++ ||.+.++|.|+||+ +. .+.|||+|++||||||+ +|+++||+|+|+|.|.
T Consensus 123 s~~~~F~~~~F~~~-~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~-~~~vaSFsT~F~F~I~ 200 (237)
T 1nls_A 123 TNALHFMFNQFSKD-QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFLIK 200 (237)
T ss_dssp EEEEEEEESCCCTT-CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEECC
T ss_pred cccchhhhcccccc-CCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecC-CCCEeeeEEEEEEEEe
Confidence 35679999999975 5689999 99997789999999 42 57999999999999997 8899999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCC
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDN 140 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~ 140 (645)
+.. ..+||||||||+|..+++|.++.||||||+|.+
T Consensus 201 ~~~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 201 SPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp CSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred cCC-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 863 457999999999998788999999999999864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.9e-23 Score=209.13 Aligned_cols=152 Identities=14% Similarity=0.103 Sum_probs=121.3
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------------------hhHHHHHHHHHHHHhc
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------------------QGIKEYASEVKIISRL 406 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l 406 (645)
..+......|...+.||+|+||.||+|.+ .+|+.||+|.++.... .....+.+|++++.++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34444555677779999999999999999 7799999999864321 1356789999999999
Q ss_pred CCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 407 ~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||+
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl 226 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV 226 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEE
Confidence 9 4 555554433 55699999999999988 421 2244799999999999998 999999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCcceeecccCccccCccccc
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 527 (645)
+ ++.+||+|||+++. +..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9 99999999999963 33478888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=181.54 Aligned_cols=138 Identities=19% Similarity=0.091 Sum_probs=107.3
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeE--EEEEEeccCCh------------------------hhHHHHHHHHHHHHhc
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSY--IAVKRVSQGSK------------------------QGIKEYASEVKIISRL 406 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~--vavK~~~~~~~------------------------~~~~~~~~Ei~~l~~l 406 (645)
-|...+.||+|+||.||+|.+..+|+. ||||.++.... .....+.+|+..+.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999999667888 99998754311 1123678999999999
Q ss_pred CCCCc--cEEEeeeeeCCeEEEEEEecCC-C----ChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hhcCCCeeecc
Q 042831 407 RHRNL--VQLLGWCHEKKELLLVYEFMPN-G----SLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ-EEWEQCVVHRD 478 (645)
Q Consensus 407 ~H~nl--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~D 478 (645)
+|+++ ..++++ +..+|||||+.+ | +|.+.... .++.....++.|++.+|.||| + .+|+|||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 88754 444432 356899999942 4 55554422 234567789999999999999 7 8999999
Q ss_pred CCCCCeEECCCCcEEEeeccCcccc
Q 042831 479 IKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 479 lkp~NILld~~~~~kl~DfGla~~~ 503 (645)
|||+|||++. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-16 Score=154.42 Aligned_cols=180 Identities=15% Similarity=0.185 Sum_probs=126.2
Q ss_pred CCCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKI 125 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~ 125 (645)
.....+. +|.+ .++.|+||...++.|.+|.+.|+++. .+|+++|+|.|..+. ..+||||||++++....
T Consensus 23 ~~~W~~~G~a~i-~~~~IrLTp~~~~~G~iWs~~p~~~~-------~~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~- 92 (222)
T 2a6z_A 23 PNNWQTGEQASL-EEGRIVLTSNQNSKGSLWLKQGFDLK-------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNI- 92 (222)
T ss_dssp CTTEEEEETCEE-ETTEEESCCSTTCEEEEEESSCEECC-------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSS-
T ss_pred cCCcEEcccEEE-cCCEEEECCCCCCeEEEEeCCCCCCC-------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCcc-
Confidence 4578888 8888 67999999965679999999999863 369999999998764 34699999999987531
Q ss_pred CCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCc---------ccceeeecccCC-CCceeEE
Q 042831 126 PTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVK---------SKKNVSWWSDVK-SGRRNEA 195 (645)
Q Consensus 126 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~---------s~~~~~~~~~~~-~g~~~~~ 195 (645)
...|..+|..+.-+ | +||+|||+.|. .++|.+.+|.-. +..-..+..... .+...++
T Consensus 93 --~~~g~~~G~~~~f~-G------L~I~~Dt~~n~----~p~i~~~~ndG~~~yd~~~~~~~~~~~C~~~~rn~~~~~~~ 159 (222)
T 2a6z_A 93 --PRDKQLYNGPVNYD-G------LQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTI 159 (222)
T ss_dssp --CCCCTBTTBCTTCE-E------EEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEEE
T ss_pred --cCCCcccCCCCCCC-E------EEEEEECCCCC----CceEEEEECCCCeeeccCCCccccccccceeccCCCCcEEE
Confidence 13455555433211 1 79999999873 345555554321 111122322333 5788999
Q ss_pred EEEEc-CCCceEEEEEecCCCcccccceee-EeeccCcCCCCc-eEEEEeeccc---ceeeeEEEEEeecc
Q 042831 196 WISYN-SSTHNLSVAFTGFRNNLVVMQGLD-YQVDLRQHLPEF-VTFGFSMATG---VDFAIFSIYSWEFN 260 (645)
Q Consensus 196 ~I~Y~-~~~~~l~v~l~~~~~~~~~~~~ls-~~vdl~~~l~~~-~~vGfsastg---~~~~~~~i~~wsf~ 260 (645)
+|+|+ ...+.|+|.+.. ..++. ..|+ ||+. .|+||||+|| +..+.|.|++|++.
T Consensus 160 rI~Y~~~~~~~l~v~id~-------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~ 219 (222)
T 2a6z_A 160 RVTYDLEDDNLLKVQVDN-------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF 219 (222)
T ss_dssp EEEEEGGGTSEEEEEETT-------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred EEEEEcCCCcEEEEEEcC-------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence 99999 667889999865 11222 1233 4555 4799999999 88899999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.4e-16 Score=164.27 Aligned_cols=144 Identities=13% Similarity=0.093 Sum_probs=101.1
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh--------------hhHHH--------HHHHHHHHHhc
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK--------------QGIKE--------YASEVKIISRL 406 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~Ei~~l~~l 406 (645)
....-|.+.++||+|++|.||+|... +|+.||||+++.... ..... ...|...|.++
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 33344889999999999999999985 488999998753210 00111 23456666666
Q ss_pred CCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 407 ~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
.+.++....-+... ..+|||||+++++|..+... +....++.||+.+|.|||+ .+||||||||.|||+
T Consensus 171 ~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 171 YEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILI 238 (397)
T ss_dssp HHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred HhcCCCCCeeeecc--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEE
Confidence 54443211111111 23799999999888665421 1235688999999999998 899999999999999
Q ss_pred CCCC----------cEEEeeccCcccccc
Q 042831 487 DSNF----------NAKIGDFGLARLVEH 505 (645)
Q Consensus 487 d~~~----------~~kl~DfGla~~~~~ 505 (645)
++++ .+.|+||+.+....+
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred eCCCCcccccccccceEEEEeCCcccCCC
Confidence 8776 389999998865543
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-13 Score=99.16 Aligned_cols=45 Identities=38% Similarity=0.705 Sum_probs=42.0
Q ss_pred cceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCccc
Q 042831 220 MQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLE 264 (645)
Q Consensus 220 ~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~~ 264 (645)
+|+|++.+||+++|+|+|+|||||+||...+.|+|++|+|++.+.
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~ 47 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS 47 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence 578999999999999999999999999999999999999987653
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.25 E-value=2.7e-10 Score=110.64 Aligned_cols=174 Identities=17% Similarity=0.140 Sum_probs=117.0
Q ss_pred CCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCCC
Q 042831 48 DNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIP 126 (645)
Q Consensus 48 ~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~ 126 (645)
....+. +|.+ .++.|+||..+++.|.+|-+.|+.+- .+|+.+|.|.|...... +||||||.++.....
T Consensus 27 ~~W~~~G~t~v-~~~~IrLTp~~s~~G~lWs~~p~~~~-------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~~-- 95 (226)
T 2a6v_A 27 SQWTLGDKVKL-EEGRFVLTPGKNTKGSLWLKPEYSIK-------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGNEG-- 95 (226)
T ss_dssp TTEEEEETCEE-ETTEEESCCSTTCEEEEEESSCBCCS-------SCEEEEEEEEEESCCSC-CSCEEEEEEECSCCC--
T ss_pred CCcEEcCCeEE-eCCEEEECCCCCceEEEeeCCCCCCC-------CCeEEEEEEEEecCCCC-CCCEEEEEEECCCCC--
Confidence 467788 8888 46689999986789999999999861 35999999999977533 699999999976531
Q ss_pred CCCCCCccc----CccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCC-c------ccceeeecccC-CCCceeE
Q 042831 127 TNKGGGSFG----LTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSV-K------SKKNVSWWSDV-KSGRRNE 194 (645)
Q Consensus 127 ~~~~g~~lG----l~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~-~------s~~~~~~~~~~-~~g~~~~ 194 (645)
..|..+| -|+. +||.|||+.|. ...|-+-+|.- . +..-..+..++ ..+...+
T Consensus 96 --~~g~vfGg~~d~f~G----------lgI~~Dt~~n~----~p~i~~~~NDGt~~yd~~~~~~~g~C~~~~rn~~~~t~ 159 (226)
T 2a6v_A 96 --DSTELFGGSSKKFNG----------LMILLRLDDKL----GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPST 159 (226)
T ss_dssp --CCCTBTTTBCSSCEE----------EEEEEEEETTT----EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEE
T ss_pred --CCcccccccCCCccE----------EEEEEECCCCC----CceEEEEECCCCcccCCCCCcccceEeEeccCCCCCEE
Confidence 2233332 2221 89999999862 12344433321 1 11112232233 3567899
Q ss_pred EEEEEc-CCCceEEEEEecCCCcccccceeeE-eeccCcCCCCc--eEEEEeecccceeeeEEEEEeec
Q 042831 195 AWISYN-SSTHNLSVAFTGFRNNLVVMQGLDY-QVDLRQHLPEF--VTFGFSMATGVDFAIFSIYSWEF 259 (645)
Q Consensus 195 ~~I~Y~-~~~~~l~v~l~~~~~~~~~~~~ls~-~vdl~~~l~~~--~~vGfsastg~~~~~~~i~~wsf 259 (645)
++|.|+ ...+.|+|.+.. ..++.. .|+ ||.. .|+||||+||+..+.|.|++-..
T Consensus 160 ~ri~Y~~~~~~~l~v~id~-------~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~~ 217 (226)
T 2a6v_A 160 LRLTYNPLDNHLLKLQMDN-------RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMKL 217 (226)
T ss_dssp EEEEEEGGGTSEEEEEETT-------EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEcC-------CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEEE
Confidence 999997 456789998863 123321 123 3433 49999999999999999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.5e-11 Score=122.16 Aligned_cols=146 Identities=14% Similarity=0.035 Sum_probs=113.7
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEE
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~l 426 (645)
.....+|.....++.|+.+.||+.... ++.+++|............+.+|+++++.+. +..+.++++++...+..++
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344457877788888889999999754 5789999986532222346888999999985 6778899999999899999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE------------------------------------- 469 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------- 469 (645)
||||++|.+|.+.+. +......++.+++++|..||+.
T Consensus 88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999999877531 1122447889999999999981
Q ss_pred -------------------cCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 470 -------------------WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 470 -------------------~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
....++|+|+++.|||++++..+.|.||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01459999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=3.7e-10 Score=112.87 Aligned_cols=137 Identities=18% Similarity=0.111 Sum_probs=99.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~~~~~~~~~~lV~E 429 (645)
.++......+.|..+.||++.. .+|..+++|..... ....+.+|+.++..+++.+ +.+++++...++..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3444333334555699999965 34677999987544 2245778999999986544 4568888888888999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW--------------------------------------- 470 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 470 (645)
|+++.+|. ... .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998884 211 11 2367788888888888631
Q ss_pred ----------------CCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 471 ----------------EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 471 ----------------~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++|+|++|.||+++++..+.|.||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.93 E-value=3.2e-09 Score=111.87 Aligned_cols=142 Identities=13% Similarity=0.182 Sum_probs=107.6
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEec--cCC-hhhHHHHHHHHHHHHhcC--CCCccEEEeeeeeC---CeEEEE
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGS-KQGIKEYASEVKIISRLR--HRNLVQLLGWCHEK---KELLLV 427 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~nlv~l~~~~~~~---~~~~lV 427 (645)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.++ +..+.+++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567899999999998765 3568888765 322 123457788999999997 45678899998776 458999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW------------------------------------- 470 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 470 (645)
|||+++..+.+.. ...++...+..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998875422 124678889999999999999999720
Q ss_pred ------------------CCCeeeccCCCCCeEECCCCc--EEEeeccCccc
Q 042831 471 ------------------EQCVVHRDIKSSNIMLDSNFN--AKIGDFGLARL 502 (645)
Q Consensus 471 ------------------~~~ivH~Dlkp~NILld~~~~--~kl~DfGla~~ 502 (645)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987653 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-09 Score=111.54 Aligned_cols=183 Identities=19% Similarity=0.200 Sum_probs=123.5
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCC--ccEEEeeeeeCC---eEEEEEEe
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRN--LVQLLGWCHEKK---ELLLVYEF 430 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--lv~l~~~~~~~~---~~~lV~Ey 430 (645)
.+.++.|....||+.. ..+++|..... .....+.+|++++..+. +.. +.+++......+ ..++|||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999863 34888876432 34567889999999884 332 445555544333 34889999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE----------------------------------------- 469 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 469 (645)
++|.+|..... ..++.+++..++.++++.|..||..
T Consensus 98 i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 98 IKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred cCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99988875432 2467788889999999999999961
Q ss_pred --------------cCCCeeeccCCCCCeEECC--CCcEEEeeccCcccccccCCcceeecccCccc---cCcccccc--
Q 042831 470 --------------WEQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGY---MAPECATT-- 528 (645)
Q Consensus 470 --------------~~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-- 528 (645)
....++|+|+++.||++++ ...+.|.||+.+...+.... ......+ ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHHH
Confidence 0135899999999999988 55688999999865432110 0000011 12221110
Q ss_pred ---CCC---------CcchhHHHHHHHHHHHHcCCCCC
Q 042831 529 ---GKA---------SKESDVYSFGIVALEIACGRKPI 554 (645)
Q Consensus 529 ---~~~---------t~~sDV~SfGvll~elltG~~pf 554 (645)
+.. ..-.+.|+++.+++++.+|+.+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12268999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.4e-06 Score=85.77 Aligned_cols=136 Identities=16% Similarity=0.133 Sum_probs=99.2
Q ss_pred ccCcCCcE-EEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeEEEEEEecCCCCh
Q 042831 359 KLGQGGFG-GVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGSL 436 (645)
Q Consensus 359 ~LG~G~fG-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL 436 (645)
.+..|..| .||+.....++..+.+|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445555 6899887766778899986432 3456788999998885 33467889999999999999999999888
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 042831 437 DSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW---------------------------------------------- 470 (645)
Q Consensus 437 ~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 470 (645)
.+..... ......+..+++..|.-||...
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7654321 1233456667777777777410
Q ss_pred ---------CCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 471 ---------EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 471 ---------~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
...++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11389999999999999877777999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=6.6e-06 Score=84.44 Aligned_cols=137 Identities=19% Similarity=0.189 Sum_probs=96.9
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCC---CccEEEeeee-eCCeEEEEEEecC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHR---NLVQLLGWCH-EKKELLLVYEFMP 432 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nlv~l~~~~~-~~~~~~lV~Ey~~ 432 (645)
.+.++.|....||+. +..+++|... .......+.+|.++|..+++. .+.+.+.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788888999988 3457888753 233456788999999999753 3566777764 4456789999999
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE------------------------------------------- 469 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 469 (645)
|.+|..... ..++...+..++.++++.|..||+.
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988865321 1235555666666666666666642
Q ss_pred --------------cCCCeeeccCCCCCeEECC---CCc-EEEeeccCcccc
Q 042831 470 --------------WEQCVVHRDIKSSNIMLDS---NFN-AKIGDFGLARLV 503 (645)
Q Consensus 470 --------------~~~~ivH~Dlkp~NILld~---~~~-~kl~DfGla~~~ 503 (645)
....++|+|+++.||+++. ++. +.|.||+.+...
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 455 589999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=6e-06 Score=86.50 Aligned_cols=82 Identities=4% Similarity=-0.021 Sum_probs=56.3
Q ss_pred CCcc-CcCCcEEEEEEEEc--C----CCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCC---CCccEEEeeeeeC--
Q 042831 357 DQKL-GQGGFGGVYKGFFR--E----TNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRH---RNLVQLLGWCHEK-- 421 (645)
Q Consensus 357 ~~~L-G~G~fG~Vy~g~~~--~----~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~nlv~l~~~~~~~-- 421 (645)
.+.| +.|....+|+.... . ++..+++|...... ......+.+|+.++..++. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 1 15678888764322 0012456788888888752 3567788887665
Q ss_pred -CeEEEEEEecCCCChhh
Q 042831 422 -KELLLVYEFMPNGSLDS 438 (645)
Q Consensus 422 -~~~~lV~Ey~~~gsL~~ 438 (645)
+..++||||+++..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-05 Score=84.18 Aligned_cols=76 Identities=16% Similarity=0.178 Sum_probs=49.7
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh-------hhHHHHHHHHHHHHhcCC--CC-ccEEEeeeeeCCeEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK-------QGIKEYASEVKIISRLRH--RN-LVQLLGWCHEKKELLL 426 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-lv~l~~~~~~~~~~~l 426 (645)
.+.||.|..+.||++....+++.++||......+ .....+..|.+++..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4679999999999998765577899997643211 123456778888888742 33 4455544 3445689
Q ss_pred EEEecCCC
Q 042831 427 VYEFMPNG 434 (645)
Q Consensus 427 V~Ey~~~g 434 (645)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.0002 Score=73.87 Aligned_cols=139 Identities=16% Similarity=0.202 Sum_probs=80.4
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCccEEEe------eeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH--RNLVQLLG------WCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~------~~~~~~~~~lV~ 428 (645)
.+.|+.|..+.||+.... +..+++|+.... . .++..|..++..|.. -.+.+++. +....+..+++|
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 345666778899998764 345889988652 2 233345555555431 12333332 123466789999
Q ss_pred EecCCCChh--------------hhhhh--cC-----------CCCCHHHHH----------------------------
Q 042831 429 EFMPNGSLD--------------SHLFK--EN-----------SLLTWEFRY---------------------------- 453 (645)
Q Consensus 429 Ey~~~gsL~--------------~~l~~--~~-----------~~l~~~~~~---------------------------- 453 (645)
||++|..+. ..++. .. ....|...+
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999987653 11121 10 011332211
Q ss_pred ---HHHHHHHHHHHHHHh----------hcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 454 ---KIAQDLASGLLYLQE----------EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 454 ---~i~~~ia~gL~yLH~----------~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666663 135789999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00043 Score=70.95 Aligned_cols=137 Identities=12% Similarity=0.114 Sum_probs=91.6
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCccEEEeeeeeCCeEEEEEEecC
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR---HRNLVQLLGWCHEKKELLLVYEFMP 432 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nlv~l~~~~~~~~~~~lV~Ey~~ 432 (645)
..+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3567899999999998753 567888987533 3467888999998884 3567888999888889999999999
Q ss_pred CCChhh-----------hhhhcCC---------------------CCCHHHHH---HHHH----------------HHHH
Q 042831 433 NGSLDS-----------HLFKENS---------------------LLTWEFRY---KIAQ----------------DLAS 461 (645)
Q Consensus 433 ~gsL~~-----------~l~~~~~---------------------~l~~~~~~---~i~~----------------~ia~ 461 (645)
+..+.. .|+.... .-+|.... ++.. .+..
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 887531 1222111 12454322 1111 1111
Q ss_pred HH-HHHHh-hcCCCeeeccCCCCCeEECCCCcEEEeecc
Q 042831 462 GL-LYLQE-EWEQCVVHRDIKSSNIMLDSNFNAKIGDFG 498 (645)
Q Consensus 462 gL-~yLH~-~~~~~ivH~Dlkp~NILld~~~~~kl~DfG 498 (645)
-+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11 22321 1246799999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00017 Score=77.26 Aligned_cols=80 Identities=10% Similarity=0.084 Sum_probs=48.7
Q ss_pred CCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcceeecccCccccCccccccC---CCCcchhHHHHHHHHHHH
Q 042831 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG---KASKESDVYSFGIVALEI 547 (645)
Q Consensus 471 ~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDV~SfGvll~el 547 (645)
...++|+|+++.|||++.++ ++|.||+.+..-.....-......-...|.+|+..... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998876 99999998875432111000000011345666654321 112235566778888887
Q ss_pred HcCC
Q 042831 548 ACGR 551 (645)
Q Consensus 548 ltG~ 551 (645)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00058 Score=69.00 Aligned_cols=80 Identities=14% Similarity=0.165 Sum_probs=57.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC---CCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH---RNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nlv~l~~~~~~~~~~~lV~E 429 (645)
.....+.+|.|..+.||+....+ |+.+.+|+...........|..|+..|+.|.. --+.+++++. .-++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34556789999999999999864 78899998765544444568889999998852 2345555543 2378999
Q ss_pred ecCCCChh
Q 042831 430 FMPNGSLD 437 (645)
Q Consensus 430 y~~~gsL~ 437 (645)
|++.+...
T Consensus 91 ~l~~~~~~ 98 (288)
T 3f7w_A 91 WVDERPPT 98 (288)
T ss_dssp CCCCCCCC
T ss_pred eecccCCC
Confidence 99876543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0018 Score=66.23 Aligned_cols=155 Identities=12% Similarity=0.152 Sum_probs=86.0
Q ss_pred ChHHHHHhhcCCCC-----CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEE
Q 042831 343 PYKELALATNDFND-----DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLL 415 (645)
Q Consensus 343 ~~~el~~~~~~f~~-----~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~ 415 (645)
+.+++......|.. .+.|+.|....+|+....+ | .+++|...... ...++..|+.++..++..+ +.+++
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 33444444444443 3456778889999987653 3 57889876521 1234556777777664222 23333
Q ss_pred ee------eeeCCeEEEEEEecCCCChhh--------------hhhhc--C---C---C---CCHHHHHH----------
Q 042831 416 GW------CHEKKELLLVYEFMPNGSLDS--------------HLFKE--N---S---L---LTWEFRYK---------- 454 (645)
Q Consensus 416 ~~------~~~~~~~~lV~Ey~~~gsL~~--------------~l~~~--~---~---~---l~~~~~~~---------- 454 (645)
.. ....+..+++++|++|..+.. .++.. . . . ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999998865431 11211 0 0 0 11322111
Q ss_pred --HHHHHHHHHHHHHhhc----CCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 455 --IAQDLASGLLYLQEEW----EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 455 --i~~~ia~gL~yLH~~~----~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+...+.+.+.+++..+ ..+++|+|+.+.|||++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112444566665432 3579999999999999887666899998775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0025 Score=67.03 Aligned_cols=141 Identities=15% Similarity=0.139 Sum_probs=84.5
Q ss_pred CCccCcCCcEEEEEEEEcC-------CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCccEEEeeeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRE-------TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nlv~l~~~~~~~~~~~lV~ 428 (645)
.+.|..|-...+|+....+ ++..+.+|+.... ........+|..+++.+.. .-..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3467778888899988742 3467889986332 2234566789999988853 223566666654 2899
Q ss_pred EecCCCChhhh-----------------hhhc----CCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 042831 429 EFMPNGSLDSH-----------------LFKE----NSLLT--WEFRYKIAQDLAS-------------------GLLYL 466 (645)
Q Consensus 429 Ey~~~gsL~~~-----------------l~~~----~~~l~--~~~~~~i~~~ia~-------------------gL~yL 466 (645)
||+++.+|... |+.. .+... |.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998666421 1111 11122 4455555544322 23344
Q ss_pred Hhh-----cCCCeeeccCCCCCeEECCC----CcEEEeeccCccc
Q 042831 467 QEE-----WEQCVVHRDIKSSNIMLDSN----FNAKIGDFGLARL 502 (645)
Q Consensus 467 H~~-----~~~~ivH~Dlkp~NILld~~----~~~kl~DfGla~~ 502 (645)
... ....++|+|+.+.||+++.+ +.+.+.||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 23469999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0018 Score=69.53 Aligned_cols=74 Identities=16% Similarity=0.178 Sum_probs=50.3
Q ss_pred CCccCcCCcEEEEEEEEcC-------CCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRE-------TNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~ 428 (645)
.+.|+.|-...+|+....+ ++..+.+|+..... ....+.+|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 24678899874321 11455679998888853334 567766543 2899
Q ss_pred EecCCCCh
Q 042831 429 EFMPNGSL 436 (645)
Q Consensus 429 Ey~~~gsL 436 (645)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986454
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00097 Score=67.79 Aligned_cols=136 Identities=11% Similarity=0.124 Sum_probs=74.6
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEEEec-CCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVYEFM-PNG 434 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~Ey~-~~g 434 (645)
.+.|+.|....+|+. ..+++|+....... ..+..+|+.++..+...++ .++++.+. +.-++++||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 677889999999998 33788887543221 1123467777777653233 45555443 3347899999 655
Q ss_pred Chhhh------------------hhhcCCCC----C-HHHHHHHHH--------------HHHHHHHHHHh-----hcCC
Q 042831 435 SLDSH------------------LFKENSLL----T-WEFRYKIAQ--------------DLASGLLYLQE-----EWEQ 472 (645)
Q Consensus 435 sL~~~------------------l~~~~~~l----~-~~~~~~i~~--------------~ia~gL~yLH~-----~~~~ 472 (645)
+|... ++.....+ . +........ .+...+..|.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 55321 01111101 1 111111110 01111111111 1234
Q ss_pred CeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 473 ~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.++|+|+.+.||+ ..++.+.+.||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5566789999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0063 Score=65.72 Aligned_cols=75 Identities=17% Similarity=0.089 Sum_probs=49.1
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEEEecCCCC
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.+.|+.|-...+|+....+.+..+++|+....... .-+-.+|..++..|...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 45688888899999988654578889987543211 1112478999998875555 46777663 2 25999998755
Q ss_pred h
Q 042831 436 L 436 (645)
Q Consensus 436 L 436 (645)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.011 Score=56.45 Aligned_cols=101 Identities=15% Similarity=0.057 Sum_probs=67.4
Q ss_pred CCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCccee
Q 042831 433 NGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTT 512 (645)
Q Consensus 433 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~~ 512 (645)
.-||.+.|...+.++++++.|.++.|.+.+|.-+-. +..-..+=+.|..|++..+|++...+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 347889998888999999999999999998776521 01111233456899999999988764 1110
Q ss_pred ecccCccccCccccccCCCCcchhHHHHHHHHHHHHcC
Q 042831 513 VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACG 550 (645)
Q Consensus 513 ~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG 550 (645)
.....+.+||... ...+.+.-|||+|++||.-+-=
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1122356888653 3567889999999999999863
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.012 Score=60.48 Aligned_cols=140 Identities=16% Similarity=0.109 Sum_probs=71.4
Q ss_pred CCccCcCCcEE-EEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCccEEEeeeeeCCeEEEEEEecCC
Q 042831 357 DQKLGQGGFGG-VYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH--RNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 357 ~~~LG~G~fG~-Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
.+.|+.|+... +|+.... ++..+++|....... .++..|+.++..+.. -.+.+++.+..+.+ +++||++++
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 34566665554 6676542 245677775433211 233456676666642 23556776654444 789999977
Q ss_pred CChhhhhhh---------------------cC----CCCCHHHHH-------H-------------HHHHHHHHHHHHHh
Q 042831 434 GSLDSHLFK---------------------EN----SLLTWEFRY-------K-------------IAQDLASGLLYLQE 468 (645)
Q Consensus 434 gsL~~~l~~---------------------~~----~~l~~~~~~-------~-------------i~~~ia~gL~yLH~ 468 (645)
..+.+++.. .. ...+..... . ....+...+..+..
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 666433211 00 011111000 0 00111122222311
Q ss_pred ---hcCCCeeeccCCCCCeEECCC----CcEEEeeccCccc
Q 042831 469 ---EWEQCVVHRDIKSSNIMLDSN----FNAKIGDFGLARL 502 (645)
Q Consensus 469 ---~~~~~ivH~Dlkp~NILld~~----~~~kl~DfGla~~ 502 (645)
.....++|+|+.+.|||++.+ ..+.|.||+.+..
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 124679999999999999874 6899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0079 Score=61.56 Aligned_cols=140 Identities=11% Similarity=0.099 Sum_probs=80.3
Q ss_pred CccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--ccEEEee-----eeeCCeEEEEEEe
Q 042831 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN--LVQLLGW-----CHEKKELLLVYEF 430 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--lv~l~~~-----~~~~~~~~lV~Ey 430 (645)
..++ |....||+.... +|+.+++|...... .....+..|..++..+.... +++++.. ....+..+++|||
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3466 777899987654 35578999886331 12345667888887774222 3444432 2234567889999
Q ss_pred cCCCChhh----h----------hhh--c------CCCCCHHHH----HHH---------------HHHHHHHHHHHHhh
Q 042831 431 MPNGSLDS----H----------LFK--E------NSLLTWEFR----YKI---------------AQDLASGLLYLQEE 469 (645)
Q Consensus 431 ~~~gsL~~----~----------l~~--~------~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~ 469 (645)
+++..+.. . ++. . ....++... ..+ ...+...+..+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98765431 0 111 0 011222211 001 11111223333322
Q ss_pred ----cCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 470 ----WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 470 ----~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
....++|+|+++.|||++ + .+.|.||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 245689999999999999 4 899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0097 Score=62.19 Aligned_cols=75 Identities=12% Similarity=0.117 Sum_probs=44.4
Q ss_pred CCccCcCCcEEEEEEEEcCC--------CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-ccEEEeeeeeCCeEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRET--------NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN-LVQLLGWCHEKKELLLV 427 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-lv~l~~~~~~~~~~~lV 427 (645)
.+.|+.|..-.+|+....+. +..+++|+...... ...+...|..++..+...+ ..++++.. .+ ++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 34677788889999987531 25788887654322 1123357888888775334 34666543 22 689
Q ss_pred EEecCCCCh
Q 042831 428 YEFMPNGSL 436 (645)
Q Consensus 428 ~Ey~~~gsL 436 (645)
|||+++..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.096 Score=53.93 Aligned_cols=32 Identities=22% Similarity=0.346 Sum_probs=28.2
Q ss_pred CCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 471 ~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
...++|+|+.+.||++++++.+.|.||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.65 E-value=0.18 Score=53.59 Aligned_cols=140 Identities=12% Similarity=0.177 Sum_probs=83.8
Q ss_pred CCccCcCCcEEEEEEEEcCC-------CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-ccEEEeeeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRET-------NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN-LVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-lv~l~~~~~~~~~~~lV~ 428 (645)
.+.+..|-...+|+....+. +..+++|+...... ..-+-.+|..++..+...+ ..++++.+. + ++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence 45677788889999987531 46788888644322 1122356888888775322 345565332 2 7899
Q ss_pred EecCCCChhhh-----------------hhh--c---------CC-CCCHHHHHHHHHHH-------------------H
Q 042831 429 EFMPNGSLDSH-----------------LFK--E---------NS-LLTWEFRYKIAQDL-------------------A 460 (645)
Q Consensus 429 Ey~~~gsL~~~-----------------l~~--~---------~~-~l~~~~~~~i~~~i-------------------a 460 (645)
||+++.+|... ++. . .. ..-|.+..++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765310 110 0 11 11244444433322 2
Q ss_pred HHHHHHHhh---------------------cCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 461 SGLLYLQEE---------------------WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 461 ~gL~yLH~~---------------------~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
..+.+|.+. ....++|+|+.+.||+ +.++.+.+.||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233444321 1246899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.35 E-value=0.57 Score=49.29 Aligned_cols=30 Identities=23% Similarity=0.378 Sum_probs=25.4
Q ss_pred CeeeccCCCCCeEE------CCCCcEEEeeccCccc
Q 042831 473 CVVHRDIKSSNIML------DSNFNAKIGDFGLARL 502 (645)
Q Consensus 473 ~ivH~Dlkp~NILl------d~~~~~kl~DfGla~~ 502 (645)
.++|+|+.+.|||+ +++..+.+.||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.47 E-value=0.1 Score=56.35 Aligned_cols=61 Identities=5% Similarity=0.046 Sum_probs=17.3
Q ss_pred CCCccCcCCcEEEEEEEEcCCCeEEEE------EEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeee
Q 042831 356 DDQKLGQGGFGGVYKGFFRETNSYIAV------KRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCH 419 (645)
Q Consensus 356 ~~~~LG~G~fG~Vy~g~~~~~~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~ 419 (645)
..++|| ||.||+|.+.....+||+ |..... +++....+.+|..++..++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 999999999765567888 766542 3344567889999999999999999877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.56 E-value=2.8 Score=39.72 Aligned_cols=116 Identities=6% Similarity=0.034 Sum_probs=78.9
Q ss_pred CCCCccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 407 RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 407 ~H~nlv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
.||++++. .+-..++.+.+.|+.-+++ ..+- .-..++...+++++..|+....+++. =+|--|.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~--~~f~--~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNH--TPFD--NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTS--EEGG--GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCccc--CCHH--HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 58888876 4555666666666654322 2222 12357888999999999877755553 4678899999999
Q ss_pred CCCCcEEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPIN 555 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~ 555 (645)
|.++.+++.-.|+... ++|. ..+...=.-.+=|++..+++++..|+
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999986665422 2232 22223334468889999999998885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 645 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 3e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 2e-51 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 2e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-50 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 3e-50 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 8e-50 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 1e-49 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-49 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 4e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-48 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-48 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-47 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 3e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-46 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-46 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 2e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-46 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 3e-46 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-46 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 7e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-45 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 5e-45 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 5e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-44 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 4e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 2e-30 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 3e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-18 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 1e-09 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 3e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 1e-71
Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVK--RVSQGSKQGIKEYASEVKIISRLRHR 409
Q++G G FG VYKG + +AVK V+ + Q ++ + +EV ++ + RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
N++ +G+ + L +V ++ SL HL + IA+ A G+ YL
Sbjct: 65 NILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL--- 120
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATT 528
+ ++HRD+KS+NI L + KIGDFGLA + GS Q L+G++ +MAPE
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 529 ---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585
S +SDVY+FGIV E+ G+ P + ++ + + G G L D
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSP--DLS 232
Query: 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL-NFEAPLP 630
R + ++RLM C + RP Q++ + LP
Sbjct: 233 KVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-68
Identities = 68/272 (25%), Positives = 127/272 (46%), Gaps = 20/272 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
++ Q++G G FG V+ G++ + A+K + + +++ E +++ +L H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE-GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
VQL G C E+ + LV+EFM +G L +L + L E + D+ G+ YL E
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EE 119
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
CV+HRD+ + N ++ N K+ DFG+ R V + + +T + + +PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591
S +SDV+SFG++ E+ K P + +++ + PRL
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKI--PYENRSNSEVVEDI------STGFRLYKPRLA---- 227
Query: 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+ ++M C RP+ +++ L
Sbjct: 228 STHVYQIM---NHCWKERPEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 1e-67
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 7/212 (3%)
Query: 347 LALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISR 405
+ L +DF +LG G G V+K + + +A K + K I+ E++++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
+V G + E+ + E M GSLD L K+ + + K++ + GL Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTY 119
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
L+E+ ++HRD+K SNI+++S K+ DFG++ + S GT YM+PE
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPER 174
Query: 526 ATTGKASKESDVYSFGIVALEIACGRKPINPK 557
S +SD++S G+ +E+A GR PI P
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 217 bits (554), Expect = 2e-66
Identities = 77/301 (25%), Positives = 137/301 (45%), Gaps = 37/301 (12%)
Query: 342 FPYKELALATNDFND---------DQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG- 388
F +++ A +F +Q +G G FG V G + ++A+K + G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 389 SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLT 448
+++ +++ SE I+ + H N++ L G + ++++ EFM NGSLDS L + + T
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 449 WEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508
+ + +A+G+ YL + VHRD+ + NI+++SN K+ DFGL+R +E
Sbjct: 127 VIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 509 SQTTVLA----GTMGYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQV 563
T A + + APE K + SDV+S+GIV E+ + G +P
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 564 SLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+ N ++ A++ L + L C D N RP Q+++ L
Sbjct: 234 ------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 624 N 624
+
Sbjct: 288 D 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (549), Expect = 9e-66
Identities = 69/286 (24%), Positives = 130/286 (45%), Gaps = 20/286 (6%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS 398
P Y + + D KLG G +G VY+G +++ + +AVK + + + + ++E+
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62
Query: 399 EVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQ 457
E ++ ++H NLVQLLG C + ++ EFM G+L +L + N ++ +A
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 458 DLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGT 517
++S + YL ++ +HRD+ + N ++ N K+ DFGL+RL+ +
Sbjct: 123 QISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 518 MGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577
+ + APE K S +SDV++FG++ EIA P Q
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------------- 224
Query: 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+ E ++ + E++ + C + + RPS ++
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 65/275 (23%), Positives = 129/275 (46%), Gaps = 23/275 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
D ++LG G FG V G +R +A+K + +GS E+ E K++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
VQL G C +++ + ++ E+M NG L ++L + + ++ +D+ + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ES 118
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA 531
+ +HRD+ + N +++ K+ DFGL+R V + + + + + PE K
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 532 SKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590
S +SD+++FG++ EI + G+ P ++ + N + E + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMP----------------YERFTNSETAEHIAQGLRLYR 222
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVI-HVLN 624
E++ + C H + RP+ + ++ ++L+
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-63
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 22/273 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
++LG G FG V+ G++ ++ +AVK + QGS + +E ++ +L+H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRL 70
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL-LTWEFRYKIAQDLASGLLYLQEEW 470
V+L ++ + ++ E+M NGSL L + + LT +A +A G+ ++
Sbjct: 71 VRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
E+ +HRD++++NI++ + KI DFGLARL+E + + + + APE G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590
+ +SDV+SFGI+ EI + P +V +Q + Y V P C
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--IQNLERGY------RMVRPDNC--- 235
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
E L + C RP+ + VL
Sbjct: 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 2e-63
Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 27/287 (9%)
Query: 345 KELALATNDFN-DDQKLGQGGFGGVYKGFFRETNS--YIAVKRVSQGSKQG-IKEYASEV 400
K+L L ++ D +LG G FG V +G +R +A+K + QG+++ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 401 KIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLA 460
+I+ +L + +V+L+G C + + L+LV E G L L + + ++ ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 461 SGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTM 518
G+ YL E+ VHRD+ + N++L + AKI DFGL++ + + + + + +
Sbjct: 120 MGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGK 577
+ APEC K S SDV+S+G+ E + G+KP + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----------------YKKMKGPE 220
Query: 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ ++ + + L + C RP V +
Sbjct: 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-63
Identities = 69/290 (23%), Positives = 121/290 (41%), Gaps = 28/290 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+ +G+G FG V++G + +AVK S ++ A E+ LRH N++ +
Sbjct: 9 ESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA-EIYQTVMLRHENILGFIAA 65
Query: 418 CHEK----KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC 473
++ +L LV ++ +GSL +L + +T E K+A ASGL +L E
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 474 -----VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS---QTTVLAGTMGYMAPEC 525
+ HRD+KS NI++ N I D GLA + A + GT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 526 ATT------GKASKESDVYSFGIVALEIACGRKPINP----KAPQGQVSLLQWVWDLYGN 575
++ K +D+Y+ G+V EIA + P + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 576 GKLLEAVDPRLCRDFDGQQIERLMI-VGLWCAHPDENLRPSIRQVIHVLN 624
+ + P + + + R+M + C + + R + ++ L+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 3e-62
Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 26/277 (9%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRN 410
D+ +G G +G K + + K + GS + + SEV ++ L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 411 LVQLLGWCHEKKE--LLLVYEFMPNGSLDSHLF---KENSLLTWEFRYKIAQDLASGLLY 465
+V+ ++ L +V E+ G L S + KE L EF ++ L L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 466 L--QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
+ + V+HRD+K +N+ LD N K+GDFGLAR++ H S GT YM+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583
E +++SD++S G + E+ P + + K+ E
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------KIREGKF 231
Query: 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
R+ + ++ ++ + + RPS+ +++
Sbjct: 232 RRIPYRYS-DELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-62
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 24/286 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+ KLGQG FG V+ G + T +A+K + + + E +++ +LRH L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENS-LLTWEFRYKIAQDLASGLLYLQEEW 470
VQL ++ + +V E+M GSL L E L +A +ASG+ Y++
Sbjct: 75 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
VHRD++++NI++ N K+ DFGLARL+E + + + + APE A G+
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590
+ +SDV+SFGI+ E+ + P +V L+ V+
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMPC 235
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN--FEAPLPALPP 634
+ E L + C + RP+ + L F + P P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-62
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 26/278 (9%)
Query: 355 NDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQGSKQG-IKEYASEVKIISRLRHRN 410
+ ++ +G+G FG VY G + + + AVK +++ + G + ++ +E I+ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 411 LVQLLGWCHE-KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
++ LLG C + L+V +M +G L + + E T + +A G+ +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFL 146
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ---TTVLAGTMGYMAPECA 526
+ VHRD+ + N MLD F K+ DFGLAR + + T + +MA E
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586
T K + +SDV+SFG++ E+ P P V+ L +LL P
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL---QPEY 258
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
C + L V L C HP +RPS +++ ++
Sbjct: 259 C-------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 66/289 (22%), Positives = 132/289 (45%), Gaps = 25/289 (8%)
Query: 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQGSKQG-IKEYASEVKII 403
+ + + +G G FG VYKG + ++ +A+K + G + ++ E I+
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63
Query: 404 SRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
+ H N+++L G + K ++++ E+M NG+LD L +++ + + + +A+G+
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH--AKGSQTTVLAGTMGYM 521
Y VHRD+ + NI+++SN K+ DFGL+R++E T+ + +
Sbjct: 124 KY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
APE + K + SDV+SFGIV E+ + W+L N ++++A
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELS-NHEVMKA 225
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630
++ + + + C + RP ++ +L+ P
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (520), Expect = 3e-61
Identities = 63/273 (23%), Positives = 108/273 (39%), Gaps = 30/273 (10%)
Query: 354 FNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG---IKEYASEVKIISRLRHRN 410
F+D +++G G FG VY + +A+K++S KQ ++ EV+ + +LRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+Q G + LV E+ + D + L + GL YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE---CAT 527
++HRD+K+ NI+L K+GDFG A ++ + GT +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAMD 187
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
G+ + DV+S GI +E+A + P+ + + + P L
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPALQ 235
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ + C RP+ ++
Sbjct: 236 SGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 62/269 (23%), Positives = 118/269 (43%), Gaps = 23/269 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+LG G FG VYK +ET+ A K + S++ +++Y E+ I++ H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+ + L ++ EF G++D+ + + LT + + L YL + ++HR
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 478 DIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA-----S 532
D+K+ NI+ + + K+ DFG++ + GT +MAPE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 533 KESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDG 592
++DV+S GI +E+A P + P + K+ ++ P L +
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLL------------KIAKSEPPTLAQPSRW 241
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+ + + D R + Q++
Sbjct: 242 SSNFKDFLKKCLEKNVDA--RWTTSQLLQ 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 203 bits (518), Expect = 2e-60
Identities = 66/293 (22%), Positives = 125/293 (42%), Gaps = 21/293 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+ ++ ++LG G FG V++ R T + A K V + + E++ +S LRH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V L + E++++YEFM G L + E++ ++ + + + + GL ++ E
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM---HE 142
Query: 472 QCVVHRDIKSSNIMLDSNFN--AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
VH D+K NIM + + K+ DFGL ++ + + T GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
+D++S G+++ + G P + + + + + ++ + D
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISED 255
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVI-HVLNFEAPLPALPPKMPVPTY 641
+ I L A P+ R +I Q + H P ++P Y
Sbjct: 256 G------KDFIRKLLLADPNT--RMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-60
Identities = 79/305 (25%), Positives = 133/305 (43%), Gaps = 43/305 (14%)
Query: 339 PKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSY--IAVKRVSQ-GSKQGIKE 395
P +P + ND +G+G FG V K ++ A+KR+ + SK ++
Sbjct: 1 PTIYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 396 YASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL-------- 446
+A E++++ +L H N++ LLG C + L L E+ P+G+L L K L
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 447 -------LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499
L+ + A D+A G+ YL ++ +HRD+ + NI++ N+ AKI DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAP 559
+R E + T+ + +MA E + SDV+S+G++ EI P
Sbjct: 174 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----P 226
Query: 560 QGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
++ + KL + + D ++ LM C RPS Q+
Sbjct: 227 YCGMTCAELYE------KLPQGYRLEKPLNCD-DEVYDLM---RQCWREKPYERPSFAQI 276
Query: 620 IHVLN 624
+ LN
Sbjct: 277 LVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-60
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 27/272 (9%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVS--QGSKQGIKEYASEVKIISRLRHRNLVQL 414
D ++G+G F VYKG ET +A + + +K + + E +++ L+H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 415 LGWCHE----KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
KK ++LV E M +G+L ++L + + + + + GL +L
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 471 EQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
++HRD+K NI + + KIGD GLA L S + GT +MAPE
Sbjct: 133 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY-EE 187
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
K + DVY+FG+ LE+A P + Q+ ++ V P
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-----------RVTSGVKPASFDK 236
Query: 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+++ ++ C +++ R SI+ +++
Sbjct: 237 VAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-60
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 27/272 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH 408
DF + LG+G FG VY +++ +A+K + + + EV+I S LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
N+++L G+ H+ + L+ E+ P G++ L K + + +LA+ L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC-- 122
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ V+HRDIK N++L S KI DFG + HA S+ T L GT+ Y+ PE
Sbjct: 123 -HSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
++ D++S G++ E G+ P Q + + V R
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SRVEFTFPDFVTEG-AR 232
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
D I L +P + RP +R+V+
Sbjct: 233 DL---------ISRLLKHNPSQ--RPMLREVL 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-60
Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL 411
+ Q +G+G FG V G + +AVK + + + + +E ++++LRH NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 62
Query: 412 VQLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKEN-SLLTWEFRYKIAQDLASGLLYLQEE 469
VQLLG E+K L +V E+M GSL +L S+L + K + D+ + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--- 119
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
VHRD+ + N+++ + AK+ DFGL + S + + APE
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEALREK 175
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD--PRLC 587
K S +SDV+SFGI+ EI + P+ P L+ V G ++A D P
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGYKMDAPDGCPPAV 229
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
+ C H D +RPS Q+ L
Sbjct: 230 YEV-----------MKNCWHLDAAMRPSFLQLREQL 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 9e-60
Identities = 64/301 (21%), Positives = 126/301 (41%), Gaps = 27/301 (8%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSY----IAVKRVSQG-SKQGIKEYASEVKIISRLR 407
+F + LG G FG VYKG + +A+K + + S + KE E +++ +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
+ ++ +LLG C + L+ + MP G L ++ + + ++ +A G+ YL
Sbjct: 70 NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 127
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECA 526
++ +VHRD+ + N+++ + + KI DFGLA+L+ K + +MA E
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586
+ +SDV+S+G+ E+ +D ++ ++
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGE 230
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA--PLPALPPKMPVPTYLSP 644
+ ++ + C D + RP R++I + A P L + +L
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPS 290
Query: 645 P 645
P
Sbjct: 291 P 291
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 67/289 (23%), Positives = 124/289 (42%), Gaps = 22/289 (7%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN 410
+ +K+GQG G VY T +A+++++ + + +E+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V L EL +V E++ GSL + + + ++ L +L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGK 530
V+HRDIKS NI+L + + K+ DFG + + S+ + + GT +MAPE T
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 531 ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590
+ D++S GI+A+E+ G P + P L + + E + + RDF
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNGTPELQNPEKLSA-IFRDF 249
Query: 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIH--VLNFEAPLPALPPKMP 637
+ R + D R S ++++ L PL +L P +
Sbjct: 250 ----LNRCL-------DMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-58
Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 356 DDQKLGQGGFGGVYKGFFR--ETNSYIAVKRVSQGSKQG--IKEYASEVKIISRLRHRNL 411
+D++LG G FG V KG+++ + +AVK + + E +E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 412 VQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWE 471
V+++G C E + +LV E G L+ +L + + + ++ ++ G+ YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV-KDKNIIELVHQVSMGMKYL---EE 125
Query: 472 QCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPECATTG 529
VHRD+ + N++L + AKI DFGL++ + + T + + APEC
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 530 KASKESDVYSFGIVALEI-ACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
K S +SDV+SFG++ E + G+KP + ++ ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGERM 229
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ + C D RP V L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 4e-58
Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 48/310 (15%)
Query: 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVS-QGSKQGIKEYA 397
L N+ + +G+G FG V++ E + +AVK + + S ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 398 SEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSL----------- 446
E +++ + N+V+LLG C K + L++E+M G L+ L +
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 447 ------------LTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKI 494
L+ + IA+ +A+G+ YL E+ VHRD+ + N ++ N KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKI 181
Query: 495 GDFGLARLVEHAKGSQ-TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKP 553
DFGL+R + A + A + +M PE + + ESDV+++G+V EI
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 554 INPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR 613
P ++ +V D G +L + L + C R
Sbjct: 242 --PYYGMAHEEVIYYVRD----GNILACPE---------NCPLELYNLMRLCWSKLPADR 286
Query: 614 PSIRQVIHVL 623
PS + +L
Sbjct: 287 PSFCSIHRIL 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-57
Identities = 65/271 (23%), Positives = 105/271 (38%), Gaps = 21/271 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHRN 410
D++ Q LG+G +G V R T +AVK V E E+ I L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V+ G E L E+ G L + + + + L +G++YL
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYL---H 120
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTG 529
+ HRDIK N++LD N KI DFGLA + + + + GT+ Y+APE
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 530 K-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
+ ++ DV+S GIV + G P + + Q + + +D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLNPWKKIDSA-PL 237
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ + +P R +I +
Sbjct: 238 AL---------LHKILVENPSA--RITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-57
Identities = 69/311 (22%), Positives = 118/311 (37%), Gaps = 43/311 (13%)
Query: 339 PKRFPY-KELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQG 392
P + PY + N + + LG G FG V + + +AVK + +
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 393 -IKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK-------- 442
+ SE+K++S L H N+V LLG C L++ E+ G L + L +
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 443 ---------ENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAK 493
+ L E + +A G+ +L + +HRD+ + NI+L K
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITK 185
Query: 494 IGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK 552
I DFGLAR +++ + +MAPE + ESDV+S+GI E+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 553 PINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENL 612
P P + K + + + + C D
Sbjct: 246 SPYPGMPV--------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 613 RPSIRQVIHVL 623
RP+ +Q++ ++
Sbjct: 292 RPTFKQIVQLI 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-57
Identities = 64/300 (21%), Positives = 119/300 (39%), Gaps = 36/300 (12%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHR 409
DF + LG+G F V T+ A+K + + + + E ++SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
V+L + ++L + NG L ++ K S R+ A+ + L+
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----IVSALEYL 124
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH-AKGSQTTVLAGTMGYMAPECATT 528
+ ++HRD+K NI+L+ + + +I DFG A+++ +K ++ GT Y++PE T
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
A K SD+++ G + ++ G P + + E P+ R
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----IKLEYDFPEKFFPK-AR 238
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHV-----------LNFEAPLPALPPKMP 637
D +E+L+ D R ++ + +E PPK+
Sbjct: 239 DL----VEKLL-------VLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 23/277 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSY---IAVKRVSQGSKQGIKE-YASEVKIISRLR 407
+ +G+G FG V++G + + +A+K + ++E + E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
H ++V+L+G E + ++ E G L S L L A L++ L YL
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL- 124
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ VHRDI + N+++ SN K+GDFGL+R +E + + + + +MAPE
Sbjct: 125 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
+ + SDV+ FG+ EI P V + ++ +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIG------RIENGERLPMP 231
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ + LM C D + RP ++ L+
Sbjct: 232 PNCP-PTLYSLM---TKCWAYDPSRRPRFTELKAQLS 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 75/344 (21%), Positives = 131/344 (38%), Gaps = 58/344 (16%)
Query: 312 RKRKEGDEEDNQGFSEYIDDEFERGAGPKRFPY-KELALATNDFNDDQKLGQGGFGGVYK 370
+ + DN+ F Y+D + + Y + + + LG G FG V
Sbjct: 6 QMVQVTGSSDNEYF--YVD--------FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMN 55
Query: 371 GFFRETNS-----YIAVKRVSQGSKQG-IKEYASEVKIISRL-RHRNLVQLLGWCHEKKE 423
+ +AVK + + + + SE+K++++L H N+V LLG C
Sbjct: 56 ATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115
Query: 424 LLLVYEFMPNGSLDSHLFKEN----------------------SLLTWEFRYKIAQDLAS 461
+ L++E+ G L ++L + ++LT+E A +A
Sbjct: 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR-LVEHAKGSQTTVLAGTMGY 520
G+ +L+ + VHRD+ + N+++ KI DFGLAR ++ + + +
Sbjct: 176 GMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKW 232
Query: 521 MAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580
MAPE G + +SDV+S+GI+ EI P P +
Sbjct: 233 MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--------------FYK 278
Query: 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ D E + I+ C D RPS + L
Sbjct: 279 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-55
Identities = 68/280 (24%), Positives = 109/280 (38%), Gaps = 26/280 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQ---GSKQGIKEYASEVKIISR 405
D +KLG G FG V +G + + +AVK + + + ++ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
L HRNL++L G + +V E P GSL L K + A +A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVE--HAKGSQTTVLAGTMGYMAP 523
L + +HRD+ + N++L + KIGDFGL R + + AP
Sbjct: 127 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583
E T S SD + FG+ E+ + P ++ Q + + G+ L
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLP--R 236
Query: 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVL 623
P C + + V + C RP+ + L
Sbjct: 237 PEDC-------PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 190 bits (484), Expect = 2e-55
Identities = 61/322 (18%), Positives = 129/322 (40%), Gaps = 28/322 (8%)
Query: 325 FSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKR 384
+ ++ +D +++ P+ K+ ++ + ++ ++LG G FG V++ + T K
Sbjct: 4 YDKFYEDIWKK-YVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 61
Query: 385 VSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKEN 444
++ +E+ I+++L H L+ L +K E++L+ EF+ G L + E+
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 445 SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA--KIGDFGLARL 502
++ + GL ++ E +VH DIK NIM ++ + KI DFGLA
Sbjct: 122 YKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178
Query: 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562
+ V T + APE +D+++ G++ + G P +
Sbjct: 179 LNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET 236
Query: 563 VSLLQWVWDLYGNGKLLEAVDPRL---CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619
+ + + + E + +DF I+ L+ + R ++
Sbjct: 237 LQNV-----KRCDWEFDEDAFSSVSPEAKDF----IKNLL-------QKEPRKRLTVHDA 280
Query: 620 IHVLNFEAPLPALPPKMPVPTY 641
+ + L ++P Y
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRY 302
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-52
Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 48/312 (15%)
Query: 328 YIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAV 382
Y+ DE+E +A ++LGQG FG VY+G + E + +A+
Sbjct: 10 YVPDEWE--------------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 55
Query: 383 KRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF 441
K V++ S + E+ +E ++ ++V+LLG + + L++ E M G L S+L
Sbjct: 56 KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 115
Query: 442 ---------KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492
+ + ++A ++A G+ YL VHRD+ + N M+ +F
Sbjct: 116 SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTV 172
Query: 493 KIGDFGLARLV-EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR 551
KIGDFG+ R + E + + +M+PE G + SDV+SFG+V EIA
Sbjct: 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 552 KPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDEN 611
+ + V G LL+ D + L + C +
Sbjct: 233 EQPYQGLSN------EQVLRFVMEGGLLDKPDNCP---------DMLFELMRMCWQYNPK 277
Query: 612 LRPSIRQVIHVL 623
+RPS ++I +
Sbjct: 278 MRPSFLEIISSI 289
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 177 bits (450), Expect = 3e-52
Identities = 90/239 (37%), Positives = 119/239 (49%), Gaps = 15/239 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL--PANRETAGRATYNQSMRLWDKAT 88
A ++FN+ SFS + I ++ SN IQL + GR Y +R+W AT
Sbjct: 1 AETVSFNFNSFSE-GNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSAT 59
Query: 89 GNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIP 148
GN+ F T FSF + ADG+ FF+AP+ ++IP GG D +
Sbjct: 60 GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT---KGAGH 116
Query: 149 FVAVEFDVYVNSW--DPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
FV VEFD Y NS DP HVGID+NSV S K V W + SG + + Y+SST L
Sbjct: 117 FVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW--NSVSGAVVKVTVIYDSSTKTL 174
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDF-AIFSIYSWEFNSSLE 264
SVA T ++ + VDL+ LPE V FGFS + + I I SW F S+L
Sbjct: 175 SVAVTNDNGDITT---IAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLI 230
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (455), Expect = 5e-52
Identities = 59/282 (20%), Positives = 114/282 (40%), Gaps = 23/282 (8%)
Query: 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKI 402
+K+ + ++ LG G F V + T +A+K +++ + +G + +E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 403 ISRLRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+ +++H N+V L L L+ + + G L + E T ++ +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDA 119
Query: 463 LLYLQEEWEQCVVHRDIKSSNIML---DSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMG 519
+ YL + +VHRD+K N++ D + I DFGL+++ + GS + GT G
Sbjct: 120 VKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPG 174
Query: 520 YMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579
Y+APE SK D +S G++A + CG P + + L +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFD 229
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+ + I L P++ R + Q +
Sbjct: 230 SPYWDDISDSA------KDFIRHLMEKDPEK--RFTCEQALQ 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 6e-52
Identities = 68/298 (22%), Positives = 130/298 (43%), Gaps = 43/298 (14%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETN-------SYIAVKRV-SQGSKQGIKEYASEVKII 403
+ + LG+G FG V + + +AVK + S +++ + + SE++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 404 SRL-RHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLF---------------KENSLL 447
+ +H+N++ LLG C + L ++ E+ G+L +L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 448 TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507
+ + A +A G+ YL + +HRD+ + N+++ + KI DFGLAR + H
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 508 GSQTT-VLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
+ T + +MAPE + +SDV+SFG++ EI P P +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243
Query: 567 QWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ ++ L G ++ P C L ++ C H + RP+ +Q++ L+
Sbjct: 244 EELFKLLKEGHRMD--KPSNC-------TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 176 bits (446), Expect = 2e-51
Identities = 80/242 (33%), Positives = 125/242 (51%), Gaps = 18/242 (7%)
Query: 34 ALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLWDK 86
+++F + +F +D+I ++ + +QL + +AGRA Y+ ++LWD
Sbjct: 1 SVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDN 60
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
T ++ F T F+F + + ADGLAFFLAP S + G GL + S
Sbjct: 61 KTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKD--AGEYLGLFNKSTATQPS 117
Query: 147 I-PFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSW-WSDVKSGRRNEAWISYNSS 202
VAVEFD + N +P++ H+GI++NS+ S W SD+ SG+ A ISY+ S
Sbjct: 118 KNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDGS 177
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD-FAIFSIYSWEFNS 261
L+V + + + L + VD+RQ+LPE V G S +TG + F I SW F+S
Sbjct: 178 AEILTVVLSYPDGSDYI---LSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSS 234
Query: 262 SL 263
+L
Sbjct: 235 NL 236
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 175 bits (445), Expect = 2e-51
Identities = 89/243 (36%), Positives = 128/243 (52%), Gaps = 16/243 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-PANRET---AGRATYNQSMRLWDKA 87
+ L+FN+ F P + I A + V+Q+ ++ T GRA Y +++WD
Sbjct: 1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSI 60
Query: 88 TGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSI 147
TG + F T FSFV+ + S DGLAFFLAP S+IP+ G FGL ++ SS
Sbjct: 61 TGKVASFATSFSFVVKADKSDG-VDGLAFFLAPANSQIPSGSSAGMFGLFSSSDS-KSSN 118
Query: 148 PFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
+AVEFD Y WDP F H+GID+NS+KS K V W D ++G + I+Y + T
Sbjct: 119 QIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW--DWRNGEVADVVITYRAPT 176
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG--VDFAIFSIYSWEFNS 261
+L+V + + + VDL+ LPE+V+ GFS G +F + SW F S
Sbjct: 177 KSLTVCLSYPSDG--TSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS 234
Query: 262 SLE 264
+LE
Sbjct: 235 NLE 237
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 55/297 (18%), Positives = 104/297 (35%), Gaps = 31/297 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+ LG+G FG V++ + K V E+ I++ RHRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
+EL++++EF+ + + L + L +L + H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL---HSHNIGHF 126
Query: 478 DIKSSNIMLDSNFNA--KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKES 535
DI+ NI+ + ++ KI +FG AR ++ G +L Y APE S +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 536 DVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL---CRDFDG 592
D++S G + + G P + Q + + + E + DF
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNAEYTFDEEAFKEISIEAMDF-- 237
Query: 593 QQIERLMIVGLWCAHPDENLRPSIRQVI-HVL---NFEAPLPALPPKMPVPTYLSPP 645
++RL+ + R + + + H E + + Y
Sbjct: 238 --VDRLL-------VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTL 285
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 172 bits (438), Expect = 3e-50
Identities = 72/243 (29%), Positives = 114/243 (46%), Gaps = 19/243 (7%)
Query: 33 SALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLWD 85
++F+++ F P D+ A + V+QL ++ GR Y + + +WD
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 86 KATGNLTDFTTHFSFVIDS-RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
TG + F T FSF I+ ADGL FF+ P SK G G G+ +++ N
Sbjct: 62 STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ--GYGYLGVFNNSKQDN 119
Query: 145 SSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
S +AVEFD + N P H+GID+NS++S K + + +G+ I Y++ +
Sbjct: 120 SY-QTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQPF--QLDNGQVANVVIKYDAPS 176
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFN 260
L V + + + VD++Q LP++V G S ATG +YSW F
Sbjct: 177 KILHVVLVY--PSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234
Query: 261 SSL 263
+SL
Sbjct: 235 ASL 237
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 171 bits (434), Expect = 8e-50
Identities = 79/244 (32%), Positives = 114/244 (46%), Gaps = 17/244 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE-----TAGRATYNQSMRLWD 85
+ L+F + +FS +++++ A V+QL T G A Y + +W+
Sbjct: 1 SDDLSFKFKNFSQN-GKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWN 59
Query: 86 KATGNLTDFTTHFSF-VIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
TG L F T FSF + S N DGL FFLAP P + GG FGL D + +
Sbjct: 60 CNTGELASFITSFSFFMETSANPKAATDGLTFFLAP--PDSPLRRAGGYFGLFNDTKC-D 116
Query: 145 SSIPFVAVEFDVYVNS---WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
SS VAVEFD + WDP F H+GID+N VKS W I Y +
Sbjct: 117 SSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIYEA 176
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDF-AIFSIYSWEFN 260
S+ L+ + T + + VDL++ LPE+V+ GFS +T + A + +W F
Sbjct: 177 SSKTLTASLTYPSDQ--TSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234
Query: 261 SSLE 264
S+
Sbjct: 235 STFI 238
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 171 bits (434), Expect = 1e-49
Identities = 83/255 (32%), Positives = 124/255 (48%), Gaps = 18/255 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE-------TAGRATYNQSMRLW 84
A ++F++ F P+ + I A S+ +QL E + GRA Y+ + +W
Sbjct: 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
DK TG++ F F+F + ++ ADGLAFFLAP + G GL +N
Sbjct: 61 DKETGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDT--KPQTHAGYLGLFNEN---E 115
Query: 145 SSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTH 204
S VAVEFD + NSWDP H+GI++NS++S K SW D+ + + + I+Y++ST
Sbjct: 116 SGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSW--DLANNKVAKVLITYDASTS 173
Query: 205 NLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG--VDFAIFSIYSWEFNSS 262
L + L VDL+ LPE+V GFS ATG + + SW F S+
Sbjct: 174 LLVASLVYPSQR--TSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231
Query: 263 LEMDDETTNPVSNPK 277
L +P+
Sbjct: 232 LPHASSNIDPLDLTS 246
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 169 bits (430), Expect = 3e-49
Identities = 89/244 (36%), Positives = 123/244 (50%), Gaps = 26/244 (10%)
Query: 35 LTFNYTSFSPQYDDNITYER-AYPDSNRVIQLPANRE------TAGRATYNQSMRLWDKA 87
++FN+ F ++ + +R A SN V++L + GRA Y + +++WD
Sbjct: 3 ISFNFNQFHQN-EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDST 61
Query: 88 TGNLTDFTTHFSFVIDS-RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
TGN+ F T FSF I + ADGL FF+AP T +GGG FG+ S
Sbjct: 62 TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAP--PNTQTGEGGGYFGIYNPL----SP 115
Query: 147 IPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
PFVAVEFD + N+WDP H+GID+NSV S K V + + +G I Y++ST L
Sbjct: 116 YPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPFT--LDNGGIANVVIKYDASTKIL 173
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG-------VDFAIFSIYSWEF 259
V +L + + VDL+Q LPE V GFS ATG I SW F
Sbjct: 174 HVVLVF--PSLGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSF 231
Query: 260 NSSL 263
++SL
Sbjct: 232 SASL 235
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-49
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGSKQG-IKEYASEVKIISR 405
+ + LG+G FG V + T +AVK + +G+ + SE+KI+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 406 -LRHRNLVQLLGWCHEKKE-LLLVYEFMPNGSLDSHLFKEN---------------SLLT 448
H N+V LLG C + L+++ EF G+L ++L + LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 449 WEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV-EHAK 507
E + +A G+ +L + +HRD+ + NI+L KI DFGLAR + +
Sbjct: 133 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQ 567
+ + +MAPE + +SDV+SFG++ EI P V + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 568 WVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
G + A D+ ++ + M L C H + + RP+ +++ L
Sbjct: 245 EFCRRLKEGTRMRAP------DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 170 bits (432), Expect = 4e-49
Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 35/284 (12%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVS---------QGSKQGIKEYASEVKII 403
++ + LG+G V + + T AVK + + ++ + EV I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 404 SRLR-HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
++ H N++QL LV++ M G L +L E L+ + KI + L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEV 122
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ L + +VHRD+K NI+LD + N K+ DFG + ++ G + + GT Y+A
Sbjct: 123 ICAL---HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177
Query: 523 PECATTGKA------SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNG 576
PE KE D++S G++ + G P + + ++ + GN
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MSGNY 232
Query: 577 KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+ + ++ P + R + + +
Sbjct: 233 QFGSPEWDDYSDTV------KDLVSRFLVVQPQK--RYTAEEAL 268
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 169 bits (430), Expect = 4e-49
Identities = 81/253 (32%), Positives = 130/253 (51%), Gaps = 22/253 (8%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE-------TAGRATYNQSMRLW 84
A +F++ +F+ + + S+ ++L + + GRA Y+ ++++
Sbjct: 1 ADIQSFSFKNFNS---SSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY 57
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN 144
DK+TG + + T F+ I + N S ADG+AF L P GS+ +N G G+ + N
Sbjct: 58 DKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSN--SGFLGVFDSDVYDN 115
Query: 145 SSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
S+ VAVEFD + N+ WDPT H+GID+NS+KS + SW + +G+ E I+YN++T
Sbjct: 116 SA-QTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTASW--GLANGQNAEILITYNAAT 172
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFN 260
L + + +VD+ LPE+V+ GFS TG+ + SW F
Sbjct: 173 SLLVASLVHPSRR--TSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFA 230
Query: 261 SSLEMDDETTNPV 273
S L DD TT P+
Sbjct: 231 SKLP-DDSTTEPL 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (430), Expect = 8e-49
Identities = 57/283 (20%), Positives = 107/283 (37%), Gaps = 27/283 (9%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLR 407
++ + + LG GG V+ + +AVK + + E + + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 408 HRNLVQLLGWCHEKKE----LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
H +V + + +V E++ +L + E + T + ++ D L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM-TPKRAIEVIADACQAL 124
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYM 521
+ + ++HRD+K +NIM+ + K+ DFG+AR + +QT + GT Y+
Sbjct: 125 NFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
+PE A SDVYS G V E+ G P +P + + A
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIPPSA 236
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-SIRQVIHVL 623
L D +++ +P+ R + ++ L
Sbjct: 237 RHEGLSADL------DAVVLKALAKNPEN--RYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (436), Expect = 1e-48
Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 28/274 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLR- 407
NDF+ + +G+GGFG VY +T A+K + + KQG +E ++S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 408 --HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
+V + H +L + + M G L HL ++ + + A ++ GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFYAAEIILGLEH 122
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPEC 525
+ + VV+RD+K +NI+LD + + +I D GLA + GT GYMAPE
Sbjct: 123 M---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASVGTHGYMAPEV 176
Query: 526 ATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584
G A +D +S G + ++ G P + + + + +L ++ P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSP 234
Query: 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
R +E L+ D N R
Sbjct: 235 E-LRSL----LEGLL-------QRDVNRRLGCLG 256
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 167 bits (425), Expect = 1e-48
Identities = 79/242 (32%), Positives = 115/242 (47%), Gaps = 23/242 (9%)
Query: 35 LTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLWDKA 87
+FN+ F + +A SN V++L ++ GRA Y + +++WD
Sbjct: 3 QSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDST 62
Query: 88 TGNLTDFTTHFSFVIDSRNS-SYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
TGN+ F T FSF I + ADGL FF+ P S P + GG+ G+ K
Sbjct: 63 TGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNS--PQGEDGGNLGVFKPP----EG 116
Query: 147 IPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
AVEFD + N+WDP H+GID+NS+ S K + + +++G I Y+S T L
Sbjct: 117 DNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF--QLENGGVANVVIKYDSPTKIL 174
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLP--EFVTFGFSMATGVDFAIFS---IYSWEFNS 261
+V +++ + L VDL+Q P E+V G S TG I SW F S
Sbjct: 175 NVVLAF--HSVGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTS 232
Query: 262 SL 263
SL
Sbjct: 233 SL 234
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 64/273 (23%), Positives = 115/273 (42%), Gaps = 26/273 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISR-LR 407
DF + LG+G FG V+ F++TN + A+K + + ++ E +++S
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ 467
H L + K+ L V E++ G L H+ + A ++ GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFL- 119
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ +V+RD+K NI+LD + + KI DFG+ + T GT Y+APE
Sbjct: 120 --HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILL 176
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
K + D +SFG++ E+ G+ P + + + + N ++
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRMDNPFYPRWLEKE-A 230
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+D +V L+ P++ R +R I
Sbjct: 231 KDL---------LVKLFVREPEK--RLGVRGDI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 67/305 (21%), Positives = 115/305 (37%), Gaps = 33/305 (10%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-----SEVKIISRLRHRNLV 412
LG+G F VYK + TN +A+K++ G + K+ E+K++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 413 QLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQ 472
LL K + LV++FM + + +LT GL YL +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYL---HQH 119
Query: 473 CVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKA- 531
++HRD+K +N++LD N K+ DFGLA+ + T T Y APE +
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGARMY 178
Query: 532 SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591
D+++ G + E+ + + Q++ + G E P +C D
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-----FETLGTPTEEQWPDMCSLPD 233
Query: 592 GQQIERLMIVGL----------------WCAHPDENLRPSIRQVI-HVLNFEAPLPALPP 634
+ + L + R + Q + P P
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC 293
Query: 635 KMPVP 639
++P P
Sbjct: 294 QLPRP 298
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 165 bits (419), Expect = 1e-47
Identities = 84/244 (34%), Positives = 122/244 (50%), Gaps = 24/244 (9%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
++ + FN+ F+ N+ +R A S+ ++L + GRA Y+ +++
Sbjct: 1 SNDIYFNFQRFNE---TNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQI 57
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
WD TG + F T F+F I N++ ADGLAF L P GS GG GL +
Sbjct: 58 WDNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGS--QPKDKGGFLGLFDGS--- 112
Query: 144 NSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSS 202
NS+ VAVEFD N WDPT H+GID+NS++S K W D +G E I+Y+SS
Sbjct: 113 NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTRW--DFVNGENAEVLITYDSS 170
Query: 203 THNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEF 259
T+ L + + + VDL+ LPE+V+ GFS TG+ + + SW F
Sbjct: 171 TNLLVASLVYPSQKTSFI--VSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228
Query: 260 NSSL 263
S L
Sbjct: 229 ASKL 232
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 164 bits (415), Expect = 3e-47
Identities = 84/239 (35%), Positives = 125/239 (52%), Gaps = 18/239 (7%)
Query: 34 ALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE------TAGRATYNQSMRLWDKA 87
+ +F++T+F+P ++ I E A +S ++L A + GRA Y + + D
Sbjct: 3 STSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN- 61
Query: 88 TGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSI 147
L FTT FSFV+ + ++ ADGLAFFLAP ++ GG GL D ++S
Sbjct: 62 -TTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQAR--GGFLGLFADRAH-DASY 117
Query: 148 PFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLS 207
VAVEFD Y N+WDP ++H+GID N ++SKK + D+ G + I+Y +ST L+
Sbjct: 118 QTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF--DMVYGEKANIVITYQASTKALA 175
Query: 208 VAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNSSL 263
+ + +VDLR LPE+V GFS TG++ + I SW F SL
Sbjct: 176 ASLVF--PVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL 232
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-46
Identities = 67/298 (22%), Positives = 117/298 (39%), Gaps = 22/298 (7%)
Query: 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRN 410
+F +K+G+G +G VYK + T +A+K++ ++ E+ ++ L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW 470
+V+LL H + +L LV+EF+ + + L GL +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---H 119
Query: 471 EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE-CATTG 529
V+HRD+K N+++++ K+ DFGLAR T T+ Y APE
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL--------QWVWDLYGNGKLLEA 581
S D++S G + E+ R + Q+ + + VW + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 582 VDPRLCRDFDGQQIERLMIVGL----WCAHPDENLRPSIRQVIH---VLNFEAPLPAL 632
P+ R + + L G H D N R S + + + P+P L
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHL 296
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 161 bits (409), Expect = 2e-46
Identities = 57/242 (23%), Positives = 105/242 (43%), Gaps = 27/242 (11%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL----PANRETAGRATYNQSMRLWDK 86
++ +FN +F+ N+ + A S + L ++ GRA Y+ +++ D+
Sbjct: 1 SNDASFNVETFNK---TNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDR 57
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
NL F+T+F+F I+++N A GLAF L P GS G GL
Sbjct: 58 TIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGS--RPKLKGRYLGL---------- 105
Query: 147 IPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTH 204
+ D + + +D + + ID+NS++ S +G + E I+Y+S +
Sbjct: 106 FNTTNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSPKN 165
Query: 205 NLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNS 261
+L V+ + + V L + + ++V+ GFS +G + SW F+S
Sbjct: 166 DLRVSLLY--PSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSS 223
Query: 262 SL 263
+
Sbjct: 224 NF 225
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 162 bits (410), Expect = 2e-46
Identities = 83/244 (34%), Positives = 120/244 (49%), Gaps = 17/244 (6%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE------TAGRATYNQSMRLWD 85
+ L+F +F P D + A S V+QL + GRA Y +R+W
Sbjct: 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWG 60
Query: 86 KATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNS 145
TG++ F+T F+FV+ + N +DGLAF+LAP S+IP+ GL ++ +S
Sbjct: 61 NTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNS-DS 119
Query: 146 SIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
S VAVEFD Y WDP + H+GID+N ++S K V W D +G A I+Y +
Sbjct: 120 SNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQW--DWINGGVAFATITYLA 177
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV--DFAIFSIYSWEF 259
L + N + VDL++ LPE+V GFS ATG + + SW F
Sbjct: 178 PNKTLIASLVYPSNQTTFS--VAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235
Query: 260 NSSL 263
S+L
Sbjct: 236 TSTL 239
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 3e-46
Identities = 61/281 (21%), Positives = 101/281 (35%), Gaps = 43/281 (15%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQ------GSKQGIKEYASEVKIISR 405
+ + LG GGFG VY G N +A+K V + G EV ++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 406 LR--HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
+ +++LL W +L+ E E L E + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMA 522
+ V+HRDIK NI++D N K+ DFG L++ + T GT Y
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSP 177
Query: 523 PECATTGKA-SKESDVYSFGIVALEIACGRKPI--NPKAPQGQVSLLQWVWDLYGNGKLL 579
PE + + + V+S GI+ ++ CG P + + +GQV Q V
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV---------- 227
Query: 580 EAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
C+ I + + RP+ ++
Sbjct: 228 ----SSECQHL----IRWCL-------ALRPSDRPTFEEIQ 253
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 161 bits (408), Expect = 3e-46
Identities = 88/241 (36%), Positives = 125/241 (51%), Gaps = 17/241 (7%)
Query: 33 SALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE------TAGRATYNQSMRLWDK 86
+L+F++ F+P I A S V+QL + GRA Y ++WD
Sbjct: 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDS 61
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
TGN+ F T F+F+I + N + ADGLAFFLAP + GG G+ KD N S
Sbjct: 62 TTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDT--QPLDLGGMLGIFKDGYF-NKS 118
Query: 147 IPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHN 205
VAVEFD + N WDP H+GI++NS++S K V W + +G +ISY +ST +
Sbjct: 119 NQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW--NWTNGEVANVFISYEASTKS 176
Query: 206 LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFNSS 262
L+ + +L +D VD++ LPE+V FGFS TG+D + SW F S+
Sbjct: 177 LTASLVY--PSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234
Query: 263 L 263
L
Sbjct: 235 L 235
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 5e-46
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 29/274 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH 408
DF + LG G FG V+ R Y A+K + + + ++ E ++S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
++++ G + +++ ++ +++ G L S L K ++ A+ L L+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----VCLALEY 119
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ +++RD+K NI+LD N + KI DFG A+ V T L GT Y+APE +T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 175
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
+K D +SFGI+ E+ G P + L + + +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----LNAELRFPPFFNED-VK 229
Query: 589 DFDGQQIERLMIVGLWCAHPDE---NLRPSIRQV 619
D + L + NL+ V
Sbjct: 230 DL---------LSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 160 bits (406), Expect = 7e-46
Identities = 81/243 (33%), Positives = 126/243 (51%), Gaps = 19/243 (7%)
Query: 34 ALTFNYTSFSPQYDDNITYERAYPDSNRVIQLPANRE-------TAGRATYNQSMRLWDK 86
+L+F + +F N+ ++ N +QL T GR ++ + LW+K
Sbjct: 3 SLSFGFPTFPS-DQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEK 61
Query: 87 ATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSS 146
++ + +F + FSF + S S+ ADG+AFF+AP + IP+ GGG GL N+S
Sbjct: 62 SSSRVANFQSQFSFSLKSPLSN-GADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTS 120
Query: 147 I-PFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNS 201
+AVEFD + WDP + H+GID+NS++S K V W D + G+ +++N
Sbjct: 121 ANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKW--DRRDGQSLNVLVTFNP 178
Query: 202 STHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261
ST NL V T + Y+VD+R LPE+V GFS A+G + ++ SW F S
Sbjct: 179 STRNLDVVATYSDGTRYE---VSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTS 235
Query: 262 SLE 264
+L
Sbjct: 236 TLL 238
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-45
Identities = 60/280 (21%), Positives = 112/280 (40%), Gaps = 29/280 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYAS------EVKIISR 405
+ ++ ++LG G F V K + T A K + + + + S EV I+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 406 LRHRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLY 465
++H N++ L K +++L+ E + G L L ++ S LT E + + + +G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNG--- 125
Query: 466 LQEEWEQCVVHRDIKSSNIMLDSN----FNAKIGDFGLARLVEHAKGSQTTVLAGTMGYM 521
+ + H D+K NIML KI DFGLA ++ G++ + GT ++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFV 183
Query: 522 APECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
APE E+D++S G++ + G P Q ++ + N + +
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-----VNYEFEDE 238
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
+ I L P + R +I+ +
Sbjct: 239 YFSNTSALA------KDFIRRLLVKDPKK--RMTIQDSLQ 270
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 158 bits (399), Expect = 5e-45
Identities = 66/244 (27%), Positives = 108/244 (44%), Gaps = 27/244 (11%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-------PANRETAGRATYNQSMRL 83
A+ +FN+ +F DD + + A S +QL ++ GRA Y+ +++
Sbjct: 1 ATETSFNFPNFHT--DDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQI 58
Query: 84 WDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL 143
D + N+ F T+F+F+I ++N S A GLAF L P S P K G+ N P
Sbjct: 59 KD--SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNS--PPQKKQEFLGIFNTNNP- 113
Query: 144 NSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSST 203
+ VAV F+ + N D D N +K N + +G + + I+Y+SS
Sbjct: 114 EPNARTVAVVFNTFKNRID-------FDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSN 166
Query: 204 HNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFS---IYSWEFN 260
++L V V + V L + + E+V+ GFS +G+ + SW F+
Sbjct: 167 NDLRVFLHF--TVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFS 224
Query: 261 SSLE 264
S
Sbjct: 225 SKFR 228
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 64/330 (19%), Positives = 117/330 (35%), Gaps = 41/330 (12%)
Query: 336 GAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKE 395
G GP R + D + +G G FG VY+ ++ +A+K+V Q + +
Sbjct: 11 GQGPDR-------PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR- 62
Query: 396 YASEVKIISRLRHRNLVQLLGWCHEKKE------LLLVYEFMPNGSLDS--HLFKENSLL 447
E++I+ +L H N+V+L + + E L LV +++P H + L
Sbjct: 63 ---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 448 TWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHA 506
+ L L Y+ + HRDIK N++LD + K+ DFG A+ +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 507 KGSQTTVLAGTMGYMAP-ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSL 565
+ + + + + Y AP + DV+S G V E+ G+ + Q+
Sbjct: 177 EPNVSYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 566 ------------LQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLR 613
++ + Y K + + F + + + R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 614 PSIRQVIH---VLNFEAPLPALPPKMPVPT 640
+ + P LP P
Sbjct: 295 LTPLEACAHSFFDELRDPNVKLPNGRDTPA 324
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 60/292 (20%), Positives = 107/292 (36%), Gaps = 26/292 (8%)
Query: 350 ATNDFNDDQKLGQGGFGGVYKGFFRET-NSYIAVKRVS-----QGSKQGIKEYASEVKII 403
A + ++G+G +G V+K + ++A+KRV +G + ++ +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 404 SRLRHRNLVQLLGWCHEKKE-----LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQD 458
H N+V+L C + L LV+E + + E +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 459 LASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTM 518
L GL +L VVHRD+K NI++ S+ K+ DFGLAR+ + V T+
Sbjct: 125 LLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTL 179
Query: 519 GYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL----------QW 568
Y APE + D++S G + E+ + + Q+ + W
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 569 VWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
D+ + + + F E + L C + R S +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 23/276 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRH 408
NDF+ + LG+G FG V + T Y A+K + + +K + +E +++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 409 RNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQE 468
L L L V E+ G L HL +E R+ A+ + L+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE----IVSALEY 120
Query: 469 EWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATT 528
+ VV+RDIK N+MLD + + KI DFGL + + G+ GT Y+APE
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLED 179
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
+ D + G+V E+ CGR P + + L+ L + + P +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEIRFPRTLSPE-AK 233
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ GL P + L V+
Sbjct: 234 SL---------LAGLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 9e-44
Identities = 49/276 (17%), Positives = 98/276 (35%), Gaps = 23/276 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+K+G G FG +Y G +A+K +K + E KI ++ + + W
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
C + + ++ + SL+ + + + +A + S + Y+ + +HR
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI---HSKNFIHR 127
Query: 478 DIKSSNIM---LDSNFNAKIGDFGLARLVEHAKGSQ------TTVLAGTMGYMAPECATT 528
D+K N + I DFGLA+ A+ Q L GT Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 529 GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588
+ S+ D+ S G V + G P + + + + K + LC+
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEVLCK 242
Query: 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
+ + + +C + +P + +
Sbjct: 243 GYP-SEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 154 bits (391), Expect = 1e-43
Identities = 77/245 (31%), Positives = 111/245 (45%), Gaps = 20/245 (8%)
Query: 33 SALTFNYTSFSPQYDDN---ITYERAYPDSNRVIQLPAN-------RETAGRATYNQSMR 82
+ + F Y F N IT+ +QL R +AG+A+Y++ +
Sbjct: 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVF 61
Query: 83 LWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEP 142
LWD TG F T F+F + + ADGLAFFLAP S + GG +
Sbjct: 62 LWDS-TGKAASFYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDY-GGFLGLFRHETAA 118
Query: 143 LNSSIPFVAVEFDVYVNSW--DPTFSHVGIDINSVKSKKNVSW-WSDVKSGRRNEAWISY 199
S VAVEFD ++N DP + H+GID+NS+ S W D A I+Y
Sbjct: 119 DPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITY 178
Query: 200 NSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF 259
++ + L+V + + L + VDL + LP+ V GFS G D + I SW F
Sbjct: 179 DARSKILTVLLSYEHGRDYI---LSHVVDLAKVLPQKVRIGFSAGVGYD-EVTYILSWHF 234
Query: 260 NSSLE 264
S+L+
Sbjct: 235 FSTLD 239
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 61/310 (19%), Positives = 118/310 (38%), Gaps = 24/310 (7%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA-SEVKIISRLRHR 409
+ + +G+G +G V + +A+K++S Q + E+KI+ R RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFK--ENSLLTWEFRYKIAQDLASGLLYLQ 467
N++ + + ++ + + L+K + L+ + + GL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI- 125
Query: 468 EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV--EHAKGSQTTVLAGTMGYMAPEC 525
V+HRD+K SN++L++ + KI DFGLAR+ +H T T Y APE
Sbjct: 126 --HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 526 ATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584
K +K D++S G + E+ R K Q++ + + L ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 585 RLCR-DFDGQQIERLMIVGLW-------------CAHPDENLRPSIRQVI-HVLNFEAPL 629
+ ++ L+ + + R + Q + H +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 630 PALPPKMPVP 639
P+ P P
Sbjct: 304 PSDEPIAEAP 313
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 68/310 (21%), Positives = 125/310 (40%), Gaps = 34/310 (10%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQG--IKEYASEVKIISRLRHR 409
+ + K+GQG FG V+K R+T +A+K+V +++ E+KI+ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 410 NLVQLLGWCHEKKE--------LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLAS 461
N+V L+ C K + LV++F + E + + Q L +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-VMQMLLN 128
Query: 462 GLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS---QTTVLAGTM 518
GL Y+ ++HRD+K++N+++ + K+ DFGLAR AK S + T T+
Sbjct: 129 GLYYI---HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 519 GYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL--------QWV 569
Y PE + D++ G + E+ + Q Q++L+ V
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 570 WDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLW-------CAHPDENLRPSIRQVI-H 621
W N +L E ++ + + + + + D R + H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 622 VLNFEAPLPA 631
+ P+P+
Sbjct: 306 DFFWSDPMPS 315
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 28/274 (10%)
Query: 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLL 415
Q LG G G V + F + T A+K + Q + EV++ R + ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71
Query: 416 GWCH----EKKELLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEW 470
+K LL+V E + G L S + + T +I + + + YL
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL---H 128
Query: 471 EQCVVHRDIKSSNIMLDSNFN---AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECAT 527
+ HRD+K N++ S K+ DFG A+ T T Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLG 186
Query: 528 TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587
K K D++S G++ + CG P L + ++ + P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSN------HGLAISPGMKTRIRMGQYEFPNPE 240
Query: 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIH 621
++++ L+ + R +I + ++
Sbjct: 241 WSEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (381), Expect = 1e-41
Identities = 40/278 (14%), Positives = 101/278 (36%), Gaps = 25/278 (8%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+++G+G FG +++G N +A+K + + + E + L + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 418 CHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHR 477
++ ++ + SL+ L + + A+ + + + + E+ +V+R
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYR 125
Query: 478 DIKSSNIMLDSNFN-----AKIGDFGLARLV------EHAKGSQTTVLAGTMGYMAPECA 526
DIK N ++ + + DFG+ + +H + L+GT YM+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 527 TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586
+ S+ D+ + G V + G P + + G+ ++ R
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------GEKKQSTPLRE 239
Query: 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624
++ + M + + + P + + +
Sbjct: 240 LCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 149 bits (377), Expect = 3e-41
Identities = 59/283 (20%), Positives = 106/283 (37%), Gaps = 19/283 (6%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHR 409
++ +K+G+G +G VYK A+K++ + + E+ I+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
N+V+L H KK L+LV+E + E L + + + Q L +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ----LLNGIAYC 116
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
++ V+HRD+K N++++ KI DFGLAR T + +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQW------------VWDLYGNGK 577
K S D++S G + E+ G + Q+ + V +L
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 578 LLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVI 620
+P F E + + D N R + +Q +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 7e-40
Identities = 58/287 (20%), Positives = 104/287 (36%), Gaps = 23/287 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRV--SQGSKQGIKEYASEVKIISRLRHR 409
+ +K+G+G +G V+K RET+ +A+KRV + E+ ++ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 410 NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE 469
N+V+L H K+L LV+EF N L E L GL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFC--- 117
Query: 470 WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTG 529
+ V+HRD+K N++++ N K+ +FGLAR + +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 530 KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589
S D++S G + E+A +P L+ ++ L G + D
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 590 FDGQQIERLMIVGL---------------WCAHPDENLRPSIRQVIH 621
+ + + + R S + +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 6e-39
Identities = 61/312 (19%), Positives = 125/312 (40%), Gaps = 33/312 (10%)
Query: 314 RKEGDEEDNQGFSEYIDDEFERGAGPKRFPYKELALATNDFNDDQKLGQGGFGGVYKGFF 373
+K ++E + F ++F + +L + F+ + LG G FG V
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKH 62
Query: 374 RETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430
+E+ ++ A+K + + + I+ +E +I+ + LV+L + L +V E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF 490
+ G + SHL + + A + YL +++RD+K N+++D
Sbjct: 123 VAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQG 178
Query: 491 NAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACG 550
++ DFG A+ V+ +T L GT +APE + +K D ++ G++ E+A G
Sbjct: 179 YIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 551 RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDE 610
P P + + + + G + L ++ L +
Sbjct: 235 YPPFFADQP---IQIYEKIV--SGKVRFPSHFSSDLKD----------LLRNLLQVDLTK 279
Query: 611 ---NLRPSIRQV 619
NL+ + +
Sbjct: 280 RFGNLKNGVNDI 291
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 137 bits (347), Expect = 4e-38
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 38/236 (16%)
Query: 32 ASALTFNYTSFSPQYDDNITYER-AYPDSNRVIQL-PANRETAGRATYNQSMRLWDKATG 89
A+ +F +F+ N+ + A SN +QL + ++ RA Y+ +++ D TG
Sbjct: 1 ATETSFIIDAFNK---TNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTG 57
Query: 90 NLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPF 149
N+ F T+F+ I + + A GL F L P S
Sbjct: 58 NVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQP--------------------ESKGDT 97
Query: 150 VAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVA 209
V VEFD +++ ++ I K+V W G+ E I+YNSST SV+
Sbjct: 98 VTVEFDTFLSRISIDVNNNDI--------KSVPWDVHDYDGQNAEVRITYNSSTKVFSVS 149
Query: 210 FTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEFNSS 262
+ + V+L + + ++V+ GFS +G + + SW F+S
Sbjct: 150 LSNPSTG--KSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 59/277 (21%), Positives = 114/277 (41%), Gaps = 27/277 (9%)
Query: 352 NDFNDDQKLGQGGFGGVYKG---FFRETNSYIAVKRVSQGS----KQGIKEYASEVKIIS 404
+F + LG G +G V+ +T A+K + + + + + +E +++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 405 RLRHR-NLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
+R LV L + +L L+ +++ G L +HL + E + + + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----IV 139
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
L L+ + +++RDIK NI+LDSN + + DFGL++ + + GT+ YMAP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 524 ECATTGKA--SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581
+ G + K D +S G++ E+ G P + + + L +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQE 258
Query: 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQ 618
+ L +D I+RL+ D R
Sbjct: 259 MSA-LAKDL----IQRLL-------MKDPKKRLGCGP 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-36
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 19/220 (8%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
+ D Q +G G +G V T + +A+K++ + S+ K E++++ +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 410 NLVQLLGWCHEKK------ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
N++ LL + + LV FM G+ L K L + + + GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQMLKGL 134
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
Y+ ++HRD+K N+ ++ + KI DFGLAR S+ T T Y AP
Sbjct: 135 RYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAP 187
Query: 524 ECA-TTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562
E + ++ D++S G + E+ G+ Q
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 2e-35
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 20/227 (8%)
Query: 338 GPKRFPYKELALATNDFND---DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIK 394
+ + Y+ + + +D +KLG+G + V++ N + VK + K+ IK
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK 77
Query: 395 EYASEVKIISRLR-HRNLVQLLGWCHE--KKELLLVYEFMPNGSLDSHLFKENSLLTWEF 451
E+KI+ LR N++ L + + LV+E + N LT
Sbjct: 78 R---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYD 130
Query: 452 RYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLARLVEHAKGSQ 510
++ L Y ++HRD+K N+M+D + ++ D+GLA G +
Sbjct: 131 IRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQE 185
Query: 511 TTVLAGTMGYMAPE-CATTGKASKESDVYSFGIVALEIACGRKPINP 556
V + + PE D++S G + + ++P
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 9e-34
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHR 409
+ + + +G G G V + + +A+K++S+ ++ K E+ ++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 410 NLVQLLGWCHEKK------ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGL 463
N++ LL +K ++ LV E M + E + + G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGI 132
Query: 464 LYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAP 523
+L ++HRD+K SNI++ S+ KI DFGLAR T T Y AP
Sbjct: 133 KHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 187
Query: 524 ECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQ 562
E + D++S G + E+ + + Q
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 50/222 (22%), Positives = 94/222 (42%), Gaps = 13/222 (5%)
Query: 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRH 408
+ + +G G +G V F +T +AVK++S+ S K E++++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 409 RNLVQLLGWCHEKKEL----LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLL 464
N++ LL + L + G+ +++ K L ++ I Q + GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-ILRGLK 135
Query: 465 YLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPE 524
Y+ ++HRD+K SN+ ++ + KI DFGLAR + T +A
Sbjct: 136 YI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEI 189
Query: 525 CATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL 566
++ D++S G + E+ GR Q+ L+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 117 bits (294), Expect = 2e-30
Identities = 46/129 (35%), Positives = 66/129 (51%), Gaps = 7/129 (5%)
Query: 149 FVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNL 206
VAVE D Y N+ DP++ H+GIDI SV+SKK W ++++G+ A I YNS L
Sbjct: 4 IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW--NMQNGKVGTAHIIYNSVDKRL 61
Query: 207 SVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMD 266
S + + + Y VDL LPE+V G S +TG+ +I SW F S L+ +
Sbjct: 62 SAVVSYPNADSAT---VSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKSN 118
Query: 267 DETTNPVSN 275
+
Sbjct: 119 STHETNALH 127
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 83.1 bits (205), Expect = 2e-18
Identities = 32/115 (27%), Positives = 52/115 (45%), Gaps = 9/115 (7%)
Query: 32 ASALTFNYTSFSPQYDDNITYERAYPDSNRVIQL-------PANRETAGRATYNQSMRLW 84
+AL F + FS D I A ++ ++L + GRA + + +W
Sbjct: 123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW 182
Query: 85 DKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKD 139
+ + + F F+F+I S +S ADG+AFF++ S IP+ G GL D
Sbjct: 183 ES-SAVVASFEATFTFLIKSPDSHP-ADGIAFFISNIDSSIPSGSTGRLLGLFPD 235
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (296), Expect = 1e-29
Identities = 40/217 (18%), Positives = 80/217 (36%), Gaps = 20/217 (9%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGW 417
+KLG G F V+ N+++A+K V K + E+K++ R+ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 418 CHE---------------KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASG 462
+++V+E + L E+ + + +I++ L G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 463 LLYLQEEWEQCVVHRDIKSSNIMLDSN-FNAKIGDFGLARLVEHAKGSQT-TVLAGTMGY 520
L Y+ ++H DIK N++++ + +A L + T T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 521 MAPECATTGKASKESDVYSFGIVALEIACGRKPINPK 557
+PE +D++S + E+ G P
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (262), Expect = 3e-26
Identities = 33/213 (15%), Positives = 61/213 (28%), Gaps = 32/213 (15%)
Query: 59 SNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFL 118
S I++ + +Q +W K ++ +F + R ADGLA +
Sbjct: 35 SADQIRIA-------PSLKSQRGSVWTKTKAAFENWEVEVTFRVTGRGRIG-ADGLAIWY 86
Query: 119 APQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSK 178
G FG V + FD + N + + N+ +
Sbjct: 87 TENQGLD-----GPVFGSADMW-------NGVGIFFDSFDNDGKKNNPAIVVVGNNGQIN 134
Query: 179 KNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQ----------VD 228
+ D + + + + + T ++ L VM +
Sbjct: 135 YDHQN--DGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKV 192
Query: 229 LRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNS 261
+P FG S ATG + S+
Sbjct: 193 ENMVIPTQGHFGISAATGGLADDHDVLSFLTFQ 225
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.1 bits (202), Expect = 1e-18
Identities = 25/159 (15%), Positives = 50/159 (31%), Gaps = 21/159 (13%)
Query: 358 QKLGQGGFGGVYKGFFRETNSYIAVK----------RVSQGSKQGIKEYASEVKIISRLR 407
+ +G+G V+ + E VK +V + G ++ +R
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 408 HRNLVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYK-IAQDLASGLLYL 466
R L +L G K Y + N L + + + + +
Sbjct: 65 FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 467 QEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505
+ + +VH D+ N+++ I DF + V
Sbjct: 120 ---YHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.9 bits (137), Expect = 1e-09
Identities = 26/211 (12%), Positives = 49/211 (23%), Gaps = 33/211 (15%)
Query: 59 SNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFL 118
L + T G + D T ++F S GLAF+L
Sbjct: 33 EEGRFVLTPGKNTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFRGST-KGGLAFWL 84
Query: 119 APQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSK 178
FG + + + + + V +N
Sbjct: 85 KQG----NEGDSTELFGGSSKK------FNGLMILLRLDDKLGE----SVTAYLND---- 126
Query: 179 KNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQG-LDYQV-----DLRQH 232
S Y S ++ T + +++ +D +V ++
Sbjct: 127 -GTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDNRVCFQTRKVKFM 185
Query: 233 LPEFVTFGFSMATGVDFAIFSIYSWEFNSSL 263
G S F I + +
Sbjct: 186 GSSPFRIGTSAINDASKESFEILKMKLYDGV 216
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.1 bits (109), Expect = 3e-06
Identities = 29/217 (13%), Positives = 55/217 (25%), Gaps = 41/217 (18%)
Query: 55 AYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGL 114
A + R I L +N+ + G Q L D FT ++F + G+
Sbjct: 31 ASLEEGR-IVLTSNQNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYSGQT-DGGI 81
Query: 115 AFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINS 174
+F+ + G + + + D +
Sbjct: 82 SFWFVQDSN--IPRDKQLYNGPVNYDG--------LQLLVDNNGPLGPTLRGQLNDGQKP 131
Query: 175 VKSKKNVS------WWSDVKSGRRNEAWISYNSSTHN-LSVAFTGFRNNLVVMQGLDYQV 227
V K S + ++Y+ N L V + +Q
Sbjct: 132 VDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK---------VCFQT 182
Query: 228 DLRQHLPEFVTFGFSMATG-----VD-FAIFSIYSWE 258
+ G + G + F IF + +
Sbjct: 183 RKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFN 219
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 645 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.96 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.93 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.8 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.52 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=1.5e-55 Score=434.19 Aligned_cols=223 Identities=37% Similarity=0.592 Sum_probs=197.1
Q ss_pred eeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 34 ALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 34 ~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
+++|+|++|++...++|.++ ||.+ .+|.|+||+ . ..++|||+|++||+|||+.+|+++||+|+|+|.|.+.
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~-~~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~ 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEE-ETTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEe-cCCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC
Confidence 47899999987656789999 9998 789999998 2 2368999999999999999999999999999999975
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCC-CCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceee
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPL-NSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~ 182 (645)
...+||||||||+|... +.+..|++||+++..+.+ ...+++|||||||++|. +||++||||||+||+.|.++..
T Consensus 80 -~~~~gDGlAFvl~p~~~--~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~ 156 (236)
T d1hqla_ 80 -GNGPADGLAFFLAPPDS--DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR 156 (236)
T ss_dssp -SSCCCCEEEEEEECTTC--CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE
T ss_pred -CCCCCceEEEEEeCCCC--CCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCcccccccc
Confidence 35679999999999875 445789999999886644 45689999999999997 7999999999999999999888
Q ss_pred e-cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce-eeeEEEEEeecc
Q 042831 183 W-WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD-FAIFSIYSWEFN 260 (645)
Q Consensus 183 ~-~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~-~~~~~i~~wsf~ 260 (645)
| ..++.+|+.++|||+||+.+++|+|+|++.+ +..|+|++.|||+++|+++||||||||||.. .+.|+|++|+|+
T Consensus 157 ~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~---~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~ 233 (236)
T d1hqla_ 157 WEDSDIFSGKIATARISYDGSAEILTVVLSYPD---GSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFS 233 (236)
T ss_dssp CCHHHHTSCSCEEEEEEEETTTTEEEEEEEETT---TEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEE
T ss_pred cccccccCCCEEEEEEEEeCCCcEEEEEEecCC---CCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeE
Confidence 7 3568899999999999999999999998744 5678999999999999999999999999974 678999999998
Q ss_pred Ccc
Q 042831 261 SSL 263 (645)
Q Consensus 261 ~~~ 263 (645)
+++
T Consensus 234 s~l 236 (236)
T d1hqla_ 234 SNL 236 (236)
T ss_dssp EEC
T ss_pred ecC
Confidence 764
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=5.9e-54 Score=425.39 Aligned_cols=227 Identities=35% Similarity=0.598 Sum_probs=202.1
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
+.+++|+|++|+++ ..+|.++ ||.+.++|.|+||+ . ..+.|||+|++||+|||+++++++||+|+|+|.|...
T Consensus 1 ~~~~sF~f~~F~~~-~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~ 79 (240)
T d1fx5a_ 1 SDDLSFKFKNFSQN-GKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETS 79 (240)
T ss_dssp CCEEEEEESSCCTT-CSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEES
T ss_pred CCceEEECCCCCCC-CCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCC
Confidence 35789999999875 5689999 99987899999998 2 2367999999999999999999999999999999765
Q ss_pred -CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC---CCCCCCceeeecCCCccccee
Q 042831 106 -NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS---WDPTFSHVGIDINSVKSKKNV 181 (645)
Q Consensus 106 -~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~---~d~~~~hvgidvns~~s~~~~ 181 (645)
.+..+||||||+|+|... |.+..|++|||++..+ ++..+++|||||||++|. +||++||||||+||+.|..+.
T Consensus 80 ~~~~~ggdG~AFvl~p~~~--~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~ 156 (240)
T d1fx5a_ 80 ANPKAATDGLTFFLAPPDS--PLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAE 156 (240)
T ss_dssp SCGGGCCCEEEEEEECTTC--CCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCcEEEEECCCCC--CCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCCccccccc
Confidence 345679999999999753 6778999999998754 456789999999999984 899999999999999999999
Q ss_pred eecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc-eeeeEEEEEeecc
Q 042831 182 SWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV-DFAIFSIYSWEFN 260 (645)
Q Consensus 182 ~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~-~~~~~~i~~wsf~ 260 (645)
.+..++.+|+.++|||+||+.+++|+|+|.+.+ +|..|+|++.|||+++|+++||||||||||. ..|.|+|++|+|+
T Consensus 157 ~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFs 234 (240)
T d1fx5a_ 157 RWNKRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFT 234 (240)
T ss_dssp ECCCCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEE
T ss_pred ccccccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeE
Confidence 998888899999999999999999999998755 5678899999999999999999999999995 6789999999999
Q ss_pred Cccc
Q 042831 261 SSLE 264 (645)
Q Consensus 261 ~~~~ 264 (645)
+.++
T Consensus 235 st~~ 238 (240)
T d1fx5a_ 235 STFI 238 (240)
T ss_dssp EESS
T ss_pred Eecc
Confidence 8765
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=1.1e-53 Score=422.20 Aligned_cols=224 Identities=35% Similarity=0.550 Sum_probs=195.8
Q ss_pred ceeeEEeCCCCCCC---CCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEE
Q 042831 33 SALTFNYTSFSPQY---DDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFV 101 (645)
Q Consensus 33 ~~~~f~f~~f~~~~---~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~ 101 (645)
.+++|+|++|++.. ..+|.++ ||.+ .+|.|+||+ . ..++|||+|++||+|||+ +++++||+|+|+|.
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~-~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~-t~~~asFsT~F~f~ 79 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATR-IPGALQLTKTDANGNPVRSSAGQASYSEPVFLWDS-TGKAASFYTSFTFL 79 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEE-ETBEEECSCBCTTSCBCSSEEEEEEESSCEECBCT-TSCBCEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEE-cCCEEEeccCCCCCCccccceEEEEeCCCeEecCC-CCcEeeEEEEEEEE
Confidence 47899999997532 4589999 9998 579999997 2 237999999999999995 89999999999999
Q ss_pred EeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCC-CCCCEEEEEEecccCC--CCCCCCceeeecCCCccc
Q 042831 102 IDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLN-SSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSK 178 (645)
Q Consensus 102 i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~ 178 (645)
|.+.. ..+||||||||+|.+. +.+..|++||+++..+.++ ..+++|||||||++|. .||++||||||+|++.|.
T Consensus 80 i~~~~-~~~gdGlAF~l~p~~~--~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~ 156 (243)
T d1leda_ 80 LKNYG-APTADGLAFFLAPVDS--SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSV 156 (243)
T ss_dssp EEESS-SSCBCEEEEEEEETTC--CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCS
T ss_pred cCCCC-CCCCCceEEEEcCCCC--CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccc
Confidence 88764 5679999999999875 4457899999998876543 5689999999999997 699999999999999999
Q ss_pred ceeeec-ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEe
Q 042831 179 KNVSWW-SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSW 257 (645)
Q Consensus 179 ~~~~~~-~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~w 257 (645)
.+..|. .++.+|+.++|||+||+.+++|+|+|++. ++..|+|++.|||+++|+++||||||||||. .|.|+|++|
T Consensus 157 ~~~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~~~h~I~sW 232 (243)
T d1leda_ 157 ATTRWENDDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSW 232 (243)
T ss_dssp EEEECCHHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-SEEEEEEEE
T ss_pred cccccccCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEEcccCC-cceeeEEEE
Confidence 998884 47889999999999999999999999874 3567899999999999999999999999996 599999999
Q ss_pred eccCcccc
Q 042831 258 EFNSSLEM 265 (645)
Q Consensus 258 sf~~~~~~ 265 (645)
+|++.+.+
T Consensus 233 sF~s~l~~ 240 (243)
T d1leda_ 233 HFFSTLDG 240 (243)
T ss_dssp EEEEECTT
T ss_pred EEEeeCCC
Confidence 99987654
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=3.3e-53 Score=419.53 Aligned_cols=224 Identities=39% Similarity=0.713 Sum_probs=200.8
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C---CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N---RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNS 107 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~---~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~ 107 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.|+||+ . ..++|||+|++||+||++.+++++||+|+|+|.|.++.
T Consensus 2 ~~lsF~f~~F~~~-~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~- 79 (237)
T d1qnwa_ 2 DDLSFNFDKFVPN-QKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKADK- 79 (237)
T ss_dssp CSEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBSS-
T ss_pred CcEEEEcCCCCCC-CCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecCC-
Confidence 5789999999876 6789999 99987889999998 3 24789999999999999999999999999999998764
Q ss_pred CCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC----CCCCCCceeeecCCCcccceeee
Q 042831 108 SYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 108 ~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~----~d~~~~hvgidvns~~s~~~~~~ 183 (645)
..+||||||||+|....+|.++.|+++|+.+.. .+...+++|||||||++|. +||++||||||+|++.|.+++.+
T Consensus 80 ~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~-~~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~~ 158 (237)
T d1qnwa_ 80 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKW 158 (237)
T ss_dssp SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSS-SCCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEEC
T ss_pred CCCcceeEEEEeCCCCCCCCCCccccccccCCC-CCCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCccccccc
Confidence 557999999999999888888899999998864 3567789999999999885 57999999999999999988876
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce--eeeEEEEEeeccC
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD--FAIFSIYSWEFNS 261 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~~wsf~~ 261 (645)
++.+|+.++|||+||+.+++|+|+|++.+ +|..|+|++.|||+++|+++||||||||||.. .|.|+|++|+|++
T Consensus 159 --~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s 234 (237)
T d1qnwa_ 159 --DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTS 234 (237)
T ss_dssp --CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEE
T ss_pred --ccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEE
Confidence 47899999999999999999999998754 57789999999999999999999999999975 4899999999988
Q ss_pred cc
Q 042831 262 SL 263 (645)
Q Consensus 262 ~~ 263 (645)
++
T Consensus 235 ~l 236 (237)
T d1qnwa_ 235 NL 236 (237)
T ss_dssp EC
T ss_pred ec
Confidence 65
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=1e-52 Score=416.29 Aligned_cols=224 Identities=33% Similarity=0.616 Sum_probs=197.5
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|+++ ..++.|+ ||.+.++|.|+||+ .. .+.|||+|++||+||++.+++++||+|+|+|.|..
T Consensus 2 ~~~sF~f~~F~~~-~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~ 80 (239)
T d1gzca_ 2 ETISFSFSEFEPG-NDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQ 80 (239)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred eeEEEEeCCCCCC-CCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEec
Confidence 4789999999976 5689999 99987889999998 32 26899999999999999999999999999999986
Q ss_pred CC-CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceee
Q 042831 105 RN-SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 105 ~~-~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~ 182 (645)
.. ...+||||||+|+|.+. +.+..||+||+++..+. ...++.|||||||++|. +||++||||||+|++.|..+..
T Consensus 81 ~~~~~~g~dG~aF~l~p~~~--~~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~HvgI~vn~~~s~~t~~ 157 (239)
T d1gzca_ 81 PYTRPLPADGLVFFMGPTKS--KPAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSNPWDPPQVPHIGIDVNSIRSIKTQP 157 (239)
T ss_dssp CCSSSCCCEEEEEEEECSSC--CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTSCSSSSEEEEEESSSSCSEEEE
T ss_pred CCCCCCCCCeEEEEECCCCC--CCCCCcccccccccCCC-CCccceEEEEEEccccCCCCCCCCEEEEEECCccccccCC
Confidence 53 45679999999999875 34567889999876543 45678899999999998 7999999999999999998887
Q ss_pred ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc---eeeeEEEEEeec
Q 042831 183 WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEF 259 (645)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf 259 (645)
+ ++.+|+.++|||+||+.+++|+|+|++.+ +|..|+|++.|||+++|+++|||||||+||. ..|.|+|++|+|
T Consensus 158 ~--~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF 233 (239)
T d1gzca_ 158 F--QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSF 233 (239)
T ss_dssp C--CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEE
T ss_pred c--cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEe
Confidence 6 57899999999999999999999998754 5778999999999999999999999999994 578999999999
Q ss_pred cCccc
Q 042831 260 NSSLE 264 (645)
Q Consensus 260 ~~~~~ 264 (645)
++.++
T Consensus 234 ~s~lp 238 (239)
T d1gzca_ 234 QASLP 238 (239)
T ss_dssp EEEEC
T ss_pred EeeCC
Confidence 98754
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=1.1e-52 Score=415.24 Aligned_cols=221 Identities=40% Similarity=0.680 Sum_probs=195.5
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ .+++.|+ ||.+.++|.|+||+ . .+++|||+|++||+|||+.+++++||+|+|+|.|...
T Consensus 1 ~t~sF~f~~F~~~-~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~ 79 (237)
T d2d3sa1 1 KTISFNFNQFHQN-EEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQP 79 (237)
T ss_dssp CEEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CeEEEEeCCCCCC-CCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecC
Confidence 3689999999876 6789999 99987789999998 2 2589999999999999999999999999999999765
Q ss_pred C-CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeec
Q 042831 106 N-SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 106 ~-~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
. ...+||||||+|+|... +.+..||+||+++.. ..+++|||||||++|.+||++||||||+|++.|.+...+
T Consensus 80 ~~~~~g~dGlaFvl~p~~~--~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~~d~~~nHvgI~vns~~s~~~~~~- 152 (237)
T d2d3sa1 80 FPRPHPADGLVFFIAPPNT--QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNTWDPQIPHIGIDVNSVISTKTVPF- 152 (237)
T ss_dssp CCSSCCCEEEEEEEECSSC--CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCCeEEEEeCCCCc--cCCccccccccccCC----CcCceEEEEEEeecCCCCCCCCcEEEEcCCCccccccce-
Confidence 3 44578999999999764 556789999998753 356789999999999999999999999999999888776
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc-------eeeeEEEEEe
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV-------DFAIFSIYSW 257 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~-------~~~~~~i~~w 257 (645)
++.+|+.++|||+||+.+++|+|+|++.+ +|..|++++.|||+.+|+++||||||||||. ..|.|+|++|
T Consensus 153 -~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sW 229 (237)
T d2d3sa1 153 -TLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSW 229 (237)
T ss_dssp -CCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEE
T ss_pred -eecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEe
Confidence 47899999999999999999999999765 4667899999999999999999999999994 5689999999
Q ss_pred eccCccc
Q 042831 258 EFNSSLE 264 (645)
Q Consensus 258 sf~~~~~ 264 (645)
+|++.++
T Consensus 230 sFss~lp 236 (237)
T d2d3sa1 230 SFSASLP 236 (237)
T ss_dssp EEEEECC
T ss_pred EeEeeCC
Confidence 9988753
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=5.7e-52 Score=413.90 Aligned_cols=227 Identities=36% Similarity=0.648 Sum_probs=193.7
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
|.+++|+|++|+++ ..++.|+ ||.+.++|.|+||+ .. .++|||+|++||+||++.+++++||+|+|+|.|.
T Consensus 1 a~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~ 79 (251)
T d1g9fa_ 1 AETVSFSWNKFVPK-QPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFY 79 (251)
T ss_dssp CEEEEEEESSCCC--CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEE
T ss_pred CceEEEEeCCCCCC-CCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEe
Confidence 45799999999876 5679999 99987889999998 22 3789999999999999999999999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeee
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~ 183 (645)
......+||||||+|+|... +.+..||+||+++.. ...+++||||||||+|.+||++||||||+|++.|..+..+
T Consensus 80 ~~~~~~~gDGlAFvl~p~~~--~~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~~D~~~~Hvgi~~n~~~s~~~~~~ 154 (251)
T d1g9fa_ 80 APDTKRLADGLAFFLAPIDT--KPQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNSWDPPNPHIGINVNSIRSIKTTSW 154 (251)
T ss_dssp CSCC--CCEEEEEEEEETTC--CCCCCGGGTTTCCTT---SCCCSCEEEEEECC-CTTSCSSSEEEEEESSSSCSEEEEC
T ss_pred cCCCCCCCCceEEEEecCCC--CCCCccCccCccccc---CCCcceEEEEEecccCCCCCCCCcEeEEecCcccccccce
Confidence 88778899999999999864 456788999998753 3457889999999999999999999999999999988877
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccccee--eeEEEEEeeccC
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDF--AIFSIYSWEFNS 261 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~--~~~~i~~wsf~~ 261 (645)
++.+|+.++|||+||+.+++|+|++.+.. +|..|++++.|||+.+|+++||||||||||... |.|+|++|+|++
T Consensus 155 --~l~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s 230 (251)
T d1g9fa_ 155 --DLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFAS 230 (251)
T ss_dssp --CCCTTCCEEEEEEEETTTTEEEEEEEEGG--GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEE
T ss_pred --EecCCCEEEEEEEEECCccEEEEEEecCC--CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeEC
Confidence 57899999999999999999999998643 677899999999999999999999999999755 889999999998
Q ss_pred ccccccC
Q 042831 262 SLEMDDE 268 (645)
Q Consensus 262 ~~~~~~~ 268 (645)
.+.+...
T Consensus 231 ~~~~~~~ 237 (251)
T d1g9fa_ 231 NLPHASS 237 (251)
T ss_dssp EECC---
T ss_pred CCCCCCc
Confidence 8766543
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=9.3e-52 Score=407.99 Aligned_cols=219 Identities=36% Similarity=0.659 Sum_probs=192.6
Q ss_pred eeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 34 ALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 34 ~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
+.+|+|++|+++ .+++.|+ ||.+.++|.|+||+ .. .++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 2 ~~SF~f~~F~~~-~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~ 80 (234)
T d1f9ka_ 2 TQSFNFDHFEEN-SKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP 80 (234)
T ss_dssp EEEEEESSCCSS-CTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred ceEEEeCCCCCC-CCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECC
Confidence 579999999865 6789999 99987889999998 22 368999999999999999999999999999999865
Q ss_pred C-CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeec
Q 042831 106 N-SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 106 ~-~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
. ...+||||||+|+|... |.+..|+++|+++.. ..++.|||||||++|.+||++||||||+|++.|.++..+
T Consensus 81 ~~~~~g~dG~aF~i~p~~~--~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~~Dp~~nHvgi~~ns~~s~~~~~~- 153 (234)
T d1f9ka_ 81 YAYPEPADGLTFFMVPPNS--PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNTWDPQVPHIGIDVNSIVSSKTLHF- 153 (234)
T ss_dssp CSSSCCCEEEEEEEECTTC--CCCCSGGGTTTCCSS----CCSCCEEEEEECSCCTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCccceEEEEECCCCC--CcccccccccccCCC----CccceEEEEEeccccCCCCCCCcEeEecCCccccccccc-
Confidence 3 34578999999999864 667789999998653 345679999999999999999999999999999888777
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCC--CceEEEEeecccc---eeeeEEEEEeec
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLP--EFVTFGFSMATGV---DFAIFSIYSWEF 259 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~--~~~~vGfsastg~---~~~~~~i~~wsf 259 (645)
++.+|+.++|||+||+.+++|+|+|++.. ++..|+|++.|||+++|+ |+|||||||+||. ..|.|+|++|+|
T Consensus 154 -~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF 230 (234)
T d1f9ka_ 154 -QLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSF 230 (234)
T ss_dssp -CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEE
T ss_pred -cccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEe
Confidence 58899999999999999999999999765 456789999999999996 5699999999994 578999999999
Q ss_pred cCcc
Q 042831 260 NSSL 263 (645)
Q Consensus 260 ~~~~ 263 (645)
++++
T Consensus 231 ~s~l 234 (234)
T d1f9ka_ 231 TSSL 234 (234)
T ss_dssp EEEC
T ss_pred EEeC
Confidence 8764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=419.24 Aligned_cols=261 Identities=26% Similarity=0.336 Sum_probs=212.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
++|+..++||+|+||+||+|+++.+|+.||||++.... .+..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888999999999999999999999999999987553 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC-c
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-S 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~ 509 (645)
|++|+|.+++.. ...+++..++.++.||++||.|||+ ++|+||||||+|||+++++++||+|||+|+....... .
T Consensus 85 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999854 4579999999999999999999998 8999999999999999999999999999987654332 2
Q ss_pred ceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 QTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .. ... ...... .+ ..
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~----~~~-~~~~~~--~~--~~ 230 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS----DWK-EKKTYL--NP--WK 230 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH----HHH-TTCTTS--TT--GG
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH----HHh-cCCCCC--Cc--cc
Confidence 2345689999999999988775 67899999999999999999999754432211 11 111 111100 00 01
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLP 630 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 630 (645)
.. ...+.+++.+||+.||++|||++|+++|.|+..+++
T Consensus 231 ~~----s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 231 KI----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp GS----CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred cC----CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 11 235667889999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=423.31 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=199.1
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCe---EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNS---YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
+|...++||+|+||+||+|++..+++ .||||++... .....++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45567899999999999999876553 6999988654 4556678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|||++|+|.+++......++|.+++.++.|||+||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999999998777789999999999999999999999 8999999999999999999999999999987654322
Q ss_pred cc----eeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 509 SQ----TTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 509 ~~----~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
.. .....||+.|+|||.+.++.++.++|||||||+||||+| |+.||...... .+... ..++...
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~----i~~~~~~---- 252 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINA----IEQDYRL---- 252 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----HHTTCCC----
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC----
Confidence 21 223457899999999999999999999999999999998 89999754321 22222 2222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+.+....+.+|+.+||+.||++||||+||++.|+.
T Consensus 253 -----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 253 -----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111223467788999999999999999999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=423.01 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=218.0
Q ss_pred hHHHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCe
Q 042831 344 YKELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKE 423 (645)
Q Consensus 344 ~~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~ 423 (645)
+++++...++|+..++||+|+||+||+|++..+++.||||+++.+. ...++|.+|+++|++++|||||+++++|.+++.
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 3445555678888999999999999999999999999999986543 345789999999999999999999999999999
Q ss_pred EEEEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
.++|||||++|+|.+++.+. ...+++..+..|+.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999754 5679999999999999999999999 8999999999999999999999999999987
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.............|++.|+|||++.++.++.++|||||||++|||++|+.|+...... . .+.+....+..
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~----~~~~~i~~~~~---- 234 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S----QVYELLEKDYR---- 234 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H----HHHHHHHTTCC----
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--H----HHHHHHhcCCC----
Confidence 6654444444456899999999999999999999999999999999977776533321 1 12222222211
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+..... ..+.+.+|+..||+.||++||||+|+++.|+.
T Consensus 235 -~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 235 -MERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp -CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111112 23467788999999999999999999998864
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=2.7e-50 Score=400.71 Aligned_cols=226 Identities=36% Similarity=0.658 Sum_probs=200.9
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
+.+++|+|++|.++ ..++.|+ ||.+.++|.||||+ . ..++|||+|++||+||++.+++++||+|+|+|.|.+
T Consensus 1 ~~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~ 79 (239)
T d1dbna_ 1 SDELSFTINNFVPN-EADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKA 79 (239)
T ss_dssp CCEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCC
T ss_pred CCceEEEeCCCCCC-CCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEEC
Confidence 45799999999876 5679999 99987889999998 2 236899999999999999999999999999999998
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC----CCCCCCceeeecCCCcccce
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKKN 180 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~----~d~~~~hvgidvns~~s~~~ 180 (645)
.....+||||||+|+|.+..++.++.|++||+++..+ ++..++.|||||||++|. +||+++|||||+|++.|.+.
T Consensus 80 ~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~ 158 (239)
T d1dbna_ 80 PNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKT 158 (239)
T ss_dssp SSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred CCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCcccccc
Confidence 8777889999999999988888888899999998654 456789999999999885 58999999999999999877
Q ss_pred eeecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce--eeeEEEEEee
Q 042831 181 VSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD--FAIFSIYSWE 258 (645)
Q Consensus 181 ~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~--~~~~~i~~ws 258 (645)
..+ .+.+|+.++|||+|++.+++|.|++.+.. ++..|.+++.+||+++|+++||||||||||.. .|.|+|++|+
T Consensus 159 ~~~--~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWs 234 (239)
T d1dbna_ 159 VQW--DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWS 234 (239)
T ss_dssp EEC--CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEE
T ss_pred ccc--eEeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEE
Confidence 665 46789999999999999999999998755 46678899999999999999999999999964 5789999999
Q ss_pred ccCcc
Q 042831 259 FNSSL 263 (645)
Q Consensus 259 f~~~~ 263 (645)
|++.+
T Consensus 235 Fss~l 239 (239)
T d1dbna_ 235 FTSTL 239 (239)
T ss_dssp EEEEC
T ss_pred eEEeC
Confidence 98764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=413.79 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=214.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...++||+|+||+||+|++..+|+.||||++........+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46899999999999999999999999999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++.+ ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...... ...
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 99999988754 358999999999999999999998 899999999999999999999999999998765432 233
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFD 591 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~ 591 (645)
....||+.|+|||++.++.++.++|||||||++|||++|+.||...... +........+... . .. +
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~-~---~~----~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPE-L---QN----P 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCC-C---SS----G
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCC-C---CC----c
Confidence 4567999999999999999999999999999999999999999753321 1111111111110 0 00 1
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 592 GQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 592 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+.+++.+||++||++|||++|+++|.|+.
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 11224567888999999999999999999999885
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=414.34 Aligned_cols=253 Identities=27% Similarity=0.493 Sum_probs=199.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|+..++||+|+||.||+|++.+ ++.||||+++... ...++|.+|++++++++||||++++|+|..++..++|||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 567788999999999999999874 6789999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++......+++..++.|+.|||+||.|||+ ++|+||||||+|||+|+++++||+|||+++..........
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 9999999998777889999999999999999999999 8999999999999999999999999999987655444444
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHcC-CCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACG-RKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG-~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....||+.|+|||++.++.++.++|||||||++|||+|+ ++|+.... ...+...+ ..+.. ...|..
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i----~~~~~--~~~p~~---- 226 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDI----STGFR--LYKPRL---- 226 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHH----HHTCC--CCCCTT----
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHHH----HhcCC--CCCccc----
Confidence 456789999999999999999999999999999999995 55554322 11222221 12211 111221
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+.+.+++.+||+.||++||||+||+++|+.
T Consensus 227 ---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 227 ---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 12467788999999999999999999999873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=416.07 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=205.4
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
...++|...++||+|+||.||+|++++ .||||+++.. ..+..+.|.+|++++++++||||+++++++.+ +.+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 345678899999999999999998753 5999998644 45567889999999999999999999998864 56899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||||++|+|.+++...+..+++..+..|+.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999999998777789999999999999999999998 89999999999999999999999999999876543
Q ss_pred CC-cceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 507 KG-SQTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 507 ~~-~~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.. .......||+.|||||++.+ +.++.++|||||||+||||+||+.||....... .+.....++......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDL 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCG
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcc
Confidence 32 23445689999999999864 358999999999999999999999997544321 111222222211111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.....+ .+.+.+++.+||+.||++||||+|++++|+.
T Consensus 232 -~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 232 -SKVRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp -GGSCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hhccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111222 2467788899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=411.51 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=211.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||+|+||.||+|+++.+++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4688899999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|||++|+|.+++.+. ..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 999999999998654 469999999999999999999999 8999999999999999999999999999976543
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+ .....++.. .+..
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~----~~~i~~~~~------~~p~ 225 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ET----YKRISRVEF------TFPD 225 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH----HHHHHTTCC------CCCT
T ss_pred CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCC------CCCc
Confidence 2334567999999999999999999999999999999999999999754321 11 122222221 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .+.+.+++.+||++||++|||++|+++|.|+.
T Consensus 226 ~~----s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 226 FV----TEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred cC----CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence 12 24567788999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=415.57 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=214.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+.|+..+.||+|+||.||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35778899999999999999999999999999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|.+++.+....+++.++..++.||++||.|||+ ++|+||||||+|||++.++++||+|||+++...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 9999999987777789999999999999999999998 899999999999999999999999999997653321 123
Q ss_pred eecccCccccCccccc-----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 512 TVLAGTMGYMAPECAT-----TGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~-----~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .... .. .+.......+
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~---i~-~~~~~~~~~~-- 238 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLK---IA-KSEPPTLAQP-- 238 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHH---HH-HSCCCCCSSG--
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHH---HH-cCCCCCCCcc--
Confidence 3467999999999984 4568999999999999999999999997654322 1111 11 1111111111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
......+.+++.+||++||++|||++|+++|.|+.
T Consensus 239 -----~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 239 -----SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp -----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred -----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11224567888999999999999999999998875
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.3e-50 Score=394.88 Aligned_cols=220 Identities=38% Similarity=0.635 Sum_probs=195.2
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
+.+++|+|++|.+. ++.|+ ||.+.++|.|+||+ .. .++|||+|++||+||++.+++++||+|+|+|.|.
T Consensus 1 ~~~~sF~f~~F~~~---nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~ 77 (233)
T d1g8wa_ 1 SNDIYFNFQRFNET---NLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQ 77 (233)
T ss_dssp CEEEEEEESSCCGG---GEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECC
T ss_pred CCceEEECCCCCcC---cEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEe
Confidence 35789999999854 79999 99987899999997 22 2789999999999999999999999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceee
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~ 182 (645)
+.+...+||||||+|+|.+. +.++.|++||+++.. +..++.|||||||++|. +||++||||||+|++.|..+..
T Consensus 78 ~~~~~~~gDGlAF~l~~~~~--~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~d~~~~Hvgi~~n~~~s~~~~~ 152 (233)
T d1g8wa_ 78 VPNNAGPADGLAFALVPVGS--QPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDWDPTERHIGIDVNSIRSIKTTR 152 (233)
T ss_dssp CCSSCBCCEEEEEEEEETTC--CCCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEE
T ss_pred cCCCCCCCCeEEEEEecCCC--CCCcccccCCccccC---CCcccEEEEEeecccCCCCCCCCCeEEEECCCcceeeecc
Confidence 88777789999999999875 456789999998753 34568899999999996 9999999999999999988777
Q ss_pred ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc---ceeeeEEEEEeec
Q 042831 183 WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG---VDFAIFSIYSWEF 259 (645)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf 259 (645)
+ ++.+|+.++|||+||+.+++|.|+|.+.+ ++..+++++.+||+++||++|||||||+|| +..|.|+|++|+|
T Consensus 153 ~--~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsF 228 (233)
T d1g8wa_ 153 W--DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSF 228 (233)
T ss_dssp C--CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEE
T ss_pred c--cccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEE
Confidence 6 57899999999999999999999998755 567889999999999999999999999999 4567899999999
Q ss_pred cCcc
Q 042831 260 NSSL 263 (645)
Q Consensus 260 ~~~~ 263 (645)
++.+
T Consensus 229 ss~l 232 (233)
T d1g8wa_ 229 ASKL 232 (233)
T ss_dssp EEEE
T ss_pred EEEc
Confidence 8864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=403.29 Aligned_cols=252 Identities=25% Similarity=0.435 Sum_probs=214.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|+..++||+|+||+||+|+++ +++.||||.++.... ..++|.+|++++++++||||++++|+|.+++.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 68899999999999999999986 578999999976533 4568999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
++|+|..++......+++..+.+++.||++||.|||+ .+|+||||||+|||+++++.+||+|||+++..........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999999988777789999999999999999999998 8999999999999999999999999999987665544445
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....||+.|+|||.+.++.++.++|||||||++|||+| |+.||+..... .+. ....++.. ...|..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~----~~i~~~~~--~~~p~~---- 225 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGLR--LYRPHL---- 225 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCC--CCCCTT----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH----HHHHhCCC--CCCccc----
Confidence 55679999999999999999999999999999999998 89999755422 122 22222211 111221
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+.+++.+||+.||++|||++|++++|.
T Consensus 226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2246778899999999999999999999985
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=2.3e-49 Score=391.40 Aligned_cols=224 Identities=41% Similarity=0.608 Sum_probs=192.6
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCC
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSS 108 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~ 108 (645)
|.+++|+|++|.++ +.++.|+ ||.+.++|.|+||+ . .++.|||+|++||+||++.+++++||+|+|+|.|.+....
T Consensus 1 a~~~sF~~~~F~~~-~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~ 79 (232)
T d1v6ia_ 1 AETVSFNFNSFSEG-NPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDY 79 (232)
T ss_dssp CEEEEEEESSCCTT-CTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSS
T ss_pred CccEEEECCCCCCC-CCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCC
Confidence 45799999999986 5679999 99987889999998 3 4689999999999999999999999999999999998778
Q ss_pred CCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeeccc
Q 042831 109 YYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSD 186 (645)
Q Consensus 109 ~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~~~ 186 (645)
.+||||||+|+|.....+....+ |+....+..+..++.|||||||++|. +||+++|||||+|++.|.....+ +
T Consensus 80 ~~gDG~AF~l~~~~~~~~~~~~~---g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~~--~ 154 (232)
T d1v6ia_ 80 DPADGIIFFIAPEDTQIPAGSIG---GGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW--N 154 (232)
T ss_dssp BCCCEEEEEEEETTCCCCTTCCC---GGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC--C
T ss_pred CCCCeEEEEEECCCCCCCCCccC---CcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccccccc--c
Confidence 88999999999998665443222 22222223455678999999999987 78999999999999998877665 5
Q ss_pred CCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce-eeeEEEEEeeccCccc
Q 042831 187 VKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD-FAIFSIYSWEFNSSLE 264 (645)
Q Consensus 187 ~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~-~~~~~i~~wsf~~~~~ 264 (645)
+.+|+.++|||+||+.+++|+|++.+.+ +..|.+++.|||+.+|+++|||||||+||.. .|.|+|++|+|++.+.
T Consensus 155 ~~~g~~~~v~I~Yd~~~~~L~V~~~~~~---~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~l~ 230 (232)
T d1v6ia_ 155 SVSGAVVKVTVIYDSSTKTLSVAVTNDN---GDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTSTLI 230 (232)
T ss_dssp CCTTCEEEEEEEEETTTTEEEEEEECTT---SCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEEEC
T ss_pred cCCCCEEEEEEEEeCCceEEEEEEecCC---CCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEeee
Confidence 7899999999999999999999998644 4567899999999999999999999999974 5899999999998765
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=1.5e-49 Score=397.65 Aligned_cols=223 Identities=34% Similarity=0.572 Sum_probs=195.8
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
|...+|+|++|++. ++.++ ||.+ .++.|+||+ .. .+.|||+|++||+|||+.+++++||+|+|+|.|.
T Consensus 1 a~~~sF~f~~F~~~---~l~l~GdA~~-~~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~ 76 (253)
T d1g7ya_ 1 ADIQSFSFKNFNSS---SFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIF 76 (253)
T ss_dssp CEEEEEEESSCCSS---CEEEEETCEE-ETTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECC
T ss_pred CcccEEecCCCCcc---cEEEEeeeEE-cCCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEe
Confidence 35689999999754 79999 9999 678899998 22 2789999999999999999999999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceee
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVS 182 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~ 182 (645)
+.....+||||||+|+|.+.. .+..||++|+++..+. ...++.|||||||++|. +||+++|||||+|++.|.++..
T Consensus 77 ~~~~~~ggDGlAF~l~~~~~~--~~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~d~~~~Hvgi~~ns~~s~~~~~ 153 (253)
T d1g7ya_ 77 APNKSSSADGIAFALVPVGSE--PKSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDWDPTSRHIGIDVNSIKSIRTAS 153 (253)
T ss_dssp CSSGGGCCCEEEEEEEETTCC--CCCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTTCCSSCEEEEEESSSSCSEEEE
T ss_pred cCCCCCCCCceEEEEeCCCCC--CCCCcccccccccCCC-CCcCceEEEEEeceecCCCCCCCCcEEEeeCCcccccccC
Confidence 877677899999999998754 3467889999986543 44577899999999996 8999999999999999998877
Q ss_pred ecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc---ceeeeEEEEEeec
Q 042831 183 WWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG---VDFAIFSIYSWEF 259 (645)
Q Consensus 183 ~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf 259 (645)
+ ++.+|+.++|||+||+.+++|+|+|.+.. +|..|++++.+||+.+|+++|||||||+|| ...+.|+|++|+|
T Consensus 154 ~--~~~~g~~~~v~I~Yd~~~~~L~v~l~~~~--~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF 229 (253)
T d1g7ya_ 154 W--GLANGQNAEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229 (253)
T ss_dssp C--CCCTTSEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEE
T ss_pred C--CccCCCEEEEEEEEeCCcEEEEEEEecCC--CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEe
Confidence 6 57899999999999999999999998643 677899999999999999999999999999 4678999999999
Q ss_pred cCcccc
Q 042831 260 NSSLEM 265 (645)
Q Consensus 260 ~~~~~~ 265 (645)
++.+++
T Consensus 230 ~s~lp~ 235 (253)
T d1g7ya_ 230 ASKLPD 235 (253)
T ss_dssp EEEECS
T ss_pred EEeCCC
Confidence 886544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=411.63 Aligned_cols=256 Identities=26% Similarity=0.403 Sum_probs=199.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--CCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--KKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--~~~~~lV 427 (645)
++|+..+.||+|+||+||+|++..+|+.||||.+... .+...+.+.+|++++++++||||+++++++.+ .+.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5788899999999999999999999999999998754 34456779999999999999999999999865 4568999
Q ss_pred EEecCCCChhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhhc--CCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 428 YEFMPNGSLDSHLFK---ENSLLTWEFRYKIAQDLASGLLYLQEEW--EQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
||||++|+|.+++.+ .+..+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3567999999999999999999999832 13499999999999999999999999999987
Q ss_pred ccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ....++...
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~----~~i~~~~~~--- 232 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELA----GKIREGKFR--- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----HHHHHTCCC---
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHH----HHHHcCCCC---
Confidence 65432 233456899999999999999999999999999999999999999975332 1222 222223221
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+...++ +.+.+++.+||+.||++|||++|+++|.|
T Consensus 233 --~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 233 --RIPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --CCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 1112222 35777889999999999999999998865
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=5.1e-49 Score=389.18 Aligned_cols=221 Identities=38% Similarity=0.653 Sum_probs=194.9
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC-----CceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR-----ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~-----~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ ..++.|+ ||.+.++|.|+||+ .. .++|||||++||+||+.. .++||+|+|+|.|.+.
T Consensus 2 ~~~sF~f~~F~~~-~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~--~~~sF~t~f~f~i~~~ 78 (233)
T d1n47a_ 2 ESTSFSFTNFNPN-QNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT--TLASFTTSFSFVMAAP 78 (233)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS--CBCEEEEEEEEECCCS
T ss_pred CceEEEeCCCCCC-CCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC--eeeeEEEEEEEEEeCC
Confidence 4789999999876 5689999 99987889999998 32 479999999999999863 5899999999999988
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeecc
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWS 185 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~~ 185 (645)
....+||||||+|+|.+. +.+..||+||+++..+. +..++.|||||||++|.+||++||||||+|++.|..+..+
T Consensus 79 ~~~~~gDGlAF~l~~~~~--~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~~d~~~~higi~~n~~~s~~~~~~-- 153 (233)
T d1n47a_ 79 AAAAVADGLAFFLAPPDT--QPQARGGFLGLFADRAH-DASYQTVAVEFDTYSNAWDPNYTHIGIDTNGIESKKTTPF-- 153 (233)
T ss_dssp STTSCCEEEEEEEECTTC--CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCTTSCSSCEEEEEESSSSCSEEEEC--
T ss_pred CCCCCCCceEEEECCCCC--CCCCCCCccccccccCC-CCcCceEEEEEEeeecCCCCCCCceeEccCCccccccccc--
Confidence 777889999999999874 44567899999976543 4567789999999999999999999999999999888776
Q ss_pred cCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc---ceeeeEEEEEeeccCc
Q 042831 186 DVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG---VDFAIFSIYSWEFNSS 262 (645)
Q Consensus 186 ~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf~~~ 262 (645)
++.+|+.++|||+||+.+++|.|++.+.. ++..|.+++.+||+++|+++|||||||+|| ...|.|+|++|+|+++
T Consensus 154 ~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 154 DMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp CCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred eecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEE
Confidence 57899999999999999999999998654 567889999999999999999999999999 5678999999999876
Q ss_pred c
Q 042831 263 L 263 (645)
Q Consensus 263 ~ 263 (645)
+
T Consensus 232 l 232 (233)
T d1n47a_ 232 L 232 (233)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=411.41 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=205.8
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
..++|...++||+|+||.||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3457788899999999999999986 47889999997543 345689999999999999999999998865 56789999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++|+|.+++... ...++|..++.|+.||++||.|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999987643 3469999999999999999999998 8999999999999999999999999999997765443
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+.. ...++. .+....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~----~i~~~~-----~~~~p~ 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQ----NLERGY-----RMVRPD 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHH----HHHTTC-----CCCCCT
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHH----HHHhcC-----CCCCcc
Confidence 344456789999999999999999999999999999999996655543222 111222 222221 111111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+ .+.+.+|+.+||+.||++||||+||++.|+
T Consensus 234 ~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 234 NC----PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 22 245778889999999999999999999885
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=400.45 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=203.0
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee----CCeEEEEE
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE----KKELLLVY 428 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~----~~~~~lV~ 428 (645)
...++||+|+||+||+|++..+++.||+|++... .....+.+.+|+++|++++||||+++++++.. +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3456799999999999999999999999998654 44556789999999999999999999999864 35689999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCC--eeeccCCCCCeEEC-CCCcEEEeeccCcccccc
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQC--VVHRDIKSSNIMLD-SNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~Dlkp~NILld-~~~~~kl~DfGla~~~~~ 505 (645)
||+++|+|.+++.+. ..+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999654 568999999999999999999998 66 99999999999996 578999999999986432
Q ss_pred cCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... . .+......+... +.
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~----~~~~~i~~~~~~----~~ 233 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--A----QIYRRVTSGVKP----AS 233 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--H----HHHHHHTTTCCC----GG
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--H----HHHHHHHcCCCC----cc
Confidence 23345689999999998865 6999999999999999999999999743321 1 122222222211 11
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+....+ ..+.+++.+||++||++|||++|+++|.|++
T Consensus 234 ~~~~~~----~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 FDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCccCC----HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112222 3467788999999999999999999998863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-49 Score=416.64 Aligned_cols=267 Identities=24% Similarity=0.324 Sum_probs=220.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
++|...++||+|+||.||+|++..+|+.||||++........+.+.+|++++++++||||+++++++.+++.+++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999999999999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC--CCCcEEEeeccCcccccccCCc
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD--SNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~kl~DfGla~~~~~~~~~ 509 (645)
++|+|.+++.+....+++..+..|+.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..... .
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~ 180 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--Q 180 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--S
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc--c
Confidence 9999999997766789999999999999999999999 9999999999999995 4678999999999876533 3
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+.. ..++.....
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~----i~~~~~--~~~~~~~~~ 251 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRN----VKSCDW--NMDDSAFSG 251 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH----HHHTCC--CSCCGGGGG
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCC--CCCcccccC
Confidence 344568999999999999999999999999999999999999999754321 12211 111111 011111111
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC-CCCCCCCCCC
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE-APLPALPPKM 636 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~~p~~~ 636 (645)
. .+.+.+++.+||+.||++|||++|+++|.|+. ...|..+...
T Consensus 252 ~----s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 252 I----SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp C----CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence 2 24567788999999999999999999998875 3334433333
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=409.38 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=207.7
Q ss_pred hcCCCCCC-ccCcCCcEEEEEEEEcC--CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQ-KLGQGGFGGVYKGFFRE--TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~-~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|...+ +||+|+||.||+|.++. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +.+++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 34555555 49999999999998753 4568999999765 34557889999999999999999999999865 56899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||||++|+|.+++...+..+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 999999999999987777789999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccC
Q 042831 507 KGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD 583 (645)
Q Consensus 507 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d 583 (645)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+. ..+.+|...+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~~--- 232 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRME--- 232 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCCC---
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCC---
Confidence 322 2233568999999999999999999999999999999998 99999864432 122 2233333221
Q ss_pred ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 584 PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 584 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..... ...+.+|+.+||+.||++||||.+|++.|+
T Consensus 233 --~p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 233 --CPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp --CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11222 245678889999999999999999988876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=409.32 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=203.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCC----eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETN----SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
..|+..++||+|+||.||+|.++.++ ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46777899999999999999987654 47999999754 34456689999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
|||||.+++|.+++......++|.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999888777889999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ..+. ....++.. +
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~~~-----~ 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDGFR-----L 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTTCC-----C
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhccCC-----C
Confidence 222 223456899999999999999999999999999999999976665433221 1122 22222211 1
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+......+.+|+.+||+.||++||||+||++.|+.
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 1122233567889999999999999999999999975
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=4e-49 Score=391.86 Aligned_cols=224 Identities=38% Similarity=0.668 Sum_probs=197.4
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C-----CCceEEEEeCCceecccCCCCCccceeEEEEEEEeeC
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N-----RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSR 105 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~-----~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~ 105 (645)
.+++|+|++|.++ ..++.++ ||.+.++|.||||+ . ..++|||+|++||+||++.+++++||+|+|+|.|.+.
T Consensus 2 ~~~sF~f~~F~~~-~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~ 80 (237)
T d1fnya_ 2 GSLSFSFPKFAPN-QPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAP 80 (237)
T ss_dssp EEEEEEESSCCTT-CTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred ceEEEEeCCCCCC-CCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecC
Confidence 4789999999876 6789999 99988889999998 2 2478999999999999999999999999999999988
Q ss_pred CCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC-CCCCCCceeeecCCCcccceeeec
Q 042831 106 NSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS-WDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 106 ~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~-~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
....+||||||+|+|.+. +.+..||+||+++..+ .+..++.+||||||++|. +||+++|||||+|++.|..+...
T Consensus 81 ~~~~~gDG~AF~l~~~~~--~~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~d~~~~Higi~~n~~~s~~~~~~- 156 (237)
T d1fnya_ 81 NPATTADGLAFFLAPVDT--QPLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDWDPKGRHLGINVNSIESIKTVPW- 156 (237)
T ss_dssp STTSCCEEEEEEEEETTC--CCCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTTCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCeeEEEEcCCCC--CcccccCcccccCCCC-ccCccceEEEEeccccccCCCCCCceEEEecCCCcccccccc-
Confidence 777889999999999875 3456788999997643 456788999999999996 89999999999999999877765
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc---ceeeeEEEEEeeccC
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG---VDFAIFSIYSWEFNS 261 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf~~ 261 (645)
++.+|+.++|||+||+.+++|.|+|.+.+ ++..+++++.+||+.+++++|||||||+|| ...|.|+|++|+|++
T Consensus 157 -~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s 233 (237)
T d1fnya_ 157 -NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFES 233 (237)
T ss_dssp -CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEE
T ss_pred -cccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEE
Confidence 57799999999999999999999998765 466889999999999999999999999999 566899999999988
Q ss_pred ccc
Q 042831 262 SLE 264 (645)
Q Consensus 262 ~~~ 264 (645)
+++
T Consensus 234 ~lp 236 (237)
T d1fnya_ 234 NLP 236 (237)
T ss_dssp EEC
T ss_pred eCC
Confidence 753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=419.02 Aligned_cols=267 Identities=25% Similarity=0.368 Sum_probs=211.7
Q ss_pred HhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEE
Q 042831 349 LATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 349 ~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
...++|+..++||+|+||+||+|++..+|+.||+|+++... ....+++.+|+.+|++++|||||+++++|.+++++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999999999999999997653 34457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||||++|+|.+++.+. ..+++..+..++.||++||.|||+. .+|+||||||+|||++.++++||+|||+|+.....
T Consensus 83 mEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999654 4689999999999999999999971 37999999999999999999999999999865432
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC-----------C
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN-----------G 576 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-----------~ 576 (645)
......||+.|+|||++.+..++.++||||+||++|||++|+.||............ ....... +
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HHHhcCCcccCCccccccc
Confidence 233468999999999999999999999999999999999999999765432211000 0000000 0
Q ss_pred cc--------------cc-------ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 577 KL--------------LE-------AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 577 ~l--------------~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .+ ...+.+.. ......+.+++.+||+.||++|||++|+++|.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~ 302 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS---GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCB---TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCcc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence 00 00 00000000 01124577788999999999999999999998763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-49 Score=414.16 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=220.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|+..++||+|+||.||+|++..+|+.||||+++.......+.+.+|++++++++||||+++++++.+++.+++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999999999999999999877666677889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC--CCCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD--SNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld--~~~~~kl~DfGla~~~~~~~~ 508 (645)
|++|+|.+++...+..+++..++.|+.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 99999999887777789999999999999999999998 9999999999999998 6789999999999876543
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+... ...+... .++....
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~----i~~~~~~--~~~~~~~ 253 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQN----VKRCDWE--FDEDAFS 253 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHH----HHHCCCC--CCSSTTT
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCCCC--CCccccc
Confidence 2344567999999999999999999999999999999999999999754321 22221 1111111 1111112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCCCCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAPLPAL 632 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~~ 632 (645)
.. ...+.+|+.+||+.||++|||++|+++|.|+......+
T Consensus 254 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~ 293 (352)
T d1koba_ 254 SV----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293 (352)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchh
Confidence 22 24567888999999999999999999998876544433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-50 Score=408.38 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=207.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..+.||+|+||+||+|++..+|+.||||++... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688899999999999999999999999999998643 2334567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC-
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK- 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~- 507 (645)
|||++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988644 569999999999999999999999 999999999999999999999999999998765433
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+. ....++.. .+.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~----~~i~~~~~------~~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIF----QKIIKLEY------DFP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH----HHHHTTCC------CCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HHHH----HHHHcCCC------CCC
Confidence 2334456799999999999999999999999999999999999999975432 1111 22222221 111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQV------IHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev------l~~L~~~ 626 (645)
..+ ...+.+|+.+||+.||++|||++|+ ++|.+++
T Consensus 231 ~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~ 271 (288)
T d1uu3a_ 231 EKF----FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271 (288)
T ss_dssp TTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred ccC----CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence 122 2456788899999999999999985 5665554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=410.44 Aligned_cols=257 Identities=28% Similarity=0.389 Sum_probs=207.9
Q ss_pred hhcCCCCCCccCcCCcEEEEEEEEcCCC-----eEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCC
Q 042831 350 ATNDFNDDQKLGQGGFGGVYKGFFRETN-----SYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKK 422 (645)
Q Consensus 350 ~~~~f~~~~~LG~G~fG~Vy~g~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~ 422 (645)
..++|+..++||+|+||+||+|++..++ ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 4467888999999999999999987544 37999998654 334557899999999998 8999999999999999
Q ss_pred eEEEEEEecCCCChhhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCC
Q 042831 423 ELLLVYEFMPNGSLDSHLFKEN----------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIK 480 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 480 (645)
..++|||||++|+|.+++.... ..+++..++.++.||++||.|||+ ++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 9999999999999999996543 358999999999999999999999 899999999
Q ss_pred CCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCC
Q 042831 481 SSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKA 558 (645)
Q Consensus 481 p~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~ 558 (645)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2234568999999999999999999999999999999997 899997644
Q ss_pred CCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 559 PQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 559 ~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
... .+ .....++.. +.. +....+.+.+|+.+||+.||++||||+||+++|.
T Consensus 272 ~~~--~~----~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA--NF----YKLIQNGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH--HH----HHHHHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HH----HHHHhcCCC-----CCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 11 122222211 111 1112346778899999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=399.51 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=198.1
Q ss_pred CccCcCCcEEEEEEEEcC--CCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEecCC
Q 042831 358 QKLGQGGFGGVYKGFFRE--TNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFMPN 433 (645)
Q Consensus 358 ~~LG~G~fG~Vy~g~~~~--~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~~~ 433 (645)
++||+|+||.||+|.+.. +++.||||+++.. .....++|.+|++++++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 4578999998653 33446789999999999999999999999965 457899999999
Q ss_pred CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcc--e
Q 042831 434 GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQ--T 511 (645)
Q Consensus 434 gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~--~ 511 (645)
|+|.+++.+ ...+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999998864 4569999999999999999999998 899999999999999999999999999998765433322 2
Q ss_pred eecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCC
Q 042831 512 TVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDF 590 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~ 590 (645)
....||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... . +...+.++.... ....+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~~~~-----~p~~~ 235 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMG-----CPAGC 235 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCC-----CCTTC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCCCCC-----CCccc
Confidence 34578999999999999999999999999999999998 89999754321 1 222233332211 11122
Q ss_pred CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 591 DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 591 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
...+.+|+.+||+.||++||||++|++.|+
T Consensus 236 ----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 236 ----PREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 245678889999999999999999987764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=407.64 Aligned_cols=257 Identities=21% Similarity=0.332 Sum_probs=196.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.+.|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456888999999999999999999999999999997543 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEEeeccCccccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl~DfGla~~~~~~ 506 (645)
||++|+|.+++.+ ...+++..+..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999999964 4579999999999999999999998 9999999999999994 5789999999999865432
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....++... .+...
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~~~--~~~~~ 232 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF----EQILKAEYE--FDSPY 232 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHTTCCC--CCTTT
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHhccCCC--CCCcc
Confidence 2 234467999999999999999999999999999999999999999753321 111 112222211 11111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... ...+.+++.+||+.||++|||++|+++|.++.
T Consensus 233 ~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 268 (307)
T d1a06a_ 233 WDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268 (307)
T ss_dssp TTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred ccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence 1222 24577888999999999999999999998875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-48 Score=404.60 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=206.5
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
.|+..++||+|+||.||+|++..+|+.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999999999999999987543 3445679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
||++|+|..++. .+..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 999999976654 44679999999999999999999999 8999999999999999999999999999986533
Q ss_pred ceeecccCccccCcccccc---CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccc
Q 042831 510 QTTVLAGTMGYMAPECATT---GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRL 586 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~---~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l 586 (645)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... +....... +......
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~-~~~~~~~---- 235 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPALQ---- 235 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCS----
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCCCCCC----
Confidence 234579999999999854 46899999999999999999999999754321 11111111 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 587 CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 587 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
...+ .+.+.+++.+||+.||++|||++|+++|.+..
T Consensus 236 ~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 236 SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCC----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 1112 24577888999999999999999999988764
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=1.5e-47 Score=381.51 Aligned_cols=224 Identities=36% Similarity=0.706 Sum_probs=197.9
Q ss_pred ceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEEEee
Q 042831 33 SALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDS 104 (645)
Q Consensus 33 ~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~ 104 (645)
.+++|+|++|.++ ..++.|+ ||.+ .++.|+||+ . ..++|||+|++||+||++.+++++||+|+|+|.|..
T Consensus 2 ~~~sF~f~~F~~~-~~~l~l~G~A~i-~~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~ 79 (241)
T d1ukga_ 2 DSLSFGFPTFPSD-QKNLIFQGDAQI-KNNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKS 79 (241)
T ss_dssp CEEEEEESSCCSC-CSSEEEEETCEE-ETTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEEC
T ss_pred ccEEEEeCCCCCC-CCCEEEeeeEEE-eCCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEec
Confidence 4789999999876 5689999 9999 578899998 2 237899999999999999999999999999999987
Q ss_pred CCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCC-CCCCCCCEEEEEEecccCC----CCCCCCceeeecCCCcccc
Q 042831 105 RNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNE-PLNSSIPFVAVEFDVYVNS----WDPTFSHVGIDINSVKSKK 179 (645)
Q Consensus 105 ~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEfDt~~n~----~d~~~~hvgidvns~~s~~ 179 (645)
+. ...|||+|||++|.....|...+|+++|+++... .+...++.|||||||++|. +||++||||||+|++.|.+
T Consensus 80 ~~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~ 158 (241)
T d1ukga_ 80 PL-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVK 158 (241)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSE
T ss_pred CC-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCccccc
Confidence 64 4569999999999887778888899999987654 3356789999999999874 5789999999999999988
Q ss_pred eeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeec
Q 042831 180 NVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF 259 (645)
Q Consensus 180 ~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf 259 (645)
+..+ ++.+|+.++|||+||+.+++|+|++...+ +..|.+++.|||+++|+++|||||||+||...|.|+|++|+|
T Consensus 159 ~~~~--~~~~g~~~~v~I~Yd~~~~~L~v~~~~~~---~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF 233 (241)
T d1ukga_ 159 TVKW--DRRDGQSLNVLVTFNPSTRNLDVVATYSD---GTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSF 233 (241)
T ss_dssp EEEC--CCCTTCCEEEEEEEETTTTEEEEEEEETT---CCEEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEE
T ss_pred cccc--ccCCCcEEEEEEEEeCCCcEEEEEEccCC---CCceEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEE
Confidence 7765 57899999999999999999999998744 556789999999999999999999999999999999999999
Q ss_pred cCccc
Q 042831 260 NSSLE 264 (645)
Q Consensus 260 ~~~~~ 264 (645)
++.++
T Consensus 234 ss~l~ 238 (241)
T d1ukga_ 234 TSTLL 238 (241)
T ss_dssp EEEEE
T ss_pred EEEee
Confidence 98765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=401.49 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=200.3
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|+..+.||+|+||.||+|+++++ +.||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 35788899999999999999999764 679999986543 345789999999999999999999999865 567899999
Q ss_pred cCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 431 MPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 431 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|++|+|..++... ...++|.+++.|+.||+.||+|||+ ++|+||||||+|||+|.++.+||+|||+++........
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 9999999888753 4579999999999999999999999 89999999999999999999999999999877554444
Q ss_pred ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCC
Q 042831 510 QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRD 589 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~ 589 (645)
......||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+..++ ..+. .+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i----~~~~-----~~~~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGY-----RMPCPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTC-----CCCCCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HhcC-----CCCCCcc
Confidence 44556799999999999999999999999999999999997766654332 11222222 2221 1111122
Q ss_pred CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 590 FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 590 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. .+.+.+++.+||+.||++||||++|++.|+.
T Consensus 239 ~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 239 C----PESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred c----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 2 3467788999999999999999999998864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=398.58 Aligned_cols=257 Identities=22% Similarity=0.291 Sum_probs=212.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC------hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS------KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~ 424 (645)
.++|...+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357888999999999999999999999999999986432 12357899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC----cEEEeeccCc
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF----NAKIGDFGLA 500 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~----~~kl~DfGla 500 (645)
+||||||++|+|.+++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999998654 469999999999999999999999 9999999999999998776 5999999999
Q ss_pred ccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 501 RLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 501 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .....+...
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~~~- 234 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANVSAVNYE- 234 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHTTCCC-
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHH----HHHHhcCCC-
Confidence 8764332 334457899999999999999999999999999999999999999754321 111 111122110
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..+...... ...+.+++.+||+.||++|||++|+++|.++.
T Consensus 235 -~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 235 -FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp -CCHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred -CCchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 011111111 24567888999999999999999999999886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=396.12 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=199.4
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.++|+..+.||+|+||.||+|++..+ +..||||.++.. .....+.|.+|++++++++||||++++++|. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 35788889999999999999998643 467999998654 3445678999999999999999999999996 467899
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
||||+++|+|.+++......+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 999999999999987777889999999999999999999999 99999999999999999999999999999877655
Q ss_pred CCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcc
Q 042831 507 KGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPR 585 (645)
Q Consensus 507 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~ 585 (645)
.........||+.|+|||++.++.++.++|||||||++|||++ |+.||...... .+... ..++... .
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~----i~~~~~~-----~ 229 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERL-----P 229 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCC-----C
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH----HHcCCCC-----C
Confidence 5445556678999999999999999999999999999999998 89999765432 22222 2223221 1
Q ss_pred ccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 586 LCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 586 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..... .+.+.+|+..||+.||++|||++||+++|+
T Consensus 230 ~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 230 MPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11222 246778889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=401.96 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=204.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCe----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNS----YIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~l 426 (645)
.+|+..++||+|+||+||+|.+..+|+ .||+|+++.. +.+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468889999999999999999987765 6899988654 445678899999999999999999999999865 5678
Q ss_pred EEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccccccc
Q 042831 427 VYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHA 506 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~ 506 (645)
++||+.+|+|.+++......+++..++.++.|||+||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 899999999999998888889999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 507 KGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 507 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
... ......||+.|+|||++.++.++.++|||||||+||||+| |+.||......+ +.. ...++...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~~----- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL----- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCCC-----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC-----
Confidence 332 2334568999999999999999999999999999999998 888987544322 222 12222111
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
..+......+.+|+.+||+.||++|||++|++++|+.
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 1111223467788999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-48 Score=399.05 Aligned_cols=263 Identities=26% Similarity=0.397 Sum_probs=213.6
Q ss_pred HHHHHhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCccEEEeee
Q 042831 345 KELALATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQGS-KQGIKEYASEVKIISRLRHRNLVQLLGWC 418 (645)
Q Consensus 345 ~el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~ 418 (645)
.+++...++|+..+.||+|+||+||+|++++ +++.||||+++... .+..++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 3455566789999999999999999999863 46789999997653 34567899999999999999999999999
Q ss_pred eeCCeEEEEEEecCCCChhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCee
Q 042831 419 HEKKELLLVYEFMPNGSLDSHLFKEN-----------------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVV 475 (645)
Q Consensus 419 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 475 (645)
...+..++||||+++|+|.+++.... ..+++..++.|+.|++.||+|||+ ++++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeE
Confidence 99999999999999999999986421 248999999999999999999998 9999
Q ss_pred eccCCCCCeEECCCCcEEEeeccCcccccccCC-cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCC-CC
Q 042831 476 HRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG-SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR-KP 553 (645)
Q Consensus 476 H~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~-~p 553 (645)
||||||+|||+|.++.+||+|||+++....... .......|++.|+|||++.+..++.++|||||||++|||++|. .|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999986644332 2334567899999999999999999999999999999999986 56
Q ss_pred CCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 554 INPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 554 f~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
|...... .+.. ...++.... ..... ...+.+|+.+||+.||++||||.||+++|+.-
T Consensus 243 ~~~~~~~---e~~~----~v~~~~~~~-----~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMAHE---EVIY----YVRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSCHH---HHHH----HHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCHH---HHHH----HHHcCCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 7643321 2222 223333221 11122 24677889999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=399.10 Aligned_cols=253 Identities=28% Similarity=0.387 Sum_probs=213.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|...+.||+|+||.||+|++..+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+++.+++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5788899999999999999999999999999999753 2334678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|||++|+|.+++.+. ..+++...+.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-G 159 (337)
T ss_dssp ECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-T
T ss_pred eccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC-C
Confidence 999999999988654 468999999999999999999999 99999999999999999999999999999865432 2
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. ....+.. .+..
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~----~i~~~~~------~~p~ 226 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFE----LILMEEI------RFPR 226 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CCCT
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHH----HHhcCCC------CCCc
Confidence 3344568999999999999999999999999999999999999999864421 2222 2222221 1112
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.++ ..+.+|+..||++||++||+ ++|+++|.++.
T Consensus 227 ~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 227 TLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp TSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred cCC----HHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 222 35677889999999999994 89999998874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=396.59 Aligned_cols=275 Identities=23% Similarity=0.271 Sum_probs=209.5
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChh-----hHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEec
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQ-----GIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEFM 431 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey~ 431 (645)
+++||+|+||+||+|++..+|+.||||+++..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999999999999999998654221 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCcce
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGSQT 511 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~~~ 511 (645)
.++++..+. ..+..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 887766554 456678999999999999999999999 9999999999999999999999999999986544322 23
Q ss_pred eecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccC-------
Q 042831 512 TVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVD------- 583 (645)
Q Consensus 512 ~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d------- 583 (645)
....||+.|+|||++..+ .++.++|||||||++|||++|+.||...... .....+.+...........+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhccchh
Confidence 345799999999998755 5799999999999999999999999754432 22333333222111100000
Q ss_pred --ccccCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC-CCCCCCCCCCCCC
Q 042831 584 --PRLCRDFDGQ-----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE-APLPALPPKMPVP 639 (645)
Q Consensus 584 --~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~~p~~~p~~ 639 (645)
-......+.. ..+.+.+|+.+||+.||++|||++|+++|.++. .|.|.-+...|.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p 298 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence 0000111111 124678889999999999999999999999875 5555544444443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-47 Score=396.76 Aligned_cols=250 Identities=27% Similarity=0.370 Sum_probs=209.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..++||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999999999999999998643 2334678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|||++|+|..++.. +..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 99999999887754 4568899999999999999999998 99999999999999999999999999999875432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+.. ...++.. .+..
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~----~i~~~~~------~~p~ 222 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYE----KILNAEL------RFPP 222 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHCCC------CCCT
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHH----HHHcCCC------CCCC
Confidence 23467999999999999999999999999999999999999999754321 1111 1112211 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
..+ ..+.+++.+||++||++|| |++|+++|.++.
T Consensus 223 ~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~ 261 (316)
T d1fota_ 223 FFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261 (316)
T ss_dssp TSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred CCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence 222 3567788999999999996 999999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-47 Score=384.54 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=210.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh---------hhHHHHHHHHHHHHhcC-CCCccEEEeeeeeC
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK---------QGIKEYASEVKIISRLR-HRNLVQLLGWCHEK 421 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~ 421 (645)
++|+..+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578889999999999999999999999999999865421 12346889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+..+||||||++|+|.+++..+ ..+++.+++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999654 468999999999999999999998 899999999999999999999999999998
Q ss_pred cccccCCcceeecccCccccCcccccc------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATT------GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN 575 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~ 575 (645)
...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .. .....+
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~---~~----~~~i~~ 229 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM----LRMIMS 229 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHH
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH---HH----HHHHHh
Confidence 765432 3344679999999998853 34688999999999999999999999854321 11 112222
Q ss_pred CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 576 GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 576 ~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
+... . ....... ..+.+.+++.+||++||++|||++|+++|.|+.
T Consensus 230 ~~~~-~-~~~~~~~----~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~ 274 (277)
T d1phka_ 230 GNYQ-F-GSPEWDD----YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274 (277)
T ss_dssp TCCC-C-CTTTGGG----SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred CCCC-C-CCccccc----CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHH
Confidence 2211 0 0101111 224677888999999999999999999998875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-47 Score=399.48 Aligned_cols=254 Identities=25% Similarity=0.325 Sum_probs=206.0
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC---hhhHHHHH---HHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS---KQGIKEYA---SEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~---~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
++|...++||+|+||.||+|++..+|+.||||++.... ......+. .|+++++.++||||+++++++.+.+.++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999999999999999986431 12223333 4467777788999999999999999999
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|||||++|+|.+++.+. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999998654 568899999999999999999999 9999999999999999999999999999986643
Q ss_pred cCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCc
Q 042831 506 AKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDP 584 (645)
Q Consensus 506 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~ 584 (645)
. ......||+.|+|||++..+ .++.++|||||||+||||++|+.||......+...+. ...... ..
T Consensus 160 ~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~------~~ 226 (364)
T d1omwa3 160 K---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------AV 226 (364)
T ss_dssp S---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC------CC
T ss_pred C---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC------CC
Confidence 2 23446799999999998754 5899999999999999999999999865443322111 111111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHhccC
Q 042831 585 RLCRDFDGQQIERLMIVGLWCAHPDENLRPS-----IRQVIHVLNFE 626 (645)
Q Consensus 585 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~L~~~ 626 (645)
.+...++ ..+.+++.+||+.||++||| ++|+++|.|+.
T Consensus 227 ~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 227 ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp CCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred CCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 1111222 35678889999999999999 79999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=387.63 Aligned_cols=248 Identities=31% Similarity=0.439 Sum_probs=196.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~~~lV~E 429 (645)
.++|+..+.||+|+||.||+|+++ |..||||+++... ..++|.+|++++++++||||++++|+|.+ .+.+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 346677889999999999999985 6789999996543 44689999999999999999999999865 466899999
Q ss_pred ecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 430 FMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 430 y~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
|+++|+|.+++.+. ...++|..+++|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999999754 3468999999999999999999999 89999999999999999999999999999865432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.....++..|+|||++.++.++.++|||||||++|||+| |+.||...... .+..++ .++.. +.+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i----~~~~~-----~~~~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV----EKGYK-----MDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH----TTTCC-----CCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH----HcCCC-----CCCC
Confidence 223467899999999999999999999999999999998 67877654322 223222 22221 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. .....+.+|+.+||+.||++||||+|++++|+.
T Consensus 223 ~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1 222467788899999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=391.01 Aligned_cols=259 Identities=19% Similarity=0.251 Sum_probs=213.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEEe
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYEF 430 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~Ey 430 (645)
.++|...+.||+|+||+||+|++..+++.||||.++.... ....+.+|+++|++++||||+++++++.+++.+++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 3578889999999999999999999999999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC--CCcEEEeeccCcccccccCC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS--NFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~--~~~~kl~DfGla~~~~~~~~ 508 (645)
|++|+|.+++...+..+++.++..++.||++||.|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 99999999997766689999999999999999999998 99999999999999984 458999999999865432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+.++... ++.....
T Consensus 158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~----~i~~~~~~--~~~~~~~ 228 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE----NIMNAEYT--FDEEAFK 228 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHTCCC--CCHHHHT
T ss_pred CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCCC--CChhhcc
Confidence 2344567899999999999999999999999999999999999999754321 1111 11111110 1111111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCCC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEAP 628 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 628 (645)
.. ...+.+++..||+.||++|||++|+++|.|+...
T Consensus 229 ~~----s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 229 EI----SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 12 2356788899999999999999999999887543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=387.49 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=198.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCC---CeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRET---NSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~---~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~ 425 (645)
++|+..+.||+|+||.||+|++... ...||||++... ..+..++|.+|++++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688889999999999999987532 247999988654 34456789999999999999999999999975 4678
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
+|||||++|+|.+++......+++..++.++.|||.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999888777789999999999999999999999 8999999999999999999999999999997654
Q ss_pred cCCc--ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchhHHHHHHHHhcCCcccccc
Q 042831 506 AKGS--QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAV 582 (645)
Q Consensus 506 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~ 582 (645)
.... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...... .... .....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~---~i~~~~~~~--- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILH---KIDKEGERL--- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHHTSCCCC---
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHH---HHHhCCCCC---
Confidence 3332 2233567889999999999999999999999999999998 89999754322 2222 222222111
Q ss_pred CccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 583 DPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 583 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...... ...+.+++.+||+.||++||||+||++.|..
T Consensus 235 --~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 --PRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111122 2457788999999999999999999998863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=389.58 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=203.8
Q ss_pred CCccCcCCcEEEEEEEEcCCC---eEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee-CCeEEEEEEec
Q 042831 357 DQKLGQGGFGGVYKGFFRETN---SYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE-KKELLLVYEFM 431 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~-~~~~~lV~Ey~ 431 (645)
.++||+|+||+||+|++..++ ..||||+++.. +....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 467999999999999986543 46999999753 55567889999999999999999999999875 56899999999
Q ss_pred CCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc--
Q 042831 432 PNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-- 509 (645)
Q Consensus 432 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-- 509 (645)
++|+|.+++......+++..+.+++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998777788999999999999999999998 89999999999999999999999999999876543222
Q ss_pred -ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 510 -QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 510 -~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... .+..++ .+|... ..|.
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~~--~~p~--- 257 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRRL--LQPE--- 257 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCCC--CCCT---
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCCCC--CCcc---
Confidence 2233568999999999999999999999999999999999888876433221 122222 223211 1121
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
.. .+.+.+|+.+||+.||++||||+||+++|+.
T Consensus 258 ~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 258 YC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11 2457788899999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=392.70 Aligned_cols=253 Identities=29% Similarity=0.417 Sum_probs=203.3
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCe--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNS--YIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~~~~~lV 427 (645)
++|+..++||+|+||.||+|+++.+|. .||||+++.. ..+..++|.+|+++|.++ +||||++++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577788999999999999999988776 4788887644 444567899999999998 799999999999999999999
Q ss_pred EEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 428 YEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
|||+++|+|.++++.. ...+++.++.+++.|||.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 9999999999998643 3679999999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCC-CCCCCCCCCchhHHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRK-PINPKAPQGQVSLLQWVWD 571 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~-pf~~~~~~~~~~l~~~~~~ 571 (645)
||+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+. .
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~----~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELY----E 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHH----H
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHH----H
Confidence 9999999986543222 233468999999999999999999999999999999999764 5654321 1122 2
Q ss_pred HhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 572 LYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 572 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
...++.. +.. +....+.+.+|+.+||+.||++||||+||+++|+.
T Consensus 238 ~i~~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 238 KLPQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HGGGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222211 111 11223467788899999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=389.83 Aligned_cols=262 Identities=26% Similarity=0.365 Sum_probs=200.6
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCccEEEeee
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQG-SKQGIKEYASEVKIISRL-RHRNLVQLLGWC 418 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~ 418 (645)
+++...++|...++||+|+||.||+|++.. +++.||||+++.. .....+.+.+|...+.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 333445678889999999999999999754 3478999998754 344567788899988887 689999999998
Q ss_pred eeC-CeEEEEEEecCCCChhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCC
Q 042831 419 HEK-KELLLVYEFMPNGSLDSHLFKE---------------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSS 482 (645)
Q Consensus 419 ~~~-~~~~lV~Ey~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~ 482 (645)
... +.+++|||||++|+|.+++... ...+++.++..++.||++||.|||+ ++|+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcc
Confidence 764 5689999999999999999643 2358999999999999999999999 89999999999
Q ss_pred CeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCCC
Q 042831 483 NIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR-KPINPKAPQ 560 (645)
Q Consensus 483 NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~-~pf~~~~~~ 560 (645)
|||+++++++||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||++|. .||......
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999866543322 334467999999999999999999999999999999999864 577644332
Q ss_pred CchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 561 GQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 561 ~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
. .+.....++... ...... ...+.+++.+||+.||++|||++|++++|+.
T Consensus 244 ~------~~~~~~~~~~~~-----~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 244 E------EFCRRLKEGTRM-----RAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp H------HHHHHHHHTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H------HHHHHHhcCCCC-----CCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 122222222221 111112 2457788899999999999999999999963
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=391.40 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=215.6
Q ss_pred CCccChHH-HHHhhcCCCCCCccCcCCcEEEEEEEEc-----CCCeEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCC
Q 042831 339 PKRFPYKE-LALATNDFNDDQKLGQGGFGGVYKGFFR-----ETNSYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRN 410 (645)
Q Consensus 339 ~~~~~~~e-l~~~~~~f~~~~~LG~G~fG~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~n 410 (645)
|++++++. ++...++|+..++||+|+||.||+|++. .+++.||||+++... .....+|.+|+.++.++ +|||
T Consensus 9 ~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hpn 88 (311)
T d1t46a_ 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88 (311)
T ss_dssp TTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCC
Confidence 45555533 3345578888999999999999999873 456799999997653 44566899999999999 6999
Q ss_pred ccEEEeeeeeCCeEEEEEEecCCCChhhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCC
Q 042831 411 LVQLLGWCHEKKELLLVYEFMPNGSLDSHLFKEN-----------------SLLTWEFRYKIAQDLASGLLYLQEEWEQC 473 (645)
Q Consensus 411 lv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 473 (645)
||+++++|.+++..++|||||++|+|.+++.... ..+++..+..++.||++||.|||+ ++
T Consensus 89 Iv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ 165 (311)
T d1t46a_ 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KN 165 (311)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred EEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 9999999999999999999999999999986532 258999999999999999999999 89
Q ss_pred eeeccCCCCCeEECCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CC
Q 042831 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GR 551 (645)
Q Consensus 474 ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~ 551 (645)
++||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+
T Consensus 166 ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCC
Confidence 999999999999999999999999999876544332 3344678999999999999999999999999999999999 45
Q ss_pred CCCCCCCCCCchhHHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 552 KPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 552 ~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+||......+. ++....++. .+. .+......+.+|+.+||+.||++||||+|+++.|+.
T Consensus 246 p~~~~~~~~~~------~~~~i~~~~-----~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 246 SPYPGMPVDSK------FYKMIKEGF-----RML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp CSSTTCCSSHH------HHHHHHHTC-----CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHH------HHHHHhcCC-----CCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 55544332211 112222221 111 111123567888999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-46 Score=395.65 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=210.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~ 428 (645)
++|+..++||+|+||.||+|+++.+|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKG 508 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~ 508 (645)
||+.+|+|..++.+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999998654 468999999999999999999998 89999999999999999999999999999876432
Q ss_pred cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCccccC
Q 042831 509 SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLCR 588 (645)
Q Consensus 509 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~~ 588 (645)
.....||+.|||||++.+..++.++|||||||++|||++|+.||..... ..+... ...+.. ....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~----i~~~~~------~~p~ 259 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEK----IVSGKV------RFPS 259 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH----HHHCCC------CCCT
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---HHHHHH----HhcCCC------CCCc
Confidence 2346799999999999999999999999999999999999999975432 122221 112211 1111
Q ss_pred CCCHHHHHHHHHHHHHcCCCCCCCC-----CCHHHHHHHhccC
Q 042831 589 DFDGQQIERLMIVGLWCAHPDENLR-----PSIRQVIHVLNFE 626 (645)
Q Consensus 589 ~~~~~~~~~l~~l~~~Cl~~dP~~R-----Ps~~evl~~L~~~ 626 (645)
..+ ..+.+++.+||+.||.+| ||++|+++|.|+.
T Consensus 260 ~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~ 298 (350)
T d1rdqe_ 260 HFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298 (350)
T ss_dssp TCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred cCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence 222 356788899999999999 4999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-46 Score=378.85 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=202.0
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----e
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK----E 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~----~ 423 (645)
.++|...+.||+|+||.||+|++..+|+.||||+++.. ..+..+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46788999999999999999999999999999999754 2344567999999999999999999999987643 4
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+++++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++..+|+|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 79999999999999888554 468999999999999999999998 99999999999999999999999999998765
Q ss_pred cccCC--cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 504 EHAKG--SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 504 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...... +........+....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~- 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP- 234 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCG-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCC-
Confidence 43322 2334567999999999999999999999999999999999999999754321 22222222222211
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-SIRQVIHVLN 624 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~ 624 (645)
.......+ +.+.+++.+||++||++|| |++++++.|.
T Consensus 235 --~~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 235 --SARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp --GGTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred --chhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 11111222 4567788999999999999 8999988764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-47 Score=391.91 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=209.2
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC---ChhhHHHHHHHHHHHH-hcCCCCccEEEeeeeeCCeEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG---SKQGIKEYASEVKIIS-RLRHRNLVQLLGWCHEKKELLLV 427 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~nlv~l~~~~~~~~~~~lV 427 (645)
++|...+.||+|+||+||+|++..+|+.||||+++.. .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788899999999999999999999999999999653 2334556777777765 68999999999999999999999
Q ss_pred EEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccC
Q 042831 428 YEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 428 ~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~ 507 (645)
||||++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999998644 468999999999999999999999 899999999999999999999999999998654332
Q ss_pred CcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccccCcccc
Q 042831 508 GSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEAVDPRLC 587 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~~d~~l~ 587 (645)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ++.....+. +.+.
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~----~~~~i~~~~------~~~p 223 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---E----LFHSIRMDN------PFYP 223 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCC------CCCC
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCC------CCCC
Confidence 3344567999999999999999999999999999999999999999754321 1 222222221 1111
Q ss_pred CCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHhccC
Q 042831 588 RDFDGQQIERLMIVGLWCAHPDENLRPSIR-QVIHVLNFE 626 (645)
Q Consensus 588 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~~L~~~ 626 (645)
...+ ..+.+|+.+||+.||++|||++ |+++|.++.
T Consensus 224 ~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~ 259 (320)
T d1xjda_ 224 RWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259 (320)
T ss_dssp TTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGT
T ss_pred ccCC----HHHHHHHHHhcccCCCCCcCHHHHHHhCchhc
Confidence 2222 3567888999999999999996 899887764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=386.27 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=206.5
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCC-------eEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCccEEEeeeeeC
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETN-------SYIAVKRVSQGS-KQGIKEYASEVKIISRL-RHRNLVQLLGWCHEK 421 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~~ 421 (645)
.++|...+.||+|+||.||+|+...++ ..||||+++.+. .....++.+|...+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 457778899999999999999976543 479999997654 35568899999999988 799999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEE
Q 042831 422 KELLLVYEFMPNGSLDSHLFKEN---------------SLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIML 486 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILl 486 (645)
+..++|||||++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999996442 458999999999999999999999 999999999999999
Q ss_pred CCCCcEEEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCCCchh
Q 042831 487 DSNFNAKIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIAC-GRKPINPKAPQGQVS 564 (645)
Q Consensus 487 d~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~ellt-G~~pf~~~~~~~~~~ 564 (645)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |+.||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----- 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence 99999999999999877544332 3344678999999999999999999999999999999998 7888864332
Q ss_pred HHHHHHHHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcc
Q 042831 565 LLQWVWDLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNF 625 (645)
Q Consensus 565 l~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 625 (645)
+.++..+.++... ...... ...+.+|+.+||+.||++|||+.||++.|+.
T Consensus 244 --~~~~~~i~~~~~~-----~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 244 --EELFKLLKEGHRM-----DKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp --HHHHHHHHTTCCC-----CCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCC-----CCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 1223333333221 111122 2467889999999999999999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-46 Score=381.19 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=206.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..++||+|+||+||+|++..+|+.||||+++... ....+++.+|++++++++||||+++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57888999999999999999999999999999996542 2345788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+.++.+..........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 997654444434456679999999999999999999998 999999999999999999999999999998664322 2
Q ss_pred ceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCc--ccccc----
Q 042831 510 QTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGK--LLEAV---- 582 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~--l~~~~---- 582 (645)
......||+.|+|||.+.... .+.++|||||||++|||++|+.||...... .............. ....+
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhcccccccc
Confidence 334457999999999877655 588999999999999999999999754321 11211111111100 00000
Q ss_pred --Ccccc--CCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 583 --DPRLC--RDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 583 --d~~l~--~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+... ...+. .....+.+++.+||+.||++|||++|+++|.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~ 287 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhc
Confidence 00000 00000 1124667788999999999999999999998875
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=3.9e-46 Score=367.83 Aligned_cols=216 Identities=28% Similarity=0.440 Sum_probs=186.2
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CC------CceEEEEeCCceecccCCCCCccceeEEEEEEEe
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NR------ETAGRATYNQSMRLWDKATGNLTDFTTHFSFVID 103 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~------~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~ 103 (645)
|..++|+|++|+++ +++.|+ ||.+.++|.|+||+ .. .++|||+|++||+||+ +++++||+|+|+|.|.
T Consensus 1 a~~~sF~f~~F~~~--~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~--~~~~~sFst~F~f~i~ 76 (228)
T d1ioaa_ 1 ATETSFNFPNFHTD--DKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD--SNNVASFNTNFTFIIR 76 (228)
T ss_dssp CCCCEEEESSCCTT--SSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBC--SSCBEEEEEEEEEECC
T ss_pred CccceEEcCCCCCC--CcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecC--CCceeeEEEEEEEEEe
Confidence 35688999999864 469999 99987889999998 32 3689999999999998 4789999999999999
Q ss_pred eCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeee
Q 042831 104 SRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSW 183 (645)
Q Consensus 104 ~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~ 183 (645)
+.+...+||||||+|+|.+. +.+..|++||+++... ++..++.|||||||++|.+|++.+||++++++..
T Consensus 77 ~~~~~~~gDGlAF~l~~~~~--~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~~~~~~~~~~~~~~~~~------- 146 (228)
T d1ioaa_ 77 AKNQSISAYGLAFALVPVNS--PPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNRIDFDKNFIKPYVNENC------- 146 (228)
T ss_dssp BSCTTSCCEEEEEEEEETTC--CCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTEEEEEESSSSCSEEEEC-------
T ss_pred cCCCCCCCCEEEEEEeCCCC--CCCCCccccccccccC-CCCcceeEEEEecCccccccCCCCccceeccccc-------
Confidence 98777889999999999875 4567889999998643 4567889999999999888888888888887532
Q ss_pred cccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeeccc---ceeeeEEEEEeecc
Q 042831 184 WSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATG---VDFAIFSIYSWEFN 260 (645)
Q Consensus 184 ~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg---~~~~~~~i~~wsf~ 260 (645)
..++.+|+.++|||+||+.+++|+|+|.+.. +|..|++++.+||+++|+++|||||||+|| ...|.|+|++|+|+
T Consensus 147 ~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFs 224 (228)
T d1ioaa_ 147 DFHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFS 224 (228)
T ss_dssp CHHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEE
T ss_pred ccccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeE
Confidence 3356799999999999999999999998754 577889999999999999999999999999 55689999999999
Q ss_pred Ccc
Q 042831 261 SSL 263 (645)
Q Consensus 261 ~~~ 263 (645)
+.+
T Consensus 225 s~~ 227 (228)
T d1ioaa_ 225 SKF 227 (228)
T ss_dssp EEE
T ss_pred Eec
Confidence 865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=388.89 Aligned_cols=260 Identities=28% Similarity=0.437 Sum_probs=211.5
Q ss_pred HHhhcCCCCCCccCcCCcEEEEEEEEcC-----CCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC
Q 042831 348 ALATNDFNDDQKLGQGGFGGVYKGFFRE-----TNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK 421 (645)
Q Consensus 348 ~~~~~~f~~~~~LG~G~fG~Vy~g~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~ 421 (645)
+...++|...++||+|+||.||+|.+.. +++.||||+++.. ..+....|.+|++++++++||||++++++|..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3344677888999999999999998853 3578999999754 445566799999999999999999999999999
Q ss_pred CeEEEEEEecCCCChhhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcE
Q 042831 422 KELLLVYEFMPNGSLDSHLFKE---------NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNA 492 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~ 492 (645)
+..++|||||++|+|.+++... ...+++..+.+++.|+|+||.|||+ ++|+||||||+|||+|+++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceE
Confidence 9999999999999999988642 1357999999999999999999999 899999999999999999999
Q ss_pred EEeeccCcccccccCCc-ceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCC-CCCCCCCCCCchhHHHHHH
Q 042831 493 KIGDFGLARLVEHAKGS-QTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGR-KPINPKAPQGQVSLLQWVW 570 (645)
Q Consensus 493 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~-~pf~~~~~~~~~~l~~~~~ 570 (645)
||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++|+ .||...... + +.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~-~~ 245 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VL 245 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------H-HH
Confidence 99999999876543332 233346899999999999999999999999999999999985 666543221 1 12
Q ss_pred HHhcCCccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 571 DLYGNGKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 571 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
....++...+. ...+ ...+.+++.+||+.||++||||+||+++|+..
T Consensus 246 ~~i~~~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 246 RFVMEGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHhCCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22223332211 1112 24678889999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=389.27 Aligned_cols=256 Identities=22% Similarity=0.279 Sum_probs=202.8
Q ss_pred cCCCCCC-ccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCccEEEeeeee----CCeEE
Q 042831 352 NDFNDDQ-KLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRL-RHRNLVQLLGWCHE----KKELL 425 (645)
Q Consensus 352 ~~f~~~~-~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nlv~l~~~~~~----~~~~~ 425 (645)
++|.+.+ .||+|+||.||+|++..+++.||||+++.. ..+.+|++++.++ +||||+++++++.+ +..++
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5777664 599999999999999999999999998643 4567899987665 89999999999865 46789
Q ss_pred EEEEecCCCChhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC---CCcEEEeeccCcc
Q 042831 426 LVYEFMPNGSLDSHLFKE-NSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS---NFNAKIGDFGLAR 501 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~---~~~~kl~DfGla~ 501 (645)
+|||||++|+|.+++.+. ...+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence 999999999999999764 3579999999999999999999998 99999999999999985 5679999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||......... .........+..
T Consensus 163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~--- 234 (335)
T d2ozaa1 163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY--- 234 (335)
T ss_dssp ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS---
T ss_pred eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCC---
Confidence 765432 334467999999999999999999999999999999999999999755432211 111111111110
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+.........+.+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 235 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 235 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp ---SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 000000112235678889999999999999999999997763
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=4e-46 Score=367.48 Aligned_cols=216 Identities=26% Similarity=0.437 Sum_probs=193.1
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC----CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCC
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA----NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRN 106 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~----~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~ 106 (645)
+.+++|+|++|.+. |+.++ ||.+.++|.|+||+ ...++|||+|++||+|||+.+++++||+|+|+|.|.+..
T Consensus 1 ~~~~sf~f~~F~~~---nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~ 77 (226)
T d1avba_ 1 SNDASFNVETFNKT---NLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKN 77 (226)
T ss_dssp CEEEEEEESSCCGG---GEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESS
T ss_pred CCceEEECCCCCcc---ceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCC
Confidence 35789999999754 79999 99987889999997 234799999999999999999999999999999999988
Q ss_pred CCCCCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeec
Q 042831 107 SSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWW 184 (645)
Q Consensus 107 ~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~ 184 (645)
...+||||||+|+|.+.. .+..||++|+++. ++|||||+.|. +|+.+||||||+|+..|..+....
T Consensus 78 ~~~~gDG~aF~i~~~~~~--~g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~ 145 (226)
T d1avba_ 78 IENSAYGLAFALVPVGSR--PKLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCN 145 (226)
T ss_dssp TTSCCEEEEEEEEETTCC--CCCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC
T ss_pred CCCCCceEEEEEccCCCC--CCCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCccccccccc
Confidence 788999999999998753 4567889999864 57999999886 899999999999999999888877
Q ss_pred ccCCCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccc---eeeeEEEEEeeccC
Q 042831 185 SDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGV---DFAIFSIYSWEFNS 261 (645)
Q Consensus 185 ~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~---~~~~~~i~~wsf~~ 261 (645)
.++.+|+.++|||+||+.+++|+|+|.+.+ ++..+.+++.+||+.+|+++||+||||+||. ..|.|+|++|+|++
T Consensus 146 ~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s 223 (226)
T d1avba_ 146 FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSS 223 (226)
T ss_dssp SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEE
T ss_pred cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEE
Confidence 788999999999999999999999998765 4677889999999999999999999999994 56889999999998
Q ss_pred ccc
Q 042831 262 SLE 264 (645)
Q Consensus 262 ~~~ 264 (645)
+++
T Consensus 224 ~~~ 226 (226)
T d1avba_ 224 NFI 226 (226)
T ss_dssp EEC
T ss_pred ecC
Confidence 763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=380.59 Aligned_cols=262 Identities=26% Similarity=0.336 Sum_probs=199.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHH--HHHHHHHhcCCCCccEEEeeeeeCC----eEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYA--SEVKIISRLRHRNLVQLLGWCHEKK----ELL 425 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~--~Ei~~l~~l~H~nlv~l~~~~~~~~----~~~ 425 (645)
.+|...++||+|+||.||+|++. |+.||||+++.... +++. .|+..+.+++||||++++++|.+.+ .++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35666788999999999999974 78999999864432 3333 4555556789999999999997653 689
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhh-----cCCCeeeccCCCCCeEECCCCcEEEeeccCc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEE-----WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLA 500 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dlkp~NILld~~~~~kl~DfGla 500 (645)
+|||||++|+|.+++.+. .++|..+++++.|+|.||+|||+. +.++|+||||||+|||++.++.+||+|||++
T Consensus 78 lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999653 589999999999999999999973 2479999999999999999999999999999
Q ss_pred ccccccCCc---ceeecccCccccCccccccCC------CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCc--------h
Q 042831 501 RLVEHAKGS---QTTVLAGTMGYMAPECATTGK------ASKESDVYSFGIVALEIACGRKPINPKAPQGQ--------V 563 (645)
Q Consensus 501 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~~sDV~SfGvll~elltG~~pf~~~~~~~~--------~ 563 (645)
+........ ......||+.|+|||++.... ++.++|||||||+||||+||+.|+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 876543322 234467999999999987642 57799999999999999999988754332111 0
Q ss_pred hHHHHHHHHhcCCccccccCccccCCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 564 SLLQWVWDLYGNGKLLEAVDPRLCRDF-DGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 564 ~l~~~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
............+.. +|.+.... +.+....+.+|+.+||+.||++||||.||++.|+
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 111222222222222 22221111 2345667889999999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=379.54 Aligned_cols=268 Identities=23% Similarity=0.275 Sum_probs=204.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCC-CeEEEEEEeccCC--hhhHHHHHHHHHHHHhc---CCCCccEEEeeeee----
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRET-NSYIAVKRVSQGS--KQGIKEYASEVKIISRL---RHRNLVQLLGWCHE---- 420 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nlv~l~~~~~~---- 420 (645)
.++|+..++||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 6789999986432 22233556777776665 79999999999853
Q ss_pred -CCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccC
Q 042831 421 -KKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGL 499 (645)
Q Consensus 421 -~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGl 499 (645)
....+++|||++++++..........+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 357899999999888766665667789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccc
Q 042831 500 ARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLL 579 (645)
Q Consensus 500 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~ 579 (645)
++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+........-.
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCGG
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCchh
Confidence 9865432 2334567999999999999999999999999999999999999999754422 2222222221110000
Q ss_pred cc----------cC---ccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 EA----------VD---PRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 ~~----------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .. +.....+.....+.+.+|+.+||+.||++|||++|+++|.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~ 297 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhc
Confidence 00 00 0000001111224566788999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=378.12 Aligned_cols=246 Identities=22% Similarity=0.386 Sum_probs=201.5
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCCh------hhHHHHHHHHHHHHhcC--CCCccEEEeeeeeCCe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSK------QGIKEYASEVKIISRLR--HRNLVQLLGWCHEKKE 423 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nlv~l~~~~~~~~~ 423 (645)
++|...++||+|+||.||+|++..+|+.||||++..... ....++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 578889999999999999999999999999999864321 12234678999999997 8999999999999999
Q ss_pred EEEEEEecCC-CChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-CCcEEEeeccCcc
Q 042831 424 LLLVYEFMPN-GSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-NFNAKIGDFGLAR 501 (645)
Q Consensus 424 ~~lV~Ey~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-~~~~kl~DfGla~ 501 (645)
.++||||+.+ +++.+++.. +..+++..++.++.||++||.|||+ ++|+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 566666644 4579999999999999999999999 99999999999999985 5799999999998
Q ss_pred cccccCCcceeecccCccccCccccccCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc
Q 042831 502 LVEHAKGSQTTVLAGTMGYMAPECATTGKA-SKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE 580 (645)
Q Consensus 502 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~ 580 (645)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ... .+..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--------~~~~-- 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--------RGQV-- 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH--------HCCC--
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh--------hccc--
Confidence 65432 2345679999999999987765 677999999999999999999996421 111 1111
Q ss_pred ccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 581 AVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 581 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.+...++ ..+.+++.+||+.||++|||++|+++|.|+..
T Consensus 222 ----~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 222 ----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp ----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred ----CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1112222 35677889999999999999999999998763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-45 Score=373.61 Aligned_cols=266 Identities=24% Similarity=0.305 Sum_probs=204.4
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS--KQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|...++||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++..++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57888999999999999999986 57999999996543 3336789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
|+.++.+..+. .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 81 HLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CCSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred eehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 99776665554 556779999999999999999999998 899999999999999999999999999998764332 2
Q ss_pred ceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc-------
Q 042831 510 QTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA------- 581 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~------- 581 (645)
......+++.|+|||.+... .++.++|||||||++|||++|+.||...... .....+............
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHHHhhCCCChhhccchhhhh
Confidence 23345689999999998754 5799999999999999999999999754322 222222222111100000
Q ss_pred -cCccc-------cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 582 -VDPRL-------CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 582 -~d~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.+... ...........+.+++.+||+.||++|||++|+++|.+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00000 0001111224677889999999999999999999998874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=373.92 Aligned_cols=269 Identities=23% Similarity=0.282 Sum_probs=203.7
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee--------C
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE--------K 421 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~--------~ 421 (645)
++|+..++||+|+||+||+|++..+|+.||||++... .....+++.+|+++|++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788899999999999999999999999999998644 33445778999999999999999999998854 3
Q ss_pred CeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 422 KELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 422 ~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
+..++||||+.++.+.... .....+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 4689999999877665443 455678999999999999999999998 999999999999999999999999999997
Q ss_pred cccccCC---cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC--
Q 042831 502 LVEHAKG---SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN-- 575 (645)
Q Consensus 502 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~-- 575 (645)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhcCCCC
Confidence 6653221 122335799999999998765 6899999999999999999999999754322 222222222111
Q ss_pred CccccccC---------ccccCCCCHH-------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 576 GKLLEAVD---------PRLCRDFDGQ-------QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 576 ~~l~~~~d---------~~l~~~~~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
.......+ .......... ....+++|+.+||++||++|||++|+++|.++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00000000 0000011111 1234567899999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=372.47 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=198.7
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC------CeEEE
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK------KELLL 426 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~------~~~~l 426 (645)
+|+..++||+|+||+||+|++..+|+.||||++...... ..+|+++|++++||||++++++|... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 577788999999999999999999999999999765322 23699999999999999999998542 35799
Q ss_pred EEEecCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccc
Q 042831 427 VYEFMPNGSLDSHLF--KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLV 503 (645)
Q Consensus 427 V~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~ 503 (645)
|||||+++.+..... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444332 345679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred cccCCcceeecccCccccCcccccc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhc--------
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATT-GKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYG-------- 574 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~-------- 574 (645)
.... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ...+....+
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCHHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH---HHHHHHHhCCChHHhhh
Confidence 5433 2334579999999998765 5689999999999999999999999975442211 111111110
Q ss_pred ---CC----ccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 575 ---NG----KLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 575 ---~~----~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.. .....................+.+|+.+||+.||++|||++|+++|.+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 00 00000000000011111234567888999999999999999999998875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-43 Score=358.19 Aligned_cols=269 Identities=24% Similarity=0.284 Sum_probs=211.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCCeEEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~~~~lV~E 429 (645)
++|+..++||+|+||+||+|++..+++.||||+++.. .....+++.+|+.++++++||||++++++|.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788899999999999999999999999999998654 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccccCCc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEHAKGS 509 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~~~~~ 509 (645)
++.+++|..++ ...+.+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 82 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 82 FCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred ecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99998887766 455678999999999999999999999 8999999999999999999999999999987654322
Q ss_pred ceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc------cccc
Q 042831 510 QTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL------LEAV 582 (645)
Q Consensus 510 ~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l------~~~~ 582 (645)
......++..|+|||.+.... ++.++|||||||++|||++|+.||..... .......+........- ....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 233345788899999887665 69999999999999999999999764332 22222222222221100 0000
Q ss_pred Cc----cc-----cCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 583 DP----RL-----CRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 583 d~----~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
+. .. ...........+.+|+.+||++||++|||++|+++|.|+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 00 00 00111122345677889999999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=371.06 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=198.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC------
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK------ 422 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~------ 422 (645)
.++|...++||+|+||+||+|++..+|+.||||+++.. +....+.+.+|+++|++++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45788899999999999999999999999999999753 3445678899999999999999999999997654
Q ss_pred eEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 423 ELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 423 ~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
++++||||+ +.+|...... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 579999999 5667666533 469999999999999999999998 9999999999999999999999999999986
Q ss_pred ccccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcC------
Q 042831 503 VEHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGN------ 575 (645)
Q Consensus 503 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~------ 575 (645)
... ..+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..........
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHH
T ss_pred cCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH---HHHHHhccCCCcHHHH
Confidence 543 23446799999999998764 578999999999999999999999976532211 1111110000
Q ss_pred ---------------CccccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 576 ---------------GKLLEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 576 ---------------~~l~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......--+......+ ..+.+|+.+||+.||++|||++|+++|.++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000000001111122 35667889999999999999999999998863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=364.68 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=201.7
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeCC----eEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEKK----ELL 425 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~~----~~~ 425 (645)
+.+|...++||+|+||+||+|++..+|+.||||+++.. .....+++.+|+++|++++|||++++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688899999999999999999999999999999754 3445678999999999999999999999987543 234
Q ss_pred EEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccccc
Q 042831 426 LVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLVEH 505 (645)
Q Consensus 426 lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~~~ 505 (645)
++++|+.+|+|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 45566779999999854 358999999999999999999999 8999999999999999999999999999986643
Q ss_pred cCC--cceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcccc--
Q 042831 506 AKG--SQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLE-- 580 (645)
Q Consensus 506 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~-- 580 (645)
... .......||+.|+|||++..+ .++.++||||+||+++||++|+.||......+.. ..............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLN 238 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHH
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhh
Confidence 322 223446799999999998554 5789999999999999999999999754422111 11111111000000
Q ss_pred ----------c-cCccccCCCCHH-----HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 581 ----------A-VDPRLCRDFDGQ-----QIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 581 ----------~-~d~~l~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
. ..+.. ...+.. ....+.+++.+||+.||++|||+.|+++|.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~ 299 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhhhhhhcccccCCcc-CCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 0 00000 001111 113567889999999999999999999998765
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.9e-42 Score=335.14 Aligned_cols=198 Identities=30% Similarity=0.502 Sum_probs=166.9
Q ss_pred CceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCC
Q 042831 32 ASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSY 109 (645)
Q Consensus 32 ~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 109 (645)
|..++|+|++|++. ++.|+ ||.+.++|.||||+ ..+++|||+|++||+||++.+++++||+|+|+|.|.+.+...
T Consensus 1 a~~~sF~~~~F~~~---~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~ 77 (204)
T d1dhkb_ 1 ATETSFIIDAFNKT---NLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQAN 77 (204)
T ss_dssp CCCCEEEESSCCGG---GEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---
T ss_pred CccceEECCCCCcc---CeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCC
Confidence 35688999999753 79999 99987889999999 777999999999999999999999999999999999987777
Q ss_pred CCCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCcccceeeecccCCC
Q 042831 110 YADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNVSWWSDVKS 189 (645)
Q Consensus 110 ~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~~~~~~~~~ 189 (645)
+||||||+++|.... ..++.|||||||++ ||+++|+|+..+ ....+...+.+
T Consensus 78 ~gdGlaf~~~~~~~~--------------------~~~~~~~vefDt~~-------n~~~~d~~~~~~-~~~~~~~~~~~ 129 (204)
T d1dhkb_ 78 SAVGLDFVLVPVQPE--------------------SKGDTVTVEFDTFL-------SRISIDVNNNDI-KSVPWDVHDYD 129 (204)
T ss_dssp CCSEEEEEEEEC--------------------------CCEEEEEETTT-------TEEEEEETTEEE-EEEECCGGGTT
T ss_pred CCceEEEEecCCCCC--------------------CCCcEeeEeeEccc-------ccccCccccccc-cccccccEecC
Confidence 899999999986521 12356999999987 588888887543 23344567889
Q ss_pred CceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccce---eeeEEEEEeeccCc
Q 042831 190 GRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVD---FAIFSIYSWEFNSS 262 (645)
Q Consensus 190 g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~---~~~~~i~~wsf~~~ 262 (645)
|+.++|||+||+.+++|+|++.+.+. +..+.|++.+||++++|++|||||||+||.. .|.|+|++|+|++.
T Consensus 130 g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss~ 203 (204)
T d1dhkb_ 130 GQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203 (204)
T ss_dssp TSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEcCCCEEEEEEEecCCC--CCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEec
Confidence 99999999999999999999997664 5578899999999999999999999999964 57899999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=369.26 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=208.6
Q ss_pred cCCCCCCccCcCCcEEEEEEEE---cCCCeEEEEEEeccC----ChhhHHHHHHHHHHHHhcCC-CCccEEEeeeeeCCe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFF---RETNSYIAVKRVSQG----SKQGIKEYASEVKIISRLRH-RNLVQLLGWCHEKKE 423 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~---~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~nlv~l~~~~~~~~~ 423 (645)
++|+..++||+|+||+||+|+. +.+|+.||||.++.. .....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688999999999999999987 446899999998643 22345678899999999977 899999999999999
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.++||||+.+|+|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999998654 356788899999999999999999 89999999999999999999999999999876
Q ss_pred cccCCcceeecccCccccCccccccC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTG--KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
............|++.|++||.+... .++.++|||||||+||||++|+.||......+....+ .......
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~~----- 251 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKS----- 251 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHC-----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcccC-----
Confidence 55444445557899999999998764 4688999999999999999999999866544332221 1111111
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHhccC
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRP-----SIRQVIHVLNFE 626 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L~~~ 626 (645)
.+.+.. .....+..++.+||++||++|| |++|+++|.++.
T Consensus 252 -~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 252 -EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp -CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred -CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 111111 2235677788999999999999 589999998875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-42 Score=353.81 Aligned_cols=258 Identities=19% Similarity=0.252 Sum_probs=199.1
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCccE-EEeeeeeCCeEEEEEEe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNLVQ-LLGWCHEKKELLLVYEF 430 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nlv~-l~~~~~~~~~~~lV~Ey 430 (645)
++|+..++||+|+||.||+|++..+|+.||||.+..... .+++..|++++++++|+|++. +.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 568899999999999999999999999999998865432 245788999999998776555 45556777889999999
Q ss_pred cCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEEC---CCCcEEEeeccCcccccccC
Q 042831 431 MPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLD---SNFNAKIGDFGLARLVEHAK 507 (645)
Q Consensus 431 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld---~~~~~kl~DfGla~~~~~~~ 507 (645)
+ +++|...+......+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 667777776667789999999999999999999999 9999999999999986 45579999999999765432
Q ss_pred C------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCccccc
Q 042831 508 G------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKLLEA 581 (645)
Q Consensus 508 ~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l~~~ 581 (645)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~----- 235 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----- 235 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-----
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-----
Confidence 2 22345679999999999999999999999999999999999999998655433222221111110000
Q ss_pred cCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 582 VDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 582 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
..+.+...++ ..+.+++..|++.+|++||+++++.+.|+
T Consensus 236 ~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 236 PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp CHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred ChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 0111222222 35677888999999999999988766654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=359.72 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=202.9
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeee--CCeEEEEE
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHE--KKELLLVY 428 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~--~~~~~lV~ 428 (645)
++|...++||+|+||+||+|++..+|+.||||+++... .+++.+|+++|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999999999999999986543 457889999999996 9999999999874 45699999
Q ss_pred EecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC-cEEEeeccCcccccccC
Q 042831 429 EFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF-NAKIGDFGLARLVEHAK 507 (645)
Q Consensus 429 Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~-~~kl~DfGla~~~~~~~ 507 (645)
|||++++|.... +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999997764 468999999999999999999999 9999999999999998654 69999999998665332
Q ss_pred CcceeecccCccccCccccccCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchh-HH-H-----HHHHHhcCCcc-
Q 042831 508 GSQTTVLAGTMGYMAPECATTGK-ASKESDVYSFGIVALEIACGRKPINPKAPQGQVS-LL-Q-----WVWDLYGNGKL- 578 (645)
Q Consensus 508 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~-l~-~-----~~~~~~~~~~l- 578 (645)
......+|+.|+|||.+.+.. ++.++||||+||+++||++|+.||.......... .+ . ...........
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 334467899999999987654 7999999999999999999999997654321110 00 0 00001000000
Q ss_pred -----ccccC-------ccccC-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 579 -----LEAVD-------PRLCR-DFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 579 -----~~~~d-------~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
..... ..... .........+.+|+.+||+.||++|||++|+++|.+|.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~ 323 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 00000 00000 00111224567888999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-42 Score=351.08 Aligned_cols=259 Identities=17% Similarity=0.233 Sum_probs=208.9
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCccEEEeeeeeCCeEEEEEE
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH-RNLVQLLGWCHEKKELLLVYE 429 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nlv~l~~~~~~~~~~~lV~E 429 (645)
.++|.+.++||+|+||.||+|++..+|+.||||.+..... ..++.+|++.+..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4678999999999999999999999999999998865432 2456789999999975 899999999999999999999
Q ss_pred ecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECC-----CCcEEEeeccCccccc
Q 042831 430 FMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDS-----NFNAKIGDFGLARLVE 504 (645)
Q Consensus 430 y~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~-----~~~~kl~DfGla~~~~ 504 (645)
|+ +++|.+++...+..+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 789999987777789999999999999999999998 99999999999999974 5789999999998765
Q ss_pred ccCC------cceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc
Q 042831 505 HAKG------SQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL 578 (645)
Q Consensus 505 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l 578 (645)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP- 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC-
Confidence 3321 123446799999999999999999999999999999999999999986554433322222221111111
Q ss_pred ccccCccccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 042831 579 LEAVDPRLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLN 624 (645)
Q Consensus 579 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 624 (645)
.+.+...++ +.+.+++..|++.+|++||+++.+.+.|+
T Consensus 237 ----~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 237 ----LRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp ----HHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ----hHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 112223333 34667778899999999999888877665
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=360.10 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=197.8
Q ss_pred cCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeee------CCe
Q 042831 352 NDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHE------KKE 423 (645)
Q Consensus 352 ~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~------~~~ 423 (645)
++|...++||+|+||+||+|++..+|+.||||++... +....+++.+|+.++++++||||+++++++.. .++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6789999999999999999999999999999999754 34456678999999999999999999999863 368
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
+|+|||||.++.+. .+ ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~-~~---~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VI---QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHH-HH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHH-hh---hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 89999999765554 33 2458999999999999999999999 99999999999999999999999999998865
Q ss_pred cccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHH----------------H
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLL----------------Q 567 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~----------------~ 567 (645)
... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||...........+ .
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 432 2334567899999999999999999999999999999999999999754321111000 0
Q ss_pred HHHHHhcCC-cc-----ccccCccccCC---CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccCC
Q 042831 568 WVWDLYGNG-KL-----LEAVDPRLCRD---FDGQQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFEA 627 (645)
Q Consensus 568 ~~~~~~~~~-~l-----~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 627 (645)
......... .. ........... ........+.+|+.+||+.||++|||++|+++|.|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 000000000 00 00111111111 11234567888999999999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=356.10 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=200.6
Q ss_pred hcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCccEEEeeeeeC-----Ce
Q 042831 351 TNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG--SKQGIKEYASEVKIISRLRHRNLVQLLGWCHEK-----KE 423 (645)
Q Consensus 351 ~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nlv~l~~~~~~~-----~~ 423 (645)
.++|...++||+|+||+||+|++..+|+.||||+++.. +....+++.+|+++|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46788999999999999999999999999999999754 344566789999999999999999999998633 34
Q ss_pred EEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEeeccCcccc
Q 042831 424 LLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLARLV 503 (645)
Q Consensus 424 ~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~~~ 503 (645)
.+++++|+.+|+|.+++.. +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 4667778889999998843 469999999999999999999998 89999999999999999999999999999754
Q ss_pred cccCCcceeecccCccccCccccccC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCchhHHHHHHHHhcCCcc--c-
Q 042831 504 EHAKGSQTTVLAGTMGYMAPECATTG-KASKESDVYSFGIVALEIACGRKPINPKAPQGQVSLLQWVWDLYGNGKL--L- 579 (645)
Q Consensus 504 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~~l~~~~~~~~~~~~l--~- 579 (645)
.. ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+......... .
T Consensus 172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~---~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHHHHT
T ss_pred Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChHHhh
Confidence 32 23345789999999987665 4689999999999999999999999754322 111111111110000 0
Q ss_pred --------cccC--ccccCCCCH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhccC
Q 042831 580 --------EAVD--PRLCRDFDG-----QQIERLMIVGLWCAHPDENLRPSIRQVIHVLNFE 626 (645)
Q Consensus 580 --------~~~d--~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 626 (645)
.... +.. ..... .....+.+|+.+||+.||++|||++|+++|.|+.
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 245 KISSESARNYIQSLTQM-PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp TCCCHHHHHHHTTSCCC-CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred hccchhhhhhhhhcccC-CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0000 000 00000 1124567888999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-37 Score=326.53 Aligned_cols=266 Identities=20% Similarity=0.232 Sum_probs=198.2
Q ss_pred CCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-----------CCCccEEEeeeee-
Q 042831 353 DFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-----------HRNLVQLLGWCHE- 420 (645)
Q Consensus 353 ~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nlv~l~~~~~~- 420 (645)
+|...++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4888999999999999999999999999999997543 23457788999888875 5789999998764
Q ss_pred -CCeEEEEEEecCCCChhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCC------c
Q 042831 421 -KKELLLVYEFMPNGSLDSHLF--KENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNF------N 491 (645)
Q Consensus 421 -~~~~~lV~Ey~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~------~ 491 (645)
....+++++++..+....... .....+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 356777777766654433332 345678999999999999999999997 37899999999999998654 3
Q ss_pred EEEeeccCcccccccCCcceeecccCccccCccccccCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCCCch----hHHH
Q 042831 492 AKIGDFGLARLVEHAKGSQTTVLAGTMGYMAPECATTGKASKESDVYSFGIVALEIACGRKPINPKAPQGQV----SLLQ 567 (645)
Q Consensus 492 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDV~SfGvll~elltG~~pf~~~~~~~~~----~l~~ 567 (645)
++++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||......... .+..
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 99999999875432 223457999999999999999999999999999999999999999755432211 1111
Q ss_pred HHHHHhcC------------------CccccccCc----------cccCCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 042831 568 WVWDLYGN------------------GKLLEAVDP----------RLCRDFDGQQIERLMIVGLWCAHPDENLRPSIRQV 619 (645)
Q Consensus 568 ~~~~~~~~------------------~~l~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 619 (645)
.++ ..+. ......+.. .............+.+|+.+||+.||++|||++|+
T Consensus 247 ~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 247 IIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111 1100 000000000 00123445677889999999999999999999999
Q ss_pred HHHhccC
Q 042831 620 IHVLNFE 626 (645)
Q Consensus 620 l~~L~~~ 626 (645)
|+|.++.
T Consensus 326 L~Hp~f~ 332 (362)
T d1q8ya_ 326 VNHPWLK 332 (362)
T ss_dssp HTCGGGT
T ss_pred hcCcccC
Confidence 9999986
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.96 E-value=3.5e-30 Score=250.08 Aligned_cols=117 Identities=39% Similarity=0.645 Sum_probs=107.9
Q ss_pred CCCEEEEEEecccCC--CCCCCCceeeecCCCcccceeeecccCCCCceeEEEEEEcCCCceEEEEEecCCCccccccee
Q 042831 146 SIPFVAVEFDVYVNS--WDPTFSHVGIDINSVKSKKNVSWWSDVKSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGL 223 (645)
Q Consensus 146 ~~~~vaVEfDt~~n~--~d~~~~hvgidvns~~s~~~~~~~~~~~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~l 223 (645)
.|++|||||||++|. +||++||||||+|++.|.++..| ++.+|+.++|||+||+.+++|+|++...+ +..|++
T Consensus 1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~--~l~~G~~~~v~I~Yd~~~~~L~V~~~~~~---~~~~~l 75 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW--NMQNGKVGTAHIIYNSVDKRLSAVVSYPN---ADSATV 75 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC--CCCTTCEEEEEEEEETTTTEEEEEEECTT---SCCEEE
T ss_pred CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc--cccCCCEEEEEEEEecCCcEEEEEEecCC---CCCeEE
Confidence 378999999999986 89999999999999999988887 57899999999999999999999998644 557889
Q ss_pred eEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcccccc
Q 042831 224 DYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSLEMDD 267 (645)
Q Consensus 224 s~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~~~~~ 267 (645)
++.|||+++|+++|||||+||||...|.|+|++|+|++.+.+..
T Consensus 76 s~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~~~~s 119 (237)
T d1nlsa_ 76 SYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKSNS 119 (237)
T ss_dssp EEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEEESS
T ss_pred EEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeeccccc
Confidence 99999999999999999999999999999999999999887764
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=1.8e-25 Score=219.56 Aligned_cols=201 Identities=18% Similarity=0.144 Sum_probs=140.0
Q ss_pred eeEEeCCCCCCC--CCCeEEe-ecccCCCCcEecCC-CCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCC
Q 042831 35 LTFNYTSFSPQY--DDNITYE-RAYPDSNRVIQLPA-NRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYY 110 (645)
Q Consensus 35 ~~f~f~~f~~~~--~~~~~~~-~a~~~~~~~~~Lt~-~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~ 110 (645)
.+|+.+.+..+. ..+..++ +|.+ .++.|+||+ ..+++|+++|++|+++ .+|+|+|+|.+.... ..+
T Consensus 9 ~sf~~P~~~~~~~~~~~w~~~G~a~i-~~~~i~LT~~~~~~~G~v~~~~p~~~--------~~F~~~f~f~~~~~~-~~g 78 (228)
T d1gv9a_ 9 YSFKGPHLVQSDGTVPFWAHAGNAIP-SADQIRIAPSLKSQRGSVWTKTKAAF--------ENWEVEVTFRVTGRG-RIG 78 (228)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEE-CSSCEEEECSSTTCEEEEEESSCBCC--------SSEEEEEEEEEECSS-SCC
T ss_pred eccCCCcccCCCCCccceEEeeeEEE-ECCEEEECCCCCCCEEEEEeCCCccc--------cCcEEEEEEeccCCC-CCC
Confidence 355556554321 3356888 9988 678999999 7789999999999987 369999999998753 467
Q ss_pred CCeEEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCccccee---------
Q 042831 111 ADGLAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSKKNV--------- 181 (645)
Q Consensus 111 g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~~~~--------- 181 (645)
||||||+|+|... ..|+.+|.... .+-+||||||+.|.+|++.+|+.+++|........
T Consensus 79 gdG~aF~i~~~~~-----~~g~~~G~~~~-------~~glaVefDt~~n~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~ 146 (228)
T d1gv9a_ 79 ADGLAIWYTENQG-----LDGPVFGSADM-------WNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQAL 146 (228)
T ss_dssp CCEEEEEEESSCC-----CEEEETTECSC-------CEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCS
T ss_pred CCEEEEEEecCCC-----CCCCccCcCCC-------CceEEEEEEcccccCCCCCCcEEEEecCCcceeeecCCCccccc
Confidence 9999999998752 34555554322 23489999999999999999999988764321111
Q ss_pred -eecccC-CCCceeEEEEEEcCCCceEEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeec
Q 042831 182 -SWWSDV-KSGRRNEAWISYNSSTHNLSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEF 259 (645)
Q Consensus 182 -~~~~~~-~~g~~~~~~I~Y~~~~~~l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf 259 (645)
.+.... .++..+++||+|+ .+.|+|.+..........+.++..++ ...+++++|+||||+||...+.|.|++|.+
T Consensus 147 ~~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~~~ 223 (228)
T d1gv9a_ 147 ASCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFLT 223 (228)
T ss_dssp EEECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEEE
T ss_pred cceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEEEE
Confidence 111122 2344556666665 68899999865544444444444444 556789999999999999999999999987
Q ss_pred c
Q 042831 260 N 260 (645)
Q Consensus 260 ~ 260 (645)
.
T Consensus 224 ~ 224 (228)
T d1gv9a_ 224 F 224 (228)
T ss_dssp E
T ss_pred E
Confidence 4
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.92 E-value=1.8e-25 Score=216.66 Aligned_cols=108 Identities=28% Similarity=0.553 Sum_probs=96.1
Q ss_pred CCCceeeEEeCCCCCCCCCCeEEe-ecccCCCCcEecCC-C------CCceEEEEeCCceecccCCCCCccceeEEEEEE
Q 042831 30 PLASALTFNYTSFSPQYDDNITYE-RAYPDSNRVIQLPA-N------RETAGRATYNQSMRLWDKATGNLTDFTTHFSFV 101 (645)
Q Consensus 30 ~~~~~~~f~f~~f~~~~~~~~~~~-~a~~~~~~~~~Lt~-~------~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~ 101 (645)
+.+.+++|+|++|+++ ..+|+++ ||.+.++|.||||+ + ..++|||+|++||||||+ +|+++||+|+|+|.
T Consensus 121 ~esn~~~F~f~~F~~~-~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~-t~~~~SFsT~F~F~ 198 (237)
T d1nlsa_ 121 HETNALHFMFNQFSKD-QKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWES-SAVVASFEATFTFL 198 (237)
T ss_dssp SCEEEEEEEESCCCTT-CTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCT-TEEEEEEEEEEEEE
T ss_pred cccccceEEeeecCCC-CCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECC-CCcEeeEEEEEEEE
Confidence 3467899999999976 6789999 99987899999998 3 236899999999999996 89999999999999
Q ss_pred EeeCCCCCCCCeEEEEEccCCCCCCCCCCCCcccCccCC
Q 042831 102 IDSRNSSYYADGLAFFLAPQGSKIPTNKGGGSFGLTKDN 140 (645)
Q Consensus 102 i~~~~~~~~g~GlaF~l~p~~~~~~~~~~g~~lGl~~~~ 140 (645)
|.+.. ..+||||||||+|.+.++|.++.||||||||.+
T Consensus 199 I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T d1nlsa_ 199 IKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp CCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred EecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCC
Confidence 98865 457999999999998889999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=3.4e-22 Score=190.39 Aligned_cols=163 Identities=15% Similarity=0.159 Sum_probs=119.4
Q ss_pred CCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCC------------------hhhHHHHHHHHHHHHhcCCCCccEEEe
Q 042831 355 NDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGS------------------KQGIKEYASEVKIISRLRHRNLVQLLG 416 (645)
Q Consensus 355 ~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~------------------~~~~~~~~~Ei~~l~~l~H~nlv~l~~ 416 (645)
...++||+|+||.||+|++. +|+.||||.++... .........|...+.++.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35689999999999999985 58899999865321 011234556889999999999998876
Q ss_pred eeeeCCeEEEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhcCCCeeeccCCCCCeEECCCCcEEEee
Q 042831 417 WCHEKKELLLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEWEQCVVHRDIKSSNIMLDSNFNAKIGD 496 (645)
Q Consensus 417 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlkp~NILld~~~~~kl~D 496 (645)
+.. .+++|||+++..+.. ++......++.|++++|.|||+ .+|+||||||+|||++++ .++|+|
T Consensus 82 ~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred ecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 532 379999998765543 2334456899999999999999 899999999999999865 589999
Q ss_pred ccCcccccccCCcceeecccCccccCc------cccccCCCCcchhHHHHHHHH
Q 042831 497 FGLARLVEHAKGSQTTVLAGTMGYMAP------ECATTGKASKESDVYSFGIVA 544 (645)
Q Consensus 497 fGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~~sDV~SfGvll 544 (645)
||+|....+..... |+.. |. ..+.++.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99997654332111 1111 11 134578889999975433
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.80 E-value=2.3e-19 Score=174.05 Aligned_cols=187 Identities=13% Similarity=0.119 Sum_probs=123.4
Q ss_pred EEeCCCCCCC--CCCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCe
Q 042831 37 FNYTSFSPQY--DDNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADG 113 (645)
Q Consensus 37 f~f~~f~~~~--~~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~G 113 (645)
|+|+++.... .++..+. +|.+ .++.|+||...++.|.+|++.|+++++ +|+++|.|.|.... ..+|||
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~-~~~~i~LTp~~~~~G~~w~~~~i~~~~-------~f~~~~~F~i~g~~-~~ggdG 80 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASL-EEGRIVLTSNQNSKGSLWLKQGFDLKD-------SFTMEWTFRSVGYS-GQTDGG 80 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEE-ETTEEESCCSTTCEEEEEESSCEECCS-------CEEEEEEEEEESCC-SCCSCE
T ss_pred ccCCCccccccCCCccEEcceeEE-ECCEEEECCCCCCceEEEECCccccCC-------CeEEEEEEEEeCCC-CCCCCc
Confidence 6666653221 4478888 8888 578999999667899999999999975 49999999998653 456999
Q ss_pred EEEEEccCCCCCCCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeec--CCCccc-------ceeeec
Q 042831 114 LAFFLAPQGSKIPTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDI--NSVKSK-------KNVSWW 184 (645)
Q Consensus 114 laF~l~p~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidv--ns~~s~-------~~~~~~ 184 (645)
|||++++... ....|+.+|..+. ..=+||||||+.|. .+++.+.+ ++..-. ....+.
T Consensus 81 ~af~~~~~~~---~~~~g~~~G~~~~-------~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~~~~~~~~~ 146 (221)
T d2a6za1 81 ISFWFVQDSN---IPRDKQLYNGPVN-------YDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYDQSFASCL 146 (221)
T ss_dssp EEEEEEECSS---SCCCCTBTTBCTT-------CEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHHHCSEEEE
T ss_pred EEEEEEcCCC---ccccccccccCCC-------CceEEEEEECCCCC----CCceEEEecCCCccccccCCcccccceee
Confidence 9999997652 2234444553221 12389999999873 23443433 332211 111233
Q ss_pred cc-CCCCceeEEEEEEcCCCce-EEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEE
Q 042831 185 SD-VKSGRRNEAWISYNSSTHN-LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIY 255 (645)
Q Consensus 185 ~~-~~~g~~~~~~I~Y~~~~~~-l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~ 255 (645)
.. ..++...+++|+|++.++. |.|.+... +...++.-.+.++..|+||||+||...+.|.++
T Consensus 147 ~~~~~~~~~~~~~I~y~~~~~~~l~v~id~~---------~c~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~ 210 (221)
T d2a6za1 147 MGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK---------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESF 210 (221)
T ss_dssp CCCTTEEEEEEEEEEEEGGGTSEEEEEETTE---------EEEEESCCCCCSSEEEEEEEEECCSGGGCCCEE
T ss_pred ecccCCCCCEEEEEEEecCccceEEEEecCc---------EeEEECCeecCCCCEEEEEEEccCCccCCCceE
Confidence 33 3467788999999876655 77877531 122233223336678999999999876666643
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.79 E-value=1.5e-18 Score=167.57 Aligned_cols=186 Identities=15% Similarity=0.095 Sum_probs=129.2
Q ss_pred CCCeEEe-ecccCCCCcEecCCCCCceEEEEeCCceecccCCCCCccceeEEEEEEEeeCCCCCCCCeEEEEEccCCCCC
Q 042831 47 DDNITYE-RAYPDSNRVIQLPANRETAGRATYNQSMRLWDKATGNLTDFTTHFSFVIDSRNSSYYADGLAFFLAPQGSKI 125 (645)
Q Consensus 47 ~~~~~~~-~a~~~~~~~~~Lt~~~~~~G~~~y~~pv~l~~~~~~~~~sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~ 125 (645)
..+..+. +|.+ .++.|+||...++.|++|++.|+++++ +|+++|+|.|.... ..+||||||++++.....
T Consensus 21 ~~~W~~~G~~~~-~~~~i~LTp~~~~~G~~w~~~~i~~~~-------~f~i~~~F~i~g~~-~~~~dG~afw~~~~~~~~ 91 (218)
T d2a6va1 21 LSQWTLGDKVKL-EEGRFVLTPGKNTKGSLWLKPEYSIKD-------AMTIEWTFRSFGFR-GSTKGGLAFWLKQGNEGD 91 (218)
T ss_dssp TTTEEEEETCEE-ETTEEESCCSTTCEEEEEESSCBCCSS-------CEEEEEEEEEESCC-SCCSCEEEEEEECSCCCC
T ss_pred cCccEECCCEEE-ECCEEEECCCCCCeeEEEeCCcccccc-------cceEEEEEEEeCCC-CCCCCcEEEEEEcCCccc
Confidence 3468888 8888 678999999656889999999999875 49999999998653 556999999999865432
Q ss_pred CCCCCCCcccCccCCCCCCCCCCEEEEEEecccCCCCCCCCceeeecCCCccc------c-eeeeccc-CCCCceeEEEE
Q 042831 126 PTNKGGGSFGLTKDNEPLNSSIPFVAVEFDVYVNSWDPTFSHVGIDINSVKSK------K-NVSWWSD-VKSGRRNEAWI 197 (645)
Q Consensus 126 ~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~n~~d~~~~hvgidvns~~s~------~-~~~~~~~-~~~g~~~~~~I 197 (645)
+.+..+|..+.++. +||||||+.|. .+||.+.+|.-... . -..+..+ ..++...+++|
T Consensus 92 ~~~~~~G~~~~f~G----------laV~fDt~~n~----~~~i~~~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~~~i 157 (218)
T d2a6va1 92 STELFGGSSKKFNG----------LMILLRLDDKL----GESVTAYLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRL 157 (218)
T ss_dssp CCTBTTTBCSSCEE----------EEEEEEEETTT----EEEEEEEEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEE
T ss_pred CCCcccccCCCcce----------EEEEEECCCCC----CCeEEEEeCCCCccccccCCcccceEEecccCCCCcEEEEE
Confidence 22223344444432 89999999873 36888877642210 0 0122222 34677889999
Q ss_pred EEcCCCce-EEEEEecCCCcccccceeeEeeccCcCCCCceEEEEeecccceeeeEEEEEeeccCcc
Q 042831 198 SYNSSTHN-LSVAFTGFRNNLVVMQGLDYQVDLRQHLPEFVTFGFSMATGVDFAIFSIYSWEFNSSL 263 (645)
Q Consensus 198 ~Y~~~~~~-l~v~l~~~~~~~~~~~~ls~~vdl~~~l~~~~~vGfsastg~~~~~~~i~~wsf~~~~ 263 (645)
.|++.+.. +.|.+.. . ..+-+..|+| ..++++|+||||+||...+.|.|++|.+...+
T Consensus 158 ~Y~~~~~~~l~v~id~--~----~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~~~~ 216 (218)
T d2a6va1 158 TYNPLDNHLLKLQMDN--R----VCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLYDGV 216 (218)
T ss_dssp EEEGGGTSEEEEEETT--E----EEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEESSC
T ss_pred EEECcccceEEEEeCC--c----EEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEEecc
Confidence 99875544 6776642 1 1111222333 34567999999999999999999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=8.8e-07 Score=86.05 Aligned_cols=148 Identities=16% Similarity=0.067 Sum_probs=101.5
Q ss_pred HHHHhhcCCCCCCccCcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCccEEEeeeeeCCeE
Q 042831 346 ELALATNDFNDDQKLGQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLR-HRNLVQLLGWCHEKKEL 424 (645)
Q Consensus 346 el~~~~~~f~~~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nlv~l~~~~~~~~~~ 424 (645)
++...-..|...+..+.+....||+... +++.+.+|+...........+.+|...+..+. +--+.+++.++.+++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 4555555666555444444578998753 35667889886554444456778888888774 33467788888888999
Q ss_pred EEEEEecCCCChhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 042831 425 LLVYEFMPNGSLDSHLFKENSLLTWEFRYKIAQDLASGLLYLQEEW---------------------------------- 470 (645)
Q Consensus 425 ~lV~Ey~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------- 470 (645)
++||+++++.++.+..... .....++.++++.|..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999998876544211 112345566666666666311
Q ss_pred ----------------------CCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 471 ----------------------EQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 471 ----------------------~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=0.0002 Score=68.34 Aligned_cols=130 Identities=20% Similarity=0.132 Sum_probs=83.8
Q ss_pred ccCcCCc-EEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCccEEEeeeeeCCeEEEEEEecCCCC
Q 042831 359 KLGQGGF-GGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRH--RNLVQLLGWCHEKKELLLVYEFMPNGS 435 (645)
Q Consensus 359 ~LG~G~f-G~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nlv~l~~~~~~~~~~~lV~Ey~~~gs 435 (645)
.+..|.. ..||+....+ +..+.+|....... ..+..|...++.+.. -.+.+++.++.+.+..++||+++++-+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444543 6789887644 56688887654432 245678887777643 335678888888888999999998876
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 042831 436 LDSHLFKENSLLTWEFRYKIAQDLASGLLYLQ------------------------------------------------ 467 (645)
Q Consensus 436 L~~~l~~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------------------------ 467 (645)
+.+.. +.. ...+.++++.|.-||
T Consensus 93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 64321 010 111222333333333
Q ss_pred ---hh----cCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 468 ---EE----WEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 468 ---~~----~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
.. ....++|+|+.|.|||++++..+-|.||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 01238999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00024 Score=72.91 Aligned_cols=78 Identities=15% Similarity=0.163 Sum_probs=49.2
Q ss_pred CCccCcCCcEEEEEEEEcCCCeEEEEEEeccC-------ChhhHHHHHHHHHHHHhcC-C--CCccEEEeeeeeCCeEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRETNSYIAVKRVSQG-------SKQGIKEYASEVKIISRLR-H--RNLVQLLGWCHEKKELLL 426 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-H--~nlv~l~~~~~~~~~~~l 426 (645)
.+.||.|....||+.....+++.++||.-... -.....+...|.+.|..+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999998777888999964321 1112234456888887663 2 345566654 3445689
Q ss_pred EEEecCCCCh
Q 042831 427 VYEFMPNGSL 436 (645)
Q Consensus 427 V~Ey~~~gsL 436 (645)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.05 E-value=0.0088 Score=58.98 Aligned_cols=133 Identities=11% Similarity=0.128 Sum_probs=76.7
Q ss_pred EEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-----cEEE--eeeeeCCeEEEEEEecCCCChhh
Q 042831 366 GGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-----VQLL--GWCHEKKELLLVYEFMPNGSLDS 438 (645)
Q Consensus 366 G~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-----v~l~--~~~~~~~~~~lV~Ey~~~gsL~~ 438 (645)
-.||++...+ |+.+++|..+.. ....+++..|...+..|...++ +..- ......+..+.++++++|..+..
T Consensus 36 N~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 4799998854 778999987644 2244667788888888753222 1111 12345667889999997654321
Q ss_pred ----h----------hhh--------cCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----hcCCC
Q 042831 439 ----H----------LFK--------ENSLLTW-------------------EFRYKIAQDLASGLLYLQE----EWEQC 473 (645)
Q Consensus 439 ----~----------l~~--------~~~~l~~-------------------~~~~~i~~~ia~gL~yLH~----~~~~~ 473 (645)
. ++. ....+++ ..+..+...+...+..+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 010 0111111 1111122222233333332 22457
Q ss_pred eeeccCCCCCeEECCCCcEEEeeccCccc
Q 042831 474 VVHRDIKSSNIMLDSNFNAKIGDFGLARL 502 (645)
Q Consensus 474 ivH~Dlkp~NILld~~~~~kl~DfGla~~ 502 (645)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.67 E-value=0.013 Score=59.49 Aligned_cols=75 Identities=16% Similarity=0.194 Sum_probs=50.3
Q ss_pred CCccCcCCcEEEEEEEEcCC-------CeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCc-cEEEeeeeeCCeEEEEE
Q 042831 357 DQKLGQGGFGGVYKGFFRET-------NSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRNL-VQLLGWCHEKKELLLVY 428 (645)
Q Consensus 357 ~~~LG~G~fG~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nl-v~l~~~~~~~~~~~lV~ 428 (645)
.+.|+.|-.=.+|+....+. ...|.+++... . .......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35688888899999987532 35566666542 2 223455678888888853344 477777753 6899
Q ss_pred EecCCCChh
Q 042831 429 EFMPNGSLD 437 (645)
Q Consensus 429 Ey~~~gsL~ 437 (645)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.52 E-value=0.13 Score=49.71 Aligned_cols=156 Identities=11% Similarity=0.031 Sum_probs=81.5
Q ss_pred cChHHHHHhhcCCCCCCcc-----CcCCcEEEEEEEEcCCCeEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-----c
Q 042831 342 FPYKELALATNDFNDDQKL-----GQGGFGGVYKGFFRETNSYIAVKRVSQGSKQGIKEYASEVKIISRLRHRN-----L 411 (645)
Q Consensus 342 ~~~~el~~~~~~f~~~~~L-----G~G~fG~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-----l 411 (645)
.+.+|+.....+|...+.. ..|---+.|+....+ | .+++|+..... ..+++..|++++..|.+.+ .
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4556677777777664443 355557789987654 4 48899875432 2234455677777764322 2
Q ss_pred cEEE-e--eeeeCCeEEEEEEecCCCChhhh--------------hhh--cC-------CCCCH----------------
Q 042831 412 VQLL-G--WCHEKKELLLVYEFMPNGSLDSH--------------LFK--EN-------SLLTW---------------- 449 (645)
Q Consensus 412 v~l~-~--~~~~~~~~~lV~Ey~~~gsL~~~--------------l~~--~~-------~~l~~---------------- 449 (645)
+... | +.........++.+..+...... ++. .. ....+
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 2111 0 12234556677777765433210 000 00 00000
Q ss_pred -HHHHHHHHHHHHHHHHHH-hhcCCCeeeccCCCCCeEECCCCcEEEeeccCcc
Q 042831 450 -EFRYKIAQDLASGLLYLQ-EEWEQCVVHRDIKSSNIMLDSNFNAKIGDFGLAR 501 (645)
Q Consensus 450 -~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlkp~NILld~~~~~kl~DfGla~ 501 (645)
......+..+...+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111112222222211 1235679999999999999988777899999875
|